PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Thompson, JK; Peterson, MR; Freeman, RD				Thompson, JK; Peterson, MR; Freeman, RD			Single-neuron activity and tissue oxygenation in the cerebral cortex	SCIENCE			English	Article							SENSORY STIMULATION; BLOOD OXYGENATION; FUNCTIONAL MRI; BRAIN; ACTIVATION; SIGNAL; FMRI; COLUMNS	Blood oxygen level-dependent functional magnetic resonance imaging uses alterations in brain hemodynamics to infer changes in neural activity. Are these hemodynamic changes regulated at a spatial scale capable of resolving functional columns within the cerebral cortex? To address this question, we made simultaneous measurements of tissue oxygenation and single-cell neural activity within the visual cortex. Results showed that increases in neuronal spike rate were accompanied by immediate decreases in tissue oxygenation. We used this decrease in tissue oxygenation to predict the orientation selectivity and ocular dominance of neighboring neurons. Our results establish a coupling between neural activity and oxidative metabolism and suggest that high-resolution functional magnetic resonance imaging may be used to localize neural activity at a columnar level.	Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen WIllis Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.				NATIONAL EYE INSTITUTE [R01EY001175, P30EY003176, T32EY007043] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY 07043-24, EY03176, EY01175] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cannestra AF, 2001, CEREB CORTEX, V11, P773, DOI 10.1093/cercor/11.8.773; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; FATT I, 1976, POLAROGRAPHIC OXYGEN, P197; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; Kanaiwa H, 1995, SURG NEUROL, V44, P172, DOI 10.1016/0090-3019(95)00126-3; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Mayhew J, 1999, NEUROIMAGE, V10, P304, DOI 10.1006/nimg.1999.0460; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Yacoub E, 2001, NMR BIOMED, V14, P408, DOI 10.1002/nbm.715; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	21	251	252	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1070	1072		10.1126/science.1079220	http://dx.doi.org/10.1126/science.1079220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586942				2022-12-01	WOS:000180960000049
J	Moller, PR; Nielsen, JG; Fossen, I				Moller, PR; Nielsen, JG; Fossen, I			Fish migration: Patagonian toothfish found off Greenland - This catch is evidence of transequatorial migration by a cold-water Antarctic fish	NATURE			English	Article									Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark; More Res, Sect Fisheries, N-6021 Alesund, Norway	University of Copenhagen	Moller, PR (corresponding author), Univ Copenhagen, Zool Museum, DK-2100 Copenhagen O, Denmark.		Møller, Peter/A-8807-2013	Møller, Peter/0000-0002-0177-0977				AGNEW D, 2002, IUCN SSC WILDLIFE TR; ANDRIASHEV AP, 1991, POLAR BIOL, V11, P213; [Anonymous], 1953, ZOOGEOGRAPHY SEA; Balushkin A.V., 2000, J ICHTHYOL+, V40, P74; Dewitt H.H., 1990, P279; DIETRICH G, 1968, ATLAS OCEANOGRAPHIE; Eastman J.T., 1990, P34; Hilbish TJ, 2000, MAR BIOL, V136, P69, DOI 10.1007/s002270050010; Wienecke B, 2002, FISH RES, V54, P253, DOI 10.1016/S0165-7836(00)00307-6; WILLIAMS R, 2002, J SCI COMMITTEE COMM, V9, P33	10	29	31	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					599	599		10.1038/421599a	http://dx.doi.org/10.1038/421599a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571586				2022-12-01	WOS:000180803200031
J	Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM				Munoz, N; Bosch, FX; de Sanjose, S; Herrero, R; Castellsague, X; Shah, KV; Snijders, PJF; Meijer, CJLM		Int Agcy Res Canc Multicenter Cerv	Epidemiologic classification of human papillomavirus types associated with cervical cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; INFECTION; PCR; IDENTIFICATION; HYBRIDIZATION; NEOPLASIA	Background: Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed. Methods: We pooled data from 11 case-control studies from nine countries involving 1918 women with histologically confirmed squamous-cell cervical cancer and 1928 control women. A common protocol and questionnaire were used. Information on risk factors was obtained by personal interviews, and cervical cells were collected for detection of HPV DNA and typing in a central laboratory by polymerase-chain-reaction-based assays (with MY09/MY11 and GP5+/6+ primers). Results: HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent) and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The most common HPV types in patients, in descending order of frequency, were types 16, 18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and 33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio for cervical cancer associated with the presence of any HPV was 158.2 (95 percent confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common and least common HPV types. Fifteen HPV types were classified as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic classification and the classification based on phylogenetic grouping. Conclusions: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.	Int Agcy Res Canc, F-69372 Lyon, France; Hosp Llobregat, Epidemiol & Canc Registrat Unit, Inst Catalad Oncol, Barcelona, Spain; Costa Rican Fdn Hlth Sci, San Jose, Costa Rica; Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	World Health Organization; International Agency for Research on Cancer (IARC); Catalan Institute of Oncology; University of Barcelona; Johns Hopkins University; Vrije Universiteit Amsterdam	Munoz, N (corresponding author), Hosp Duran & Reynals, Inst Catalad Oncol, Serv Epidemiol & Registre Canc, Epidemiol & Canc Registrat Unit, Av Gran Via,S-N Km 2 7, Barcelona 08907, Spain.	cris@ico.scs.es	Eluf-Neto, Jose/B-2522-2009; JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; Pique, Xavier Castellsagué/N-5795-2014; de Sanjosé Llongueras, Silvia/H-6339-2014	Eluf-Neto, Jose/0000-0001-7504-2115; JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; Pique, Xavier Castellsagué/0000-0002-0802-3595; 				Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Breslow NE., 1980, IARC SCI PUBLICATION, V32; Chaouki N, 1998, INT J CANCER, V75, P546, DOI 10.1002/(SICI)1097-0215(19980209)75:4&lt;546::AID-IJC9&gt;3.0.CO;2-T; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Davies P, 2001, BEST PRACT RES CL OB, V15, P677, DOI 10.1053/beog.2001.0214; de Sanjose S, 1999, DIAGN MOL PATHOL, V8, P26, DOI 10.1097/00019606-199903000-00005; De Villiers E-M, 2001, PAPILLOMAVIRUS REP, V12, P57; DURST M, 1987, ONCOGENE, V1, P251; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; *INT AG RES CANC, 1995, IARC MON EV CARC RIS, V64; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901, DOI 10.1128/JCM.33.4.901-905.1995; Kjaer SK, 1996, INT J CANCER, V65, P601, DOI 10.1002/(SICI)1097-0215(19960301)65:5<601::AID-IJC8>3.0.CO;2-6; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; MANOS MM, 1989, CANCER CEL, V7, P209; McDougall J K, 1994, Curr Top Microbiol Immunol, V186, P101; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; Myers G, 1997, HUMAN PAPILLOMAVIRUS; Ngelangel C, 1998, JNCI-J NATL CANCER I, V90, P43, DOI 10.1093/jnci/90.1.43; Rolon PA, 2000, INT J CANCER, V85, P486, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;486::AID-IJC7&gt;3.0.CO;2-S; Santos C, 2001, BRIT J CANCER, V85, P966, DOI [10.1038/sj.bjc.6691948, 10.1054/bjoc.2001.1948]; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	31	4365	4779	12	484	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					518	527		10.1056/NEJMoa021641	http://dx.doi.org/10.1056/NEJMoa021641			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571259	Green Published			2022-12-01	WOS:000180801400005
J	Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE				Moll, AC; Imhof, SM; Cruysberg, JRM; Schouten-van Meeteren, AYN; Boers, M; van Leeuwen, FE			Incidence of retinoblastoma in children born after in-vitro fertilisation	LANCET			English	Article							FERTILIZATION; CANCER	Every year, 3000 women in the Netherlands are treated with in-vitro fertilisation (IVF), and results from studies suggest that the offspring of these women do not have a heightened risk of cancer. Between November, 2000, and February, 2002, we diagnosed retinoblastoma in five patients born after IVF. To calculate the relative risk of the disease, we assumed that the proportion of children conceived by IVF in the Netherlands is between 1.0 and 1.5%, and that the five patients who we diagnosed with the disease represent all new cases in the Netherlands during that period. Relative risks for retinoblastoma were significantly raised (7.2 [95% CI 2.4-17.0], and 4.9 [1.6-11.3], for 1% and 1.5% rates, respectively). This possible association of an increased risk of retinoblastoma in a population-based study needs to be established.	Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Paediat Oncol, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; Univ Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Netherlands Cancer Institute	Moll, AC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, NL-1081 HV Amsterdam, Netherlands.	a.moll@vumc.nl	Cruysberg, Johannes R. M./D-4313-2009	Cruysberg, Johannes R. M./0000-0002-5330-0774				Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Klip H, 2001, HUM REPROD, V16, P2451, DOI 10.1093/humrep/16.11.2451; Koudstaal J, 1999, Ned Tijdschr Geneeskd, V143, P2375; Moll AC, 1997, BRIT J OPHTHALMOL, V81, P559, DOI 10.1136/bjo.81.7.559	5	211	227	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					309	310		10.1016/S0140-6736(03)12332-X	http://dx.doi.org/10.1016/S0140-6736(03)12332-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559867				2022-12-01	WOS:000180643900014
J	Hung, J; Beilby, JP; Knuiman, MW; Divitini, M				Hung, J; Beilby, JP; Knuiman, MW; Divitini, M			Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; SERUM FOLATE; HOMOCYSTEINE; HEALTH; ATHEROSCLEROSIS; HOMOCYST(E)INE; DIET	Objective To test the hypothesis that the incidence of fatal coronary heart disease and cardiovascular disease in a general population is related to serum and red cell folate and vitamin B-12 concentrations. Design Cohort study with follow up of 29 years. Setting Busselton, Western Australia. Participants 1419 men and 1531 women aged 20 to 90 years, who were alive more than three years after their participation in the 1969 Busselton health survey. 2314 (78.4%) had no cardiovascular disease at the initial survey. Main outcome measures Hazard. ratios for fatal coronary heart disease and cardiovascular disease in men and women according to baseline concentrations of serum and red cell folate and serum vitamin B-12. Results 213 men and 159 women died from coronary heart disease, and 342 men and 302 women died from cardiovascular disease. Serum and red cell folate concentrations showed a moderate positive correlation (r=0.26, P<0.001) but other-wise serum and red cell folate and serum B-12 concentrations were not strongly correlated with each other or with other standard risk factors. After age and standard risk factors were adjusted for, there was no independent association between folate and B-12 concentrations and death from coronary heart disease or cardiovascular disease in the full cohort or the subcohort with no cardiovascular disease at baseline. The multivariate adjusted hazard ratio for death from cardiovascular disease in the lowest versus the highest category of red cell folate concentration was 1.05 (95% confidence interval 0.77 to 1.43) in men and 1.10 (0.81 to 1.51) in women. Conclusions These findings do not support the hypothesis that lower folate and B-12 concentrations increase the risk of fatal cardiovascular disease in a general population. The routine use of these vitamins for preventing cardiovascular disease should await evidence from clinical trials.	Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia; Univ Western Australia, Sir Charles Gairdner Hosp, Dept Med, Nedlands, WA 6009, Australia; QEII Med Ctr, PathCtr, Nedlands, WA 6009, Australia; Univ Western Australia, Dept Publ Hlth, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Hung, J (corresponding author), Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia.		Knuiman, Matthew W/I-5549-2013	Knuiman, Matthew/0000-0001-8874-2305; Beilby, John/0000-0002-4915-2254				BABIOR BM, 2001, WILLIAMS HEMATOLOGY, P425; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; ChasanTaber L, 1996, J AM COLL NUTR, V15, P136; Clarke R, 1998, J Cardiovasc Risk, V5, P249, DOI 10.1097/00043798-199808000-00007; CULLEN KJ, 1972, MED J AUSTRALIA, V2, P714, DOI 10.5694/j.1326-5377.1972.tb103506.x; Davis R. E., 1979, Proceedings of the Nutrition Society of Australia, V4, P45; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Ford ES, 1998, INT J EPIDEMIOL, V27, P592, DOI 10.1093/ije/27.4.592; Knuiman M W, 1996, J Cardiovasc Risk, V3, P447; KNUIMAN MW, 1995, AUST J PUBLIC HEALTH, V19, P375; Knuiman MW, 1998, AUST NZ J PUBL HEAL, V22, P747, DOI 10.1111/j.1467-842X.1998.tb01487.x; Knuiman MW, 1997, J EPIDEMIOL COMMUN H, V51, P515, DOI 10.1136/jech.51.5.515; Lonn E, 2001, J AM COLL CARDIOL, V38, P1795, DOI 10.1016/S0735-1097(01)01626-6; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; MILLBANK L, 1970, J CLIN PATHOL, V23, P54, DOI 10.1136/jcp.23.1.54; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; UBBINK JB, 1994, NUTR REV, V52, P383, DOI 10.1111/j.1753-4887.1994.tb01369.x; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; WELBORN TA, 1969, AM J EPIDEMIOL, V89, P521, DOI 10.1093/oxfordjournals.aje.a120965	23	39	40	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					131	134		10.1136/bmj.326.7381.131	http://dx.doi.org/10.1136/bmj.326.7381.131			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531843	Bronze, Green Published			2022-12-01	WOS:000180575900022
J	Reilly, SM; White, TD				Reilly, SM; White, TD			Hypaxial motor patterns and the function of epipubic bones in primitive mammals	SCIENCE			English	Article							LOCOMOTION; MUSCLES; WALKING	Since the first description of epipubic bones in 1698, their functions and those of the associated abdominal muscles of monotremes and marsupial mammals have remained unresolved. We show that each epipubic bone is part of a kinetic linkage extending from the femur, by way of the pectineus muscle, to the epipubic bone, through the pyramidalis and rectus abdominis muscles on one side of the abdomen, and through the contralateral external and internal oblique muscles to the vertebrae and ribs of the opposite side. This muscle series is activated synchronously as the femur and contralateral forelimb are retracted during the stance phase in locomotion. The epipubic bone acts as a lever that is retracted ( depressed) to stiffen the trunk between the diagonal limbs that support the body during each step. This cross-couplet kinetic linkage and the stiffening function of the epipubic bone appear to be the primitive conditions for mammals.	Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA	University System of Ohio; Ohio University; State University of New York (SUNY) System; Buffalo State College	Reilly, SM (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	reilly@ohiou.edu						Bennett WO, 2001, J EXP BIOL, V204, P1979; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1993, J EXP BIOL, V180, P75; Fife MM, 2001, J EXP BIOL, V204, P2371; FOURIE S, 1963, NATURE, V198, P201, DOI 10.1038/198201a0; Gambaryan P.P., 1974, MAMMALS RUN ANATOMIC; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; JENKINS FA, 1970, EVOLUTION, V24, P230, DOI 10.1111/j.1558-5646.1970.tb01756.x; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; OWEN R, 1943, P ZOOL SOC LOND 1843, P148; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Ritter D, 1996, J EXP BIOL, V199, P2499; Tyson, 1698, PHIL T R SOC, V239, P105, DOI [10.1098/rstl.1698.0023, DOI 10.1098/RSTL.1698.0023]; VAUGHN PETER PAUL, 1956, JOUR ELISHA MITCHELL SCI SOC, V72, P243; WHITE TD, 1989, J THEOR BIOL, V139, P343, DOI 10.1016/S0022-5193(89)80213-9; WHITE TD, 1990, J MAMMAL, V71, P79, DOI 10.2307/1381321	17	25	27	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					400	402		10.1126/science.1074905	http://dx.doi.org/10.1126/science.1074905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532019				2022-12-01	WOS:000180426800047
J	Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR				Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR			Lung, cancer screening with helical computed tomography in older adult smokers - A decision and cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING CESSATION; ACTION PROJECT; SURVIVAL; ASPIRATION; SURGERY; UTILITY; PROGRAM; SCANNER; STATES; BIOPSY	Context Encouraged by direct-to-consumer marketing, smokers and-their physicians are contemplating lung cancer screening with a promising but unproven imaging procedure, helical computed tomography (CT). Objective To estimate the potential benefits, harms, and cost-effectiveness of lung cancer screening with helical CT in various efficacy scenarios. Design, Setting, and Population Using a computer-simulated model, we compared annual helical CT screening to no screening for hypothetical cohorts of 100000 current, quitting, and former heavy smokers, aged 60 years, of whom 55% were men. We simulated efficacy by changing the clinical stage distribution of lung cancers so that the screened group would have fewer advanced-stage cancers and more localized-stage cancers than the nonscreened group (ie, a stage shift). Our model incorporated known biases in screening programs such as lead time, length, and overdiagnosis bias. Main Outcome Measures We measured the benefits of screening by comparing the absolute and relative difference in lung cancer-specific deaths. We measured harms by the number of false-positive invasive tests or surgeries per 100000 and incremental cost-effectiveness in US dollars per quality-adjusted life-year (QALY) gained. Results Over a 20-year period, assuming a 50% stage shift, the current heavy smoker cohort had 553 fewer lung cancer deaths (13% lung cancer-specific mortality reduction) and 1186 false-positive invasive procedures per 100000 persons. The incremental cost-effectiveness for current smokers was $116300 per QALY gained. For quitting and former smokers, the incremental cost-effectiveness was $558600 and $2322700 per QALY gained, respectively. Other than the degree of stage shift, the most influentia parameters were adherence to screening, degree of length or overdiagnosis bias in the first year of screening, quality of life of persons with screen-detected localized lung cancers, cost of helical CT, and anxiety about indeterminate nodule diagnoses. In 1-way sensitivity analyses, none of these parameters was sufficient to make screening highly cost-effective for any of the cohorts. In multiway sensitivity analyses, a program screening current smokers was $42 500 per QALY gained if extremely favorable estimates were used for all of the influential parameters simultaneously. Conclusion Even if efficacy is eventually proven, screening must overcome multiple additional barriers to be highly cost-effective. Given the current uncertainty of benefits, the harms from invasive testing, and the high costs associated with screening, direct-to-consumer marketing of helical CT is not advisable.	Johns Hopkins Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; MEDTAP Int, Bethesda, MD 20814 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Mahadevia, PJ (corresponding author), MEDTAP Int, 7101 Wisconsin Ave, Bethesda, MD 20814 USA.		Lee A, Fleisher/Q-9894-2019	Goodman, Steven/0000-0002-3872-5723; Frick, Kevin/0000-0002-0178-5319				*AM MED ASS, 1998, 1998 NAT PHYS FREE S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BRICE J, 2000, DIAGN IMAGING SAN FR, V22, P44; Burns DM, 2000, CANCER, V89, P2506, DOI 10.1002/1097-0142(20001201)89:11+<2506::AID-CNCR33>3.3.CO;2-#; Celik M, 1998, EUR J CARDIO-THORAC, V14, P113, DOI 10.1016/S1010-7940(98)00167-5; DECAMP MM, 1995, J AM COLL SURGEONS, V181, P113; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; EDDY DM, 1990, ANN INTERN MED, V112, P73, DOI 10.7326/0003-4819-112-1-73; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Fry WA, 1999, CANCER, V86, P1867, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9; Grannis FW, 2002, CHEST, V121, P1388, DOI 10.1378/chest.121.5.1388; Gurley MB, 1998, RADIOLOGY, V209, P717, DOI 10.1148/radiology.209.3.9844664; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2000, RADIOL CLIN N AM, V38, P487, DOI 10.1016/S0033-8389(05)70179-2; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hillner BE, 1996, SEMIN ONCOL, V23, P25; HULKA BS, 1986, J OCCUP ENVIRON MED, V28, P687, DOI 10.1097/00043764-198608000-00030; Jaklitsch MT, 1996, CHEST, V110, P751, DOI 10.1378/chest.110.3.751; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; KOLATA G, 2001, NY TIMES        0720, pA1; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LERNER BH, 2002, NY TIMES        0305, pD6; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; MELAMED MR, 1987, SURG CLIN N AM, V67, P909; *NAT ALL CAR AM AS, 2001, CAR US FIND NAT SURV; *NAT CANC I, 2001, DEVC PROB DEV DYING; *NAT CANC I, 2001, SURV EP END RES SEER; *NAT CANC I AM CAN, 2001, EARL LUNG CANC SCREE; Palmisano WA, 2000, CANCER RES, V60, P5954; Patz EF, 2000, NEW ENGL J MED, V343, P1627, DOI 10.1056/NEJM200011303432208; Patz EF, 2000, CHEST, V117, P1568, DOI 10.1378/chest.117.6.1568; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; SAGEL SS, 1978, ANN THORAC SURG, V26, P399, DOI 10.1016/S0003-4975(10)62917-7; SHAH SS, 1992, RESPIRATION, V59, P243; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; *THOMS HEALTHC, 2001, RED BOOK DRUG TOP 20; TOCKMAN MS, 1986, CHEST S, V89, P324; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; *TREEAG INC, 2002, DAT PRO COMP PROGR V; Trippoli S, 2001, PHARMACOECONOMICS, V19, P855, DOI 10.2165/00019053-200119080-00007; WALTER SD, 1992, CANCER CAUSE CONTROL, V3, P115, DOI 10.1007/BF00051651; 2000, ONCOL NEWS INT, V9, P1	50	248	252	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					313	322		10.1001/jama.289.3.313	http://dx.doi.org/10.1001/jama.289.3.313			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525232	Bronze			2022-12-01	WOS:000180345100026
J	Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W				Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W			Parc: A cytoplasmic anchor for p53	CELL			English	Article							WILD-TYPE P53; NUCLEAR EXPORT SIGNAL; TUMOR-SUPPRESSOR P53; RING-FINGER DOMAIN; COLORECTAL ADENOCARCINOMA; MDM2-MEDIATED DEGRADATION; DNA-DAMAGE; PROTEIN; MDM2; UBIQUITINATION	Nuclear localization of p53 is essential for its tumor suppressor function. Here, we have identified Parc, a Parkin-like ubiquitin ligase, as a cytoplasmic anchor protein in p53-associated protein complexes. Parc directly interacts and forms a similar to1 MDa complex with p53 in the cytoplasm of unstressed cells. In the absence of stress, inactivation of Parc induces nuclear localization of endogenous p53 and activates p53-dependent apoptosis. Overexpression of Parc promotes cytoplasmic sequestration of ectopic p53. Furthermore, abnormal cytoplasmic localization of p53 was observed in a number of neuroblastoma cell lines; RNAi-mediated reduction of endogenous Parc significantly sensitizes these neuroblastoma cells in the DNA damage response. These results reveal that Parc is a critical regulator in controlling p53 subcellular localization and subsequent function.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Nikolaev, Anatoly/0000-0003-2818-5839				BOSARI S, 1995, AM J PATHOL, V147, P790; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elela Sherif Abou, 1997, Cancer Letters, V117, P23; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GANNON JV, 1991, NATURE, V349, P802; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	47	307	324	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					29	40		10.1016/S0092-8674(02)01255-2	http://dx.doi.org/10.1016/S0092-8674(02)01255-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526791	Bronze			2022-12-01	WOS:000181191500004
J	Check, E				Check, E			Biologists seek blueprint for international stem-cell effort	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102b	http://dx.doi.org/10.1038/421102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520271	Bronze			2022-12-01	WOS:000180267200009
J	Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB				Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB			Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; REGULAR DRINKERS; CONTROLLED TRIAL; BRITISH MEN; CONSUMPTION; RISK; WINE; BEER; MORTALITY	BACKGROUND: Although moderate drinking confers a decreased risk of myocardial infarction, the roles of the drinking pattern and type of beverage remain unclear. METHODS: We studied the association of alcohol consumption with the risk of myocardial infarction among 38,077 male health professionals who were free of cardiovascular disease and cancer at base line. We assessed the consumption of beer, red wine, white wine, and liquor individually every four years using validated food-frequency questionnaires. We documented cases of nonfatal myocardial infarction and fatal coronary heart disease from 1986 to 1998. RESULTS: During 12 years of follow-up, there were 1418 cases of myocardial infarction. As compared with men who consumed alcohol less than once per week, men who consumed alcohol three to four or five to seven days per week had decreased risks of myocardial infarction (multivariate relative risk, 0.68 [95 percent confidence interval, 0.55 to 0.84] and 0.63 [95 percent confidence interval, 0.54 to 0.74], respectively). The risk was similar among men who consumed less than 10 g of alcohol per drinking day and those who consumed 30 g or more. No single type of beverage conferred additional benefit, nor did consumption with meals. A 12.5-g increase in daily alcohol consumption over a four-year follow-up period was associated with a relative risk of myocardial infarction of 0.78 (95 percent confidence interval, 0.62 to 0.99). CONCLUSIONS: Among men, consumption of alcohol at least three to four days per week was inversely associated with the risk of myocardial infarction. Neither the type of beverage nor the proportion consumed with meals substantially altered this association. Men who increased their alcohol consumption by a moderate amount during follow-up had a decreased risk of myocardial infarction.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Sydney; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY-303, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Mukamal, Kenneth/GVR-7978-2022	Camargo, Carlos A./0000-0002-5071-7654; Mittleman, Murray/0000-0001-9788-7274; Conigrave, Katherine/0000-0002-6428-1441	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA00299, AA11181] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABE H, 1994, CIRCULATION, V89, P2626, DOI 10.1161/01.CIR.89.6.2626; *AM CANC SOC, 2002, ALC CANC; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; [Department of Agriculture US Department of Health and Human Services], 2000, HOM GARD B, V232; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GOLDBERG RJ, 1994, CIRCULATION, V89, P651, DOI 10.1161/01.CIR.89.2.651; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; JACKSON R, 1992, AM J EPIDEMIOL, V136, P819, DOI 10.1093/aje/136.7.819; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; MIKHAILIDIS DP, 1990, ALCOHOL, V7, P171, DOI 10.1016/0741-8329(90)90080-V; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; *NUTR DAT LAB, 1999, USDA NUTR DAT STAND; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Rehm J, 2001, AM J EPIDEMIOL, V153, P64, DOI 10.1093/aje/153.1.64; RENAUD SC, 1992, AM J CLIN NUTR, V55, P1012, DOI 10.1093/ajcn/55.5.1012; Rimm E, 2001, EPIDEMIOLOGY, V12, P380, DOI 10.1097/00001648-200107000-00006; Rimm EB, 1996, AM J EPIDEMIOL, V143, P1094; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Rose GA., 1982, WHO MONOGRAPH SERIES, V58; Sesso HD, 2000, ARCH INTERN MED, V160, P2605, DOI 10.1001/archinte.160.17.2605; SHAPER AG, 1988, LANCET, V2, P1267; SHAPER AG, 1987, BMJ-BRIT MED J, V294, P733, DOI 10.1136/bmj.294.6574.733; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TASKINEN MR, 1985, METABOLISM, V34, P112, DOI 10.1016/0026-0495(85)90118-0; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Wouters S, 2000, AM J EPIDEMIOL, V151, P1189, DOI 10.1093/oxfordjournals.aje.a010169	37	566	590	0	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					109	118		10.1056/NEJMoa022095	http://dx.doi.org/10.1056/NEJMoa022095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519921				2022-12-01	WOS:000180263900003
J	Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S				Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S			Larval stages of a living sea lily (stalked crinoid echinoderm)	NATURE			English	Article							RADIATION	The embryos and larvae of stalked crinoids, which are considered the most basal group of extant echinoderms(1,2), have not previously been described. In contrast, much is known about the development of the more accessible stalkless crinoids (feather stars)(3), which are phylogenetically derived from stalked forms(4). Here we describe the development of a sea lily from fertilization to larval settlement. There are two successive larval stages: the first is a non-feeding auricularia stage with partly longitudinal ciliary bands (similar to the auricularia and bipinnaria larvae of holothurian and asteroid echinoderms, respectively); the second is a doliolaria larva with circumferential ciliary bands (similar to the earliest larval stage of stalkless crinoids). We suggest that a dipleurula-type larva is primitive for echinoderms and is the starting point for the evolution of additional larval forms within the phylum. From a wider evolutionary viewpoint, the demonstration that the most basal kind of echinoderm larva is a dipleurula is consistent with Garstang's auricularia theory(5) for the phylogenetic origin of the chordate neural tube.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Amemiya, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bldg FSB-501,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		拓, 日比野/D-8115-2013; Oji, Tatsuo/A-1840-2009	拓, 日比野/0000-0002-4789-7375; Oji, Tatsuo/0000-0002-1034-1111				Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; GARSTANG W, 1894, ZOOL ANT, V17, P122; Gee C. H. R., COMMUNICATION; HENDLER G, 1991, REPRODUCTION MARINE, V6, P355; Holland N. D, 1991, REPROD MARINE INVERT, V4, P247; Hyman L.H., 1955, INVERTEBRATES, V4; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; LACALLI TC, 1986, J EMBRYOL EXP MORPH, V96, P303; Metschnikoff E, 1881, ZOOL ANZ, V4, p[139, 153]; Nielsen C., 1995, ANIMAL EVOLUTION; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Smiley S., 1991, P663; Strathmann R., 1974, Thalassia Jugosl, V10, P321	13	86	89	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					158	160		10.1038/nature01236	http://dx.doi.org/10.1038/nature01236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520300				2022-12-01	WOS:000180267200038
J	Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S				Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S			Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin	SCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; MATERNAL-BEHAVIOR; NULL MUTATION; INSECT BRAIN; RECEPTOR; MOUSE; MECHANISMS; RAT	Neurogenesis occurs in the olfactory system of the adult brain throughout life, in both invertebrates and vertebrates, but its physiological regulation is not understood. We show that the production of neuronal progenitors is stimulated in the forebrain subventricular zone of female mice during pregnancy and that this effect is mediated by the hormone prolactin. The progenitors then migrate to produce new olfactory interneurons, a process likely to be important for maternal behavior, because olfactory discrimination is critical for recognition and rearing of offspring. Neurogenesis occurs even in females that mate with sterile males. These findings imply that forebrain olfactory neurogenesis may contribute to adaptive behaviors in mating and pregnancy.	Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Cross, James/F-4814-2011; Cross, James/AAU-2973-2020	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Bridges RS, 2001, ENDOCRINOLOGY, V142, P730, DOI 10.1210/en.142.2.730; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; DIAZRUIZ C, 1993, NEUROSCI LETT, V164, P44, DOI 10.1016/0304-3940(93)90853-D; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Exton MS, 2001, PSYCHONEUROENDOCRINO, V26, P287, DOI 10.1016/S0306-4530(00)00053-6; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Harzsch S, 1999, J NEUROSCI, V19, P3472; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hull KL, 1998, COMP BIOCHEM PHYS C, V119, P389, DOI 10.1016/S0742-8413(98)00010-3; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roky R, 1996, NEUROENDOCRINOLOGY, V63, P422, DOI 10.1159/000127067; Schmidt M, 1997, BRAIN RES, V762, P131, DOI 10.1016/S0006-8993(97)00376-4; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001	43	520	541	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					117	120		10.1126/science.1076647	http://dx.doi.org/10.1126/science.1076647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511652				2022-12-01	WOS:000180165800048
J	Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE				Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE			Uncoupling of initiation factor eIF5B/IF2 GTPase and translational activities by mutations that lower ribosome affinity	CELL			English	Article							ELONGATION-FACTOR G; TRANSFER-RNA; LATE EVENTS; FACTOR IF2; BINDING; HYDROLYSIS; VISUALIZATION; MECHANISM; SUBUNITS; SWITCH	Translation initiation factor eIF5B/IF2 is a GTPase that promotes ribosomal subunit joining. We show that eIF5B mutations in Switch I, an element conserved in all GTP binding domains, impair GTP hydrolysis and general translation but not eIF5B subunit joining function. Intragenic suppressors of the Switch I mutation restore general translation, but not eIF5B GTPase activity. These suppressor mutations reduce the ribosome affinity of eIF5B and increase AUG skipping/leaky scanning. The uncoupling of translation and eIF5B GTPase activity suggests a regulatory rather than mechanical function for eIF5B GTP hydrolysis in translation initiation. The translational defect suggests eIF5B stabilizes Met-tRNAi(Met) binding and that GTP hydrolysis by eIF5B is a checkpoint monitoring 80S ribosome assembly in the final step of translation initiation.	NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Dever, TE (corresponding author), NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@box-t.nih.gov	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678; Lorsch, Jon/0000-0002-4521-4999; Burley, Stephen/0000-0002-2487-9713; Roll-Mecak, Antonina/0000-0003-2621-7307	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128, R01GM061262] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62128, GM61262] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LaTeana A, 1996, J MOL BIOL, V256, P667; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	33	95	97	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1015	1025		10.1016/S0092-8674(02)01171-6	http://dx.doi.org/10.1016/S0092-8674(02)01171-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507428	Bronze			2022-12-01	WOS:000180086000011
J	Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC				Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC			MEP-1 and a homolog of the NURD complex component Mi-2 act together to maintain germline-soma distinctions in C-elegans	CELL			English	Article							ZYGOTIC GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLYCOMB GROUP; HISTONE DEACETYLASE; RNA INTERFERENCE; MATERNAL CONTROL; PROTEIN; LINE; PIE-1; MES-3	A rapid cascade of regulatory events defines the developmental fates of embryonic cells. However, once established, these developmental fates and the underlying transcriptional programs can be remarkably stable. Here, we describe two proteins, MEP-1 and LET-418/Mi-2, required for maintenance of somatic differentiation in C. elegans. In animals lacking MEP-1 and LET-418, germline-specific genes become derepressed in somatic cells, and Polycomb group (PcG) and SET domain-related proteins promote this ectopic expression. MEP-1 and LET-418 interact in vivo with the germline-protein PIE-1. Our findings support a model in which PIE-1 inhibits MEP-1 and associated factors to maintain the pluripotency of germ cells, while at later times MEP-1 and LET-418 remodel chromatin to establish new stage- or cell-type-specific differentiation potential.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		/0000-0001-7230-1767	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033769, R01HD036247] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36247, HD33769] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Belfiore M, 2002, RNA, V8, P725, DOI 10.1017/S1355838202028595; BOWERMAN B, 1993, CELL, V74, P443, DOI 10.1016/0092-8674(93)80046-H; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; DEMBURG AF, 2002, CELL, V111, P159; EPSTEIN RJ, 1988, CYTOMETRY, V9, P349, DOI 10.1002/cyto.990090412; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Garvin C, 1998, GENETICS, V148, P167; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Holdeman R, 1998, DEVELOPMENT, V125, P2457; James P, 1996, GENETICS, V144, P1425; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kelly WG, 2002, DEVELOPMENT, V129, P479; Korf I, 1998, DEVELOPMENT, V125, P2469; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; Lukacsovich T, 2001, GENETICS, V157, P727; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; PAULSEN JE, 1995, GENETICS, V141, P1383; Pirrotta V, 2002, CELL, V110, P661, DOI 10.1016/S0092-8674(02)00967-4; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Van Doren M, 1998, CURR BIOL, V8, P243; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xu L, 2001, GENETICS, V159, P1019; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	44	148	178	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					991	1002		10.1016/S0092-8674(02)01202-3	http://dx.doi.org/10.1016/S0092-8674(02)01202-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507426	Bronze			2022-12-01	WOS:000180086000009
J	Reader, JS; Joyce, GF				Reader, JS; Joyce, GF			A ribozyme composed of only two different nucleotides	NATURE			English	Article							RNA; CYTIDINE; DNA	RNA molecules are thought to have been prominent in the early history of life on Earth because of their ability both to encode genetic information and to exhibit catalytic function(1). The modern genetic alphabet relies on two sets of complementary base pairs to store genetic information. However, owing to the chemical instability of cytosine, which readily deaminates to uracil(2), a primitive genetic system composed of the bases A, U, G and C may have been difficult to establish. It has been suggested that the first genetic material instead contained only a single base-pairing unit(3-7). Here we show that binary informational macromolecules, containing only two different nucleotide sub-units, can act as catalysts. In vitro evolution was used to obtain ligase ribozymes composed of only 2,6-diaminopurine and uracil nucleotides, which catalyse the template-directed joining of two RNA molecules, one bearing a 5'-triphosphate and the other a 3'-hydroxyl. The active conformation of the fastest isolated ribozyme had a catalytic rate that was about 36,000-fold faster than the uncatalysed rate of reaction. This ribozyme is specific for the formation of biologically relevant 3',5'-phosphodiester linkages.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu						CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Gesteland R. F., 1999, RNA WORLD; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; McGinness KE, 2002, CHEM BIOL, V9, P585, DOI 10.1016/S1074-5521(02)00136-9; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORO J, 1961, NATURE, V191, P1193, DOI 10.1038/1911193a0; Plaxco KW, 1998, CURR OPIN STRUC BIOL, V8, P80, DOI 10.1016/S0959-440X(98)80013-4; Rich A., 1962, HORIZONS BIOCH, P103; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; SANCHEZ RA, 1968, J MOL BIOL, V38, P121, DOI 10.1016/0022-2836(68)90132-0; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; WACHTERSHAUSER G, 1988, P NATL ACAD SCI USA, V85, P1134, DOI 10.1073/pnas.85.4.1134; ZUBAY G, 1991, CHEMTRACTS, V2, P439	19	69	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					841	844		10.1038/nature01185	http://dx.doi.org/10.1038/nature01185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490955				2022-12-01	WOS:000179897300063
J	Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC				Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC			Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; LIFE-SPAN; SIR2; GENE	Acetyl-coenzyme A (CoA) synthetase (Acs) is an enzyme central to metabolism in prokaryotes and eukaryotes. Acs synthesizes acetyl CoA from acetate, adenosine triphosphate, and CoA through an acetyl-adenosine monophosphate (AMP) intermediate. Immunoblotting and mass spectrometry analysis showed that Salmonella enterica Acs enzyme activity is posttranslationally regulated by acetylation of lysine-609. Acetylation blocks synthesis of the adenylate intermediate but does not affect the thioester-forming activity of the enzyme. Activation of the acetylated enzyme requires the nicotinamide adenine dinucleotide-dependent protein deacetylase activity of the CobB Sir2 protein from S. enterica. We propose that acetylation modulates the activity of all the AMP-forming family of enzymes, including nonribosomal peptide synthetases, luciferase, and aryl- and acyl-CoA synthetases. These findings extend our knowledge of the roles of Sir2 proteins in gene silencing, chromosome stability, and cell aging and imply that lysine acetylation is a common regulatory mechanism in eukaryotes and prokaryotes.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	escalante@bact.wisc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062385, R01GM062203] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10-RR14702] Funding Source: Medline; NIGMS NIH HHS [R01 GM062203, GM62385, GM62203] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; BERG P, 1956, J BIOL CHEM, V222, P991; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; LEE Y, 1981, BIOCHEMISTRY-US, V20, P1253, DOI 10.1021/bi00508a031; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; STARAI VJ, IN PRESS GENETICS; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1996, J BACTERIOL, V178, P7016, DOI 10.1128/jb.178.23.7016-7019.1996	15	442	465	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2390	2392		10.1126/science.1077650	http://dx.doi.org/10.1126/science.1077650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493915				2022-12-01	WOS:000179915900057
J	Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH				Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH			Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair	CELL			English	Article							LEUKOCYTE PROTEASE INHIBITOR; SECRETORY LEUKOPROTEASE INHIBITOR; PROTEINASE-INHIBITOR; HUMAN-NEUTROPHILS; EPITHELIN/GRANULIN PRECURSOR; BACTERIAL LIPOPOLYSACCHARIDE; GRANULIN/EPITHELIN PRECURSOR; 2-HYBRID SYSTEM; GENE-EXPRESSION; GROWTH-FACTORS	Increased leukocyte elastase activity in mice lacking secretory leukocyte protease inhibitor (SLPI) leads to impaired wound healing due to enhanced activity of TGFbeta and perhaps additional mechanisms. Proepithelin (PEPI), an epithelial growth factor, can be converted to epithelins (EPIs) in vivo by unknown mechanisms with unknown consequences. We found that PEPI and EPIs exert opposing activities. EPIs inhibit the growth of epithelial cells but induce them to secrete the neutrophil attractant IL-8, while PEPI blocks neutrophil activation by tumor necrosis factor, preventing release of oxidants and proteases. SLPI and PEPI form complexes, preventing elastase from converting PEPI to EPIs. Supplying PEPI corrects the wound-healing defect in SLPI null mice. Thus, SLPI/elastase act via PEPI/EPIs to operate a switch at the interface between innate immunity and wound healing.	Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Program Pharmacol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Immunol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA; NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Cornell University; Cornell University; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Memorial Sloan Kettering Cancer Center; Amgen	Ding, AH (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIAID NIH HHS [AI46382] Funding Source: Medline; NIGMS NIH HHS [GM61710] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000691, Z01DE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Avrova AO, 1999, MOL PLANT MICROBE IN, V12, P1114, DOI 10.1094/MPMI.1999.12.12.1114; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELCOURT DR, 1993, J BIOL CHEM, V268, P9230; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, P138; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COUTO MA, 1992, INFECT IMMUN, V60, P3065, DOI 10.1128/IAI.60.8.3065-3071.1992; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; He ZH, 1999, CANCER RES, V59, P3222; HELMIG R, 1995, EUR J OBSTET GYN R B, V59, P95, DOI 10.1016/0028-2243(94)02023-8; Hong SJ, 1999, PROTEIN EXPRES PURIF, V16, P340; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; HUNT TK, 1990, J TRAUMA, V30, P122; Hutchison D C, 1987, Eur J Respir Dis Suppl, V153, P78; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; KRAMPS JA, 1983, SCAND J CLIN LAB INV, V43, P427; LEE CH, 1993, AM REV RESPIR DIS, V147, P710, DOI 10.1164/ajrccm/147.3.710; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MELLET P, 1995, BIOCHEMISTRY-US, V34, P2645, DOI 10.1021/bi00008a031; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; OHLSSON K, 1995, J ANDROL, V16, P64; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; RAPPOLEE DA, 1988, CURR OPIN IMMUNOL, V1, P47, DOI 10.1016/0952-7915(88)90050-7; Rehault S, 1999, J BIOL CHEM, V274, P13810, DOI 10.1074/jbc.274.20.13810; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SOMORIN O, 1979, J BIOCHEM-TOKYO, V85, P157, DOI 10.1093/oxfordjournals.jbchem.a132305; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; Sparro G, 1997, PROTEIN EXPRES PURIF, V10, P169, DOI 10.1006/prep.1997.0726; Taggart AV, 2000, HEALTH SOC CARE COMM, V8, P1, DOI 10.1046/j.1365-2524.2000.00227.x; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; Wahl SM, 1997, AM J PATHOL, V150, P1275; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108; Xu SQ, 1998, J BIOL CHEM, V273, P20078, DOI 10.1074/jbc.273.32.20078; YING QL, 1994, BIOCHEMISTRY-US, V33, P5445, DOI 10.1021/bi00184a013; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 1999, BBA-MOL CELL RES, V1451, P219, DOI 10.1016/S0167-4889(99)00111-1; Zhu JW, 1997, P NATL ACAD SCI USA, V94, P13063, DOI 10.1073/pnas.94.24.13063; Zitnik RJ, 1997, BIOCHEM BIOPH RES CO, V232, P687, DOI 10.1006/bbrc.1997.6358	70	501	529	5	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					867	878		10.1016/S0092-8674(02)01141-8	http://dx.doi.org/10.1016/S0092-8674(02)01141-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526812	Bronze			2022-12-01	WOS:000179862600012
J	Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD				Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD			Effect of sunlight and season on serotonin turnover in the brain	LANCET			English	Article							AFFECTIVE-DISORDER; LIGHT THERAPY	Alterations in monoaminergic neurotransmission in the brain are thought to underlie seasonal variations in mood, behaviour, and affective disorders. We took blood samples from internal jugular veins in 101 healthy men, to assess the relation between concentration of serotonin metabolite in these samples and weather conditions and season. We showed that turnover of serotonin by the brain was lowest in winter (p=0-013). Moreover, the rate of production of serotonin by the brain was directly related to the prevailing duration of bright sunlight (r=0.294, p=0.010), and rose rapidly with increased luminosity. Our findings are further evidence for the notion that changes in release of serotonin by the brain underlie mood seasonality and seasonal affective disorder.	Baker Heart Res Inst, Human Neurotransmitter Lab, Melbourne, Vic 8008, Australia; Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 8008, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute	Lambert, GW (corresponding author), Baker Heart Res Inst, Human Neurotransmitter Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	gavin.lambert@baker.edu.au	Lambert, Gavin W/E-7384-2010; Lambert, Gavin/Q-4869-2017; Kaye, David/AAF-1202-2021; Jennings, Garry/B-3914-2009; Reid, Christopher M/AAP-8135-2021	Lambert, Gavin W/0000-0003-0315-645X; Lambert, Gavin/0000-0003-0315-645X; Reid, Christopher/0000-0001-9173-3944; Jennings, Garry/0000-0002-7865-5483; Kaye, David/0000-0003-4058-0372				CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41; LAMBERT GW, 1995, LIFE SCI, V57, P255, DOI 10.1016/0024-3205(95)00269-C; RUDORFER MV, 1993, PSYCHIAT RES, V46, P19, DOI 10.1016/0165-1781(93)90004-Z; TORK I, 1990, ANN NY ACAD SCI, V600, P9	5	335	345	4	59	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1840	1842		10.1016/S0140-6736(02)11737-5	http://dx.doi.org/10.1016/S0140-6736(02)11737-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623MB	12480364				2022-12-01	WOS:000179706100014
J	Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M				Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M			A role for the protease falcipain 1 in host cell invasion by the human malaria parasite	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; PROTEINASE; ERYTHROCYTE; HEMOGLOBINASE; MEROZOITES; EXPRESSION; INHIBITORS; SEQUENCE	Cysteine proteases of Plasmodium falciparum are required for survival of the malaria parasite, yet their specific cellular functions remain unclear. We used a chemical proteomic screen with a small-molecule probe to characterize the predominant cysteine proteases throughout the parasite life cycle. Only one protease, falcipain 1, was active during the invasive merozoite stage. Falcipain 1-specific inhibitors, identified by screening of chemical libraries, blocked parasite invasion of host erythrocytes, yet had no effect on normal parasite processes such as hemoglobin degradation. These results demonstrate a specific role for falcipain 1 in host cell invasion and establish a potential new target for antimalarial therapeutics.	Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, San Francisco, CA 94043 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94043 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; MRC National Institute for Medical Research	Greenbaum, DC (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, 513 Parnassus Ave, San Francisco, CA 94043 USA.		Bozdech, Zbynek/A-2205-2011; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Bozdech, Zbynek/0000-0002-9830-8446; Bogyo, Matthew/0000-0003-3753-4412	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; GREENBAUM DC, UNPUB; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; MAYER R, 1991, J MED CHEM, V34, P3029, DOI 10.1021/jm00114a011; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262; SALAS F, 1995, INFECT IMMUN, V63, P2120, DOI 10.1128/IAI.63.6.2120-2125.1995; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481	24	236	256	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2002	2006		10.1126/science.1077426	http://dx.doi.org/10.1126/science.1077426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471262				2022-12-01	WOS:000179629200049
J	Schwalbe, N; Harrington, P				Schwalbe, N; Harrington, P			HIV and tuberculosis in the former Soviet Union	LANCET			English	Article									Open Soc Inst, New York, NY 10019 USA		Schwalbe, N (corresponding author), Open Soc Inst, 400 W 59th St, New York, NY 10019 USA.							*DEP SOC MED, 1999, PROGR SOC INF DIS SO; *INT HARM RED DEV, 2001, DRUGS AIDS HARM RED; RUHL C, 2002, EC CONSEQUENCES HIV; SHRESTHA L, 2002, HIV AIDS CENTRAL ASI; Stem V., 1998, SIN FUTURE IMPRISONM; VINOKUR A, 2001, 510 WORLD BANK; *WHO, 2002, GLOB PLAN STOP TB	7	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S19	S20		10.1016/S0140-6736(02)11805-8	http://dx.doi.org/10.1016/S0140-6736(02)11805-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504488				2022-12-01	WOS:000180064500009
J	Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J				Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J			Time to act: global apathy towards HIV/AIDS is a crime against humanity	LANCET			English	Editorial Material									Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Fdn Huesped, Buenos Aires, DF, Argentina; Makerere Univ, Fac Med, Kampala, Uganda; Univ Amsterdam, Acad Med Ctr, IATEC, NL-1105 AZ Amsterdam, Netherlands; TN DR MGR Med Univ, Dept Expt Med, Chennai, India; Univ British Columbia, Fac Med, Vancouver, BC, Canada; Ist Super Sanita, HIV AIDS Clin Res, I-00161 Rome, Italy; McGill Univ, AIDS Ctr, AIDS Res Lab, Lady Davis Inst Med Res, Montreal, PQ, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Istituto Superiore di Sanita (ISS); Lady Davis Institute; McGill University	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada.		VELLA, STEFANO/V-8440-2019; Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012; VELLA, STEFANO/ABI-3368-2020; Vella, Stefano/GZM-0519-2022	VELLA, STEFANO/0000-0003-2347-5984; Hogg, Robert S/0000-0003-3463-5488; 				BUMILLER E, 2002, LA DAILY NEWS   0826; CHANG GG, 2002, CHINA BRIEF, V2; Luo RF, 2002, JAMA-J AM MED ASSOC, V288, P1649, DOI 10.1001/jama.288.13.1649; MERCER M, 2002, GAINESVILLE SUN 0430; Ramasundaram S, 2002, BRIT MED J, V324, P182, DOI 10.1136/bmj.324.7331.182; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Weber AE, 1999, AIDS, V13, P2481, DOI 10.1097/00002030-199912030-00024; 2002, BLOBE MAIL      1022, pA20	8	34	35	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1710	1711		10.1016/S0140-6736(02)11722-3	http://dx.doi.org/10.1016/S0140-6736(02)11722-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480418				2022-12-01	WOS:000179636800002
J	Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT				Courcelle, J; Donaldson, JR; Chow, KH; Courcelle, CT			DNA damage-induced replication fork regression and processing in Escherichia coli	SCIENCE			English	Article							AGAROSE-GEL ELECTROPHORESIS; ILLEGITIMATE RECOMBINATION; EXCISION-REPAIR; RECR PROTEINS; HELICASE; RESUMPTION; FILAMENTS; STRAND	DNA lesions that block replication are a primary cause of rearrangements, mutations, and lethality in all cells. After ultraviolet (UV)-induced DNA damage in Escherichia coli, replication recovery requires RecA and several other recF pathway proteins. To characterize the mechanism by which lesion-blocked replication forks recover, we used two-dimensional agarose get electrophoresis to show that replication-blocking DNA lesions induce a transient reversal of the replication fork in vivo. The reversed replication fork intermediate is stabilized by RecA and RecF and is degraded by the RecQ-RecJ helicase-nuclease when these proteins are absent. We propose that fork regression allows repair enzymes to gain access to the replication-blocking lesion, allowing processive replication to resume once the blocking lesion is removed.	Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA	Mississippi State University	Courcelle, J (corresponding author), Mississippi State Univ, Dept Biol Sci, Box GY, Mississippi State, MS 39762 USA.							Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GANESAN AK, 1971, MOL GEN GENET, V113, P285, DOI 10.1007/BF00272328; GANESAN AK, 1974, J MOL BIOL, V87, P103, DOI 10.1016/0022-2836(74)90563-4; Hanada K, 2000, P NATL ACAD SCI USA, V97, P5989, DOI 10.1073/pnas.100101297; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; HORII ZI, 1968, PHOTOCHEM PHOTOBIOL, V8, P93, DOI 10.1111/j.1751-1097.1968.tb05850.x; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; RUPP WD, 1971, J MOL BIOL, V61, P25, DOI 10.1016/0022-2836(71)90204-X; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SETLOW RB, 1964, P NATL ACAD SCI USA, V51, P226, DOI 10.1073/pnas.51.2.226; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; TSUJIMURA T, 1990, P NATL ACAD SCI USA, V87, P1566, DOI 10.1073/pnas.87.4.1566; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	28	185	191	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1064	1067		10.1126/science.1081328	http://dx.doi.org/10.1126/science.1081328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12543983				2022-12-01	WOS:000180960000047
J	Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A				Darby, S; McGale, P; Peto, R; Granath, F; Hall, P; Ekbom, A			Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women	BRITISH MEDICAL JOURNAL			English	Article							LATERALITY		Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, S-10401 Stockholm, Sweden	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Karolinska Institutet; Karolinska Institutet	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Paszat LF, 1998, J CLIN ONCOL, V16, P2625, DOI 10.1200/JCO.1998.16.8.2625; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887	5	173	182	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					256	257		10.1136/bmj.326.7383.256	http://dx.doi.org/10.1136/bmj.326.7383.256			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560277	Green Published, Bronze			2022-12-01	WOS:000180908300020
J	de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P				de Jong-van den Berg, L; Tobi, H; Bijker, B; van den Berg, P			Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study	BRITISH MEDICAL JOURNAL			English	Article							3RD-GENERATION		Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands	University of Groningen	de Jong-van den Berg, L (corresponding author), Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, Antonius Deusinglaan 2, NL-9713 AV Groningen, Netherlands.		Tobi, Hilde/A-1512-2013	Tobi, Hilde/0000-0002-8804-0298				de Vries CS, 1998, CONTRACEPTION, V57, P247, DOI 10.1016/S0010-7824(98)00021-3; Drife JO, 2001, BRIT MED J, V323, P119, DOI 10.1136/bmj.323.7305.119; GEIJER RMM, 1996, HUISARTS WET, V39, P110; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; POULTER NR, 1995, LANCET, V346, P1575	5	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					254	254		10.1136/bmj.326.7383.254	http://dx.doi.org/10.1136/bmj.326.7383.254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560275	Bronze, Green Published			2022-12-01	WOS:000180908300018
J	Knight, J				Knight, J			Meeting aims to find brain's benchmarks for beauty	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					305	305		10.1038/421305b	http://dx.doi.org/10.1038/421305b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540868	Bronze			2022-12-01	WOS:000180533000012
J	Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH				Spranger, J; Kroke, A; Mohlig, M; Bergmann, MM; Ristow, M; Boeing, H; Pfeiffer, AFH			Adiponectin and protection against type 2 diabetes mellitus	LANCET			English	Article							PROTEIN	Adiponectin is an adipocyte-derived peptide, which has anti-inflammatory and insulin-sensitising properties. We designed a nested case-control study to assess whether baseline adiponectin concentrations in plasma are independently associated with risk of type 2 diabetes. We found that adiponectin concentrations in plasma were lower among individuals who later developed type 2 diabetes than among controls (mean 5.34 mug/mL [SD 3.49] vs 6.87 mug/mL [4.58], p<0.0001). High concentrations of adiponectin were associated with a substantially reduced relative risk of type 2 diabetes after adjustment for age, sex, waist-to-hip ratio, body-mass index, smoking, exercise, alcohol consumption, education, and glycosylated haernoglobin A(1c) (odds ratio 4th vs 1st quartile 0.3 [95% CI 0.2-0.7], p=0.0051). We conclude that adiponectin is independently associated with a reduced risk of type 2 diabetes in apparently healthy individuals.	German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Bergholz Rehbrucke, Germany; Free Univ Berlin, Benjamin Franklin Med Ctr, Dept Nut Endocrinol & Metab, D-1000 Berlin, Germany; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Epidemiol, D-1000 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spranger, J (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany.	spranger@mail.dife.de	Pfeiffer, Andreas F.H./AAJ-2311-2020; Ristow, Michael/O-9858-2014	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Ristow, Michael/0000-0003-2109-2453				Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; KUBOTA N, 2002, J BIOL CHEM, V24, P24; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746	5	835	883	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					226	228		10.1016/S0140-6736(03)12255-6	http://dx.doi.org/10.1016/S0140-6736(03)12255-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547549				2022-12-01	WOS:000180535400015
J	Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF				Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF			Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study	LANCET			English	Article							TOTAL GLANDULAR MASTECTOMY; FOLLOW-UP; PROPHYLACTIC MASTECTOMY; CARCINOMA INSITU; DISEASE; WOMEN; NEOPLASIA	Background Clinical decisions about atypical lobular hyperplasia are based on the belief that later invasive breast-cancer risk is equal in both breasts. We aimed to show laterality and subsequent risk implications of invasive breast cancer in women with atypical lobular hyperplasia. Methods We did a retrospective cohort study of 252 women who had undergone 261 benign surgical biopsies that showed atypical lobular hyperplasia from 1950 to 1985, as part of the Nashville Breast Studies. Primary outcomes were development of invasive breast cancer and laterality of cancer compared with side of the biopsied breast. Findings 50 (20%) of 252 women treated by biopsy only developed invasive breast cancer. Relative risk of breast cancer in women with atypical lobular hyperplasia was 3.1 (95% Cl 2.3-4.3, p<0.0001). Of these 50 women, the breast with invasive cancer was the same breast diagnosed with atypical lobular hyperplasia (ipsilateral) in 34 (68%) and the contralateral breast in 12 (24%). The ratio of ipsilateral/ contralateral cancers for atypical lobular hyperplasia without other atypical lesions was 17/5. For six women with atypical lobular hyperplasia plus atypical ductal hyperplasia, the ratio was 1/1. Interpretation Invasive carcinoma after atypical lobular hyperplasia is about three times more likely to arise in the breast diagnosed with atypical lobular hyperplasia than in the opposite breast without these initial findings. Our findings suggest a model of premalignancy for atypical lobular hyperplasia intermediate between a local precursor and a generalised risk for both breasts.	Vanderbilt Univ, Med Ctr, Dept Anat Pathol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Page, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, MCN, C-3311, Nashville, TN 37232 USA.		Jensen, Roy A/B-9739-2011; Dupont, William D./I-4430-2012	Jensen, Roy A/0000-0003-4430-2281; 	NATIONAL CANCER INSTITUTE [R01CA062212, R01CA050468] Funding Source: NIH RePORTER; NCI NIH HHS [CA-31698, CA-50468, CA-62212] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs G, 2001, AM J CLIN PATHOL, V115, P85; BARTON FE, 1991, PLAST RECONSTR SURG, V88, P389, DOI 10.1097/00006534-199109000-00001; Beller F K, 1988, Recent Results Cancer Res, V106, P73; Bodian CA, 1996, CANCER, V78, P1024, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4; Brinton LA, 2001, CANCER, V91, P478, DOI 10.1002/1097-0142(20010201)91:3<478::AID-CNCR1025>3.3.CO;2-X; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Fleiss J.L., 1981, STAT METHODS RATES P, V2nd ed., P321; FREEMAN BS, 1978, PLAST RECONSTR SURG, V62, P167, DOI 10.1097/00006534-197808000-00003; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HUTTER RVP, 1969, CANCER, V24, P1081, DOI 10.1002/1097-0142(196911)24:5<1081::AID-CNCR2820240534>3.0.CO;2-D; LAMBIRD PA, 1969, J AMER MED ASSOC, V210, P689; Lawless, 2011, STAT MODELS METHODS; Lishman SC, 1999, HISTOPATHOLOGY, V35, P195; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MCDIVITT RW, 1967, J AMER MED ASSOC, V201, P82, DOI 10.1001/jama.201.2.82; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Newman LA, 2000, J AM COLL SURGEONS, V191, P322, DOI 10.1016/S1072-7515(00)00361-6; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1988, HUM PATHOL, V19, P201, DOI 10.1016/S0046-8177(88)80350-2; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; ROSEN PP, 1981, CANCER, V47, P813, DOI 10.1002/1097-0142(19810215)47:4<813::AID-CNCR2820470431>3.0.CO;2-J; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; SIMPSON JF, 1998, BREAST, P91; SLOANE JP, 1995, PATHOLOGY REPORTING, P21	29	218	226	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					125	129		10.1016/S0140-6736(03)12230-1	http://dx.doi.org/10.1016/S0140-6736(03)12230-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531579				2022-12-01	WOS:000180428000011
J	Van Gelder, RN; Wee, R; Lee, JA; Tu, DC				Van Gelder, RN; Wee, R; Lee, JA; Tu, DC			Reduced pupillary light responses in mice lacking cryptochromes	SCIENCE			English	Article							OCULAR PHOTORECEPTORS; NON-CONE; NON-ROD		Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63131 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL)	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63131 USA.		Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659	NATIONAL EYE INSTITUTE [K08EY000403] Funding Source: NIH RePORTER; NEI NIH HHS [K08EY00403] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Van Gelder RN, 2002, J BIOL RHYTHM, V17, P110, DOI 10.1177/074873002129002401; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301	13	82	83	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					222	222		10.1126/science.1079536	http://dx.doi.org/10.1126/science.1079536			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522242				2022-12-01	WOS:000180284000029
J	Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL				Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL			High-resolution magnetic resonance angiography of hands with timed arterial compression (tac-MRA)	LANCET			English	Article								Timed arterial compression (tac) of blood flow can be achieved by inflation of a blood-pressure cuff. We postulated that this technique might improve contrast-enhanced magnetic resonance angiography (MRA) of the arteries of the hands. We studied eight volunteers and six patients with occlusive arterial disease of the hands with standard MRA and tac-MRA. Compared with standard MRA, acquisition time was extended with the blood-pressure cuff by a factor of four, leading to quadrupled image resolution (512x1024). Furthermore, flow-related artifacts were not seen. Tac-MRA permits visualisation of the peripheral arterial system in finer detail than that achieved with standard MRA.	Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland; Cantonal Hosp, Dept Internal Med, Div Angiol, CH-8401 Winterthur, Switzerland; Univ Witten Herdecke, Dept Radiol & MicroTherapy, Witten, Germany	Witten Herdecke University	Wentz, KU (corresponding author), Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland.							Earls JP, 1996, RADIOLOGY, V201, P705, DOI 10.1148/radiology.201.3.8939219; Goldfarb JW, 2001, AM J ROENTGENOL, V177, P1177, DOI 10.2214/ajr.177.5.1771177; Rofsky N M, 1995, Magn Reson Imaging Clin N Am, V3, P345; Winterer JT, 2000, J COMPUT ASSIST TOMO, V24, P903, DOI 10.1097/00004728-200011000-00017	4	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					49	50		10.1016/S0140-6736(03)12112-5	http://dx.doi.org/10.1016/S0140-6736(03)12112-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517469				2022-12-01	WOS:000180191600023
J	Gruber, N; Keeling, CD; Bates, NR				Gruber, N; Keeling, CD; Bates, NR			Interannual variability in the North Atlantic Ocean carbon sink	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; SARGASSO SEA; EL-NINO; INORGANIC CARBON; C-13; CO2; OSCILLATION; SEAWATER; BERMUDA; DIOXIDE	The North Atlantic is believed to represent the largest ocean sink for atmospheric carbon dioxide in the Northern Hemisphere, yet little is known about its temporal variability. We report an 18-year time series of upper-ocean inorganic carbon observations from the northwestern subtropical North Atlantic near Bermuda that indicates substantial variability in this sink. We deduce that the carbon variability at this site is largely driven by variations in winter mixed-layer depths and by sea surface temperature anomalies. Because these variations tend to occur in a basinwide coordinated pattern associated with the North Atlantic Oscillation, it is plausible that the entire North Atlantic Ocean may vary in concert, resulting in a variability of the strength of the North Atlantic carbon sink of about +/-0.3 petagrams of carbon per year (1 petagram=10(15) grams) or nearly +/-50%. This extrapolation is supported by basin-wide estimates from atmospheric carbon dioxide inversions.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Scripps Institution of Oceanography	Gruber, N (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	ngruber@igpp.ucla.edu	Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P335, DOI 10.1029/96GB00192; Bates NR, 1998, J GEOPHYS RES-OCEANS, V103, P15567, DOI 10.1029/98JC00247; Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; Cullen HM, 2001, PALEOCEANOGRAPHY, V16, P27, DOI 10.1029/1999PA000434; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; GLOOR M, IN PRESS GEOPHYS RES; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Gruber N, 1998, DEEP-SEA RES PT I, V45, P673, DOI 10.1016/S0967-0637(97)00098-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KAWAMURA R, 1994, J PHYS OCEANOGR, V24, P707, DOI 10.1175/1520-0485(1994)024<0707:AREAOG>2.0.CO;2; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Le Quere C, 2000, GLOBAL BIOGEOCHEM CY, V14, P1247, DOI 10.1029/1999GB900049; Lee K, 1998, NATURE, V396, P155, DOI 10.1038/24139; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Molinari RL, 1997, J GEOPHYS RES-OCEANS, V102, P3267, DOI 10.1029/96JC03544; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Stammer D, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000888; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; *US DOE, 1994, ORNLCDIAC74 US DEP E; WINGUTH AME, 1994, GLOBAL BIOGEOCHEM CY, V8, P39, DOI 10.1029/93GB03134	36	184	188	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2374	2378		10.1126/science.1077077	http://dx.doi.org/10.1126/science.1077077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493911				2022-12-01	WOS:000179915900052
J	Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A				Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A			Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; BLOOD-DONORS; AMINOTRANSFERASE LEVELS; PROGRESSION; FIBROSIS	Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons. Design: Population-based cross-sectional study. Setting: Northeastern Italy. Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). Results: 116 persons (2.4% [95% Cl, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [Cl, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (Cl, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (Cl, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.	Univ Padua, Clin Med 5, Dept Clin & Expt Med, I-35100 Padua, Italy	University of Padua	Alberti, A (corresponding author), Univ Padua, Clin Med 5, Dept Clin & Expt Med, Via Giustiniani 2, I-35100 Padua, Italy.	alfredo.alberti@unipd.it	Noventa, Franco/C-1202-2008	Noventa, Franco/0000-0003-4622-5523; ALBERTI, ALFREDO/0000-0001-9926-2382				Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; ALBERTI A, 1991, ANN INTERN MED, V114, P1010, DOI 10.7326/0003-4819-114-12-1010; ALBERTI A, 1992, LANCET, V340, P697, DOI 10.1016/0140-6736(92)92234-7; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528; ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443; Hirsch KR, 2000, AM J MED, V109, P66, DOI 10.1016/S0002-9343(00)00456-3; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mathurin P, 1998, HEPATOLOGY, V27, P868, DOI 10.1002/hep.510270333; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pagliaro L, 1999, ITAL J GASTROENTEROL, V31, P28; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; RoudotThoraval F, 1997, HEPATOLOGY, V26, P485, DOI 10.1002/hep.510260233; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; 1999, EASL INT CONS C HEP, V31, P3	20	117	122	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					961	964		10.7326/0003-4819-137-12-200212170-00009	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484711				2022-12-01	WOS:000179857500004
J	Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK				Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK			ROS1, a repressor of transcriptional gene silencing in Arabidopsis, encodes a DNA glycosylase/lyase	CELL			English	Article							BASE EXCISION-REPAIR; DE-NOVO METHYLATION; ESCHERICHIA-COLI; RNA; MAINTENANCE; MECHANISMS; DEMETHYLATION; DISRUPTION; INITIATION; MUTATIONS	Mutations in the Arabidopsis ROS1 locus cause transcriptional silencing of a transgene and a homologous endogenous gene. In the ros1 mutants, the promoter of the silenced loci is hypermethylated, which may be triggered by small RNAs produced from the transgene repeats. The transcriptional silencing in ros1 mutants can be released by the ddm1 mutation or the application of the DNA methylation inhibitor 5-aza-2'-deoxycytidine. ROS1 encodes an endonuclease III domain nuclear protein with bifunctional DNA glycosylase/lyase activity against methylated but not unmethylated DNA. The ros1 mutant shows enhanced sensitivity to genotoxic agents methyl methanesulfonate and hydrogen peroxide. We suggest that ROS1 is a DNA repair protein that represses homology-dependent transcriptional gene silencing by demethylating the target promoter DNA.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	University of Arizona; Universidad de Cordoba	Zhu, JK (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.		Roldan-Arjona, Teresa/H-5976-2015; Morales-Ruiz, Teresa/L-4842-2014; Zhu, Jian-Kang/F-7658-2011; Gong, Zhizhong/AAS-4796-2021	Roldan-Arjona, Teresa/0000-0003-2842-3956; Morales-Ruiz, Teresa/0000-0002-6357-6977; Zhu, Jian-Kang/0000-0001-5134-731X; Rodriguez Ariza, Rafael/0000-0002-0338-7306				Adams S, 2000, DEVELOPMENT, V127, P2493; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Habu Y, 2001, CURR OPIN GENET DEV, V11, P215, DOI 10.1016/S0959-437X(00)00182-9; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rine J, 1999, P NATL ACAD SCI USA, V96, P8309, DOI 10.1073/pnas.96.15.8309; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	39	500	551	14	172	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					803	814		10.1016/S0092-8674(02)01133-9	http://dx.doi.org/10.1016/S0092-8674(02)01133-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526807	Bronze, Green Published			2022-12-01	WOS:000179862600007
J	Poss, KD; Wilson, LG; Keating, MT				Poss, KD; Wilson, LG; Keating, MT			Heart regeneration in zebrafish	SCIENCE			English	Article							MITOTIC CHECKPOINT; MPS1	Cardiac injury in mammals and amphibians typically leads to scarring, with minimal regeneration of heart muscle. Here, we demonstrate histologically that zebrafish fully regenerate hearts within 2 months of 20% ventricular resection. Regeneration occurs through robust proliferation of cardiomyocytes localized at the leading epicardial edge of the new myocardium. The hearts of zebrafish with mutations in the Mps1 mitotic checkpoint kinase, a critical cell cycle regulator, failed to regenerate and formed scars. Thus, injury-induced cardiomyocyte proliferation in zebrafish can overcome scar formation, allowing cardiac muscle regeneration. These findings indicate that zebrafish will be useful for genetically dissecting the molecular mechanisms of cardiac regeneration.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Poss, KD (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, 320 Longwood Ave, Boston, MA 02115 USA.			Poss, Kenneth/0000-0002-6743-5709				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; HOGG D, 1994, ONCOGENE, V9, P89; JOHNSON SL, 1995, GENETICS, V141, P1583; Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poss KD, 2002, DEVELOPMENT, V129, P5141; POSS KD, UNPUB; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; SCHNITT SJ, 1993, CIRC RES, V72, P914, DOI 10.1161/01.RES.72.4.914; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111	17	1264	1305	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2188	2190		10.1126/science.1077857	http://dx.doi.org/10.1126/science.1077857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481136				2022-12-01	WOS:000179773700047
J	Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M				Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M			Prediction of the risk of myocardial infarction from polymorphisms in candidate genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY ATHEROSCLEROSIS; HEART-DISEASE; PROMOTER; PROGRESSION; STROMELYSIN-1; THROMBOSIS; VARIANT; WOMEN	Background: Although epidemiologic studies have suggested that several genetic variants increase the risk of myocardial infarction, large-scale association studies that examine many polymorphisms simultaneously are required to allow reliable prediction of the genetic risk of myocardial infarction. Methods: We used a fluorescence- or colorimetry-based allele-specific DNA-primer-probe assay system to determine the genotypes of 112 polymorphisms of 71 candidate genes in 2819 unrelated Japanese patients with myocardial infarction (2003 men and 816 women) and 2242 unrelated Japanese controls (1306 men and 936 women). Results: In an initial screening of the 112 polymorphisms for an association with myocardial infarction in 909 subjects, 19 polymorphisms were selected in men and 18 in women by means of logistic-regression analysis, after adjustment for age, body-mass index, and the prevalence of smoking, hypertension, diabetes mellitus, hypercholesterolemia, and hyperuricemia. In a large-scale study involving the selected polymorphisms and the remaining 4152 subjects, similar logistic-regression analysis revealed that the risk of myocardial infarction was significantly associated with the C1019T polymorphism in the connexin 37 gene (P<0.001) in men and the 4G-668/5G polymorphism in the plasminogen-activator inhibitor type 1 gene (P<0.001) and the 5A-1171/6A polymorphism in the stromelysin-1 gene (P<0.001) in women. Conclusions: Determination of the genotypes of the connexin 37, plasminogen-activator inhibitor type 1, and stromelysin-1 genes may prove reliable in predicting the genetic risk of myocardial infarction and might thus contribute to the primary prevention of this condition.	Gifu Int Inst Biotechnol, Dept Gene Therapy, Mitake, Tokyo, Japan; Nagoya Univ, Grad Sch Med, Dept Pathophysiol, Div Cardiovasc, Nagoya, Aichi, Japan; Kosei Hosp, Div Cardiol, Anjo, Japan; Okazaki City Hosp, Div Cardiol, Okazaki, Aichi, Japan; Nagoya Daini Red Cross Hosp, Ctr Cardiovasc, Nagoya, Aichi, Japan; Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan	Nagoya University; Japanese Red Cross Nagoya Daini Hospital; Ogaki Municipal Hospital	Yokota, M (corresponding author), Nagoya Univ Hosp, Dept Clin Lab & Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.							Boerma M, 1999, J INTERN MED, V246, P211, DOI 10.1046/j.1365-2796.1999.00564.x; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cahilly C, 2000, CIRC RES, V86, P391, DOI 10.1161/01.RES.86.4.391; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Guetta V, 1996, CIRCULATION, V93, P1928, DOI 10.1161/01.CIR.93.10.1928; Guzik TJ, 2000, CIRCULATION, V102, P1744; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; KNIVENHOVEN JA, 1998, NEW ENGL J MED, V338, P86; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; Roest M, 2000, CIRCULATION, V101, P67, DOI 10.1161/01.CIR.101.1.67; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; YE S, 1995, BRIT HEART J, V73, P209; Yeh HI, 2001, INT J CARDIOL, V81, P251, DOI 10.1016/S0167-5273(01)00574-5	22	545	592	1	21	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1916	1923		10.1056/NEJMoa021445	http://dx.doi.org/10.1056/NEJMoa021445			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477941				2022-12-01	WOS:000179735800003
J	Echeverri, K; Tanaka, EM				Echeverri, K; Tanaka, EM			Ectoderm to mesoderm lineage switching during axolotl tail regeneration	SCIENCE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD REGENERATION; NERVOUS-SYSTEM; IN-VIVO; BRAIN; NEUROGENESIS; BLASTEMA; DERMIS	Foreign environments may induce adult stem cells to switch lineages and populate multiple tissue types, but whether this mechanism is used for tissue repair remains uncertain. Urodele amphibians can regenerate fully functional, multitissue structures including the limb and tail. To determine whether lineage switching is an integral feature of this regeneration, we followed individual spinal cord cells live during tail regeneration in the axolotl. Spinal cord cells frequently migrate into surrounding tissue to form regenerating muscle and cartilage. Thus, in axolotls, cells switch lineage during a real example of regeneration.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Tanaka, Elly M/F-8572-2010; Echeverri, Karen/F-5422-2010	Tanaka, Elly/0000-0003-4240-2158				Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; ARSANTO JP, 1992, J EXP ZOOL, V264, P273, DOI 10.1002/jez.1402640307; Benraiss A, 1999, DEV GENES EVOL, V209, P363, DOI 10.1007/s004270050265; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; CLARKE JDW, 1988, NEUROSCI LETT, V89, P1, DOI 10.1016/0304-3940(88)90471-5; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; ECHEVERRI K, UNPUB; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; GERAUDIE J, 1988, AM J ANAT, V183, P359, DOI 10.1002/aja.1001830409; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HOLDER N, 1988, TRENDS NEUROSCI, V11, P94, DOI 10.1016/0166-2236(88)90151-8; HOLTZER HOWARD, 1955, J MORPH, V96, P145, DOI 10.1002/jmor.1050960107; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nolte C, 2001, GLIA, V33, P72; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	25	168	175	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1993	1996		10.1126/science.1077804	http://dx.doi.org/10.1126/science.1077804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471259				2022-12-01	WOS:000179629200046
J	Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T				Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T			Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP	SCIENCE			English	Article							GERM-CELL APOPTOSIS; MICE LACKING; SPERMIOGENESIS DEFICIENCY; GENE; TRANSCRIPTION; MOUSE; CREM; DIFFERENTIATION; TRANSLATION; EXPRESSION	Spermatogenesis is a highly specialized process of cellular differentiation to produce spermatozoa. This differentiation process accompanies morphological changes that are controlled by a number of genes expressed in a stage-specific manner during spermatogenesis. Here we show that in mice, the absence of a testis-specific, cytoplasmic polyadenylate [poly(A)] polymerase, TPAP, results in the arrest of spermiogenesis. TPAP-deficient mice display impaired expression of haploid-specific genes that are required for the morphogenesis of germ cells. The TPAP deficiency also causes incomplete elongation of poly(A) tails of particular transcription factor messenger RNAs. Although the overall cellular level of the transcription factor TAF10 is unaffected, TAF10 is insufficiently transported into the nucleus of germ cells. We propose that TPAP governs germ cell morphogenesis by modulating specific transcription factors at posttranscriptional and posttranslational levels.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Agrobiol Resources, Germ Cell Conservat Lab, Tsukuba, Ibaraki 3058602, Japan; Inst Phys & Chem Res RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	University of Tsukuba; University of Tsukuba; National Institute of Agrobiological Sciences - Japan; RIKEN	Baba, T (corresponding author), Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan.	acroman@sakura.cc.tsukuba.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Fimia GM, 2001, MOL CELL ENDOCRINOL, V179, P17, DOI 10.1016/S0303-7207(01)00463-4; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	22	99	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1999	2002		10.1126/science.1074632	http://dx.doi.org/10.1126/science.1074632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471261				2022-12-01	WOS:000179629200048
J	Buckling, A; Rainey, PB				Buckling, A; Rainey, PB			The role of parasites in sympatric and allopatric host diversification	NATURE			English	Article							ESCHERICHIA-COLI; DIVERSITY; COEVOLUTION; COMPETITION; ADAPTATION; DIVERGENCE; PREDATION; EVOLUTION; MODEL	Exploiters (parasites and predators) are thought to play a significant role in diversification, and ultimately speciation, of their hosts or prey(1-3). Exploiters may drive sympatric (within-population) diversification if there are a variety of exploiter-resistance strategies or fitness costs associated with exploiter resistance(4-8). Exploiters may also drive allopatric (between-population) diversification by creating different selection pressures and increasing the rate of random divergence(9,10). We examined the effect of a virulent viral parasite (phage) on the diversification of the bacterium Pseudomonas fluorescens in spatially structured microcosms(11). Here we show that in the absence of phages, bacteria rapidly diversified into spatial niche specialists with similar patterns of diversity across replicate populations. In the presence of phages, sympatric diversity was greatly reduced, as a result of phage-imposed reductions in host density decreasing competition for resources. In contrast, allopatric diversity was greatly increased as a result of phage-imposed selection for resistance, which caused populations to follow divergent evolutionary trajectories. These results show that exploiters can drive diversification between populations, but may inhibit diversification within populations by opposing diversifying selection that arises from resource competition.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Bath; University of Oxford; University of Auckland	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BROWN JS, 1992, EVOLUTION, V46, P1269, DOI 10.1111/j.1558-5646.1992.tb01123.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Darwin C, 1872, ORIGIN SPECIES; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; HELLING RB, 1987, GENETICS, V116, P349; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Lack D., 1947, DARWINS FINCHES; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 2000, ECOLOGY ADAPTIVE RAD, V157, pS4; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stone HMI, 1998, PALAEONTOLOGY, V41, P1051; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Travis J, 1996, AM NAT, V148, pS1, DOI 10.1086/285899; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1006/bijl.1996.9999	29	203	209	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					496	499		10.1038/nature01164	http://dx.doi.org/10.1038/nature01164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466840				2022-12-01	WOS:000179611600043
J	Butler, D				Butler, D			Prion data suggest BSE link to sporadic CJD	NATURE			English	News Item																		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; 2002, NATURE, V418, P266	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					450	450		10.1038/420450a	http://dx.doi.org/10.1038/420450a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466801	Bronze			2022-12-01	WOS:000179611600004
J	Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS				Hutson, MS; Tokutake, Y; Chang, MS; Bloor, JW; Venakides, S; Kiehart, DP; Edwards, GS			Forces for morphogenesis investigated with laser microsurgery and quantitative modeling	SCIENCE			English	Article							DROSOPHILA DORSAL CLOSURE; DYNAMIC ANALYSIS; AMNIOSEROSA; ADHESION; BIOLOGY; REVEAL; EMBRYO; CELLS	We investigated the forces that connect the genetic program of development to morphogenesis in Drosophila. We focused on dorsal closure, a powerful model system for development and wound healing. We found that the bulk of progress toward closure is driven by contractility in supracellular "purse strings" and in the amnioserosa, whereas adhesion-mediated zipping coordinates the forces produced by the purse strings and is essential only for the end stages. We applied quantitative modeling to show that these forces, generated in distinct cells, are coordinated in space and synchronized in time. Modeling of wild-type and mutant phenotypes is predictive; although closure in myospheroid mutants ultimately fails when the cell sheets rip themselves apart, our analysis indicates that beta(PS) integrin has an earlier, important role in zipping.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Dept Math, Durham, NC 27708 USA; Duke Univ, Dept Phys, Durham, NC 27708 USA; Duke Univ, Free Electron Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Chang, Ming-Shien/F-7922-2012	Chang, Ming-Shien/0000-0002-6385-0374	NIGMS NIH HHS [GM61240, GM33830] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830, R01GM061240] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnes F, 1999, CR ACAD SCI III-VIE, V322, P5, DOI 10.1016/S0764-4469(99)80012-2; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Campos-Ortega JA., 1997, EMBRYONIC DEV DROSOP; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Davidson LA, 1999, DEV BIOL, V209, P221, DOI 10.1006/dbio.1999.9249; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FOE VE, 1989, DEVELOPMENT, V107, P1; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 2002, J CELL SCI, V115, P2119; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kiehart DP, 1999, CURR BIOL, V9, pR602, DOI 10.1016/S0960-9822(99)80384-4; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Magie CR, 1999, DEVELOPMENT, V126, P5353; Martinez Arias Alfonso, 1993, P517; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reed BH, 2001, CURR BIOL, V11, P1098, DOI 10.1016/S0960-9822(01)00318-9; Stronach BE, 2001, DEVELOPMENT, V128, P2905; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	22	373	374	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					145	149		10.1126/science.1079552	http://dx.doi.org/10.1126/science.1079552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12574496				2022-12-01	WOS:000181988900053
J	Mitchell, CE; Power, AG				Mitchell, CE; Power, AG			Release of invasive plants from fungal and viral pathogens	NATURE			English	Article							DISEASES	Invasive plant species both threaten native biodiversity and are economically costly(1-5), but only a few naturalized species become pests(2,4). Here we report broad, quantitative support for two long-standing hypotheses that explain why only some naturalized species have large impacts. The enemy release hypothesis argues that invaders' impacts result from reduced natural enemy attack(2,4,6-10). The biotic resistance hypothesis argues that interactions with native species, including natural enemies, limit invaders' impacts(6-8). We tested these hypotheses for viruses and for rust, smut and powdery mildew fungi that infect 473 plant species naturalized to the United States from Europe. On average, 84% fewer fungi and 24% fewer virus species infect each plant species in its naturalized range than in its native range. In addition, invasive plant species that are more completely released from pathogens are more widely reported as harmful invaders of both agricultural and natural ecosystems. Together, these results strongly support the enemy release hypothesis. Among noxious agricultural weeds, species accumulating more pathogens in their naturalized range are less widely noxious, supporting the biotic resistance hypothesis. Our results indicate that invasive plants' impacts may be a function of both release from and accumulation of natural enemies, including pathogens.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Mitchell, CE (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.		Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993				Agrios G.N.., 1997, PLANT PATHOL; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Braun U., 1995, POWDERY MILDEWS ERYS; Charudattan R, 2001, BIOCONTROL, V46, P229, DOI 10.1023/A:1011477531101; CLAY K, 1995, CAN J BOT, V73, pS42, DOI 10.1139/b95-223; Darwin C., 1859, ORIGIN SPECIES MEANS; Elton C. S., 1958, ECOLOGY INVASIONS; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Gaumann E, 1959, ROSTPILZE MITTELEURO; HOKKANEN H, 1985, AGR ECOSYST ENVIRON, V14, P63, DOI 10.1016/0167-8809(85)90085-4; Holm LG, 1977, WORLDS WORST WEEDS D; Julien M.H., 1998, BIOL CONTROL WEEDS W, V4th; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Liebman M., 2001, ECOLOGICAL MANAGEMEN, P375; Mabberly DJ., 1997, PLANT BOOK PORTABLE; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pimentel D., 2002, BIOL INVASIONS EC EN; TORCHIN ME, IN PRESS NATURE; Tutin T.G., 1976, FLORA EUROPAEA; *US C OFF TECHN AS, 1993, OTAF565 US C; Van der Putten WH, 2002, NATURE, V417, P32, DOI 10.1038/417032a; VuYnky K., 1994, EUROPEAN SMUT FUNGI; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M, 1996, BIOL INVASIONS; Wilson M., 1966, BRIT RUST FUNGI	30	839	892	7	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					625	627		10.1038/nature01317	http://dx.doi.org/10.1038/nature01317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571594				2022-12-01	WOS:000180803200040
J	Palmer, K; Backman, L; Winblad, B; Fratiglioni, L				Palmer, K; Backman, L; Winblad, B; Fratiglioni, L			Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; OLD ADULTS; SAMPLE; PREDICT; WILL; AD	Objectives To evaluate a simple three step procedure to identify people in the general population who are in the preclinical phase of Alzheimer's disease and dementia. Design Three year population based cohort study. Setting Kunasholmen cohort, Stockholm, Sweden. Participants 1435 people aged 75-95 years without dementia. Assessments Single question asking about memory complaints, assessment by mini-mental state examination, and neuropsychological testing. Main outcome measure Alzheimer's disease and dementia at three year follow up. Results None of the three instruments was sufficiently predictive of Alzheimer's disease and dementia when administered separately. After participants had been screened for memory complaints and global cognitive impairment, specific tests of word recall and verbal fluency had positive predictive values for dementia of 85-100% (95% confidence interval range from 62% to 100%). However, only 18% of future dementia cases were identified in the preclinical phase by this three step procedure. Memory complaints were the most sensitive indicator of Alzheimer's disease and dementia in the whole population, but only half the future dementia cases reported memory problems three years before diagnosis. Conclusion This three step procedure, which simulates what might occur in clinical practice, has a high positive predictive value for dementia, although only a small number of future cases can be identified.	Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, S-11382 Stockholm, Sweden; Stockholm Gerontol Res Ctr, S-11382 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Palmer, K (corresponding author), Karolinska Inst, Aging Res Ctr, Div Geriatr Epidemiol & Med, Box 6401, S-11382 Stockholm, Sweden.		Palmer, Katie/A-1430-2016	Palmer, Katie/0000-0001-8783-016X				Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; BACKMAN L, 1994, J ABNORM PSYCHOL, V103, P361; BACKMAN L, IN PRESS NEW FRONTIE; BACKMAN L, NEW FRONTIERS COGNIT; Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; CHRISTENSEN AL, 1984, LURIAS NEUROPSYCHOLO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Hogan DB, 2000, CAN J NEUROL SCI, V27, P18, DOI 10.1017/S0317167100051921; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.3.CO;2-9; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; Neri M, 1998, DEMENT GERIATR COGN, V9, P56, DOI 10.1159/000017023; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Petersen R C, 2000, Neurologia, V15, P93; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ritchie K, 2001, NEUROLOGY, V56, P37, DOI 10.1212/WNL.56.1.37; Ritchie K, 2000, COMPR PSYCHIAT, V41, P61, DOI 10.1016/S0010-440X(00)80010-3; Small BJ, 1997, PSYCHOL AGING, V12, P309, DOI 10.1037/0882-7974.12.2.309; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Wechsler, 1981, WECHSLER ADULT INTEL	25	117	123	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					245	247		10.1136/bmj.326.7383.245	http://dx.doi.org/10.1136/bmj.326.7383.245			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644FY	12560271	Bronze, Green Published			2022-12-01	WOS:000180908300014
J	Smith, O				Smith, O			Weathering the big chill	SCIENCE			English	Editorial Material																		Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOFFMEISTER KM, 2002, BLOOD, V100	2	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					530	530		10.1126/science.299.5606.530	http://dx.doi.org/10.1126/science.299.5606.530			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543964				2022-12-01	WOS:000180559800037
J	Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M				Woywodt, A; Streiber, F; de Groot, K; Regelsberger, H; Haller, H; Haubitz, M			Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis	LANCET			English	Article							TISSUE FACTOR; WEGENERS-GRANULOMATOSIS; ANTIBODY; PROTEINASE-3; EXPRESSION; INDUCTION	Background Histological findings in small-vessel vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs) suggest that damaged endothelial cells undergo necrosis and detachment from the basement membrane. We postulated that isolation of these cells from peripheral blood might provide a novel marker of the disease and elucidate pathogenetic events. Methods 18 patients with active ANCA-associated vasculitis, 20 patients in remission, 20 healthy controls, 12 patients with infection, and 12 patients with glomerular disease not associated with ANCA were studied. Endothelial cells were isolated from peripheral blood by use of Dynabeads coated with antibodies against CD146, and were stained for von Willebrand factor (vWF), CD31, and Ulex Europaeus lectin 1 (UEA-1). Tissue-factor immunocytochemistry and assays for markers of apoptosis and necrosis were also done. Findings Few circulating endothelial cells were seen in healthy controls (0-20 cells/mL, median 5 cells/mL), patients with infection (0-16 cells/mL, median 8 cells/mL), and patients with non-ANCA glomerulonephritis (0-21 cells/mL, median 4 cells/mL). By contrast, large numbers of circulating endothelial cells were detected in patients with active vasculitis (20-5700 cells/mL, median 136 cells/mL, p<0.0001 when compared with healthy controls). Cell numbers fell substantially during 6 months of successful immunosuppressive treatment among those with active disease. Patients in remission had moderately raised cell numbers (0.60 cells/mL, median 16 cells/mL). 84% of cells obtained from patients with active disease stained positive for annexin/propidium iodide and 86% stained tissue factor positive, indicating a necrotic and procoagulant phenotype. Interpretation Circulating endothelial cells are a novel marker of active ANCA-associated small-vessel vasculitis. The clinical use of this tool and the pathogenic mechanisms leading to these findings require further investigation.	Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany	Hannover Medical School	Woywodt, A (corresponding author), Hannover Med Sch, Dept Med, Div Nephrol, D-30625 Hannover, Germany.	Woywodt.Alexander@MH-Hannover.de	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955				Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; Barker RN, 2002, CLIN EXP IMMUNOL, V127, P220, DOI 10.1046/j.1365-2249.2002.01774.x; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; BOUVIER CA, 1970, THROMB DIATH HAEMOST, P163; Contrino J, 1997, CIRCULATION, V96, P605; DAGATI V, 1986, AM J KIDNEY DIS, V7, P95, DOI 10.1016/S0272-6386(86)80062-2; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Gobel U, 1996, AM J KIDNEY DIS, V28, P186, DOI 10.1016/S0272-6386(96)90300-5; Haubitz M, 2001, CLIN EXP IMMUNOL, V126, P584, DOI 10.1046/j.1365-2249.2001.01587.x; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Jennette JC, 1998, HEPTINSTALLSPATHOLOG, P1059; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; LUQMANI RA, 1994, Q J MED, V87, P671; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Mutin M, 1999, BLOOD, V93, P2951; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Preston GA, 2001, KIDNEY INT, V59, P1981, DOI 10.1046/j.1523-1755.2001.0590051981.x; SBARBATI R, 1991, BLOOD, V77, P764; Semeraro N, 1997, THROMB HAEMOSTASIS, V78, P759; Sibelius U, 1998, J EXP MED, V187, P497, DOI 10.1084/jem.187.4.497; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203	25	243	263	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					206	210		10.1016/S0140-6736(03)12269-6	http://dx.doi.org/10.1016/S0140-6736(03)12269-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547543				2022-12-01	WOS:000180535400009
J	Charlebois, RL; Beiko, RG; Ragan, MA				Charlebois, RL; Beiko, RG; Ragan, MA			Branching out	NATURE			English	Editorial Material									Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Ottawa; University of Queensland	Charlebois, RL (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.		Ragan, Mark A/A-9825-2014	Ragan, Mark A/0000-0003-1672-7020				Clarke GDP, 2002, J BACTERIOL, V184, P2072, DOI 10.1128/JB.184.8.2072-2080.2002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8	5	28	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					217	217		10.1038/421217a	http://dx.doi.org/10.1038/421217a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529621	Bronze			2022-12-01	WOS:000180397600026
J	Reichhardt, T				Reichhardt, T			NSF urged to take multidisciplinary tack on environment	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102a	http://dx.doi.org/10.1038/421102a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520270	Bronze			2022-12-01	WOS:000180267200008
J	Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB				Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB			Years of life lost due to obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; WHITE; DISEASE; COHORT; HEALTH; MEN	Context Public health officials and organizations have disseminated health messages regarding the dangers of obesity, but these have not produced the desired effect. Objective To estimate the expected number of years of life lost (YLL) due to overweight and obesity across the life span of an adult. Design, Setting, and Subjects Data from the (1) US Life Tables (1999); (2) Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994); and (3) First National Health and Nutrition Epidemiologic Follow-up Study (NHANES I and II; 1971-1992) and NHANES II, Mortality Study (1976-1992) were used to derive YLL estimates for adults aged 18 to 85 years. Body mass index (BMI) integer-defined categories were used (ie, <17; 17 to <18; 18 to <19; 20 to <21; 21 to 45; or greater than or equal to45). A BMI of 24 was used as the reference category. Main Outcome Measure The difference between the number of years of life expected if an individual were obese vs not obese, which was designated YLL. Results Marked race and sex differences were observed in estimated YLL. Among whites, a J- or U-shaped association was found between overweight or obesity and YLL. The optimal BMI (associated with the least YLL or greatest longevity) is approximately 23 to 25 for whites and -23 to 30 for blacks. For any given degree of overweight, younger adults generally had greater YLL than did older adults. The maximum YLL for white men aged 20 to 30 years with a severe level of obesity (BMI >45) is 13 and is 8 for white women. For men, this could represent a 22% reduction in expected remaining life span. Among black men and black women older than 60 years, overweight and moderate obesity were generally not associated with an increased YLL and only severe obesity resulted in YLL. However, blacks at younger ages with severe levels of obesity had a maximum YLL of 20 for men and 5 for women. Conclusion Obesity appears to lessen life expectancy markedly, especially among younger adults.	Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Sect Stat Genet, Birmingham, AL 35294 USA; Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, 327 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@ms.soph.uab.edu	Kohn, Geoffrey P/A-9056-2009	Allison, David/0000-0003-3566-9399; Westfall, Andrew/0000-0002-0468-4695	NIDDK NIH HHS [P30DK56336] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison D. B., 2001, International textbook of obesity, P31, DOI 10.1002/0470846739.ch3; Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1997, AM J EPIDEMIOL, V146, P672; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; ANDRES R, 1985, PRINCIPLES GERIATRIC, P311; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Berman DM, 2001, J CLIN ENDOCR METAB, V86, P97, DOI 10.1210/jc.86.1.97; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1988, MMWR-MORBID MORTAL W, V37, P543; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; Cox C S, 1997, Vital Health Stat 1, P1; David H.A., 1978, THEORY COMPETING RIS; DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443; Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401; Ezzati T M, 1992, Vital Health Stat 2, P1; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; FLEGAL KM, 1997, OBES RES, V5, pS93; Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; GREEN L, 1999, HLTH PROMOTION PLANN; HEO M, IN PRESS STAT MED; JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24; Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018; Services U.S. Department of Health and Human, 2001, SURG GEN CALL ACT PR; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4	34	1529	1590	8	106	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					187	193		10.1001/jama.289.2.187	http://dx.doi.org/10.1001/jama.289.2.187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517229				2022-12-01	WOS:000180226400029
J	Hoermann, R				Hoermann, R			Thyroid-hormone suppressive therapy in benign thyroid nodules - is it effective?	LANCET			English	Editorial Material							MULTINODULAR GOITERS; LEVOTHYROXINE; PREVALENCE		Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany		Hoermann, R (corresponding author), Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany.			Hoermann, Rudolf/0000-0002-1326-4270				BURGI H, 1990, ACTA ENDOCRINOL-COP, V123, P577, DOI 10.1530/acta.0.1230577; Castro MR, 2002, J CLIN ENDOCR METAB, V87, P4154, DOI 10.1210/jc.2001-011762; HAMPEL R, 1995, MED KLIN, V90, P324; KOPP P, 1994, J CLIN ENDOCR METAB, V79, P134, DOI 10.1210/jc.79.1.134; Krohn K, 2002, MOL GENET METAB, V75, P202, DOI 10.1006/mgme.2001.3290; Lima N, 1997, THYROID, V7, P691, DOI 10.1089/thy.1997.7.691; Quadbeck B, 2002, EXP CLIN ENDOCR DIAB, V110, P348, DOI 10.1055/s-2002-34992; STUDER H, 1995, ENDOCR REV, V16, P411, DOI 10.1210/er.16.4.411; Zelmanovitz F, 1998, J CLIN ENDOCR METAB, V83, P3881, DOI 10.1210/jc.83.11.3881	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1899	1900		10.1016/S0140-6736(02)11934-9	http://dx.doi.org/10.1016/S0140-6736(02)11934-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493251				2022-12-01	WOS:000179870200003
J	Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ				Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ			The cortical topography of tonal structures underlying Western music	SCIENCE			English	Article							PREFRONTAL CORTICES; MEMORY; PITCH; EXPECTANCY; CONNECTIONS; MECHANISMS; CHORDS; CORTEX; TIME; ERP	Western tonal music relies on a formal geometric structure that determines distance relationships within a harmonic or tonal space. In functional magnetic resonance imaging experiments, we identified an area in the rostromedial prefrontal cortex that tracks activation in tonal space. Different voxels in this area exhibited selectivity for different keys. Within the same set of consistently activated voxels, the topography of tonality selectivity rearranged itself across scanning sessions. The tonality structure was thus maintained as a dynamic topography in cortical areas known to be at a nexus of cognitive, affective, and mnemonic processing.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA; State Univ Ghent, Inst Psychoacoust & Electron Music, B-9000 Ghent, Belgium	Dartmouth College; Dartmouth College; Dartmouth College; Ghent University	Janata, P (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.			Van Horn, John Darrell/0000-0003-1537-0816; Birk, Jeffrey/0000-0002-1313-0993	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS17778-18] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BIGAND E, IN PRESS J EXP PSYCH; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; FRANCES R, 1958, PERCEPTION MUSIQUE; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gazzaniga M., 2000, NEW COGNITIVE NEUROS, P1047; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huron D., 1993, PSYCHOMUSICOLOGY J R, V12, P154, DOI DOI 10.1037/H0094110; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; Leman M, 2000, MUSIC PERCEPT, V17, P481; Lerdahl F., 2001, TONAL PITCH SPACE; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Meyer LB, 1956, EMOTION MEANING MUSI; ORAM N, 1995, PSYCHOL RES-PSYCH FO, V57, P103; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2001, BRAIN, V124, P928, DOI 10.1093/brain/124.5.928; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	30	250	255	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2167	2170		10.1126/science.1076262	http://dx.doi.org/10.1126/science.1076262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481131				2022-12-01	WOS:000179773700040
J	Matter, N; Herrlich, P; Konig, H				Matter, N; Herrlich, P; Konig, H			Signal-dependent regulation of splicing via phosphorylation of Sam68	NATURE			English	Article							MESSENGER-RNA; CD44; KINASE; TRANSDUCTION; ACTIVATION; SELECTION; DOMAINS; BINDING; MITOSIS; VARIANT	Evolution of human organismal complexity from a relatively small number of genes(1,2-)only approximately twice that of worm or fly-is explained mainly by mechanisms generating multiple proteins from a single gene, the most prevalent of which is alternative pre-messenger-RNA splicing(1,3,4). Appropriate spatial and temporal generation of splice variants demands that alternative splicing be subject to extensive regulation, similar to transcriptional control. Activation by extracellular cues of several cellular signalling pathways can indeed regulate alternative splicing(5-8). Here we address the link between signal transduction and splice regulation. We show that the nuclear RNA-binding protein Sam68 is a new extracellular signal-regulated kinase (ERK) target. It binds exonic splice-regulatory elements of an alternatively spliced exon that is physiologically regulated by the Ras signalling pathway, namely exon v5 of CD44. Forced expression of Sam68 enhanced ERK-mediated inclusion of the v5-exon sequence in mRNA. This enhancement was impaired by mutation of ERK-phosphorylation sites in Sam68, whereas ERK phosphorylation of Sam68 stimulated splicing of the v5 exon in vitro. Finally, Ras-pathway-induced alternative splicing of the endogenous CD44-v5 exon was abolished by suppression of Sam68 expression. Our data define Sam68 as a prototype regulator of alternative splicing whose function depends on protein modification in response to extracellular cues.	Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; Univ Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Konig, H (corresponding author), Forschungszentrum Karlsruhe, Inst Toxicol & Genet, Postfach 3640, D-76021 Karlsruhe, Germany.	harald.koenig@itg.fzk.de		Konig, Harald/0000-0002-0117-0939				ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593	26	354	365	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					691	695		10.1038/nature01153	http://dx.doi.org/10.1038/nature01153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478298				2022-12-01	WOS:000179751800051
J	Collins, S; Sadler, K				Collins, S; Sadler, K			Outpatient care for severely malnourished children in emergency relief programmes: a retrospective cohort study	LANCET			English	Article							SEVERE MALNUTRITION; MORTALITY	Background In emergency nutritional relief programmes, therapeutic feeding centres are the accepted intervention for the treatment of severely malnourished people. These centres often cannot treat all the people requiring care. Consequently, coverage of therapeutic feeding centre programmes can be low, reducing their effectiveness. We aimed to assess the effectiveness of outpatient treatment for severe malnutrition in an emergency relief programme. Methods We did a retrospective cohort study in an outpatient therapeutic feeding programme in Ethiopia from September, 2000, to January, 2001. We assessed clinical records for 170 children aged 6-120 months. The children had either marasmus, kwashiorkor, or marasmic kwashiorkor. Outcomes were mortality, default from programme, discharge from programme, rate of weight gain, and length of stay in programme. Findings 144 (85%) patients recovered, seven (4%) died, 11 (6%) were transferred, and eight (5%) defaulted. Median time to discharge was 42 days (IQR 28-56), days to death 14 (7-26), and days to default 14 (7-28). Median rate of weight gain was 3.16 g kg(-1) day(-1) (1.86-5.60). In patients who recovered, median rates of weight gain were 4.80 g kg(-1) day(-1) (2.95-8.07) for marasmic patients, 4.03 g kg(-1) day(-1) (2.68-4.29) for marasmic kwashiorkor patients, and 2.70 g kg(-1) day(-1) (0.00-4.76) for kwashiorkor patients. Interpretation Outpatient treatment exceeded internationally accepted minimum standards for recovery, default, and mortality rates. Time spent in the programme and rates of weight gain did not meet these standards. Outpatient care could provide a complementary treatment strategy to therapeutic feeding centres. Further research should compare the effectiveness of outpatient and centre-based treatment of severe malnutrition in emergency nutritional interventions.	Valid Int, London, England; Inst Child Hlth, Ctr Int Child Hlth, London, England; Concern Worldwide, Dublin, Ireland	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; BOELAERT M, 1995, NUTR GUIDELINES; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; de Waal A., 1989, FAMINE KILLS DARFUR; DEGOYET CV, 2000, MANAGEMENT NUTR EMER; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; Gomez Federico, 1956, J Trop Pediatr (Lond), V2, P77; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; *NAT CTR HLTH STAT, 1979, NCHS GROWTH CURV CHI; Prudhon C, 1997, EUR J CLIN NUTR, V51, P771, DOI 10.1038/sj.ejcn.1600483; *SPHER PROJ, 2000, PROJ TEAM SPHER PROJ; WATERLOW JC, 1993, PROTEIN ENERGY MALNU; *WHO UN HIGH COMM, 2000, MAN NUTR MAJ EM; *WORLD FOOD PROGR, 2000, FOOD NUTR HDB; World Health Organization, 1998, MAN SEV MALN MAN PHY	19	91	92	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1824	1830		10.1016/S0140-6736(02)11770-3	http://dx.doi.org/10.1016/S0140-6736(02)11770-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480359				2022-12-01	WOS:000179706100009
J	Kazmierczak, J; Kremer, B				Kazmierczak, J; Kremer, B			Palaeontology (Communication arising): Thermal alteration of the Earth's oldest fossils	NATURE			English	Article									Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Kazmierczak, J (corresponding author), Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland.		Kremer, Barbara/ABB-1201-2020	Kremer, Barbara/0000-0002-0464-1265				Aleksandrowski P, 2000, T ROY SOC EDIN-EARTH, V90, P127, DOI 10.1017/S0263593300007197; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Dalton R, 2002, NATURE, V417, P782, DOI 10.1038/417782a; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KOMAREK J, 1986, Archiv fuer Hydrobiologie Supplement, V73, P157; KREMER B, 2001, EARLY PALAEOZOIC PAL, P36; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; TISSOT BP, 1987, AAPG BULL, V71, P1445; Wyzga B, 1987, GEOL SUDETICA, V22, P119	9	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					477	478		10.1038/420477b	http://dx.doi.org/10.1038/420477b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466835				2022-12-01	WOS:000179611600037
J	White, F				White, F			Water: life force or instrument of war?	LANCET			English	Article									Aga Khan Univ, Karachi 74800, Pakistan	Aga Khan University	White, F (corresponding author), Aga Khan Univ, Stadium Rd,Box 3500, Karachi 74800, Pakistan.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S29	S30		10.1016/S0140-6736(02)11810-1	http://dx.doi.org/10.1016/S0140-6736(02)11810-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504493				2022-12-01	WOS:000180064500014
J	Sudlow, CLM; Counsell, CE				Sudlow, CLM; Counsell, CE			Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; SECONDARY PROGRESSIVE MS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1B; GLATIRAMER ACETATE; NATURAL-HISTORY; CLINICAL-TRIALS; FINAL REPORT; RELAPSE RATE	The government plans to make interferon beta and glatiramer available to patients with multiple sclerosis through a risk sharing scheme, despite lack of evidence of cost effectiveness. Sudlow and colleagues argue that the money would be better spent on independent research.	Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Aberdeen Royal Infirm, Dept Neurol, Aberdeen AB25 2ZN, Scotland	University of Edinburgh; University of Aberdeen	Sudlow, CLM (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	csudlow@skull.dcn.ed.ac.uk		Sudlow, Cathie/0000-0002-7725-7520	Wellcome Trust [063668] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *ASS BRIT NEUR WOR, 2002, AC NEUR EM AD; BORNSTEIN MB, 1991, NEUROLOGY, V41, P533, DOI 10.1212/WNL.41.4.533; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; CLEGG A, 2000, HLTH TECHNOLOGY ASSE, V4; Collins R, 1996, OXFORD TXB MED, V1, P21; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Confavreux C, 1996, NEUROLOGY, V46, P1607, DOI 10.1212/WNL.46.6.1607; Department of Health, 2002, 2002004 DEP HLTH HLT; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; ELLISON GW, 1989, NEUROLOGY, V39, P1018, DOI 10.1212/WNL.39.8.1018; GHEZZI A, 1989, INT CONGR SER, V863, P345; GOODKIN DE, 1991, NEUROLOGY, V41, P20, DOI 10.1212/WNL.41.1.20; Goodkin DE, 2000, NEUROLOGY, V54, P2352; HUGHES RAC, 1988, LANCET, V2, P179; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; King J, 2001, NEUROLOGY, V56, P1496; KINLEN LJ, 1985, AM J MED, V78, P44, DOI 10.1016/0002-9343(85)90245-1; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; MERTIN J, 1982, LANCET, V2, P351; MILANESE C, 1993, J NEUROL, V240, P295, DOI 10.1007/BF00838165; *MS STUD GROUP, 1999, LANCET, V53, P679; *NAT I CLIN EXC, BET INT GLAT AC TREA; *NO YORKSH REG DRU, 2000, ASS INT GLAT TREATM; NOSEWORTHY JH, 1994, NEUROLOGY, V44, P16, DOI 10.1212/WNL.44.1.16; Rice G, 1998, ARCH NEUROL-CHICAGO, V55, P1578, DOI 10.1001/archneur.55.12.1578; Rice GPA, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002002; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SWINBURN WR, 1973, J NEUROL NEUROSUR PS, V36, P124, DOI 10.1136/jnnp.36.1.124; Tappenden P, 2001, COST EFFECTIVENESS B; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E	42	50	50	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					388	392		10.1136/bmj.326.7385.388	http://dx.doi.org/10.1136/bmj.326.7385.388			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586677	Green Submitted, Green Published			2022-12-01	WOS:000181165500027
J	Steinman, MA; Landefeld, CS; Gonzales, R				Steinman, MA; Landefeld, CS; Gonzales, R			Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE BRONCHITIS; PATIENTS EXPECTATIONS; EDUCATIONAL OUTREACH; PHYSICIANS BEHAVIOR; CLINICAL-PRACTICE; CONTROLLED TRIAL; DRUG COMPANIES; PERCEPTIONS; PRESCRIPTION; PRINCIPLES	Context Broad-spectrum antibiotics are commonly prescribed, but little is known about the physicians who prescribe and the patients who take these agents. Objective To identify factors associated with prescribing of broad-spectrum antibiotics by physicians caring for patients with nonpneumonic acute respiratory tract infections (ARTIs). Design, Setting, and Patients Cross-sectional study using data from the National Ambulatory Medical Care Survey between 1997 and 1999. Information was collected on a national sample of 1981 adults seen by physicians for the common cold and nonspecific upper respiratory tract infections (URTIs) (24%), acute sinusitis (24%), acute bronchitis (23%), otitis media (5%), pharyngitis, laryngitis, and tracheitis (11%), or more than 1 of the above diagnoses (13%). Main Outcome Measure Prescription of broad-spectrum antibiotics, defined for this study as quinolones; amoxicillin/clavulanate, second- and third-generation cephalosporins, and azithromycin and clarithromycin. Results, Antibiotics were prescribed to 63% of patients with an ARTI, ranging from 46% of patients with,the common cold or nonspecific URTIs to 69% of patients with acute sinusitis. Broad-spectrum agents were chosen in 54% of patients prescribed an antibiotic, including 51% of patients with the common cold and nonspecific URTIs, 53% with acute sinusitis, 62% with acute bronchitis, and 65% with otitis media. Multivariable analysis identified several clinical and nonclinical factors associated with choice of a broad-spectrum agent. After adjusting for diagnosis and chronic comorbid illnesses, the strongest independent predictors of broad-spectrum antibiotic prescribing were physician specialty (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.6-3.5 for internal medicine physicians compared with general and family physicians) and geographic region (OR, 2.6; 95% CI, 1.4-4.8 for Northeast and OR, 2.4; 95% CI, 1.4-4.2 for South [both compared with West]). Other independent predictors of choosing a broad-spectrum agent included black race, lack of health insurance, and health maintenance organization membership, each of which was associated with lower rates of broad-spectrum prescribing. Patient age, sex, and urban vs rural location were not significantly associated with prescribing choice. Conclusions Broad-spectrum antibiotics are commonly prescribed for the treatment of ARTIs, especially by internists and physicians in the Northeast and South. These high rates of prescribing, wide variations in practice patterns, and the strong association of nonclinical factors with antibiotic choice suggest opportunities to improve prescribing patterns.	San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, VA Natl Qual Scholars Program, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Steinman, MA (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Box 181-G, San Francisco, CA 94121 USA.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Avery AJ, 1997, BRIT J GEN PRACT, V47, P810; Avorn J, 2000, ANN INTERN MED, V133, P128, DOI 10.7326/0003-4819-133-2-200007180-00012; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bell RA, 1999, J FAM PRACTICE, V48, P446; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CARRIN G, 1987, HEALTH POLICY, V7, P73, DOI 10.1016/0168-8510(87)90048-0; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P800; Chew LD, 2000, J GEN INTERN MED, V15, P478, DOI 10.1046/j.1525-1497.2000.08014.x; CHREN MM, 1989, JAMA-J AM MED ASSOC, V262, P3448, DOI 10.1001/jama.262.24.3448; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; EPSTEIN AM, 1984, AM J MED, V77, P313, DOI 10.1016/0002-9343(84)90709-5; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hadley J, 1999, HEALTH SERV RES, V34, P307; Hamm RM, 1996, J FAM PRACTICE, V43, P56; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Hasty M, 1999, J GEN INTERN MED, V14, P756, DOI 10.1046/j.1525-1497.1999.04099.x; HEMMINKI E, 1975, SOC SCI MED, V9, P111, DOI 10.1016/0037-7856(75)90103-1; Hutchinson JM, 1999, CAN MED ASSOC J, V160, P1013; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Lambert BL, 1997, SOC SCI MED, V45, P1767, DOI 10.1016/S0277-9536(97)00108-1; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; LURIE N, 1990, J GEN INTERN MED, V5, P240, DOI 10.1007/BF02600542; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mainous AG, 1998, ARCH PEDIAT ADOL MED, V152, P349; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; Mather J. L., 1994, Canadian Journal of Hospital Pharmacy, V47, P111; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Metlay JP, 2002, J GEN INTERN MED, V17, P87, DOI 10.1046/j.1525-1497.2002.10711.x; *NAT CTR HLTH STAT, 2001, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 2000, PUBL US MICR FIL DOC; *NAT CTR HLTH STAT, 1999, PUBL US MICR FIL DOC; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Piccirillo JF, 2001, JAMA-J AM MED ASSOC, V286, P1849, DOI 10.1001/jama.286.15.1849; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; SAFAVI KT, 1992, J GEN INTERN MED, V7, P32, DOI 10.1007/BF02599099; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Snow V, 2001, ANN INTERN MED, V134, P487, DOI 10.7326/0003-4819-134-6-200103200-00014; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Soumerai SB, 2000, PHARMACOEPIDEM DR S, P483; Takata GS, 2001, PEDIATRICS, V108, P239, DOI 10.1542/peds.108.2.239; *US DEP HHS, 1988, INT CLASS DIS 9 REV; Walker S, 2000, CAN MED ASSOC J, V163, P273; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296	58	210	214	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					719	725		10.1001/jama.289.6.719	http://dx.doi.org/10.1001/jama.289.6.719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585950	Bronze			2022-12-01	WOS:000180886000026
J	Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB				Tassicker, R; Savulescu, J; Skene, L; Marshall, P; Fitzgerald, L; Delatycki, MB			Prenatal diagnosis requests for Huntington's disease when the father is at risk and does not want to know his genetic status: clinical, legal, and ethical viewpoints	BRITISH MEDICAL JOURNAL			English	Article									Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Fac Law, Parkville, Vic 3052, Australia; Launceston Gen Hosp, Dept Psychiat, Launceston, Tas 7250, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Delatycki, MB (corresponding author), Royal Childrens Hosp, Genet Hlth Serv Victoria, Flemington Rd, Parkville, Vic 3052, Australia.		Delatycki, Martin B/A-5409-2013					Binedell J, 1998, CLIN GENET, V54, P477; Craufurd D, 1996, PRENATAL DIAG, V16, P1237, DOI 10.1002/(SICI)1097-0223(199612)16:13<1237::AID-PD98>3.0.CO;2-T; Decruyenaere M, 1996, J MED GENET, V33, P737, DOI 10.1136/jmg.33.9.737; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Richards F, 1997, AUST SOC WORK, V50, P61, DOI DOI 10.1080/03124079708415747; ROSE P, 1999, PRACTICAL GENETICS P; Savulescu J, 1997, J MED ETHICS, V23, P282, DOI 10.1136/jme.23.5.282; WENT L, 1994, J MED GENET, V31, P555	9	14	14	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					331	333		10.1136/bmj.326.7384.331	http://dx.doi.org/10.1136/bmj.326.7384.331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574051	Green Published			2022-12-01	WOS:000180997000025
J	Culi, J; Mann, RS				Culi, J; Mann, RS			Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila	CELL			English	Article							LONG-RANGE ACTION; VITELLOGENIN RECEPTOR; GENOME SEQUENCE; VESTIGIAL GENE; IN-VIVO; POLARITY; MELANOGASTER; TRANSDUCTION; EXPRESSION; HOMOLOG	The maturation of cell surface receptors through the secretory pathway often requires chaperones that aid in protein folding and trafficking from one organelle to another. Here we describe boca, an evolutionarily conserved gene in Drosophila melanogaster, which encodes an endoplasmic reticulum protein that is specifically required for the intracellular trafficking of members of the low-density lipoprotein family of receptors (LDLRs). Two LDLRs in flies, Arrow, which is required for Wingless signal transduction, and Yolkless, which is required for yolk protein uptake during oogenesis, both require boca function. Consequently, boca is an essential component of the Wingless pathway but is more generally required for the activities of multiple LDL receptor family members.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St,HHSC 1104, New York, NY 10032 USA.		Culi, Joaquim/Y-6270-2019	Culi, Joaquim/0000-0001-6233-7379	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM058575] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054510, R01 GM058575] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; BAKER NE, 1988, DEVELOPMENT, V102, P489; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Bu GJ, 2001, INT REV CYTOL, V209, P79; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Chou TB, 1996, GENETICS, V144, P1673; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COUSO JP, 1994, DEVELOPMENT, V120, P621; Dantuma NP, 1999, J LIPID RES, V40, P973; DEAK II, 1978, DEV BIOL, V66, P422, DOI 10.1016/0012-1606(78)90249-X; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Grandea AG, 2001, TRENDS IMMUNOL, V22, P194, DOI 10.1016/S1471-4906(01)01861-0; HEITZLER P, 1993, GENETICS, V135, P105; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Milanesi L, 1999, BIOINFORMATICS, V15, P612, DOI 10.1093/bioinformatics/15.7.612; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rulifson EJ, 1996, NATURE, V384, P72, DOI 10.1038/384072a0; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Sen J, 2000, DEVELOPMENT, V127, P5541; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Uden E, 1999, NEUROSCIENCE, V88, P687, DOI 10.1016/S0306-4522(98)00272-3; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	57	117	129	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					343	354		10.1016/S0092-8674(02)01279-5	http://dx.doi.org/10.1016/S0092-8674(02)01279-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581524	Bronze			2022-12-01	WOS:000181252200006
J	Hill, JO; Wyatt, HR; Reed, GW; Peters, JC				Hill, JO; Wyatt, HR; Reed, GW; Peters, JC			Obesity and the environment: Where do we go from here?	SCIENCE			English	Editorial Material							ENERGY-EXPENDITURE; COST		Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, Denver, CO 80262 USA; Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; Procter & Gamble Co, Cincinnati, OH 45252 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Massachusetts System; University of Massachusetts Worcester; Procter & Gamble	Hill, JO (corresponding author), Univ Colorado, Hlth Sci Ctr, Ctr Human Nutr, 4200 E 9th Ave, Denver, CO 80262 USA.	james.hill@uchsc.edu			NIDDK NIH HHS [DK42549, DK48520] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK042549, R37DK042549] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, SURG GEN CALL ACT PR; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Blundell JE, 1998, INT J OBESITY, V22, pS22; DONNELLY JD, IN PRESS ARCH INTERN; Economos CD, 2001, NUTR REV, V59, pS40; FRENCH SA, 2001, ANNU REV PUBL HEALTH, V22, P63, DOI DOI 10.1146/ANNUREV.PUBLHEALTH.22.1.309; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gleick J., 1999, ACCELERATION JUST EV; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; HORTON TJ, 1995, AM J CLIN NUTR, V62, P19, DOI 10.1093/ajcn/62.1.19; Kortt MA, 1998, CLIN THER, V20, P772, DOI 10.1016/S0149-2918(98)80140-9; Lewis CE, 2001, CIRCULATION, V104, P787; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Reich RB, 2001, FUTURE SUCCESS; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; TREMBLAY A, 1992, AM J CLIN NUTR, V56, P857, DOI 10.1093/ajcn/56.5.857; Wadden T. A., 2002, Handbook of obesity treatment, P144; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x	19	1520	1547	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					853	855		10.1126/science.1079857	http://dx.doi.org/10.1126/science.1079857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574618				2022-12-01	WOS:000180830900039
J	Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O				Mazmanian, SK; Skaar, EP; Gaspar, AH; Humayun, M; Gornicki, P; Jelenska, J; Joachmiak, A; Missiakas, DM; Schneewind, O			Passage of heme-iron across the envelope of Staphylococcus aureus	SCIENCE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; PENICILLIN; HEMOGLOBIN; VIRULENCE; SORTASE; ANCHOR; FUR	The cell wall envelope of Gram-positive pathogens functions as a scaffold for the attachment of virulence factors and as a sieve that prevents diffusion of molecules. Here the isd genes (iron-regulated surface determinant) of Staphylococcus aureus were found to encode factors responsible for hemoglobin binding and passage of heme-iron to the cytoplasm, where it acts as an essential nutrient. Heme-iron passage required two sortases that tether Isd proteins to unique locations within the cell wall. Thus, Isd appears to act as an import apparatus that uses cell wall-anchored proteins to relay heme-iron across the bacterial envelope.	Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Schneewind, O (corresponding author), Univ Chicago, Comm Microbiol, 920 E 58th St, Chicago, IL 60637 USA.		Humayun, Munir/A-1247-2007	Humayun, Munir/0000-0001-8516-9435	NIAID NIH HHS [AI5474, AI38897] Funding Source: Medline; NIGMS NIH HHS [GM58266] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058266] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNHEIMER AW, 1968, J BACTERIOL, V96, P487, DOI 10.1128/JB.96.2.487-491.1968; BHAKDI S, 1984, PHILOS T R SOC B, V306, P311, DOI 10.1098/rstb.1984.0092; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; STROMINGER JL, 1967, SCIENCE, V156, P213, DOI 10.1126/science.156.3772.213	23	461	495	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					906	909		10.1126/science.1081147	http://dx.doi.org/10.1126/science.1081147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574635				2022-12-01	WOS:000180830900057
J	Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD				Allen, SA; Spaulding, AC; Osei, AM; Taylor, LE; Cabral, AM; Rich, JD			Treatment of chronic hepatitis C in a state correctional facility	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIVIRAL TREATMENT; INFECTION	Background: Approximately 1 in 4 of the nearly 2 million individuals in state and federal correctional facilities are infected with hepatitis C virus (HCV). Currently, there are few reports of treatment outcomes of this common infection in this setting. Objective: To describe HCV therapy in the incarcerated setting. Design: Retrospective, descriptive observational study. Setting: Rhode Island Department of Corrections, Cranston, Rhode island. Patients: 93 inmates with chronic HCV infection. Intervention: Interferon-alpha with ribavirin. Measurements: HCV RNA levels 6 months after treatment. Results: Response rates are similar to previously published rates achieved in the community; 63% (50 of 79) of patients achieved viral clearance after 6 months of therapy, and 46% (26 of 57) achieved sustained response 6 months after treatment. Conclusion: The incarcerated population (which is disproportionately affected by addiction and psychiatric illness) can be effectively treated for HCV infection with interferon and ribavirin. The correctional setting may provide an opportunity to safely treat patients with these two challenging comorbid conditions.	Miriam Hosp, Providence, RI 02906 USA; Rhode Isl Dept Correct, Cranston, RI USA; Brown Univ, Sch Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University	Rich, JD (corresponding author), Miriam Hosp, 164 Summit Ave, Providence, RI 02906 USA.	jrich@lifespan.org	Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714; Taylor, Lynn/0000-0002-0472-8125	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NIAID NIH HHS [P30-AI-42853] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; HAMMET TM, 2002, NAT HIV PREV C ATL G; MACALINO GE, 2002, 1999 NAT HIV PREV C; *NIH, 2002, CONS DEV C STAT MAN; Reindollar Robert W., 1999, American Journal of Medicine, V107, p100S; Rich JD, 2001, AM J PUBLIC HEALTH, V91, P699, DOI 10.2105/AJPH.91.5.699; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	13	98	99	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					187	190		10.7326/0003-4819-138-3-200302040-00010	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558357				2022-12-01	WOS:000181018600004
J	Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R				Carney, PA; Miglioretti, DL; Yankaskas, BC; Kerlikowske, K; Rosenberg, R; Rutter, CM; Geller, BM; Abraham, LA; Taplin, SH; Dignan, M; Cutter, G; Ballard-Barbash, R			Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER RISK; SENSITIVITY; ESTROGEN; WOMEN; ASSOCIATION; SPECIFICITY; PROGESTIN; HISTORY; TRIAL	Background: The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated. Objective: To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography. Design: Prospective cohort study. Setting: 7 population-based mammography registries in North Carolina; New Mexico; New Hampshire; Vermont; Colorado; Seattle, Washington; and San Francisco, California. Participants: 329 495 women 40 to 89 years of age who had 463 372 screening mammograms from 1996 to 1998; 2223 women received a diagnosis of breast cancer. Measurements: Breast density, age, HRT use, rate of breast cancer occurrence, and sensitivity and specificity of screening mammography. Results: Adjusted sensitivity ranged from 62.9% in women with extremely dense breasts to 87.0% in women with almost entirely fatty breasts; adjusted sensitivity increased with age from 68.6% in women 40 to 44 years of age to 83.3% in women 80 to 89 years of age. Adjusted specificity increased from 89.1% in women with extremely dense breasts to 96.9% in women with almost entirely fatty breasts. In women who did not use HRT, adjusted specificity increased from 91.4% in women 40 to 44 years of age to 94.4% in women 80 to 89 years of age. In women who used HRT, adjusted specificity was about 91.7% for all ages. Conclusions: Mammographic breast density and age are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.	Dartmouth Coll, Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Univ Vermont, Burlington, VT 05405 USA; AMC Canc Res Ctr, Denver, CO USA; NCI, Bethesda, MD 20892 USA	Dartmouth College; Group Health Cooperative; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of New Mexico; University of Vermont; AMC Cancer Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Carney, PA (corresponding author), Dartmouth Coll, Sch Med, Dept Community & Family Med, 1 Med Ctr Dr,HB 7925, Lebanon, NH 03756 USA.	Patricia.A.Carney@dartmouth.edu	Rutter, Carolyn/AAZ-3677-2021; SALAZAR, ANTONIO/A-5806-2013; Cutter, Gary/AAY-5392-2021	SALAZAR, ANTONIO/0000-0003-2639-2340; Cutter, Gary/0000-0002-8455-980X	NATIONAL CANCER INSTITUTE [U01CA086082, U01CA070040, U01CA069976, U01CA086076, U01CA063731, U01CA070013, R01CA080888, U01CA063736, U01CA063740] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA70040, UO1CA86076, UO1CA86082, R01 CA80888, UO1CA63731, UO1CA63736, UO1CA63740, UO1CA69976, UO1CA70013] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American College of Radiology (ACR), 1998, ILL BREAST IM REP DA; [Anonymous], 1994, AHCPR PUBL, V94-0592; Baines CJ, 1997, CANCER-AM CANCER SOC, V80, P720; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Byrne C, 1997, J NATL CANCER I, V89, P531, DOI 10.1093/jnci/89.8.531; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; COVENEY EC, 1994, CLIN RADIOL, V49, P123, DOI 10.1016/S0009-9260(05)83454-3; Ernster V L, 1997, J Natl Cancer Inst Monogr, P151; Harvey SC, 1996, AM J ROENTGENOL, V167, P394, DOI 10.2214/ajr.167.2.8686614; HOUN F, 1995, RADIOL CLIN N AM, V33, P1059; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Lam PB, 2000, CANCER, V89, P369, DOI 10.1002/1097-0142(20000715)89:2&lt;369::AID-CNCR23&gt;3.0.CO;2-J; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; Leung W, 1997, SURGERY, V122, P669, DOI 10.1016/S0039-6060(97)90072-6; Litherland JC, 1997, CLIN RADIOL, V52, P276, DOI 10.1016/S0009-9260(97)80053-0; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; Pankow JS, 1997, J NATL CANCER I, V89, P549, DOI 10.1093/jnci/89.8.549; Persson I, 1997, J CLIN ONCOL, V15, P3201, DOI 10.1200/JCO.1997.15.10.3201; Rosenberg RD, 2000, ACAD RADIOL, V7, P1058, DOI 10.1016/S1076-6332(00)80057-4; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Taplin SH, 2002, RADIOLOGY, V222, P529, DOI 10.1148/radiol.2222010647; Thurfjell EL, 1997, RADIOLOGY, V203, P339, DOI 10.1148/radiology.203.2.9114085; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; White E, 1998, J NATL CANCER I, V90, P906, DOI 10.1093/jnci/90.12.906; Yankaskas BC, 2001, AM J ROENTGENOL, V177, P543, DOI 10.2214/ajr.177.3.1770543	33	779	800	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					168	175		10.7326/0003-4819-138-3-200302040-00008	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558355				2022-12-01	WOS:000181018600002
J	Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B				Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B			Paucity of genes on the Drosophila X chromosome showing male-biased expression	SCIENCE			English	Article							MELANOGASTER; SPERMATOGENESIS; EVOLUTION; SEX	Sex chromosomes are primary determinants of sexual dimorphism in many organisms. These chromosomes are thought to arise via the divergence of an ancestral autosome pair and are almost certainly influenced by differing selection in mates and females. Exploring how sex chromosomes differ from autosomes is highly amenable to genomic analysis. We examined global gene expression in Drosophila melanogaster and report a dramatic underrepresentation of X-chromosome genes showing high relative expression in mates. Using comparative genomics, we find that these same X-chromosome genes are exceptionally poorly conserved in the mosquito Anopheles gambiae. These data indicate that the X chromosome is a disfavored location for genes selectively expressed in males.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Incyte Genom, Palo Alto, CA 94304 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA; NHGRI, Natl Inst Hlth Intramural Sequencing Ctr, NIH, US Dept HHS, Gaithersburg, MD 20877 USA; NIH, Ctr Informat Technol, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Incyte; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Oliver, B (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.		Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER; NIDDK NIH HHS [Z01 DK015600-10] Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kelly WG, 2002, DEVELOPMENT, V129, P479; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Oliver B, 2002, INT REV CYTOL, V219, P1; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.1111/j.1558-5646.1984.tb00346.x, 10.2307/2408385]; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	20	403	412	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					697	700		10.1126/science.1079190	http://dx.doi.org/10.1126/science.1079190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12511656	Green Accepted			2022-12-01	WOS:000180687700044
J	Ben-Yehuda, S; Rudner, DZ; Losick, R				Ben-Yehuda, S; Rudner, DZ; Losick, R			RacA, a bacterial protein that anchors chromosomes to the cell poles	SCIENCE			English	Article							BACILLUS-SUBTILIS SPOIIIE; DIVISION SEPTUM; DNA SEGREGATION; SITE; LOCALIZATION; DIVIVA; SPORULATION; SELECTION	Eukaryotic chromosomes are anchored to a spindle apparatus during mitosis, but no such structure is known during chromosome segregation in bacteria. When sister chromosomes are segregated during sporulation in Bacillus subtilis, the replication origin regions migrate to opposite poles of the cell. If and how origin regions are fastened at the poles has not been determined. Here we describe a developmental protein, RacA, that acts as a bridge between the origin region and the cell poles. We propose that RacA assembles into an adhesive patch at a centromere-like element near the origin, causing chromosomes to stick at the poles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NIGMS NIH HHS [GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Graumann PL, 2001, J BACTERIOL, V183, P4052, DOI 10.1128/JB.183.13.4052-4060.2001; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; RYTER A, 1966, ANN I PASTEUR PARIS, V110, P305; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393	23	254	262	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					532	536		10.1126/science.1079914	http://dx.doi.org/10.1126/science.1079914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12493822				2022-12-01	WOS:000180559800039
J	Fitzgerald, DW; Behets, FMT				Fitzgerald, DW; Behets, FMT			Women's health and human rights in HIV prevention research	LANCET			English	Editorial Material									Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA; Univ N Carolina, Sch Publ Hlth, Dept Med, Chapel Hill, NC USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fitzgerald, DW (corresponding author), Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA.							Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; COELHO HLL, 1993, LANCET, V341, P1261, DOI 10.1016/0140-6736(93)91157-H; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; PIOT P, PREFACE REPORT GLOBA; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954	5	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					68	69		10.1016/S0140-6736(03)12166-6	http://dx.doi.org/10.1016/S0140-6736(03)12166-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517474				2022-12-01	WOS:000180191600028
J	Yedid, G; Bell, G				Yedid, G; Bell, G			Macroevolution simulated with autonomously replicating computer programs	NATURE			English	Article							EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; POPULATIONS; ADAPTATION; DIVERGENCE; COMPLEXITY; RESISTANCE; DROSOPHILA; SELECTION; BACTERIA	The process of adaptation occurs on two timescales. In the short term, natural selection merely sorts the variation already present in a population, whereas in the longer term genotypes quite different from any that were initially present evolve through the cumulation of new mutations. The first process is described by the mathematical theory of population genetics. However, this theory begins by defining a fixed set of genotypes and cannot provide a satisfactory analysis of the second process because it does not permit any genuinely new type to arise. The evolutionary outcome of selection acting on novel variation arising over long periods is therefore difficult to predict. The classical problem of this kind is whether 'replaying the tape of life' would invariably lead to the familiar organisms of the modern biota(1,2). Here we study the long-term behaviour of populations of autonomously replicating computer programs and find that the same type, introduced into the same simple environment, evolves on any given occasion along a unique trajectory towards one of many well-adapted end points.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	McGill University; Michigan State University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.							ADAMI C, 1995, PHYSICA D, V80, P154, DOI 10.1016/0167-2789(95)90073-X; Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; Bull JJ, 1997, GENETICS, V147, P1497; COHAN FM, 1986, GENETICS, V114, P145; DYKHUIZEN D, 1981, EVOLUTION, V35, P581, DOI 10.1111/j.1558-5646.1981.tb04919.x; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Fisher R.A., 1930, GENETICAL THEORY NAT; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gould S.J., 1989, WONDERFUL LIFE BURGE; Hartley B.S., 1984, MICROORGANISMS MODEL, P23; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Nakatsu CH, 1998, J BACTERIOL, V180, P4325, DOI 10.1128/JB.180.17.4325-4331.1998; Ray T.S., 1991, SANTA FE I STUDIES S, VXI, P371; SPIEGELMAN S, 1971, Quarterly Reviews of Biophysics, V4, P213; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 1997, GENETICS, V146, P471; Wahl LM, 2000, GENETICS, V156, P1437; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; YIN J, 1993, J BACTERIOL, V175, P1272, DOI 10.1128/JB.175.5.1272-1277.1993	26	53	54	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					810	812		10.1038/nature01151	http://dx.doi.org/10.1038/nature01151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490948				2022-12-01	WOS:000179897300055
J	Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P				Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P			CREM-dependent transcription in male germ cells controlled by a kinesin	SCIENCE			English	Article							NUCLEAR EXPORT; LEPTOMYCIN-B; PROTEIN; CRM1; TRANSPORT; SIGNAL; ACTIVATION; INHIBITION; RECEPTOR; BINDING	ACT is a LIM-only protein expressed exclusively in round spermatids, where it cooperates with transcriptional activator CREM in regulating various postmeiotic genes. Targeted inactivation of CREM leads to a complete block of mouse spermiogenesis. We sought to identify the regulatory steps controlling the functional interplay between CREM and ACT. We found that ACT selectively associates with KIF17b, a kinesin highly expressed in male germ cells. The ACT-KIF17b interaction is restricted to specific stages of spermatogenesis and directly determines the intracellular localization of ACT. Sensitivity to leptomycin B indicates that KIF17b can be actively exported from the nucleus through the Crm1 receptor. Thus, a kinesin directly controls the activity of a transcriptional coactivator by a tight regulation of its intracellular localization.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tokyo	Sassone-Corsi, P (corresponding author), Inst Genet & Biol Mol & Cellulaire, BP 10142, F-67404 Strasbourg, France.	paolosc@gbmc.u-strasbg.fr	Brancorsini, Stefano/L-8770-2015; Sassone-Corsi, Paolo/H-6182-2011; Fimia, Gian Maria/K-3232-2016	Brancorsini, Stefano/0000-0002-8410-7248; Fimia, Gian Maria/0000-0003-4438-3325				Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PARVINEN M, 1993, METHODS TOXICOLOGY A, V3, P142; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	24	90	103	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2388	2390		10.1126/science.1077265	http://dx.doi.org/10.1126/science.1077265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493914				2022-12-01	WOS:000179915900056
J	Fieggen, G; Peter, J; Millar, A; Rode, H				Fieggen, G; Peter, J; Millar, A; Rode, H			Conjoined spinal cords in pygopagus twins	LANCET			English	Editorial Material									Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa		Fieggen, G (corresponding author), Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa.		Fieggen, Anthony Graham/AAT-6510-2021	Fieggen, Anthony Graham/0000-0001-6541-8377					0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1934	1934		10.1016/S0140-6736(02)11916-7	http://dx.doi.org/10.1016/S0140-6736(02)11916-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493260				2022-12-01	WOS:000179870200012
J	Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E				Ramsay, ME; Andrews, NJ; Trotter, CL; Kaczmarski, EB; Miller, E			Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis	BRITISH MEDICAL JOURNAL			English	Article									Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Manchester Publ Hlth Lab, Meningococcal Reference Unit, Publ Hlth Lab Serv, Manchester M20 2LR, Lancs, England	Public Health England	Ramsay, ME (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Trotter, Caroline/0000-0003-4000-2708; Ramsay, Mary Elizabeth/0000-0002-7156-7640				Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Trotter C L, 2002, Commun Dis Public Health, V5, P220; Trotter CL, 2002, BRIT MED J, V324, P809, DOI 10.1136/bmj.324.7341.809	5	306	320	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					365	366		10.1136/bmj.326.7385.365	http://dx.doi.org/10.1136/bmj.326.7385.365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586669	Bronze, Green Published			2022-12-01	WOS:000181165500019
J	Young, B; Dixon-Woods, M; Windridge, KC; Heney, D				Young, B; Dixon-Woods, M; Windridge, KC; Heney, D			Managing communication with young people who have a potentially life threatening chronic illness: qualitative study of patients and parents	BRITISH MEDICAL JOURNAL			English	Article							CANCER-PATIENTS; INFORMATION; CHILDREN; PREFERENCES; INTERVIEW	Objectives To examine young people's and parents' accounts of communication about cancer in childhood. Design Semistructured interviews analysed using the constant comparative method. Setting Paediatric oncology unit. Participants 13 families, comprising 19 parents (13 mothers, six fathers) and 13 patients aged 8-17 years. The patients had cancer or brain tumour. Results Most parents described acting in an executive-like capacity, managing what and how their children were told about their illness, particularly at the time of diagnosis. Their accounts were shaped by concerns to manage their identity as strong and optimistic parents and to protect their child's wellbeing. The patients identified elements of their parents' role that both facilitated and constrained their communication, and while they welcomed their parents' involvement, some expressed unease with the constraining aspects of their parents' role. Some young people described feeling marginalised in consultations and pointed to difficulties they experienced in encounters with some doctors. Conclusions There are difficulties in managing communication with young people who have a chronic, life threatening illness. Health professionals need to be aware of how the social positioning of young people (relative to adults) and the executive role of parents can contribute to the marginalisation of young people and hamper the development of successful relationships between themselves and young patients.	Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ Leicester, Leicester Gen Hosp, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Leicester Royal Infirm, Childrens Hosp, Leicester LE1 5WW, Leics, England	University of Hull; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Young, B (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.		Young, Bridget/A-2184-2014	Young, Bridget/0000-0001-6041-9901; Dixon-Woods, Mary/0000-0002-5915-0041				Alderson P., 1993, CHILDRENS CONSENT SU; Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; BLUEBONDLANGNER.M, 1978, PRIVATE WORLDS DYING; British Medical Association, 2001, CONSENT RIGHTS CHOIC; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; CLAFLIN CJ, 1991, J PEDIATR PSYCHOL, V16, P169, DOI 10.1093/jpepsy/16.2.169; DAVIS A, 1982, CHILDREN CLIN; Dixon-Woods M, 1999, BRIT MED J, V319, P778, DOI 10.1136/bmj.319.7212.778; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; GAHAN C, 1998, DOING QUALITATIVE AN; Glaser B. G., 1978, THEORETICAL SENSITIV; Goffman E., 1959, PRESENTATION SELF EV; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Hunt Pauline, 1990, CONSTRUCTING RECONST, P99; JAMES N, 1989, SOV REV, V37, P118; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Mayall Berry., 1996, CHILDREN HLTH SOCIAL; SCOTT JT, 2002, COCHRANE LIB; STEWART TJ, 1981, J FAM PRACTICE, V13, P827; STRONG PM, 1979, CEREMONIAL ORDER CLI; Tates K, 2001, SOC SCI MED, V52, P839, DOI 10.1016/S0277-9536(00)00193-3; TIMMERMANS S, 1994, SOCIOL HEALTH ILL, V16, P322, DOI 10.1111/1467-9566.ep11348751; van Dulmen AM, 1998, PEDIATRICS, V102, P563, DOI 10.1542/peds.102.3.563	23	173	176	1	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					305	308B		10.1136/bmj.326.7384.305	http://dx.doi.org/10.1136/bmj.326.7384.305			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574042	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000180997000016
J	Qaim, M; Zilberman, D				Qaim, M; Zilberman, D			Yield effects of genetically modified crops in developing countries	SCIENCE			English	Article								Onfarm field trials carried out with Bacillus thuringiensis (Bt) cotton in different states of India show that the technology substantially reduces pest damage and increases yields. The yield gains are much higher than what has been reported for other countries where genetically modified crops were used mostly to replace and enhance chemical pest control. In many developing countries, small-scale farmers especially suffer big pest-related yield losses because of technical and economic constraints. Pest-resistant genetically modified crops can contribute to increased yields and agricultural growth in those situations, as the case of Bt cotton in India demonstrates.	Univ Bonn, Ctr Dev Res, D-53113 Bonn, Germany; Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA	University of Bonn; University of California System; University of California Berkeley	Qaim, M (corresponding author), Univ Bonn, Ctr Dev Res, Walter Flex Str 3, D-53113 Bonn, Germany.	mqaim@uni-bonn.de	Qaim, Matin/P-4489-2016	Qaim, Matin/0000-0003-4143-0763				ALTIERI MA, 2001, 1 FOOD 1; Carpenter J, 2002, COMP ENV IMPACTS BIO; Committee on the Future Role of Pesticides in U.S. Agriculture, 2000, FUT ROL PEST US AGR; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; *IND COUNC AGR RES, 2002, ALL IND COORD COTT I, P97; *ISAAA, 2002, BT COTT IND; *ISCI, 1999, HDB COTTON IND; ISMAEL Y, 2002, AGBIOFORUM, V5, P4; Jayaraman KS, 2002, NAT BIOTECHNOL, V20, P415, DOI 10.1038/nbt0502-415; Lauer J, 1999, J PROD AGRIC, V12, P373, DOI 10.2134/jpa1999.0373; Moffat AS, 1999, SCIENCE, V285, P370, DOI 10.1126/science.285.5426.370; Oerke EC, 1994, CROP PRODUCTION CROP; Paarlberg RobertL., 2001, POLITICS PRECAUTION; PINSTRUPANDERSE.P, 2001, SEEDS CONTENTION WOR; Pray CE, 2002, PLANT J, V31, P423, DOI 10.1046/j.1365-313X.2002.01401.x; Puri S.N., 1999, HDB COTTON INDIA, P233; QAIM M, 2002, 6 INT C INT CONS AGR; Qaim M., 2000, AGR BIOTECHNOLOGY DE; RUTTAN VW, 1999, AGBIOFORUM, V2, P54; *UK SOIL ASS, 2002, SEEDS DOUBT N AM FAR, P11; WIDAWSKY D, 1998, AGR EC, V19, P205; WOSSINK GAA, 1998, EC AGROCHEMICALS INT; ZILBERMAN D, 1991, SCIENCE, V253, P518, DOI 10.1126/science.253.5019.518	25	375	416	0	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					900	902		10.1126/science.1080609	http://dx.doi.org/10.1126/science.1080609			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574633				2022-12-01	WOS:000180830900055
J	Rich, P				Rich, P			The cost of living	NATURE			English	Editorial Material									UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Rich, P (corresponding author), UCL, Dept Biol, Gower St, London WC1E 6BT, England.							Gilbert G.N., 1984, OPENING PANDORAS BOX; Kiberstis PA, 1999, SCIENCE, V283, P1475; PREBBLE J, 2003, WANDERING GARDENS MI; 1997, CATALOGUE PAPERS COR	4	78	80	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					583	583		10.1038/421583a	http://dx.doi.org/10.1038/421583a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571574	Bronze			2022-12-01	WOS:000180803200021
J	Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S				Yankovskaya, V; Horsefield, R; Tornroth, S; Luna-Chavez, C; Miyoshi, H; Leger, C; Byrne, B; Cecchini, G; Iwata, S			Architecture of succinate dehydrogenase and reactive oxygen species generation	SCIENCE			English	Article							COLI FUMARATE REDUCTASE; QUINONE BINDING-SITES; ESCHERICHIA-COLI; COMPLEX-II; HEREDITARY PARAGANGLIOMA; RESPIRATORY-CHAIN; 2FE-2S CLUSTER; MUTATIONS; GENE; REPLACEMENT	The structure of Escherichia coli succinate dehydrogenase (SQR), analogous to the mitochondrial respiratory complex II, has been determined, revealing the electron transport pathway from the electron donor, succinate, to the terminal electron acceptor, ubiquinone. It was found that the SQR redox centers are arranged in a manner that aids the prevention of reactive oxygen species (ROS) formation at the flavin adenine dinucleotide. This is likely to be the main reason SQR is expressed during aerobic respiration rather than the related enzyme fumarate reductase, which produces high levels of ROS. Furthermore, symptoms of genetic disorders associated with mitochondrial SQR mutations may be a result of ROS formation resulting from impaired electron transport in the enzyme.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; Uppsala Univ, Dept Biochem, S-75123 Uppsala, Sweden; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England	Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Uppsala University; University of California System; University of California San Francisco; Kyoto University; University of Oxford; Imperial College London	Cecchini, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.	ceccini@itsa.ucsf.edu; s.iwata@ic.ac.uk	Léger, Christophe/C-7230-2016; Horsefield, Rob/B-1378-2010; Törnroth-Horsefield, Susanna/B-2702-2010	Léger, Christophe/0000-0002-8871-6059; Byrne, Bernadette/0000-0001-9598-9832; Tornroth-Horsefield, Susanna/0000-0002-9435-8243	NIGMS NIH HHS [GM61606] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; Hagen WR, 2000, J BIOL INORG CHEM, V5, P527, DOI 10.1007/PL00021452; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hederstedt L, 1999, SCIENCE, V284, P1941, DOI 10.1126/science.284.5422.1941; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Kita K, 2002, BBA-BIOENERGETICS, V1553, P123, DOI 10.1016/S0005-2728(01)00237-7; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU L, 1987, J BIOL CHEM, V262, P1137	31	651	685	22	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					700	704		10.1126/science.1079605	http://dx.doi.org/10.1126/science.1079605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560550				2022-12-01	WOS:000180687700045
J	Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F				Orlicky, S; Tang, XJ; Willems, A; Tyers, M; Sicheri, F			Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase	CELL			English	Article							CYCLIN-E; MULTISITE PHOSPHORYLATION; PROTEOLYSIS; COMPLEX; DEGRADATION; PROTEINS; INSIGHTS; RECOGNITION; TARGETS; NOTCH	Cell cycle progression depends on precise elimination of cyclins and cyclin-dependent kinase (CDK) inhibitors by the ubiquitin system. Elimination of the CDK inhibitor Sic1 by the SCFCdc4 ubiquitin ligase at the onset of S phase requires phosphorylation of Sic1 on at least six of its nine Cdc4-phosphodegron (CPD) sites. A 2.7 Angstrom X-ray crystal structure of a Skp1-Cdc4 complex bound to a high-affinity CPD phosphopeptide from human cyclin E reveals a core CPD motif, Leu-Leu-pThr-Pro, bound to an eight-bladed WD40 propeller domain in Cdc4. The low affinity of each CPD motif in Sic1 reflects structural discordance with one or more elements of the Cdc4 binding site. Reengineering of Cdc4 to reduce selection against Sic1 sequences allows ubiquitination of lower phosphorylated forms of Sic1. These features account for the observed phosphorylation threshold in Sic1 recognition and suggest an equilibrium binding mode between a single receptor site in Cdc4 and multiple low-affinity CPD sites in Sic1.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca; sicheri@mshri.on.ca	Sicheri, Frank/F-8856-2013; Tyers, Michael/ABE-3194-2021	Orlicky, Stephen/0000-0002-8172-2042				Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	48	418	427	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					243	256		10.1016/S0092-8674(03)00034-5	http://dx.doi.org/10.1016/S0092-8674(03)00034-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553912	Bronze			2022-12-01	WOS:000181191600013
J	Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A				Chanteau, S; Rahalison, L; Ralafiarisoa, L; Foulon, J; Ratsitorahina, M; Ratsifasoamanana, L; Carniel, E; Nato, A			Development and testing of a rapid diagnostic test for bubonic and pneumonic plague	LANCET			English	Article							IMMUNOCHROMATOGRAPHIC ASSAY; MADAGASCAR; ANTIGEN	Background Plague is often fatal without prompt and appropriate treatment. It affects mainly poor and remote populations. Late diagnosis is one of the major causes of human death and spread of the disease, since it limits the effectiveness of control measures. We aimed to develop and assess a rapid diagnostic test (RDT) for plague. Methods We developed a test that used monoclonal antibodies to the F1 antigen of Yersinia pestis. Sensitivity and specificity were assessed with a range of bacterial cultures and clinical samples, and compared with findings from available ELISA and bacteriological tests for plague. Samples from patients thought to have plague were tested with the RDT in the laboratory and by health workers in 26 pilot sites in Madagascar. Findings The RDT detected concentrations of F1 antigen as low as 0.5 ng/mL in up to 15 min, and had a shelf life of 21 days at 60degreesC. Its sensitivity and specificity were both 100%. RDT detected 41.6% and 31% more positive clinical specimens than did bacteriological methods and ELISA, respectively. The agreement rate between tests done at remote centres and in the laboratory was 89.8%. With the combination of bacteriological methods and F1 ELISA as reference standard, the positive and negative predictive values of the ROT were 90.6% and 86.7%, respectively. Interpretation Our RDT is a specific, sensitive, and reliable test that can easily be done by health workers at the patient's bedside, for the rapid diagnosis of pneumonic and bubonic plague. This test will be of key importance for the control of plague in endemic countries.	WHO, Collaborating Ctr Plague, Inst Pasteur Madagascar, Antananarivo, Madagascar; Minist Hlth, Plague Natl Control Programme, Antananarivo, Madagascar; WHO, Collaborating Ctr Yersinia, Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Chanteau, S (corresponding author), CERMES, POB 10 887, Niamey, Niger.							BAKER EE, 1952, J IMMUNOL, V68, P131; Bellamy RJ, 2001, QJM-MON J ASSOC PHYS, V94, P227, DOI 10.1093/qjmed/94.4.227; BIMBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; BRUBAKER R R, 1970, Infection and Immunity, V1, P446; Chanteau S, 2000, MICROBES INFECT, V2, P25, DOI 10.1016/S1286-4579(00)00289-6; Chanteau S, 1998, EMERG INFECT DIS, V4, P101, DOI 10.3201/eid0401.980114; Chanteau S, 1998, T ROY SOC TROP MED H, V92, P572, DOI 10.1016/S0035-9203(98)90923-3; Chanteau S, 2000, INT J MED MICROBIOL, V290, P279; CHEN TH, 1966, B WORLD HEALTH ORGAN, V34, P911; Cole RA, 1996, TUBERCLE LUNG DIS, V77, P363, DOI 10.1016/S0962-8479(96)90103-3; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Makler MT, 1998, ANN TROP MED PARASIT, V92, P419, DOI 10.1080/00034989859401; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; *WHO, 2000, WKLY EPIDEMIOL REC, V75, P337; WILLIAMS JE, 1986, B WORLD HEALTH ORGAN, V64, P745	21	129	149	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					211	216		10.1016/S0140-6736(03)12270-2	http://dx.doi.org/10.1016/S0140-6736(03)12270-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547544				2022-12-01	WOS:000180535400010
J	Hoy, D; Toole, MJ; Morgan, D; Morgan, C				Hoy, D; Toole, MJ; Morgan, D; Morgan, C			Low back pain in rural Tibet	LANCET			English	Article								In a baseline assessment of 30 rural villages surrounding Shigatse City, Tibet, many people, especially women, identified low back pain as a serious health problem. Consequently, we aimed to establish the prevalence of such pain and to develop appropriate interventions. We did a cross-sectional study of the prevalence of low back pain and related functional disability using two-stage random cluster sampling. We included 499 adults aged at least 15 years from 19 villages. The point prevalence of low back pain was 34.1% (95% CI 27.9-40.3% [170 people]); the 12-month prevalence was 41.9% (35.5-48.3% [209 people]). 100 (20%) villagers had substantial functional disability associated with low back pain. Low back pain is likely to be an important and under recognised problem in rural societies like Tibet.	Ctr Int Hlth, Burnet Inst, Melbourne, Vic 3001, Australia	Burnet Institute	Hoy, D (corresponding author), Ctr Int Hlth, Burnet Inst, POB 2284, Melbourne, Vic 3001, Australia.		Morgan, Chris/L-1613-2019	Morgan, Chris/0000-0003-0931-5474				Anderson R T, 1984, Med Anthropol, V8, P46; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; TOROPTSOVA NV, 1995, SPINE, V20, P328, DOI 10.1097/00007632-199502000-00012; WIGLEY RD, 1994, J RHEUMATOL, V21, P1484	4	51	52	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					225	226		10.1016/S0140-6736(03)12254-4	http://dx.doi.org/10.1016/S0140-6736(03)12254-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547548				2022-12-01	WOS:000180535400014
J	Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL				Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL			Coupling of agonist binding to channel gating in the GABA(A) receptor	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; MUTATIONS; SUBUNIT; AFFINITY; SITE; PORE; M2	Neurotransmitters such as acetylcholine and GABA (gamma-aminobutyric acid) mediate rapid synaptic transmission by activating receptors belonging to the gene superfamily of ligand-gated ion channels (LGICs)(1). These channels are pentameric proteins that function as signal transducers, converting chemical messages into electrical signals(2). Neurotransmitters activate LGICs by interacting with a ligand-binding site(3-7), triggering a conformational change in the protein that results in the opening of an ion channel(8). This process, which is known as 'gating', occurs rapidly and reversibly, but the molecular rearrangements involved are not well understood(9). Here we show that optimal gating in the GABA(A) receptor, a member of the LGIC superfamily, is dependent on electrostatic interactions between the negatively charged Asp 57 and Asp 149 residues in extracellular loops 2 and 7, and the positively charged Lys 279 residue in the transmembrane 2-3 linker region of the alpha(1)-subunit. During gating, Asp 149 and Lys 279 seem to move closer to one another, providing a potential mechanism for the coupling of ligand binding to opening of the ion channel.	Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Anesthesiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Stanford Univ, Dept Anesthesia, Stanford, CA 94305 USA; Stanford Univ, Beckman Program Mol & Genet Med, Stanford, CA 94305 USA	Cornell University; Cornell University; Cornell University; Stanford University; Stanford University	Harrison, NL (corresponding author), Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA.	neh2001@med.cornell.edu	Jenkins, Andrew/E-1180-2011; Kash, Thomas/G-9625-2013					Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/ng0501-46; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bertaccini E, 2002, PROTEIN ENG, V15, P443, DOI 10.1093/protein/15.6.443; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; Dougherty DA, 2001, NATURE, V411, P252, DOI 10.1038/35077192; Ebert B, 1997, MOL PHARMACOL, V52, P1150, DOI 10.1124/mol.52.6.1150; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sigel E, 1999, J NEUROCHEM, V73, P1758, DOI 10.1046/j.1471-4159.1999.731758.x; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Trudell JR, 2002, BRIT J ANAESTH, V89, P32, DOI 10.1093/bja/aef157; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9	28	266	271	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					272	275		10.1038/nature01280	http://dx.doi.org/10.1038/nature01280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529644				2022-12-01	WOS:000180397600048
J	Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F				Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F			Intact fetal cells in maternal plasma: are they really there?	LANCET			English	Article							PRENATAL DETECTION; DOWNS-SYNDROME	Rare fetal cells can be recovered from maternal blood, which suggests that non-invasive prenatal diagnosis is possible. However, recovery and analysis of fetal cells from blood is complex, and sensitivity is low because of the rarity of these cells in the maternal circulation. An alternative strategy, which suggested that intact fetal cells can be found in maternal plasma by use of simple enrichment methods, has been reported. We aimed to replicate this technique. However, five independent laboratories were unable to identify any intact male cells from the plasma of 38 women known to be carrying male fetuses. Although apoptotic intact fetal cells could contribute to the detection of fetal DNA in maternal plasma, we believe that recovery of these cells is difficult and not clinically practical.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Basel, Dept Obstet & Gynecol, CH-4003 Basel, Switzerland; Tufts Univ, Sch Med, Dept Pediat Obstet & Gynecol, Div Genet, Boston, MA 02111 USA; Genzyme Genet, Framingham, MA USA; Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA; Med Coll Penn & Hahnemann Univ, Dept Obstet & Gynecol, Philadelphia, PA USA; NICHHD, Mental Retardat Res Branch, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Basel; Tufts University; Sanofi-Aventis; Genzyme Corporation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Drexel University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bischoff, FZ (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 6550 Fannin St,Suite 885, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043204, N01HD043201, N01HD043202, N01HD043203] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-4-3201, N01-HD-4-3202, N01-HD-4-3204, N01-HD-4-3203] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Choolani M, 2001, LANCET, V357, P958, DOI 10.1016/S0140-6736(05)71658-5; Pertl B, 1999, SEMIN PERINATOL, V23, P393, DOI 10.1016/S0146-0005(99)80005-6; Poon LLM, 2000, LANCET, V356, P1819, DOI 10.1016/S0140-6736(00)03237-2; van Wijk IJ, 2000, CLIN CHEM, V46, P729	5	29	44	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					139	140		10.1016/S0140-6736(03)12191-5	http://dx.doi.org/10.1016/S0140-6736(03)12191-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531583				2022-12-01	WOS:000180428000015
J	Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P				Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P			Fluids from aging ocean crust that support microbial life	SCIENCE			English	Article							HYDROTHERMAL SYSTEMS; RIDGE; FLANK	Little is known about the potential for life in the vast, low-temperature (<100&DEG;C) reservoir of fluids within mid-ocean ridge flank and ocean basin crust. Recently, an overpressured 300-meter-deep borehole was fitted with an experimental seal (CORK) delivering crustal fluids to the sea floor for discrete and large-volume sampling and characterization. Results demonstrate that the 65&DEG;C fluids from 3.5-million-year-old ocean crust support microbial growth. Ribosomal RNA gene sequence data indicate the presence of diverse Bacteria and Archaea, including gene clones of varying degrees of relatedness to known nitrate reducers (with ammonia production), thermophilic sulfate reducers, and thermophilic fermentative heterotrophs, all consistent with fluid chemistry.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Hawaii System; Oregon State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cowen, JP (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA.		Kenig, Fabien/A-4961-2008; Butterfield, David/H-3815-2016; Lam, Phyllis/D-9574-2011	Butterfield, David/0000-0002-1595-9279; Lam, Phyllis/0000-0003-2067-171X; Kenig, Fabien/0000-0003-4868-5232				Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BECKER K, 1999, EOS, V80, pF931; Butterfield DA, 2001, GEOCHIM COSMOCHIM AC, V65, P4141, DOI 10.1016/S0016-7037(01)00712-8; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Cowen JP, 1999, GEOPHYS RES LETT, V26, P3637, DOI 10.1029/1999GL002343; Davis E, 1999, EARTH PLANET SC LETT, V172, P141, DOI 10.1016/S0012-821X(99)00197-1; Davis E.E., 1997, P OCEAN DRILLING PRO, V168, P470; Davis EE, 1992, P OCEAN DRILL PROGRA, V139, P43, DOI DOI 10.2973/ODP.PROC.IR.139.103.1992; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; Huber R, 1996, SYST APPL MICROBIOL, V19, P40, DOI 10.1016/S0723-2020(96)80007-5; KARL DM, 1980, SCIENCE, V207, P1345, DOI 10.1126/science.207.4437.1345; KENIG F, UNPUB; MARESCOTTI P, 2000, P OCEAN DRILL PROGRA, V168; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; SHOCK EL, 1992, ORIGINS LIFE EVOL B, V22, P67, DOI 10.1007/BF01808019; WARWICK B, 1991, STUDIES PLANT SCI, V1, P162; Wheat CG, 2000, GEOCHIM COSMOCHIM AC, V64, P629, DOI 10.1016/S0016-7037(99)00347-6	20	189	200	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					120	123		10.1126/science.1075653	http://dx.doi.org/10.1126/science.1075653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511653				2022-12-01	WOS:000180165800049
J	Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS				Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS			Directed evolution of substrate-optimized GroEL/S chaperonins	CELL			English	Article							GREEN FLUORESCENT PROTEIN; HEAT-SHOCK PROTEINS; FOLDING IN-VIVO; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; TRIGGER FACTOR; CENTRAL CAVITY; BINDING; COMPLEX	GroEL/S chaperonin ring complexes fold many unrelated proteins. To understand the basis and extent of the chaperonin substrate spectrum, we used rounds of selection and DNA shuffling to obtain GroEL/S variants that dramatically enhanced folding of a single substrate-green fluorescent protein (GFP). Changes in the substrate-optimized chaperonins increase the polarity of the folding cavity and alter the ATPase cycle. These findings reveal a surprising plasticity of GroEL/S, which can be exploited to aid folding of recombinant proteins. Our studies also reveal a conflict between specialization and generalization of chaperonins as increased GFP folding comes at the expense of the ability of GroEL/S to fold its natural substrates. This conflict and the nature of the ring structure may help explain the evolution of cellular chaperone systems.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol & Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X; Weissman, Jonathan/0000-0003-2445-670X	NIGMS NIH HHS [GM55595, GM36278] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055595, R37GM036278, R01GM036278] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang D, 2000, ANNU REV GENET, V34, P439, DOI 10.1146/annurev.genet.34.1.439; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chan HS, 1996, PROTEINS, V24, P345; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; deLeon P, 1997, MICROBIOL-SGM, V143, P3563, DOI 10.1099/00221287-143-11-3563; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Farinas ET, 2001, CURR OPIN BIOTECH, V12, P545, DOI 10.1016/S0958-1669(01)00261-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GULUKOTA K, 1994, P NATL ACAD SCI USA, V91, P9292, DOI 10.1073/pnas.91.20.9292; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HERMAN C, 1995, MOL MICROBIOL, V18, P247, DOI 10.1111/j.1365-2958.1995.mmi_18020247.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; KANEMORI M, 1994, J BACTERIOL, V176, P4235, DOI 10.1128/jb.176.14.4235-4242.1994; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KHODURSKY A, 2002, IN PRESS METHODS MOL; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Leroux MR, 2001, ADV APPL MICROBIOL, V50, P219, DOI 10.1016/S0065-2164(01)50007-6; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; LUO GX, 1993, J BIOL CHEM, V268, P10246; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mogk A, 1997, EMBO J, V16, P4579, DOI 10.1093/emboj/16.15.4579; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997	62	110	115	4	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1027	1039		10.1016/S0092-8674(02)01198-4	http://dx.doi.org/10.1016/S0092-8674(02)01198-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507429	Bronze			2022-12-01	WOS:000180086000012
J	Grutzendler, J; Kasthuri, N; Gan, WB				Grutzendler, J; Kasthuri, N; Gan, WB			Long-term dendritic spine stability in the adult cortex	NATURE			English	Article							VISUAL-CORTEX; MACACA-NEMESTRINA; OCULAR DOMINANCE; STRIATE CORTEX; LIVING MICE; PLASTICITY; NEURONS; SYNAPTOGENESIS; FILOPODIA; SYNAPSES	The structural dynamics of synapses probably has a crucial role in the development and plasticity of the nervous system. In the mammalian brain, the vast majority of excitatory axo-dendritic synapses occur on dendritic specializations called 'spines'. However, little is known about their long-term changes in the intact developing or adult animal. To address this question we developed a transcranial two-photon imaging technique to follow identified spines of layer-5 pyramidal neurons in the primary visual cortex of living transgenic mice expressing yellow fluorescent protein. Here we show that filopodia-like dendritic protrusions, extending and retracting over hours, are abundant in young animals but virtually absent from the adult. In young mice, within the 'critical period' for visual cortex development, similar to73% of spines remain stable over a one-month interval; most changes are associated with spine elimination. In contrast, in adult mice, the overwhelming majority of spines (similar to96%) remain stable over the same interval with a half-life greater than 13 months. These results indicate that spines, initially plastic during development, become remarkably stable in the adult, providing a potential structural basis for long-term information storage.	NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.		Grutzendler, Jaime/F-3691-2010					Antonini A, 1999, J NEUROSCI, V19, P4388; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BOOTHE RG, 1979, J COMP NEUROL, V186, P473, DOI 10.1002/cne.901860310; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	29	862	881	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					812	816		10.1038/nature01276	http://dx.doi.org/10.1038/nature01276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490949				2022-12-01	WOS:000179897300056
J	Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD				Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD			Admissions for myocardial infarction and World Cup football: database survey	BRITISH MEDICAL JOURNAL			English	Article							EARTHQUAKE; DISEASE; STRESS; CIVILIANS; MORTALITY; TRIGGERS	Objectives To examine hospital admissions for a range of diagnoses on days surrounding England's 1998 World Cup football matches. Design Analysis of hospital admissions obtained from English hospital episode statistics. Setting England. Participants Population aged 15-64 years. Main outcome measures Ratio of number of admissions for acute myocardial infarction, stroke, deliberate self harm, and road traffic injuries on the day of and five days after England's World Cup matches, compared with admissions at die same time in previous and following years and in the month preceding the tournament. Results Risk of admission for acute myocardial infarction increased by 25% on 30 June 1998 (the day England lost to Argentina in a penalty shoot-out) and the following two days. No excess admissions occurred for other diagnoses or on the days of the other England matches. The effect was the same when only the two days after the match were treated as the exposed condition. Individual analyses of the day of and the two days after the Argentina match showed 55 extra admissions for myocardial infarctions compared with the number expected. Conclusion The increase in admissions suggests that myocardial infarction can be triggered by emotional upset, such as watching your football team lose an important match.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Bristol; University of Birmingham; University of Birmingham	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.		Tilling, Kate/AAY-1578-2021; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Tilling, Kate/0000-0002-1010-8926				BERGOVEC M, 1992, LANCET, V339, P303, DOI 10.1016/0140-6736(92)91370-N; BRODKIN J, 1998, GUARDIAN        0702, P3; Brunekreef B, 2002, EPIDEMIOLOGY, V13, P491, DOI 10.1097/00001648-200207000-00022; Harrison LK, 2000, BIOL PSYCHOL, V52, P113, DOI 10.1016/S0301-0511(99)00033-2; Heslop P, 2001, BRIT J HEALTH PSYCH, V6, P167, DOI 10.1348/135910701169133; KATSOUYANNI K, 1986, INT J EPIDEMIOL, V15, P326, DOI 10.1093/ije/15.3.326; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kondo N I, 1995, J Cardiovasc Risk, V2, P499, DOI 10.1097/00043798-199512000-00003; LEAR J, 1996, AM J CARDIOL, V77, P1230; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; SUZUKI S, 1995, LANCET, V345, P981, DOI 10.1016/S0140-6736(95)90727-0; *TEL AUD RES INF S, 1999, UK TEL VID YB; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; TRICHOPOULOS D, 1983, LANCET, V1, P441; WITTE DR, 2000, BRIT MED J, V321, P1332; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; 2002, GUARDIAN        0620, P11	19	142	147	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1439	1442		10.1136/bmj.325.7378.1439	http://dx.doi.org/10.1136/bmj.325.7378.1439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493655	Green Accepted, Green Published			2022-12-01	WOS:000180188600007
J	Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C				Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C			Risk of hip and renal fracture among dialysis transplant recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; KIDNEY-TRANSPLANTATION; INDUCED OSTEOPOROSIS; DISEASE; HYPERPARATHYROIDISM	Context Renal failure places people at particularly high risk of hip fracture. However, the possible differential impact of dialysis and renal transplantation on this risk is not well understood. Objective To determine if patients who receive kidney transplants are at greater risk of hip fracture compared with those who continue to undergo dialysis. Design, Setting, and Participants Cohort study of 101039 patients with end-stage renal disease placed on the renal transplant waiting list in the United States between January 1, 1990, and December 31, 1999. Main Outcome Measures I Hip fractures, identified from Medicare claims data. Results Among the patients included in this analysis, 971 hip fractures were observed during the follow-up period of 314767 person-years. The incidence rate of hip fracture in patients receiving dialysis was 2.9 per 1000 patients per year compared with 3.3 hip fractures per 1000 patients per year in those who had previously received a renal transplant. Initially, the relative risk (RR) of hip fracture associated with transplantation was 1.34-fold greater when compared with dialysis (adjusted RR, 1.34; 95 % confidence interval [CI], 1.12-1.61) but then decreased by 1 % per month (adjusted RR, 0.99; 95% Cl, 0.98-0.99) until the estimated risk became equal for dialysis and transplant recipients approximately 630 days after transplantation (adjusted RR, 1.00; 95 % Cl, 0.87-1-15). Among transplant recipients, risk of fracture was relatively higher in persons with a prolonged period of dialysis before transplantation. Conclusion The high risk of hi p fracture among dialysis patients is exceeded by that among renal, transplant patients during the first 1 to 3 years after transplantation.	Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, Seattle, WA 98108 USA; Univ Washington, Sch Med, Div Nephrol, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Stehman-Breen, C (corresponding author), Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, 1660 S Columbian Way,Mailstop 111A, Seattle, WA 98108 USA.							Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; ALMOND MK, 1994, NEPHRON, V66, P52, DOI 10.1159/000187765; Caglar M, 1999, ANN NUCL MED, V13, P141, DOI 10.1007/BF03164853; Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jc.81.10.3441; Carlini RG, 2000, AM J KIDNEY DIS, V36, P160, DOI 10.1053/ajkd.2000.8289; Chevalley T, 1996, EUR J ENDOCRINOL, V134, P591, DOI 10.1530/eje.0.1340591; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; CUNDY T, 1983, Q J MED, V52, P67; Dalen N, 1973, Clin Nephrol, V1, P338; Epstein Sol, 1995, Current Opinion in Rheumatology, V7, P255, DOI 10.1097/00002281-199505000-00018; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; GROTZ WH, 1995, NEPHROL DIAL TRANSPL, V10, P2096; HORBER FF, 1994, J BONE MINER RES, V9, P1; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; KWAN JTC, 1992, MINER ELECTROL METAB, V18, P166; Manolagas SC, 1999, J BONE MINER RES, V14, P1061, DOI 10.1359/jbmr.1999.14.7.1061; *NIH, 1999, US REN DAT SYST USRD; PARFITT AM, 1982, MINER ELECTROL METAB, V8, P92; Pichette V, 1996, AM J KIDNEY DIS, V28, P105, DOI 10.1016/S0272-6386(96)90138-9; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Stein MS, 1996, AM J KIDNEY DIS, V28, P515, DOI 10.1016/S0272-6386(96)90461-8; *US C, 1994, HIP FRACT OUTC PEOPL; Weisinger JR, 1999, TRANSPLANT P, V31, P3033, DOI 10.1016/S0041-1345(99)00658-2; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	26	297	304	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3014	3018		10.1001/jama.288.23.3014	http://dx.doi.org/10.1001/jama.288.23.3014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479766	Bronze			2022-12-01	WOS:000179854200036
J	Graham, SM				Graham, SM			Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa	LANCET			English	Editorial Material							VIRUS-INFECTED CHILDREN; COTRIMOXAZOLE PROPHYLAXIS; TRIMETHOPRIM; RESISTANCE		Univ Malawi, Wellcome Trust Res Labs, Blantyre 3, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Graham, SM (corresponding author), Univ Malawi, Wellcome Trust Res Labs, POB 30096, Blantyre 3, Malawi.	sgraham@mlw.medcol.mw		Graham, Stephen/0000-0003-3525-2294				Abdel-Haq N, 1999, PEDIATR INFECT DIS J, V18, P647, DOI 10.1097/00006454-199907000-00017; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Chokephaibulkit K, 1999, PEDIATR INFECT DIS J, V18, P147, DOI 10.1097/00006454-199902000-00012; DOUNG T, 1999, BMJ-BRIT MED J, V319, P1227; Fisher RG, 2001, AIDS PATIENT CARE ST, V15, P263, DOI 10.1089/10872910152050784; GIBB DM, 1994, ARCH DIS CHILD, V70, P241, DOI 10.1136/adc.70.3.241; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Grimwade K, 2001, CURR OPIN INFECT DIS, V14, P507, DOI 10.1097/00001432-200110000-00002; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; JohannLiang R, 1997, PEDIATR INFECT DIS J, V16, P1145, DOI 10.1097/00006454-199712000-00009; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; SIMONDS RJ, 1993, JAMA-J AM MED ASSOC, V270, P470, DOI 10.1001/jama.270.4.470; *UNAIDS WHO, 2000, UNAIDS PROV WHO UNAI; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P202, DOI 10.1016/S0035-9203(02)90306-8; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004	20	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1966	1968		10.1016/S0140-6736(02)11921-0	http://dx.doi.org/10.1016/S0140-6736(02)11921-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493279				2022-12-01	WOS:000179870200031
J	Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R				Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R			beta Blockers for glaucoma and excess risk of airways obstruction: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							TOPICAL TIMOLOL; PULMONARY		Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England; Royal Brompton Hosp, London SW3 6LY, England; Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Royal Brompton Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Kirwan, JF (corresponding author), Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England.			Nightingale, Julia/0000-0002-8978-2840; Bunce, Catey/0000-0002-0935-3713	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bateman DN, 2001, BRIT MED J, V323, P1401, DOI 10.1136/bmj.323.7326.1401; CHARAN NB, 1980, ARCH INTERN MED, V140, P843, DOI 10.1001/archinte.140.6.843; DIGGORY P, 1995, LANCET, V345, P1604, DOI 10.1016/S0140-6736(95)90116-7; Quigley HA, 1996, AM J OPHTHALMOL, V122, P355, DOI 10.1016/S0002-9394(14)72062-8; Stewart WC, 2001, J GLAUCOMA, V10, P227, DOI 10.1097/00061198-200106000-00015	5	20	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1396	1397		10.1136/bmj.325.7377.1396	http://dx.doi.org/10.1136/bmj.325.7377.1396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480856	Green Published			2022-12-01	WOS:000179975000025
J	Rutz, HP				Rutz, HP			Effects of corticosteroid use on treatment of solid tumours	LANCET			English	Editorial Material							IONIZING-RADIATION; GENE-EXPRESSION; DEXAMETHASONE; CELLS; RESISTANCE; AGENTS; RADIORESISTANCE; APOPTOSIS; INVITRO		Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Rutz, HP (corresponding author), Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland.							AAPRO MS, 1991, RECENT RESULTS CANC, P91; AMBRUS JL, 1985, LANCET, V2, P148; BANSAL N, 1991, FASEB J, V5, P211, DOI 10.1096/fasebj.5.2.2004665; Biswas T, 1999, ONCOGENE, V18, P525, DOI 10.1038/sj.onc.1202320; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; BROCK WA, 1984, INT J RADIAT ONCOL, V10, P2113, DOI 10.1016/0360-3016(84)90210-4; DEVITA D, 1993, CANC PRINCIPLES PRAC; FREI E, 1965, BLOOD, V26, P624; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409, DOI 10.1200/JCO.2000.18.19.3409; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Mariotta M, 1999, STRAHLENTHER ONKOL, V175, P392, DOI 10.1007/s000660050027; MILLAR BC, 1985, INT J RADIAT BIOL, V47, P539, DOI 10.1080/09553008514550771; Nauck M, 1997, AM J RESP CELL MOL, V16, P398, DOI 10.1165/ajrcmb.16.4.9115750; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; ORTH DN, 1992, WILLIAMS TXB ENDOCRI, P513; Pruschy M, 1997, BIOCHEM BIOPH RES CO, V241, P519, DOI 10.1006/bbrc.1997.7846; RENAN MJ, 1989, RADIAT RES, V120, P442, DOI 10.2307/3577795; ROILA F, 1995, NEW ENGL J MED, V332, P1; Roila F, 2000, NEW ENGL J MED, V342, P1554; Rutz HP, 1998, STRAHLENTHER ONKOL, V174, P71, DOI 10.1007/BF03038478; ZHAO JY, 1993, ENDOCRINOLOGY, V133, P521, DOI 10.1210/en.133.2.521	21	95	99	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1969	1970		10.1016/S0140-6736(02)11922-2	http://dx.doi.org/10.1016/S0140-6736(02)11922-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493280				2022-12-01	WOS:000179870200032
J	Larkin, RM; Alonso, JM; Ecker, JR; Chory, J				Larkin, RM; Alonso, JM; Ecker, JR; Chory, J			GUN4, a regulator of chlorophyll synthesis and intracellular signaling	SCIENCE			English	Article							CHELATASE H-SUBUNIT; MAGNESIUM-CHELATASE; NUCLEUS; CHLOROPLAST; BIOSYNTHESIS; ACCUMULATION; PROTEIN; IX	Nuclear genes control plastid differentiation in response to developmental signals, environmental signals, and retrograde signals from plastids themselves. In return, plastids emit signals that are essential for proper expression of many nuclear photosynthetic genes. Accumulation of magnesium-protoporphyrin IX (Mg-Proto), an intermediate in chlorophyll biosynthesis, is a plastid signal that represses nuclear transcription through a signaling pathway that, in Arabidopsis, requires the GUN4 gene. GUN4 binds the product and substrate of Mg-chelatase, an enzyme that produces Mg-Proto, and activates Mg-chelatase. Thus, GUN4 participates in plastid-to-nucleus signaling by regulating Mg-Proto synthesis or trafficking.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; , Robert/0000-0002-4665-3731				[Anonymous], METHODS CHLOROPLAST; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; FALBEL TG, 1994, PLANT PHYSIOL, V104, P639, DOI 10.1104/pp.104.2.639; FIDAI S, 1995, FEBS LETT, V372, P264, DOI 10.1016/0014-5793(95)00995-L; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; JACOBS JM, 1993, PLANT PHYSIOL, V101, P1181, DOI 10.1104/pp.101.4.1181; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; LARKIN RM, UNPUB; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Popperl G, 1998, J PLANT PHYSIOL, V153, P40, DOI 10.1016/S0176-1617(98)80042-4; Reid JD, 2002, BIOCHEM SOC T, V30, P643, DOI 10.1042/bst0300643; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Takamiya K, 2000, TRENDS PLANT SCI, V5, P426, DOI 10.1016/S1360-1385(00)01735-0; TERRY MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P1, DOI 10.1006/abbi.1993.1473; THOMAS J, 1990, PLANT PHYSIOL, V94, P1414, DOI 10.1104/pp.94.3.1414; Walker CJ, 1997, BIOCHEM J, V327, P321	24	373	427	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					902	906		10.1126/science.1079978	http://dx.doi.org/10.1126/science.1079978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574634				2022-12-01	WOS:000180830900056
J	Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P				Ruban, AV; Wentworth, M; Yakushevska, AE; Andersson, J; Lee, PJ; Keegstra, W; Dekker, JP; Boekema, EJ; Jansson, S; Horton, P			Plants lacking the main light-harvesting complex retain photosystem II macro-organization	NATURE			English	Article							A/B-BINDING PROTEIN; ANTENNA; MEMBRANE; MECHANISM; SPINACH	Photosystem II (PSII) is a key component of photosynthesis, the process of converting sunlight into the chemical energy of life. In plant cells, it forms a unique oligomeric macrostructure in membranes of the chloroplasts(1). Several light-harvesting antenna complexes are organized precisely in the PSII macrostructure-the major trimeric complexes (LHCII)(2) that bind 70% of PSII chlorophyll and three minor monomeric complexes(3)-which together form PSII supercomplexes(4-6). The antenna complexes are essential for collecting sunlight and regulating photosynthesis(7-9), but the relationship between these functions and their molecular architecture is unresolved. Here we report that antisense Arabidopsis plants lacking the proteins that form LHCII trimers(10) have PSII supercomplexes with almost identical abundance and structure to those found in wild-type plants. The place of LHCII is taken by a normally minor and monomeric complex, CP26, which is synthesized in large amounts and organized into trimers. Trimerization is clearly not a specific attribute of LHCII. Our results highlight the importance of the PSII macrostructure: in the absence of one of its main components, another protein is recruited to allow it to assemble and function.	Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; Vrije Univ Amsterdam, Fac Sci, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; University of Groningen; Umea University; Vrije Universiteit Amsterdam	Horton, P (corresponding author), Univ Sheffield, Robert Hill Inst, Dept Mol Biol & Biotechnol, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk	Jansson, Stefan/A-1119-2009; Horton, Peter/A-3958-2012	Jansson, Stefan/0000-0002-7906-6891; Horton, Peter/0000-0002-6095-1460				Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; ANDERSSON J, IN PRESS PLANT J; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CAFFARRI S, 2001, PS2001 P 12 INT C PH, pS31; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Garab G, 1999, AUST J PLANT PHYSIOL, V26, P649, DOI 10.1071/PP99069; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; Kuttkat A, 1996, EUR J BIOCHEM, V242, P288, DOI 10.1111/j.1432-1033.1996.0288r.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nield J, 2000, NAT STRUCT BIOL, V7, P44; PAULSEN H, 1995, PHOTOCHEM PHOTOBIOL, V62, P367, DOI 10.1111/j.1751-1097.1995.tb02357.x; PETER GF, 1991, J BIOL CHEM, V266, P16745; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Walters RG, 1999, PLANTA, V209, P517, DOI 10.1007/s004250050756; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	30	131	136	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					648	652		10.1038/nature01344	http://dx.doi.org/10.1038/nature01344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571599	Green Published, Green Accepted			2022-12-01	WOS:000180803200046
J	Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA				Wong, KK; Maser, RS; Bachoo, RM; Menon, J; Carrasco, DR; Gu, YS; Alt, FW; DePinho, RA			Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing	NATURE			English	Article							ATAXIA-TELANGIECTASIA; STEM-CELL; MICE; DNA; CANCER; MOUSE; STABILITY; DEFECTS; LEADS	Ataxia-telangiectasia (A-T) results from the loss of ataxia-telangiectasia mutated (Atm) function and is characterized by accelerated telomere loss, genomic instability, progressive neurological degeneration, premature ageing and increased neoplasia incidence(1). Here we evaluate the functional interaction of Atm and telomeres in vivo. We examined the impact of Atm deficiency as a function of progressive telomere attrition at both the cellular and whole-organism level in mice doubly null for Atm and the telomerase RNA component (Terc)(2-4). These compound mutants showed increased telomere erosion and genomic instability, yet they experienced a substantial elimination of T-cell lymphomas associated with Atm deficiency. A generalized proliferation defect was evident in all cell types and tissues examined, and this defect extended to tissue stem/progenitor cell compartments, thereby providing a basis for progressive multi-organ system compromise, accelerated ageing and premature death. We show that Atm deficiency and telomere dysfunction act together to impair cellular and whole-organism viability, thus supporting the view that aspects of A-T pathophysiology are linked to the functional state of telomeres and its adverse effects on stem/progenitor cell reserves.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 92507 USA; Univ Washington, Sch Med, Dept Radiat Oncol & Immunol, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Maser, Richard/B-2970-2012	DePinho, Ronald/0000-0002-5625-577X; wong, kwok kin/0000-0001-6323-235X				AHMED S, 1995, J NEUROSCI, V15, P5765; ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P727; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hande MP, 2001, HUM MOL GENET, V10, P519, DOI 10.1093/hmg/10.5.519; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sekiguchi J, 2001, P NATL ACAD SCI USA, V98, P3243, DOI 10.1073/pnas.051632098; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Spector BD, 1982, ATAXIA TELANGIECTASI, P103; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	30	312	323	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					643	648		10.1038/nature01385	http://dx.doi.org/10.1038/nature01385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540856				2022-12-01	WOS:000180803200045
J	Yen, HCS; Gordon, C; Chang, EC				Yen, HCS; Gordon, C; Chang, EC			Schizosaccharomyces pombe Int6 and Ras homologs regulate cell division and mitotic fidelity via the proteasome	CELL			English	Article							MAMMARY-TUMOR VIRUS; FISSION YEAST INT6; COP9 SIGNALOSOME; 26S PROTEASOME; TRANSLATION INITIATION; GENE; PROTEIN; SUBUNIT; LOCALIZATION; COMPLEXES	Yin6 is a yeast homolog of Int6, which is implicated in tumorigenesis. We show that Yin6 binds to and regulates proteasome activity. Overexpression of Yin6 strengthens proteasome function while inactivation weakens and causes the accumulation of polyubiquitinated proteins including securin/Cut2 and cyclin/Cdc13. Yin6 regulates the proteasome by preferentially interacting with Rpn5, a conserved proteasome subunit, and affecting its localization/assembly. We showed previously that Yin6 cooperates with Ras1 to mediate chromosome segregation; here, we demonstrate that Ras1 similarly regulates the proteasome via Rpn5. In yeast, human Int6 binds Rpn5 and regulates its localization. We propose that human Int6, either alone or cooperatively with Ras, influences proteasome activities via Rpn5. Inactivating Int6 can lead to accumulation of mitotic regulators affecting cell division and mitotic fidelity.	Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, Houston, TX 77030 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Baylor College of Medicine; University of Edinburgh	Chang, EC (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Breast Canc Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	echang@breastcenter.tmc.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	NCI NIH HHS [R01-CA90464] Funding Source: Medline; OAPP OPHS HHS [RPG-97-137-01-MGO] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OAPP OPHS HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; AYSCOUGH K, 1994, YEAST, V10, P1, DOI 10.1002/yea.320100102; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; BASELGA J, 2000, CANCER CELL, V1, P31; Berry LD, 1999, MOL CELL BIOL, V19, P2535; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chen CR, 1999, P NATL ACAD SCI USA, V96, P517, DOI 10.1073/pnas.96.2.517; Chen CR, 2000, MOL BIOL CELL, V11, P4067, DOI 10.1091/mbc.11.12.4067; Criekinge W. V., 1999, BIOL P ONLINE, V2, P1; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gohring UJ, 1999, TUMOR BIOL, V20, P173, DOI 10.1159/000030061; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Grishchuk EL, 1998, GENETICS, V149, P1251; Guo JJ, 2000, J VIROL, V74, P1892, DOI 10.1128/JVI.74.4.1892-1899.2000; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemelaar J, 2001, J VIROL, V75, P11106, DOI 10.1128/JVI.75.22.11106-11115.2001; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; KIARIS H, 1995, INT J ONCOL, V7, P413; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Lafarga M, 2002, GLIA, V38, P313, DOI 10.1002/glia.10075; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Leclercq G, 2002, J STEROID BIOCHEM, V80, P259, DOI 10.1016/S0960-0760(02)00026-2; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu SQ, 2002, P NATL ACAD SCI USA, V99, P3770, DOI 10.1073/pnas.052710299; Lonning Per Eystein, 2002, Int J Clin Oncol, V7, P265, DOI 10.1007/s101470200038; LUCA FC, 1989, J CELL BIOL, V109, P1895, DOI 10.1083/jcb.109.5.1895; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Miyazaki S, 1997, GENOMICS, V46, P155, DOI 10.1006/geno.1997.4996; NADINDAVIS SA, 1986, EMBO J, V5, P2963, DOI 10.1002/j.1460-2075.1986.tb04593.x; Pajonk F, 2001, RADIAT RES, V156, P447, DOI 10.1667/0033-7587(2001)156[0447:TPICBA]2.0.CO;2; PALMER A, 1994, EUR J CELL BIOL, V64, P163; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Saito A, 1997, GENE, V203, P241, DOI 10.1016/S0378-1119(97)00524-6; Schondorf T, 1999, ONCOL REP, V6, P1029; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; Yen HCS, 2000, P NATL ACAD SCI USA, V97, P14370, DOI 10.1073/pnas.97.26.14370; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	66	72	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					207	217		10.1016/S0092-8674(03)00043-6	http://dx.doi.org/10.1016/S0092-8674(03)00043-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553909	Bronze			2022-12-01	WOS:000181191600010
J	Evans, JP; Zane, L; Francescato, S; Pilastro, A				Evans, JP; Zane, L; Francescato, S; Pilastro, A			Directional postcopulatory sexual selection revealed by artificial insemination	NATURE			English	Article							SPERM PRECEDENCE; POECILIA-RETICULATA; TRINIDADIAN GUPPY; FEMALE CHOICE; FLOUR BEETLES; PATTERNS; PATERNITY; BENEFITS; MALES	Postcopulatory sexual selection comprises both sperm competition, where the sperm from different males compete for fertilization(1), and cryptic female choice, where females bias sperm use in favour of particular males(2). Despite intense current interest in both processes as potential agents of directional sexual selection(3), few studies have attributed the success of attractive males to events that occur exclusively after insemination. This is because the interactions between pre- and post-insemination episodes of sexual selection can be important sources of variation in paternity(4). The use of artificial insemination overcomes this difficulty because it controls for variation in male fertilization success attributable to the female's perception of male quality, as well as effects due to mating order and the relative contribution of sperm from competing males(5). Here, we adopt this technique and show that in guppies, when equal numbers of sperm from two males compete for fertilization, relatively colourful individuals achieve greater parentage than their less ornamented counterparts. This finding indicates that precopulatory female mating preferences can be reinforced exclusively through postcopulatory processes occurring at a physiological level. Our analysis also revealed that relatively small individuals were advantaged in sperm competition, suggesting a possible trade-off between sperm competitive ability and body growth.	Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Evans, JP (corresponding author), Univ Padua, Dept Biol, Via U Bassi 58-B, I-35131 Padua, Italy.		Zane, Lorenzo/G-6249-2010; Pilastro, Andrea/G-3868-2011; Evans, Jonathan/A-1992-2011	Zane, Lorenzo/0000-0002-6963-2132; Pilastro, Andrea/0000-0001-9803-6308; 				[Anonymous], 1998, SPERM COMPETITION SE; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 2000, EVOLUTION, V54, P1057; Blount JD, 2001, ECOL LETT, V4, P393, DOI 10.1046/j.1461-0248.2001.00255.x; Constantz G.D., 1989, P33; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1997, SEX COLOR MALE CHOIC; JAMES WH, 1975, GENET RES, V26, P45, DOI 10.1017/S0016672300015834; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Krackow S, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P112, DOI 10.1017/CBO9780511542053.006; LEWIS SM, 1994, BEHAV ECOL, V5, P219; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Neems RM, 1998, BEHAV ECOL, V9, P279, DOI 10.1093/beheco/9.3.279; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Simmons L.W., 2001, SPERM COMPETITION IT; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	30	214	221	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					360	363		10.1038/nature01367	http://dx.doi.org/10.1038/nature01367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540898				2022-12-01	WOS:000180533000039
J	Heiling, AM; Herberstein, ME; Chittka, L				Heiling, AM; Herberstein, ME; Chittka, L			Pollinator attraction - Crab-spiders manipulate flower signals	NATURE			English	Article							COLOR-PERCEPTION; ULTRAVIOLET; CAMOUFLAGE; BEES		Univ Vienna, Inst Zool, A-1090 Vienna, Austria; Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; Univ London, Queen Mary Coll, Sch Biol Sci, London E1 4NS, England	University of Vienna; Macquarie University; University of London; Queen Mary University London	Heiling, AM (corresponding author), Univ Vienna, Inst Zool, A-1090 Vienna, Austria.	astrid.heiling@univie.ac.at	Chittka, Lars/C-3110-2012; Herberstein, Marie/D-2042-2011	Chittka, Lars/0000-0001-8153-1732; Herberstein, Marie/0000-0001-5071-2952				Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2001, ENTOMOL GEN, V25, P181; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a	8	145	154	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					334	334		10.1038/421334a	http://dx.doi.org/10.1038/421334a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540891	Bronze			2022-12-01	WOS:000180533000031
J	Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP				Kemper, C; Chan, AC; Green, JM; Brett, KA; Murphy, KM; Atkinson, JP			Activation of human CD4(+) cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype	NATURE			English	Article							COFACTOR PROTEIN CD46; SELF-TOLERANCE; MEASLES-VIRUS; RECEPTOR; COMPLEMENT; ELIMINATION; MOLECULE; IMMUNITY; THYMUS; MCP	The immune system must distinguish not only between self and non-self, but also between innocuous and pathological foreign antigens to prevent unnecessary or self-destructive immune responses. Unresponsiveness to harmless antigens is established through central and peripheral processes(1). Whereas clonal deletion and anergy are mechanisms of peripheral tolerance(2,3), active suppression by T-regulatory 1 (Tr1) cells has emerged as an essential factor in the control of autoreactive cells(4). Tr1 cells are CD4(+) T lymphocytes that are defined by their production of interleukin 10 (IL-10)(5) and suppression of T-helper cells(6); however, the physiological conditions underlying Tr1 differentiation are unknown. Here we show that co-engagement of CD3 and the complement regulator CD46 in the presence of IL-2 induces a Tr1-specific cytokine phenotype in human CD4(+) T cells. These CD3/CD46-stimulated IL-10-producing CD4(+) cells proliferate strongly, suppress activation of bystander T cells and acquire a memory phenotype. Our findings identify an endogenous receptor-mediated event that drives Tr1 differentiation and suggest that the complement system has a previously unappreciated role in T-cell-mediated immunity and tolerance.	Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA; Genentech Inc, San Francisco, CA 94080 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Grad Program Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pathol & Immunol, St Louis, MO 63110 USA; Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Roche Holding; Genentech; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA.		Kemper, Claudia/A-3673-2008; Kemper, Claudia/B-1502-2015	Kemper, Claudia/0000-0003-4196-1417; Green, Jonathan/0000-0002-7449-4387				Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Karp CL, 1996, SCIENCE, V273, P228, DOI 10.1126/science.273.5272.228; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; LeDouarin N, 1996, IMMUNOL REV, V149, P35; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Van Parijs L, 1998, SCIENCE, V280, P243; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839	30	453	480	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					388	392		10.1038/nature01315	http://dx.doi.org/10.1038/nature01315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540904				2022-12-01	WOS:000180533000046
J	Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA				Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA			Collapse and conservation of shark populations in the Northwest Atlantic	SCIENCE			English	Article							EXTINCTION; MANAGEMENT	Overexploitation threatens the future of many large vertebrates. In the ocean, tunas and sea turtles are current conservation concerns because of this intense pressure. The status of most shark species, in contrast, remains uncertain. Using the largest data set in the Northwest Atlantic, we show rapid large declines in large coastal and oceanic shark populations. Scalloped hammerhead, white, and thresher sharks are each estimated to have declined by over 75% in the past 15 years. Closed-area models highlight priority areas for shark conservation, and the need to consider effort reallocation and site selection if marine reserves are to benefit multiple threatened species.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Dalhousie University	Baum, JK (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.		Baum, Julia K/A-4693-2008	Worm, Boris/0000-0002-5742-8716; Baum, Julia/0000-0002-9827-1612				Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; AU D, 1985, SCRS8475 INT COMM CO; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R., 1994, 341 FAO; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Castro J.I., 1999, 380 FAO; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; COMPAGNO LJV, 1984, FISH SYNOP, V125; Essington TE, 2002, ECOL APPL, V12, P724; Fernandez de Oviedo Gonzalo, 1959, HIST GEN NATURAL IND; GROGGER JT, 1991, J APPL ECONOM, V6, P225, DOI 10.1002/jae.3950060302; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; IUCN, 2002, 2002 IUCN RED LIST T; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; NAKANO H, 1993, SCRS92145 INT COMM C; *NMFS, 2001, US NAT PLAN ACT CONS; NMFS, 1999, FIN FISH MAN PLAN AT; *NMFS, 2002, STOCK ASS FISH EV AT; ROSE DA, 1996, OVERVIEW WORLD TRADE; Safina C., 1998, SONG BLUE OCEAN; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; FED REG, V66, P36711; FED REG, V67, P5393	28	814	857	8	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					389	392		10.1126/science.1079777	http://dx.doi.org/10.1126/science.1079777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532016				2022-12-01	WOS:000180426800044
J	Dial, KP				Dial, KP			Wing-assisted incline running and the evolution of flight	SCIENCE			English	Article							BIRDS	Flapping wings of galliform birds are routinely used to produce aerodynamic forces oriented toward the substrate to enhance hindlimb traction. Here, I document this behavior in natural and laboratory settings. Adult birds fully capable of aerial flight preferentially employ wing-assisted incline running (WAIR), rather than flying, to reach elevated refuges (such as cliffs, trees, and boulders). From the day of hatching and before attaining sustained aerial flight, developing ground birds use WAIR to enhance their locomotor performance through improved foot traction, ultimately permitting vertical running. WAIR provides insight from behaviors observable in living birds into the possible role of incipient wings in feathered theropod dinosaurs and offers a previously unstudied explanation for the evolution of avian flight.	Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA	University of Montana System; University of Montana	Dial, KP (corresponding author), Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA.	kdial@selway.umt.edu						BERGERS P, 2001, NATURE, V399, P60; BILO D, 1985, BIONA REPORT, V3, P87; Bock W.J., 1985, P199; CAPLE G, 1983, AM NAT, V121, P455, DOI 10.1086/284076; Chatterjee S., 1997, THE RISE OF BIRDS; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Feduccia A., 1996, ORIGIN EVOLUTION BIR; Gall L.F., 2002, NEW PERSPECTIVES ORI; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; Hecht M.K., 1985, BEGINNINGS BIRDS; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; OSTROM JH, 1979, AM SCI, V67, P46; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Starck J.M., 1998, AVIAN GROWTH DEV; Tobalske BW, 1996, J EXP BIOL, V199, P263	18	144	152	0	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					402	404		10.1126/science.1078237	http://dx.doi.org/10.1126/science.1078237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532020	Green Submitted			2022-12-01	WOS:000180426800048
J	Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP				Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP			Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification	SCIENCE			English	Article							HOYERAAL-HREIDARSSON-SYNDROME; TELOMERASE; MUTATIONS; GENE; YEAST; IDENTIFICATION; PSEUDOURIDINE; COMPONENT; PROTEIN; DKC1	Mutations in DKC1 cause dyskeratosis congenita (DC), a disease characterized by premature aging and increased tumor susceptibility. The DKC1 protein binds to the box H + ACA small nucleolar RNAs and the RNA component of telomerase. Here we show that hypomorphic Dkc1 mutant (Dkc1(m)) mice recapitulate in the first and second generations (G1 and G2) the clinical features of DC. Dkc1(m) cells from G1 and G2 mice were impaired in ribosomal RNA pseudouridylation before the onset of disease. Reductions of telomere length in Dkc1(m) mice became evident only in later generations. These results suggest that deregulated ribosome function is important in the initiation of DC, whereas telomere shortening may modify and/or exacerbate DC.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Univ Sao Paulo, FUNDHERP, Ctr Cell Based Therapy, BR-14049900 Ribeirao Preto, SP, Brazil; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Piazza, Francesco/AAD-1600-2019; Piazza, Francesco/K-6695-2016; Rego, Eduardo/AFS-7973-2022; Mari, Francesca/E-7737-2012; Rego, Eduardo M/A-1058-2012; Rego, Eduardo M./Y-5572-2019	Piazza, Francesco/0000-0002-2831-623X; Piazza, Francesco/0000-0002-2831-623X; Rego, Eduardo/0000-0003-1567-4086; Mari, Francesca/0000-0003-1992-1654; Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo M./0000-0003-1567-4086				Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; MASUREKAR M, 1981, J MOL BIOL, V147, P381, DOI 10.1016/0022-2836(81)90490-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Phillips B, 1998, MOL GEN GENET, V260, P20, DOI 10.1007/s004380050866; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Yaghmai R, 2000, J PEDIATR-US, V136, P390, DOI 10.1067/mpd.2000.104295; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	22	312	331	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					259	262		10.1126/science.1079447	http://dx.doi.org/10.1126/science.1079447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522253				2022-12-01	WOS:000180284000042
J	Shi, SH; Jan, LY; Jan, YN				Shi, SH; Jan, LY; Jan, YN			Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity	CELL			English	Article							PROTEIN-KINASE-C; EPITHELIAL TIGHT JUNCTION; ASYMMETRIC CELL-DIVISION; ANTERIOR-POSTERIOR AXIS; TUMOR-SUPPRESSOR PTEN; CAENORHABDITIS-ELEGANS; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC POLARITY; AXON FORMATION; RHO-GTPASES	How a neuron becomes polarized remains an outstanding question. Here, we report that selection of the future axon among neurites of a cultured hippocampal neuron requires the activity of growth factor receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI 3-kinase), as well as atypical protein kinase C (aPKC). The PI 3-kinase activity, highly localized to the tip of the newly specified axon of stage 3 neurons, is essential for the proper subcellular localization of mPar3, the mammalian homolog of C. elegans polarity protein Par3. Polarized distribution of not only mPar3 but also mPar6 is important for axon formation; ectopic expression of mPar6 or mPar3, or just the N terminus of mPar3, leaves neurons with no axon specified. Thus, neuronal polarity is likely to be controlled by the mPar3/mPar6/aPKC complex and the PI 3-kinase signaling pathway, both serving evolutionarily conserved roles in specifying cell polarity.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, 533 Parnassus Ave, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; CHANT J, 1994, TRENDS GENET, V10, P328, DOI 10.1016/0168-9525(94)90036-1; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GOSLIN K, 1989, J CELL BIOL, V108, P1506; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Hirose T, 2002, J CELL SCI, V115, P2485; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kabir N, 2001, J CELL BIOL, V152, P1033, DOI 10.1083/jcb.152.5.1033; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Namikawa K, 2000, J NEUROSCI, V20, P2875; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; TEJERODIEZ P, 1995, FEBS LETT, V363, P293, DOI 10.1016/0014-5793(95)00303-Q; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; TURING A, 1952, PHILOS T R SOC B, V237, P32; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	61	489	502	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					63	75		10.1016/S0092-8674(02)01249-7	http://dx.doi.org/10.1016/S0092-8674(02)01249-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526794	Bronze			2022-12-01	WOS:000181191500007
J	Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT			Modelling vaccination strategies against foot-and-mouth disease	NATURE			English	Article							GREAT-BRITAIN; EPIDEMIC; TRANSMISSION; DYNAMICS; SPREAD; DESIGN; IMPACT; FMD	Vaccination has proved a powerful defence against a range of infectious diseases of humans and animals. However, its potential to control major epidemics of foot-and-mouth disease (FMD) in livestock is contentious. Using an individual farm-based model, we consider either national prophylactic vaccination campaigns in advance of an outbreak, or combinations of reactive vaccination and culling strategies during an epidemic. Consistent with standard epidemiological theory, mass prophylactic vaccination could reduce greatly the potential for a major epidemic, while the targeting of high-risk farms increases efficiency. Given sufficient resources and preparation, a combination of reactive vaccination and culling might control ongoing epidemics. We also explore a reactive strategy, 'predictive' vaccination, which targets key spatial transmission loci and can reduce markedly the long tail that characterizes many FMD epidemics. These analyses have broader implications for the control of human and livestock infectious diseases in heterogeneous spatial landscapes.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Zinnia, Woking GU21 4JJ, Surrey, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Warwick; University of Warwick; University of Edinburgh; University of Oxford; University of Cambridge	Keeling, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	m.j.keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				ANDERSON R M, 1991; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; *COMM INQ FOOT MOU, 1968, REP COMM INQ FOOT MO; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAYDON DT, 2001, IN PRESS P R SOC L B; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Muller J, 2000, J MATH BIOL, V41, P143, DOI 10.1007/s002850070003; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Salt J. S., 1997, VET VACCINOLOGY, P641; *SCI COMM AN HLTH, EU STRAT EM VACC FOO; Verschueren, 1997, VET VACCINOLOGY; Williams JR, 1996, J EPIDEMIOL COMMUN H, V50, P667, DOI 10.1136/jech.50.6.667; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; Woolhouse M.E.J., 1997, VET VACCINOLOGY, P565; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	28	321	326	2	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					136	142		10.1038/nature01343	http://dx.doi.org/10.1038/nature01343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12508120	Bronze			2022-12-01	WOS:000180267200032
J	Haider, AW; Larson, MG; Franklin, SS; Levy, D				Haider, AW; Larson, MG; Franklin, SS; Levy, D			Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ARTERIAL DISTENSIBILITY; SUBENDOCARDIAL ISCHEMIA; MYOCARDIAL-INFARCTION; AORTIC COMPLIANCE; HYPERTENSION; DISEASE; DOGS; PROGRESSION; PREVENTION	Background: Although hypertension is a principal precursor of congestive heart failure (CHF), the separate relations of systolic, diastolic, and pulse pressure with risk for heart failure have not been fully elucidated. Objective: To examine the value of blood pressure predictors of heart failure. Design: Community-based inception cohort study. Setting: Framingham, Massachusetts. Patients: 2040 free-living Framingham Heart Study participants (mean age, 61 years [range, 50 to 79 years]). Measurements: The association of baseline systolic, diastolic, and pulse pressure with risk for incident CHF was examined in 894 men and 1146 women. Framingham Heart Study participants free of CHF at the baseline examination (performed from 1968 to 1973) were monitored for up to 24 years (mean, 17.4 years) for new-onset heart failure. Cox proportional hazards models were used to adjust for age, sex, smoking, left ventricular hypertrophy, body mass index, diabetes mellitus, high-density lipoprotein cholesterol level, and heart rate; hazard ratios and 95% Cis for blood pressure variables were estimated. Results: CHF developed in 234 participants (11.8%) during the follow-up period. All three blood pressure components were related to the risk for CHF, but the relation was strongest for systolic and pulse pressure. A 1-SD (20 mm Hg) increment in systolic pressure conferred a 56% increased risk for CHF (hazard ratio, 1.56 [95% Cl, 1.37 to 1.77]); similarly, a 1-SD (16 mm Hg) increment in pulse pressure conferred a 55% increased risk for CHF (hazard ratio, 1.55 [Cl, 1.37 to 1.75]). These associations were unrelated to age, duration of follow-up, and initiation of treatment for hypertension during follow-up; they were also observed in patients with systolic hypertension (systolic blood pressure greater than or equal to 140 mm Hg) at the baseline examination (hazard ratio, 1.41 [Cl, 1.18 to 1.69] for pulse pressure and 1.42 [Cl, 1.14 to 1.76] for systolic pressure). Conclusions: Although each component of blood pressure was associated with risk for CHF, pulse and systolic pressure conferred greater risk than diastolic pressure. Increased pulse pressure may help identify hypertensive patients at high risk for overt CHF who are candidates for aggressive blood pressure control.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Calif Irvine, Irvine, CA 92717 USA; Vet Adm Med Ctr, W Roxbury, MA USA; MCP Hahnemann Univ Hosp, Philadelphia, PA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Drexel University	Levy, D (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254	NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABERNETHY J, 1986, American Journal of Preventive Medicine, V2, P123; [Anonymous], 1991, JAMA, V265, P3255; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; BAUMBACH GL, 1991, CIRC RES, V68, P338, DOI 10.1161/01.RES.68.2.338; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90, DOI 10.1161/01.ATV.13.1.90; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; BOUTHIER JD, 1985, AM HEART J, V109, P1345, DOI 10.1016/0002-8703(85)90364-3; BUCKBERG GD, 1972, CIRC RES, V30, P67, DOI 10.1161/01.RES.30.1.67; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; CHRISTENSEN KL, 1991, HYPERTENSION, V18, P722, DOI 10.1161/01.HYP.18.6.722; CUPPLES LA, 1998, PUBLICATION; Cutler Jeffrey A., 1995, P253; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Franklin SS, 1997, CIRCULATION, V96, P308; FRANKLIN SS, 1994, AM HEART J, V128, P793, DOI 10.1016/0002-8703(94)90278-X; FREIS ED, 1982, JAMA-J AM MED ASSOC, V248, P2004; GIRERD X, 1991, AM HEART J, V122, P1210, DOI 10.1016/0002-8703(91)90941-A; KANNEL WB, 1981, JAMA-J AM MED ASSOC, V245, P1225, DOI 10.1001/jama.245.12.1225; KANNEL WB, 1972, NEW ENGL J MED, V287, P782; Kass DA, 1996, CIRCULATION, V93, P1533, DOI 10.1161/01.CIR.93.8.1533; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee MLT, 1999, ANN EPIDEMIOL, V9, P101, DOI 10.1016/S1047-2797(98)00034-9; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; LYON RT, 1987, J VASC SURG, V5, P59, DOI 10.1067/mva.1987.avs0050059; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; MATERSON BJ, 1982, JAMA-J AM MED ASSOC, V248, P1996; Mitchell GF, 1997, CIRCULATION, V96, P4254; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; NICHOLS WW, 1990, MCDONALDS BLOOD FLOW, P216; OROURKE MF, 1989, AM J CARDIOL, V63, pI38, DOI 10.1016/0002-9149(89)90127-6; OROURKE MF, 1992, ARTERIAL PULSE, P201; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P381; Smulyan H, 2000, ANN INTERN MED, V132, P233, DOI 10.7326/0003-4819-132-3-200002010-00010; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; WATANABE H, 1993, J AM COLL CARDIOL, V21, P1497, DOI 10.1016/0735-1097(93)90330-4; WATANABE H, 1992, CARDIOVASC RES, V26, P1212, DOI 10.1093/cvr/26.12.1212	45	346	362	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					10	16		10.7326/0003-4819-138-1-200301070-00006	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513039				2022-12-01	WOS:000180996200002
J	Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR				Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR			The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy	CELL			English	Article							CYSTEINE-RICH PROTEIN; HEART-FAILURE; BIOMECHANICAL STRESS; T-CAP; TITIN; HYPERTROPHY; DOMAIN; PATHWAYS; MYOCYTES; MUSCLE	Muscle cells respond to mechanical stretch stimuli by triggering downstream signals for myocyte growth and survival. The molecular components of the muscle stretch sensor are unknown, and their role in muscle disease is unclear. Here, we present biophysical/biochemical studies in muscle LIM protein (MLP) deficient cardiac muscle that support a selective role for this Z disc protein in mechanical stretch sensing. MLP interacts with and colocalizes with telethonin (T-cap), a titin interacting protein. Further, a human MLP mutation (W4R) associated with dilated cardiomyopathy (DCM) results in a marked defect in T-cap interaction/localization. We propose that a Z disc MLP/T-cap complex is a key component of the in vivo cardiomyocyte stretch sensor machinery, and that defects in the complex can lead to human DCM and associated heart failure.	Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Max Planck Inst, D-61231 Bad Nauheim, Germany; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1010062, Japan; Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Kobe, Hyogo 6500017, Japan; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA; Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 2, D-12200 Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Tokyo Medical & Dental University (TMDU); Kobe University; St Georges University London; University of Arizona; University of Arizona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Chien, KR (corresponding author), Univ Calif San Diego, Inst Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		McKenna, William J/C-3243-2008; Knöll, Ralph/GOH-3587-2022; Kimura, Akinori/I-5989-2018; Bang, Marie-Louise/B-5683-2015; Ralph, Knoell/AAE-5990-2020; Poller, Wolfgang/AAB-2185-2021	McKenna, William J/0000-0001-7994-2460; Kimura, Akinori/0000-0002-4933-2132; Bang, Marie-Louise/0000-0001-8859-5034; Ralph, Knoell/0000-0001-8871-112X; Schork, Nicholas/0000-0003-0920-5013; Poller, Wolfgang/0000-0002-2805-6634				Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.3.CO;2-K; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Granzier H, 2002, J PHYSIOL-LONDON, V541, P335, DOI 10.1113/jphysiol.2001.014381; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Harper BD, 2000, BIOCHEM J, V350, P269, DOI 10.1042/0264-6021:3500269; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI200215380; HUNTER JJ, 1999, MOL BASIS CARDIOVASC, P211; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Maisel A, 2002, CIRCULATION, V105, P2328, DOI 10.1161/01.CIR.0000019121.91548.C2; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Rana BK, 1999, GENETICS, V151, P1547; Reid ME, 2000, TRANSFUSION, V40, P48, DOI 10.1046/j.1537-2995.2000.40010048.x; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Trombitas K, 2000, ADV EXP MED BIOL, V481, P405; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zolk O, 2000, CIRCULATION, V101, P2674, DOI 10.1161/01.CIR.101.23.2674	46	582	599	0	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					943	955		10.1016/s0092-8674(02)01226-6	http://dx.doi.org/10.1016/s0092-8674(02)01226-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507422	Bronze			2022-12-01	WOS:000180086000005
J	Aldhous, P				Aldhous, P			Agribiotech - More heat than light	NATURE			English	Editorial Material																		Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Kaplinsky N, 2002, NATURE, V416, P601, DOI 10.1038/nature739; Metz M, 2002, NATURE, V416, P600, DOI 10.1038/nature738; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Quist D, 2002, NATURE, V416, P602, DOI 10.1038/nature740; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Surridge C, 2002, NATURE, V416, P576, DOI 10.1038/416576a; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	9	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					730	731		10.1038/420730a	http://dx.doi.org/10.1038/420730a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490904				2022-12-01	WOS:000179897300013
J	He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A				He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A			Fish consumption and risk of stroke in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; FOOD FREQUENCY QUESTIONNAIRE; ISCHEMIC-HEART-DISEASE; EICOSAPENTAENOIC ACID; PLATELET-FUNCTION; CORONARY-DISEASE; DOSE-RESPONSE; VITAMIN-E; REPRODUCIBILITY; INHIBITION	Context The effect of fish consumption or long-chain omega-3 polyunsaturated fatty acid (PUFA) intake on risk of stroke remains uncertain. Objective To examine the relation of fish consumption and long-chain omega-3 PUFA intake and risk of stroke in men. Design and Setting The Health Professional Follow-up Study, a US prospective cohort study with 12 years of follow-up. Participants A total of 43 671 men aged 40 to 75 years who completed a detailed and validated semiquantitative food frequency questionnaire and who were free of cardiovascular disease at baseline in 1986. Main Outcome Measure Relative risk (RR) of stroke by subtype based on cumulative average fish consumption or long-chain omega-3 PUFA intake, ascertained in 1986, 1990, and 1994. Results We documented 608 strokes during the 12-year follow-up period, including 377 ischemic, 106 hemorrhagic, and 125 unclassified strokes. Compared with men who consumed fish less than once per month, the multivariate RR of ischemic stroke was significantly lower among those who ate fish 1 to 3 times per month (RR, 0.57; 95% confidence interval [Cl], 0.35-0.95). However, a higher frequency of fish intake was not associated with further risk reduction; the RR was 0.54 (95% Cl, 0.31-0.94) for men who consumed fish 5 or more times per week. This lack of linearity was confirmed by spline analyses. By dichotomized fish intake, the multivariate RR for men who consumed fish at least once per month compared with those who ate fish less than once per month was 0.56 (95% Cl, 0.38-0.83) for ischemic stroke and 1.36 (95% Cl, 0.48-3.82) for hemorrhagic stroke. The inverse association between fish intake and risk of ischemic stroke was not materially modified by use of aspirin. No significant associations were found between fish or long-chain omega-3 PUFA intake and risk of hemorrhagic stroke. Conclusion Our findings suggest that eating fish once per month or more can reduce the risk of ischemic stroke in men.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	He, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 335 Huntington Ave, Boston, MA 02115 USA.	khe@hsph.harvard.edu	Merchant, Anwar/B-5233-2009		NHLBI NIH HHS [HL35464] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BJERREGAARD P, 1988, INT J EPIDEMIOL, V17, P514, DOI 10.1093/ije/17.3.514; *CONS FOOD EC I, 1976, HDB 8 SER; De Caterina R, 1998, J LIPID RES, V39, P1062; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DRISS F, 1984, THROMB RES, V36, P389, DOI 10.1016/0049-3848(84)90295-0; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Greenland S, 1999, AM J EPIDEMIOL, V149, P1077; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HARRIS WS, 1989, J LIPID RES, V30, P785; HIRAI A, 1980, LANCET, V2, P1132; HUI R, 1992, J HYPERTENS, V10, P1145, DOI 10.1097/00004872-199210000-00006; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Kang JX, 2000, AM J CLIN NUTR, V71, p202S, DOI 10.1093/ajcn/71.1.202S; KELI SO, 1994, STROKE, V25, P328, DOI 10.1161/01.STR.25.2.328; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KRISTENSEN SD, 1989, J INTERN MED, V225, P141, DOI 10.1111/j.1365-2796.1989.tb01448.x; KROMANN N, 1980, ACTA MED SCAND, V208, P401; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MCKEIGUE P, 1994, LANCET, V343, P1445, DOI 10.1016/S0140-6736(94)92575-5; MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; NESTEL PJ, 1990, ANNU REV NUTR, V10, P149, DOI 10.1146/annurev.nu.10.070190.001053; Orencia AJ, 1996, STROKE, V27, P204, DOI 10.1161/01.STR.27.2.204; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; RAPER NR, 1992, J AM COLL NUTR, V11, P304; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Roche HM, 2000, AM J CLIN NUTR, V71, p232S, DOI 10.1093/ajcn/71.1.232s; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; STEINBERG D, 1992, CIRCULATION, V85, P2338, DOI 10.1161/01.CIR.85.6.2337; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; *USDA, 1993, COMP FOODS RAW PROC; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Walker AE, 1981, STROKE S1, V12, pI13; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YAMORI Y, 1985, J NUTR SCI VITAMINOL, V31, P417, DOI 10.3177/jnsv.31.417; Zhang JJ, 1999, PREV MED, V28, P520, DOI 10.1006/pmed.1998.0472	50	238	243	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3130	3136		10.1001/jama.288.24.3130	http://dx.doi.org/10.1001/jama.288.24.3130			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495393	Bronze			2022-12-01	WOS:000180008200023
J	Srygley, RB; Thomas, ALR				Srygley, RB; Thomas, ALR			Unconventional lift-generating mechanisms in free-flying butterflies	NATURE			English	Article							WEIS-FOGH MECHANISM; INSECT FLIGHT; 3-DIMENSIONAL SEPARATION; VORTEX; FLOW; AIRFOILS; AERODYNAMICS; VORTICES; DYNAMICS; HAWKMOTH	Flying insects generate forces that are too large to be accounted for by conventional steady-state aerodynamics(1,2). To investigate these mechanisms of force generation, we trained red admiral butterflies, Vanessa atalanta, to fly freely to and from artificial flowers in a wind tunnel, and used high-resolution, smoke-wire flow visualizations to obtain qualitative, high-speed digital images of the air flow around their wings. The images show that free-flying butterflies use a variety of unconventional aerodynamic mechanisms to generate force: wake capture(3), two different types of leading-edge vortex(3-7), active and inactive upstrokes(8), in addition to the use of rotational mechanisms 3 and the Weis-Fogh 'clap-and-fling' mechanism(9-12). Free-flying butterflies often used different aerodynamic mechanisms in successive strokes. There seems to be no one 'key' to insect flight, instead insects rely on a wide array of aerodynamic mechanisms to take off, manoeuvre, maintain steady flight, and for landing.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Thomas, ALR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Delery JM, 2001, ANNU REV FLUID MECH, V33, P129, DOI 10.1146/annurev.fluid.33.1.129; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1995, BIOL FLUID DYNAMICS, V49, P109; GADELHAK M, 1986, AIAA J, V24, P713, DOI 10.2514/3.9337; GURSUL I, 1992, AIAA J, V30, P1117, DOI 10.2514/3.11034; HORNUNG H, 1984, Z FLUGWISS WELTRAUM, V8, P77; HUANG MK, 1982, AIAA J, V20, P292, DOI 10.2514/3.7913; Legendre R., 1956, RECH AERO, V54, P3; LIGHTHILL M, 1963, LAMINAR BOUNDARY LAY, V2, P72; LIGHTHILL MJ, 1973, J FLUID MECH, V60, P1, DOI 10.1017/S0022112073000017; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; MAXWORTHY T, 1981, ANNU REV FLUID MECH, V13, P329, DOI 10.1146/annurev.fl.13.010181.001553; Mourtos NJ, 1996, J APPL MECH-T ASME, V63, P543, DOI 10.1115/1.2788902; PERRY AE, 1987, ANNU REV FLUID MECH, V19, P125, DOI 10.1146/annurev.fl.19.010187.001013; Poincar? H., 1882, CR HEBD ACAD SCI, V94, P416; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; Riddle TW, 1999, J FLUID ENG-T ASME, V121, P555, DOI 10.1115/1.2823504; ROSSOW VJ, 1978, J AIRCRAFT, V15, P618, DOI 10.2514/3.58416; ROSSOW VJ, 1992, J AIRCRAFT, V29, P847, DOI 10.2514/3.46255; ROSSOW VJ, 1994, J AIRCRAFT, V31, P146, DOI 10.2514/3.46467; SAFFMAN PG, 1977, STUD APPL MATH, V57, P107; Sane SP, 2002, J EXP BIOL, V205, P1087; SPEDDING GR, 1993, ADV COMP ENV PHYSL, V11; TOBAK M, 1982, ANNU REV FLUID MECH, V14, P61, DOI 10.1146/annurev.fl.14.010182.000425; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P317, DOI 10.1098/rstb.1997.0023; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Zbikowski R, 2002, PHILOS T ROY SOC A, V360, P273, DOI 10.1098/rsta. 2001.0930	30	259	281	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					660	664		10.1038/nature01223	http://dx.doi.org/10.1038/nature01223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478291				2022-12-01	WOS:000179751800043
J	Fitzgerald, DW; Behets, FMTF				Fitzgerald, DW; Behets, FMTF			Beyond folklore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREGNANCY											Dennie CC, 1962, HIST SYPHILIS; Farmer P., 1999, INFECT INEQUALITIES; FARMER P, 1992, COMP STUDIES HLTH SY; Fitzgerald D W, 1998, Int J Infect Dis, V2, P127, DOI 10.1016/S1201-9712(98)90113-8; FITZGERALD DW, IN PRESS AM J PUBLIC; HIRA SK, 1990, GENITOURIN MED, V66, P159; JENNISKENS F, 1995, INT J GYNECOL OBSTET, V48, pS121, DOI 10.1016/0020-7292(95)02326-8; Moore JE., 1933, MODERN TREATMENT SYP; RADOLF JD, 1999, SEXUALLY TRANSMITTED, P1168; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2791	2792		10.1001/jama.288.22.2791	http://dx.doi.org/10.1001/jama.288.22.2791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472303				2022-12-01	WOS:000179732600001
J	Connolly, MA; Heymann, DL				Connolly, MA; Heymann, DL			Deadly comrades: war and infectious diseases	LANCET			English	Article									WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland	World Health Organization	Connolly, MA (corresponding author), WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland.								0	34	34	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S23	S24		10.1016/S0140-6736(02)11807-1	http://dx.doi.org/10.1016/S0140-6736(02)11807-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504490				2022-12-01	WOS:000180064500011
J	Barbour, DL; Wang, XQ				Barbour, DL; Wang, XQ			Contrast tuning in auditory cortex	SCIENCE			English	Article							TOPOGRAPHY; RESPONSES; NUCLEUS	The acoustic features useful for converting auditory information into perceived objects are poorly understood. Although auditory cortex neurons have been described as being narrowly tuned and preferentially responsive to narrowband signals, naturally occurring sounds are generally wideband with unique spectral energy profiles. Through the use of parametric wideband acoustic stimuli, we found that such neurons in awake marmoset monkeys respond vigorously to wideband sounds having complex spectral shapes, preferring stimuli of either high or low spectral contrast. Low contrast-preferring neurons cannot be studied thoroughly with narrowband stimuli and have not been previously described. These findings indicate that spectral contrast reflects an important stimulus decomposition in auditory cortex and may contribute to the recognition of acoustic objects.	Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Barbour, DL (corresponding author), Johns Hopkins Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,424 Ross Bldg, Baltimore, MD 21205 USA.	dbarbour@bme.jhu.edu		Barbour, Dennis/0000-0003-0851-0665	NIDCD NIH HHS [R01 DC003180, DC-03180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Barbour DL, 2002, J NEUROPHYSIOL, V88, P2684, DOI 10.1152/jn.00253.2002; CALHOUN BM, 1998, PSYCHOPHYSICAL PHYSL, P170; Dan Y, 1996, J NEUROSCI, V16, P3351; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; EHRET G, 1985, SCIENCE, V227, P1245, DOI 10.1126/science.3975613; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SEIDEN HR, 1957, THESIS PRINCETON U P; SUGA N, 1988, AUDITORY FUNCTION NE, P679; Suga N., 1994, COGNITIVE NEUROSCIEN, P295; WANG X, 2003, P NATL ACAD SCI USA, V97, P11843; Young E. D., 1998, SYNAPTIC ORG BRAIN, P121; Young ED, 1998, P NATL ACAD SCI USA, V95, P933, DOI 10.1073/pnas.95.3.933; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	24	82	83	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1073	1075		10.1126/science.1080425	http://dx.doi.org/10.1126/science.1080425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586943	Green Accepted, Green Submitted			2022-12-01	WOS:000180960000050
J	Friedman, JM				Friedman, JM			A war on obesity, not the obese	SCIENCE			English	Editorial Material							BODY-MASS INDEX; EARLY-ONSET OBESITY; DIABETES-MELLITUS; LIFE-STYLE; LEPTIN; WEIGHT; ADULTS; PREVALENCE; MUTATIONS; MORTALITY		Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 New York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK41096] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1996, INT J OBESITY, V20, P501; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Critser G., 2003, FAT LAND AM BECAME F; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Diamond J., 1999, GUNS GERMS STEEL FAT; DIAMOND JM, 1992, NATURE, V357, P362, DOI 10.1038/357362a0; DOWSE GK, 1990, DIABETES, V39, P390, DOI 10.2337/diabetes.39.3.390; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; FAROOQI S, COMMUNICATION; FLEGAL K, COMMUNICATION; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; HOWARD BV, 1991, AM J CLIN NUTR, V53, pS1577, DOI 10.1093/ajcn/53.6.1577S; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kumanyika Shiriki, 2002, Ethnicity and Disease, V12, P316; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Murray JE, 1997, J ECON HIST, V57, P585, DOI 10.1017/S0022050700113373; NEEL JV, 1962, AM J HUM GENET, V14, P353; RAVUSSIN E, 1995, METABOLISM, V44, P12, DOI 10.1016/0026-0495(95)90312-7; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 1998, J CLIN ENDOCR METAB, V83, P214, DOI 10.1210/jc.83.1.214; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Weiner, 1995, BEAK FINCH STORY EVO; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zimmet P, 1984, Diabetes Res, V1, P13; 2002, NY TIMES        1124	37	276	283	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					856	858		10.1126/science.1079856	http://dx.doi.org/10.1126/science.1079856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574619				2022-12-01	WOS:000180830900040
J	Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P				Chan, CLH; Facer, P; Davis, JB; Smith, GD; Egerton, J; Bountra, C; Williams, NS; Anand, P			Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency	LANCET			English	Article							RAT; IMMUNOREACTIVITY; DISTENSION; SENSATION; PEPTIDE; NEURONS	Background Faecal urgency and incontinence with rectal hypersensitivity is a distressing, unexplained disorder that is inadequately treated. We aimed to determine whether expression of the heat and capsaicin receptor vanilloid receptor 1 (TRPV1 or VR1) was changed in rectal sensory fibres, and to correlate nerve fibre density with sensory abnormalities. Methods We compared full-thickness rectal biopsy samples from nine patients with physiologically characterised rectal hypersensitivity with tissue samples from 12 controls. Sensory thresholds to rectal balloon distension and heating the rectal mucosa were measured before biopsy. We assessed specimens with immunohistochemistry and image analysis using specific antibodies to TRPV1; nerve growth factor (NGF) receptor tyrosine kinase A; glial cell line-derived neurotrophic factor (GDNF); neuropeptides calcitonin gene-related peptide (CGRP) and substance P; the related vanilloid receptor-like protein (VRL) 2; glial markers S-100 and glial fibrillary acid protein (GFAP); and the nerve structural marker peripherin. Findings In rectal hypersensitivity, nerve fibres immunoreactive to TRPV1 were increased in muscle, submucosal, and mucosal layers: in the mucosal layer, the median % area positive was 0.44 (range 0.30-0.59) in patients who were hypersensitive and 0.11 (0.00-0.21) in controls (p=0.0005). The numbers of peripherin-positive fibres also increased in the mucosal layer (hypersensitive 3.00 [1.80-6.50], controls 1.20 [0.39-2.10]: (p=0.0002). The increase in TRVP1 correlated significantly with the decrease in rectal heat (p=0.03) and the distension (p=0.02) sensory thresholds. The thresholds for heat and distension were also significantly correlated (p=0.0028). Expression of nerve fibres positive for GDNF (p=0.001) and tyrosine kinase A (p=0.002) was also increased, as were cell bodies of the submucosal ganglia immunoreactive to CGRP (P=0.0009). Interpretation Faecal urgency and rectal hypersensitivity could result from increased numbers of polymodal sensory nerve fibres expressing TRPV1. The triggering factor or factors remain uncertain, but drugs that target nerve terminals that express this receptor, such as topical resiniferatoxin, deserve consideration.	Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, London W12 0NN, England; GlaxoSmithKline, Neurol CEDD, Harlow, Essex, England; Barts & London Queen Marys Sch Med & Dent, Acad Dept Surg, London, England	Imperial College London; GlaxoSmithKline; University of London; Queen Mary University London	Anand, P (corresponding author), Hammersmith Hosp, Imperial Coll London, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, Du Cane Rd, London W12 0NN, England.	p.anand@ic.ac.uk						Anavi-Goffer S, 2002, NEUROSCI LETT, V319, P53, DOI 10.1016/S0304-3940(01)02480-6; Avelino A, 2000, AUTON NEUROSCI-BASIC, V86, P37, DOI 10.1016/S1566-0702(00)00204-6; BREWER DB, 1990, J PATHOL, V161, P301, DOI 10.1002/path.1711610406; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; CHAN CL, 2001, COLORECTAL DIS S, V3, P78; Dasgupta P, 2000, BJU INT, V85, P238, DOI 10.1046/j.1464-410x.2000.00427.x; DUTHIE HL, 1960, BRIT J SURG, V47, P585, DOI 10.1002/bjs.18004720602; FARTHING MJG, 1978, GUT, V19, P64, DOI 10.1136/gut.19.1.64; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Peters RJ, 1998, J AUTONOM NERV SYST, V70, P115, DOI 10.1016/S0165-1838(98)00044-7; PILOWSKY I, 1984, GEN HOSP PSYCHIAT, V6, P123, DOI 10.1016/0163-8343(84)90070-7; Plourde V, 1997, AM J PHYSIOL-GASTR L, V273, pG191, DOI 10.1152/ajpgi.1997.273.1.G191; PRIOR A, 1992, GUT, V33, P264, DOI 10.1136/gut.33.2.264; Sloots CEJ, 2000, NEUROGASTROENT MOTIL, V12, P361; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI DOI 10.1136/BMJ.292.6516.344; Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X; Su X, 1998, J NEUROPHYSIOL, V80, P2632, DOI 10.1152/jn.1998.80.5.2632; SUN WM, 1992, GUT, V33, P807, DOI 10.1136/gut.33.6.807; WALKER K, 2001, SOC NEUR ABSTR, V27; Williams NS, 2001, DIS COLON RECTUM, V44, P192, DOI 10.1007/BF02234292; WINNING AJ, 1986, CLIN SCI, V71, P519, DOI 10.1042/cs0710519; WINTER J, 1988, NEURON, V1, P973, DOI 10.1016/0896-6273(88)90154-7; Yiangou Y, 2001, LANCET, V357, P1338, DOI 10.1016/S0140-6736(00)04503-7	27	253	279	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2003	361	9355					385	391		10.1016/S0140-6736(03)12392-6	http://dx.doi.org/10.1016/S0140-6736(03)12392-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573376				2022-12-01	WOS:000180787000012
J	Burgio, GR; Gluckman, E; Locatelli, F				Burgio, GR; Gluckman, E; Locatelli, F			Ethical reappraisal of 15 years of cord-blood transplantation	LANCET			English	Review							BONE-MARROW; PREIMPLANTATION DIAGNOSIS; FANCONIS ANEMIA; LEUKEMIA; CHILDREN; BANKING; DISEASE; DONORS	Since the first successful use of cord blood as source of haemopoietic stem cells for transplantation in 1988, more than 2000 patients with malignant or non-malignant disorders have been treated with this procedure. Collection and storage of cord blood has prompted ethical considerations, mainly dealing with the issues of autonomy in making decisions about donation of cord blood, and of privacy and confidentiality in the tests required before use of placental cells for transplantation. The ethical implications of possible storage of cord-blood cells for autologous use has also been discussed. Preimplantation selection of HLA-matched embryos to obtain a donor of cells for cord-blood transplantation of a sibling with a life-threatening disease has raised the issue of the extent to which this approach complies with the principles of bioethics.	Hop St Louis, Serv Greffe Moelle, Paris, France; Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, I-27100 Pavia, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Fondazione San Matteo; University of Pavia	Locatelli, F (corresponding author), Univ Pavia, Policlin San Matteo, Ist Ricovero & Cura Carattere Sci, Dept Paediat, Ple Golgi 2, I-27100 Pavia, Italy.							Alby N., 1987, REV MED PSYCHOSOM, V9, P15; Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923; Bauchamp TL, 1994, PRINCIPLES BIOMEDICA; BERTOLINI F, 1995, BLOOD, V85, P3361, DOI 10.1182/blood.V85.11.3361.bloodjournal85113361; BURGIO GR, 1987, LANCET, V1, P1484; Burgio GR, 2000, LANCET, V356, P1868, DOI 10.1016/S0140-6736(00)03254-2; Burgio GR, 1997, BONE MARROW TRANSPL, V19, P1163, DOI 10.1038/sj.bmt.1700825; Damewood MD, 2001, JAMA-J AM MED ASSOC, V285, P3143, DOI 10.1001/jama.285.24.3143; Dufour C, 2001, BRIT J HAEMATOL, V112, P796, DOI 10.1046/j.1365-2141.2001.02572.x; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HOROWITZ MM, 1990, BLOOD, V75, P555; *INT WORK GROUP PR, 2000, J ASSIST REPROD GEN, V17, P75; Jones HW, 1999, BEST PRACT RES CL OB, V13, P473, DOI 10.1053/beog.1999.0043; Locatelli F, 1999, BLOOD, V93, P3662; Marshall E, 1996, SCIENCE, V271, P586, DOI 10.1126/science.271.5249.586; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Sugarman J, 1997, JAMA-J AM MED ASSOC, V278, P938, DOI 10.1001/jama.278.11.938; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1	22	46	49	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					250	252		10.1016/S0140-6736(03)12276-3	http://dx.doi.org/10.1016/S0140-6736(03)12276-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547553				2022-12-01	WOS:000180535400028
J	Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G				Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G			Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes	NATURE			English	Article							LIFE-SPAN; LONGEVITY; GENETICS; MUTATION; DAF-16; FOOD	Regulation of body fat storage involves signalling between centres that regulate feeding in the brain and sites of fat storage and use in the body(1,2). Here we describe an assay for analysing fat storage and mobilization in living Caenorhabditis elegans. By using RNA-mediated interference (RNAi)(3,4) to disrupt the expression of each of the 16,757 worm genes, we have systematically screened the C. elegans genome for genes necessary for normal fat storage. We identify 305 gene inactivations that cause reduced body fat and 112 gene inactivations that cause increased fat storage. Analysis of the fat-reducing gene inactivations in insulin, serotonin and tubby signalling mutants of C. elegans, which have increased body fat, identifies a core set of fat regulatory genes as well as pathway-specific fat regulators. Many of the newly identified worm fat regulatory genes have mammalian homologues, some of which are known to function in fat regulation. Other C. elegans fat regulatory genes that are conserved across animal phylogeny, but have not previously been implicated in fat storage, may point to ancient and universal features of fat storage regulation, and identify targets for treating obesity and its associated diseases.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Cambridge, Wellcome Canc Res UK Inst, Cambridge CB2 1QR, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington State University; University of Cambridge	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639; Ahringer, Julie/0000-0002-7074-4051; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GOODMAN R, 1997, CHILD PSYCHOL PSYCHI, V2, P15; GREENSPAN P, 1985, J LIPID RES, V26, P781; Johnstone I.J., 1999, C ELEGANS PRACTICAL, P201; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Riddle DL, 1997, C ELEGANS, P739; ROLLAND V, 1995, J BIOL CHEM, V270, P1102, DOI 10.1074/jbc.270.3.1102; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; YAMASAKI H, 1984, MECHANISMS TUMOR PRO, V4, P1	29	761	834	5	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					268	272		10.1038/nature01279	http://dx.doi.org/10.1038/nature01279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529643				2022-12-01	WOS:000180397600047
J	Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K				Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K			Mortality associated with influenza and respiratory syncytial virus in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY PERSONS; PROTECTIVE EFFICACY; US CHILDREN; VACCINE; INFECTION; YOUNG; OLDER; DISEASE; DEATHS; IMPACT	Context Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality. Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation. Objective To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype. Design, Setting, and Population Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths. Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons. Main Outcome Measures Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes. Results Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category). For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1). Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36155 (11055) and 11321 (668) underlying respiratory and circulatory deaths, and 51203 (15081) and 17358 (1086) all-cause deaths. For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older, Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year. On average, influenza was associated with 3 times as many deaths as RSV. Conclusions Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons. Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,MS E61, Atlanta, GA 30333 USA.	wct2@cdc.gov	Markofski, Melissa M/Q-6372-2016	Markofski, Melissa M/0000-0003-0214-4246; Fukuda, Keiji/0000-0002-9598-9565; Shay, David/0000-0001-9619-4820				ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 1992, MAN INT STAT CLASS D; Barker WH, 1998, ARCH INTERN MED, V158, P645, DOI 10.1001/archinte.158.6.645; BISNO AL, 1971, AM J MED SCI, V261, P251, DOI 10.1097/00000441-197105000-00004; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; Bridges Carolyn B, 2002, MMWR Recomm Rep, V51, P1; *CDCP, 1999, DHHS PUBL; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1091; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Douglas R G Jr, 1976, Hosp Pract, V11, P43; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; Falsey AR, 1999, J MED VIROL, V59, P221, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;221::AID-JMV16&gt;3.0.CO;2-H; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Farr W, 1985, VITAL STAT MEMORIAL; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; HETZEL AM, 1997, HIST ORG VITAL SAT S; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Katz JM, 2000, VACCINE, V18, P2177, DOI 10.1016/S0264-410X(00)00022-0; Longini IM, 2000, VACCINE, V18, P1902, DOI 10.1016/S0264-410X(99)00419-3; *NAT CTR HLTH STAT, 1999, VIT STAT MORT DAT MU; Nichol KL, 1996, GERONTOLOGY, V42, P274, DOI 10.1159/000213803; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; TREANOR JJ, 1992, ANN INTERN MED, V117, P625, DOI 10.7326/0003-4819-117-8-625; *US BUR CENS, 1990, INT EST POP AG SEX R; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; *WHO, 1977, MAN INT STAT CLASS D; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	46	2747	2912	6	456	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					179	186		10.1001/jama.289.2.179	http://dx.doi.org/10.1001/jama.289.2.179			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517228	Bronze			2022-12-01	WOS:000180226400028
J	van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M				van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M			Orangutan cultures and the evolution of material culture	SCIENCE			English	Article							TOOL USE; CHIMPANZEES; PRIMATES; BEHAVIOR	Geographic variation in some aspects of chimpanzee behavior has been interpreted as evidence for culture. Here we document similar geographic variation in orangutan behaviors. Moreover, as expected under a cultural interpretation, we find a correlation between geographic distance and cultural difference, a correlation between the abundance of opportunities for social learning and the size of the local cultural repertoire, and no effect of habitat on the content of culture. Hence, great-ape cultures exist, and may have done so for at least 14 million years.	Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Kinabatangan Orang Utan Conservat Project, Sandakan 90734, Sabah, Malaysia; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; Orangutan Fdn Int, Los Angeles, CA 90049 USA; Harvard Univ, Dept Anthropol, Peabody Museum, Cambridge, MA 02138 USA; Sumatran Orangutan Conservat Programme, Medan 20000, Indonesia; Kyoto Univ, Primate Inst, Inuyama, Aichi 484, Japan; Univ Nas, Fak Biol, Jakarta 12520, Indonesia; Univ Utrecht, Dept Behav Biol, NL-3508 TB Utrecht, Netherlands	Duke University; Simon Fraser University; Harvard University; Kyoto University; Universitas Nasional Pionir Perubahan; Utrecht University	van Schaik, CP (corresponding author), Duke Univ, Dept Biol Anthropol & Anat, POB 90383, Durham, NC 27708 USA.		Merrill, Michelle Yvonne/D-7807-2014	Merrill, Michelle Yvonne/0000-0002-7337-7533; utami, sri/0000-0002-5138-242X				BOESCH C, 1994, J HUM EVOL, V26, P325, DOI 10.1006/jhev.1994.1020; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Curio E., 1988, P75; de Waal FBM, 1999, NATURE, V399, P635, DOI 10.1038/21310; FOX EA, IN PRESS AM J PHYS A; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; GALEF BG, IN PRESS BIOL ANIMAL; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hudson J. C., 1972, NW U STUDIES GEOGRAP; Keesing F. M, 1958, CULTURAL ANTHR SCI C; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; MANTEL N, 1967, CANCER RES, V27, P209; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; Myowa-Yamakoshi M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P349; Nishida T., 1987, P462; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; STOINSKI T, IN PRESS COMP PSYCHO; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; Sugiyama Y., 1968, Primates, V9, P225, DOI 10.1007/BF01730972; Tomasello M., 1999, CULTURAL ORIGINS HUM; Tuttle RH, 2001, CURR ANTHROPOL, V42, P407, DOI 10.1086/320476; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; VANSCHAIK CP, IN PRESS BIOL ANIMAL; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2000, COGNITIVE SCI, V24, P477	29	614	632	6	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					102	105		10.1126/science.1078004	http://dx.doi.org/10.1126/science.1078004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511649				2022-12-01	WOS:000180165800042
J	Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH				Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH			Role of duplicate genes in genetic robustness against null mutations	NATURE			English	Article							REDUNDANCY; GENOME; YEAST; EVOLUTION	Deleting a gene in an organism often has little phenotypic effect(1-5), owing to two mechanisms of compensation(4-10). The first is the existence of duplicate genes: that is, the loss of function in one copy can be compensated by the other copy or copies. The second mechanism of compensation stems from alternative metabolic pathways, regulatory networks, and so on. The relative importance of the two mechanisms has not been investigated except for a limited study, which suggested that the role of duplicate genes in compensation is negligible(10). The availability of fitness data for a nearly complete set of single-gene-deletion mutants of the Saccharomyces cerevisiae genome(11) has enabled us to carry out a genome-wide evaluation of the role of duplicate genes in genetic robustness against null mutations. Here we show that there is a significantly higher probability of functional compensation for a duplicate gene than for a singleton, a high correlation between the frequency of compensation and the sequence similarity of two duplicates, and a higher probability of a severe fitness effect when the duplicate copy that is more highly expressed is deleted. We estimate that in S. cerevisiae at least a quarter of those gene deletions that have no phenotype are compensated by duplicate genes.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; Iowa State Univ, Dept Zool, Ames, IA 50011 USA; Iowa State Univ, Dept Genet, Ames, IA 50011 USA	University of Chicago; Stanford University; Stanford University; Iowa State University; Iowa State University	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.			Steinmetz, Lars/0000-0002-3962-2865; Li, Wen-Hsiung/0000-0003-1086-1456				Brookfield John, 1992, Current Biology, V2, P553, DOI 10.1016/0960-9822(92)90036-A; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson TJ, 1998, TRENDS GENET, V14, P46, DOI 10.1016/S0168-9525(97)01367-X; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43	22	644	660	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					63	66		10.1038/nature01198	http://dx.doi.org/10.1038/nature01198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511954				2022-12-01	WOS:000180165500037
J	Parrish, AG				Parrish, AG			Country gardens	LANCET			English	Editorial Material											Parrish, AG (corresponding author), POB 244, ZA-5256 Gonuble, South Africa.								0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2059	2060		10.1016/S0140-6736(02)11996-9	http://dx.doi.org/10.1016/S0140-6736(02)11996-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504416				2022-12-01	WOS:000179974200027
J	Winfree, AT				Winfree, AT			On emerging coherence	SCIENCE			English	Editorial Material									Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona								BASAR E, 1980, EEG BRAIN DYNAMICS, P176; Dano S, 1999, NATURE, V402, P320, DOI 10.1038/46329; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kuramoto, 1984, SPRINGER SERIES SYNE; STROGATZ SH, UNPUB; TYSON J, 1978, J THEOR BIOL, V73, P723, DOI 10.1016/0022-5193(78)90133-9; Vanag VK, 2001, SCIENCE, V294, P835, DOI 10.1126/science.1064167; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFREE AT, 1966, PROGRESS REPORT; WINFREE AT, 2001, GEOMETRY BIOL TIME, P119	13	54	54	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2336	2337		10.1126/science.1072560	http://dx.doi.org/10.1126/science.1072560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493899				2022-12-01	WOS:000179915900038
J	Bernasconi, NL; Traggiai, E; Lanzavecchia, A				Bernasconi, NL; Traggiai, E; Lanzavecchia, A			Maintenance of serological memory by polyclonal activation of human memory B cells	SCIENCE			English	Article							PLASMA-CELLS; IMMUNOLOGICAL MEMORY; HUMORAL IMMUNITY; BONE-MARROW; ANTIGEN; DIFFERENTIATION; LYMPHOCYTES	Production of antibodies can last for a lifetime, through mechanisms that remain poorly understood. Here, we show that human memory B lymphocytes proliferate and differentiate into plasma cells in response to polyclonal stimuli, such as bystander T cell help and CpG DNA. Furthermore, plasma cells secreting antibodies to recall antigens are produced in vivo at levels proportional to the frequency of specific memory B cells, even several years after antigenic stimulation. Although antigen boosting leads to a transient increase in specific antibody levels, ongoing polyclonal activation of memory B cells offers a means to maintain serological memory for a human lifetime.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Biomed Res, Via Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch	traggiai, elisabetta/A-2316-2009					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881; BERNASCONI NL, UNPUB; CELADA F, 1967, J EXP MED, V125, P199, DOI 10.1084/jem.125.2.199; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Uhr J W, 1968, Adv Immunol, V8, P81, DOI 10.1016/S0065-2776(08)60465-4; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	28	1003	1060	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2199	2202		10.1126/science.1076071	http://dx.doi.org/10.1126/science.1076071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481138				2022-12-01	WOS:000179773700050
J	Shaye, DD; Greenwald, I				Shaye, DD; Greenwald, I			Endocytosis-mediated downregulation of LIN-12/Notch upon Ras activation in Caenorhabditis elegans	NATURE			English	Article							CELL FATE DECISIONS; C-ELEGANS; NEGATIVE REGULATOR; RECEPTOR; EXPRESSION; DROSOPHILA; NOTCH; DELTA; GENE; INDUCTION	The coordination of signals from different pathways is important for cell fate specification during animal development. Here, we define a novel mode of crosstalk between the epidermal growth factor receptor/Ras/mitogen-activated protein kinase cascade and the LIN-12/Notch pathway during Caenorhabditis elegans vulval development. Six vulval precursor cells (VPCs) are initially equivalent but adopt different fates as a result of an inductive signal mediated by the Ras pathway and a lateral signal mediated by the LIN-12/Notch pathway(1). One consequence of activating Ras is a reduction of LIN-12 protein in P6.p (ref. 2), the VPC believed to be the source of the lateral signal. Here we identify a 'downregulation targeting signal' (DTS) in the LIN-12 intracellular domain, which encompasses a di-leucine-containing endocytic sorting motif. The DTS seems to be required for internalization of LIN-12, and on Ras activation it might mediate altered endocytic routing of LIN-12, leading to downregulation. We also show that if LIN-12 is stabilized in P6.p, lateral signalling is compromised, indicating that LIN-12 downregulation is important in the appropriate specification of cell fates in vivo.	Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Greenwald, I (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.		Shaye, Daniel/AAY-5351-2020	Shaye, Daniel/0000-0002-3962-6903				Ambros V, 1999, DEVELOPMENT, V126, P1947; Burdine RD, 1998, DEVELOPMENT, V125, P1083; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ehrlich M, 2001, J CELL SCI, V114, P1777; Fares H, 2001, GENETICS, V159, P133; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenwald Iva, 1997, Cold Spring Harbor Monograph Series, V33, P519; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Levitan D, 1998, DEVELOPMENT, V125, P3101; Mello C, 1995, CAENORHABDITIS ELEGA, P451; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; WILKINSON HA, 1995, GENETICS, V141, P513	30	113	117	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					686	690		10.1038/nature01234	http://dx.doi.org/10.1038/nature01234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478297				2022-12-01	WOS:000179751800050
J	Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S				Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S			Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; NEURODEGENERATIVE DISEASES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; CLINICAL-DIAGNOSIS; MOLECULAR-BASIS; SCRAPIE; MUCOSA; EXPRESSION; ACCURACY	BACKGROUND: Olfactory cortexes and the olfactory tracts are involved in sporadic Creutzfeldt-Jakob disease. We examined peripheral regions of the olfactory sensory pathway, including the olfactory mucosa, to assess whether pathologic infectious prion protein (PrP(sup Sc)) is deposited in the epithelium lining the nasal cavity. METHODS: We studied nine patients with neuropathologically confirmed sporadic Creutzfeldt-Jakob disease. We obtained the brain, the cribriform plate with the attached olfactory mucosa, and the surrounding respiratory epithelium at autopsy. Control samples of nasal mucosa were obtained post mortem or at biopsy from age-matched control subjects and from control patients with other neurodegenerative diseases. The olfactory and respiratory mucosa and the intracranial olfactory system were analyzed by light microscopy, immunohistochemistry, and Western blotting for pathological changes and for deposition of PrP(sup Sc). RESULTS: In all nine patients with sporadic Creutzfeldt-Jakob disease, PrP(sup Sc) was found in the olfactory cilia and central olfactory pathway but not in the respiratory mucosa. No PrP(sup Sc) was detected in any of the tissue samples from the 11 controls. CONCLUSIONS: Our pathological and biochemical studies show that PrP(sup Sc) is deposited in the neuroepithelium of the olfactory mucosa in patients with sporadic Creutzfeldt-Jakob disease, indicating that olfactory biopsy may provide diagnostic information in living patients. The olfactory pathway may represent a route of infection and a means of spreading prions.	Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, I-37134 Verona, Italy; Univ Verona, Dept Ear Nose & Throat, I-37134 Verona, Italy; Univ Verona, Dept Morphol & Biomed Sci, I-37134 Verona, Italy; Univ Verona, Dept Agr & Ind Biotechnol, I-37134 Verona, Italy; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy; Univ Padua, Dept Pathol, I-35100 Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; University of Verona; Istituto Superiore di Sanita (ISS); University of Padua	Monaco, S (corresponding author), Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, Piazzale LA Scuro 10, I-37134 Verona, Italy.	salvatore.monaco@mail.univr.it	Pocchiari, Maurizio/J-8443-2018; Monaco, Salvatore/K-4659-2018; Bentivoglio, Marina/K-1008-2016; Ferrari, Sergio/AAE-5649-2019; Zanusso, Gianluigi/K-2823-2018; Gelati, Matteo/AAR-1692-2020; Cardone, Franco/D-1724-2009	Pocchiari, Maurizio/0000-0002-7269-2486; Monaco, Salvatore/0000-0003-3191-8597; Bentivoglio, Marina/0000-0003-4958-9795; Zanusso, Gianluigi/0000-0001-5199-6264; Cardone, Franco/0000-0002-2376-0470; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716				BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Castellani R, 1996, NEUROLOGY, V46, P1690, DOI 10.1212/WNL.46.6.1690; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Duda JE, 1999, EXP NEUROL, V160, P515, DOI 10.1006/exnr.1999.7228; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Haywood AM, 1997, NEW ENGL J MED, V337, P1821, DOI 10.1056/NEJM199712183372508; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; KITAMOTO T, 1987, LAB INVEST, V57, P230; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reuber M, 2001, J NEUROL NEUROSUR PS, V71, P412, DOI 10.1136/jnnp.71.3.412; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SALVATORE M, 1994, HUM GENET, V94, P375, DOI 10.1007/BF00201596; SALVATORE M, 1995, HUM GENET, V95, P605; SHIPLEY MT, 1996, HAND CHEM N, V12, P469; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017; TABATON M, 1991, NEUROLOGY, V41, P391, DOI 10.1212/WNL.41.3.391; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Zanusso G, 2001, BRAIN PATHOL, V11, P182; Zanusso G, 2001, J BIOL CHEM, V276, P40377, DOI 10.1074/jbc.C100458200; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	38	117	120	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					711	719		10.1056/NEJMoa022043	http://dx.doi.org/10.1056/NEJMoa022043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594315				2022-12-01	WOS:000181014400006
J	Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K				Helms, M; Vastrup, P; Gerner-Smidt, P; Molbak, K			Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study	BRITISH MEDICAL JOURNAL			English	Article							CHARLSON COMORBIDITY INDEX; ADMINISTRATIVE DATA; UNITED-STATES; SALMONELLA; MORBIDITY	Objectives To determine the excess mortality associated with infections with Salmonella, Campylobacter, Yersinia enterocolitica, and Shigella and to examine the effect of pre-existing illness. Design Registry based, matched cohort study. Setting Denmark. Participants 48 857 people with gastrointestinal infections plus 487 138 controls from the general population. Main outcome measure One year mortality among patients with gastrointestinal infections compared with controls after adjustment for comorbidity. Results 1071 (2.2%) people with gastrointestinal infections died within one year after infection compared with 3636 (0.7%) controls. The relative mortality within one year was 3.1 times higher in patients than in controls. The relative mortality within 30 days of infection was high in all four bacterial groups. Furthermore, there was excess mortality one to six months after infection with Yersinia enterocolitica (relative risk 2.53, 95% confidence interval 1.38 to 4.62) and from six months to one year after infection with Campylobacter (1.35, 1.02 to 1.80) and Salmonella (1.53,1.31 to 1.79). Conclusions Infections with all these bacteria were associated with an increased short term risk of death, even after pre-existing illnesses were taken into account. Salmonella, Campylobacter, and Yersinia enterocolitica infections were also associated with increased long term mortality.	Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Aarhus University; Statens Serum Institut	Molbak, K (corresponding author), Statens Serum Inst, Dept Gastrointestinal Infect, DK-2300 Copenhagen S, Denmark.			Molbak, Kare/0000-0002-3100-4990				Altekruse SF, 1997, EMERG INFECT DIS, V3, P285, DOI 10.3201/eid0303.970304; Banatvala N, 1999, EPIDEMIOL INFECT, V122, P201, DOI 10.1017/S0950268899002162; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; de Wit MAS, 2000, EUR J EPIDEMIOL, V16, P713, DOI 10.1023/A:1026754218713; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FANG FC, 1991, MEDICINE, V70, P198, DOI 10.1097/00005792-199105000-00004; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Lester A, 1995, Ugeskr Laeger, V157, P20; LESTER A, 1990, Ugeskrift for Laeger, V152, P529; MAUSKOPF JA, 1991, RISK ANAL, V11, P619, DOI 10.1111/j.1539-6924.1991.tb00651.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mosbech J, 1995, Ugeskr Laeger, V157, P3741; Potter Morris E., 1997, World Health Statistics Quarterly, V50, P24; RYAN CA, 1987, JAMA-J AM MED ASSOC, V258, P3269, DOI 10.1001/jama.258.22.3269; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30	19	160	162	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2003	326	7385					357	359		10.1136/bmj.326.7385.357	http://dx.doi.org/10.1136/bmj.326.7385.357			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648RZ	12586666	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000181165500015
J	Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW				Ment, LR; Vohr, B; Allan, W; Katz, KH; Schneider, KC; Westerveld, M; Duncan, CC; Makuch, RW			Change in cognitive function over time in very low-birth-weight infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTICENTER RANDOMIZED TRIAL; HEMORRHAGE PREVENTION TRIAL; LOW-DOSE INDOMETHACIN; AGE 8 YEARS; INTRAVENTRICULAR HEMORRHAGE; PRETERM INFANTS; DEVELOPMENT PROGRAM; EARLY INTERVENTION; PREMATURE-INFANTS; GESTATIONAL-AGE	Context Preterm very low-birth-weight (VLBW) infants have a high prevalence of neurodevelopmental disability when evaluated during the first several years of life. However, recent experimental data suggest that the developing brain may recover from or compensate for injury. Objective To determine if there is cognitive improvement throughout early and middle childhood following VLBW birth. Design, Setting, and Participants Follow-up data of 296 infants born weighing 600 to 1250 g who participated in a prospective, randomized, placebo-controlled intraventricular hemorrhage (IVH) prevention study performed at 3 northeastern US hospitals between September 1989 and August 1992 and who were serially evaluated at 36, 54, 72, and 96 months of corrected age (CA). Main Outcome Measures The age-normed Peabody Picture Vocabulary Test-Revised (PPVT-R) score and measures of intelligence. Results Overall,,the median PPVT-R score increased from 88 at 36 months of CA to 99 at 96 months of CA; when data from 36 and 96 months of CA were compared, 45% of children gained 10 points or more and 12.5% showed a 5- to 9-point increase in test scores. Similar findings were noted for full-scale and verbal IQ scores. Multivariate analyses demonstrated that increasing age, residence in a 2-parent household, and higher levels of maternal education were all significantly associated with higher PPVT-R scores (for each, P<.001). In addition, early intervention led to greater increases over time in PPVT-R scores among children whose mothers had less than a high school education compared with those with a high school education level or greater (P=.03 by test for interaction). Although most children showed improvement in PPVT-R scores with increasing CA, children with early-onset IVH and subsequent significant central nervous system injury had the lowest PPVT-R scores initially and the scores declined over time (P=.009 by test for interaction). Conclusions The majority of VLBW children had improvement in verbal and IQ test scores over time. Only children with early-onset IVH followed by significant central nervous system injury had low PPVT-R scores that declined over time.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; Brown Univ, Sch Med, Dept Pediat, Providence, RI 02912 USA; Maine Med Ctr, Dept Neurol, Portland, ME 04102 USA	Yale University; Yale University; Yale University; Yale University; Brown University; Maine Medical Center	Ment, LR (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St, New Haven, CT 06520 USA.				NCRR NIH HHS [RR 06022] Funding Source: Medline; NINDS NIH HHS [NS 27116] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027116] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan WC, 1997, ARCH PEDIAT ADOL MED, V151, P580, DOI 10.1001/archpedi.1997.02170430046010; BROOKSGUNN J, 1994, JAMA-J AM MED ASSOC, V272, P1257, DOI 10.1001/jama.272.16.1257; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Dunn LM, 1981, PPVT PEABODY PICTURE; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; HACK M, 1995, AM J OBSTET GYNECOL, V172, P457, DOI 10.1016/0002-9378(95)90557-X; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Johnston M V, 2001, Adv Pediatr, V48, P1; LEVINE SC, 1987, DEV MED CHILD NEUROL, V29, P27; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; McCormick MC, 1996, PEDIATRICS, V97, P18; MENT LR, 1994, J PEDIATR-US, V124, P951, DOI 10.1016/S0022-3476(05)83191-9; Ment LR, 2000, PEDIATRICS, V105, P485, DOI 10.1542/peds.105.3.485; Ment LR, 2002, NEUROLOGY, V58, P1726, DOI 10.1212/WNL.58.12.1726; Ment LR, 1996, PEDIATRICS, V98, P714; MENT LR, 1994, PEDIATRICS, V93, P543; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Pinto-Martin JA, 1999, DEV MED CHILD NEUROL, V41, P826, DOI 10.1017/S0012162299001644; Roth S, 2001, EARLY HUM DEV, V65, P81, DOI 10.1016/S0378-3782(01)00173-6; SAIGAL S, 1991, J PEDIATR-US, V118, P751, DOI 10.1016/S0022-3476(05)80043-5; SAIGAL S, 1995, J PEDIATR-US, V126, pS61, DOI 10.1016/S0022-3476(95)70009-9; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; Salokorpi T, 2001, ACTA PAEDIATR, V90, P218, DOI 10.1080/080352501300049505; Singer LT, 2001, J DEV BEHAV PEDIATR, V22, P19, DOI 10.1097/00004703-200102000-00003; Soll Roger F., 1992, P325; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Taylor HG, 2000, DEV NEUROPSYCHOL, V17, P289, DOI 10.1207/S15326942DN1703_2; TERMAN LM, 1973, STANFORDBINET SCALE; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr B, 1999, SEMIN PERINATOL, V23, P212, DOI 10.1016/S0146-0005(99)80065-2; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, V3rd; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	42	237	244	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	2003	289	6					705	711		10.1001/jama.289.6.705	http://dx.doi.org/10.1001/jama.289.6.705			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643WP	12585948	Bronze			2022-12-01	WOS:000180886000024
J	Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B				Meier, C; Trittibach, P; Guglielmetti, M; Staub, JJ; Muller, B			Serum thyroid stimulating hormone in assessment of severity of tissue hypothyroidism in patients with overt primary thyroid failure: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland	University of Basel	Meier, C (corresponding author), Univ Basel Hosp, Dept Med, Div Endocrinol, CH-4031 Basel, Switzerland.		Mueller, Beat/G-2662-2012					Canaris GJ, 1997, J GEN INTERN MED, V12, P544, DOI 10.1046/j.1525-1497.1997.07109.x; FRANKLYN JA, 1993, CLIN ENDOCRINOL, V38, P453, DOI 10.1111/j.1365-2265.1993.tb00339.x; RIDGWAY EC, 1980, CLIN ENDOCRINOL, V13, P479, DOI 10.1111/j.1365-2265.1980.tb03414.x; STAUB JJ, 1992, AM J MED, V92, P631, DOI 10.1016/0002-9343(92)90782-7; Zulewski H, 1997, J CLIN ENDOCR METAB, V82, P771, DOI 10.1210/jc.82.3.771	5	30	32	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					311	312		10.1136/bmj.326.7384.311	http://dx.doi.org/10.1136/bmj.326.7384.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574044	Bronze, Green Published			2022-12-01	WOS:000180997000018
J	Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M				Niven, JE; Vahasoyrinki, M; Kauranen, M; Hardie, RC; Juusola, M; Weckstrom, M			The contribution of Shaker K+ channels to the information capacity of Drosophila photoreceptors	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; POTASSIUM CHANNELS; CONDUCTANCE; PROPAGATION; DENDRITES; DIVERSITY; MEMBRANE; MUTANTS	An array of rapidly inactivating voltage-gated K+ channels is distributed throughout the nervous systems of vertebrates and invertebrates(1-5). Although these channels are thought to regulate the excitability of neurons by attenuating voltage signals, their specific functions are often poorly understood. We studied the role of the prototypical inactivating K+ conductance, Shaker(6,7), in Drosophila photoreceptors(8,9) by recording intracellularly from wild-type and Shaker mutant photoreceptors. Here we show that loss of the Shaker K+ conductance produces a marked reductionin the signal-to-noise ratio of photoreceptors, generating a 50% decrease in the information capacity of these cells in fully light-adapted conditions. By combining experiments with modelling, we show that the inactivation of Shaker K+ channels amplifies voltage signals and enables photoreceptors to use their voltage range more effectively. Loss of the Shaker conductance attenuated the voltage signal and induced a compensatory decrease in impedance. Our results demonstrate the importance of the Shaker K+ conductance for neural coding precision and as a mechanism for selectively amplifying graded signals in neurons, and highlight the effect of compensatory mechanisms on neuronal information processing.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England; Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge; University of Oulu; University of Cambridge	Juusola, M (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.	mj216@cus.cam.ac.uk	Juusola, Mikko/E-6948-2011; Niven, Jeremy E/A-5883-2011	Hardie, Roger/0000-0001-5531-3264; Juusola, Mikko/0000-0002-4428-5330				Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1991, J NEUROSCI, V11, P3079; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HEVERS W, 1995, NEURON, V14, P845, DOI 10.1016/0896-6273(95)90228-7; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D., 1995, FDN CELLULAR NEUROPH; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAPLAN WD, 1969, GENETICS, V61, P399; KOUVALAINEN E, 1994, VISUAL NEUROSCI, V11, P1221, DOI 10.1017/S095252380000701X; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAURENT G, 1990, J NEUROSCI, V10, P2268; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WECKSTROM M, 1995, TRENDS NEUROSCI, V18, P17, DOI 10.1016/0166-2236(95)93945-T	30	66	66	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					630	634		10.1038/nature01384	http://dx.doi.org/10.1038/nature01384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571596				2022-12-01	WOS:000180803200042
J	Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J				Doiron, B; Chacron, MJ; Maler, L; Longtin, A; Bastian, J			Inhibitory feedback required for network oscillatory responses to communication but not prey stimuli	NATURE			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; ENCODING NEURAL ASSEMBLIES; CORTICOTHALAMIC FEEDBACK; SENSORY SEARCHLIGHT; VISUAL-CORTEX; SYNCHRONIZATION; NEURONS; CELLS; MECHANISMS	Stimulus-induced oscillations occur in visual(1,2), olfactory(3-6) and somatosensory(7) systems. Several experimental(2,3,5) and theoretical(8-13) studies have shown how such oscillations can be generated by inhibitory connections between neurons. But the effects of realistic spatiotemporal sensory input on oscillatory network dynamics and the overall functional roles of such oscillations in sensory processing are poorly understood. Weakly electric fish must detect electric field modulations produced by both prey (spatially localized)(14) and communication (spatially diffuse)(15) signals. Here we show, through in vivo recordings, that sensory pyramidal neurons in these animals produce an oscillatory response to communication-like stimuli, but not to prey-like stimuli. On the basis of well-characterized circuitry(16), we construct a network model of pyramidal neurons that predicts that diffuse delayed inhibitory feedback is required to achieve oscillatory behaviour only in response to communication-like stimuli. This prediction is experimentally verified by reversible blockade of feedback inhibition that removes oscillatory behaviour in the presence of communication-like stimuli. Our results show that a sensory system can use inhibitory feedback as a mechanism to 'toggle' between oscillatory and non-oscillatory firing states, each associated with a naturalistic stimulus.	Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman	Doiron, B (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.		Longtin, Andre/D-2443-2009	Chacron, Maurice/0000-0002-3032-452X				AHISSAR E, 1990, P NATL ACAD SCI USA, V87, P8935, DOI 10.1073/pnas.87.22.8935; Bastian J, 2002, J NEUROSCI, V22, P4577, DOI 10.1523/JNEUROSCI.22-11-04577.2002; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3197, DOI 10.1152/jn.1998.80.6.3197; Berman NJ, 1999, J EXP BIOL, V202, P1243; Berman NJ, 1997, J NEUROPHYSIOL, V78, P1869, DOI 10.1152/jn.1997.78.4.1869; Bressloff PC, 2000, NEURAL COMPUT, V12, P91, DOI 10.1162/089976600300015907; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Dayan P., 2001, THEORETICAL NEUROSCI; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Kloeden P. E., 1992, NUMERICAL SOLUTIONS; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519, DOI 10.1152/jn.2000.84.3.1519; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALER L, 1994, J COMP NEUROL, V345, P224, DOI 10.1002/cne.903450206; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; Metzner W, 1999, J EXP BIOL, V202, P1365; Nelson ME, 1999, J EXP BIOL, V202, P1195; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; van Vreeswijk C, 2001, NEURAL COMPUT, V13, P959, DOI 10.1162/08997660151134280; WANG XJ, 1993, NEUROSCIENCE, V53, P899, DOI 10.1016/0306-4522(93)90474-T; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	30	133	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					539	543		10.1038/nature01360	http://dx.doi.org/10.1038/nature01360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556894				2022-12-01	WOS:000180670600047
J	Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD				Ma, D; Yang, CH; McNeill, H; Simon, MA; Axelrod, JD			Fidelity in planar cell polarity signalling	NATURE			English	Article							TISSUE POLARITY; DROSOPHILA EYE; CADHERIN SUPERFAMILY; GENE; ENCODES; MEMBER; PROTEIN; MORPHOGENESIS; MUTATIONS; GROWTH	The polarity of Drosophila wing hairs displays remarkable fidelity. Each of the approximately 30,000 wing epithelial cells constructs an actin-rich prehair that protrudes from its distal vertex and points distally. The distal location and orientation of the hairs is virtually error free, thus forming a nearly perfect parallel array. This process is controlled by the planar cell polarity signalling pathway(1-4). Here we show that interaction between two tiers of the planar cell polarity signalling mechanism results in the observed high fidelity. The first tier, mediated by the cadherin Fat(5), dictates global orientation by transducing a directional signal to individual cells. The second tier, orchestrated by the 7-pass transmembrane receptor Frizzled(6,7), aligns each cell's polarity with that of its neighbours through the action of an intercellular feedback loop, enabling polarity to propagate from cell to cell(8). We show that all cells need not respond correctly to the presumably subtle signal transmitted by Fat. Subsequent action of the Frizzled feedback loop is sufficient to align all the cells cooperatively. This economical system is therefore highly robust, and produces virtually error-free arrays.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Canc Res UK, London Res Inst, London WC2A 3PX, England	Stanford University; Stanford University; Cancer Research UK	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.		McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Adler PN, 1998, DEVELOPMENT, V125, P959; Axelrod JD, 2001, GENE DEV, V15, P1182; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Chae J, 1999, DEVELOPMENT, V126, P5421; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt DI, 2002, SEMIN CELL DEV BIOL, V13, P225, DOI 10.1016/S1084-9521(02)00041-1; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Taylor J, 1998, GENETICS, V150, P199; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wolff T, 1998, DEVELOPMENT, V125, P1149; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	30	255	256	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					543	547		10.1038/nature01366	http://dx.doi.org/10.1038/nature01366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540853				2022-12-01	WOS:000180670600048
J	Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE				Komiyama, T; Johnson, WA; Luo, LQ; Jefferis, GSXE			From lineage to wiring specificity: POU domain transcription factors control precise connections of Drosophila olfactory projection neurons	CELL			English	Article							C-ELEGANS; MOTOR-NEURONS; CELL LINEAGE; SENSORY MAP; IDENTITY; CODES; ACJ6; DIFFERENTIATION; REPRESENTATION; MELANOGASTER	Axonal selection of synaptic partners is generally believed to determine wiring specificity in the nervous system. However, we have recently found evidence for specific dendritic targeting in the olfactory system of Drosophila: second order olfactory neurons (Projection Neurons) from the anterodorsal (adPN) and lateral (IPN) lineages send their dendrites to stereotypical, intercalating but non-overlapping glomeruli. Here we show that POU domain transcription factors, Acj6 and Drifter, are expressed in adPNs and IPNs respectively, and are required for their dendritic targeting. Moreover, misexpression of Acj6 in IPNs, or Drifter in adPNs, results in dendritic targeting to glomeruli normally reserved for the other PN lineage. Thus, Acj6 and Drifter translate PN lineage information into distinct dendritic targeting specificity. Acj6 also controls stereotypical axon terminal arborization of PNs in a central target, suggesting that the connectivity of PN axons and dendrites in different brain centers is coordinately regulated.	Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Stanford University; University of Iowa	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Neurosci Program, Stanford, CA 94305 USA.	lluo@stanford.edu	Jefferis, Gregory/C-6386-2012	Johnson, Wayne/0000-0002-6961-5498; Jefferis, Gregory/0000-0002-0587-9355; Komiyama, Takaki/0000-0001-9609-4600; Luo, Liqun/0000-0001-5467-9264				ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; Certel K, 2000, DEVELOPMENT, V127, P3173; Certel SJ, 2000, DEVELOPMENT, V127, P2395; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	34	125	125	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					157	167		10.1016/S0092-8674(03)00030-8	http://dx.doi.org/10.1016/S0092-8674(03)00030-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553905	Bronze			2022-12-01	WOS:000181191600006
J	Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M				Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M			Original biological reconstruction of the hip in a 4-year-old girl	LANCET			English	Article							BONE	We resected the proximal femur in a 4-year-old child who had Ewing's sarcoma. We reconstructed her hip by an autotransplant of the ipsilateral proximal fibula with its vascular supply, inserted inside a massive bone allograft, and fixed to the residual femur by a plate. Serial postoperative imaging showed the progressive hypertrophy of the transplanted fibula, whose head displayed impressive tridimensional growth inside the acetabulum. 4 years after surgery, hip motility is 100degrees in flexion, 10degrees in extension, and 30degrees in abduction, and the patient's limb is weight bearing.	Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, I-40136 Bologna, Italy; Ctr Traumatol Ortoped, Unit REconstruct Microsurg, Florence, Italy	IRCCS Istituto Ortopedico Rizzoli	Manfrini, M (corresponding author), Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, Via Pupulli 1, I-40136 Bologna, Italy.			MANFRINI, MARCO/0000-0003-2961-0171				Bacci G, 2000, J CLIN ONCOL, V18, P4, DOI 10.1200/JCO.2000.18.1.4; Innocenti M, 1998, J RECONSTR MICROSURG, V14, P137, DOI 10.1055/s-2007-1000157; Manfrini M, 1999, CLIN ORTHOP RELAT R, P111; MERCURI M, 1991, CLIN ORTHOP RELAT R, P156; Restrepo J., 1980, INT J MICROSUG, V2, P49	5	53	55	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					140	142		10.1016/S0140-6736(03)12192-7	http://dx.doi.org/10.1016/S0140-6736(03)12192-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531584				2022-12-01	WOS:000180428000016
J	Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH				Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH			Apical complex genes control mitotic spindle geometry and relative size of daughter cells in Drosophila neuroblast and pl asymmetric divisions	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ZINC-FINGER PROTEINS; C-ELEGANS EMBRYOS; PROSPERO GENE; 2 DISTINCT; G-ALPHA; LOCALIZATION; POLARITY; BAZOOKA; ORIENTATION	Drosophila neuroblast asymmetric divisions generate two daughters of unequal size and fate. A complex of apically localized molecules mediates basal localization of cell fate determinants and apicobasal orientation of the mitotic spindle, but how daughter cell size is controlled remains unclear. Here we show that mitotic spindle geometry and unequal daughter cell size are controlled by two parallel pathways (Bazooka/DaPKC and Pins/Galphai) within the apical complex. While the localized activity of either pathway alone is sufficient to mediate the generation of an asymmetric mitotic spindle and unequal size neuroblast daughters, loss of both pathways results in symmetric divisions. In sensory organ precursors, Bazooka/DaPKC and Pins/Galphai localize to opposite sides of the cortex and function in opposition to generate a symmetric spindle.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Inst Mol & Cell Biol, Singapore 117609, Singapore	University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chia, W (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Hosp Campus,4th Floor New Hunts House, London SE1 1UL, England.	william.chia@kcl.ac.uk; mcbyangn@imcb.nus.edu.sg	Cai, Yu/R-7737-2019	Cai, Yu/0000-0003-2044-3290; Yu, Fengwei/0000-0003-0268-199X				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Ashraf SI, 1999, EMBO J, V18, P6426, DOI 10.1093/emboj/18.22.6426; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; HEUER JG, 1995, DEVELOPMENT, V121, P3861; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SPANA EP, 1995, DEVELOPMENT, V121, P3187; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002	41	113	116	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					51	62		10.1016/S0092-8674(02)01170-4	http://dx.doi.org/10.1016/S0092-8674(02)01170-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526793	Bronze			2022-12-01	WOS:000181191500006
J	Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K				Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K			Atomic-force microscopy: Rhodopsin dimers in native disc membranes	NATURE			English	Article									Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Basel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.	palczews@u.washington.edu	Filipek, Slawomir/A-2985-2008	Filipek, Slawomir/0000-0003-3147-3858				Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7	6	619	636	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					127	128		10.1038/421127a	http://dx.doi.org/10.1038/421127a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520290				2022-12-01	WOS:000180267200027
J	Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS				Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS			Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia	LANCET			English	Article							NATURAL-HISTORY; RISK-FACTORS; CANCER; ADENOCARCINOMA; GRADE; PREVALENCE; EXPRESSION; INFECTION; CARCINOMA; HPV-18	Background Human papillomavirus type 18 (HPV-18) is the second most frequent of the HPV types detected when squamous-cell cancer is diagnosed and the type most strongly associated with adenocarcinoma of the cervix. However, in cross-sectional studies, HPV-18 is rarely detected at the time of diagnosis of high-grade cervical intraepithelial neoplasia (CIN). We used a longitudinal study design to describe the occurrence of cytological abnormality after incident HPV-18 and HPV-16 infections. Methods The analysis was based on 1075 women aged 15-19 years, who had normal cytology and were negative for HPV at recruitment from a single family-planning clinic, and who had further follow-up. The women reattended every 6 months, and samples were taken for cytological and virological examination. Findings The relative risk of a cytological diagnosis of borderline nuclear abnormality after exposure to HPV-18 was 2.06 (95% CI 1.24-3.43) and that after exposure to HPV-16 was 1.99 (1.32-3.01). The relative risks of mild dyskaryosis were 3.11 (1.86-5.18) and 4.76 (3.15-7.18), and the relative risks of moderate or severe dyskaryosis were 0.80 (0.24-2.65) and 2.85 (1.36-5.97). Time to acquisition of cytological abnormality was unrelated to the infecting type (p=0.88). Interpretation Our findings do not support the long-held view that the reason why HPV-18 infection is under-represented at the time of diagnosis of high-grade CIN is because HPV-18-associated disease rapidly progresses through the preinvasive stages of neoplasia. We suggest that the cytological changes detected after HPV-18 infection might understate the severity of underlying disease. This feature could compromise the effectiveness of screening programmes in reducing the frequency of HPV-18-associated cancers.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England; Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Cent Manchester Healthcare Trust, Dept Clin Virol, Manchester, Lancs, England	University of Manchester; Birmingham Women's Hospital; University of Birmingham; Cancer Research UK; University of Birmingham	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.	ciaran.woodman@cce.man.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298				BARNES W, 1990, GYNECOL ONCOL, V38, P343, DOI 10.1016/0090-8258(90)90070-2; BERGERON C, 1992, AM J SURG PATHOL, V16, P641, DOI 10.1097/00000478-199207000-00002; BJERSING L, 1991, ANTICANCER RES, V11, P123; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Collett, 2014, MODELLING SURVIVAL D; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; GENEST DR, 1993, HUM PATHOL, V24, P730, DOI 10.1016/0046-8177(93)90009-6; HECHT JL, 1995, INT J CANCER, V60, P369, DOI 10.1002/ijc.2910600317; Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; JARMULOWICZ MR, 1989, BRIT J OBSTET GYNAEC, V96, P1061, DOI 10.1111/j.1471-0528.1989.tb03381.x; Kalantari M, 1997, HUM PATHOL, V28, P899, DOI 10.1016/S0046-8177(97)90004-6; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; McLachlin CM, 1997, HUM PATHOL, V28, P1226, DOI 10.1016/S0046-8177(97)90194-5; MCLACHLIN CM, 1994, AM J PATHOL, V144, P141; MITCHELL H, 1995, BRIT J CANCER, V71, P894, DOI 10.1038/bjc.1995.172; Nindl I, 1999, J CLIN PATHOL, V52, P17, DOI 10.1136/jcp.52.1.17; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Riethdorf S, 2000, VIRCHOWS ARCH, V437, P491, DOI 10.1007/s004280000277; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Schwartz SM, 2001, J CLIN ONCOL, V19, P1906, DOI 10.1200/JCO.2001.19.7.1906; Steenbergen RDM, 1998, J VIROL, V72, P749, DOI 10.1128/JVI.72.1.749-757.1998; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; UNGER ER, 1995, J INFECT DIS, V172, P1184, DOI 10.1093/infdis/172.5.1184; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.3.CO;2-E; WALKER J, 1989, OBSTET GYNECOL, V74, P781; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	30	56	57	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					40	43		10.1016/S0140-6736(03)12120-4	http://dx.doi.org/10.1016/S0140-6736(03)12120-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517465				2022-12-01	WOS:000180191600019
J	Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK				Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK			Changing incidence,of out-of-hospital ventricular fibrillation. 1980-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; UNITED-STATES; TRENDS; ARREST; DELAY; RESUSCITATION	Context Recent reports from 2 European cities and an earlier observation from Seattle, Wash, suggest that the number of patients treated for out-of-hospital ventricular fibrillation (VF) has declined. Objective To analyze the incidence of cardiac arrest and to examine relationships among incidence, sex, race, age, and first identified cardiac rhythm in Seattle. Design, Setting, and Patients Population-based study of all cardiac arrest cases with presumed cardiac etiology who received advanced life support from Seattle Fire Department emergency medical services during specified periods between 1979 and 2000 . United States Census data for Seattle in 1980, 1990, and 2000 were used to determine incidence rates for treated cardiac arrest with adjustments for age and sex. Main Outcome Measures Changes in incidence of cardiac arrest and initial recorded cardiac rhythm. Results The adjusted annual incidence of cardiac arrest with VF as the first identified rhythm decreased by about 56% from 1980 to 2000 (from 0.85 to 0.38 per 1000; relative risk [RR], 0.44; 95% confidence/interval [CI], 0.37-0.53). Similar reductions occurred in blacks (54%; RR, 0.45; 95% Cl, 0.26-0.79) and whites (53%; RR, 0.47; 95% Cl, 0.38-0.58) and was most evident in men (57%; RR, 0.43; 95% Cl, 0.35-0.53), in whom the baseline incidence was relatively high. When all treated arrests with presumed cardiac etiology were considered, that incidence decreased by 43% (RR, 0.58; 95 % Cl, 0.49-0.67) in men but negligibly in women, for whom a relatively low incidence of VF also declined but was offset by more cases with asystole or pulseless electrical activity. Conclusion We observed a major decline in the incidence of out-of-hospital VF and in all cases of treated cardiac arrest presumably due to heart disease in Seattle. These changes likely reflect the national decline in coronary heart disease mortality.	Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cobb, LA (corresponding author), Univ Washington, Harborview Med Ctr, Box 359748,325 9th Ave, Seattle, WA 98104 USA.							Altman D.G., 2000, STAT CONFIDENCE, V2nd ed.; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; COBB LA, 1992, CIRCULATION, V85, P98; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Cooper R, 2000, CIRCULATION, V102, P3137; Every NR, 1997, AM HEART J, V134, P1129, DOI 10.1016/S0002-8703(97)70035-8; Fox JP, 1970, EPIDEMIOLOGY MAN DIS; GILLUM RF, 1994, J AM COLL CARDIOL, V23, P1273, DOI 10.1016/0735-1097(94)90367-0; Goldberg RJ, 1999, ARCH INTERN MED, V159, P2141, DOI 10.1001/archinte.159.18.2141; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; HO MT, 1989, ANN EMERG MED, V18, P727, DOI 10.1016/S0196-0644(89)80004-6; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Kuisma M, 2001, LANCET, V358, P473, DOI 10.1016/S0140-6736(01)05634-3; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; *SPSS INC, 2001, SPSS VERS 11 0 COMP; *US BUR CENS, 1990, 1990 CENS TRANSP PLA; *US BUR CENS, 1984, 1980 CENS POP SUBJ R; *US BUR CENS, 2000, CENS 2000 SUMM FIL 1, pCH8; US Census Bureau, 2001, QUEST ANSW CENS 2000; WEAVER WD, 1987, J AM COLL CARDIOL, V10, P1259, DOI 10.1016/S0735-1097(87)80128-6; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	470	501	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3008	3013		10.1001/jama.288.23.3008	http://dx.doi.org/10.1001/jama.288.23.3008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479765	Bronze			2022-12-01	WOS:000179854200035
J	Okajima, T; Irvine, KD				Okajima, T; Irvine, KD			Regulation of notch signaling by O-linked fucose	CELL			English	Article							WING FORMATION; DROSOPHILA; FRINGE; DORSAL; MODULES; DELTA; CELLS; GLYCOSYLTRANSFERASE; TRANSDUCTION; FUCOSYLATION	Notch and its ligands are modified by a protein O-fucosyltransferase (OFUT1) that attaches fucose to a Serine or Threonine within EGF domains. By using RNAi to decrease Ofut1 expression in Drosophila, we demonstrate that O-linked fucose is positively required for Notch signaling, including both Fringe-dependent and Fringe-independent processes. The requirement for Ofut1 is cell autonomous, in the signal-receiving cell, and upstream of Notch activation. The transcription of Ofut1 is developmentally regulated, and surprisingly, overexpression of Ofut1 inhibits Notch signaling. Together, these results indicate that OFUT1 is a core component of the Notch pathway, which is required for the activation of Notch by its ligands, and whose regulation may contribute to the pattern of Notch activation during development.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.		Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM54594] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	34	307	315	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					893	904		10.1016/S0092-8674(02)01114-5	http://dx.doi.org/10.1016/S0092-8674(02)01114-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526814	Bronze			2022-12-01	WOS:000179862600014
J	Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M				Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M			The mechanosensory protein MEC-6 is a subunit of the C-elegans touch-cell degenerin channel	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; MEMBER; FAMILY; PARAOXONASE; UNC-8	Mechanosensory transduction in touch receptor neurons is believed to be mediated by DEG/ENaC (degenerin/epithelial Na+ channel) proteins in nematodes and mammals(1). In the nematode Caenorhabditis elegans, gain-of-function mutations in the degenerin genes mec-4 and mec-10 (denoted mec-4(d) and mec-10(d), respectively) cause degeneration of the touch cells(2,3). This phenotype is completely suppressed by mutation in a third gene, mec-6 (refs 3, 4), that is needed for touch sensitivity. This last gene is also required for the function of other degenerins(4-8). Here we show that mec-6 encodes a single-pass membrane-spanning protein with limited similarity to paraoxonases, which are implicated in human coronary heart disease(9). This gene is expressed in muscle cells and in many neurons, including the six touch receptor neurons. MEC-6 increases amiloride-sensitive Na+ currents produced by MEC-4(d)/MEC-10(d) by similar to30-fold, and functions synergistically with MEC-2 (a stomatin-like protein(10) that regulates MEC-4(d)/MEC-10(d) channel activity(11)) to increase the currents by 200-fold. MEC-6 physically interacts with all three channel proteins. In vivo, MEC-6 colocalizes with MEC-4, and is required for punctate MEC-4 expression along touch-neuron processes. We propose that MEC-6 is a part of the degenerin channel complex that may mediate mechanotransduction in touch cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu	O'Hagan, Robert/AAE-9789-2020; Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NIGMS NIH HHS [R37 GM030997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ERNSTROM GG, IN PRESS ANN REV GEN; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; SHREFFLER W, 1995, GENETICS, V139, P1261; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7	26	121	137	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					669	673		10.1038/nature01205	http://dx.doi.org/10.1038/nature01205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478294				2022-12-01	WOS:000179751800046
J	Levine, JD; Funes, P; Dowse, HB; Hall, JC				Levine, JD; Funes, P; Dowse, HB; Hall, JC			Resetting the circadian clock by social experience in Drosophila melanogaster	SCIENCE			English	Article							MUTANT DROSOPHILA; COURTSHIP; OLFACTION; RHYTHMS; ENTRAINMENT; SYSTEM	Circadian clocks are influenced by social interactions in a variety of species, but little is known about the sensory mechanisms underlying these effects. We investigated whether social cues could reset circadian rhythms in Drosophila melanogaster by addressing two questions: Is there a social influence on circadian timing? If so, then how is that influence communicated? The experiments show that in a social context Drosophila transmit and receive cues that influence circadian time and that these cues are likely olfactory.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Icosyst Corp, Cambridge, MA 02138 USA; Univ Maine, Dept Math & Stat, Orono, ME 04469 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	Brandeis University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Hall, JC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.				NIGMS NIH HHS [GM-33205] Funding Source: Medline; NINDS NIH HHS [NS-44232] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; AVERHOFF WW, 1974, BEHAV GENET, V4, P207, DOI 10.1007/BF01074155; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; KAVALIERS M, 1980, BIOL BULL, V158, P69, DOI 10.2307/1540759; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEVINE JH, UNPUB; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LILLY M, 1990, GENETICS, V124, P293; Moore-Ede MC., 1982, CLOCKS TIME US; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Saunders DS, 1982, INSECT CLOCKS; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135	25	179	179	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2010	2012		10.1126/science.1076008	http://dx.doi.org/10.1126/science.1076008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471264				2022-12-01	WOS:000179629200051
J	Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J				Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J			Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism	LANCET			English	Article							CALCIUM-BINDING PROTEINS; MYELOID DIFFERENTIATION; IMMUNE-RESPONSE; S100 PROTEIN; CALPROTECTIN; CELLS; PLASMA; FAMILY; MRP14; NEUTROPHILS	Background Calprotectin (complex of S100A8 and S100A9) is the major calcium and zinc-binding protein of phagocytes. We report a new syndrome with recurrent infections, inflammation, and hyperzincaemia associated with excessively high plasma concentrations of calprotectin. Methods We measured calprotectin in plasma and protein fractions by ELISA assay and zinc by atomic absorption spectrometry. Plasma proteins were fractionated by size exclusion chromatography and electrophoresis. Mass spectra of purified proteins were determined by MALDI-TOFMS. Findings We assessed five patients, two of whom are related. All patients had much the same biochemical findings of hyperzincaemia (77-200 mumol/L, reference range 11-18 mumol/L) and raised plasma calprotectin concentrations (1.4-6.5 g/L, reference range <1 mg/L). All patients presented with recurrent infections, hepatosplenomegaly, anaemia, and evidence of systemic inflammation. Three patients had cutaneous inflammation and three presented in infancy with severe growth failure. Size exclusion chromatography showed that zinc and calprotectin were associated in a broad fraction with molecular weight range 100-300 kDa. Analysis by electrophoresis and mass spectrometry showed that the patients' protein contained normal S100A8 and S100A9 subunits. Interpretation Dysregulation of zinc metabolism associated with accumulation in plasma of S100A8 and S100A9 defines a new disease, which encompasses a pathological role for dysregulation of two members of the large S100 protein family.	Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England; Ullevaal Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway; Univ Munster, Dept Dermatol, D-4400 Munster, Germany; Univ Munster, Inst Expt Dermatol, D-4400 Munster, Germany; Univ Aberdeen, Dept Child Hlth, Aberdeen, Scotland; Inst Child Hlth, Immunobiol Unit, London, England; Chelsea & Westminster Hosp, Dept Paediat, London, England; Rowett Res Inst, Aberdeen, Scotland; Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland; Tokyo Womens Med Univ, Dept Paediat, Tokyo, Japan	Imperial College London; University of Oslo; University of Munster; University of Munster; University of Aberdeen; University of London; University College London; Imperial College London; University of Aberdeen; Children's Memorial Health Institute; Tokyo Women's Medical University	Sampson, B (corresponding author), Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England.		Richmond, Peter C/G-3379-2012	Richmond, Peter C/0000-0001-7562-7228; Klein, Nigel/0000-0003-3925-9258; Wolska-Kusnierz, Beata/0000-0003-4863-4443; Fagerhol, Magne Kristoffer/0000-0002-5103-6981; Sunderkotter, Cord/0000-0002-2929-145X				BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; CHANDRA RK, 1984, JAMA-J AM MED ASSOC, V252, P1443, DOI 10.1001/jama.252.11.1443; Clohessy PA, 1996, J LEUKOCYTE BIOL, V60, P674, DOI 10.1002/jlb.60.5.674; DANKS DM, 1985, CLIN ENDOCRINOL META, V14, P591, DOI 10.1016/S0300-595X(85)80008-6; EVERSOLE LR, 1992, ARCH ORAL BIOL, V37, P963, DOI 10.1016/0003-9969(92)90068-J; FAILLA ML, 1982, J LAB CLIN MED, V100, P943; HAMBIDGE KM, 1985, J PEDIATR-US, V106, P450, DOI 10.1016/S0022-3476(85)80677-6; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Mikami M, 1998, MICROBIOL IMMUNOL, V42, P211, DOI 10.1111/j.1348-0421.1998.tb02273.x; MYERS MA, 1984, J CLIN PATHOL, V37, P862, DOI 10.1136/jcp.37.8.862; Neves I, 1998, CLIN EXP IMMUNOL, V111, P264; Newton RA, 1998, J IMMUNOL, V160, P1427; PRASAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166, DOI 10.1001/jama.240.20.2166; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICHMOND P, 1999, ARCH DIS CHILD, V80, pA67; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; ROTH J, 1993, BLOOD, V82, P1875; Saito Y, 2002, J PEDIATR-US, V140, P267, DOI 10.1067/mpd.2002.121699; Sampson B, 1997, PEDIATR RES, V42, P219, DOI 10.1203/00006450-199708000-00015; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SMITH JC, 1983, SCIENCE, V193, P496; Sohnle PG, 1997, REV MED MICROBIOL, V8, P217; Sorg C, 1992, Behring Inst Mitt, P126; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Unoshima M, 2001, J LAB CLIN MED, V137, P28, DOI 10.1067/mlc.2001.111514; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; YUI S, 1995, J LEUKOCYTE BIOL, V58, P307, DOI 10.1002/jlb.58.3.307	32	93	97	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1742	1745		10.1016/S0140-6736(02)11683-7	http://dx.doi.org/10.1016/S0140-6736(02)11683-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480428				2022-12-01	WOS:000179636800012
J	Titus, TN; Kieffer, HH; Christensen, PR				Titus, TN; Kieffer, HH; Christensen, PR			Exposed water ice discovered near the south pole of Mars	SCIENCE			English	Article							THERMAL MAPPER OBSERVATIONS; GROUND ICE; SUMMER TEMPERATURES; LAYERED DEPOSITS; CARBON-DIOXIDE; NEAR-SURFACE; BEHAVIOR; VAPOR; ALBEDO; SUBSURFACE	The Mars Odyssey Thermal Emission Imaging System (THEMIS) has discovered water ice exposed near the edge of Mars' southern perennial polar cap. The surface H2O ice was first observed by THEMIS as a region that was cooler than expected for dry soil at that latitude during the summer season. Diurnal and seasonal temperature trends derived from Mars Global Surveyor Thermal Emission Spectrometer observations indicate that there is H2O ice at the surface. Viking observations, and the few other relevant THEMIS observations, indicate that surface H2O ice may be widespread around and under the perennial CO2 cap.	US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe	Titus, TN (corresponding author), US Geol Survey, Branch Astrogeol, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA.	ttitus@usgs.gov						BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; Forget F, 1998, ASTROPHYS SPACE SC L, V227, P477, DOI 10.1007/978-94-011-5252-5_20; HERKENHOFF KE, 1990, J GEOPHYS RES-SOLID, V95, P1343, DOI 10.1029/JB095iB02p01343; HERKENHOFF KE, 2001, USGS MISC INV SERI I, V2686; HOFSTADTER MD, 1990, ICARUS, V84, P352, DOI 10.1016/0019-1035(90)90043-9; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; JAKOSKY BM, 1992, MARS, pCH28; JAMES PB, 1992, MARS, pCH27; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; MOROZ VI, 1964, SOV ASTRON, V8, P273; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; SMITH MD, 2002, ANN M DIV PLAN SCI B; THOMAS P, 1992, MARS, pCH23; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	31	163	166	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1048	1051		10.1126/science.1080497	http://dx.doi.org/10.1126/science.1080497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12471268				2022-12-01	WOS:000180960000042
J	Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T				Zheng, XY; Wang, J; Haerry, TE; Wu, AYH; Martin, J; O'Connor, MB; Lee, CHJ; Lee, T			TGF-beta signaling activates steroid hormone receptor expression during neuronal remodeling in the Drosophila brain	CELL			English	Article							REPRESSIBLE CELL MARKER; ECDYSONE RECEPTOR; MUSHROOM BODIES; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; MOSAIC ANALYSIS; NERVOUS-SYSTEM; II RECEPTOR; C-ELEGANS; METAMORPHOSIS	Metamorphosis of the Drosophila brain involves pruning of many larval-specific dendrites and axons followed by outgrowth of adult-specific processes. From a genetic mosaic screen, we recovered two independent mutations that block neuronal remodeling in the mushroom bodies (MBs). These phenotypically indistinguishable mutations affect Baboon function, a Drosophila TGF-beta/activin type I receptor, and dSmad2, its downstream transcriptional effector. We also show that Punt and Wit, two type II receptors, act redundantly in this process. In addition, knocking out dActivin around the mid-third instar stage interferes with remodeling. Binding of the insect steroid hormone ecdysone to distinct ecdysone receptor isoforms induces different metamorphic responses in various larval tissues. Interestingly, expression of the ecdysone receptor B1 isoform (EcR-B1) is reduced in activin pathway mutants, and restoring EcR-B1 expression significantly rescues remodeling defects. We conclude that the Drosophila Activin signaling pathway mediates neuronal remodeling in part by regulating EcR-B1 expression.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Internal Med, Hematol Oncol Sect, Chicago, IL 60612 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Lee, T (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		O'Connor, Michael B/C-9977-2014; Zheng, Xiaoyan/AAG-1251-2020	O'Connor, Michael B/0000-0002-3067-5506; Zheng, Xiaoyan/0000-0003-4983-5503	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER; NINDS NIH HHS [NS42049] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Antebi A, 2000, GENE DEV, V14, P1512; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Das P, 1999, GENES CELLS, V4, P123, DOI 10.1046/j.1365-2443.1999.00244.x; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dockendorff TC, 2000, MOL GEN GENET, V263, P137, DOI 10.1007/s004380050040; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Henderson KD, 1998, BIOCHEM BIOPH RES CO, V252, P195, DOI 10.1006/bbrc.1998.9562; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; KONEV AY, 1994, GENETIKA+, V30, P201; Kutty G, 1998, BIOCHEM BIOPH RES CO, V246, P644, DOI 10.1006/bbrc.1998.8678; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVINE RB, 1984, J EXP BIOL, V112, P27; Levine Richard B., 1995, Current Opinion in Neurobiology, V5, P28, DOI 10.1016/0959-4388(95)80083-2; Li H, 2001, NEUROSCIENCE, V106, P193, DOI 10.1016/S0306-4522(01)00263-9; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MURAKAMI F, 1992, NEUROSCI RES, V15, P235, DOI 10.1016/0168-0102(92)90045-E; Newfeld SJ, 1999, GENETICS, V152, P783; Nguyen M, 2000, MECH DEVELOP, V95, P201, DOI 10.1016/S0925-4773(00)00338-5; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Osada SI, 1999, DEVELOPMENT, V126, P3229; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, GENETIC ENV REGULATI, P739, DOI DOI 10.1101/087969532.33.739; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Savage-Dunn C, 2001, CYTOKINE GROWTH F R, V12, P305, DOI 10.1016/S1359-6101(01)00015-6; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; YANG MY, 1995, NEURON, V15, P45; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F	55	173	177	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					303	315		10.1016/S0092-8674(03)00072-2	http://dx.doi.org/10.1016/S0092-8674(03)00072-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581521	Bronze			2022-12-01	WOS:000181252200003
J	Rona, PA				Rona, PA			Resources of the sea floor	SCIENCE			English	Editorial Material									Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Rona, PA (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	rona@imcs.rutgers.edu						BROARD WJ, 1997, NY TIMES        0127, pA1; GARNETT RHT, 2000, MAR SCI SER, P103; HEIN JR, COMMUNICATION; Herzig P.M., 2000, MAR SCI SER, P347; HUMPHRIS SE, 1995, NATURE, V377, P713, DOI 10.1038/377713a0; Iizasa K, 1999, SCIENCE, V283, P975, DOI 10.1126/science.283.5404.975; JANNASCH HW, 1995, J MAR BIOTECHNOL, V3, P5; Koschinsky A, 2000, MAR SCI SER, P239; LENOBLE JP, 1995, MARINE MINERAL OCCUR, P1; MEADE C, 1991, SCIENCE, V252, P68, DOI 10.1126/science.252.5002.68; Mero JL, 1965, MINERAL RESOURCES SE, P103, DOI [10.1016/S0422-9894(08)70765-7, DOI 10.1016/S0422-9894(08)70765-7]; Nawab Z, 2001, PROPOSED TECHNOLOGIE, P26; Rona PA, 2002, EPISODES, V25, P2, DOI 10.18814/epiiugs/2002/v25i1/001; RONA PA, 1993, ECON GEOL, V8, P1989; Yang KH, 1996, NATURE, V383, P420, DOI 10.1038/383420a0	15	109	117	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					673	674		10.1126/science.1080679	http://dx.doi.org/10.1126/science.1080679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560541				2022-12-01	WOS:000180687700035
J	Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM				Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM			Rhythmic histone acetylation underlies transcription in the mammalian circadian clock	NATURE			English	Article							GENE-EXPRESSION; MECHANISMS; MOUSE; COMPONENTS; HDA1; LIMB	In the mouse circadian clock, a transcriptional feedback loop is at the centre of the clockwork mechanism. Clock and Bmal1 are essential transcription factors that drive the expression of three period genes (Per1-3) and two cryptochrome genes (Cry1 and Cry2)(1-5). The Cry proteins feedback to inhibit Clock/Bmal1-mediated transcription by a mechanism that does not alter Clock/Bmal1 binding to DNA(6). Here we show that transcriptional regulation of the core clock mechanism in mouse liver is accompanied by rhythms in H3 histone acetylation, and that H3 acetylation is a potential target of the inhibitory action of Cry. The promoter regions of the Per1, Per2 and Cry1 genes exhibit circadian rhythms in H3 acetylation and RNA polymerase II binding that are synchronous with the corresponding steady-state messenger RNA rhythms. The histone acetyltransferase p300 precipitates together with Clock in vivo in a time-dependent manner. Moreover, the Cry proteins inhibit a p300-induced increase in Clock/Bmal1-mediated transcription. The delayed timing of the Cry1 mRNA rhythm, relative to the Per rhythms, is due to the coordinated activities of Rev-Erbalpha and Clock/Bmal1, and defines a new mechanism for circadian phase control.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Massachusetts System; University of Massachusetts Worcester; Emory University	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wade PA, 1999, METHOD ENZYMOL, V304, P715; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	23	517	536	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					177	182		10.1038/nature01314	http://dx.doi.org/10.1038/nature01314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483227				2022-12-01	WOS:000180267200044
J	Gerard, C				Gerard, C			Complement C5a in the sepsis syndrome - too much of a good thing?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Div Pulm, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Gerard, C (corresponding author), Childrens Hosp, Div Pulm, Enders Bldg,Rm 144,300 Longwood Ave, Boston, MA 02115 USA.							Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506	5	66	74	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					167	169		10.1056/NEJMcibr022995	http://dx.doi.org/10.1056/NEJMcibr022995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519929				2022-12-01	WOS:000180263900011
J	Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R				Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R			Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis	NATURE			English	Article							DENSITY-LIPOPROTEIN HDL; HIGH-AFFINITY BINDING; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX; BOVINE F-1-ATPASE; INHIBITOR PROTEIN; SR-BI; SURFACE; SUBUNIT; SITES	The effect of high-density lipoprotein (HDL) in protecting against atherosclerosis is usually attributed to its role in 'reverse cholesterol transport'(1). In this process, HDL particles mediate the efflux and the transport of cholesterol from peripheral cells to the liver for further metabolism and bile excretion. Thus, cell-surface receptors for HDL on hepatocytes are chief partners in the regulation of cholesterol homeostasis(2). A high-affinity HDL receptor for apolipoprotein A-I (apoA-I) was previously identified on the surface of hepatocytes(3,4). Here we show that this receptor is identical to the beta-chain of ATP synthase, a principal protein complex of the mitochondrial inner membrane. Different experimental approaches confirm this ectopic localization of components of the ATP synthase complex and the presence of ATP hydrolase activity at the hepatocyte cell surface. Receptor stimulation by apoA-I triggers the endocytosis of holo-HDL particles (protein plus lipid) by a mechanism that depends strictly on the generation of ADP. We confirm this effect on endocytosis in perfused rat liver ex vivo by using a specific inhibitor of ATP synthase. Thus, membrane-bound ATP synthase has a previously unsuspected role in modulating the concentrations of extracellular ADP and is regulated by a principal plasma apolipoprotein.	Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France; Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Immunol Mol & Biol Lymphocyte T, F-31059 Toulouse, France; Hop Rangueil, IFR 31, INSERM,U531, Inst Federatif REch Louis Bugnard, F-31403 Toulouse, France; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; INRA, Lab Pharmacol & Toxicol, F-31931 Toulouse 9, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; INRAE	Barbaras, R (corresponding author), Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France.	Ronald.Barbaras@toulouse.inserm.fr	Cabezon, Elena/K-5874-2014; Tercé, François/M-5863-2018; Champagne, Eric/M-1543-2014; Martinez, Laurent O./ABD-6880-2020; Collet, Xavier/M-6938-2017; Martinez, Laurent O/B-8343-2015; Eckhardt, Erik/G-1567-2010	Tercé, François/0000-0003-4488-2167; Champagne, Eric/0000-0002-8852-0734; Martinez, Laurent O./0000-0002-0985-3152; Martinez, Laurent O/0000-0002-0985-3152; Cabezon, Elena/0000-0002-6177-5016; Bertrand, PERRET/0000-0001-7568-445X; Walker, John/0000-0001-7929-2162				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BARBARAS R, 1994, BIOCHEMISTRY-US, V33, P2335, DOI 10.1021/bi00174a047; BARRANS A, 1994, J BIOL CHEM, V269, P11572; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burgess JW, 2002, J BIOL CHEM, V277, P31318, DOI 10.1074/jbc.M204200200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Ferrini JB, 1997, CHEM-BIOL INTERACT, V107, P31, DOI 10.1016/S0009-2797(97)00072-0; Fidge NH, 1999, J LIPID RES, V40, P187; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Guendouzi K, 1998, BIOCHEMISTRY-US, V37, P14974, DOI 10.1021/bi9810508; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; MAHLEY RW, 1989, ARTERIOSCLEROSIS, V9, pI14; Martinez LO, 2000, BIOCHEMISTRY-US, V39, P1076, DOI 10.1021/bi991971y; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WILLIAMS N, 1984, ANAL BIOCHEM, V140, P581, DOI 10.1016/0003-2697(84)90210-0	29	369	399	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					75	79		10.1038/nature01250	http://dx.doi.org/10.1038/nature01250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511957				2022-12-01	WOS:000180165500040
J	Check, E				Check, E			Gene therapy - Shining hopes dented - but not dashed	NATURE			English	Editorial Material																			0	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	735		10.1038/420735b	http://dx.doi.org/10.1038/420735b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490910	Bronze			2022-12-01	WOS:000179897300020
J	Free, C; Lee, RM; Ogden, J				Free, C; Lee, RM; Ogden, J			Young women's accounts of factors influencing their use and non-use of emergency contraception: in-depth interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNOWLEDGE	Objectives To explore young women's accounts of their use and non-use of emergency contraception. Design Qualitative study using in-depth interviews. Participants 30 women aged 16-25; participants from socially deprived inner city areas were specifically included. Setting Community, service, and educational settings in the London area. Results Young women's accounts of their non-use of emergency contraception principally concerned evaluations of the risk conferred by different contraceptive behaviours, their evaluations of themselves in needing emergency contraception, and personal difficulties in asking for emergency contraception. Conclusions The attitudes and concerns of young women, especially those from disadvantaged backgrounds, may make them less able or willing than others to take advantage of recent increases in access to emergency contraception. Interventions that aim to increase the use of emergency contraception need to address the factors that influence young women's non-use of emergency contraception.	Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; Royal Holloway Univ London, Dept Social & Polit Sci, Egham TW20 0EX, Surrey, England	University of London; King's College London; University of London; Royal Holloway University London	Free, C (corresponding author), Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.	caroline.free@kcl.ac.uk		Free, Caroline/0000-0003-1711-0006; Ogden, Jane/0000-0003-4271-5621				ANDERSON C, 2001, LAMBETH SOUTHWORK LE; Barrett G, 2000, SOCIOL HEALTH ILL, V22, P197, DOI 10.1111/1467-9566.00199; Beck U., 1992, RISK SOC NEW MODERNI; Crosier A, 1996, BRIT J FAM PLAN, V22, P87; Crosier A., 1997, EMERGENCY CONTRACEPT; Department of the Environment Transport and the Regions, 2000, IND DEPR 2000 REG RE; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567; HALPER C, 1995, FAM PLANN PERSPECT, V27, P149, DOI 10.2307/2136258; Harrison-Woolrych M, 2001, BRIT MED J, V322, P186; Rosenstock I., 1974, HLTH ED MONOGR, V2, DOI [DOI 10.1177/109019817400200403, 10.1177/109019817400200403]; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; Ziebland S, 1996, BRIT J FAM PLAN, V22, P84	15	75	77	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1393	1396		10.1136/bmj.325.7377.1393	http://dx.doi.org/10.1136/bmj.325.7377.1393			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480855	Green Accepted, Green Published			2022-12-01	WOS:000179975000024
J	Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR				Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR		Alliance Cellular Signaling	Overview of the Alliance for Cellular Signaling	NATURE			English	Editorial Material								The Alliance for Cellular Signaling is a large-scale collaboration designed to answer global questions about signalling networks. Pathways will be studied intensively in two cells-B lymphocytes (the cells of the immune system) and cardiac myocytes-to facilitate quantitative modelling. One goal is to catalyse complementary research in individual laboratories; to facilitate this, all alliance data are freely available for use by the entire research community.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75390 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Aventis Pharmaceut, Bridgewater, NJ 08807 USA; NIGMS, Pharmacol Physiol & Biol Chem Div, NIH, Bethesda, MD 20892 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Chem, Berkeley, CA 94720 USA; Johns Hopkins Univ, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Ctr Clin Sci Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Babraham Inst, Cambridge CB2 4AT, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Boston Univ, BMERC, Boston, MA 02215 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Dept Elect & Med Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Dept Elect & Med Engn, Cambridge, MA 02139 USA; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Shriners Burn Hosp, Boston, MA 02114 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Johns Hopkins University; Stanford University; Stanford University; Stanford University; University of California System; University of California Irvine; University of British Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Boston University; University of Michigan System; University of Michigan; Salk Institute; Duke University; Howard Hughes Medical Institute; Duke University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Universite de Montreal; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gilman, AG (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.		Brekken, Deirdre/I-7999-2012; Gold, Michael/AAF-2081-2021; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Cantley, Lewis C/D-1800-2014; Lefkowitz, Robert/AAW-2649-2021; O'Connell, Timothy/D-5048-2013; Fraser, Iain DC/L-4735-2017; Ivanova, Pavlina/K-8307-2012	Gold, Michael/0000-0003-1222-3191; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Cantley, Lewis C/0000-0002-1298-7653; Fraser, Iain DC/0000-0003-2272-3907; Cobb, Melanie/0000-0003-0833-5473; Casey, Patrick/0000-0002-7366-9309; Natarajan, Madhusudan/0000-0003-1607-2917; Brekken, Deirdre/0000-0003-2790-0108; Meyer, Tobias/0000-0003-4339-3804; Sinkovits, Robert/0000-0001-7377-9762	NCI NIH HHS [T32 CA121938] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	89	92	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					703	706		10.1038/nature01304	http://dx.doi.org/10.1038/nature01304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478301	Green Published, Bronze			2022-12-01	WOS:000179751800054
J	Buckley, NA; McManus, PR				Buckley, NA; McManus, PR			Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data	BRITISH MEDICAL JOURNAL			English	Article							OVERDOSE		Canberra Hosp, Dept Clin Pharmacol & Therapeut, Woden, ACT 2606, Australia; Canberra Hosp, Dept Pharm, Woden, ACT, Australia	Australian National University; Canberra Hospital; Australian National University; Canberra Hospital	Buckley, NA (corresponding author), Canberra Hosp, Dept Clin Pharmacol & Therapeut, POB 11, Woden, ACT 2606, Australia.		Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711				Buckley NA, 1998, DRUG SAFETY, V18, P369, DOI 10.2165/00002018-199818050-00006; HENRY JA, 1995, BRIT MED J, V310, P221, DOI 10.1136/bmj.310.6974.221; ISACSSON G, 1994, BRIT MED J, V309, P1546, DOI 10.1136/bmj.309.6968.1546; OWENS D, 1994, BRIT J PSYCHIAT, V165, P797, DOI 10.1192/bjp.165.6.797; Sarko J, 2000, EMERG MED CLIN N AM, V18, P637, DOI 10.1016/S0733-8627(05)70151-6	5	121	122	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1332	1333		10.1136/bmj.325.7376.1332	http://dx.doi.org/10.1136/bmj.325.7376.1332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468481	Bronze, Green Published			2022-12-01	WOS:000179817100019
J	Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL				Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL			CD4(+)CD25(+) regulatory T cells control Leishmania major persistence and immunity	NATURE			English	Article							AZAR DERMAL LEISHMANIASIS; INTERFERON-GAMMA; KALA-AZAR; DENDRITIC CELLS; ACTIVATION; INTERLEUKIN-10; IL-10; SKIN; EXPRESSION; DISEASE	The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation(1-3). Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4(+)CD25(+) regulatory T cells. These cells constitute 5-10% of peripheral CD4(+) T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens(4). During infection by L. major, CD4(+)CD25(+) T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4(+)CD25(-) effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), Childrens Hosp, Div Mol Immunol, Res Fdn, 3333 Burnet Ave,MLC 7021, Cincinnati, OH 45229 USA.			Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000494, Z01AI000224, ZIAAI000224, Z01AI000494] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; ELHASSAN AM, 1992, T ROY SOC TROP MED H, V86, P245, DOI 10.1016/0035-9203(92)90294-M; Gasim S, 1998, CLIN EXP IMMUNOL, V111, P64; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; MOMENI AZ, 1994, INT J DERMATOL, V33, P260, DOI 10.1111/j.1365-4362.1994.tb01039.x; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Plebanski M, 1999, IMMUNITY, V10, P651, DOI 10.1016/S1074-7613(00)80064-3; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547	26	1348	1429	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					502	507		10.1038/nature01152	http://dx.doi.org/10.1038/nature01152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466842				2022-12-01	WOS:000179611600045
J	Piskorowski, R; Aldrich, RW				Piskorowski, R; Aldrich, RW			Calcium activation of BKCa potassium channels lacking the calcium bowl and RCK domains	NATURE			English	Article							ALLOSTERIC GATING MECHANISM; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; CA CHANNELS; HAIR-CELLS; VOLTAGE; SENSITIVITY; CURRENTS; IDENTIFICATION; SUBUNIT	In many physiological systems such as neurotransmitter release, smooth muscle relaxation and frequency tuning of auditory hair cells, large-conductance calcium-activated potassium (BKCa) channels create a connection between calcium signalling pathways and membrane excitability(1-4). BKCa channels are activated by voltage and by micromolar concentrations of intracellular calcium. Although it is possible to open BKCa channels in the absence of calcium(5-9), calcium binding is essential for their activation under physiological conditions. In the presence of intracellular calcium, BKCa channels open at more negative membrane potentials(5,10-14). Many experiments investigating the molecular mechanism of calcium activation of the BKCa channel have focused on the large intracellular carboxy terminus, and much evidence supports the hypothesis that calcium-binding sites are located in this region of the channel. Here we show that BKCa channels that lack the whole intracellular C terminus retain wild-type calcium sensitivity. These results show that the intracellular C terminus, including the 'calcium bowl' and the RCK domain, is not necessary for the calcium-activated opening of these channels.	Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Aldrich, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA.		Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360				Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krauss J K, 1996, Parkinsonism Relat Disord, V2, P35, DOI 10.1016/1353-8020(95)00018-6; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; MARTY A, 1981, NATURE, V291, P597; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	30	56	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					499	502		10.1038/nature01199	http://dx.doi.org/10.1038/nature01199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466841				2022-12-01	WOS:000179611600044
J	de Quadros, CA; Epstein, D				de Quadros, CA; Epstein, D			Health as a bridge for peace: PAHO's experience	LANCET			English	Article									Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC 20037 USA; Pan Amer Hlth Org, Off Publ Informat, Washington, DC 20037 USA	Pan American Health Organization; Pan American Health Organization	de Quadros, CA (corresponding author), Pan Amer Hlth Org, Div Vaccines & Immunizat, 525 23rd St NW, Washington, DC 20037 USA.								0	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S25	S26		10.1016/S0140-6736(02)11808-3	http://dx.doi.org/10.1016/S0140-6736(02)11808-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504491				2022-12-01	WOS:000180064500012
J	Hogg, PJ; McLachlan, EM				Hogg, PJ; McLachlan, EM			Blood vessels and nerves: together or not?	LANCET			English	Editorial Material							GROWTH-FACTOR; ENDOTHELIAL-CELLS; BIOLOGY; PROLIFERATION; ANGIOGENESIS; REGENERATION; EXPRESSION		Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Med Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Prince Wales Medical Research Institute	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.		McLachlan, Elspeth M/A-1844-2013	McLachlan, Elspeth M/0000-0003-0755-8747; Hogg, Philip/0000-0001-6486-2863				Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Jackman A, 2000, J COMP NEUROL, V418, P281; MITCHELL BS, 1994, TUMOR BIOL, V15, P269, DOI 10.1159/000217901; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Pincelli C, 2000, EUR J DERMATOL, V10, P85; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Smith PG, 2002, CELL TISSUE RES, V307, P281, DOI 10.1007/s00441-001-0477-8; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709	14	6	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1714	1714		10.1016/S0140-6736(02)11726-0	http://dx.doi.org/10.1016/S0140-6736(02)11726-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480422				2022-12-01	WOS:000179636800006
J	Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA				Kochendoerfer, GG; Chen, SY; Mao, F; Cressman, S; Traviglia, S; Shao, HY; Hunter, CL; Low, DW; Cagle, EN; Carnevali, M; Gueriguian, V; Keogh, PJ; Porter, H; Stratton, SM; Wiedeke, MC; Wilken, J; Tang, J; Levy, JJ; Miranda, LP; Crnogorac, MM; Kalbag, S; Botti, P; Schindler-Horvat, J; Savatski, L; Adamson, JW; Kung, A; Kent, SBH; Bradburne, JA			Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein	SCIENCE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; POLYETHYLENE-GLYCOL; TRANSFER-RNAS; LIGATION; CSF	We report the design and total chemical synthesis of "synthetic erythropoiesis protein" (SEP), a 51-kilodalton protein-polymer construct consisting of a 166-amino-acid polypeptide chain and two covalently attached, branched, and monodisperse polymer moieties that are negatively charged. The ability to control the chemistry allowed us to synthesize a macromolecule of precisely defined covalent structure. SEP was homogeneous as shown by high-resolution analytical techniques, with a mass of 50,825+/-10 daltons by electrospray mass spectrometry, and with a pI of 5.0. In cell and animal assays for erythropoiesis, SEP displayed potent biological activity and had significantly prolonged duration of action in vivo. These chemical methods are a powerful tool in the rational design of protein constructs with potential therapeutic applications.	Gryphon Therapeut, San Francisco, CA 94080 USA; Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin	Kochendoerfer, GG (corresponding author), Gryphon Therapeut, 250 E Grand Ave,Suite 90, San Francisco, CA 94080 USA.		Mao, Feng/B-8280-2019					Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Clark R, 1996, J BIOL CHEM, V271, P21969, DOI 10.1074/jbc.271.36.21969; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Eliason JF, 2001, BIODRUGS, V15, P705, DOI 10.2165/00063030-200115110-00001; FUKUDA MN, 1989, BLOOD, V73, P84; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KOCHENDOERFER G, UNPUB; Kochendoerfer G G, 2001, Curr Opin Drug Discov Devel, V4, P205; KOMATSU N, 1993, BLOOD, V82, P456; LAI PH, 1986, J BIOL CHEM, V261, P3116; MAO F, UNPUB; MISAIZU T, 1995, BLOOD, V86, P4097, DOI 10.1182/blood.V86.11.4097.bloodjournal86114097; Morstyn G, 2001, ACTA HAEMATOL-BASEL, V105, P151, DOI 10.1159/000046557; Rose K, 1999, J AM CHEM SOC, V121, P7034, DOI 10.1021/ja9909879; ROSE K, 1994, J AM CHEM SOC, V116, P30, DOI 10.1021/ja00080a004; SAXENA VP, 1970, BIOCHEMISTRY-US, V9, P5015; SCHNOLZER M, 1992, SCIENCE, V256, P221, DOI 10.1126/science.1566069; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SPIVAK JL, 1989, BLOOD, V73, P90; TSUTSUMI Y, 1994, JPN J CANCER RES, V85, P9, DOI 10.1111/j.1349-7006.1994.tb02879.x; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; YAMASAKI M, 1994, J BIOCHEM-TOKYO, V115, P814, DOI 10.1093/oxfordjournals.jbchem.a124421	27	271	307	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					884	887		10.1126/science.1079085	http://dx.doi.org/10.1126/science.1079085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574628				2022-12-01	WOS:000180830900050
J	Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V				Mohler, PJ; Schott, JJ; Gramolini, AO; Dilly, KW; Guatimosim, S; duBell, WH; Haurogne, K; Kyndt, F; Ali, ME; Rogers, TB; Lederer, WJ; Escande, D; Le Marec, H; Bennett, V			Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death	NATURE			English	Article							SODIUM-CALCIUM EXCHANGE; VENTRICULAR MYOCYTES; SPECTRIN; CHANNELS; GENE	Mutations in ion channels involved in the generation and termination of action potentials constitute a family of molecular defects that underlie fatal cardiac arrhythmias in inherited long-QT syndrome(1). We report here that a loss-of-function (E1425G) mutation in ankyrin-B (also known as ankyrin(2)), a member of a family of versatile membrane adapters(2),causes dominantly inherited type 4 long-QT cardiac arrhythmia in humans. Mice heterozygous for a null mutation in ankyrin-B are haploinsufficient and display arrhythmia similar to humans. Mutation of ankyrin-B results in disruption in the cellular organization of the sodium pump, the sodium/calcium exchanger, and inositol-1,4,5-trisphosphate receptors (all ankyrin-B-binding proteins), which reduces the targeting of these proteins to the transverse tubules as well as reducing overall protein level. Ankyrin-B mutation also leads to altered Ca2+ signalling in adult cardiomyocytes that results in extrasystoles, and provides a rationale for the arrhythmia. Thus, we identify a new mechanism for cardiac arrhythmia due to abnormal coordination of multiple functionally related ion channels and transporters.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurosci, Durham, NC 27710 USA; Hop Hotel Dieu, INSERM, U533, Lab Physiopathol & Pharmacol Cellulaires & Mol, Paris, France; Hosp G&R Laennec, Dept Cardiol, Nantes, France; Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21021 USA; Univ Maryland, Inst Biotechnol, Dept Physiol, Baltimore, MD 21021 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21021 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.		Guatimosim, Silvia/AAN-7441-2021; Le Marec, Hervé/D-2718-2015; KYNDT, Florence/D-6370-2015; Lederer, William/B-1285-2010; Schott, jean-Jacques/F-8842-2013	Guatimosim, Silvia/0000-0001-8386-3722; Le Marec, Hervé/0000-0002-8288-8693; KYNDT, Florence/0000-0001-6651-1696; Schott, jean-Jacques/0000-0002-9578-9475; Song, Long-Sheng/0000-0002-6035-8106				Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bers DM., 2001, EXCITATION CONTRACTI, V2, DOI [10.1007/978-94-010-0658-3, DOI 10.1007/978-94-010-0658-3]; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; FRANK JS, 1997, MYOCARDIUM, P1; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Marks AR, 2002, J CELL PHYSIOL, V190, P1, DOI 10.1002/jcp.10031; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; Santana LF, 1997, J PHYSIOL-LONDON, V503, P21, DOI 10.1111/j.1469-7793.1997.021bi.x; Santana LF, 1998, SCIENCE, V279, P1027, DOI 10.1126/science.279.5353.1027; SCHOTT JJ, 1995, AM J HUM GENET, V57, P1114; Towbin JA, 2001, AM J MED, V110, P385, DOI 10.1016/S0002-9343(00)00715-4; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995	19	715	758	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					634	639		10.1038/nature01335	http://dx.doi.org/10.1038/nature01335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571597				2022-12-01	WOS:000180803200043
J	Li, J; Precht, DH; Mortensen, PB; Olsen, J				Li, J; Precht, DH; Mortensen, PB; Olsen, J			Mortality in parents after death of a child in Denmark: a nationwide follow-up study	LANCET			English	Article							CONJUGAL BEREAVEMENT; CANCER INCIDENCE; STRESS; LIFE; EDUCATION; SMOKING; ADULTS; COHORT; SPOUSE; RISK	Background Little is known about the effect of parental bereavement on physical health. We investigated whether the death of a child increased mortality in parents. Methods We undertook a follow-up study based on national registers. From 1980 to 1996, we enrolled 21062 parents in Denmark who had a child who had died (exposed cohort), and 293 745 controls-ie, parents whose children were alive, and whose family structure matched that of the exposed cohort. Natural deaths were defined with ICD8 codes 0000-7969 and ICD10 codes A00-R99, and unnatural deaths with codes 8000-9999 and V01-Y98. We used Cox's proportional-hazards regression models to assess the mortality rate, of parents up to 18 years after bereavement. Findings We observed an increased overall mortality rate in mothers whose child had died (hazards ratio 1.43, 95% CI 1.24-1.64; p<0.0001). An excess mortality from natural causes (1.44, 1.15-1.78; p<0.0001) was noted in mothers only during the 10th-18th year of follow-up. Mothers had increased mortality rates from unnatural causes throughout follow-up, with the highest rate recorded during the first 3 years (3.84,.2.48-5.88; p<0.0001). Bereaved fathers had only an early excess mortality from unnatural causes (1.57, 1.06-2.32; p=0.04). Mothers who lost a child due to an unnatural death or an unexpected death had a hazard ratio of 1.72 (1.38-2.15; p=0.0040) and 1.67 (1.37-2.03; p=0.0037), respectively. Interpretation The death of a child is associated with an overall increased mortality from both natural and unnatural causes in mothers, and an early increased mortality from unnatural causes in fathers.	Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark; Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus, Denmark; Natl Inst Publ Hlth, Copenhagen, Denmark	Aarhus University; Aarhus University	Olsen, J (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark.		Harding, Richard/G-9729-2012; Mortensen, Preben B/D-2358-2015; li, jiong/L-6534-2014	Mortensen, Preben B/0000-0002-5230-9865; li, jiong/0000-0002-1716-8067; li, jiong/0000-0003-1125-026X				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BATTEN PJ, 1992, AM J FOREN MED PATH, V13, P159, DOI 10.1097/00000433-199206000-00016; DYRGROVEN A, 1990, SCAND J PSYCHOL, V31, P266; Goodkin K, 2001, HDB BEREAVEMENT RES, P671; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; KLATSKY AL, 1993, ALCOHOL CLIN EXP RES, V17, P1156, DOI 10.1111/j.1530-0277.1993.tb05221.x; KRAUSE N, 1986, J GERONTOL, V41, P512, DOI 10.1093/geronj/41.4.512; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; Leistikow BN, 1998, PREV MED, V27, P871, DOI 10.1006/pmed.1998.0374; LEVAV I, 1981, ISRAEL J MED SCI, V17, P176; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; LEVAV I, 1988, NEW ENGL J MED, V319, P457, DOI 10.1056/NEJM198808253190801; LI GH, 1994, AM J PUBLIC HEALTH, V84, P1402, DOI 10.2105/AJPH.84.9.1402; Lichtenstein P, 1998, PSYCHOL MED, V28, P635, DOI 10.1017/S0033291798006692; Lusyne P, 2001, POP STUD-J DEMOG, V55, P281, DOI 10.1080/00324720127701; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1998, EPIDEMIOLOGY, V9, P530, DOI 10.1097/00001648-199809000-00010; Matthews KA, 2002, ARCH INTERN MED, V162, P309, DOI 10.1001/archinte.162.3.309; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Moriarty HJ, 1996, RES NURS HEALTH, V19, P461, DOI 10.1002/(SICI)1098-240X(199612)19:6<461::AID-NUR2>3.0.CO;2-M; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; REES WD, 1967, BRIT MED J, V4, P13, DOI 10.1136/bmj.4.5570.13; Roed AS, 1999, DAN MED BULL, V46, P269; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; VANCE JC, 1991, MED J AUSTRALIA, V155, P292, DOI 10.5694/j.1326-5377.1991.tb142283.x; Vassilas CA, 1997, BRIT J PSYCHIAT, V170, P453, DOI 10.1192/bjp.170.5.453; 1998, FERTILITY DATABASE G	29	312	315	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					363	367		10.1016/S0140-6736(03)12387-2	http://dx.doi.org/10.1016/S0140-6736(03)12387-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642CP	12573371				2022-12-01	WOS:000180787000007
J	McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO				McCormack, VA; Silva, ID; De Stavola, BL; Mohsen, R; Leon, DA; Lithell, HO			Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort	BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; FACTOR-I; WOMEN; HEIGHT	Objective To investigate whether size at birth and rate of fetal growth influence the risk of breast cancer in adulthood. Design Cohort identified from detailed birth records, with 97% follow up. Setting Uppsala Academic Hospital, Sweden. Participants 5358 singleton females born during 1915-29, alive and traced to the 1960 census. Main outcome measures Incidence of breast cancer before (at age < 50 years) and after (&GE; 50 years) the menopause. Results Size at birth was positively associated with rates of breast cancer in premenopausal women. In women who weighed &GE; 4000 g at birth rates of breast cancer were 3.5 times (95% confidence interval 1.3 to 9.3) those in women of similar gestational age who weighed < 3000 g at birth. Rates in women in the top fifths of the distributions of birth length and head circumference were 3.4 (1.5 to 7.9) and 4.0 (1.6 to 10.0) times those in the lowest fifths (adjusted for gestational age). The effect of birth weight disappeared after adjustment for birth length or head circumference, whereas the effects of birth length and head circumference remained significant after adjustment for birth weight. For a given size at birth, gestational age was inversely associated with risk (P=0.03 for linear trend). Adjustment for markers of adult risk factors did not affect these findings. Birth size was not associated with rates of breast cancer in postmenopausal women. Conclusions Size at birth, particularly length and head circumference, is associated with risk of breast cancer in women aged < 50 years. Fetal growth rate, as measured by birth size adjusted for gestational age, rather than size at birth may be the aetiologically relevant factor in premenopausal breast cancer.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Uppsala Univ, Dept Geriatr, S-75125 Uppsala, Sweden	University of London; London School of Hygiene & Tropical Medicine; Uppsala University	McCormack, VA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762; De Stavola, Bianca Lucia/0000-0001-7853-0528; dos Santos Silva, Isabel/0000-0002-6596-8798; McCormack, Valerie/0000-0001-7397-3442				De Stavola BL, 2000, BRIT J CANCER, V83, P964, DOI 10.1054/bjoc.2000.1370; Diggle P., 2002, ANAL LONGITUDINAL DA; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Ekbom A, 1997, JNCI-J NATL CANCER I, V89, P71, DOI 10.1093/jnci/89.1.71; EKBOM A, 1992, LANCET, V340, P1015, DOI 10.1016/0140-6736(92)93019-J; Ekbom A, 2000, J NATL CANCER I, V92, P840, DOI 10.1093/jnci/92.10.840; GARNE JP, 1995, ACTA ONCOL, V34, P153, DOI 10.3109/02841869509093949; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; LEMARCHAND L, 1988, BRIT J CANCER, V57, P437, DOI 10.1038/bjc.1988.99; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; LEON DA, 1999, FETAL PROGRAMMING IN; MARUBINI E, 1994, ANAL SURVIVAL DATA C; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; Sanderson M, 2002, BRIT J CANCER, V86, P84, DOI 10.1038/sj.bjc.6600009; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; Sorensen HT, 1999, AM J EPIDEMIOL, V149, P726; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Titus-Ernstoff L, 2002, CANCER EPIDEM BIOMAR, V11, P207; Toniolo P, 2000, INT J CANCER, V88, P828, DOI 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Tuvemo T, 1999, PEDIATR RES, V46, P491, DOI 10.1203/00006450-199911000-00001; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Vatten LJ, 2002, BRIT J CANCER, V86, P89, DOI 10.1038/sj.bjc.6600011	24	107	107	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					248	251		10.1136/bmj.326.7383.248	http://dx.doi.org/10.1136/bmj.326.7383.248			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560272	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000180908300015
J	Carroll, D; Corfield, A; Spicer, R; Cairns, P				Carroll, D; Corfield, A; Spicer, R; Cairns, P			Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis	LANCET			English	Article								Calprotectin has been proposed as a useful marker of inflammatory bowel disease in children. We did a pilot study to establish whether it can be used to aid diagnosis of necrotising enterocolitis in preterm infants. Patients with clinical features of necrotising enterocolitis had raised faecal calprotectin concentrations at the time of diagnosis compared with matched controls (288.4 mg/L [SD 49.1] and 98.0 mg/L [60.6], respectively; p=0.0006). Faecal calprotectin might be a useful marker of gastrointestinal mucosal inflammation in neonates.	Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England	Bristol Royal Hospital For Children	Carroll, D (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Bristol BS2 8BJ, Avon, England.							Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187; Fagerhol MK, 2000, LANCET, V356, P1783, DOI 10.1016/S0140-6736(00)03224-4; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506	5	94	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					310	311		10.1016/S0140-6736(03)12333-1	http://dx.doi.org/10.1016/S0140-6736(03)12333-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559868				2022-12-01	WOS:000180643900015
J	Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC				Rekart, ML; Patrick, DM; Chakraborty, B; Maginley, JJL; Jones, HD; Bajdik, CD; Pourbohloul, B; Brunham, RC			Targeted mass treatment for syphilis with oral azithromycin	LANCET			English	Article								From mid 1997 to end of 1999, there was a sexually-transmitted infectious syphilis outbreak mainly in heterosexual people in British Columbia, Canada, that was concentrated in Vancouver. The rate across the province increased from less than 0.5 to 3.4 per 100 000, and the rate in Vancouver reached 12.9 per 100 000. We aimed to eliminate the syphillis outbreak by treating people at risk of infection. In 2000, a targeted mass treatment programme provided azithromycin (1.8 g orally) to 4384 at-risk residents in this city. After the programme, syphilis frequency fell significantly for 6 months (p=0.016), but rose again in 2001. Results from curve fitting analyses showed that the number of cases in 2001 (177) was higher than expected (0.0001<p<0.0044). This rate rebound and the absence of a sustained effect suggest that targeted mass treatment for syphilis, even though feasible, should not be done routinely.	Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada; British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; British Columbia Canc Agcy, Canc Control Res Programme, Vancouver, BC V5Z 4E6, Canada	University of British Columbia; British Columbia Cancer Agency	Rekart, ML (corresponding author), Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada.							HIBBS JR, 1991, AM J PUBLIC HEALTH, V81, P1259, DOI 10.2105/AJPH.81.10.1259; Hook EW, 1999, ANN INTERN MED, V131, P434, DOI 10.7326/0003-4819-131-6-199909210-00007; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Patrick DM, 2002, SEX TRANSM INFECT, V78, pI164, DOI 10.1136/sti.78.suppl_1.i164; ROSSI MA, 1990, CAN J CARDIOL, V6, P293	5	46	47	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					313	314		10.1016/S0140-6736(03)12335-5	http://dx.doi.org/10.1016/S0140-6736(03)12335-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559870				2022-12-01	WOS:000180643900017
J	Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS				Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS			Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER WOMEN; CLINICAL GUIDELINES; CONSERVING SURGERY; RADIATION-THERAPY; LINKED MEDICARE; NATIONAL SURVEY; AGE; CARCINOMA; CARE; DETERMINANTS	Background: Although the efficacy of adjuvant chemotherapy in prolonging survival for women with breast cancer has been well documented, limited population-based information is available on the actual use of chemotherapy. Objective: To examine the relationship between age and chemotherapy use. Design: Cohort study. Setting: New Mexico. Patients: 5101 women 20 years of age or older receiving a diagnosis of stage 1, stage 11, or stage IIIA breast cancer from 1991 through 1997. Measurements: Pattern of chemotherapy use by age; logistic regression analysis to generate the odds and probabilities of receiving chemotherapy; and sensitivity analysis to estimate potential effects of unmeasured confounders. Results: Overall, 29% of women received chemotherapy. The rate of chemotherapy use for women with stage I, stage II, or stage IIIA breast cancer was 11%, 47%, and 68%, respectively. Across all tumor stages, the use of chemotherapy decreased substantially with increasing age (P < 0.001). overall, 66% of women younger than 45 years of age received chemotherapy compared with 44% of women between 50 and 54 years of age, 31% of women between 55 and 59 years of age, and 18% of women between 60 and 64 years of age. The decreasing pattern of chemotherapy use with age continued after adjustment for prognostic factors and was relatively insensitive to changes in unmeasured factors. Conclusions: There is considerable discrepancy between the 1990 National Institutes of Health Consensus Conference recommendations for chemotherapy administration in women with breast cancer and the actual use of chemotherapy in the community. The decrease in use with age may relate to the decreasing efficacy of chemotherapy with age, as reported in clinical trials. Outcomes studies should address whether the recommendations are overly aggressive or whether practicing oncologists are too conservative in their use of chemotherapy.	Univ Texas, Dept Internal Med, Med Branch, Galveston, TX 77555 USA; Univ New Mexico, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico	Du, XLL (corresponding author), Univ Texas, Dept Internal Med, Med Branch, 3-134 Jennie Sealy Hosp, Galveston, TX 77555 USA.	xdu@utmb.edu			NCI NIH HHS [R01 CA090626-02, R01-CA871773, R01 CA090626-04, R01 CA090626-03, R01 CA090626, R01 CA090626-02S1, R01-CA90626, R01 CA090626-01, R01 CA090626-03S1] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P3461; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1992, Lancet, V339, P1; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Carlson RW, 2000, ONCOLOGY-NY, V14, P33; CHRISTMAN K, 1992, JAMA-J AM MED ASSOC, V268, P57, DOI 10.1001/jama.268.1.57; CHU J, 1987, J GERONTOL, V42, P185, DOI 10.1093/geronj/42.2.185; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Du XL, 2001, CANCER-AM CANCER SOC, V92, P730, DOI 10.1002/1097-0142(20010815)92:4<730::AID-CNCR1376>3.0.CO;2-P; Du XL, 2001, J CLIN ONCOL, V19, P1455, DOI 10.1200/JCO.2001.19.5.1455; Du XL, 1999, J GERONTOL A-BIOL, V54, pM474, DOI 10.1093/gerona/54.9.M474; Du XLL, 2002, J CLIN ONCOL, V20, P4636, DOI 10.1200/JCO.2002.05.088; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Field MJ, 1992, GUIDELINES CLIN PRAC; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Fisher B, 1999, CA-CANCER J CLIN, V49, P159, DOI 10.3322/canjclin.49.3.159; FISHER B, 1998, LANCET, V352, P930; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; GOODWIN JS, 1988, ARCH INTERN MED, V148, P2258, DOI 10.1001/archinte.148.10.2258; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; GREENLAND S, 1998, EPIDEMIOLOGY, P343; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Hosmer D.W., 2000, WILEY PS TX, DOI 10.1002/0471722146; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; MUSS HB, 1994, CANCER, V74, P2165, DOI 10.1002/1097-0142(19941001)74:7+<2165::AID-CNCR2820741727>3.0.CO;2-6; MUSS HB, 1995, SEMIN ONCOL, V22, P14; National Cancer Institute, 1994, NIH PUBLICATION; NERENZ DR, 1986, HEALTH SERV RES, V20, P961; *NEW MEX TUM REG, 2002, NEW MEX TUM REG; OSTEEN RT, 1994, J AM COLL SURGEONS, V178, P213; POTOSKY AL, 1993, MED CARE, V31, P732; RIES LA, 1997, NIH PUBLICAITON; RIES LAG, 1997, NIH PUBLICATION; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS52; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS43; WETLE T, 1987, JAMA-J AM MED ASSOC, V258, P516, DOI 10.1001/jama.1987.03400040114035; WILSON RE, 1984, SURG GYNECOL OBSTET, V159, P309; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; [No title captured]	46	81	82	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					90	97		10.7326/0003-4819-138-2-200301210-00009	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529090	Green Accepted			2022-12-01	WOS:000181018300002
J	Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR			An active DNA transposon family in rice	NATURE			English	Article							ELEMENTS; MAIZE; INSERTION; HEARTBREAKER; SEQUENCES; REVEALS	The publication of draft sequences for the two subspecies of Oryza sativa (rice), japonica (cv. Nipponbare) and indica (cv. 93-11)(1,2), provides a unique opportunity to study the dynamics of transposable elements in this important crop plant. Here we report the use of these sequences in a computational approach to identify the first active DNA transposons from rice and the first active miniature inverted-repeat transposable element (MITE) from any organism. A sequence classified as a Tourist-like MITE of 430 base pairs, called miniature Ping (mPing), was present in about 70 copies in Nipponbare and in about 14 copies in 93-11. These mPing elements, which are all nearly identical, transpose actively in an indica cell-culture line. Database searches identified a family of related transposase-encoding elements (called Pong), which also transpose actively in the same cells. Virtually all new insertions of mPing and Pong elements were into low-copy regions of the rice genome. Since the domestication of rice mPing MITEs have been amplified preferentially in cultivars adapted to environmental extremes-a situation that is reminiscent of the genomic shock theory for transposon activation(3).	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 305, Japan; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); National Institute of Agrobiological Sciences - Japan; Cornell University	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.		Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Burr B, 2002, PLANT CELL, V14, P521, DOI 10.1105/tpc.140310; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gautam R. K., 2014, RICE GENET NEWSL, V19, P136; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kushibuchi K., 1997, SCI RICE PLANT, P837; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MORISHIMA H, 1981, JPN J BREED, V31, P402; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Tarchini R, 2000, PLANT CELL, V12, P381, DOI 10.1105/tpc.12.3.381; Ting Y., 1957, ACTA AGRON SIN, V8, P243; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; UENO K, 1988, Bulletin of the Institute for Agricultural Research Tohoku University, V39, P43; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	30	332	364	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					163	167		10.1038/nature01214	http://dx.doi.org/10.1038/nature01214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520302				2022-12-01	WOS:000180267200040
J	Kramer, KL; Barnette, JE; Yost, HJ				Kramer, KL; Barnette, JE; Yost, HJ			PKC gamma regulates syndecan-2 inside-out signaling during Xenopus left-right development	CELL			English	Article							PROTEIN-KINASE-C; LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; MUTANT MICE; IN-VIVO; PHOSPHORYLATION; DOMAIN; EXPRESSION; GENE; PROTEOGLYCAN	The transmembrane proteoglycan syndecan-2 cell nonautonomously regulates left-right (LR) development in migrating mesoderm by an unknown mechanism, leading to LR asymmetric gene expression and LR orientation of the heart and gut. Here, we demonstrate that protein kinase C gamma (PKCgamma) mediates phosphorylation of the cytoplasmic domain of syndecan-2 in right, but not left, animal cap ectodermal cells. Notably, both phosphorylation states of syndecan-2 are obligatory for normal LR development, with PKCgamma-dependent phosphorylated syndecan-2 in right ectodermal cells and nonphosphorylated syndecan-2 in left cells. The ectodermal cells contact migrating mesodermal cells during early gastrulation, concurrent with the transmission of LR information. This precedes the appearance of monocilia and is one of the earliest steps of LR development. These results demonstrate that PKCgamma regulates the cytoplasmic phosphorylation of syndecan-2 and, consequently, syndecan-2-mediated inside-out signaling to adjacent cells.	Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, 2000 Circle Hope, Salt Lake City, UT 84112 USA.							ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; BAUER DV, 1994, DEVELOPMENT, V120, P1179; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; FREISEWINKEL I, 1991, FEBS LETT, V280, P262, DOI 10.1016/0014-5793(91)80307-O; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; MARYNEN P, 1989, J BIOL CHEM, V264, P7017; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; OTTE AP, 1991, SCIENCE, V251, P570, DOI 10.1126/science.1990433; Pauken CM, 2000, DEV BIOL, V223, P411, DOI 10.1006/dbio.2000.9763; Prasthofer T, 1995, BIOCHEM MOL BIOL INT, V36, P793; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; Teel AL, 1996, MECH DEVELOP, V59, P115, DOI 10.1016/0925-4773(96)00584-9; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Ward KW, 1998, REPROD TOXICOL, V12, P525, DOI 10.1016/S0890-6238(98)00032-X; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; YOST HJ, 1995, CELL, V82, P689, DOI 10.1016/0092-8674(95)90464-6; YOST HJ, 1992, NATURE, V357, P158, DOI 10.1038/357158a0; YOST HJ, 1991, CIBA F SYMP, V162, P165	41	86	87	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					981	990		10.1016/S0092-8674(02)01200-X	http://dx.doi.org/10.1016/S0092-8674(02)01200-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507425	Bronze			2022-12-01	WOS:000180086000008
J	Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J				Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J			SRC-1 and TIF2 control energy balance between white and brown adipose tissues	CELL			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR RECEPTORS; MESSENGER-RNA; LIGAND; MOUSE; ALPHA	We have explored the effects of two members of the p160 coregulator family on energy homeostasis. TIF2-/- mice are protected against obesity and display enhanced adaptive thermogenesis, whereas SRC-1-/- mice are prone to obesity due to reduced energy expenditure. In white adipose tissue, lack of TIF2 decreases PPARgamma activity and reduces fat accumulation, whereas in brown adipose tissue it facilitates the interaction between SRC-1 and PGC-1alpha, which induces PGC-1alpha's thermogenic activity. Interestingly, a high-fat diet increases the TIF2/SRC-1 expression ratio, which may contribute to weight gain. These results reveal that the relative level of TIF2/SRC-1 can modulate energy metabolism.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Inst Clin Souris Genopole Strasbourg, F-67404 Illkirch Graffenstaden, France; Baylor Coll Med, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine	Auwerx, J (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.		Annicotte, Jean-Sébastien/H-4641-2018; Rocchi, Stephane/O-4152-2016; Auwerx, Johan/ABE-9307-2021	Annicotte, Jean-Sébastien/0000-0002-2109-4849; Rocchi, Stephane/0000-0002-0943-1304; Auwerx, Johan/0000-0002-5065-5393	NIDDK NIH HHS [1-P01-DK59820-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Arvaniti K, 1998, ENDOCRINOLOGY, V139, P4000, DOI 10.1210/en.139.9.4000; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Choi DS, 1997, DEVELOPMENT, V124, P1745; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Glass CK, 2000, GENE DEV, V14, P121; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GUEZENNEC CY, 1988, EUR J APPL PHYSIOL O, V57, P114, DOI 10.1007/BF00691249; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; LARSEN ML, 1993, CURR OPIN LIPIDOL, V4, P34, DOI 10.1097/00041433-199302000-00007; Lefebvre AM, 1997, ARTERIOSCL THROM VAS, V17, P1756, DOI 10.1161/01.ATV.17.9.1756; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MARETTE A, 1991, AM J PHYSIOL, V261, pE204, DOI 10.1152/ajpendo.1991.261.2.E204; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Richard D, 2002, INT J OBESITY, V26, P344, DOI 10.1038/sj.ijo.0801873; RICHARD D, 1992, AM J PHYSIOL, V262, pR921, DOI 10.1152/ajpregu.1992.262.5.R921; RICQUIER D, 1979, FEBS LETT, V101, P35, DOI 10.1016/0014-5793(79)81289-2; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shao G, 2000, MOL ENDOCRINOL, V14, P1198, DOI 10.1210/me.14.8.1198; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trayhurn P, 1996, BIOCHEM SOC T, V24, P565, DOI 10.1042/bst0240565; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Weiss RE, 2002, ENDOCRINOLOGY, V143, P1554, DOI 10.1210/en.143.4.1554; Xu JJ, 1998, ELECTROCHEM SOLID ST, V1, P1, DOI 10.1149/1.1390615; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	50	351	367	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					931	941		10.1016/S0092-8674(02)01169-8	http://dx.doi.org/10.1016/S0092-8674(02)01169-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507421	Bronze			2022-12-01	WOS:000180086000004
J	Wolpert, L; Szathmary, E				Wolpert, L; Szathmary, E			Multicellularity: Evolution and the egg	NATURE			English	Editorial Material									UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1014 Budapest, Hungary; Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary	University of London; University College London; Eotvos Lorand University	Wolpert, L (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.		Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011	Szathmary, Eors/0000-0001-5227-2997; 				BONNER JT, 2002, 1 SIGNALS EVOLUTION; HAMMERSTEIN P, IN PRESS DAHL WORKSH, V90; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; Kerszberg M, 1998, J THEOR BIOL, V193, P535, DOI 10.1006/jtbi.1998.0714; Maynard Smith J., 1995, MAJOR TRANSITIONS EV	5	59	59	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					745	745		10.1038/420745a	http://dx.doi.org/10.1038/420745a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490925	Bronze			2022-12-01	WOS:000179897300033
J	Myat, MM; Andrew, DJ				Myat, MM; Andrew, DJ			Epithelial tube morphology is determined by the polarized growth and delivery of apical membrane	CELL			English	Article							DROSOPHILA SALIVARY-GLAND; GENE-EXPRESSION; NUCLEAR MIGRATION; HAIRY; PROTEIN; CELL; MORPHOGENESIS; SEGMENTATION; CRUMBS; MELANOGASTER	Formation of tubes of the correct size and shape is essential for viability of most organisms, yet little is understood of the mechanisms controlling tube morphology. We identified a new allele of hairy in a mutagenesis screen and showed that hairy mutations cause branching and bulging of the normally unbranched salivary tube, in part through prolonged expression of huckebein (hkb). HKB controls polarized cell shape change and apical membrane growth during salivary cell invagination via two downstream target genes, crumbs (crb), a determinant of the apical membrane, and klarsicht (klar), which mediates microtubule-dependent organelle transport. In invaginating salivary cells, crb and klar mediate growth and delivery of apical membrane, respectively, thus regulating the size and shape of the salivary tube.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Andrew, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013899] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01DE13899] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5; Andrew DJ, 1997, DEVELOPMENT, V124, P181; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bowes RC, 1999, J CELL PHYSIOL, V180, P81, DOI 10.1002/(SICI)1097-4652(199907)180:1<81::AID-JCP9>3.0.CO;2-J; Bradley PL, 2001, BIOESSAYS, V23, P901, DOI 10.1002/bies.1131; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; CARROLL SB, 1986, NATURE, V323, P278, DOI 10.1038/323278a0; Clark IE, 1997, DEVELOPMENT, V124, P461; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; GINIGER E, 1993, DEVELOPMENT, V117, P431; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOOPER KL, 1989, DEVELOPMENT, V107, P489; HOWARD K, 1986, CELL, V44, P949, DOI 10.1016/0092-8674(86)90018-8; INGHAM PW, 1985, GENETICS, V111, P463; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; LEHMANN R, 1994, DROSOPHILA MELANOGAS, P755; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Myat MM, 2000, DEVELOPMENT, V127, P679; Myat MM, 2000, DEVELOPMENT, V127, P4217; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; ORENIC TV, 1993, DEVELOPMENT, V118, P9; PARKHURST SM, 1990, CELL, V63, P1179, DOI 10.1016/0092-8674(90)90414-A; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; REUTER R, 1990, DEVELOPMENT, V110, P1031; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	41	101	101	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					879	891		10.1016/S0092-8674(02)01140-6	http://dx.doi.org/10.1016/S0092-8674(02)01140-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526813	Bronze			2022-12-01	WOS:000179862600013
J	van de Put, W				van de Put, W			Addressing mental health in Afghanistan	LANCET			English	Article									HealthNet Int, NL-1062 GL Amsterdam, Netherlands		van de Put, W (corresponding author), HealthNet Int, Maassluisstr 258, NL-1062 GL Amsterdam, Netherlands.								0	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S41	S42		10.1016/S0140-6736(02)11816-2	http://dx.doi.org/10.1016/S0140-6736(02)11816-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	629TG	12504499				2022-12-01	WOS:000180064500020
J	Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E				Alexander, EK; Hurwitz, S; Heering, JP; Benson, CB; Frates, MC; Doubilet, PM; Cibas, ES; Larsen, PR; Marqusee, E			Natural history of benign solid and cystic thyroid nodules	ANNALS OF INTERNAL MEDICINE			English	Article							TERM FOLLOW-UP; SUPPRESSIVE THERAPY; LEVOTHYROXINE; ULTRASOUND; THYROXINE; GOITER	Background: Thyroid nodules are common and most often benign. The natural history of benign thyroid nodules, however, is unclear. Objective: To determine the natural history of cytologically benign thyroid nodules using ultrasonography. Design: Retrospective case series. Setting: Single tertiary care clinic. Participants: All patients referred to the Brigham and Women's Hospital Thyroid Nodule Clinic, Boston, Massachusetts, who had benign cytologic results on ultrasonography-guided fine-needle aspiration of a thyroid nodule between 1995 and 2000 and returned for a requested follow-up examination 1 month to 5 years later. Measurements: Nodule dimensions were measured at both visits, and growth was defined as an increase in calculated volume of 15% or greater. These results were correlated with the time between examinations, age, sex, baseline serum thyroid-stimulating hormone concentration, and cystic content of each nodule. Results: Nodule volume increased over time (P < 0.001). The estimated proportion of nodules with an increase in volume of 15% or greater after 5 years was 89%. Nodules with greater cystic content were less likely to grow than solid nodules (P = 0.01). Seventy-four of the 330 nodules were reaspirated on the second visit. Despite an average increase in volume of 69%, only 1 of 74 reaspirated nodules was malignant. Conclusion: Most solid, benign thyroid nodules grow. Therefore, an increase in nodule volume alone is not a reliable predictor of malignancy.	Brigham & Womens Hosp, Div Endocrine, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Alexander, EK (corresponding author), Brigham & Womens Hosp, Div Endocrine, 221 Longwood Ave,2nd Floor, Boston, MA 02115 USA.	ekalexander@partners.org	Doubilet, Peter/AAY-7351-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-07609] Funding Source: Medline; NIDDK NIH HHS [DK-07529] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGHOUT A, 1990, LANCET, V336, P193, DOI 10.1016/0140-6736(90)91730-X; BRANDER A, 1992, J CLIN ULTRASOUND, V20, P37, DOI 10.1002/jcu.1870200107; Brander AEE, 2000, RADIOLOGY, V215, P801, DOI 10.1148/radiology.215.3.r00jn07801; BRUNN J, 1981, DEUT MED WOCHENSCHR, V106, P1338, DOI 10.1055/s-2008-1070506; CHEUNG PSY, 1989, WORLD J SURG, V13, P818, DOI 10.1007/BF01658447; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Daniels Gilbert H., 1996, Comprehensive Therapy, V22, P239; Erdogan MF, 1998, THYROID, V8, P1087, DOI 10.1089/thy.1998.8.1087; GHARIB H, 1987, NEW ENGL J MED, V317, P70, DOI 10.1056/NEJM198707093170202; GRANT CS, 1989, SURGERY, V106, P980; KUMA K, 1994, WORLD J SURG, V18, P495, DOI 10.1007/BF00353745; KUMA K, 1992, WORLD J SURG, V16, P583, DOI 10.1007/BF02067327; LAROSA GL, 1995, ANN INTERN MED, V122, P1, DOI 10.7326/0003-4819-122-1-199501010-00001; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Papini E, 1998, J CLIN ENDOCR METAB, V83, P780, DOI 10.1210/jc.83.3.780; REVERTER JL, 1992, CLIN ENDOCRINOL, V36, P25, DOI 10.1111/j.1365-2265.1992.tb02898.x; RIDGWAY EC, 2000, WERNER INGBARS THYRO, P949; Singer PA, 1996, ARCH INTERN MED, V156, P2165, DOI 10.1001/archinte.156.19.2165; TANNIRANDORN P, 2001, 83 M END SOC DENV CO	20	189	202	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2003	138	4					315	318		10.7326/0003-4819-138-4-200302180-00010	http://dx.doi.org/10.7326/0003-4819-138-4-200302180-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DK	12585829				2022-12-01	WOS:000181019400005
J	Zeyl, C; Vanderford, T; Carter, M				Zeyl, C; Vanderford, T; Carter, M			An evolutionary advantage of haploidy in large yeast populations	SCIENCE			English	Article							LIFE-CYCLES; DIPLOIDY; ADAPTATION	Although seed plants and multicellular animals are predominantly diploid, the prominence of diploidy varies greatly among eukaryote life cycles, and no general evolutionary advantage of diploidy has been demonstrated. By doubling the copy number of each gene, diploidy may increase the rate at which adaptive mutations are produced. However, models suggest that this does not necessarily accelerate adaptation by diploid populations. We tested model predictions regarding rates of adaptation using asexual yeast populations. Adaptive mutations were on average partially recessive. As predicted, diploidy slowed adaptation by large populations but not by small populations.	Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Zeyl, C (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.							Bell G., 1982, MASTERPIECE NATURE E; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Hiraoka M, 2000, GENETICS, V156, P1531; JENKINS CD, 1995, EVOLUTION, V49, P512, DOI [10.1111/j.1558-5646.1995.tb02283.x, 10.2307/2410275]; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; ORR HA, 1994, GENETICS, V136, P1475; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; OTTO S, 1994, THEORIES EVOLUTION H, P69; OTTO SP, 1992, GENETICS, V131, P745; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PERROT V, 1991, NATURE, V351, P315, DOI 10.1038/351315a0; VALERO M, 1992, TRENDS ECOL EVOL, V7, P25, DOI 10.1016/0169-5347(92)90195-H	13	104	106	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					555	558		10.1126/science.1078417	http://dx.doi.org/10.1126/science.1078417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543972				2022-12-01	WOS:000180559800046
J	Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O				Weimerskirch, H; Chastel, O; Barbraud, C; Tostain, O			Frigatebirds ride high on thermals - This bird's bizarre physique and sparse hunting grounds account for its languid lifestyle.	NATURE			English	Article									CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France; Assoc Aratai, F-97357 Remire Montjoly, Guyane, France; DIREN, F-97328 Cayenne, Guyane, French Guiana	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Villiersen Bois, France.	henriw@cebc.cnrs.fr	Herberstein, Marie E./D-2042-2011; Weimerskirch, Henri/K-7306-2019; Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/F-5562-2013	Herberstein, Marie E./0000-0001-5071-2952; Weimerskirch, Henri/0000-0002-0457-586X; Barbraud, Christophe/0000-0003-0146-212X; 				Alerstam T., 1990, BIRD MIGRATION, DOI 10.1046/j.1420-9101.1992.5030529.x; AUGSTEIN E, 1980, METEOROLOGY TROPICAL; Ballance L. T., 1999, P INT ORN C, P2057; DIAMOND AW, 1973, CONDOR, V75, P200, DOI 10.2307/1365868; GOULD PJ, 1974, PELAGIC STUDIES SEAB, P6; LACK D, 1956, SWIFTSIN TOWER; NELSON J B, 1975, Living Bird, V14, P113; Orta J., 1992, P362; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Weimerskirch H, 2001, BIOL MARINE BIRDS, P115	10	78	86	6	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					333	334		10.1038/421333a	http://dx.doi.org/10.1038/421333a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540890				2022-12-01	WOS:000180533000030
J	Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S				Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S		Heart Estrogen Progestin Replaceme	Risk factors and secondary prevention in women with heart disease: The heart and estrogen/progestin replacement study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; ASSOCIATION TASK-FORCE; RENAL-INSUFFICIENCY; AMERICAN-COLLEGE; POTENTIAL IMPACT; ELDERLY-PATIENTS; SEX-DIFFERENCES; BETA-BLOCKERS; PREDICTORS	Background: Risk factors for coronary heart disease events have most commonly been evaluated in healthy men. Objective: To assess risk factors, event rates, and use of secondary prevention treatments in women with preexisting coronary disease. Design: A prospective cohort of clinical trial participants. Setting: 20 U.S. clinical centers. Participants: 2763 postmenopausal women with known coronary disease in the Heart and Estrogen/progestin Replacement Study (HERS). Measurements: Myocardial infarction or death from coronary heart disease. Results: On multivariable analysis, the researchers found 11 risk factors: 6 noted by history (nonwhite ethnicity, lack of exercise, treated diabetes, angina, congestive heart failure, and more than one previous myocardial infarction) and 5 that were measured (blood pressure, low-density lipoprotein cholesterol level, high-density lipoprotein cholesterol level, lipoprotein(a) level, and creatinine clearance). The annual rate of coronary events was 1.3% (95% Cl, 0.7% to 2.5%) in women with no risk factors and 8.7% (Cl, 7.1% to 10.8%) in women with five or more risk factors (a sixfold increase). At entry into HERS, 83% of participants were receiving aspirin or other antiplatelet agents, 33% were receiving beta-blockers, 18% were receiving angiotensin-converting enzyme inhibitors, and 53% were receiving lipid-lowering drugs. Women with more risk factors were less likely to be taking aspirin (P < 0.001) and lipid-lowering drugs (P = 0.006). Conclusions: Women with coronary disease are at high risk for myocardial infarction or death from coronary heart disease even in the absence of other risk factors, and their risk increases up to sixfold when many risk factors are present. Established drugs for secondary prevention, including. aspirin, beta-blockers, and lipid-lowering agents, are underused in these women, especially those at highest risk.	Univ Calif San Francisco, San Francisco, CA 94105 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; University of California System; University of California Los Angeles; Johns Hopkins University; University of California System; University of California San Diego	Vittinghoff, E (corresponding author), Univ Calif San Francisco, 74 New Montgomery,Suite 600, San Francisco, CA 94105 USA.		Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; Allen JK, 2001, AM J CARDIOL, V87, P1203, DOI 10.1016/S0002-9149(01)01496-5; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; CLARKE KW, 1994, BMJ-BRIT MED J, V309, P563, DOI 10.1136/bmj.309.6954.563; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Denke Margo A., 1999, American Journal of Medicine, V107, p48S; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; EPSTEIN SE, 1982, NEW ENGL J MED, V307, P1487, DOI 10.1056/NEJM198212093072404; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giugliano RP, 1998, ARCH INTERN MED, V158, P1113, DOI 10.1001/archinte.158.10.1113; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HENNING H, 1979, CIRCULATION, V59, P1124, DOI 10.1161/01.CIR.59.6.1124; Herrington DM, 1998, AM HEART J, V136, P115, DOI 10.1016/S0002-8703(98)70191-7; Hulley S, 1999, JAMA-J AM MED ASSOC, V281, P796; HULLEY S, 1998, JAMA-J AM MED ASSOC, V280, P608; KANNEL WB, 1990, J HYPERTENS, V8, pS3; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; MANSON JE, 1996, PREVENTION MYOCARDIO; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; Mosca L, 1997, CIRCULATION, V96, P2468; MOSS AJ, 1977, AM J CARDIOL, V39, P635, DOI 10.1016/S0002-9149(77)80122-7; OROURKE RA, 1991, CIRCULATION, V84, pI177; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Shlipak MG, 2000, JAMA-J AM MED ASSOC, V283, P1845, DOI 10.1001/jama.283.14.1845; Shlipak MG, 2001, LANCET, V357, P717, DOI 10.1016/S0140-6736(05)71473-2; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 1974, J CHRONIC DIS, V27, P267	46	74	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					81	89		10.7326/0003-4819-138-2-200301210-00007	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529088				2022-12-01	WOS:000181018300001
J	Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J				Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J			Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE	Background: Hallervorden-Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase-associated neurodegeneration. In this study, we compared the clinical and radiographic features of patients with Hallervorden-Spatz syndrome with and without mutations in PANK2. Methods: One hundred twenty-three patients from 98 families with a diagnosis of Hallervorden-Spatz syndrome were classified on the basis of clinical assessment as having classic disease (characterized by early onset with rapid progression) or atypical disease (later onset with slow progression). Their genomic DNA was sequenced for PANK2 mutations. Results: All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations. Whereas almost all mutations in patients with atypical disease led to amino acid changes, those in patients with classic disease more often resulted in predicted protein truncation. Patients with atypical disease who had PANK2 mutations were more likely to have prominent speech-related and psychiatric symptoms than patients with classic disease or mutation-negative patients with atypical disease. In all patients with pantothenate kinase-associated neurodegeneration, whether classic or atypical, T(sub 2)-weighted magnetic resonance imaging (MRI) of the brain showed a specific pattern of hyperintensity within the hypointense medial globus pallidus. This pattern was not seen in any patients without mutations. Conclusions: PANK2 mutations are associated with all cases of classic Hallervorden-Spatz syndrome and one third of cases of atypical disease. A specific MRI pattern distinguishes patients with PANK2 mutations. Predicted levels of pantothenate kinase 2 protein correlate with the severity of disease.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Hayflick, SJ (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd,Mailcode L-103A, Portland, OR 97201 USA.				NEI NIH HHS [R01 EY012353] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ching KHL, 2002, NEUROLOGY, V58, P1673, DOI 10.1212/WNL.58.11.1673; COPPETO JR, 1990, NEUROLOGY, V40, P1359, DOI 10.1212/WNL.40.9.1359; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Guimaraes J, 1999, EUR J NEUROL, V6, P509, DOI 10.1046/j.1468-1331.1999.640509.x; Hallervorden J, 1922, Z GESAMTE NEUROL PSY, V79, P254, DOI 10.1007/BF02878455; HALLERVORDEN J, 1924, DTSCH Z NERVENHEILK, V81, P204; Halliday W, 1995, J NEUROL SCI, V134, P84, DOI 10.1016/0022-510X(95)00212-K; Hickman SJ, 2001, ACTA NEUROL SCAND, V103, P201, DOI 10.1034/j.1600-0404.2001.103003201.x; JANKOVIC J, 1985, NEUROLOGY, V35, P227, DOI 10.1212/WNL.35.2.227; LUCKENBACH MW, 1983, AM J OPHTHALMOL, V95, P369, DOI 10.1016/S0002-9394(14)78308-4; MORPHY MA, 1989, J CLIN PSYCHIAT, V50, P66; NARDOCCI N, 1994, MOVEMENT DISORD, V9, P369, DOI 10.1002/mds.870090322; ROTH AM, 1971, SURV OPHTHALMOL, V16, P24; SETHI KD, 1988, ANN NEUROL, V24, P692, DOI 10.1002/ana.410240519; SHEVELL M, 1992, NEUROLOGY, V42, P2214, DOI 10.1212/WNL.42.11.2214; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029; SWISHER CN, 1972, T AM NEUROL ASSOC, V97, P212; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	20	462	489	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					33	40		10.1056/NEJMoa020817	http://dx.doi.org/10.1056/NEJMoa020817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510040				2022-12-01	WOS:000180134400005
J	Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT				Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT			Palaeontology - First Devonian tetrapod from Asia	NATURE			English	Article							JAWS		Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Natural History Museum London	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012; Ahlberg, Per/E-8086-2013	Zhu, Min/0000-0002-4786-0898; Ahlberg, Per/0000-0001-9054-2900				AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; Metcalfe Ian, 1998, P25; Milner A.R., 1993, P324; Pan J., 1987, CONTINENTAL DEVONIAN	10	39	47	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					760	761		10.1038/420760a	http://dx.doi.org/10.1038/420760a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490937				2022-12-01	WOS:000179897300044
J	Round, JEC; Deheragoda, M				Round, JEC; Deheragoda, M			Sex - can you get it right?	BRITISH MEDICAL JOURNAL			English	Article									Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Round, JEC (corresponding author), Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England.			Round, Jonathan/0000-0002-7404-2006				PORTER RH, 1984, PEDIATRICS, V74, P501	1	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1446	1447		10.1136/bmj.325.7378.1446	http://dx.doi.org/10.1136/bmj.325.7378.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493659	Green Published			2022-12-01	WOS:000180188600011
J	Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW				Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW			Genetic structure of human populations	SCIENCE			English	Article							MULTILOCUS GENOTYPES; DIVERSITY; APPORTIONMENT; STRATIFICATION; PATTERNS; BIAS	We studied human population structure using genotypes at 377 autosomal microsatellite loci in 1056 individuals from 52 populations. Within-population differences among individuals account for 93 to 95% of genetic variation; differences among major groups constitute only 3 to 5%. Nevertheless, without using prior information about the origins of individuals, we identified six main genetic clusters, five of which correspond to major geographic regions, and subclusters that often correspond to individual populations. General agreement of genetic and predefined populations suggests that self-reported ancestry can facilitate assessments of epidemiological risks but does not obviate the need to use genetic information in genetic association studies.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Marshfield Med Res Fdn, Ctr Genet Med, Marshfield, WI 54449 USA; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 117809, Russia; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Southern California; University of Chicago; Foundation Jean Dausset-CEPH; Yale University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University	Rosenberg, NA (corresponding author), Univ So Calif, 1042 W 36th Pl DRB 289, Los Angeles, CA 90089 USA.	noahr@usc.edu	Zhivotovsky, Lev A/A-1351-2012; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brown RA, 2001, EVOL ANTHROPOL, V10, P34, DOI 10.1002/1520-6505(2001)10:1<34::AID-EVAN1011>3.0.CO;2-P; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cann HM, 2002, SCIENCE, V296, P261; DU R, 1996, ETHNIC GROUPS CHINA; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Haywood John, 1995, PENGUIN HIST ATLAS V; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOLUTIONARY BIOL, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Risch N, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2001, GENETICS, V159, P699; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	26	1906	1979	3	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2381	2385		10.1126/science.1078311	http://dx.doi.org/10.1126/science.1078311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493913				2022-12-01	WOS:000179915900054
J	Hong, MK; Bero, LA				Hong, MK; Bero, LA			How the tobacco industry responded to an influential study of the health effects of secondhand smoke	BRITISH MEDICAL JOURNAL			English	Article							WILLIAMSON DOCUMENTS; PASSIVE SMOKING; LAWYER CONTROL; LUNG-CANCER; AUTHORSHIP; RISK		Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bero, LA (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, Box 0613, San Francisco, CA 94143 USA.			Bero, Lisa/0000-0003-1893-6651	NCI NIH HHS [CA-87472, R01 CA087472] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; BARNES DE, 1995, JAMA-J AM MED ASSOC, V274, P248, DOI 10.1001/jama.274.3.248; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; BERO LA, 1993, TOB CONTROL, V2, P103; BEROLA, 2001, TOBACCO CONTROL, V10, P329; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; GLATNZ S, 1996, CIGARETTE PAPERS; GREEN CR, 1991, ETS DIVISION WEEKLY; GREEN CR, 1991, CIAR; HANAUER P, 1995, JAMA-J AM MED ASSOC, V274, P234; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; *INT COMM MED J ED, 1993, JAMA-J AM MED ASSOC, V269, P2282; Lee P, 1994, LIMITATIONS STUDIES; LEE PN, 1995, INT ARCH OCC ENV HEA, V67, P287, DOI 10.1007/BF00385642; LEE PN, LIMITATIONS STUDIES; LEE PN, 1991, DRAFT PROPOSAL STUDY; LEE PN, 1993, PN LEE STAT COM 0815; LEE PN, 1994, IS ENV TOBACCO SMOKE; Malone RE, 2000, SOC STUD SCI, V30, P713, DOI 10.1177/030631200030005003; MARCOTULLIO RJ, 1991, INT ETS MANAGEMENT C; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; MORRIS P, 1991, LIFESTYLE QUESTIONNA; MORRIS P, 1991, PROPOSAL APPL RES ST; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; OSDENE TS, 1991, INVESTIGATION EXPOSU; PAGES R, 1991, JAPAN EXPOSURE ASSES; PAGES R, 1991, COMMUNICATION   0415; PAGES R, 1991, COMMUNICATION   1108; PROCTOR C, 1993, COMMUNICATION   0726; PROCTOR C, 1991, STUDY RESULTS JAPANE; PROCTOR C, 1991, QUESTIONNAIRE DEV JA; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; SADLER PA, 1993, COMMUNICATION   1005; Schotland MS, 2002, RISK ANAL, V22, P131, DOI 10.1111/0272-4332.t01-1-00011; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; YANO E, 1992, CONFOUNDING FACTORS; YANO E, 1992, LACK VALIDITY MARRIA; 1981, BMJ, V283, P1464; 1981, BMJ, V283, P914	40	59	59	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1413	1416		10.1136/bmj.325.7377.1413	http://dx.doi.org/10.1136/bmj.325.7377.1413			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480862	Green Submitted, Green Published			2022-12-01	WOS:000179975000030
J	Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J				Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J			Outbreak of varicella at a day-care center despite vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Interscience Conference on Antimicrobial Agents and Chemotherapy	DEC 16-20, 2001	CHICAGO, ILLINOIS				HEALTHY-CHILDREN; FOLLOW-UP; EFFICACY; POSTLICENSURE; ADOLESCENTS; LICENSURE	Background: In seven studies of the effectiveness of the varicella vaccine conducted since it was licensed, the effectiveness was 71 to 100 percent against disease of any severity and 95 to 100 percent against moderate and severe disease. We investigated an outbreak of varicella in a population of children with a high proportion of vaccinees who were attending a day-care center in a small community in New Hampshire. Methods: Using standardized questionnaires, we collected information about the children's medical and vaccination history from parents and health care providers. The analysis of the effectiveness of the vaccine and of risk factors for vaccine failure was restricted to children who were enrolled in the day-care center continuously during the outbreak and attended for one week or more and who were cared for in the building that represented the epicenter of the outbreak, since transmission was not documented in a second building. Results: Varicella developed in 25 of 88 children (28.4 percent) between December 1, 2000, and January 11, 2001. The index case occurred in a healthy child who had been vaccinated three years previously and who infected more than 50 percent of his classmates who had no history of varicella. The effectiveness of the vaccine was 44.0 percent (95 percent confidence interval, 6.9 to 66.3 percent) against disease of any severity and 86.0 percent (95 percent confidence interval, 38.7 to 96.8 percent) against moderate or severe disease. Children who had been vaccinated three years or more before the outbreak were at greater risk for vaccine failure than those who had been vaccinated more recently (relative risk, 2.6 [95 percent confidence interval, 1.3 to 5.3]). Conclusions: In this outbreak, vaccination provided poor protection against varicella, although there was good protection against moderate or severe disease. A longer interval since vaccination was associated with an increased risk of vaccine failure. Breakthrough infections in vaccinated, healthy persons can be as infectious as varicella in unvaccinated persons.	Ctr Dis Control & Prevent, Atlanta, GA USA; New Hampshire Dept Hlth & Human Serv, Concord, NH 03301 USA; Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA	Centers for Disease Control & Prevention - USA; Washington State University	Galil, K (corresponding author), 65 Hayden Ave, Lexington, MA 02421 USA.							[Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P637; ARBETER AM, 1986, PEDIATRICS, V78, P748; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; CLEMENTS DA, 1995, PEDIATR INFECT DIS J, V14, P874, DOI 10.1097/00006454-199510000-00011; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Galil Karin, 2001, Pediatric Research, V49, p150A; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOHNSON C, 1989, PEDIATRICS, V84, P418; JOHNSON CE, 1988, PEDIATRICS, V81, P512; Johnson CE, 1997, PEDIATRICS, V100, P761, DOI 10.1542/peds.100.5.761; KUTER BJ, 1991, VACCINE, V9, P643, DOI 10.1016/0264-410X(91)90189-D; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Loparev VN, 2000, J CLIN MICROBIOL, V38, P3156, DOI 10.1128/JCM.38.9.3156-3160.2000; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rothstein EP, 1997, J INFECT DIS, V175, P444, DOI 10.1093/infdis/175.2.444; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; WHITE CJ, 1991, PEDIATRICS, V87, P604	25	164	175	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1909	1915		10.1056/NEJMoa021662	http://dx.doi.org/10.1056/NEJMoa021662			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477940				2022-12-01	WOS:000179735800002
J	Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT				Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT			Navigating the signalling network in mouse cardiac myocytes	NATURE			English	Article							MYOCARDIAL-CONTRACTILITY; CELL-SIZE; PHOSPHOLAMBAN; MECHANISM; PATHWAYS; HEART	Cardiac myocytes have a complex network of signals that regulates their essential role in the rhythmic pumping of the heart. This network is an appealing model system in which to study the basic principles underlying cellular signalling mechanisms. Progress in this effort has come through the establishment of standardized myocyte isolation and culture procedures and characterization of important signalling responses.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; San Francisco Vet Adm Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu	O'Connell, Timothy/D-5048-2013; Fraser, Iain DC/L-4735-2017	Fraser, Iain DC/0000-0003-2272-3907; Yan, Zhen/0000-0002-4826-9813				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; BENNDORF K, 1985, PFLUG ARCH EUR J PHY, V404, P190, DOI 10.1007/BF00585418; Bers DM., 2001, EXCITATION CONTRACTI, V2, DOI [10.1007/978-94-010-0658-3, DOI 10.1007/978-94-010-0658-3]; Colan Steven D., 1997, Cardiology Clinics, V15, P355, DOI 10.1016/S0733-8651(05)70345-3; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; KRUPPENBACHER JP, 1993, NATURWISSENSCHAFTEN, V80, P132, DOI 10.1007/BF01131017; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; ROBISON GA, 1965, MOL PHARMACOL, V1, P168; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Thum T, 2001, Cardiovasc Toxicol, V1, P61, DOI 10.1385/CT:1:1:61; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; XIAO RP, 2001, BETA ADRENERGIC SIGN; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	25	70	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					712	714		10.1038/nature01306	http://dx.doi.org/10.1038/nature01306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478303				2022-12-01	WOS:000179751800056
J	Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY				Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY			Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP	SCIENCE			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; TERATOCARCINOMA CELLS; WNT; HOMOLOG; PATHWAY; FAMILY	The Frizzled-2 receptor (Rfz2) from rat binds Wnt proteins and can signal by activating calcium release from intracellular stores. We show that wildtype Rfz2 and a chimeric receptor consisting of the extracellular and transmembrane portions of the beta(2)-adrenergic receptor with cytoplasmic domains of Rfz2 also signaled through modulation of cyclic guanosine 3',5'-monophosphate (cGMP). Activation of either receptor led to a decline in the intracellular concentration of cGMP, a process that was inhibited in cells treated with pertussis toxin, reduced by suppression of the expression of the heterotrimeric GTP-binding protein (G protein) transducin, and suppressed through inhibition of cGMP-specific phosphodiesterase (PDE) activity. Moreover, PDE inhibitors blocked Rfz2-induced calcium transients in zebrafish embryos. Thus, Frizzled-2 appears to couple to PDEs and calcium transients through G proteins.	SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; University of Iowa; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, HY (corresponding author), SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	wangh@pharm.sunysb.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014; malbon, craig/ABF-3604-2020	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; 	NIDDK NIH HHS [T32-DK07521] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHUMADA A, UNPUB; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; RAPORT CJ, 1989, J BIOL CHEM, V264, P7122; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; Wang YS, 1996, J BIOL CHEM, V271, P4468; Weinberg ES, 1996, DEVELOPMENT, V122, P271; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	26	137	141	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					2006	2010		10.1126/science.1073776	http://dx.doi.org/10.1126/science.1073776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471263				2022-12-01	WOS:000179629200050
J	Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB				Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB			Grassland responses to global environmental changes suppressed by elevated CO2	SCIENCE			English	Article							PLANT-RESPONSES; CARBON; NITROGEN; ECOSYSTEM; CLIMATE; PRODUCTIVITY; ASSIMILATION; ENRICHMENT; BIOSPHERE; WHEAT	Simulated global changes, including warming, increased precipitation, and nitrogen deposition, alone and in concert, increased net primary production (NPP) in the third year of ecosystem-scale manipulations in a California annual grassland. Elevated carbon dioxide also increased NPP, but only as a single-factor treatment. Across all multifactor manipulations, elevated carbon dioxide suppressed root allocation, decreasing the positive effects of increased temperature, precipitation, and nitrogen deposition on NPP. The NPP responses to interacting global changes differed greatly from simple combinations of single-factor responses. These findings indicate the importance of a multifactor experimental approach to understanding ecosystem responses to global change.	Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Jasper Ridge Biol Preserve, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University; Stanford University	Shaw, MR (corresponding author), Nat Conservancy Calif, 201 Mission St,4th Floor, San Francisco, CA 94105 USA.	shaw@globalecology.stanford.edu						[Anonymous], 1996, CARBON DIOXIDE POPUL; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Diaz S, 1996, PLANT SOIL, V187, P309, DOI 10.1007/BF00017096; Drake B. G., 1996, CARBON DIOXIDE TERRE, P197; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; Edwards NT, 1999, PLANT SOIL, V206, P85, DOI 10.1023/A:1004319109772; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD CB, 2000, EARTH SYSTEMS PROCES, P297; Higgins PAT, 2002, GLOBAL CHANGE BIOL, V8, P841, DOI 10.1046/j.1365-2486.2002.00514.x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hungate BA, 2000, OECOLOGIA, V124, P589, DOI 10.1007/s004420000405; IDSO KE, 1994, AGR FOREST METEOROL, V69, P153, DOI 10.1016/0168-1923(94)90025-6; *INT PAN CLIM CHAN, 2001, WORK GROUP 1 3 ASS R; KARL TR, 1998, REGIONAL IMPACTS CLI, P412; Kimball BA, 1995, GLOB CHANGE BIOL, V1, P429, DOI 10.1111/j.1365-2486.1995.tb00041.x; KIMBALL BA, 1993, AGRON J, V85, P706, DOI 10.2134/agronj1993.00021962008500030035x; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Koch G.W., 1996, CARBON DIOXIDE TERRE, ppp 415, DOI DOI 10.1016/B978-012505295-5/50023-9; Koide RT, 1988, FUNCT ECOL, V2, P335, DOI 10.2307/2389406; Korner C, 1997, ACTA OECOL, V18, P165, DOI 10.1016/S1146-609X(97)80002-1; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; LUO Y, 1994, PLANT CELL ENVIRON, V17, P1195, DOI 10.1111/j.1365-3040.1994.tb02017.x; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mooney H.A., 1999, TERRESTRIAL BIOSPHER, P141; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volk M, 2000, OECOLOGIA, V125, P380, DOI 10.1007/s004420000454; ZAVALETA ES, 2001, THESIS STANFORD U	38	408	451	13	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1987	1990		10.1126/science.1075312	http://dx.doi.org/10.1126/science.1075312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471257				2022-12-01	WOS:000179629200044
J	Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T				Hill, JM; Zalos, G; Halcox, JPJ; Schenke, WH; Waclawiw, MA; Quyyumi, AA; Finkel, T			Circulating endothelial progenitor cells, vascular function, and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; POSTNATAL NEOVASCULARIZATION; ATHEROSCLEROSIS; DYSFUNCTION; INCREASE; THERAPY; BLOOD; VIVO	BACKGROUND: Cardiovascular risk factors contribute to atherogenesis by inducing endothelial-cell injury and dysfunction. We hypothesized that endothelial progenitor cells derived from bone marrow have a role in ongoing endothelial repair and that impaired mobilization or depletion of these cells contributes to endothelial dysfunction and cardiovascular disease progression. METHODS: We measured the number of colony-forming units of endothelial progenitor cells in peripheral-blood samples from 45 men (mean [+/-SE] age, 50+/-2 years). The subjects had various degrees of cardiovascular risk but no history of cardiovascular disease. Endothelium-dependent and endothelium-independent function was assessed by high-resolution ultrasonography of the brachial artery. RESULTS: We observed a strong correlation between the number of circulating endothelial progenitor cells and the subjects' combined Framingham risk factor score (r=-0.47, P=0.001). Measurement of flow-mediated brachial-artery reactivity also revealed a significant relation between endothelial function and the number of progenitor cells (r=0.59, P<0.001). Indeed, the levels of circulating endothelial progenitor cells were a better predictor of vascular reactivity than was the presence or absence of conventional risk factors. In addition, endothelial progenitor cells from subjects at high risk for cardiovascular events had higher rates of in vitro senescence than cells from subjects at low risk. CONCLUSIONS: In healthy men, levels of endothelial progenitor cells may be a surrogate biologic marker for vascular function and cumulative cardiovascular risk. These findings suggest that endothelial injury in the absence of sufficient circulating progenitor cells may affect the progression of cardiovascular disease.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA; Emory Univ Hosp, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10-6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.	finkelt@nih.gov	Mordwinkin, Nicholas M/A-4347-2010	Halcox, Julian/0000-0001-6926-2947	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Corretti M. C., 2002, J AM COLL CARDIOL, V39, P1082; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Ito H, 1999, CANCER RES, V59, P5875; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI200113131; Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9; Masuda H, 1999, CIRCULATION, V100, P691; Masuda H, 1999, CIRCULATION, V100, P475; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Prasad A, 2001, J AM COLL CARDIOL, V38, P1089, DOI 10.1016/S0735-1097(01)01511-X; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; WILSON PWF, 1987, AM J CARDIOL, V59, pG91, DOI 10.1016/0002-9149(87)90165-2; WILSON PWF, 1987, AM J CARDIOL, V60, pA11	38	2836	3151	1	152	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					593	600		10.1056/NEJMoa022287	http://dx.doi.org/10.1056/NEJMoa022287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584367				2022-12-01	WOS:000180912900004
J	Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA				Cawthon, RM; Smith, KR; O'Brien, E; Sivatchenko, A; Kerber, RA			Association between telomere length in blood and mortality in people aged 60 years or older	LANCET			English	Article								During normal ageing, the gradual loss of telomeric DNA in dividing somatic cells can contribute to replicative senescence, apoptosis, or neoplastic transformation. In the genetic disorder dyskeratosis congenita, telomere shortening Is accelerated, and patients have premature onset of many age-related diseases and early death. We aimed to assess an association between telomere length and mortality In 143 normal unrelated individuals over the age of 60 years. Those with shorter telomeres in blood DNA had poorer survival, attributable In part to a 3.18-fold higher mortality rate from heart disease (95% CI 1.36-7.45, p=0.0079), and an 8.54-fold higher mortality rate from infectious disease (1.52-47.9, p=0.015). These results lend support to the hypothesis that telomere shortening in human beings contributes to mortality in many age-related diseases.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Family & Consumer Studies, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Cawthon, RM (corresponding author), Univ Utah, Dept Human Genet, 15 N 2030 E St,Room 2100, Salt Lake City, UT 84112 USA.		Kerber, Richard/B-8038-2009; Smith, Ken/B-6451-2011	Smith, Ken/0000-0003-0682-3705	NCI NIH HHS [R29CA69421] Funding Source: Medline; NIA NIH HHS [AG13478, K01 AG00767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA069421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG000767, R01AG013478] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0	5	1258	1303	5	145	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					393	395		10.1016/S0140-6736(03)12384-7	http://dx.doi.org/10.1016/S0140-6736(03)12384-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573379				2022-12-01	WOS:000180787000015
J	Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M				Yanez-Mo, M; Lara-Pezzi, E; Selgas, R; Ramirez-Huesca, M; Dominguez-Jimenez, C; Jimenez-Heffernan, JA; Aguilera, A; Sanchez-Tomero, JA; Bajo, MA; Alvarez, V; Castro, MA; del Peso, G; Cirujeda, A; Gamallo, C; Sanchez-Madrid, F; Lopez-Cabrera, M			Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR SNAIL; EXTRACELLULAR-MATRIX; E-CADHERIN; TGF-BETA; GROWTH; ADHESION; EXPRESSION; MEMBRANE; GLUCOSE; JUNCTIONS	BACKGROUND: During continuous ambulatory peritoneal dialysis, the peritoneum is exposed to bioincompatible dialysis fluids that cause denudation of mesothelial cells and, ultimately, tissue fibrosis and failure of ultrafiltration. However, the mechanism of this process has yet to be elucidated. METHODS: Mesothelial cells isolated from effluents in dialysis fluid from patients undergoing continuous ambulatory peritoneal dialysis were phenotypically characterized by flow cytometry, confocal immunofluorescence, Western blotting, and reverse-transcriptase polymerase chain reaction. These cells were compared with mesothelial cells from omentum and treated with various stimuli in vitro to mimic the transdifferentiation observed during continuous ambulatory peritoneal dialysis. Results were confirmed in vivo by immunohistochemical analysis performed on peritoneal-biopsy specimens. RESULTS: Soon after dialysis is initiated, peritoneal mesothelial cells undergo a transition from an epithelial phenotype to a mesenchymal phenotype with a progressive loss of epithelial morphology and a decrease in the expression of cytokeratins and E-cadherin through an induction of the transcriptional repressor snail. Mesothelial cells also acquire a migratory phenotype with the up-regulation of expression of a(sub 2) integrin. In vitro analyses point to wound repair and profibrotic and inflammatory cytokines as factors that initiate mesothelial transdifferentiation. Immunohistochemical studies of peritoneal-biopsy specimens from patients undergoing continuous ambulatory peritoneal dialysis demonstrate the expression of the mesothelial markers intercellular adhesion molecule 1 and cytokeratins in fibroblast-like cells entrapped in the stroma, suggesting that these cells stemmed from local conversion of mesothelial cells. CONCLUSIONS: Our results suggest that mesothelial cells have an active role in the structural and functional alteration of the peritoneum during peritoneal dialysis. The findings suggest potential targets for the design of new dialysis solutions and markers for the monitoring of patients.	Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, Madrid 28006, Spain; Univ Autonoma Madrid, Hosp Univ Princesa, Serv Inmunol, Madrid 28006, Spain; Hosp Univ La Paz, Serv Nefrol, Madrid, Spain; Inst Reina Sofia Invest Nefrol, Madrid, Spain; Hosp Univ Guadalajara, Serv Anat Patol, Guadalajara, Spain	Autonomous University of Madrid; Hospital de La Princesa; Autonomous University of Madrid; Hospital de La Princesa; Hospital Universitario La Paz	Lopez-Cabrera, M (corresponding author), Univ Autonoma Madrid, Hosp Univ Princesa, Dept Biol Mol, C Diego de Leon 62, Madrid 28006, Spain.		Yáñez-Mó, María/K-8577-2014; Sanchez-Madrid, Francisco/M-7889-2016; Cabrera, Manuel López/AAA-5463-2019; SANCHEZ TOMERO, JOSE ANTONIO/Q-9346-2017; YÃÃez-MÃ, Maria/AAI-4544-2020; Lara-Pezzi, Enrique/E-2350-2015; Bajo, Maria A/ABF-6991-2020	Yáñez-Mó, María/0000-0001-7484-2866; Sanchez-Madrid, Francisco/0000-0001-5303-0762; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Lara-Pezzi, Enrique/0000-0002-2743-1033; Bajo, Maria A/0000-0001-7364-557X; Lopez Cabrera, Manuel/0000-0002-0976-9719				Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Birchmeier C, 1996, ACTA ANAT, V156, P217; BRULEZ HFH, 1995, PERITON DIALYSIS INT, V15, pS24; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; CHAIMOVITZ C, 1994, KIDNEY INT, V45, P1226, DOI 10.1038/ki.1994.163; CHAIMOVITZ C, 1994, KIDNEY INT, V46, P285; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Faull RJ, 2001, KIDNEY INT, V59, P614, DOI 10.1046/j.1523-1755.2001.059002614.x; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hay ED, 1995, ACTA ANAT, V154, P8; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Ito T, 2000, J AM SOC NEPHROL, V11, P1969, DOI 10.1681/ASN.V11111969; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lai KN, 2000, AM J KIDNEY DIS, V35, P644, DOI 10.1016/S0272-6386(00)70011-4; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; Leavesley DI, 1999, NEPHROL DIAL TRANSPL, V14, P1208, DOI 10.1093/ndt/14.5.1208; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Medcalf JF, 2001, NEPHROL DIAL TRANSPL, V16, P1885, DOI 10.1093/ndt/16.9.1885; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rampino T, 2001, AM J PATHOL, V159, P1275, DOI 10.1016/S0002-9440(10)62514-X; ROUSSELLE P, 1995, J BIOL CHEM, V270, P13766, DOI 10.1074/jbc.270.23.13766; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; SUASSUNA JHR, 1994, KIDNEY INT, V46, P443, DOI 10.1038/ki.1994.292; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yanez-Mo M, 2001, J CELL SCI, V114, P577; Yang WS, 1999, PERITON DIALYSIS INT, V19, P211	31	581	614	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					403	413		10.1056/NEJMoa020809	http://dx.doi.org/10.1056/NEJMoa020809			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556543				2022-12-01	WOS:000180643800005
J	Pinn, VW				Pinn, VW			Sex and gender factors in medical studies - Implications for health and clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMENS HEALTH; MYOCARDIAL-INFARCTION; TRIALS; HEART; CARE; REPRESENTATION; PROLONGATION; DELIVERY; TRENDS		NIH, Off Res Womens Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pinn, VW (corresponding author), NIH, Off Res Womens Hlth, 9000 Rockville Pike,Bldg 1,Room 201, Bethesda, MD 20892 USA.	orwh-research@od.nih.gov						*AM PSYCH ASS, 2002, SUMM WOM DEPR P REC; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P601, DOI 10.1089/152460902760360559; Arnold K, 2000, J NATL CANCER I, V92, P1561, DOI 10.1093/jnci/92.19.1561; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; BERG MJ, 1999, NIH PUBLICATION, V2; BLEHAR MC, 2001, TEN, V3, P42; Brandt E N Jr, 1998, J Gend Specif Med, V1, P48; Buring JE, 2000, NEW ENGL J MED, V343, P505, DOI 10.1056/NEJM200008173430711; Campaigne B N, 2000, J Gend Specif Med, V3, P51; CARLSON KJ, 1997, TXB WOMENS HLTH, P33; *CDCP, HIV AIDS SURV WOM; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V285, P1508, DOI 10.1001/jama.285.11.1508; Desai H D, 2000, J Am Pharm Assoc (Wash), V40, P525; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; FISHMAN JR, 1999, NIH PUBLICATION, V2; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; Gesensway D, 2001, ANN INTERN MED, V135, P935, DOI 10.7326/0003-4819-135-10-200111200-00032; Gwinn DE, 2000, AM J SPORT MED, V28, P98, DOI 10.1177/03635465000280012901; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hobbs F. B., ELDERLY POPULATION; Hoffman E, 1995, J Am Med Womens Assoc (1972), V50, P17; Hoffman E, 1997, WOMEN HEALTH ISS, V7, P362, DOI 10.1016/S1049-3867(97)00074-1; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Horwitz BJ, 2001, NEW ENGL J MED, V344, P1846, DOI 10.1056/NEJM200106143442407; KASPER AS, 1997, TXB WOMENS HLTH, P3; Kendler K S, 1998, J Gend Specif Med, V1, P28; Krummel DA, 2001, J WOMEN HEALTH GEN-B, V10, P117, DOI 10.1089/152460901300039467; LaRosa J H, 1993, J Am Med Womens Assoc (1972), V48, P145; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Legato M J, 2000, J Gend Specif Med, V3, P15; LEGATO MJ, 2000, J GEND SPECIF MED, V3, P12; LENFANT C, 1999, NIH PUBLICATION, V2; Mastroianni AC, 1994, WOMEN HLTH RES ETHIC; Mehilli J, 2002, JAMA-J AM MED ASSOC, V287, P210, DOI 10.1001/jama.287.2.210; Meinert CL, 2000, CONTROL CLIN TRIALS, V21, P462, DOI 10.1016/S0197-2456(00)00086-6; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; *NIH OFF RES WOM H, 1999, NIH PUBL, V2; Perkins KA, 2001, CNS DRUGS, V15, P391, DOI 10.2165/00023210-200115050-00005; Phelan EA, 2000, J GEN INTERN MED, V15, P8, DOI 10.1046/j.1525-1497.2000.12178.x; Pinn V W, 1998, J Gend Specif Med, V1, P50; Pinn VW, 1999, ACAD MED, V74, P1104, DOI 10.1097/00001888-199910000-00013; PINN VW, 1997, TXB WOMENS HLTH, P971; PINN VW, 2002, MONITORING ADHERENCE; Prout M N, 2001, Medscape Womens Health, V6, P1; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Romanzi L J, 2001, J Gend Specif Med, V4, P14; Shlipak MG, 2001, ANN INTERN MED, V134, P1043, DOI 10.7326/0003-4819-134-11-200106050-00010; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; *US GEN ACC OFF, 2001, WOM HLTH WOM CLIN DR; *US GEN ACC OFF, 2000, WOMENS HLTH NIH INCR; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Weisman C S, 2000, J Gend Specif Med, V3, P22; Weisman CS, 1997, HEALTH AFFAIR, V16, P276, DOI 10.1377/hlthaff.16.3.276-a; Weisman CS, 2000, ACAD MED, V75, P1107, DOI 10.1097/00001888-200011000-00016; Wizemann TM, 2001, EXPLORING BIOL CONTR; 2000, HARV WOMENS HLTH WAT, V7, P4; [No title captured]	59	117	122	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					397	400		10.1001/jama.289.4.397	http://dx.doi.org/10.1001/jama.289.4.397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TD	12533102				2022-12-01	WOS:000180472300001
J	Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ				Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ			Direct activation of RNA polymerase III transcription by c-Myc	NATURE			English	Article							TATA-BINDING-PROTEIN; CELL-GROWTH; RIBOSOME BIOGENESIS; GENES; EXPRESSION; TARGET; CYCLE; P107; TRANSACTIVATION; FIBROBLASTS	The proto-oncogene product c-Myc has a direct role in both metazoan cell growth and division(1-4). RNA polymerase III (pol III) is involved in the generation of transfer RNA and 5S ribosomal RNA, and these molecules must be produced in bulk to meet the need for protein synthesis in growing cells(5). We demonstrate here that c-Myc binds to TFIIIB, a pol III-specific general transcription factor, and directly activates pol III transcription. Chromatin immunoprecipitation reveals that endogenous c-Myc is present at tRNA and 5S rRNA genes in cultured mammalian cells. These results suggest that activation of pol III may have a role in the ability of c-Myc to stimulate cell growth.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Fred Hutchinson Cancer Center; University of Glasgow	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Gomez-Roman, Natividad/0000-0002-2325-7517				Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Brown TRP, 2000, GENE EXPRESSION, V9, P15; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dang CV, 1999, MOL CELL BIOL, V19, P1; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HATEBOER G, 1993, P NATL ACAD SCI USA, V90, P8489, DOI 10.1073/pnas.90.18.8489; Hirst SK, 2000, ONCOGENE, V19, P5189, DOI 10.1038/sj.onc.1203904; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Schubeler D, 2000, GENE DEV, V14, P940; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Scott PH, 2001, J BIOL CHEM, V276, P1005, DOI 10.1074/jbc.M005417200; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; Sutcliffe JE, 1999, MOL CELL BIOL, V19, P4255; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097	30	314	320	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					290	294		10.1038/nature01327	http://dx.doi.org/10.1038/nature01327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529648				2022-12-01	WOS:000180397600053
J	Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP				Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP			Trends in community knowledge of the warning signs and risk factors for stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NORTHERN MANHATTAN STROKE; HEALTH-CARE DASH; ALCOHOL-CONSUMPTION; ISCHEMIC STROKE; SYMPTOMS; EMERGENCY; DELAYS; DETERMINANTS; INFARCTION; POPULATION	Context Poor public knowledge of stroke warning signs and risk factors limits effective stroke intervention and prevention. Objective To examine temporal trends in public knowledge of stroke warning signs and risk factors. Design and Setting Population-based random-digit telephone survey conducted in July-November 2000 among individuals in the greater Cincinnati, Ohio, region. Participants A total of 2173 survey respondents (69% response rate) were randomly identified based on their demographic similarities to the ischemic stroke population with regard to age, race, and sex. Main Outcome Measures Spontaneous recall of at least 1 important stroke warning sign and 1 established stroke risk factor in comparison with findings from the same survey in 1995. Results In 2000, 70% of respondents correctly named at least 1 established stroke warning sign vs 57% in 1995 (P<.001), and 72% correctly named at least 1 established stroke risk factor vs 68% in 1995. Groups of individuals with the highest risk and incidence of stroke, such as persons at least 75 years old, blacks, and men, were the least knowledgeable about warning signs and risk factors. Television was the most frequently cited source of knowledge, 32% in 2000 vs 24% in 1995 (P<.001). Conclusions Public knowledge of stroke warning signs within the greater Cincinnati region has significantly improved from 1995 to 2000, although knowledge of stroke risk factors did not improve significantly during the same time period. Public education efforts must continue and should focus on groups at the highest risk of stroke.	Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Inst Policy Res, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Schneider, AT (corresponding author), Univ Cincinnati, Dept Neurol, Med Sci Bldg 0525,231 Albert Sabin Way, Cincinnati, OH 45267 USA.		Khoury, Jane/O-2068-2015	Kissela, Brett/0000-0002-9773-4013	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U10NS077311, R01NS030678] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS30678-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM STROK ASS, KNOW WARN SIGNS STRO; Amarenco P, 2001, NEUROLOGY, V57, pS35, DOI 10.1212/WNL.57.suppl_2.S35; BARSAN WG, 1993, ARCH INTERN MED, V153, P2558, DOI 10.1001/archinte.153.22.2558; BARSAN WG, 1994, STROKE, V25, P2132, DOI 10.1161/01.STR.25.11.2132; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Caicoya M, 1999, J CLIN EPIDEMIOL, V52, P677, DOI 10.1016/S0895-4356(98)00074-2; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; Evenson KR, 2001, NEUROEPIDEMIOLOGY, V20, P65, DOI 10.1159/000054763; Ezzati TM, 1992, VITAL HLTH STAT 2, V2, P1; FELDMANN E, 1993, STROKE, V24, P1805, DOI 10.1161/01.STR.24.12.1805; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Morris DL, 2000, STROKE, V31, P2585, DOI 10.1161/01.STR.31.11.2585; *NAT STROK ASS, REC STROK SYMPT; Pancioli AM, 1998, JAMA-J AM MED ASSOC, V279, P1288, DOI 10.1001/jama.279.16.1288; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosamond WD, 1998, ACAD EMERG MED, V5, P45, DOI 10.1111/j.1553-2712.1998.tb02574.x; Rowe AE, 2001, SOUTHERN MED J, V94, P613, DOI 10.1097/00007611-200194060-00014; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Samsa GP, 1997, STROKE, V28, P916, DOI 10.1161/01.STR.28.5.916; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; *US CENS BUR, 1990 CENS QUICK TABL; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926	29	253	261	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					343	346		10.1001/jama.289.3.343	http://dx.doi.org/10.1001/jama.289.3.343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525235	Bronze			2022-12-01	WOS:000180345100029
J	Adams, MD; McVey, M; Sekelsky, JJ				Adams, MD; McVey, M; Sekelsky, JJ			Drosophila BLM in double-strand break repair by synthesis-dependent strand annealing	SCIENCE			English	Article							SYNDROME GENE-PRODUCT; INDUCED GAP REPAIR; BLOOM-SYNDROME; IN-VIVO; RECOMBINATION; MELANOGASTER; JUNCTIONS; MECHANISM; HELICASE; PROTEIN	Bloom syndrome, characterized by a predisposition to cancer, is caused by mutation of the RecQ DNA helicase gene BLM. The precise function of BLM remains unclear. Previous research suggested that Drosophila BLM functions in the repair of DNA double-strand breaks. Most double-strand breaks in flies are repaired by homologous recombination through the synthesis-dependent strand-annealing pathway. Here, we demonstrate that Drosophila BLM mutants are severely impaired in their ability to carry out repair DNA synthesis during synthesis-dependent strand annealing. Consequently, repair in the mutants is completed by error-prone pathways that create large deletions. These results suggest a model in which BLM maintains genomic stability by promoting efficient repair DNA synthesis and thereby prevents double-strand break repair by less precise pathways.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, SPIRE Program, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, JJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Sekelsky, Jeff J/F-9892-2010		NIGMS NIH HHS [GM000678] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Beall EL, 1997, GENE DEV, V11, P2137, DOI 10.1101/gad.11.16.2137; BOYD JB, 1981, GENETICS, V97, P607; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; KURKULOS M, 1994, GENETICS, V136, P1001; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; STAVELEY BE, 1995, GENETICS, V139, P1321; Welzel N, 2001, CANCER RES, V61, P1629; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200	24	194	200	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					265	267		10.1126/science.1077198	http://dx.doi.org/10.1126/science.1077198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522255				2022-12-01	WOS:000180284000044
J	Lyder, CH				Lyder, CH			Pressure ulcer prevention and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; RISK		Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA; Yale Univ, Sch Nursing, Program Advancement Chron Wound Care, New Haven, CT 06536 USA	University of Virginia; Yale University	Lyder, CH (corresponding author), Univ Virginia, Sch Nursing, McLeod Hall,POB 800782, Charlottesville, VA 22908 USA.							*AG HEALTHC RES QU, 2002, CLIN PRACT GUID ONL; ALLMAN RM, 1999, PRINCIPLES GERIATRIC, P1577; [Anonymous], 1975, INVESTIGATION GERIAT; Baker Lucinda L., 1996, Wound Repair and Regeneration, V4, P21, DOI 10.1046/j.1524-475X.1996.40106.x; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; Bennett RG, 2000, J AM GERIATR SOC, V48, P73, DOI 10.1111/j.1532-5415.2000.tb03033.x; BERGSTROM N, 1994, AHCPR PUBL; Bergstrom N, 1992, CLIN PRACTICE GUIDEL; Bliss M R, 1998, J Tissue Viability, V8, P4; COLWELL S, 1993, NEW STATESMAN SOC, V6, P28; CUDDIGAN J, 2001, PRESSURE ULCERS AM P; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Kloth L C, 1996, Adv Wound Care, V9, P42; Kloth L C, 2000, Adv Skin Wound Care, V13, P69; Knox D M, 1994, Adv Wound Care, V7, P48; Knox DM, 1994, ADV WOUND CARE, V7, P54; Lyder C H, 1998, Ostomy Wound Manage, V44, p42S; Lyder CH, 2001, ARCH INTERN MED, V161, P1549, DOI 10.1001/archinte.161.12.1549; Lyder Courtney H, 2002, Ostomy Wound Manage, V48, P52; *NAT PRESS ULC ADV, 1989, S N PUBL, P3; Philippidis TP, 1999, COMPOS STRUCT, V45, P41, DOI 10.1016/S0263-8223(99)00012-4; RACKETT SC, 1993, J AM ACAD DERMATOL, V29, P447, DOI 10.1016/0190-9622(93)70210-K; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Strauss E A, 1996, Adv Wound Care, V9, P37; Thomas DR, 1996, J AM GERIATR SOC, V44, P1435, DOI 10.1111/j.1532-5415.1996.tb04067.x; Thomas DR, 2001, NUTRITION, V17, P121, DOI 10.1016/S0899-9007(00)00514-1; Xakellis G C Jr, 1998, Adv Wound Care, V11, P22; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Xia ZD, 2000, WOUND REPAIR REGEN, V8, P138, DOI 10.1046/j.1524-475x.2000.00138.x	30	260	271	1	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					223	226		10.1001/jama.289.2.223	http://dx.doi.org/10.1001/jama.289.2.223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517234				2022-12-01	WOS:000180226400034
J	Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J				Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J			A cryo-electron microscopic study of ribosome-bound termination factor RF2	NATURE			English	Article							MESSENGER-RNA; TRANSLATION TERMINATION; CHAIN TERMINATION; CODON RECOGNITION; FACTOR-II; RELEASE; RESOLUTION; PROTEINS; LOCATION; BINDING	Protein synthesis takes place on the ribosome, where genetic information carried by messenger RNA is translated into a sequence of amino acids. This process is terminated when a stop codon moves into the ribosomal decoding centre (DC) and is recognized by a class-1 release factor (RF). RFs have a conserved GGQ amino-acid motif, which is crucial for peptide release and is believed to interact directly with the peptidyl-transferase centre (PTC) of the 50S ribosomal subunit(1),(2). Another conserved motif of RFs (SPF in RF2) has been proposed to interact directly with stop codons in the DC of the 30S subunit(3). The distance between the DC and PTC is, 73 Angstrom. However, in the X-ray structure of RF2, SPF and GGQ are only 23 Angstrom apart(4), indicating that they cannot be at DC and PTC simultaneously. Here we show that RF2 is in an open conformation when bound to the ribosome, allowing GGQ to reach the PTC while still allowing SPF-stop-codon interaction. The results indicate new interpretations of accuracy in termination, and have implications for how the presence of a stop codon in the DC is signalled to PTC.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr, Albany, NY 12201 USA; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; Uppsala University; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.		Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Vestergaard, Bente/0000-0001-8011-6414; Zavialov, Andrey/0000-0001-6420-0368				Arkov AL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1354; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Drugeon G, 1997, NUCLEIC ACIDS RES, V25, P2254, DOI 10.1093/nar/25.12.2254; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; TATE WP, 1984, J BIOL CHEM, V259, P7317; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; YUSUPOV MM, 2001, SCIENCE, V4, P897; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	28	199	202	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					87	90		10.1038/nature01224	http://dx.doi.org/10.1038/nature01224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511960				2022-12-01	WOS:000180165500043
J	Bassand, JP; Martin, J; Ryden, L; Sirnoons, M				Bassand, JP; Martin, J; Ryden, L; Sirnoons, M			The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration	LANCET			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; ACADEMIC MEDICINE; EUROASPIRE-II; HEART SURVEY; GUIDELINES; COUNTRIES		Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France; UCL, London, England; Karolinska Hosp, S-10401 Stockholm, Sweden; Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands	Universite de Franche-Comte; CHU Besancon; University of London; University College London; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	Bassand, JP (corresponding author), Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France.	jean-pierre.bassand@ufc-chu.univ-fcomte.fr						Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Bell JI, 1999, NAT MED, V5, P477, DOI 10.1038/8353; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; KAITIN KI, 1993, J CLIN PHARMACOL, V33, P412, DOI 10.1002/j.1552-4604.1993.tb04680.x; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; Lindahl S, 2000, LANCET, V356, pS54, DOI 10.1016/S0140-6736(00)92040-3; Montaner JSG, 2001, LANCET, V358, P1893, DOI 10.1016/S0140-6736(01)06891-X; Sans S, 1997, EUR HEART J, V18, P1231; Simoons ML, 2002, EUR HEART J, V23, P1148, DOI 10.1053/euhj.2002.3269; Williams N, 2002, CURR BIOL, V12, pR267, DOI 10.1016/S0960-9822(02)00795-9	13	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1866	1869		10.1016/S0140-6736(02)11776-4	http://dx.doi.org/10.1016/S0140-6736(02)11776-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480378				2022-12-01	WOS:000179706100028
J	Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM				Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM			Inhibition of excess nodal signaling during mouse gastrulation by the transcriptional corepressor DRAP1	SCIENCE			English	Article							IN-VIVO; EXPRESSION; REPRESSION; PROTEINS; ACTIVIN; PATTERNS; PROMOTER; BINDING; HOMOLOG; LEFTY2	The formation and patterning of mesoderm during mammalian gastrulation require the activity of Nodal, a secreted mesoderm-inducing factor of the transforming growth factor-beta (TGF-beta) family. Here we show that the transcriptional corepressor DRAP1 has a very specific role in regulation of Nodal activity during mouse embryogenesis. We find that loss of Drap1 leads to severe gastrulation defects that are consistent with increased expression of Nodal and can be partially suppressed by Nodal heterozygosity. Biochemical studies indicate that DRAP1 interacts with and inhibits DNA binding by the winged-helix transcription factor FoxH1 (FAST), a critical component of a positive feedback loop for Nodal activity. We propose that DRAP1 limits the spread of a morphogenetic signal by down-modulating the response to the Nodal autoregulatory loop.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, 679 Hoes Lane, Piscataway, NJ 08854 USA.		Shen, Michael M/C-7546-2009; Yan, Yu-Ting/Q-3065-2018	Shen, Michael M/0000-0002-4042-1657; Yan, Yu-Ting/0000-0002-9559-706X; Zhang, Yi/0000-0002-2789-0811; Reinberg, Danny/0000-0003-4288-2016				Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Norris DP, 2002, DEVELOPMENT, V129, P3455; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	26	65	67	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1996	1999		10.1126/science.1073405	http://dx.doi.org/10.1126/science.1073405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471260				2022-12-01	WOS:000179629200047
J	Khan, K; Muennig, P; Behta, M; Zivin, JG				Khan, K; Muennig, P; Behta, M; Zivin, JG			Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; ISONIAZID PREVENTIVE THERAPY; HEPATOTOXICITY; PREVALENCE; POPULATION; TRENDS	Background: In the United States, an increasingly disproportionate burden of tuberculosis among the foreign-born population has led to calls for improvements in the detection and treatment of latent infection in new immigrants. Current treatment guidelines do not take into account global differences in drug-resistance patterns or their implications for the treatment of immigrants. The use of multinational surveillance systems to guide the management of latent infection according to region-specific drug-resistance profiles could improve the efficiency of efforts to reduce the burden of tuberculosis in immigrants to the United States. Methods: We constructed a decision-analysis model by using a hypothetical cohort of all documented immigrants entering the United States from developing nations. Region-specific drug-resistance profiles were derived from data on 30,388 cases of infection. The model examined the effectiveness and cost effectiveness of four strategies: no intervention or tuberculin skin testing followed by treatment with isoniazid, treatment with rifampin, or treatment with rifampin plus pyrazinamide for those with a positive test result. Results: A strategy of detecting and treating latent tuberculosis infection was cost-saving among immigrants from Mexico, Haiti, sub-Saharan Africa, South Asia, and developing nations in East Asia and the Pacific. This strategy was highly cost effective among immigrants from other developing nations. Rifampin plus pyrazinamide was the preferred strategy for treating latent infection in immigrants from Vietnam, Haiti, and the Philippines. Conclusions: For new immigrants to the United States from developing nations, a strategy of detecting and treating latent tuberculosis infection would lead to substantial health and economic benefits. Because of the high prevalence of resistance to isoniazid, treatment with a rifampin-containing regimen should be strongly considered for immigrants from Vietnam, Haiti, and the Philippines.	New York Presbyterian Hosp, Dept Publ Hlth, New York, NY USA; New York Presbyterian Hosp, Dept Med, Div Int Med & Infect Dis, New York, NY USA; New York Presbyterian Hosp, Dept Pharm, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; Columbia Univ, Program Gen Publ Hlth, New York, NY USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; Columbia Univ, Int Ctr Hlth Outcomes & Innovat Res, New York, NY USA; CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10021 USA	NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Cornell University; Columbia University; Columbia University; Columbia University; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Khan, K (corresponding author), Univ Toronto, St Michaels Hosp, Inner City Hlth Res Unit, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Zivin, Joshua Graff/ABF-1697-2020	Graff Zivin, Joshua/0000-0002-0820-4900; Muennig, Peter/0000-0002-4234-0498				*AG HEALTHC RES QU, 2002, HEALTC COST UT PROJ; *AM PUBL TRANSP AS, 2002, PASS FAR SUMM; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; *BUR LAB STAT DEP, 2002, CONS PRIC IND; *BUR LAB STAT DEP, 2002, NAT EMPL WAG DAT OCC; *CDCP, 1996, NAT TUB SURV SYST; *CDCP, 2002, TUB CAS FOR BORN PER; *CDCP, 2002, TUB CAS CAS RAT 1000; *CENS BUR, JOURN WORK PLAC WORK; *CENS BUR, 2002, 2000 DEC CENS; Chaisson RE, 2002, JAMA-J AM MED ASSOC, V288, P165, DOI 10.1001/jama.288.2.165; Coker R, 2001, Lancet Infect Dis, V1, P270, DOI 10.1016/S1473-3099(01)00122-0; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COOK PP, 2001, INF DIS SOC AM 39 AN, P1147; *CTR MED MED SERV, 2002, MED PAYM SYST CLIN L; *CTR MED MED SERV, 2000, NAT PHYS FEE SCHED P; *CTR MED MED SERV, 2002, MED PROV AN REV MEDP; *DEP EN, 2002, MOT GAS RET PRIC; *DEP EN, 2002, MOT VEH MIL FUEL CON; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; *EUROTB, 2002, SURV DRUG RES EUR; FAIRSHTER RD, 1975, AM REV RESPIR DIS, V112, P37; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; GEITER L, 2000, ENDING NEGLECT ELIMI; GEITER LJ, 1997, THESIS JOHNS HOPKINS, P180; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; Gold MR., 1996, COST EFFECTIVENESS H; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; Gushulak BD, 2000, CLIN INFECT DIS, V31, P776, DOI 10.1086/313998; *IMM NAT SERV, 2002, STATISTICS; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; KING MD, 2001, INF DIS SOC AM 39 AN, P1146; Kochanek K.D., 2001, NATL VITAL STAT REPO, V49; LOLLOCK L, 1908, P20534 CENS BUR; MCGLYNN KA, 1986, AM REV RESPIR DIS, V134, P666; *MED EC, 2000, DRUG TOP RED BOOK PH; Moore M, 1998, JAMA-J AM MED ASSOC, V279, P656; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; *NAT CTR HLTH STAT, 1997, MULT CAUSE DEATH PUB; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Weis SE, 2001, AM J RESP CRIT CARE, V164, P953, DOI 10.1164/ajrccm.164.6.2102132; *WORLD BANK GROUP, 2002, COUNTR REG; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304; 2000, MMWR MORB MORTAL WKL, V49, P1	55	126	129	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1850	1859		10.1056/NEJMsa021099	http://dx.doi.org/10.1056/NEJMsa021099			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466510	Green Published			2022-12-01	WOS:000179596900007
J	Peyton, R				Peyton, R			Punishment beatings and the rule of law	LANCET			English	Article									S Tyrone Hosp, Dungannon BT71 6AU, North Ireland; Royal Coll Surgeons England, London, England	Royal College of Surgeons of England	Peyton, R (corresponding author), S Tyrone Hosp, Carland Rd, Dungannon BT71 6AU, North Ireland.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S53	S54		10.1016/S0140-6736(02)11822-8	http://dx.doi.org/10.1016/S0140-6736(02)11822-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504505	Bronze			2022-12-01	WOS:000180064500026
J	Park, SH; Zarrinpar, A; Lim, WA				Park, SH; Zarrinpar, A; Lim, WA			Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms	SCIENCE			English	Article							PDZ-DOMAIN PROTEIN; MUTATIONAL ANALYSIS; YEAST; STE5; ACTIVATION; ORGANIZATION; COMPLEXES; CASCADE; BINDING; SYSTEM	How scaffold proteins control information flow in signaling pathways is poorly understood: Do they simply tether components, or do they precisely orient and activate them? We found that the yeast mitogen-activated protein (MAP) kinase scaffold Ste5 is tolerant to major stereochemical perturbations; heterologous protein interactions could functionally replace native kinase recruitment interactions, indicating that simple tethering is largely sufficient for scaffold-mediated signaling. Moreover, by engineering a scaffold that tethers a unique kinase set, we could create a synthetic MAP kinase pathway with non-natural input-output properties. These findings demonstrate that scaffolds are highly flexible organizing factors that can facilitate pathway evolution and engineering.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CHOI KY, 1994, CELL, V78, P499; Elion EA, 2001, J CELL SCI, V114, P3967; FERRELL JE, 2002, SCI STKE; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Inouye C, 1997, GENETICS, V147, P479; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Park S.C., UNPUB; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; PRINTEN JA, 1994, GENETICS, V138, P609; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	27	267	289	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1061	1064		10.1126/science.1076979	http://dx.doi.org/10.1126/science.1076979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12511654				2022-12-01	WOS:000180960000046
J	Piperno, DR; Stothert, KE				Piperno, DR; Stothert, KE			Phytolith evidence for early Holocene Cucurbita domestication in Southwest Ecuador	SCIENCE			English	Article								Cucurbita (squash and gourd) phytoliths recovered from two early Holocene archaeological sites in southwestern Ecuador and directly dated to 10,130 to 9320 carbon-14 years before the present (about 12,000 to 10,000 calendar years ago) are identified as derived from domesticated plants because they are considerably larger than those from modern wild taxa. The beginnings of plant husbandry appear to have been preceded by the exploitation of a wild species of Cucurbita during the terminal Pleistocene. These data provide evidence for an independent emergence of plant food production in lowland South America that was contemporaneous with or slightly before that in highland Mesoamerica.	Univ Texas, Ctr Archaeol Res, San Antonio, TX 78249 USA; Smithsonian Trop Res Inst, Balboa, Panama	University of Texas System; Smithsonian Institution; Smithsonian Tropical Research Institute	Piperno, DR (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.							Andres T. C, 2002, CUCURBITACEAE 2002, P95; BOZARTH SR, 1987, AM ANTIQUITY, V52, P607, DOI 10.2307/281602; Flannery K., 1986, GUILA NAQUITZ ARCHAI; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; LATHRAP DW, 1975, ANCIENT ECUADOR CULT; NEE M, 1990, ECON BOT, V44, P56, DOI 10.1007/BF02860475; PEARSALL DM, 1996, DUMB OAKS C EC FORM, P213; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno D. R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2000, J ARCHAEOL SCI, V27, P193, DOI 10.1006/jasc.1999.0443; Piperno DR, 2002, P NATL ACAD SCI USA, V99, P10923, DOI 10.1073/pnas.152275499; Sanjur OI, 2002, P NATL ACAD SCI USA, V99, P535, DOI 10.1073/pnas.012577299; Sauer CO, 1952, AGR ORIGINS DISPERSA; Smith BD, 1997, SCIENCE, V276, P932, DOI 10.1126/science.276.5314.932; STOTHERT KE, 1985, AM ANTIQUITY, V50, P613, DOI 10.2307/280325; STOTHERT KE, IN PRESS QUAT INT	16	155	172	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1054	1057		10.1126/science.1080365	http://dx.doi.org/10.1126/science.1080365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	645DB	12586940				2022-12-01	WOS:000180960000044
J	Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H				Deres, K; Schroder, CH; Paessens, A; Goldmann, S; Hacker, HJ; Weber, O; Kramer, T; Niewohner, U; Pleiss, U; Stoltefuss, J; Graef, E; Koletzki, D; Masantschek, RNA; Reimann, A; Jaeger, R; Gross, R; Beckermann, B; Schlemmer, KH; Haebich, D; Rubsamen-Waigmann, H			Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids	SCIENCE			English	Article							DNA-SYNTHESIS	Chronic hepatitis B virus (HBV) infection is a major cause of liver disease. Only interferon-alpha and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy. However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors. Potent new antiviral compounds suitable for monotherapy or combination therapy are highly desired. We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity. These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.	Bayer Res Ctr, Dept Virol, Wuppertal, Germany; Bayer Res Ctr, Chem, Wuppertal, Germany; Bayer Res Ctr, Isotope Chem, Wuppertal, Germany; Bayer Res Ctr, Preclin Pharmakokinet, Wuppertal, Germany; Bayer Res Ctr, Toxicol, Wuppertal, Germany; Bayer Res Ctr, Safety Pharmacol, Wuppertal, Germany; Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; Bayer Corp, Div Pharmaceut, West Haven, CT 06516 USA	Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Bayer AG; Helmholtz Association; German Cancer Research Center (DKFZ); Bayer AG	Deres, K (corresponding author), Bayer Res Ctr, Dept Virol, Wuppertal, Germany.							Delaney WE, 2001, ANTIVIR CHEM CHEMOTH, V12, P1; Deres K, 1999, INFECTION, V27, pS45, DOI 10.1007/BF02561672; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Fischer KR, 2001, DRUG RESIST UPDATE, V4, P118, DOI 10.1054/drup.2001.0190; King RW, 1998, ANTIMICROB AGENTS CH, V42, P3179, DOI 10.1128/AAC.42.12.3179; LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993; Nassal M, 1996, CURR TOP MICROBIOL, V214, P297; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Weber O, 2002, ANTIVIR RES, V54, P69, DOI 10.1016/S0166-3542(01)00216-9	10	417	486	7	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					893	896		10.1126/science.1077215	http://dx.doi.org/10.1126/science.1077215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574631				2022-12-01	WOS:000180830900053
J	Pi-Sunyer, X				Pi-Sunyer, X			A clinical view of the obesity problem	SCIENCE			English	Editorial Material							WEIGHT-LOSS; LONG-TERM; MAINTENANCE		Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Pi-Sunyer, X (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp, Obes Res Ctr, New York, NY 10025 USA.							KEYS A, 1950, BIOL HUMAN STARVATIO, P827; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Klem ML, 1997, AM J CLIN NUTR, V66, P239, DOI 10.1093/ajcn/66.2.239; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; PiSunyer FX, 1996, CLIN THER, V18, P1006, DOI 10.1016/S0149-2918(96)80057-9; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WADDEN TA, 1994, J CONSULT CLIN PSYCH, V62, P165, DOI 10.1037/0022-006X.62.1.165; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Wing R. R., 1998, HDB OBESITY, P855; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	13	85	91	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					859	860		10.1126/science.1082319	http://dx.doi.org/10.1126/science.1082319			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574620				2022-12-01	WOS:000180830900041
J	Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ				Xiao, B; Jing, C; Wilson, JR; Walker, PA; Vasisht, N; Kelly, G; Howell, S; Taylor, IA; Blackburn, GM; Gamblin, SJ			Structure and catalytic mechanism of the human histone methyltransferase SET7/9	NATURE			English	Article							CHROMATIN-STRUCTURE; DOMAIN; METHYLATION; ACETYLATION; SITE	Acetylation(1,2), phosphorylation(3) and methylation(4) of the amino-terminal tails of histones are thought to be involved in the regulation of chromatin structure and function(5-7). With just one exception(8,9), the enzymes identified in the methylation of specific lysine residues on histones (histone methyltransferases) belong to the SET family(10). The high-resolution crystal structure of a ternary complex of human SET7/9 with a histone peptide and cofactor reveals that the peptide substrate and cofactor bind on opposite surfaces of the enzyme. The target lysine accesses the active site of the enzyme and the S-adenosyl-L-methionine (AdoMet) cofactor by inserting its side chain into a narrow channel that runs through the enzyme, connecting the two surfaces. Here we show from the structure and from solution studies that SET7/9, unlike most other SET proteins, is exclusively a mono-methylase. The structure indicates the molecular basis of the specificity of the enzyme for the histone target, and allows us to propose a model for the methylation reaction that accounts for the role of many of the residues that are invariant across the SET family.	Natl Inst Med Res, Struct Biol Grp, London NW7 1AA, England; Univ Sheffield, Dept Chem, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England	MRC National Institute for Medical Research; University of Sheffield	Gamblin, SJ (corresponding author), Natl Inst Med Res, Struct Biol Grp, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432; Gamblin, Steve/0000-0001-5331-639X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	20	299	310	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					652	656		10.1038/nature01378	http://dx.doi.org/10.1038/nature01378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12540855	Green Accepted			2022-12-01	WOS:000180803200047
J	Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW				Forster, AJ; Murff, HJ; Peterson, JF; Gandhi, TK; Bates, DW			The incidence and severity of adverse events affecting patients after discharge from the hospital	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG EVENTS; CARE; PREVENTABILITY; INFECTIONS; QUALITY	Background: Studies of hospitalized patients identify safety as a significant problem, but few data are available regarding injuries occurring after discharge. Patients may be vulnerable during this transition period. Objective: To describe the incidence, severity, preventability, and "ameliorability" of adverse events affecting patients after discharge from the hospital and to develop strategies for improving patient safety during this interval. Design: Prospective cohort study. Setting: A tertiary care academic hospital. Patients: 400 consecutive patients discharged home from the general medical service. Measurements: The three main outcomes were adverse events, defined as injuries occurring as a result of medical management; preventable adverse events, defined as adverse events judged to have been caused by an error; and ameliorable adverse events, defined as adverse events whose severity could have been decreased. Posthospital course was determined by performing a medical record review and a structured telephone interview approximately 3 weeks after each patient's discharge. Outcomes were determined by independent physician reviews. Results: Seventy-six patients had adverse events after discharge (19% [95% Cl, 15% to 23%]). Of these, 23 had preventable adverse events (6% [Cl, 4% to 9%]) and 24 held ameliorable adverse events (6% [Cl, 4% to 9%]). Three percent of injuries were serious laboratory abnormalities, 65% were symptoms, 30% were symptoms associated with a nonpermanent disability, and 3% were permanent disabilities. Adverse drug events were the most common type of adverse event (66% [Cl, 55% to 76%]), followed by procedure-related injuries (17% [Cl, 86% to 26%]). Of the 25 adverse events resulting in at least a nonpermanent disability, 12 were preventable (48% [Cl, 28% to 68%]) and 6 were ameliorable (24% [Cl, 7% to 41%]). Conclusion: Adverse events occurred frequently in the peridischarge period, and many could potentially have been prevented or ameliorated with simple strategies.	Univ Ottawa, Ottawa, ON K1N 6N5, Canada; Harvard Univ, Sch Med, Boston, MA USA	University of Ottawa; Harvard University; Harvard Medical School	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med, 75 Francis St,PBB-A3, Boston, MA 02115 USA.	dbates@partners.org	Bates, David/AAE-7283-2019					BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CAPLAN RA, 1991, JAMA-J AM MED ASSOC, V265, P1957, DOI 10.1001/jama.265.15.1957; Cook RI, 2000, BRIT MED J, V320, P791, DOI 10.1136/bmj.320.7237.791; Delgado-Rodriguez M, 2001, INFECT CONT HOSP EP, V22, P24, DOI 10.1086/501820; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; *I MED, 2000, ERR HUM BUILD SAF HL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kelley MA, 1999, ANN INTERN MED, V130, P373, DOI 10.7326/0003-4819-130-4-199902161-00009; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Mitchell DH, 1999, AUST NZ J SURG, V69, P117, DOI 10.1046/j.1440-1622.1999.01500.x; PARKES J, 2000, COCHRANE DATABASE SY; SANAZARO PJ, 1991, JAMA-J AM MED ASSOC, V265, P1977, DOI 10.1001/jama.265.15.1977; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003	18	1199	1222	0	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					161	167		10.7326/0003-4819-138-3-200302040-00007	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558354				2022-12-01	WOS:000181018600001
J	Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW				Hammarstrom, P; Wiseman, RL; Powers, ET; Kelly, JW			Prevention of transthyretin amyloid disease by changing protein misfolding energetics	SCIENCE			English	Article							ALZHEIMERS-DISEASE; FIBRIL FORMATION; INHIBITORS	Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of transthyretin amyloidosis inhibitors that functioned by increasing the kinetic barrier associated with misfolding, preventing amyloidogenesis by stabilizing the native state. The trans-suppressor mutation, threonine 119 --> methionine 119, which is known to ameliorate familial amyloid disease, also functioned through kinetic stabilization, implying that this small-molecule strategy should be effective in treating amyloid diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Powers, Evan/0000-0001-8185-8487	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046335, R37DK046335, R01DK046335] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 46335] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Jacobson D R, 1991, Adv Hum Genet, V20, P69; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; PURKEY HE, UNPUB; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	28	416	430	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					713	716		10.1126/science.1079589	http://dx.doi.org/10.1126/science.1079589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560553				2022-12-01	WOS:000180687700049
J	Gupta, AK; Anderson, DM; Overpeck, JT				Gupta, AK; Anderson, DM; Overpeck, JT			Abrupt changes in the Asian southwest monsoon during the Holocene and their links to the North Atlantic Ocean	NATURE			English	Article							LATE QUATERNARY; ARABIAN-SEA; SUMMER MONSOON; CLIMATE; VARIABILITY; RECORD; OMAN; FORAMINIFERA; GREENLAND; SURFACE	During the last ice age, the Indian Ocean southwest monsoon exhibited abrupt changes that were closely correlated with millennial-scale climate events in the North Atlantic region(1-3), suggesting a mechanistic link. In the Holocene epoch, which had a more stable climate, the amplitude of abrupt changes in North Atlantic climate was much smaller, and it has been unclear whether these changes are related to monsoon variability. Here we present a continuous record of centennial-scale monsoon variability throughout the Holocene from rapidly accumulating and minimally bioturbated sediments in the anoxic Arabian Sea. Our monsoon proxy record reveals several intervals of weak summer monsoon that coincide with cold periods documented in the North Atlantic region(4)-including the most recent climate changes from the Medieval Warm Period to the Little Ice Age and then to the present. We therefore suggest that the link between North Atlantic climate and the Asian monsoon is a persistent aspect of global climate.	Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India; NOAA, Paleoclimatol Program, Boulder, CO 80305 USA; Univ Arizona, Ctr Study Planet Earth, Tucson, AZ 85721 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; National Oceanic Atmospheric Admin (NOAA) - USA; University of Arizona; University of Arizona	Gupta, AK (corresponding author), Indian Inst Technol, Dept Geol & Geophys, Kharagpur 721302, W Bengal, India.		anderson, david/E-6416-2011	Gupta, Anil/0000-0003-0536-3911				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ANDERSON DM, 1993, PALEOCEANOGRAPHY, V8, P193, DOI 10.1029/93PA00256; Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; BARNETT TP, 1989, J ATMOS SCI, V46, P661, DOI 10.1175/1520-0469(1989)046<0661:TEOESC>2.0.CO;2; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CURRY WB, 1992, UPWELLING SYSTEMS EV, P93; Gupta AK, 2001, GEOPHYS RES LETT, V28, P4131, DOI 10.1029/2001GL013315; Houghton J. T., 2001, CLIMATE CHANGE 2001; Janowiak JE, 1999, J CLIMATE, V12, P3335, DOI 10.1175/1520-0442(1999)012<3335:COAGSR>2.0.CO;2; Jennings AE, 1996, HOLOCENE, V6, P179, DOI 10.1177/095968369600600205; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; MEEHL GA, 1994, J CLIMATE, V7, P1033, DOI 10.1175/1520-0442(1994)007<1033:IOTLSI>2.0.CO;2; Naidu PD, 1996, PALEOCEANOGRAPHY, V11, P129, DOI 10.1029/95PA03198; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; Prell W.L., 1984, CLIM PROCESSES CLIM, V29, P48; PRELL WL, 1986, NATURE, V323, P526, DOI 10.1038/323526a0; REYNOLDS RW, 1995, J CLIMATE, V8, P1571, DOI 10.1175/1520-0442(1995)008<1571:AHRGSS>2.0.CO;2; RIND D, 1993, QUATERNARY SCI REV, V12, P357, DOI 10.1016/S0277-3791(05)80002-2; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; SIROCKO F, 1999, MECH GLOBAL CLIMATE, P113; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TRENBERTH K, 1989, NCARTN388PLUSSTR, P1; Wang LJ, 1999, GEOPHYS RES LETT, V26, P2889, DOI 10.1029/1999GL900443	30	818	898	3	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					354	357		10.1038/nature01340	http://dx.doi.org/10.1038/nature01340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540924				2022-12-01	WOS:000180533000037
J	Younis, N; Broadbent, DM; Vora, JP; Harding, SP				Younis, N; Broadbent, DM; Vora, JP; Harding, SP			Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study	LANCET			English	Article							PROGRESSION; POPULATION; PREVALENCE; DISEASE; RISK; AGE; OPHTHALMOSCOPY; DIAGNOSIS; BLINDNESS; MELLITUS	Background Incidence data on which to base targets and protocols for screening for sight-threatening diabetic retinopathy are few. We aimed to investigate yearly and cumulative incidence of any retinopathy, maculopathy, and sight-threatening diabetic retinopathy in patients with type 2 diabetes in an established systematic programme and to calculate optimum screening intervals according to retinopathy grade at baseline. Methods We investigated all patients with type 2 diabetes registered with enrolled general practices (except those who were attending an ophthalmologist) who had retinopathy data available at baseline and at least one further screening event. To screen patients, we used non-stereoscopic three-field mydriatic photography and modified Wisconsin grading. Sight-threatening diabetic retinopathy was defined as moderate preproliferative retinopathy or worse, or clinically significant maculopathy in either or both eyes. Findings Results were obtained from 20 570 screening events. Yearly incidence of sight-threatening diabetic retinopathy in patients without retinopathy at baseline was 0.3% (95% CI 0.1-0.5) in the first year, rising to 1.8% (1.2-2.5) in the fifth year; cumulative incidence at 5 years was 3.9% (2.8-5.0). Rates of progression to sight-threatening diabetic retinopathy in year 1 by baseline status were: background 5.0% (3.5-6.5), and mild preproliferative 15% (10.2-19.8). For a 95% probability of remaining free of sight-threatening diabetic retinopathy, mean screening intervals by baseline status were: no retinopathy 5.4 years (95% CI 4.7-6.3), background 1.0 years (0.7-1.3), and mild preproliferative 0.3 years (0.2-0.5). Interpretation A 3-year screening interval could be safely adopted for patients with no retinopathy, but yearly or more frequent screening is needed for patients with higher grades of retinopathy.	Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England; Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Younis, N (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Endocrinol & Diabet, Walton Hosp Site,Rice Lane, Liverpool L9 1AE, Merseyside, England.	naveedy@tinyonline.co.uk		Harding, Simon/0000-0003-4676-1158				Aiello LP, 1998, DIABETES CARE, V21, P157; *AM AC OPHTH, 1992, COMPR AD EYE EV PREF; [Anonymous], 1976, Am J Ophthalmol, V81, P383; [Anonymous], 1991, Ophthalmology, V98, P786; [Anonymous], 1991, Diabet Med, V8, P263; Bachmann MO, 1998, J EPIDEMIOL COMMUN H, V52, P45, DOI 10.1136/jech.52.1.45; Broadbent DM, 1999, EYE, V13, P160, DOI 10.1038/eye.1999.43; BROADBENT DM, 2000, DIABETIC MED, V17, pP69; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Garvican L, 2000, DIABETIC MED, V17, P627, DOI 10.1046/j.1464-5491.2000.00353.x; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P528; Henricsson M, 1996, ACTA OPHTHALMOL SCAN, V74, P523; Henricsson M, 1999, ACTA OPHTHALMOL SCAN, V77, P218, DOI 10.1034/j.1600-0420.1999.770221.x; James M, 2000, BRIT MED J, V320, P1627, DOI 10.1136/bmj.320.7250.1627; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; KLEIN R, 1985, OPHTHALMOLOGY, V92, P485; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; KOHNER EM, 1983, DIABETES, V32, P1010; Kohner EM, 2001, DIABETIC MED, V18, P178; KRISTINSSON JK, 1994, ACTA OPHTHALMOL, V72, P341; LEE ET, 1992, DIABETES CARE, V15, P1620, DOI 10.2337/diacare.15.11.1620; *NAT DEP LAB HHS E, 1988, NAT EYE HLTH ED PROG, P100; NIELSEN NV, 1984, ACTA OPHTHALMOL, V62, P266; *ROYAL COLLOPHTH, 1997, GUID DIAB RET; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Taylor R, 1998, DIABETIC MED, V15, P344; TEUSCHER A, 1988, DIABETES CARE, V11, P246, DOI 10.2337/diacare.11.3.246; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889	34	208	217	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					195	200		10.1016/S0140-6736(03)12267-2	http://dx.doi.org/10.1016/S0140-6736(03)12267-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547541				2022-12-01	WOS:000180535400007
J	Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M				Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M			Responses of ferns to red light are mediated by an unconventional photoreceptor	NATURE			English	Article							ADIANTUM-CAPILLUS-VENERIS; ORIENTED CHLOROPLAST MOVEMENT; BLUE-LIGHT; ARABIDOPSIS NPH1; PHYTOCHROME; PHOTOTROPISM; PROTONEMATA; RELOCATION; PLANTS; NPL1	Efficient photosynthesis is essential for plant survival. To optimize photosynthesis, plants have developed several photo-responses. Stems bend towards a light source (phototropism), chloroplasts move to a place of appropriate light intensity (chloroplast photorelocation) and stomata open to absorb carbon dioxide. These responses are mediated by the blue-light receptors phototropin 1 (phot1) and phototropin 2 (phot2) in Arabidopsis (refs 1-5). In some ferns, phototropism and chloroplast photorelocation are controlled by red light as well as blue light(6). However, until now, the photoreceptor mediating these red-light responses has not been identified. The fern Adiantum capillus-veneris has an unconventional photoreceptor, phytochrome 3 (phy3), which is a chimaera of the red/far-red light receptor phytochrome and phototropin(7). We identify here a function of phy3 for red-light-induced phototropism and for red-light-induced chloroplast photorelocation, by using mutational analysis and complementation. Because phy3 greatly enhances the sensitivity to white light in orienting leaves and chloroplasts, and PHY3 homologues exist among various fern species, this chimaeric photoreceptor may have had a central role in the divergence and proliferation of fern species under low-light canopy conditions.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Aichi 4448585, Japan	Tokyo Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Wada, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan.		Sato, Yoshikatsu/I-6129-2014					Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Bunning E., 1958, BER DEUT BOT GES, V71, P304; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; DAVIS BD, 1975, PLANT CELL PHYSIOL, V16, P537; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1982, PHOTOCHEM PHOTOBIOL, V35, P533, DOI 10.1111/j.1751-1097.1982.tb02605.x; Kadota A, 1999, PLANT CELL PHYSIOL, V40, P238, DOI 10.1093/oxfordjournals.pcp.a029533; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 1996, PLANTA, V198, P488, DOI 10.1007/BF00620067; Kanegae T, 1998, MOL GEN GENET, V259, P345, DOI 10.1007/s004380050821; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; MILLER JH, 1974, AM J BOT, V61, P296, DOI 10.2307/2441609; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; TAYLOR TN, 1993, BIOL EVOLUTION FOSSI, P346; TIDWELL WD, 1994, J PLANT RES, V107, P417, DOI 10.1007/BF02344066; WADA M, 1994, J PLANT RES, V107, P181, DOI 10.1007/BF02346015; WADA M, 1989, ANNU REV PLANT PHYS, V40, P169; Willis K. J, 2002, EVOLUTION PLANTS, P130; YATSUHASHI H, 1990, PLANT SCI, V68, P87, DOI 10.1016/0168-9452(90)90156-I; YATSUHASHI H, 1993, J PHOTOCH PHOTOBIO B, V19, P25, DOI 10.1016/1011-1344(93)80089-R; YATSUHASHI H, 1985, PLANTA, V165, P43, DOI 10.1007/BF00392210	29	166	182	5	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					287	290		10.1038/nature01310	http://dx.doi.org/10.1038/nature01310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529647				2022-12-01	WOS:000180397600052
J	Watzman, H				Watzman, H			German researchers set to receive Israeli stem-cell shipment	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					199	199		10.1038/421199b	http://dx.doi.org/10.1038/421199b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529601	Bronze			2022-12-01	WOS:000180397600008
J	Smith, LK; Peake, MD; Botha, JL				Smith, LK; Peake, MD; Botha, JL			Recent changes in lung cancer incidence for south Asians: a population based register study	BRITISH MEDICAL JOURNAL			English	Article									Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England; Weston Pk Hosp, Trent Canc Registry, Sheffield S10 2SJ, S Yorkshire, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Weston Park Hospital	Smith, LK (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.		Smith, Lucy K/I-6300-2018; Smith, Lucy K/S-6593-2019	Smith, Lucy K/0000-0001-9470-0793; Smith, Lucy K/0000-0001-9470-0793				Bhopal RS, 1996, BRIT J CANCER, V74, pS22; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Johnson M, 1999, BLACK MINORITY ETHNI; Winter H, 1999, BRIT J CANCER, V79, P645, DOI 10.1038/sj.bjc.6690102	4	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					81	82		10.1136/bmj.326.7380.81	http://dx.doi.org/10.1136/bmj.326.7380.81			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521972	Green Published, Bronze			2022-12-01	WOS:000180426900016
J	Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML				Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML			Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk	SCIENCE			English	Article							B-CELL DEVELOPMENT; ENDOTHELIAL-CELLS; MICE LACKING; ANGIOGENESIS; EXPRESSION; VIABILITY; RECEPTORS; COLLAGEN	Lymphatic vessels develop from specialized endothelial cells in preexisting blood vessels, but the molecular signals that regulate this separation are unknown. Here we identify a failure to separate emerging lymphatic vessels from blood vessels in mice lacking the hematopoietic signaling protein SLP-76 or Syk. Blood-lymphatic connections lead to embryonic hemorrhage and arteriovenous shunting. Expression of slp-76 could not be detected in endothelial cells, and blood-filled lymphatics also arose in wild-type mice reconstituted with SLP-76 deficient bone marrow. These studies reveal a hematopoietic signaling pathway required for separation of the two major vascular networks in mammals.	Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; John Radcliffe Hosp, MRC, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Francisco; University of Oxford; MRC National Institute for Medical Research; University of Pennsylvania	Koretzky, GA (corresponding author), Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Koretzky, Gary/AAU-5381-2021; Mocsai, Attila/B-2792-2008	Ferrari, Victor/0000-0001-8696-3243; Tybulewicz, Victor/0000-0003-2439-0798; Mocsai, Attila/0000-0002-0512-1157; , david/0000-0002-4133-9364	NIBIB NIH HHS [R21 EB002473, R21 EB002473-02] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002473] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ABTAHIAN F, UNPUB; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Braunwald E., 1997, HEART DIS; Carmeliet P, 2001, THROMB HAEMOSTASIS, V86, P289; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; SABIN F, 2001, AM J ANAT, V4, P367; Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165, DOI 10.1177/002215549804600205; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	25	312	330	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					247	251		10.1126/science.1079477	http://dx.doi.org/10.1126/science.1079477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522250	Green Accepted			2022-12-01	WOS:000180284000038
J	Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A				Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A			Genetic variation in the renin-angiotensin system and abdominal adiposity in men: The olivetti prospective heart study	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME GENE; HUMAN OBESITY GENES; INSERTION DELETION POLYMORPHISM; HUMAN ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-RENAL RISK; BLOOD-PRESSURE; ACE GENE; INSULIN-RESISTANCE; TISSUE; ASSOCIATION	Background: The renin-angiotensin system is involved in adipocyte growth and differentiation and possibly in adipose tissue metabolism. Objective: To investigate the association of polymorphism in the angiotensin-converting enzyme (ACE) I/D gene, angiotensinogen M235T gene, and angiotensin II type 1 receptor A1166C gene with body mass index, body fat pattern, and obesity-associated hypertension. Design: Cross-sectional longitudinal study. Setting: The Olivetti factories in Marcianise and Pozzuoli, suburbs of Naples, Italy. Participants: 959 adult men, 25 to 75 years of age. Measurements: Renin-angiotensin system polymorphism, anthropometric indexes, blood pressure, and serum glucose and insulin levels. Results: No association was detected between angiotensinogen or angiotensin II type 1 receptor gene polymorphism and anthropometric indexes or blood pressure. For ACE I/D polymorphism, significant age-genotype interaction was detected on cross-sectional observation; the relation of body mass index, waist circumference, and diastolic blood pressure to age was significantly greater in persons with the DD genotype than in those with the ID or II genotype. Overweight and abdominal adiposity were more common in men with the DD genotype, particularly among older participants (51.1% vs. 36.5% and 33.1% vs. 22.0%, respectively). Odds ratios were 1.82 (95% Cl, 1.16 to 2.87) for overweight and 1.76 (Cl, 1.06 to 2.90) for abdominal adiposity. Among 314 untreated men first examined 20 years earlier, those with the DD genotype had greater age-adjusted weight gain (1.45 kg [Cl, 0.12 to 2.78 kg]) and change in diastolic blood pressure (2.83 mm Hg [Cl, 0.39 to 5.28 mm Hg]). The relative risk for overweight was 2.34 (Cl, 1.32 to 4.15) among participants with the DD genotype versus those with the ID or II genotype. Conclusions: The ACE I/D polymorphism was a significant predictor of overweight and abdominal adiposity in men. DD homozygosity was associated with larger increases in body weight and blood pressure in aging persons, as well as with higher incidence of overweight.	Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, I-80131 Naples, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; CNR, Inst Food Sci, Avellino, Italy; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	University of Naples Federico II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); St Georges University London	Strazzullo, P (corresponding author), Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, Via S Pansini 5, I-80131 Naples, Italy.	strazzul@unina.it	Siani, Alfonso/B-7925-2015; Iacoviello, Licia/K-4676-2016; Cappuccio, Francesco/D-3028-2009; Russo, Paola/AAW-8308-2020; Cappuccio, Francesco Paolo/ABF-1094-2020; Iacoviello, Licia/AGX-7071-2022; Barbato, Antonio/AAG-3313-2020	Iacoviello, Licia/0000-0003-0514-5885; Cappuccio, Francesco Paolo/0000-0002-7842-5493; Iacoviello, Licia/0000-0003-0514-5885; Barbato, Antonio/0000-0002-4660-821X; IACONE, ROBERTO/0000-0003-3360-3855				Ailhaud G, 2000, INT J OBESITY, V24, pS33, DOI 10.1038/sj.ijo.0801501; Arner P, 2000, INT J OBESITY, V24, pS57, DOI 10.1038/sj.ijo.0801507; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; BOUCHARD C, 1993, ANNU REV NUTR, V13, P337, DOI 10.1146/annurev.nu.13.070193.002005; CAMPBELL DJ, 1995, J CARDIOVASC PHARM, V26, P426, DOI 10.1097/00005344-199509000-00013; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cooper R, 1998, J HYPERTENS, V16, P571, DOI 10.1097/00004872-199816050-00003; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; CRANDALL DL, 1994, DRUG DEVELOP RES, V32, P117, DOI 10.1002/ddr.430320208; DARIMONT C, 1994, ENDOCRINOLOGY, V135, P2030, DOI 10.1210/en.135.5.2030; EGAN BM, 1994, AM J HYPERTENS, V7, P886, DOI 10.1093/ajh/7.10.886; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Giacchetti G, 1999, INT J OBES RELAT S5, V23, pS71; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; Jones BH, 1997, AM J PHYSIOL-REG I, V273, pR236, DOI 10.1152/ajpregu.1997.273.1.R236; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; LICATA G, 1994, AM J HYPERTENS, V7, P314, DOI 10.1093/ajh/7.4.314; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RUSS AP, 1993, HUM MOL GENET, V2, P609, DOI 10.1093/hmg/2.5.609; Ryan AS, 2001, DIABETES CARE, V24, P1646, DOI 10.2337/diacare.24.9.1646; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; Strazzullo P, 2001, J HYPERTENS, V19, P399, DOI 10.1097/00004872-200103000-00007; Thomas GN, 2001, DIABETES CARE, V24, P356, DOI 10.2337/diacare.24.2.356; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; TIRET L, 1992, AM J HUM GENET, V51, P197; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Viitanen L, 2001, ATHEROSCLEROSIS, V157, P57, DOI 10.1016/S0021-9150(00)00705-X	47	140	143	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					17	23		10.7326/0003-4819-138-1-200301070-00007	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513040				2022-12-01	WOS:000180996200003
J	Nishida, M; MacKinnon, R				Nishida, M; MacKinnon, R			Structural basis of inward rectification: Cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 angstrom resolution	CELL			English	Article							K+-CHANNEL; POTASSIUM CHANNEL; BETA-GAMMA; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; MECHANISM; SUBUNIT; ACTIVATION; CELLS; BLOCK	Inward rectifier K+ channels govern the resting membrane voltage in many cells. Regulation of these ion channels via G protein-coupled receptor signaling underlies the control of heart rate and the actions of neurotransmitters in the central nervous system. We have determined the protein structure formed by the intracellular N- and C termini of the G protein-gated inward rectifier K+ channel GIRK1 at 1.8 Angstrom resolution. A cytoplasmic pore, conserved among inward rectifier K+ channels, extends the ion pathway to 60 Angstrom, nearly twice the length of a canonical transmembrane K+ channel. The cytoplasmic pore is lined by acidic and hydrophobic amino acids, creating a favorable environment for polyamines, which block the pore. These results explain in structural and chemical terms the basis of inward rectification, and they also have implications for G protein regulation of GIRK channels.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGEN ASV, 1953, J PHYSIOL-LONDON, V120, P449, DOI 10.1113/jphysiol.1953.sp004910; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, ION CHANNELS EXCITAB, V3; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	60	301	319	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					957	965		10.1016/S0092-8674(02)01227-8	http://dx.doi.org/10.1016/S0092-8674(02)01227-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507423	Bronze			2022-12-01	WOS:000180086000006
J	Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J				Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J			Informing participants of allocation to placebo at trial closure: postal survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIAL; CONSUMERS; CONSENT	Objectives To assess whether and how investigators of placebo controlled randomised trials inform participants of their treatment allocation at trial closure and to assess barriers to feedback. Design Postal survey With a semistructured questionnaire. Participants All investigators who published a placebo controlled randomised trial in 2000 in five leading medical journals, and a random sample of 120 trials listed in the national research register database. Main outcome measures Number of investigators who informed participants of their treatment allocation at trial closure, methods for delivering the information, and barriers to unmasking treatment. Results 45% of investigators informed either,all or most participants of their treatment allocation, and 55% did not inform any participant or only informed those who asked. The main reasons for not informing participants were that the investigators never considered this option (40%) or to avoid biasing results at study follow up (24%). Conclusion Further research is required to examine sensitive ways to communicate treatment information to trial participants.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Harvard Univ, Sch Med, Osher Inst, Boston, MA 02215 USA; Guys Kings & St Thomas Sch Med, Unit Psychol, London SE1 9RT, England; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of York - UK; Harvard University; Harvard Medical School; University of London; King's College London; University of York - UK	Di Blasi, Z (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	zdb1@york.ac.uk		Di Blasi, Zelda/0000-0001-8950-4958; Weinman, John Alfred/0000-0002-6786-0166				[Anonymous], 1986, HIST THEORY INFORM C; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Chalmers I, 2001, INT J EPIDEMIOL, V30, P1156, DOI 10.1093/ije/30.5.1156; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [10.3310/hta3030, DOI 10.3310/HTA3030]; DAHAN R, 1986, BRIT MED J, V293, P363, DOI 10.1136/bmj.293.6543.363; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; *DEP HLTH, 2001, RES GOVT FRAM HLTH S; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; FOX M, 2002, BRAIN SCAN STUDY SHO; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; *NHS CTR REV DISS, 2001, 4 U YORK NHS CTR REV; RABKIN JG, 1990, AM J PSYCHIAT, V147, P1622; Royle J, 2001, BRIT MED J, V323, P48; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; 2001, NATL RES REGISTER	20	27	27	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1329	1331		10.1136/bmj.325.7376.1329	http://dx.doi.org/10.1136/bmj.325.7376.1329			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468480	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000179817100017
J	Bidle, KD; Manganelli, M; Azam, F				Bidle, KD; Manganelli, M; Azam, F			Regulation of oceanic silicon and carbon preservation by temperature control on bacteria	SCIENCE			English	Article							BIOGENIC SILICA; SOUTHERN-OCEAN; ORGANIC-CARBON; WATER-COLUMN; MARINE DIATOMS; ROSS SEA; DISSOLUTION; CYCLE; AVAILABILITY; CONSUMPTION	We demonstrated in laboratory experiments that temperature control of marine bacteria action on diatoms strongly influences the coupling of biogenic silica and organic carbon preservation. Low temperature intensified the selective regeneration of organic matter by marine bacteria as the silicon: carbon preservation ratio gradually increased from similar to1 at 33degreesC to similar to6 at -1.8degreesC. Temperature control of bacteria-mediated selective preservation of silicon versus carbon should help to interpret and model the variable coupling of silicon and carbon sinking fluxes and the spatial patterns of opal accumulation in oceanic systems with different temperature regimes.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Bidle, KD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.		Manganelli, Maura/M-7103-2017; Azam, Farooq/A-2306-2012	Manganelli, Maura/0000-0002-5650-8191; 				ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; BIDLE KD, UNPUB; BRZEZINSKI MA, 1989, DEEP-SEA RES, V36, P1009, DOI 10.1016/0198-0149(89)90075-7; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; CHRISTIAN JR, 1995, LIMNOL OCEANOGR, V40, P1042, DOI 10.4319/lo.1995.40.6.1042; CHRISTIAN JR, 1993, ANTARCT J US, V28, P221; Christian JR, 1992, ANTARCT J US, V27, P170; DeMaster DJ, 2002, DEEP-SEA RES PT II, V49, P3155, DOI 10.1016/S0967-0645(02)00076-0; DEMASTER DJ, 1991, MAR CHEM, V35, P489, DOI 10.1016/S0304-4203(09)90039-1; DEMASTER DJ, 1992, OCEANOGRAPHY, V5, P146, DOI DOI 10.5670/OCEANOG.1992.03; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; HANSON R B, 1981, Antarctic Journal of the United States, V16, P130; HODSON RE, 1981, MAR BIOL, V61, P89, DOI 10.1007/BF00386648; HURD DC, 1983, AM J SCI, V283, P1, DOI 10.2475/ajs.283.1.1; KAMATANI A, 1979, MAR BIOL, V55, P29, DOI 10.1007/BF00391714; KAMATANI A, 1982, MAR BIOL, V68, P91, DOI 10.1007/BF00393146; KARL DM, 1993, ANTARCTIC MICROBIOLO, V1, P1; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; NELSON DM, 1982, GEOCHIM COSMOCHIM AC, V46, P491, DOI 10.1016/0016-7037(82)90153-3; Nelson DM, 2002, DEEP-SEA RES PT II, V49, P1645, DOI 10.1016/S0967-0645(02)00005-X; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; NELSON DM, 1991, MAR CHEM, V35, P461, DOI 10.1016/S0304-4203(09)90037-8; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; POMEROY LR, 1986, SCIENCE, V233, P359, DOI 10.1126/science.233.4761.359; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TREGUER P, 1989, POLAR BIOL, V9, P397, DOI 10.1007/BF00442531	40	87	88	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1980	1984		10.1126/science.1076076	http://dx.doi.org/10.1126/science.1076076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471255				2022-12-01	WOS:000179629200042
J	Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK				Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK			A general model for designing networks of marine reserves	SCIENCE			English	Article							CONNECTIVITY; POPULATION; RETENTION	There is debate concerning the most effective conservation of marine biodiversity, especially regarding the appropriate location, size, and connectivity of marine reserves. We describe a means of establishing marine reserve networks by using optimization algorithms and multiple levels of information on biodiversity, ecological processes (spawning, recruitment, and larval connectivity), and socioeconomic factors in the Gulf of California. A network covering 40% of rocky reef habitat can fulfill many conservation goals while reducing social conflict. This quantitative approach provides a powerful tool for decision-makers tasked with siting marine reserves.	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Univ Autonoma Baja California, La Paz, Baja Calif Sur, Mexico; World Wildlife Fund, Gulf Calif Program, Hermosillo, Sonora, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad Autonoma de Baja California	Sala, E (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	esala@ucsd.edu		Aburto-Oropeza, Octavio/0000-0002-8173-1432				AIRAME S, IN PRESS ECOL APPL; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Botsford LW, 2001, ECOL LETT, V4, P144; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dayton PK, 2000, B MAR SCI, V66, P617; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; KINLAN BP, IN PRESS ECOLOGY; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; LESLIE H, IN PRESS ECOL APPL; Lockwood DR, 2002, THEOR POPUL BIOL, V61, P297, DOI 10.1006/tpbi.2002.1572; LUBCHENCO J, IN PRESS ECOL APPL; Malakoff D, 2002, SCIENCE, V296, P245, DOI 10.1126/science.296.5566.245; Mangel M, 2000, ECOL LETT, V3, P15, DOI 10.1046/j.1461-0248.2000.00104.x; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:MEADFS>2.0.CO;2; National Research Council, 2001, MAR PROT AR TOOLS SU; Ogden JC, 1997, SCIENCE, V278, P1414, DOI 10.1126/science.278.5342.1414; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; SALA E, UNPUB; SALA E, IN PRESS B MAR SCI; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Ward TJ, 1999, ECOL APPL, V9, P691; Warner RR, 2000, B MAR SCI, V66, P821	29	303	315	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1991	1993		10.1126/science.1075284	http://dx.doi.org/10.1126/science.1075284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471258	Green Submitted			2022-12-01	WOS:000179629200045
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Toll pathway-dependent blockade of CD4(+)CD25(+) T cell-mediated suppression by dendritic cells	SCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SELF-TOLERANCE; IL-6-DEFICIENT MICE; ACTIVATION; RECEPTOR; DISEASE; IMMUNITY; INTERLEUKIN-6; RESISTANT; INDUCTION	Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (T-R cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs,which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4(+)CD25(+) T-R cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.							Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; KISHIMOTO T, 1992, J AUTOIMMUN, V5, P123, DOI 10.1016/0896-8411(92)90027-N; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Onizuka S, 1999, CANCER RES, V59, P3128; PASARE C, UNPUB; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rose NR, 1998, SEMIN IMMUNOL, V10, P5, DOI 10.1006/smim.1997.0100; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878	28	1685	1800	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1033	1036		10.1126/science.1078231	http://dx.doi.org/10.1126/science.1078231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12532024				2022-12-01	WOS:000180960000037
J	Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L				Rohde, JU; In, JH; Lim, MH; Brennessel, WW; Bukowski, MR; Stubna, A; Munck, E; Nam, W; Que, L			Crystallographic and spectroscopic characterization of a nonheme Fe(IV)=O complex	SCIENCE			English	Article							FE-2(MU-O)(2) DIAMOND CORE; PEROXIDASE COMPOUND-I; METHANE MONOOXYGENASE; CRYSTAL-STRUCTURE; MECHANISM; HYDROXYLATION; INTERMEDIATE; LIGAND; METALLOPORPHYRINS; ACTIVATION	Following the heme paradigm, it is often proposed that dioxygen activation by nonheme monoiron enzymes involves an iron(IV)=oxo intermediate that is responsible for the substrate oxidation step. Such a transient species has now been obtained from a synthetic complex with a nonheme macrocyclic ligand and characterized spectroscopically. Its high-resolution crystal structure reveals an iron-oxygen bond length of 1.646(3) angstroms, demonstrating that a terminal iron(IV)=oxo unit can exist in a nonporphyrin ligand environment and [ending credence to proposed mechanisms of nonheme iron catalysis.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA; Ewha Womans Univ, Dept Chem, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Ewha Womans University; Ewha Womans University; Carnegie Mellon University	Munck, E (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.		Lim, Mi Hee/D-1913-2018	Bukowski, Michael/0000-0001-8381-4429; Nam, Wonwoo/0000-0001-8592-4867	NIGMS NIH HHS [GM-33162, GM-22701, GM-38767] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038767, R01GM033162, R01GM022701, R37GM033162] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basch H, 1999, J AM CHEM SOC, V121, P7249, DOI 10.1021/ja9906296; CHANCE M, 1986, BIOCHEMISTRY-US, V25, P1266, DOI 10.1021/bi00354a011; CHE CM, 1985, J CHEM SOC CHEM COMM, P546, DOI 10.1039/c39850000546; CHIN DH, 1980, J AM CHEM SOC, V102, P5945, DOI 10.1021/ja00538a059; Costas M, 2001, J AM CHEM SOC, V123, P12931, DOI 10.1021/ja017204f; DEBRUNNER PG, 1989, IRON PORPHYRINS, V3, P199; EDWARDS SL, 1987, BIOCHEMISTRY-US, V26, P1503, DOI 10.1021/bi00380a002; FULOP V, 1994, STRUCTURE, V2, P210; Grapperhaus CA, 2000, INORG CHEM, V39, P5306, DOI 10.1021/ic0005238; Groves John T., 1995, P3; Hata M, 2001, J AM CHEM SOC, V123, P6410, DOI 10.1021/ja000908p; HOPPE R, 1982, ACTA CRYSTALLOGR B, V38, P2237; Hsu HF, 1999, J AM CHEM SOC, V121, P5230, DOI 10.1021/ja983666q; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; KITAGAWA T, 1994, COORDIN CHEM REV, V135, P685, DOI 10.1016/0010-8545(94)80081-2; KOSTKA KL, 1993, J AM CHEM SOC, V115, P6746, DOI 10.1021/ja00068a035; Lange SJ, 1999, J AM CHEM SOC, V121, P6330, DOI 10.1021/ja990233u; Lee D, 2002, J AM CHEM SOC, V124, P3993, DOI 10.1021/ja012251t; MacBeth CE, 2000, SCIENCE, V289, P938, DOI 10.1126/science.289.5481.938; Miyake H, 2001, INORG CHEM, V40, P3534, DOI 10.1021/ic000935g; NAM WW, 1991, J AM CHEM SOC, V113, P7052, DOI 10.1021/ja00018a062; Ogliaro F, 2000, J AM CHEM SOC, V122, P8977, DOI 10.1021/ja991878x; OOSTERHUIS WT, 1973, J CHEM PHYS, V58, P4757, DOI 10.1063/1.1679055; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SCHAPPACHER M, 1985, J AM CHEM SOC, V107, P3736, DOI 10.1021/ja00298a065; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Siegbahn PEM, 2001, J BIOL INORG CHEM, V6, P27, DOI 10.1007/s007750000184; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Watanabe Y, 2000, STRUCT BOND, V97, P61; Wolter T, 2000, J INORG BIOCHEM, V78, P117, DOI 10.1016/S0162-0134(99)00217-2; Zheng H, 2000, J AM CHEM SOC, V122, P3789, DOI 10.1021/ja9936722	34	734	738	10	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1037	1039		10.1126/science.299.5609.1037	http://dx.doi.org/10.1126/science.299.5609.1037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586936				2022-12-01	WOS:000180960000038
J	Garner, D; Weston, V				Garner, D; Weston, V			Effectiveness of vaccination for Haemophilus influenzae type b	LANCET			English	Article							CONJUGATE	Several cases of invasive Haemophilus influenzae type b (Hib) infection have been identified in children previously vaccinated against this disease. We have reviewed all cases of Hib in Nottingham, UK, since the conjugated vaccine was introduced into the primary course of childhood immunisations in 1992. Our results show a worrying increase in the frequency of Hib in Nottingham, which is much the same as the national trends. We believe that the medical profession should be aware of the return of Hib, and that we now need to review the need for a booster vaccination for what was thought to be a disease of the past.	Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Publ Hlth Lab, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Garner, D (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Dept Microbiol, Nottingham NG7 2UH, England.							Eskola J, 1999, LANCET, V354, P2063, DOI 10.1016/S0140-6736(99)04377-9; Heath PT, 2000, CLIN INFECT DIS, V31, P973, DOI 10.1086/318132; MCVERNON J, 2000, 15 BRIT PAED SURV UN, P23; *PUBL HLTH LAB SER, 2002, CDR WEEKLY      0124, P3	4	29	31	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					395	396		10.1016/S0140-6736(03)12385-9	http://dx.doi.org/10.1016/S0140-6736(03)12385-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573380				2022-12-01	WOS:000180787000016
J	Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D				Festenstein, R; Pagakis, SN; Hiragami, K; Lyon, D; Verreault, A; Sekkali, B; Kioussis, D			Modulation of heterochromatin protein 1 dynamics in primary mammalian cells	SCIENCE			English	Article							POSITION-EFFECT VARIEGATION; LIVING HUMAN-CELLS; RAPID EXCHANGE; HISTONE H3; CHROMATIN STRUCTURE; TRANSGENIC MICE; HP1 PROTEINS; LYSINE 9; DROSOPHILA; EXPRESSION	Heterochromatin protein 1 (HP1beta), a key component of condensed DNA, is strongly implicated in gene silencing and centromeric cohesion. Heterochromatin has been considered a static structure, stabilizing crucial aspects of nuclear organization and prohibiting access to transcription factors. We demonstrate here, by fluorescence recovery after photobleaching, that a green fluorescent protein-HP1beta fusion protein is highly mobile within both the euchromatin and heterochromatin of ex vivo resting murine T cells. Moreover, T cell activation greatly increased this mobility, indicating that such a process may facilitate (hetero)chromatin remodeling and permit access of epigenetic modifiers and transcription factors to the many genes that are consequently derepressed.	Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, London W12 0NN, England; Natl Inst Med Res, Confocal & Image Anal Lab, London NW7 1AA, England; London Res Inst, Canc Res UK, Chromosome Dynam Lab, Potters Bar EN6 3LD, Herts, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research; Cancer Research UK; MRC National Institute for Medical Research	Festenstein, R (corresponding author), Imperial Coll Sch Med, Div Med, CSC Gene Control Mech & Dis Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.							Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Briggs SD, 2002, NAT GENET, V30, P241, DOI 10.1038/ng0302-241; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; EISSENBERG JC, 1992, GENETICS, V131, P345; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; McMorrow T, 2000, EMBO J, V19, P4986, DOI 10.1093/emboj/19.18.4986; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Paro R, 2000, NATURE, V406, P579, DOI 10.1038/35020675; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	30	234	239	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					719	721		10.1126/science.1078694	http://dx.doi.org/10.1126/science.1078694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560554				2022-12-01	WOS:000180687700051
J	Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL				Ciesla, FJ; Lauretta, DS; Cohen, BA; Hood, LL			A nebular origin for chondritic fine-grained phyllosilicates	SCIENCE			English	Article							SOLAR NEBULA; CHONDRULE FORMATION; WATER; PARTICLES; EVOLUTION; MODEL	Hydrated minerals occur in accretionary rims around chondrules in CM chondrites. Previous models suggested that these phyllosilicates did not form by gas-solid reactions in the canonical solar nebula. We propose that chondrule-forming shock waves in icy regions of the nebula produced conditions that allowed rapid mineral hydration. The time scales for phyllosilicate formation are similar to the time it takes for a shocked system to cool from the temperature of phyllosilicate stability to that of water ice condensation. This scenario allows for simultaneous formation of chondrules and their fine-grained accretionary rims.	Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Arizona; University of Hawaii System	Ciesla, FJ (corresponding author), Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, 1629 E Univ Blvd, Tucson, AZ 85721 USA.	fciesla@lpl.arizona.edu	COHEN, BARBARA/AAV-8199-2021	Cohen, Barbara/0000-0001-5896-5903				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Bischoff A, 1998, METEORIT PLANET SCI, V33, P1113, DOI 10.1111/j.1945-5100.1998.tb01716.x; Ciesla FJ, 2002, ICARUS, V158, P281, DOI 10.1006/icar.2002.6895; Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; Connolly HC, 1998, GEOCHIM COSMOCHIM AC, V62, P2725, DOI 10.1016/S0016-7037(98)00176-8; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CONNOLLY HC, 1994, NATURE, V371, P136, DOI 10.1038/371136a0; Cuzzi JN, 2001, ASTROPHYS J, V546, P496, DOI 10.1086/318233; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; Desch SJ, 2002, METEORIT PLANET SCI, V37, P183, DOI 10.1111/j.1945-5100.2002.tb01104.x; Fegley B.J., 1989, FORMATION EVOLUTION, P171; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; Hewins R. H., 1996, CHONDRULES PROTOPLAN, P197; Iida A, 2001, ICARUS, V153, P430, DOI 10.1006/icar.2001.6682; Lauretta DS, 2000, GEOCHIM COSMOCHIM AC, V64, P3263, DOI 10.1016/S0016-7037(00)00425-7; Lauretta DS, 2001, GEOCHIM COSMOCHIM AC, V65, P1337, DOI 10.1016/S0016-7037(00)00615-3; LEE MR, 1993, METEORITICS, V28, P53, DOI 10.1111/j.1945-5100.1993.tb00248.x; LODDERS K, 1998, PLANETARY SCI COMPAN, V80, P80; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; Rasmussen MG, 1998, CAN MINERAL, V36, P147; Sears DWG, 1998, METEORIT PLANET SCI, V33, P1157, DOI 10.1111/j.1945-5100.1998.tb01720.x; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Supulver KD, 2000, ICARUS, V146, P525, DOI 10.1006/icar.2000.6418; WEGNER WW, 1983, AM J SCI A, V283, P151; WEIDENSCHILLING SJ, 1988, METEORITES EARLY SOL, P348	26	112	112	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					549	552		10.1126/science.1079427	http://dx.doi.org/10.1126/science.1079427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543970				2022-12-01	WOS:000180559800044
J	Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ				Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ			Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTOXIN LETHALITY; MICE; BUNGAROTOXIN; DEFICIENT; CACHECTIN; CLONING; CALCIUM; SHOCK	Excessive inflammation and tumour-necrosis factor (TNF) synthesis cause morbidity and mortality in diverse human diseases including endotoxaemia, sepsis, rheumatoid arthritis and inflammatory bowel disease(1-4). Highly conserved, endogenous mechanisms normally regulate the magnitude of innate immune responses and prevent excessive inflammation. The nervous system, through the vagus nerve, can inhibit significantly and rapidly the release of macrophage TNF, and attenuate systemic inflammatory responses(5-7). This physiological mechanism, termed the 'cholinergic anti- inflammatory pathway'(5) has major implications in immunology and in therapeutics; however, the identity of the essential macrophage acetylcholine-mediated (cholinergic) receptor that responds to vagus nerve signals was previously unknown. Here we report that the nicotinic acetylcholine receptor alpha7 subunit is required for acetylcholine inhibition of macrophage TNF release. Electrical stimulation of the vagus nerve inhibits TNF synthesis in wild-type mice, but fails to inhibit TNF synthesis in alpha7-deficient mice. Thus, the nicotinic acetylcholine receptor alpha7 subunit is essential for inhibiting cytokine synthesis by the cholinergic anti- inflammatory pathway.	N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Res Inst, Med Chem Lab, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Tracey, KJ (corresponding author), N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.		Ulloa, Luis/AAE-8751-2019; Wang, Haichao/K-6310-2012; Susarla, Srinivas/P-1051-2019; Wang, Haichao/AAU-2237-2021	Ulloa, Luis/0000-0002-7702-7549; Wang, Haichao/0000-0002-0211-9000; Susarla, Srinivas/0000-0003-0155-8260; Wang, Haichao/0000-0002-0211-9000; Tracey, Kevin J/0000-0003-1884-6314; Wang, Hong/0000-0003-4130-8741				Andersson L1992A, SCRIPTA BOT BELG, V1, P1; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Feng GP, 1998, J NEUROSCI, V18, P4166; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Kumins NH, 1996, SHOCK, V5, P385, DOI 10.1097/00024382-199605000-00012; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Leonard S, 2001, Nicotine Tob Res, V3, P203; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lindstrom J.M., 1995, HDB RECEPTORS CHANNE, P153; Marubio LM, 2000, EUR J PHARMACOL, V393, P113, DOI 10.1016/S0014-2999(00)00007-8; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PENG X, 1994, MOL PHARMACOL, V45, P546; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shoop RD, 2000, J NEUROSCI, V20, P4021; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Steinlein O, 1998, BEHAV BRAIN RES, V95, P31, DOI 10.1016/S0166-4328(97)00207-6; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	27	2247	2517	16	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					384	388		10.1038/nature01339	http://dx.doi.org/10.1038/nature01339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12508119				2022-12-01	WOS:000180533000045
J	Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ				Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ			Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface	SCIENCE			English	Article							HIGH-ENDOTHELIAL VENULES; HUMAN CYTOTROPHOBLASTS; LYMPHOCYTES; INVASION; RECEPTORS; LIGAND; CELLS	Trophoblast adhesion to the uterine wall is the requisite first step of implantation and, subsequently, placentation. At the maternal-fetal interface, we investigated the expression of selectin adhesion systems that enable leukocyte capture from the bloodstream. On the maternal side, human uterine epithelial cells up-regulated selectin oligosaccharide-based ligands during the window of receptivity. On the fetal side, human trophoblasts expressed L-selectin. This ligand-receptor system was functional, because beads coated with the selectin ligand 6-sulfo sLe(x) bound to trophoblasts, and trophoblasts bound to ligand-expressing uterine luminal epithelium in tissue sections. These results suggest that trophoblast L-selectin mediates interactions with the uterus and that this adhesion mechanism may be critical to establishing human pregnancy.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Nevada Ctr Reprod Med, Reno, NV 89509 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fisher, SJ (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Kiessling, Laura L/A-4074-2008	ILIC, DUSKO/0000-0003-1647-0026; Rosen, Steven/0000-0002-6245-701X; Kiessling, Laura/0000-0001-6829-1500	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042283] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007244, R37DE007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023547] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64597] Funding Source: Medline; NICHD NIH HHS [U01 HD 42283] Funding Source: Medline; NIDCR NIH HHS [DE 07244] Funding Source: Medline; NIGMS NIH HHS [R37GM23547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Calatayud S, 1996, INT IMMUNOL, V8, P1637, DOI 10.1093/intimm/8.10.1637; Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Frenette PS, 1997, THROMB HAEMOSTASIS, V78, P60; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Giblin PA, 1997, J IMMUNOL, V159, P3498; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Kimber SJ, 2000, SEMIN CELL DEV BIOL, V11, P77, DOI 10.1006/scdb.2000.0154; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; NORWITZ ER, 1907, NEW ENGL J MED, V345, P1400; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	18	348	384	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					405	408		10.1126/science.1079546	http://dx.doi.org/10.1126/science.1079546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532021				2022-12-01	WOS:000180426800049
J	Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD				Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD			Recent expansion of Toxoplasma through enhanced oral transmission	SCIENCE			English	Article							INTERNAL TRANSCRIBED SPACER; GONDII STRAINS; 2 ALLELES; SEQUENCE; PLASMODIUM; ANTIGEN; IDENTIFICATION; PHYLOGENY; VIRULENCE; CLONING	The global predominance of three clonal Toxoplasma gondii lineages suggests that they are endowed with an exceptional trait responsible for their current parasitism of nearly all warm-blooded vertebrates. Genetic polymorphism analyses indicate that these clonal lineages emerged within the last 10,000 years after a single genetic cross. Comparison with ancient strains (similar to1 million years) suggests that the success of the clonal lineages resulted from the concurrent acquisition of direct oral infectivity. This key adaptation circumvented sexual recombination, simultaneously promoting transmission through successive hosts, hence leading to clonal expansion. Thus, changes in complex life cycles can occur rapidly and can profoundly influence pathogenicity.	Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Washington University (WUSTL); University of Cambridge; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sibley, LD (corresponding author), Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu	Kissinger, Jessica C/E-9610-2010; Su, Chunlei/M-1892-2013; Kissinger, Jessica/M-9920-2019; Sibley, L. David/C-4616-2008	Kissinger, Jessica C/0000-0002-6413-1101; Su, Chunlei/0000-0001-8392-7108; Kissinger, Jessica/0000-0002-6413-1101; 				BULOW R, 1991, J IMMUNOL, V147, P3496; CAI J, 1992, BIOCHIM BIOPHYS ACTA, V1131, P317, DOI 10.1016/0167-4781(92)90032-U; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; DUBEY JP, 1980, AM J VET RES, V41, P427; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GAGNON S, 1993, MOL BIOCHEM PARASIT, V60, P145, DOI 10.1016/0166-6851(93)90037-X; GAJADHAR AA, 1991, MOL BIOCHEM PARASIT, V45, P147, DOI 10.1016/0166-6851(91)90036-6; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hnida JA, 1999, J PARASITOL, V85, P873, DOI 10.2307/3285824; HOLE F, 1994, ORIGINS AGR, P373; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Israelski D M, 1993, Curr Clin Top Infect Dis, V13, P322; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Levine ND., 1988, PROTOZOAN PHYLUM API; Levine ND, 1988, PROTOZOAN PHYLUM API, V2, P203; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meisel R, 1996, MOL BIOCHEM PARASIT, V81, P259, DOI 10.1016/0166-6851(96)02719-3; Mugridge NB, 1999, INT J PARASITOL, V29, P1545, DOI 10.1016/S0020-7519(99)00150-2; Olivier C, 2001, INT J PARASITOL, V31, P1475, DOI 10.1016/S0020-7519(01)00283-1; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Remington JS, 2001, INFECT DIS FETUS NEW, P205; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; SERPELL J, 2000, DOMESTIC CAT; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	36	261	272	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					414	416		10.1126/science.1078035	http://dx.doi.org/10.1126/science.1078035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532022	Green Published			2022-12-01	WOS:000180426800052
J	Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W				Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W			Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; INFECTION; OUTBREAK; STERILIZATION	Background: Several outbreaks and pseudo-outbreaks of Pseudomonas aeruginosa and Serratia marcescens infections associated with bronchoscopy have been reported. We conducted an investigation of P. aeruginosa and S. marcescens isolates related to bronchoscopy at a community hospital. Methods: We reviewed the records of all bronchoscopic procedures at the community hospital from July to October 2001. Environmental samples were obtained. Pulsed-field gel electrophoresis (PFGE) was performed on isolates of P. aeruginosa. Results: From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients, and 43 specimens were obtained for bacterial culture; 20 of the specimens (47 percent) were positive for P. aeruginosa. Six (30 percent) of the specimens that were positive for P. aeruginosa also yielded S. marcescens. All 20 P. aeruginosa isolates were associated with procedures performed with three of four new bronchoscopes from the same manufacturer. Contrary to manufacturing specifications, the biopsy-port caps on all four bronchoscopes were easily removable, and P. aeruginosa was cultured from the biopsy ports of the three implicated bronchoscopes. The PFGE patterns of P. aeruginosa isolates from the bronchoscopes, patients, and two environmental samples were indistinguishable. One patient was hospitalized with P. aeruginosa pneumonia 11 days after bronchoscopy. The manufacturer reported a design change instituted in 1997, and production problems may have resulted in the distribution of bronchoscopes that did not meet specifications. Conclusions: We documented contamination of bronchoscopes with P. aeruginosa and S. marcescens and possible infection of patients at a community hospital as a result of the inadequate disinfection of bronchoscopes because of a manufacturing defect.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; Tennessee Dept Hlth, Nashville, TN USA; Skyline Med Ctr, Nashville, TN USA	Vanderbilt University; Centers for Disease Control & Prevention - USA; Tennessee Department Health	Schaffner, W (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N,Rm A-1124, Nashville, TN 37232 USA.	william.schaffner@vanderbilt.edu						Alvarado CJ, 2000, AM J INFECT CONTROL, V28, P138; [Anonymous], MMWR MORB MORTAL WKL; *BIOR LAB, 1992, MOL AN SOFTW VERS 1; Blanc DS, 1997, INFECT CONT HOSP EP, V18, P134; BOND WW, 1998, DISINFECTION STERILI, P151; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEAN AG, 2001, INFO 2000 VERSION 1; Favero M., 1991, DISINFECTION STERILI, P617; FEIGAL DW, 1999, FDA CDC PUBLIC HLTH; KOLMOS HJ, 1994, SCAND J INFECT DIS, V26, P653, DOI 10.3109/00365549409008632; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; Muscarella LF, 2000, INFECT CONT HOSP EP, V21, P628, DOI 10.1086/503241; Muscarella LF, 1996, INFECT CONT HOSP EP, V17, P183; Ostrowsky B., 2001, SEMIN INFECT CONTROL, V1, P267; OWINGS MF, 1996, VITAL HLTH STAT 13, V139; PRAKASH UBS, 1993, CHEST, V104, P552, DOI 10.1378/chest.104.2.552; Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3; Rutala WA, 1999, INFECT CONT HOSP EP, V20, P302; Sammartino M T, 1982, J Hosp Infect, V3, P65, DOI 10.1016/0195-6701(82)90032-9; Seijo LM, 2001, NEW ENGL J MED, V344, P740, DOI 10.1056/NEJM200103083441007; SIEGMANIGRA Y, 1985, J HOSP INFECT, V6, P218; Sorin M, 2001, INFECT CONT HOSP EP, V22, P409, DOI 10.1086/501925; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; VANDENBROUCKEGRAULS CMJE, 1993, J HOSP INFECT, V23, P263, DOI 10.1016/0195-6701(93)90143-N; Weber DJ, 2001, INFECT CONT HOSP EP, V22, P403, DOI 10.1086/501924; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	28	94	101	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					214	220		10.1056/NEJMoa021791	http://dx.doi.org/10.1056/NEJMoa021791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529461				2022-12-01	WOS:000180390600005
J	Friend, M; Vucenik, I; Miller, M				Friend, M; Vucenik, I; Miller, M			Platelet responsiveness to aspirin in patients with hyperlipidaemia	BRITISH MEDICAL JOURNAL			English	Article							RESISTANCE		Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA; Univ Maryland, Med Ctr, Dept Med & Res Technol & Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Miller, M (corresponding author), Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA.		Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095	NHLBI NIH HHS [R01 HL061369, HL 61369] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061369] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARVALHO AC, 1974, NEW ENGL J MED, V290, P434, DOI 10.1056/NEJM197402212900805; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; Kawasaki T, 2000, STROKE, V31, P591, DOI 10.1161/01.STR.31.3.591; SATHIROPAS P, 1988, THROMB RES, V51, P55, DOI 10.1016/0049-3848(88)90282-4; Weber AA, 1999, LANCET, V353, P900, DOI 10.1016/S0140-6736(99)00498-5	5	117	129	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					82	83		10.1136/bmj.326.7380.82	http://dx.doi.org/10.1136/bmj.326.7380.82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521973	Green Published, Bronze			2022-12-01	WOS:000180426900017
J	Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J				Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J			Role of a highly conserved bacterial protein in outer membrane protein assembly	SCIENCE			English	Article							CHLOROPLASTIC ENVELOPE MEMBRANES; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; PHOSPHOLIPASE-A; GONORRHOEAE; ORIGIN	After transport across the cytoplasmic membrane, bacterial outer membrane proteins are assembled into the outer membrane. Meningococcal Omp85 is a highly conserved protein in Gram-negative bacteria, and its homolog Toc75 is a component of the chloroplast protein-import machinery. Omp85 appeared to be essential for viability, and unassembled forms of various outer membrane proteins accumulated upon Omp85 depletion. Immuno fluorescence microscopy revealed decreased surface exposure of outer membrane proteins, which was particularly apparent at the cell-division planes. Thus, Omp85 is likely to play a role in outer membrane protein assembly.	Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.		Voulhoux, Rome/AAT-5333-2021; Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; BROK RGPM, 1994, J BACTERIOL, V176, P861, DOI 10.1128/jb.176.3.861-870.1994; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Jansen C, 2000, BBA-BIOMEMBRANES, V1464, P284, DOI 10.1016/S0005-2736(00)00155-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Manning DS, 1998, MICROB PATHOGENESIS, V25, P11, DOI 10.1006/mpat.1998.0206; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Martin D, 1997, J EXP MED, V185, P1173, DOI 10.1084/jem.185.7.1173; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prinz T, 2000, FEMS MICROBIOL LETT, V183, P49, DOI 10.1016/S0378-1097(99)00629-1; Reumann S, 1999, TRENDS PLANT SCI, V4, P302, DOI 10.1016/S1360-1385(99)01449-1; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Thomas KL, 2001, INFECT IMMUN, V69, P4438, DOI 10.1128/IAI.69.7.4438-4446.2001; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	22	571	582	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					262	265		10.1126/science.1078973	http://dx.doi.org/10.1126/science.1078973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522254				2022-12-01	WOS:000180284000043
J	Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM				Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM			Influenza-related hospitalizations among children in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISEASE; COST-EFFECTIVENESS; VIRUS INFECTION; YOUNG-CHILDREN; INFANTS; IMPACT; EPIDEMICS; DIAGNOSIS; VACCINE; ILLNESS	Background: It has been difficult to define the burden of influenza in children because of confounding by the cocirculation of respiratory syncytial virus (RSV). In Hong Kong, China, the influenza and RSV infection seasons sometimes do not overlap, thus providing an opportunity to estimate the rate of influenza-related hospitalization in a defined population, free from the effects of RSV. Methods: In a retrospective, population-based study, we estimated the influenza-associated excess rate of hospitalization among children 15 years old or younger in the Hong Kong Special Administrative Region from 1997 to 1999. Data from a single hospital with intensive use of virologic analyses for diagnosis were obtained to define and adjust for underestimation of the model. Results: Peaks of influenza and RSV infection activity were well separated in 1998 and 1999 but overlapped in 1997. The adjusted rates of excess hospitalization for acute respiratory disease that were attributable to influenza were 278.5 and 288.2 per 10,000 children less than 1 year of age in 1998 and 1999, respectively; 218.4 and 209.3 per 10,000 children 1 to less than 2 years of age; 125.6 and 77.3 per 10,000 children 2 to less than 5 years of age; 57.3 and 20.9 per 10,000 children 5 to less than 10 years of age; and 16.4 and 8.1 per 10,000 children 10 to 15 years of age. Conclusions: In the subtropics, influenza is an important cause of hospitalization among children, with rates exceeding those reported for temperate regions.	Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Wong, Wilfred/Q-8751-2019; Lau, Yu Lung/C-4322-2009; Chiu, Susan Shui Seng/C-4247-2009	Lau, Yu Lung/0000-0002-4780-0289; Wong, Hing Sang Wilfred/0000-0001-8396-2368; Chiu, Susan Shui Seng/0000-0002-3908-1974				ADAMS PF, 1995, VITAL HLTH STAT, V10; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P191; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chiu SS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e63; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; Drinka P, 1999, J AM GERIATR SOC, V47, P1363; Edwards KM, 2001, PEDIATRICS, V108, P1004, DOI 10.1542/peds.108.4.1004; Fitzner K. A., 1999, Hong Kong Medical Journal, V5, P87; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Glezen WP, 1999, JAMA-J AM MED ASSOC, V281, P944, DOI 10.1001/jama.281.10.944; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Glezen WP, 1997, PEDIATR INFECT DIS J, V16, P1065, DOI 10.1097/00006454-199711000-00012; *GOV HONG KONG SPE, INFL SURV; *HONG KONG GOV, 1993, HONG KONG COR REP; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; McIntosh K, 2000, NEW ENGL J MED, V342, P275, DOI 10.1056/NEJM200001273420409; Monto Arnold S., 1997, Journal of Infectious Diseases, V176, pS32, DOI 10.1086/514172; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2001, INFECT DIS CLIN N AM, V15, P123, DOI 10.1016/S0891-5520(05)70271-3; Poland GA, 1999, PEDIATRICS, V103, P1280, DOI 10.1542/peds.103.6.1280; SHORTRIDGE KF, 1995, LANCET, V346, P1210, DOI 10.1016/S0140-6736(95)92906-1; SHORTRIDGE KF, 1982, LANCET, V2, P812; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SUGAYA N, 1992, J INFECT DIS, V165, P373, DOI 10.1093/infdis/165.2.373; Szucs TD, 1999, PHARMACOECONOMICS, V16, P27, DOI 10.2165/00019053-199916001-00004; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2000, N ENGL J MED, V342, P1752	32	225	241	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2097	2103		10.1056/NEJMoa020546	http://dx.doi.org/10.1056/NEJMoa020546			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501221	Bronze			2022-12-01	WOS:000180040900002
J	Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ				Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ			Photosynthetic light harvesting by carotenoids: Detection of an intermediate excited state	SCIENCE			English	Article							BETA-CAROTENE; ELECTRONIC EXCITATIONS; ENERGY-TRANSFER; 1B(U)(+); DEPENDENCE; ABSORPTION; LIFETIME; COMPLEX; FINITE	We present the first direct evidence of the presence of an intermediate singlet excited state (S-x) mediating the internal conversion from S-2 to S-1 in carotenoids. The S-2 to S-x transition is extremely fast and is completed within approximately 50 femtoseconds. These results require a reassessment of the energy transfer pathways from carotenoids to chlorophylls in the primary step of photosynthesis.	Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, I-20133 Milan, Italy; Univ Glasgow, Div Biochem & Mol Biol, Glasgow, Lanark, Scotland	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Milan; University of Glasgow	Cerullo, G (corresponding author), Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, Piazza L da Vinci 32, I-20133 Milan, Italy.	giulio.cerullo@fisi.polimi.it	Polli, Dario/B-4809-2011; Cerullo, Giulio/F-6534-2011	Polli, Dario/0000-0002-6960-5708; Cerullo, Giulio/0000-0002-9534-2702				Cerullo G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.241104; Cerullo G, 1998, OPT LETT, V23, P1283, DOI 10.1364/OL.23.001283; Damjanovic A, 1999, PHYS REV E, V59, P3293, DOI 10.1103/PhysRevE.59.3293; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; ISLER O, 1971, CAROTENOIDS; KANDORI H, 1994, J AM CHEM SOC, V116, P2671, DOI 10.1021/ja00085a078; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; Macpherson AN, 1998, J PHYS CHEM A, V102, P5049, DOI 10.1021/jp980979z; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; PELLEGRIN E, 1991, PHYS REV LETT, V66, P2022, DOI 10.1103/PhysRevLett.66.2022; Ritz T, 2000, PHOTOSYNTH RES, V66, P125, DOI 10.1023/A:1010750332320; Sashima T, 2000, J PHYS CHEM B, V104, P5011, DOI 10.1021/jp994185b; Sashima T, 1999, CHEM PHYS LETT, V299, P187, DOI 10.1016/S0009-2614(98)01278-0; SHREVE AP, 1991, CHEM PHYS LETT, V178, P89, DOI 10.1016/0009-2614(91)85058-5; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; TAVAN P, 1986, J CHEM PHYS, V85, P6602, DOI 10.1063/1.451442; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; YOSHIZAWA M, 2001, PHYS REV B, V63; Zavelani-Rossi M, 2001, OPT LETT, V26, P1155, DOI 10.1364/OL.26.001155; Zhang JP, 2001, PHOTOCHEM PHOTOBIOL, V73, P219, DOI 10.1562/0031-8655(2001)073<0219:TAFTUS>2.0.CO;2; Zhang JP, 2000, CHEM PHYS LETT, V332, P351, DOI 10.1016/S0009-2614(00)01275-6	23	224	226	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2395	2398		10.1126/science.1074685	http://dx.doi.org/10.1126/science.1074685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493917				2022-12-01	WOS:000179915900059
J	Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J				Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J			HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; HUMAN MONOCLONAL-ANTIBODY; TYPE-1 GP120; EFFICIENT NEUTRALIZATION; CELLS; RETROVIRUS; EPITOPES; COMPLEX; FUSION	The ability of human immunodeficiency virus (HIV-1) to persist and cause AIDS is dependent on its avoidance of antibody-mediated neutralization. The virus elicits abundant, envelope-directed antibodies that have little neutralization capacity(1). This lack of neutralization is paradoxical, given the functional conservation and exposure of receptor-binding sites on the gp120 envelope glycoprotein, which are larger than the typical antibody footprint(2) and should therefore be accessible for antibody binding. Because gp120-receptor interactions involve conformational reorganization(3), we measured the entropies of binding for 20 gp120-reactive antibodies. Here we show that recognition by receptor-binding-site antibodies induces conformational change. Correlation with neutralization potency and analysis of receptor-antibody thermodynamic cycles suggested a receptor-binding-site 'conformational masking' mechanism of neutralization escape. To understand how such an escape mechanism would be compatible with virus-receptor interactions, we tested a soluble dodecameric receptor molecule and found that it neutralized primary HIV-1 isolates with great potency, showing that simultaneous binding of viral envelope glycoproteins by multiple receptors creates sufficient avidity to compensate for such masking. Because this solution is available for cell-surface receptors but not for most antibodies, conformational masking enables HIV-1 to maintain receptor binding and simultaneously to resist neutralization.	NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; GlaxosmithKline Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Tanox Biosyst Inc, Cell Biol, Houston, TX 77025 USA; Univ Agr & Forestry, Inst Appl Microbiol, A-1190 Vienna, Austria; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Div AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University; Howard Hughes Medical Institute; GlaxoSmithKline; Johns Hopkins University; University of Pennsylvania; Scripps Research Institute; Scripps Research Institute; Tulane University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.			Doyle, Michael/0000-0003-4569-6315; Parren, Paul/0000-0002-4365-3859	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000883, ZIAAI000883] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Doyle ML, 2000, METHOD ENZYMOL, V323, P207; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Luque I, 1998, METHOD ENZYMOL, V295, P100; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou JY, 1997, J VIROL, V71, P2512, DOI 10.1128/JVI.71.3.2512-2517.1997; Zhu P, 2001, J VIROL, V75, P6682, DOI 10.1128/JVI.75.14.6682-6686.2001	30	712	760	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					678	682		10.1038/nature01188	http://dx.doi.org/10.1038/nature01188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478295				2022-12-01	WOS:000179751800048
J	Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N				Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N			A short-term sink for atmospheric CO2 in subtropical mode water of the North Atlantic Ocean	NATURE			English	Article							INTERANNUAL VARIABILITY; TIME-SERIES; SEA; OSCILLATION; GYRE	Large-scale features of ocean circulation, such as deep water formation in the northern North Atlantic Ocean(1), are known to regulate the long-term physical uptake of CO2 from the atmosphere by moving CO2-laden surface waters into the deep ocean. But the importance of CO2 uptake into water masses that ventilate shallower ocean depths, such as subtropical mode waters(2) of the subtropical gyres, are poorly quantified. Here we report that, between 1988 and 2001, dissolved CO2 concentrations in subtropical mode waters of the North Atlantic have increased at a rate twice that expected from these waters keeping in equilibrium with increasing atmospheric CO2. This accounts for an extra similar to0.4-2.8 Pg C (1 Pg = 10(15) g) over this period (that is, about 0.03-0.24 Pg Cyr(-1)), equivalent to similar to3-10% of the current net annual ocean uptake of CO2 (ref. 3). We suggest that the lack of strong winter mixing events, to greater than 300 m in depth, in recent decades is responsible for this accumulation, which would otherwise disturb the mode water layer and liberate accumulated CO2 back to the atmosphere. However, future climate variability (which influences subtropical mode water formation(1,4-8)) and changes in the North Atlantic Oscillation(9) (leading to a return of deep winter mixing events) may reduce CO2 accumulation in subtropical mode waters. We therefore conclude that, although CO2 uptake by subtropical mode waters in the North Atlantic-and possibly elsewhere-does not always represent a long-term CO2 sink, the phenomenon is likely to contribute substantially to interannual variability in oceanic CO2 uptake(3).	Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Bates, NR (corresponding author), Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda.	nick@bbsr.edu	Gruber, Nicolas/B-7013-2009; Pequignet, Christine/H-5618-2014	Gruber, Nicolas/0000-0002-2085-2310; 				Alfultis MA, 2001, J PHYS OCEANOGR, V31, P2066, DOI 10.1175/1520-0485(2001)031<2066:AAICIT>2.0.CO;2; Bates NR, 1996, DEEP-SEA RES PT II, V43, P347, DOI 10.1016/0967-0645(95)00093-3; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; BEHRINGER DW, 1980, DEEP-SEA RES, V27, P225, DOI 10.1016/0198-0149(80)90014-X; Conte MH, 2001, DEEP-SEA RES PT II, V48, P1471, DOI 10.1016/S0967-0645(00)00150-8; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; GRAEDEL TE, 1988, APPL GEOCHEM, V3, P37; HANAWA K, 2001, INT GEOPHYSICS SERIE, V77, P378; Hazeleger W, 1998, J PHYS OCEANOGR, V28, P266, DOI 10.1175/1520-0485(1998)028<0266:MWVIAM>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jenkins WJ, 1982, J MAR RES, V40, P265; Jenkins WJ, 1998, J GEOPHYS RES-OCEANS, V103, P15817, DOI 10.1029/98JC00141; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KARL DM, IN PRESS DEEP SEA RE; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; Klein B, 1996, DEEP-SEA RES PT I, V43, P1777, DOI 10.1016/S0967-0637(96)00069-6; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; Marsh R, 1996, J PHYS OCEANOGR, V26, P1059, DOI 10.1175/1520-0485(1996)026<1059:MWV>2.0.CO;2; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; SPALL MA, 1992, J PHYS OCEANOGR, V22, P564, DOI 10.1175/1520-0485(1992)022<0564:CSARIT>2.0.CO;2; SPEER K, 1992, J PHYS OCEANOGR, V22, P93, DOI 10.1175/1520-0485(1992)022<0093:ROWMFI>2.0.CO;2; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Talley LD, 1982, J MAR RES, V40, P757; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Williams RG, 1995, J PHYS OCEANOGR, V25, P3089, DOI 10.1175/1520-0485(1995)025<3089:DSMLW>2.0.CO;2; WOODS JD, 1986, NATURE, V319, P574, DOI 10.1038/319574a0; WORTHINGTON LV, 1959, DEEP-SEA RES, V5, P297, DOI 10.1016/0146-6313(58)90026-1	30	84	85	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					489	493		10.1038/nature01253	http://dx.doi.org/10.1038/nature01253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12487116				2022-12-01	WOS:000179611600041
J	Hori, S; Nomura, T; Sakaguchi, S				Hori, S; Nomura, T; Sakaguchi, S			Control of regulatory T cell development by the transcription factor Foxp3	SCIENCE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; AUTOIMMUNE-DISEASE; SCURFY MOUSE; ENTEROPATHY; HOMEOSTASIS; INDUCTION; CD25(+); MUTANT	Regulatory T cells engage in the maintenance of immunological self-tolerance by actively suppressing self-reactive lymphocytes. Little is known, however, about the molecular mechanism of their development. Here we show that Foxp3, which encodes a transcription factor that is genetically defective in an autoimmune and inflammatory syndrome in humans and mice, is specifically expressed in naturally arising CD4(+) regulatory T cells. Furthermore, retroviral gene transfer of Foxp3 converts naive T cells toward a regulatory T cell phenotype similar to that of naturally occurring CD4(+) regulatory T cells. Thus, Foxp3 is a key regulatory gene for the development of regulatory T cells.	Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	RIKEN; Kyoto University	Sakaguchi, S (corresponding author), Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan.		Hori, Shohei/O-6163-2019; Sakaguchi, Shimon/C-9535-2009	Hori, Shohei/0000-0001-8770-4593; 				Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; Coutinho A, 2001, IMMUNOL REV, V182, P89, DOI 10.1034/j.1600-065X.2001.1820107.x; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hori S., UNPUB; Itoh M, 1999, J IMMUNOL, V162, P5317; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Van Parijs L, 1998, SCIENCE, V280, P243; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zahorsky-Reeves JL, 2001, EUR J IMMUNOL, V31, P196, DOI 10.1002/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9	31	6201	6832	11	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1057	1061		10.1126/science.1079490	http://dx.doi.org/10.1126/science.1079490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12522256				2022-12-01	WOS:000180960000045
J	Janata, K; Holzer, M; Laggner, AN; Mullner, M				Janata, K; Holzer, M; Laggner, AN; Mullner, M			Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study	BRITISH MEDICAL JOURNAL			English	Article							RIGHT-VENTRICULAR DYSFUNCTION		Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, A-1090 Vienna, Austria	University of Vienna	Mullner, M (corresponding author), Univ Vienna, Allgemeines Krankenhaus Wien, Jkub BItfakkned, Wahringer Gurtel 18-20-6D, A-1090 Vienna, Austria.							Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; GROSSER KD, 1980, INTERNIST, V21, P273; Kasper W, 1997, HEART, V77, P346, DOI 10.1136/hrt.77.4.346; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Meyer T, 2000, J AM COLL CARDIOL, V36, P1632, DOI 10.1016/S0735-1097(00)00905-0	5	77	85	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					312	313		10.1136/bmj.326.7384.312	http://dx.doi.org/10.1136/bmj.326.7384.312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645UD	12574045	Bronze, Green Published			2022-12-01	WOS:000180997000019
J	Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW				Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW			Effects of household dynamics on resource consumption and biodiversity	NATURE			English	Article							HUMAN-POPULATION; ENERGY USE; HOTSPOTS	Human population size and growth rate are often considered important drivers of biodiversity loss(1-6), whereas household dynamics are usually neglected. Aggregate demographic statistics may mask substantial changes in the size and number of households, and their effects on biodiversity. Household dynamics influence per capita consumption(7,8) and thus biodiversity through, for example, consumption of wood for fuel(9), habitat alteration for home building and associated activities(10-12), and greenhouse gas emissions(13). Here we report that growth in household numbers globally, and particularly in countries with biodiversity hotspots (areas rich in endemic species and threatened by human activities 14), was more rapid than aggregate population growth between 1985 and 2000. Even when population size declined, the number of households increased substantially. Had the average household size (that is, the number of occupants) remained static, there would have been 155 million fewer households in hotspot countries in 2000. Reduction in average household size alone will add a projected 233 million additional households to hotspot countries during the period 2000-15. Rapid increase in household numbers, often manifested as urban sprawl, and resultant higher per capita resource consumption in smaller households(15-19) pose serious challenges to biodiversity conservation.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA	Michigan State University; Stanford University	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	feng, tingting/A-9545-2012; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Luck, Gary/0000-0002-7266-5568				An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; BONGAARTS J, 2001, END FERTILITY TRANSI; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cincotta RP., 2000, NATURES PLACE HUMAN; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Dompka V, 1996, HUMAN POPULATION BIO; Durrenberger G, 2001, INT J ENVIRON POLLUT, V15, P159, DOI 10.1504/IJEP.2001.000599; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; GARDNEROUTLAW T, 1999, FOREST FUTURES POPUL; HOLDREN JP, 1974, AM SCI, V62, P282; IRONMONGER DS, 1995, ENERG ECON, V17, P301, DOI 10.1016/0140-9883(95)00032-P; KAUL S, 1992, ENERGY, V17, P405, DOI 10.1016/0360-5442(92)90114-F; Kinsella K., 2001, AGING WORLD 2001; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Kluza DA, 2000, ANIM CONSERV, V3, P15, DOI 10.1111/j.1469-1795.2000.tb00083.x; Lenzen M, 2001, ECOL ECON, V37, P229, DOI 10.1016/S0921-8009(00)00275-5; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; MacKellar FL, 1995, POPUL DEV REV, V21, P849, DOI 10.2307/2137777; MICHAEL RT, 1980, DEMOGRAPHY, V17, P39, DOI 10.2307/2060962; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NILON CH, 1995, LANDSCAPE URBAN PLAN, V32, P81, DOI 10.1016/0169-2046(94)00192-6; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rutledge DT, 2001, CONSERV BIOL, V15, P475, DOI 10.1046/j.1523-1739.2001.015002475.x; SANDIFORD P, 1990, J TROP MED HYG, V93, P383; THOMPSON WC, 1989, LAW HUMAN BEHAV, V13, P185, DOI 10.1007/BF01055923; *UN CTR HUMAN SETT, 2001, CIT GLOB WORLD GLOB; Wilson E.O., 1988, P3; YOUSIF HM, 1995, INT J SUST DEV WORLD, V2, P54, DOI 10.1080/13504509509469889	28	422	456	5	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					530	533		10.1038/nature01359	http://dx.doi.org/10.1038/nature01359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640DB	12540852				2022-12-01	WOS:000180670600044
J	Mack, T				Mack, T			A different view of smallpox and vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPONSES		Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Southern California	Mack, T (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.							*ADV COMM IMM PRAC, 2002, SUMM OCT 2002 ACIP S; Alibek K, 1999, BIOHAZARD CHILLING T; *ANDR AIR FORC BAS, 2001, DARK WINT BIOT EX; ARITA I, 1970, AM J PUBLIC HEALTH N, V60, P1960, DOI 10.2105/AJPH.60.10.1960; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BROAD WJ, 2002, NY TIMES A      0615, P1; *BUR LAB STAT, 2002, 2000 NAT IND SPEC OC; COWLEY G, 2002, NEWSWEEK        1014; DERUGY V, 2002, 434 CAT I, P1; DIXON C.W, 1962, SMALLPOX; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P615; DOWNIE AW, 1961, B WORLD HEALTH ORGAN, V25, P49; Fenner F., 1988, SMALLPOX ITS ERADICA; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; HEINER GG, 1971, AM J EPIDEMIOL, V94, P435, DOI 10.1093/oxfordjournals.aje.a121340; IRONS JV, 1953, AM J PUBLIC HEALTH, V43, P25, DOI 10.2105/AJPH.43.1.25; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; KEMPE CH, 1960, PEDIATRICS, V26, P176; KEMPE CH, 1961, B WORLD HEALTH ORGAN, V25, P41; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Lane JM, 1972, SMALLPOX YUGOSLAVIA; MACK TM, 1970, J INFECT DIS, V122, P479, DOI 10.1093/infdis/122.6.479; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; MACK TM, 1972, AM J EPIDEMIOL, V95, P169, DOI 10.1093/oxfordjournals.aje.a121382; MARENNIKOVA SS, 1962, B WORLD HEALTH ORGAN, V27, P325; MAYHEW CJ, 1970, APPL MICROBIOL, V20, P313, DOI 10.1128/AEM.20.3.313-316.1970; MEIKLEJOHN G, 1961, B WORLD HEALTH ORGAN, V25, P63; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Palmquist Emil E., 1947, CANADIAN JOUR PUBL HEALTH, V38, P213; Rao AR., 1972, SMALLPOX; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; THOMAS DB, 1972, AM J EPIDEMIOL, V95, P178, DOI 10.1093/oxfordjournals.aje.a121383; THOMAS DB, 1971, AM J EPIDEMIOL, V93, P361, DOI 10.1093/oxfordjournals.aje.a121269; WEINSTEIN I, 1947, AM J PUBLIC HEALTH, V37, P1376	35	41	42	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					460	463		10.1056/NEJMsb022994	http://dx.doi.org/10.1056/NEJMsb022994			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496354				2022-12-01	WOS:000180643800014
J	Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR				Egan, MF; Kojima, M; Callicott, JH; Goldberg, TE; Kolachana, BS; Bertolino, A; Zaitsev, E; Gold, B; Goldman, D; Dean, M; Lu, B; Weinberger, DR			The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function	CELL			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY STIMULATION; N-ACETYL ASPARTATE; NEUROTROPHIC FACTOR; SYNAPTIC TRANSMISSION; ALZHEIMERS-DISEASE; WORKING-MEMORY; RELATIVE RISK; KNOCKOUT MICE; SCHIZOPHRENIA	Brain-derived neurotrophic factor (BDNF) modulates hippocampal plasticity and hippocampal-dependent memory in cell models and in animals. We examined the effects of a valine (val) to methionine (met) substitution in the 5' pro-region of the human BDNF protein. In human subjects, the met allele was associated with poorer episodic memory, abnormal hippocampal activation assayed with fMRI, and lower hippocampal n-acetyl aspartate (NAA), assayed with MRI spectroscopy. Neurons transfected with met-BDNF-GFP showed lower depolarization-induced secretion, while constitutive secretion was unchanged. Furthermore, met-BDNF-GFP failed to localize to secretory granules or synapses. These results demonstrate a role for BDNF	NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bethesda, MD 20892 USA; NIMH, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; NIAAA, Neurogenet Lab, Rockville, MD 20857 USA; NCI, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Natl Inst AIST, Cell Dynam Res Grp, Osaka 5638577, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Lu, B (corresponding author), NICHHD, Sect Neural Dev & Plast, NIH, DHHS, Bldg 49-6A67, Bethesda, MD 20892 USA.		Majid, Salma/AAT-2616-2020; Callicott, Joseph H/AAE-7243-2022; Dean, Michael/R-7501-2019; Lu, Bai/A-4018-2012; Callicott, Joseph H/C-9102-2009; Goldman, David/F-9772-2010; Dean, Michael C/G-8172-2012; BERTOLINO, ALESSANDRO/O-6352-2016	Majid, Salma/0000-0002-1724-5405; Callicott, Joseph H/0000-0003-1298-3334; Goldman, David/0000-0002-1724-5405; Dean, Michael C/0000-0003-2234-0631; Lu, Bai/0000-0001-5418-9759; BERTOLINO, ALESSANDRO/0000-0002-1251-1380	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002716, ZIAMH002734, ZIAMH002716, Z01MH002734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000303, Z01AA000302] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bertolino A, 1996, AM J PSYCHIAT, V153, P1554; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 1998, BIOL PSYCHIAT, V44, P941, DOI 10.1016/S0006-3223(98)00264-9; de Geus EJC, 2001, BEHAV GENET, V31, P489, DOI 10.1023/A:1013360909048; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Farhadi HF, 2000, J NEUROSCI, V20, P4059; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; GOODMAN LJ, 1996, MOL CELL NEUROSCI, V7, P223; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Jenkins BG, 2000, J NEUROCHEM, V74, P2108, DOI 10.1046/j.1471-4159.2000.0742108.x; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kojima M, 2001, J NEUROSCI RES, V64, P1, DOI 10.1002/jnr.1080; Kopelman MD, 1998, BRAIN, V121, P875, DOI 10.1093/brain/121.5.875; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lu B, 2000, PROG BRAIN RES, V128, P231; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MAIER M, 1995, PSYCHOL MED, V25, P1201, DOI 10.1017/S0033291700033171; Mattay VS, 1996, J NEUROSCI, V16, P4816; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakatani A, 1998, J BIOCHEM-TOKYO, V123, P707; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Roses AD, 1998, ANN NY ACAD SCI, V855, P738, DOI 10.1111/j.1749-6632.1998.tb10653.x; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Tartaglia N, 2001, J BIOL CHEM, V276, P37585, DOI 10.1074/jbc.M101683200; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	52	2873	2988	5	256	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					257	269		10.1016/S0092-8674(03)00035-7	http://dx.doi.org/10.1016/S0092-8674(03)00035-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553913	Bronze			2022-12-01	WOS:000181191600014
J	Bell, JI				Bell, JI			The double helix in clinical practice	NATURE			English	Article							ASSOCIATION; GENETICS; CANCER; ASTHMA	The discovery of the double helix half a century ago has so far been slow to affect medical practice, but significant transformations are likely over the next 50 years. Changes to the way medicine is practised and new doctors are trained will be required before potential benefits are realized.	Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England	University of Oxford	Bell, JI (corresponding author), Univ Oxford, Off Regius Professor Med, Oxford OX3 9DU, England.	regius@medsci.ox.ac.uk						Abraham EP, 1941, LANCET, V2, P177; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; COOKSON WOCM, 1989, LANCET, V1, P1292; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; FISHER RA, 1958, NATURE, V182, P596, DOI 10.1038/182596a0; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Lewis T, 1944, LANCET, V1, P619; Osler W., 1892, PRINCIPLES PRACTICE; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Shirakawa T, 2000, IMMUNOL TODAY, V21, P60, DOI 10.1016/S0167-5699(99)01492-9; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WEBER WW, 1997, PHARMACOGENETICS	15	22	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					414	416		10.1038/nature01402	http://dx.doi.org/10.1038/nature01402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540912	Bronze			2022-12-01	WOS:000180533000053
J	Counihan, TJ				Counihan, TJ			Conjugal Parkinson's disease	LANCET			English	Editorial Material									Eastman Dent Ctr, Rochester, NY 14618 USA	Eastman Chemical Company; University of Rochester	Counihan, TJ (corresponding author), Eastman Dent Ctr, Rochester, NY 14618 USA.								0	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 18	2003	361	9353					252	252		10.1016/S0140-6736(03)12277-5	http://dx.doi.org/10.1016/S0140-6736(03)12277-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547554				2022-12-01	WOS:000180535400029
J	Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ				Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ			Risk factors for retained instruments and sponges after surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAABDOMINAL SURGERY; SURGICAL SPONGE; CLAIMS	Background: Risk factors for medical errors remain poorly understood. We performed a case-control study of retained foreign bodies in surgical patients in order to identify risk factors for this type of error. Methods: We reviewed the medical records associated with all claims or incident reports of a retained surgical sponge or instrument filed between 1985 and 2001 with a large malpractice insurer representing one third of the physicians in Massachusetts. For each case, we identified an average of four randomly selected controls who underwent the same type of operation during the same six-month period. Results: Our study included 54 patients with a total of 61 retained foreign bodies (of which 69 percent were sponges and 31 percent instruments) and 235 control patients. Thirty-seven of the patients with retained foreign bodies (69 percent) required reoperation, and one died. Patients with retained foreign bodies were more likely than controls to have had emergency surgery (33 percent vs. 7 percent, P<0.001) or an unexpected change in surgical procedure (34 percent vs. 9 percent, P<0.001). Patients with retained foreign bodies also had a higher mean body-mass index and were less likely to have had counts of sponges and instruments performed. In multivariate analysis, factors associated with a significantly increased risk of retention of a foreign body were emergency surgery (risk ratio, 8.8 [95 percent confidence interval, 2.4 to 31.9]), unplanned change in the operation (risk ratio, 4.1 [95 percent confidence interval, 1.4 to 12.4]), and body-mass index (risk ratio for each one-unit increment, 1.1 [95 percent confidence interval, 1.0 to 1.2]). Conclusions: The risk of retention of a foreign body after surgery significantly increases in emergencies, with unplanned changes in procedure, and with higher body-mass index. Case -control analysis of medical-malpractice claims may identify and quantify risk factors for specific types of errors.	Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, AA (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Gawande, Atul/0000-0002-1824-9176	AHRQ HHS [KO2HS11285, U18HS11886] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS011285, U18HS011886] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; CLARK C, 2002, SAN DIEGO UNION 0223, pB1; *DEP HHS, 1980, DHHS PUBL; Gibbs VC, 2001, MAKING HLTH CARE SAF, P255; Gonzalez-Ojeda A, 1999, HEPATO-GASTROENTEROL, V46, P808; HYSLOP JW, 1982, SOUTH MED J, V75, P657, DOI 10.1097/00007611-198206000-00006; Jason R S, 1979, J Natl Med Assoc, V71, P501; Kaiser CW, 1996, ANN SURG, V224, P79, DOI 10.1097/00000658-199607000-00012; KOHN LT, 1999, ERR HUMAN BUILDING S; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; MALERNEE J, 2001, ST PETERSBURG T 0724, P3; Pierson MA., 1995, ALEXANDERS CARE PATI, P19; POPOVIC JR, 2001, ADV DATA VITAL HLTH, V319; RAPPAPORT W, 1990, ARCH SURG-CHICAGO, V125, P405; SMITH C, 2001, SEATTLE POSTINT 1208, pB1; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002	16	579	594	0	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					229	235		10.1056/NEJMsa021721	http://dx.doi.org/10.1056/NEJMsa021721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529464	Bronze			2022-12-01	WOS:000180390600008
J	Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C				Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C		Tubingen 2000 Screen Consortium	A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor	NATURE			English	Article							HIV-1 ENTRY; PROTEIN; CHEMOTAXIS; ACTIVATION; AKT/PKB; RNA	Germ cells preserve an individual's genetic information and transmit it to the next generation. Early in development germ cells are set aside and undergo a specialized developmental programme, a hallmark of which is the migration from their site of origin to the future gonad(1). In Drosophila, several factors have been identified that control germ-cell migration to their target tissues(2-4); however, the germ-cell chemoattractant or its receptor have remained unknown. Here we apply genetics and in vivo imaging to show that odysseus, a zebrafish homologue of the G-protein-coupled chemokine receptor Cxcr4, is required specifically in germ cells for their chemotaxis. odysseus mutant germ cells are able to activate the migratory programme, but fail to undergo directed migration towards their target tissue, resulting in randomly dispersed germ cells. SDF-1, the presumptive cognate ligand for Cxcr4, shows a similar loss-of-function phenotype and can recruit germ cells to ectopic sites in the embryo, thus identifying a vertebrate ligand-receptor pair guiding migratory germ cells at all stages of migration towards their target.	Max Planck Inst Entwicklungsbiol, Abt Genet 3, D-72076 Tubingen, Germany	Max Planck Society	Knaut, H (corresponding author), Max Planck Inst Entwicklungsbiol, Abt Genet 3, Spemannstr 35, D-72076 Tubingen, Germany.		Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311; Dahm, Ralf/0000-0001-5203-8578; Knaut, Holger/0000-0002-8399-8720; Maderspacher, Florian/0000-0003-4324-8455				Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; TACHMINTZIS J, 1994, BIOCONTROL SCI TECHN, V4, P591, DOI 10.1080/09583159409355372; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Weidinger G, 2002, DEVELOPMENT, V129, P25; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	24	327	338	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					279	282		10.1038/nature01338	http://dx.doi.org/10.1038/nature01338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12508118				2022-12-01	WOS:000180397600050
J	Benner, SA				Benner, SA			Act natural	NATURE			English	Editorial Material									Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.							BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Gee H, 2001, NATURE, V409, P1079; WOODWARD R B, 1968, Pure and Applied Chemistry, V17, P519, DOI 10.1351/pac196817030519	3	67	73	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					118	118		10.1038/421118a	http://dx.doi.org/10.1038/421118a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520282				2022-12-01	WOS:000180267200020
J	Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A				Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A			Syncope, driving recommendations, and clinical reality: survey of patients	BRITISH MEDICAL JOURNAL			English	Article									Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Cardiol, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg	Maas, R (corresponding author), Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, Martinistr 52, D-20246 Hamburg, Germany.							Brignole M, 2001, EUR HEART J, V22, P1256, DOI 10.1053/euhj.2001.2739; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Olshansky B., 1998, SYNCOPE MECH MANAGEM; Petch MC, 1998, EUR HEART J, V19, P1165; SHELDON R, 1995, AM J CARDIOL, V75, P955, DOI 10.1016/S0002-9149(99)80699-7	5	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					21	21		10.1136/bmj.326.7379.21	http://dx.doi.org/10.1136/bmj.326.7379.21			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511456	Bronze, Green Published			2022-12-01	WOS:000180302000020
J	Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW				Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW			The organizing principle in the formation of the T cell receptor-CD3 complex	CELL			English	Article							ANTIGEN RECEPTOR; SURFACE EXPRESSION; TCR/CD3 COMPLEX; MULTIVALENT STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEIN; CD3-GAMMA CHAIN; CD3 COMPLEX; IN-VITRO; ASSOCIATION	The T cell receptor (TCR) serves a critical function in the immune system and represents one of the most complex receptor structures. A striking feature is the presence of nine highly conserved, potentially charged residues in the transmembrane helices. Previous models have attempted to explain assembly based on pairwise interactions of these residues. Using a novel method for the isolation of intact radiolabeled protein complexes, we demonstrate that one basic and two acidic transmembrane residues are required for the assembly of each of the three signaling dimers with the TCR. This remarkable three-helix arrangement applies to all three assembly steps and represents the organizing principle for the formation of this intricate receptor structure.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Program Immunol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.			Call, Matthew/0000-0001-5846-6469	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039096] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI045757, AI45757] Funding Source: Medline; NINDS NIH HHS [NS39096, R01 NS039096] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BIJLMAKERS MJE, 1993, EUR J IMMUNOL, V23, P1305, DOI 10.1002/eji.1830230618; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BLUMBERG RS, 1990, P NATL ACAD SCI USA, V87, P7220, DOI 10.1073/pnas.87.18.7220; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BUFERNE M, 1992, J IMMUNOL, V148, P657; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Exley M, 1991, Semin Immunol, V3, P283; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GEISLER C, 1992, J IMMUNOL, V148, P2437; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; JACOBS RR, 1997, INT J OCCUP ENV HL S, V3, P3; KEARSE KP, 1995, IMMUNITY, V2, P391; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	34	307	324	2	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					967	979		10.1016/S0092-8674(02)01194-7	http://dx.doi.org/10.1016/S0092-8674(02)01194-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507424	Green Accepted, Bronze			2022-12-01	WOS:000180086000007
J	Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW				Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW			Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin	CELL			English	Article							LEUCINE-RICH REPEAT; CELL-ADHESION; SURFACE-PROTEINS; ENTRY; RECOGNITION; REFINEMENT; EXPRESSION; CATENINS; DOMAIN; SRTA	Listeria monocytogenes, a food-borne bacterial pathogen, enters mammalian cells by inducing its own phagocytosis. The listerial protein internalin (InIA) mediates bacterial adhesion and invasion of epithelial cells in the human intestine through specific interaction with its host cell receptor E-cadherin. We present the crystal structures of the functional domain of InIA alone and in a complex with the extracellular, N-terminal domain of human E-cadherin (hEC1). The leucine rich repeat (LRR) domain of InIA surrounds and specifically recognizes hEC1. Individual interactions were probed by mutagenesis and analytical ultracentrifugation. These include Pro16 of hEC1, a major determinant for human susceptibility to L. monocytogenes infection that is essential for intermolecular recognition. Our studies reveal the structural basis for host tropism of this bacterium and the molecular deception L. monocytogenes employs to exploit the E-cadherin system.	German Res Ctr Biotechnol, Dept Biol Struct, D-38124 Braunschweig, Germany; German Res Ctr Biotechnol, Dept Cell Biol, D-38124 Braunschweig, Germany; Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany; Univ Giessen, Inst Med Microbiol, D-35385 Giessen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Justus Liebig University Giessen	Heinz, DW (corresponding author), German Res Ctr Biotechnol, Dept Biol Struct, Mascheroder Weg 1, D-38124 Braunschweig, Germany.	dih@gbf.de	Machner, Matthias/G-2758-2015; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Machner, Matthias/0000-0002-6971-7451				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Daniels JJD, 2000, FEMS MICROBIOL LETT, V190, P323, DOI 10.1016/S0378-1097(00)00356-6; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; DRAMSI S, 1993, MOL MICROBIOL, V9, P931, DOI 10.1111/j.1365-2958.1993.tb01223.x; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Glaser P, 2001, SCIENCE, V294, P849; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HARTMAN AB, 1990, J BACTERIOL, V172, P1905, DOI 10.1128/jb.172.4.1905-1915.1990; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2002, TRENDS BIOCHEM SCI, V27, P308, DOI 10.1016/S0968-0004(02)02108-4; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 2000, J APPL CRYSTALLOGR, V33, P990; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Lecuit M, 2000, P NATL ACAD SCI USA, V97, P10008, DOI 10.1073/pnas.97.18.10008; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Machner MP, 2001, J BIOL CHEM, V276, P40096, DOI 10.1074/jbc.M104279200; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5; Schlech WF, 2000, CLIN INFECT DIS, V31, P770, DOI 10.1086/314008; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X	57	222	246	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					825	836		10.1016/S0092-8674(02)01136-4	http://dx.doi.org/10.1016/S0092-8674(02)01136-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526809	Bronze			2022-12-01	WOS:000179862600009
J	Jayaraman, KS				Jayaraman, KS			Syngenta ready to drop plans for Indian rice venture	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					596	596		10.1038/420596b	http://dx.doi.org/10.1038/420596b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478254	Bronze			2022-12-01	WOS:000179751800010
J	Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM				Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM			Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?	LANCET			English	Article							HUMAN INFECTION; EXPRESSION; TRANSCRIPTION; PATHOGENESIS; INHIBITION; RESPONSES; POULTRY; BLOOD; LUNG	Background In 1997, the first documented instance of human respiratory disease and death associated with a purely avian H5N1 influenza virus resulted in an overall case-fatality rate of 33%. The biological basis for the severity of human H5N1 disease has remained unclear. We tested the hypothesis that virus-induced cytokine dysregulation has a role. Methods We used cDNA arrays and quantitative RT-PCR to, compare the profile of cytokine gene expression induced by viruses A/HK/486/97 and A/HK/483/97 (both H5N1/97) with that of human H3N2 and H1N1 viruses in human primary monocyte-derived macrophages in vitro. Secretion of tumour necrosis factor alpha (TNF alpha) from macrophages infected with the viruses was compared by ELISA. By use of naturally occurring viral reassortants and recombinant viruses generated by reverse genetic techniques, we investigated the viral genes associated with the TNF-alpha response. Findings The H5N1/97 viruses induced much higher gene transcription of proinflammatory cytokines than did H3N2 or H1N1 viruses, particularly TNF alpha. and interferon beta. The concentration of TNF-alpha. protein in culture supernatants of macrophages infected with these viruses was similar to that induced by stimulation with Escherichia coli lipopolysaccharide. The non-structural (NS) gene-segment of H5N1/97 viruses contributed to the increase in TNF alpha induced by the virus. Interpretation The H5N1/97 viruses are potent inducers of proinflammatory cytokines in macrophages, the most notable being TNF alpha. This characteristic may contribute to the unusual severity of human H5N1 disease.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Hong Kong; University of Hong Kong; University of Oxford	Peiris, JSM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Cheung, Chung Yan/C-4233-2009; Poon, Leo/AAP-6887-2020; Lau, Yu Lung/C-4322-2009; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Guan, Yi/0000-0001-6057-9243				Aggarwal B., 2001, CYTOKINE REFERENCE C, V1, P413; Blaschke V, 2000, J IMMUNOL METHODS, V246, P79, DOI 10.1016/S0022-1759(00)00304-5; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Ciesielski CJ, 2002, EUR J IMMUNOL, V32, P2037, DOI 10.1002/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO;2-I; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; DEHOUX MS, 1994, AM J RESP CRIT CARE, V150, P710, DOI 10.1164/ajrccm.150.3.8087341; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; GORDON S, 1997, LUNG MACROPHAGES DEN, P3; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P10096, DOI 10.1073/pnas.152327499; Liu EM, 2001, PEDIATR RES, V50, P184, DOI 10.1203/00006450-200108000-00004; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; MONTANER LJ, 1996, WEIRS HDB EXPT IMMUN, V4, P1; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	30	691	748	1	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1831	1837		10.1016/S0140-6736(02)11772-7	http://dx.doi.org/10.1016/S0140-6736(02)11772-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480361				2022-12-01	WOS:000179706100011
J	Lardner, B; bin Lakim, M				Lardner, B; bin Lakim, M			Tree-hole frogs exploit resonance effects	NATURE			English	Article							CALL DURATION; GRAY; ACOUSTICS; BURROW; CHOICE		Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA; Sabah Pk, Res & Educ Div, Kota Kinabalu 88806, Sabah, Malaysia	Field Museum of Natural History (Chicago)	Lardner, B (corresponding author), Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA.							BAILEY WJ, 1981, J NAT HIST, V15, P693, DOI 10.1080/00222938100770491; Bailey WJ, 2001, J EXP BIOL, V204, P2827; BENNETCLARK HC, 1987, J EXP BIOL, V128, P383; Daws A. G., 1996, Bioacoustics, V7, P81; Gerhardt H.C., 2002, ACOUSTIC COMMUNICATI; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; KLUMP GM, 1987, NATURE, V326, P286, DOI 10.1038/326286a0; Penna M, 1996, ANIM BEHAV, V51, P255, DOI 10.1006/anbe.1996.0026; PROZESKYSCHULZE L, 1975, NATURE, V255, P142, DOI 10.1038/255142a0; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Wells Kentwood D., 2001, P45	12	73	75	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					475	475		10.1038/420475a	http://dx.doi.org/10.1038/420475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466831	Bronze			2022-12-01	WOS:000179611600033
J	Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ				Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ			The mosaic structure of variation in the laboratory mouse genome	NATURE			English	Article							GENETIC-VARIATION; INBRED STRAINS; MICE; DNA	Most inbred laboratory mouse strains are known to have originated from a mixed but limited founder population in a few laboratories(1,2). However, the effect of this breeding history on patterns of genetic variation among these strains and the implications for their use are not well understood. Here we present an analysis of the fine structure of variation in the mouse genome, using single nucleotide polymorphisms (SNPs). When the recently assembled genome sequence from the C57BL/6J strain(3) is aligned with sample sequence from other strains, we observe long segments of either extremely high (similar to40 SNPs per 10 kb) or extremely low (similar to0.5 SNPs per 10 kb) polymorphism rates. In all strain-to-strain comparisons examined, only one-third of the genome falls into long regions (averaging >1 Mb) of a high SNP rate, consistent with estimated divergence rates between Mus musculus domesticus and either M. m. musculus or M. m. castaneus. These data suggest that the genomes of these inbred strains are mosaics with the vast majority of segments derived from domesticus and musculus sources. These observations have important implications for the design and interpretation of positional cloning experiments.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; Univ Queensland, Sch Vet Sci, St Lucia, Qld 4067, Australia; Sanger Ctr, Hinxton CB10 1RQ, Cambs, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Queensland; Wellcome Trust Sanger Institute	Lindblad-Toh, K (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Wade, Claire/0000-0003-3413-4771				Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Prager EM, 1998, GENETICS, V150, P835; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schalkwyk LC, 1999, GENOME RES, V9, P878, DOI 10.1101/gr.9.9.878; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; YONEKAWA H, 1980, JPN J GENET, V55, P289, DOI 10.1266/jjg.55.289	18	370	381	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					574	578		10.1038/nature01252	http://dx.doi.org/10.1038/nature01252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466852	Bronze			2022-12-01	WOS:000179611600055
J	Barbera, JA; Macintyre, AG				Barbera, JA; Macintyre, AG			The reality of the modern bioterrorism response	LANCET			English	Article									George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA	George Washington University	Barbera, JA (corresponding author), George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S33	S34		10.1016/S0140-6736(02)11812-5	http://dx.doi.org/10.1016/S0140-6736(02)11812-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504495	Bronze			2022-12-01	WOS:000180064500016
J	Harrod, HL				Harrod, HL			An essay on desire	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					813	814		10.1001/jama.289.7.813	http://dx.doi.org/10.1001/jama.289.7.813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588245				2022-12-01	WOS:000181072200001
J	Evans, JG				Evans, JG			Drugs and falls in later life	LANCET			English	Editorial Material							RISK		Univ Oxford Green Coll, Oxford OX2 6HE, England	University of Oxford	Evans, JG (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HE, England.	john.grimleyevans@geratology.oxford.ac.uk						COOK PJ, 1986, ACTA PSYCHIAT S S332, V73, P149; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; EVANS JG, 1990, AGE AGEING, V19, P268, DOI 10.1093/ageing/19.4.268; EVANS JG, 1992, FALLS, BALANCE AND GAIT DISORDERS IN THE ELDERLY, P39; HECKMAN GA, 2002, COCHRANE LIB; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; MURPHY J, 1982, GERONTOLOGY, V28, P265, DOI 10.1159/000212543; PRUDHAM D, 1981, AGE AGEING, V10, P264; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303	10	32	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					448	448		10.1016/S0140-6736(03)12502-0	http://dx.doi.org/10.1016/S0140-6736(03)12502-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583941				2022-12-01	WOS:000180900600006
J	Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA				Dajee, M; Lazarov, M; Zhang, JY; Cai, T; Green, CL; Russell, AJ; Marinkovich, MP; Tao, SY; Lin, Q; Kubo, Y; Khavari, PA			NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia	NATURE			English	Article							SQUAMOUS-CELL CARCINOMAS; HUMAN BREAST-CANCER; SKIN; ALPHA-6-BETA-4; CARCINOGENESIS; ACTIVATION; EXPRESSION; APOPTOSIS; LAMININ-5; SUBUNITS	The nuclear factor NF-kappaB and oncogenic Ras can alter proliferation in epidermis, the most common site of human cancer(1,2). These proteins are implicated in epidermal squamous cell carcinoma in mice(3-5), however, the potential effects of altering their function are uncertain. Whereas inhibition of NF-kappaB enhances apoptosis in certain tumours(6), blockade of NF-kappaB predisposes murine skin to squamous cell carcinoma(5,7). Because therapeutics inhibiting Ras and NF-kappaB pathways are being developed to treat human cancer(8,9), it is essential to assess the effects of altering these regulators. The medical relevance of murine studies is limited, however, by differences between mouse and human skin, and by the greater ease of transforming murine cells. Here we show that in normal human epidermal cells both NF-kappaB and oncogenic Ras trigger cell-cycle arrest. Growth arrest triggered by oncogenic Ras can be bypassed by IkappaBalpha-mediated blockade of NF-kappaB, generating malignant human epidermal tissue resembling squamous cell carcinoma. Human cell tumorigenesis is dependent on laminin 5 and alpha6beta4 integrin. Thus, IkappaBalpha circumvents restraints on growth promotion induced by oncogenic Ras and can act with Ras to induce invasive human tissue neoplasia.	Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Vet Affairs Palo Alto Healthcare Syst, Stanford, CA 94305 USA.		Zhang, Junyi/HDN-7815-2022	Russell, Alan/0000-0001-7545-5008; Zhang, Jennifer Y./0000-0002-4485-1750				Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; LAAROV M, 2002, NAT MED, V8, P1105; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARINKOVICH MP, 1999, DERMATOLOGY GEN MED, P690; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Nordemar S, 2001, ANTICANCER RES, V21, P509; Pazzaglia S, 2001, MOL CARCINOGEN, V30, P111, DOI 10.1002/1098-2744(200102)30:2<111::AID-MC1019>3.0.CO;2-L; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; SAVOIA P, 1993, J INVEST DERMATOL, V101, P352, DOI 10.1111/1523-1747.ep12365531; Seitz CS, 2000, CANCER RES, V60, P4085; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Stambolic V, 1999, ONCOGENE, V18, P6094, DOI 10.1038/sj.onc.1203126; VAN AD, 1996, SCIENCE, V274, P787; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; YUSPA SH, 1994, CANCER RES, V54, P1178; Zimonjic D, 2001, CANCER RES, V61, P8838	30	452	465	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					639	643		10.1038/nature01283	http://dx.doi.org/10.1038/nature01283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571598				2022-12-01	WOS:000180803200044
J	Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N				Inadomi, JM; Sampliner, R; Lagergren, J; Lieberman, D; Fendrick, AM; Vakil, N			Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX DISEASE; SPECIALIZED INTESTINAL METAPLASIA; PROSPECTIVE MULTIVARIATE-ANALYSIS; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; GASTROINTESTINAL-ENDOSCOPY; SURGICAL-TREATMENT; OVERRATED RISK; CANCER-RISK	Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed for patients with gastroesophageal reflux disease (GERD) but there is little evidence of its cost-effectiveness. Objective: 1) To determine the cost-effectiveness of screening high-risk groups for Barrett esophagus and providing surveillance to patients with Barrett esophagus and dysplasia or to all patients With Barrett esophagus and 2) to compare the results with the cost-effectiveness of no screening or surveillance. Design: A decision analytic model was developed to examine no screening or surveillance and screening and surveillance for Barrett esophagus with dysplasia only or Barrett esophagus without dysplasia every 2 to 5 years. Low- or high-grade dysplasia received surveillance every 6 or 3 months, respectively. Data Sources: Published literature and the Health Care Financing Administration. Target Population: 50-year-old white men with symptoms of GERD. Time Horizon: 50 years of age until 80 years of age or death. Perspective: Third-party payer. Outcome Measure: incremental cost-effectiveness ratio. Results of Base-Case Analysis: Screening with surveillance limited to patients with Barrett esophagus with dysplasia required $10 440 per quality-adjusted life-year (QALY) saved compared to no screening or surveillance. The incremental cost-effectiveness ratio of surveillance every 5 years in patients with Barrett esophagus without dysplasia compared to surveillance of patients with Barrett esophagus with dysplasia was $596 000 per QALY saved. Results of Sensitivity Analysis: The annual incidence of adenocarcinoma must exceed 1 case per 54 patient-years of follow-up (1.9%) foe surveillance of Barrett esophagus without dysplasia every 5 years to yield an incremental cost-effectiveness ratio less than $50 000 per QALY saved. Conclusions: Screening 50-year-old men with symptoms of GERD to detect adenocarcinoma associated with Barrett esophagus is probably cost-effective. However, subsequent surveillance of patients with Barrett esophagus but no dysplasia, even at 5-year intervals, is an expensive practice.	Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, Milwaukee, WI 53233 USA; Univ Michigan, Vet Adm Ctr Practice Management & Outcomes Res, Ann Arbor, MI 48109 USA; Consortium Hlth Outcomes Innovat & Cost Effective, Ann Arbor, MI USA; SO Arizona Vet Affairs Healthcare Syst, Tucson, AZ USA; Univ Arizona, Tucson, AZ 85724 USA; Karolinska Inst, S-10521 Stockholm, Sweden; Karolinska Hosp, S-10401 Stockholm, Sweden; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; University of Arizona; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Oregon Health & Science University	Vakil, N (corresponding author), Univ Wisconsin, Sch Med, Aurora Sinai Med Ctr, Div Gastroenterol, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu	Inadomi, John/A-6221-2014	Inadomi, John/0000-0001-6776-8661; Lagergren, Jesper/0000-0002-5143-5448				ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; BONELLI L, 1993, ENDOSCOPY, V25, P652, DOI 10.1055/s-2007-1010425; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Caygill CPJ, 1999, EUR J GASTROEN HEPAT, V11, P1355, DOI 10.1097/00042737-199912000-00003; Caygill CPJ, 1999, EUR J CANCER PREV, V8, P539, DOI 10.1097/00008469-199912000-00010; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; DEMEESTER TR, 1988, J THORAC CARDIOV SUR, V95, P42; DENT J, 1991, J GASTROEN HEPATOL, V6, P1, DOI 10.1111/j.1440-1746.1991.tb01137.x; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; Ellis FH, 1997, J THORAC CARDIOV SUR, V113, P836, DOI 10.1016/S0022-5223(97)70256-3; ELLIS FH, 1983, ANN SURG, V198, P531, DOI 10.1097/00000658-198310000-00013; Eloubeidi MA, 1999, AM J GASTROENTEROL, V94, P2033; Eloubeidi MA, 2001, J CLIN GASTROENTEROL, V33, P306, DOI 10.1097/00004836-200110000-00010; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; GALANDIUK S, 1986, ANN SURG, V203, P101, DOI 10.1097/00000658-198601000-00016; Gorelick AB, 2001, J CLIN GASTROENTEROL, V33, P210, DOI 10.1097/00004836-200109000-00008; HABRGAMA A, 1989, WORLD J SURG, V13, P193, DOI 10.1007/BF01658399; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; Johnston MH, 1996, AM J GASTROENTEROL, V91, P1507; Katz D, 1998, AM J GASTROENTEROL, V93, P536; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; MENKEPLUYMERS MBE, 1992, GUT, V33, P1454, DOI 10.1136/gut.33.11.1454; *NAT CTR HLTH STAT, 2001, VIT STAT US 2000; Nguyen NT, 2000, SURGERY, V127, P284, DOI 10.1067/msy.2000.103489; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; PERA M, 1992, ANN THORAC SURG, V54, P199, DOI 10.1016/0003-4975(92)91370-O; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; ROBERTSON CS, 1988, BRIT J SURG, V75, P760, DOI 10.1002/bjs.1800750813; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Schoenfeld P, 1998, AM J GASTROENTEROL, V93, P906; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Sharma P, 2001, GASTROENTEROLOGY, V120, pA16, DOI 10.1016/S0016-5085(08)80081-9; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; SILVIS SE, 1976, JAMA-J AM MED ASSOC, V235, P928, DOI 10.1001/jama.235.9.928; SKINNER DB, 1983, J THORAC CARDIOV SUR, V85, P59; Soni A, 2000, AM J GASTROENTEROL, V95, P2086; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; SPECHLER SJ, 1984, GASTROENTEROLOGY, V87, P927; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; Streitz JM, 1998, AM J GASTROENTEROL, V93, P911; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; van Sandick JW, 1998, GUT, V43, P216, DOI 10.1136/gut.43.2.216; VANDERVEEN AH, 1989, GUT, V30, P14, DOI 10.1136/gut.30.1.14; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Weston AP, 1996, AM J GASTROENTEROL, V91, P981; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Weston AP, 1999, AM J GASTROENTEROL, V94, P3420, DOI 10.1016/S0002-9270(99)00662-0; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; WOLFE WG, 1993, J THORAC CARDIOV SUR, V105, P749; Wright TA, 1996, GUT, V39, P574, DOI 10.1136/gut.39.4.574; WU YK, 1979, ANN SURG, V190, P361	63	296	302	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					176	186		10.7326/0003-4819-138-3-200302040-00009	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558356				2022-12-01	WOS:000181018600003
J	Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN				Sosic, D; Richardson, JA; Yu, K; Ornitz, DM; Olson, EN			Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappa B activity	CELL			English	Article							TRANSCRIPTION FACTORS; DROSOPHILA EMBRYO; BHLH PROTEIN; INFLAMMATORY DISEASES; MESODERMAL CELLS; ZYGOTIC GENE; ACTIVATION; CACHEXIA; PATTERN; ENHANCER	During Drosophila embryogenesis, the dorsal transcription factor activates the expression of twist, a transcription factor required for mesoderm formation. We show here that the mammalian twist proteins, twist-1 and -2, are induced by a cytokine signaling pathway that requires the dorsal-related protein RelA, a member of the NF-kappaB family of transcription factors. Twist-1 and -2 repress cytokine gene expression through interaction with RelA. Mice homozygous for a twist-2 null allele or doubly heterozygous for twist-1 and -2 alleles show elevated expression of proinflammatory cytokines, resulting in perinatal death from cachexia. These findings reveal an evolutionarily conserved signaling circuit in which twist proteins regulate cytokine signaling by establishing a negative feedback loop that represses the NF-kappaB-dependent cytokine pathway.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.			Ornitz, David/0000-0003-1592-7629	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039952] Funding Source: NIH RePORTER; NICHD NIH HHS [HD39952] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Castanon I, 2001, DEVELOPMENT, V128, P3145; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; DEKOSSODO S, 1995, J INVEST DERMATOL, V104, P318, DOI 10.1111/1523-1747.ep12665361; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; IP TY, 1992, GENE DEV, V6, P1518; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; JIANG J, 1992, EMBO J, V11, P3147, DOI 10.1002/j.1460-2075.1992.tb05387.x; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KHABAR KSA, 1995, IMMUNOL LETT, V46, P107, DOI 10.1016/0165-2478(95)00026-2; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Ling PR, 1996, AM J PHYSIOL-ENDOC M, V270, pE305, DOI 10.1152/ajpendo.1996.270.2.E305; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Misra S, 1998, DEVELOPMENT, V125, P1261; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; Protonotariou E, 1999, EARLY HUM DEV, V56, P31, DOI 10.1016/S0378-3782(99)00029-8; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sheehan D., 1980, THEORY PRACTICE HIST; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; STJOHNSTON D, 1992, CELL, V68, P201; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; THISSE B, 1987, GENE DEV, V1, P709, DOI 10.1101/gad.1.7.709; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; WURST W, 1993, GENE TARGETING PRACT	43	337	371	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					169	180		10.1016/S0092-8674(03)00002-3	http://dx.doi.org/10.1016/S0092-8674(03)00002-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553906	Bronze			2022-12-01	WOS:000181191600007
J	Hoag, H				Hoag, H			Transgenic salmon still out in the cold in United States	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657	1	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					304	304		10.1038/421304b	http://dx.doi.org/10.1038/421304b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540865	Bronze			2022-12-01	WOS:000180533000010
J	Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH				Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH			Review of deaths related to taking ecstasy, England and Wales, 1997-2000	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England	St Georges University London	Schifano, F (corresponding author), St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England.		Webb, Lucy/AAA-3078-2022	Webb, Lucy/0000-0003-2580-3654; Corkery, John Martin/0000-0002-3849-817X				*EUR MON CTR DRUG, 2001, ANN REP STAT DRUGS P; GHODSE AH, 2002, 9 NPSAD EUR CTR ADD; Giroud C, 1997, Praxis (Bern 1994), V86, P510; Gore SM, 1999, LANCET, V354, P1265, DOI 10.1016/S0140-6736(99)02729-4; Schifano F, 2000, NEUROPSYCHOBIOLOGY, V42, P25, DOI 10.1159/000026667	5	41	42	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					80	81		10.1136/bmj.326.7380.80	http://dx.doi.org/10.1136/bmj.326.7380.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521971	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000180426900015
J	Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A				Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A			Ringlike structure of the Deinococcus radiodurans genome: A key to radioresistance?	SCIENCE			English	Article							IONIZING-RADIATION; CELL-DIVISION; DNA; RESISTANT; REPAIR; RECOMBINATION; FRAGMENTS; MODEL	The bacterium Deinococcus radiodurans survives ionizing irradiation and other DNA-damaging assaults at doses that are lethal to all other organisms. How D. radiodurans accurately reconstructs its genome from hundreds of radiation-generated fragments in the absence of an intact template is unknown. Here we show that the D. radiodurans genome assumes an unusual toroidal morphology that may contribute to its radioresistance. We propose that, because of restricted diffusion within the tightly packed and laterally ordered DNA toroids, radiation-generated free DNA ends are held together, which may facilitate template-independent yet error-free joining of DNA breaks.	Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA	Minsky, A (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.							Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; CHOU FI, 1990, J BACTERIOL, V172, P2029, DOI 10.1128/jb.172.4.2029-2035.1990; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; DALY MJ, 1995, SCIENCE, V270, P1318, DOI 10.1126/science.270.5240.1318; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; Jary D, 1999, BIOCHEMISTRY-US, V38, P3223, DOI 10.1021/bi982770h; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; MA CL, 1994, BIOPHYS J, V67, P1678, DOI 10.1016/S0006-3495(94)80641-1; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MURRAY RGE, 1983, CAN J MICROBIOL, V29, P1412, DOI 10.1139/m83-217; NORRIS V, 1995, J MOL BIOL, V253, P739, DOI 10.1006/jmbi.1995.0587; RAU DC, 1992, BIOPHYS J, V61, P260, DOI 10.1016/S0006-3495(92)81832-5; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z	22	185	209	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					254	256		10.1126/science.1077865	http://dx.doi.org/10.1126/science.1077865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522252				2022-12-01	WOS:000180284000040
J	Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L				Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L		Netherlands Epidemiology Demograph	Obesity in adulthood and its consequences for, life expectancy: A life-table analysis	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; WEIGHT CHANGE; DIABETES-MELLITUS; RISK-FACTORS; FOLLOW-UP; MORTALITY; HEALTH; ASSOCIATION; OVERWEIGHT	Background: Overweight and obesity in adulthood are linked to an increased risk for death and disease. Their potential effect on life expectancy and premature death has not yet been described. Objective: To analyze reductions in life expectancy and increases in premature death associated with overweight and obesity at 40 years of age. Design: Prospective cohort study. Setting: The Framingham Heart Study with follow-up from 1948 to 1990. Participants: 3457 Framingham Heart Study participants who were 30 to 49 years of age at baseline. Measurements: Mortality rates specific for age and body mass index group (normal weight, overweight, or obese at baseline) were derived within sex and smoking status strata. Life expectancy and the probability of death before 70 years of age were analyzed by using life tables. Results: Large decreases in life expectancy were associated with overweight and obesity. Forty-year-old female nonsmokers lost 3.3 years and 40-year-old male nonsmokers lost 3.1 years of life expectancy because of overweight. Forty-year-old female nonsmokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8 years because of obesity. Obese female smokers lost 7.2 years and obese male smokers lost 6.7 years of life expectancy compared with normal-weight, smokers. Obese female smokers lost 13.3 years and obese male smokers lost 13.7 years compared with normal-weight nonsmokers. Body mass index at ages 30 to 49 years predicted mortality after ages 50 to 69 years, even after adjustment for body mass index at age 50 to 69 years. Conclusions: Obesity and overweight in adulthood are associated with large decreases in life expectancy and increases in early mortality. These decreases are similar to those seen with smoking. Obesity in adulthood is. a powerful predictor of death at older ages. Because of the increasing prevalence of obesity, more efficient prevention and treatment should become high priorities in public health.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Univ Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	Peeters, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	peeters@mgz.fgg.eur.nl	Barendregt, Jan J/F-6895-2010; Peeters, Anna/M-8284-2019; PEETERS, ANNA/B-3663-2013; Mamun, Abdullah A/A-4673-2011	Peeters, Anna/0000-0003-4340-9132; PEETERS, ANNA/0000-0003-4340-9132; Mamun, Abdullah A/0000-0002-1535-8086; Kunst, Anton/0000-0002-3313-5273				ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1989, US DEC LIF TABL 1989, V2; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; Efron B., 1993, INTRO BOOTSTRAP, P184; Garrison RJ, 1996, CURR OPIN LIPIDOL, V7, P199, DOI 10.1097/00041433-199608000-00005; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Magarey AM, 2001, MED J AUSTRALIA, V174, P561, DOI 10.5694/j.1326-5377.2001.tb143435.x; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Peeters A, 2002, EUR HEART J, V23, P458, DOI 10.1053/euhj.2001.2838; PEKKANEN J, 1993, CARDIOLOGY, V82, P181, DOI 10.1159/000175867; PETERS ETJ, 1995, INT J OBESITY, V19, P862; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; ROGERS RG, 1991, SOC SCI MED, V32, P1151, DOI 10.1016/0277-9536(91)90092-Q; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, P422; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; SHURTLEFF D, 1971, FRAMINGHAM STUDY EPI; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Wannamethee SG, 1999, HEART, V81, P374, DOI 10.1136/hrt.81.4.374; Wannamethee SG, 2001, INT J EPIDEMIOL, V30, P777, DOI 10.1093/ije/30.4.777; *WHO, 1998, REP WHO CONS OB 3 5	35	893	923	2	78	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					24	32		10.7326/0003-4819-138-1-200301070-00008	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513041	Green Published			2022-12-01	WOS:000180996200004
J	Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M				Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M			Structure of the Escherichia coli ribosomal termination complex with release factor 2	NATURE			English	Article							TRANSFER-RNA HYDROLYSIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; FACTOR RF3; TRANSLATION; ERF1; RESOLUTION; BINDING; ERRORS; SITE	Termination of protein synthesis(1) occurs when the messenger RNA presents a stop codon in the ribosomal aminoacyl (A) site. Class I release factor proteins (RF1 or RF2) are believed to recognize stop codons via tripeptide motifs(2), leading to release of the completed polypeptide chain from its covalent attachment to transfer RNA in the ribosomal peptidyl (P) site. Class I RFs possess a conserved GGQ amino-acid motif that is thought to be involved directly in protein-transfer-RNA bond hydrolysis(3,4). Crystal structures of bacterial and eukaryotic class I RFs have been determined(5,6), but the mechanism of stop codon recognition and peptidyl-tRNA hydrolysis remains unclear. Here we present the structure of the Escherichia coli ribosome in a post-termination complex with RF2, obtained by single-particle cryo-electron microscopy (cryo-EM). Fitting the known 70S and RF2 structures into the electron density map reveals that RF2 adopts a different conformation on the ribosome when compared with the crystal structure of the isolated protein. The amino-terminal helical domain of RF2 contacts the factor-binding site of the ribosome, the 'SPF' loop of the protein is situated close to the mRNA, and the GGQ-containing domain of RF2 interacts with the peptidyl-transferase centre (PTC). By connecting the ribosomal decoding centre with the PTC, RF2 functionally mimics a tRNA molecule in the A site. Translational termination in eukaryotes is likely to be based on a similar mechanism.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark	Imperial College London; Uppsala University; Aarhus University	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.		Orlova, Elena/CAF-8290-2022; Myasnikov, Alexander/T-4654-2018	Orlova, Elena/0000-0003-3371-415X; Vestergaard, Bente/0000-0001-8011-6414; Pape, Tillmann/0000-0002-0612-3568; Zavialov, Andrey/0000-0001-6420-0368				Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HARAUZ G, 1986, OPTIK, V73, P146; Inagaki Y, 2002, NUCLEIC ACIDS RES, V30, P532, DOI 10.1093/nar/30.2.532; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASTNER B, 1990, J MOL BIOL, V212, P241, DOI 10.1016/0022-2836(90)90120-B; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Tin OF, 2000, BIOCHIMIE, V82, P765, DOI 10.1016/S0300-9084(00)01149-4; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Xu WB, 2002, J BACTERIOL, V184, P1200, DOI 10.1128/jb.184.4.1200-1203.2002; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZAVIALOV AV, IN PRESS MOL CELL	29	166	170	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					90	94		10.1038/nature01225	http://dx.doi.org/10.1038/nature01225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511961				2022-12-01	WOS:000180165500044
J	Taylor, WR; Lin, K				Taylor, WR; Lin, K			Protein knots - A tangled problem	NATURE			English	Editorial Material									Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, Div Math Biol, Mill Hill, London NW7 1AA, England.							MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; TAYLOR WR, IN PRESS COMP BIOL C	4	86	87	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					25	25		10.1038/421025a	http://dx.doi.org/10.1038/421025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511935	Bronze			2022-12-01	WOS:000180165500019
J	Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS				Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS			Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; LIFE-STYLE; US ADULTS; OVERWEIGHT; GLUCOSE	Context Obesity and diabetes are increasing in the United States. Objective To estimate the prevalence of obesity and diabetes among US adults in 2001. Design, Setting, and Participants Random-digit telephone survey of 195 005 adults aged 18 years or older residing in all states participating in the Behavioral Risk Factor Surveillance System in 2001. Main Outcome Measures Body mass index,based on self-reported weight and height and self-reported diabetes., Results In 2001 the prevalence of obesity (BMI greater than or equal to30) was 20.9% vs 19.8% in 2000, an increase of 5.6%. The prevalence of diabetes increased to 7.9% vs 7.3% in 2000, an increase of 8.2%. The prevalence of BMI of 40 or higher in 2001 was 2.3%. Overweight and obesity were significantly associated with diabetes, high blood pressure, high cholesterol, asthma, arthritis, and poor health status. Compared with adults with normal weight, adults with a BMI of 40 or higher had an odds ratio (OR) of 7.37 (95% confidence interval [CI], 6.39-8.50) for diagnosed diabetes, 6.38 (95% Cl, 5.67-7.17) for high blood pressure, 1.88 (95% CI,1.67-2.13) for high cholesterol levels, 2.72 (95% CI, 2.38-3.12) for asthma, 4.41 (95% CI, 3.91-4.97),for arthritis, and 4.19 (95% CI, 3.68-4.76) for fair or poor health. Conclusions Increases in obesity and diabetes among US adults continue in both sexes, all ages, all races, all educational levels, and all smoking levels. Obesity is strongly associated with several major health risk factors.	CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K66, Atlanta, GA 30341 USA.	ahm1@cdc.gov	Adiels, Martin/C-9278-2011					ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *CDCP, 2000, NAT DIAB FACT SHEET; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 2001, SAS SYST VERS 8; SHAH BV, 2000, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Will JC, 2002, AM J PUBLIC HEALTH, V92, P1245, DOI 10.2105/AJPH.92.8.1245	23	2971	3033	9	458	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					76	79		10.1001/jama.289.1.76	http://dx.doi.org/10.1001/jama.289.1.76			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503980				2022-12-01	WOS:000180136600029
J	Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR				Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR			Role for a Drosophila Myb-containing protein complex in site-specific DNA replication	NATURE			English	Article							CHORION GENE AMPLIFICATION; ORIGIN RECOGNITION COMPLEX; BINDING DOMAIN; IDENTIFICATION; ELEMENT; CELLS	There is considerable interest in the developmental, temporal and tissue-specific patterns of DNA replication in metazoans(1,2). Site-specific DNA replication at the chorion loci in Drosophila follicle cells leads to extensive gene amplification, and the organization of the cis-acting DNA elements that regulate this process may provide a model for how such regulation is achieved(3). Two elements important for amplification of the third chromosome chorion gene cluster, ACE3 and Ori-beta, are directly bound by Orc(4-6) (origin recognition complex), and two-dimensional gel analysis has revealed that the primary origin used is Ori-beta (refs 7-9). Here we show that the Drosophila homologue of the Myb (Myeloblastosis) oncoprotein family is tightly associated with four additional proteins, and that the complex binds site-specifically to these regulatory DNA elements. Drosophila Myb is required in trans for gene amplification, showing that a Myb protein is directly involved in DNA replication. A Drosophila Myb binding site, as well as the binding site for another Myb complex member (p120), is necessary in cis for replication of reporter transgenes. Chromatin immunoprecipitation experiments localize both proteins to the chorion loci in vivo. These data provide evidence that specific protein complexes bound to replication enhancer elements work together with the general replication machinery for site-specific origin utilization during replication.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University; Stanford University	Botchan, MR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Manak, John/0000-0002-6562-7694				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Ausubel M., 1989, MOL REPROD DEV, V1, P146, DOI [10.1002/mrd.1080010210, DOI 10.1002/MRD.1080010210]; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; DELIDAKIS C, 1989, EMBO J, V8, P891, DOI 10.1002/j.1460-2075.1989.tb03450.x; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fitzpatrick CA, 2002, DEVELOPMENT, V129, P4497; Ganter B, 1999, ADV CANCER RES, V76, P21, DOI 10.1016/S0065-230X(08)60773-3; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Harlow E., 1989, ANTIBODIES LAB MANUA; HECK MMS, 1990, J CELL BIOL, V110, P903, DOI 10.1083/jcb.110.4.903; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; ORRWEAVER TL, 1991, BIOESSAYS, V13, P97, DOI 10.1002/bies.950130302; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; RIO DC, 1988, P NATL ACAD SCI USA, V85, P8929, DOI 10.1073/pnas.85.23.8929; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; STOBERGRASSER U, 1992, ONCOGENE, V7, P589; Suzanne M, 2001, DEV BIOL, V237, P282, DOI 10.1006/dbio.2001.0384; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002	26	183	187	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					833	837		10.1038/nature01228	http://dx.doi.org/10.1038/nature01228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490953				2022-12-01	WOS:000179897300061
J	Di Tanna, GL; Rosano, A; Mastroiacovo, P				Di Tanna, GL; Rosano, A; Mastroiacovo, P			Prevalence of gastroschisis at birth: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-WALL DEFECTS; ENGLAND		Int Ctr Birth Defects, I-00195 Rome, Italy; Italian Inst Social Med, I-00196 Rome, Italy		Mastroiacovo, P (corresponding author), Int Ctr Birth Defects, I-00195 Rome, Italy.		Rosano, Aldo/G-6525-2012; Di Tanna, Gian Luca/AAF-2352-2019; rosano, Aldo/T-7180-2019	Rosano, Aldo/0000-0002-5453-2294; Di Tanna, Gian Luca/0000-0002-5470-3567; 				Barisic I, 2001, ULTRASOUND OBST GYN, V18, P309, DOI 10.1046/j.0960-7692.2001.00534.x; Nichols C R, 1997, J Matern Fetal Med, V6, P225; Rankin J, 1999, PRENATAL DIAG, V19, P662, DOI 10.1002/(SICI)1097-0223(199907)19:7<662::AID-PD607>3.0.CO;2-C; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107	5	47	52	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1389	1390		10.1136/bmj.325.7377.1389	http://dx.doi.org/10.1136/bmj.325.7377.1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480852	Green Submitted, Green Published			2022-12-01	WOS:000179975000021
J	Stephens, DW; McLinn, CM; Stevens, JR				Stephens, DW; McLinn, CM; Stevens, JR			Discounting and reciprocity in an iterated prisoner's dilemma	SCIENCE			English	Article							TIT-FOR-TAT; COOPERATION; GAME; EVOLUTION; CHOICE; MODELS; DELAYS	The Iterated Prisoner's Dilemma (IPD) is a central paradigm in the study of animal cooperation. According to the IPD framework, repeated play ( repetition) and reciprocity combine to maintain a cooperative equilibrium. However, experimental studies with animals suggest that cooperative behavior in IPDs is unstable, and some have suggested that strong preferences for immediate benefits (that is, temporal discounting) might explain the fragility of cooperative equilibria. We studied the effects of discounting and strategic reciprocity on cooperation in captive blue jays. Our results demonstrate an interaction between discounting and reciprocity. Blue jays show high stable levels of cooperation in treatments with reduced discounting when their opponent reciprocates, but their levels of cooperation decline in all other treatment combinations. This suggests that stable cooperation requires both reduced discounting and reciprocity, and it offers an explanation of earlier failures to find cooperation in controlled payoff games.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Stephens, DW (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Stevens, Jeffrey R/C-4619-2011	Stevens, Jeffrey R/0000-0003-2375-1360; Stephens, David/0000-0003-3720-5248				AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; DUGATKIN LA, 1992, TRENDS ECOL EVOL, V7, P202, DOI 10.1016/0169-5347(92)90074-L; Dugatkin LA., 1997, COOPERATION ANIMALS; FLOOD M, 1983, BEHAV SCI, V28, P65, DOI 10.1002/bs.3830280108; GARDNER RM, 1984, PSYCHOL REP, V55, P687, DOI 10.2466/pr0.1984.55.3.687; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; GREEN L, 1995, J EXP ANAL BEHAV, V64, P1, DOI 10.1901/jeab.1995.64-1; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Heinrich B., 1989, RAVENS WINTER; Mazur J. E., 1987, EFFECT DELAY INTERVE, V344, P55, DOI DOI 10.1039/c4qo00187g; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Pusey Anne E., 1997, P254; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Silverstein A, 1998, J BEHAV DECIS MAKING, V11, P123, DOI 10.1002/(SICI)1099-0771(199806)11:2<123::AID-BDM283>3.3.CO;2-X; STEPHENS DW, 1995, J THEOR BIOL, V176, P457, DOI 10.1006/jtbi.1995.0213; Stephens DW, 1997, ANIM BEHAV, V53, P113, DOI 10.1006/anbe.1996.0283; Stephens DW, 2000, J THEOR BIOL, V205, P1, DOI 10.1006/jtbi.2000.2041; Weitzman ML, 2001, AM ECON REV, V91, P260, DOI 10.1257/aer.91.1.260	24	138	144	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2216	2218		10.1126/science.1078498	http://dx.doi.org/10.1126/science.1078498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481142	Green Submitted			2022-12-01	WOS:000179773700056
J	Segura, TL; Toon, OB; Colaprete, A; Zahnle, K				Segura, TL; Toon, OB; Colaprete, A; Zahnle, K			Environmental effects of large impacts on Mars	SCIENCE			English	Article							CLIMATE	The martian valley networks formed near the end of the period of heavy bombardment of the inner solar system, about 3.5 billion years ago. The largest impacts produced global blankets of very hot ejecta, ranging in thickness from meters to hundreds of meters. Our simulations indicated that the ejecta warmed the surface, keeping it above the freezing point of water for periods ranging from decades to millennia, depending on impactor size, and caused shallow subsurface or polar ice to evaporate or melt. Large impacts also injected steam into the atmosphere from the craters or from water innate to the impactors. From all sources, a typical 100-, 200-, or 250-kilometers asteroid injected about 2, 9, or 16 meters, respectively, of precipitable water into the atmosphere, which eventually rained out at a rate of about 2 meters per year. The rains from a large impact formed rivers and contributed to recharging aquifers.	Univ Colorado, Program Atmospher & Ocean Sci, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Segura, TL (corresponding author), NASA, Ames Res Ctr, MS 245-3, Moffett Field, CA 94035 USA.							Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Carr M.H, 1996, WATER MARS; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; Christensen PR, 1998, SCIENCE, V279, P1692, DOI 10.1126/science.279.5357.1692; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; COLAPRETE A, IN PRESS J GEOPHYS R; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2002, GEOPHYS RES LETT, V29; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; JAKOSKY BM, 1983, ICARUS, V55, P1, DOI 10.1016/0019-1035(83)90046-5; KASTING JF, 1991, ICARUS, V91, P1; LEOVY CB, UNPUB; Lodders K., 1998, PLANETARY SCI COMPAN; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MALIN MC, 1986, GEOPHYS RES LETT, V13, P444, DOI 10.1029/GL013i005p00444; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka K. L., 1992, MARS, P345; ZAHNLE K, 1990, GEOCHIM COSMOCHIM AC, V54, P2577, DOI 10.1016/0016-7037(90)90243-E; Zahnle K. J., 1990, GEOL SOC AM SPEC PAP, V247, P271, DOI DOI 10.1130/SPE247-P271	25	216	220	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1977	1980		10.1126/science.1073586	http://dx.doi.org/10.1126/science.1073586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471254				2022-12-01	WOS:000179629200041
J	Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J				Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J			Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study	LANCET			English	Article							METHYLMERCURY EXPOSURE; VACCINATION; SEYCHELLES; HAIR	Background Thiomersal is a preservative containing small amounts of ethylmercury that is used in routine vaccines for infants and children. The effect of vaccines containing thiomersal on concentrations of mercury in infants' blood has not been extensively assessed, and the metabolism of ethylmercury in infants is unknown. We aimed to measure concentrations of mercury in blood, urine, and stools of infants who received such vaccines. Methods 40 full-term infants aged 6 months and younger were given vaccines that contained thiomersal (diptheria-tetanus-acellular pertussis vaccine, hepatitis B vaccine, and in some children Haemophilus influenzae type B vaccine). 21 control infants received thiomersal-free vaccines. We obtained samples of blood, urine, and stools 3-28 days after vaccination. Total mercury (organic and inorganic) in the samples was measured by cold vapour atomic absorption. Findings Mean mercury doses in infants exposed to thiomersal were 45.6 mug (range 37.5-62.5) for 2-month-olds and 111.3 mug (range 87.5-175.0) for 6-month-olds. Blood mercury in thiomersal-exposed 2-month-olds ranged from less than 3.75 to 20.55 nmol/L (parts per billion); in 6-month-olds all values were lower than 7.50 nmol/L. Only one of 15 blood samples from controls contained quantifiable mercury. Concentrations of mercury were low in urine after vaccination but were high in stools of thiomersal-exposed 2-month-olds (mean 82 ng/g dry weight) and in 6-month-olds (mean 58 ng/g dry weight). Estimated blood half-life of ethylmercury was 7 days (95% CI 4-10 days). Interpretation Administration of vaccines containing thiomersal does not seem to raise blood concentrations of mercury above safe values in infants. Ethylmercury seems to be eliminated from blood rapidly via the stools after parenteral administration of thiomersal in vaccines.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Rochester, NY 14642 USA; Natl Naval Med Res Inst, Bethesda, MD USA	University of Rochester; University of Rochester; University of Rochester; Naval Medical Research Center (NMRC)	Pichichero, ME (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	michael_pichichero@urmc.rochester.edu	Pichichero, Michael E/AID-7886-2022		ACF HHS [1 AF-45248] Funding Source: Medline	ACF HHS		Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; AXTON JH, 1972, POSTGRAD MED J, V561, P417; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Clements CJ, 2000, LANCET, V355, P1279, DOI 10.1016/S0140-6736(05)74714-0; COX NH, 1988, CONTACT DERMATITIS, V18, P229, DOI 10.1111/j.1600-0536.1988.tb02809.x; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; FAGAN DG, 1977, ARCH DIS CHILD, V52, P962, DOI 10.1136/adc.52.12.962; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Lowell J A, 1996, Liver Transpl Surg, V2, P475, DOI 10.1002/lt.500020612; MATHESON DS, 1980, J PEDIATR-US, V97, P153, DOI 10.1016/S0022-3476(80)80159-4; National Academy of Sciences, 2000, TOX EFF METH; NIELSEN JB, 1994, ARCH TOXICOL, V68, P317, DOI 10.1007/s002040050075; Pfab R, 1996, J TOXICOL-CLIN TOXIC, V34, P453, DOI 10.3109/15563659609013818; Shenker BJ, 1998, ENVIRON RES, V77, P149, DOI 10.1006/enrs.1997.3816; Stajich GV, 2000, J PEDIATR-US, V136, P679, DOI 10.1067/mpd.2000.105133; YESS NJ, 1993, J AOAC INT, V76, P36; [No title captured]	20	157	170	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1737	1741		10.1016/S0140-6736(02)11682-5	http://dx.doi.org/10.1016/S0140-6736(02)11682-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480426				2022-12-01	WOS:000179636800010
J	Hwang, JS; Druffel, ERM				Hwang, JS; Druffel, ERM			Lipid-like material as the source of the uncharacterized organic carbon in the ocean?	SCIENCE			English	Article							MACROMOLECULAR CONSTITUENTS; SELECTIVE PRESERVATION; ISOTOPE FRACTIONATION; COMPOUND CLASSES; MATTER; PACIFIC; RADIOCARBON; SEDIMENTS; ORIGIN; VARIABILITY	The composition and formation mechanisms of the uncharacterized fraction of oceanic particulate organic carbon (POC) are not well understood. We isolated biologically important compound classes and the acid-insoluble fraction, a proxy of the uncharacterized fraction, from sinking POC in the deep Northeast Pacific and measured carbon isotope ratios to constrain the source(s) of the uncharacterized fraction. Stable carbon and radiocarbon isotope signatures of the acid-insoluble fraction were similar to those of the lipid fraction, implying that the acid-insoluble fraction might be composed of selectively accumulated lipid-like macromolecules.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hwang, JS (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jeomshik@uci.edu; edruffel@uci.edu						Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; DEGENS ET, 1968, DEEP-SEA RES, V15, P11, DOI 10.1016/0011-7471(68)90025-9; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; EGLINTON TI, 1994, ORG GEOCHEM, V21, P721, DOI 10.1016/0146-6380(94)90015-9; FLAVIANO C, 1994, ORG GEOCHEM, V22, P759, DOI 10.1016/0146-6380(94)90137-6; Garcette-Lepecq A, 2000, ORG GEOCHEM, V31, P1663, DOI 10.1016/S0146-6380(00)00100-5; Gelinas Y, 2001, SCIENCE, V294, P145, DOI 10.1126/science.1062363; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1978, GEOCHIM COSMOCHIM AC, V42, P69, DOI 10.1016/0016-7037(78)90218-1; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; HENRICHS SM, 1995, MAR CHEM, V49, P127, DOI 10.1016/0304-4203(95)00012-G; HWANG JH, UNPUB; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; Knicker H, 1996, ORG GEOCHEM, V24, P661, DOI 10.1016/0146-6380(96)00057-5; Largeau C, 1995, ADV MICROB ECOL, V14, P77; Largeau C, 1993, ORGANIC GEOCHEMISTRY, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; Masiello CA, 1998, DEEP-SEA RES PT II, V45, P617, DOI 10.1016/S0967-0645(97)00096-9; Masiello CA, 2001, GLOBAL BIOGEOCHEM CY, V15, P407, DOI 10.1029/2000GB001290; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; MINOR EC, UNPUB GEOCHIM COSMOC; Peulve S, 1996, GEOCHIM COSMOCHIM AC, V60, P1239, DOI 10.1016/0016-7037(95)00442-4; QIAN Y, 1992, CHEM GEOL, V101, P201, DOI 10.1016/0009-2541(92)90002-M; Sherrell RM, 1998, DEEP-SEA RES PT II, V45, P733, DOI 10.1016/S0967-0645(97)00100-8; Smith KL, 2001, LIMNOL OCEANOGR, V46, P543, DOI 10.4319/lo.2001.46.3.0543; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; TISSOT BP, 1984, PETROLEUM FORMATIO 2, pCH2; Wakeham SG, 1997, GEOCHIM COSMOCHIM AC, V61, P5363, DOI 10.1016/S0016-7037(97)00312-8; Wang XC, 2001, MAR CHEM, V73, P65, DOI 10.1016/S0304-4203(00)00090-6; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X	32	71	74	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					881	884		10.1126/science.1078508	http://dx.doi.org/10.1126/science.1078508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574627	Green Submitted			2022-12-01	WOS:000180830900049
J	Fledelius, HC				Fledelius, HC			High atmospheric pressure and myopic shift in caisson workers	LANCET			English	Editorial Material							HYPERBARIC-OXYGEN THERAPY		Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Fledelius, HC (corresponding author), Rigshosp, Univ Eye Dept, DK-2100 Copenhagen O, Denmark.							Anderson B Jr, 1978, Trans Am Ophthalmol Soc, V76, P116; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL, P3; Fledelius HC, 2002, ACTA OPHTHALMOL SCAN, V80, P188, DOI 10.1034/j.1600-0420.2002.800213.x; Kindwall EP, 1994, HYPERBARIC MED, pS45; LYNE AJ, 1978, T OPHTHAL SOC UK, V98, P66; Onoo A, 2002, BRIT J OPHTHALMOL, V86, P1274, DOI 10.1136/bjo.86.11.1274; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Ross ME, 1996, OPTOMETRY VISION SCI, V73, P487, DOI 10.1097/00006324-199607000-00006	8	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					362	362		10.1016/S0140-6736(03)12443-9	http://dx.doi.org/10.1016/S0140-6736(03)12443-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573370				2022-12-01	WOS:000180787000006
J	Brown, BR				Brown, BR			Sensing temperature without ion channels	NATURE			English	Article							NEURONS		Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA	University of San Francisco	Brown, BR (corresponding author), Univ San Francisco, Dept Phys, San Francisco, CA 94117 USA.							Brown BR, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061903; CAREY FG, 1982, COPEIA, P254; GROSSO G, 2000, SOLID STATE PHYSICS; KALMIJN AJ, 1966, NATURE, V212, P1232, DOI 10.1038/2121232b0; MacDonald D. K. C, 1962, THERMOELECTRICITY IN; MONTGOMERY JC, 1984, COMP BIOCHEM PHYS A, V79, P189, DOI 10.1016/0300-9629(84)90731-X; MURRAY RW, 1960, NATURE, V187, P957, DOI 10.1038/187957a0; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sand A, 1938, PROC R SOC SER B-BIO, V125, P524, DOI 10.1098/rspb.1938.0041; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wilkens LA, 1997, P ROY SOC B-BIOL SCI, V264, P1723, DOI 10.1098/rspb.1997.0239; Wissing H, 1988, Prog Brain Res, V74, P99	13	40	40	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					495	495		10.1038/421495a	http://dx.doi.org/10.1038/421495a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556879	Bronze			2022-12-01	WOS:000180670600031
J	Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ				Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ			Endoproteolytic activity of the proteasome	SCIENCE			English	Article							HIGH-MOLECULAR-WEIGHT; TRANSCRIPTION FACTOR; 26S PROTEASOME; 20S PROTEASOME; CORE PARTICLE; UBIQUITIN; DEGRADATION; ACTIVATION; CHAPERONE; PROTEINS	The proteasome plays a central role in the degradation of regulatory and misfolded proteins. Current models suggest that substrates access the internal catalytic sites by processively threading their termini through the gated substrate channel. Here, we found that latent (closed) and activated (open) proteasomes degraded two natively disordered substrates at internal peptide bonds even when they lacked accessible termini, suggesting that these substrates themselves promoted gating of the proteasome. This endoproteolysis provides a molecular mechanism for regulated release of transcription factors from inactive precursors as well as a means of accessing internal folding defects of misfolded multidomain proteins.	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.		Thomas, Philip J/F-7115-2012		NIDDK NIH HHS [DK49835, R01 DK049835, DK46818, R37 DK049835] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835, R01DK049835] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	30	315	320	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					408	411		10.1126/science.1079293	http://dx.doi.org/10.1126/science.1079293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12481023	Green Accepted			2022-12-01	WOS:000180426800050
J	Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J				Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J			Systematic functional analysis of the Caenorhabditis elegans genome using RNAi	NATURE			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; GENE-EXPRESSION; C-ELEGANS; INTERFERENCE; SEQUENCE; DATABASE; GERMLINE; DOMAINS; SIRNAS	A principal challenge currently facing biologists is how to connect the complete DNA sequence of an organism to its development and behaviour. Large-scale targeted-deletions have been successful in defining gene functions in the single-celled yeast Saccharomyces cerevisiae, but comparable analyses have yet to be performed in an animal. Here we describe the use of RNA interference to inhibit the function of similar to86% of the 19,427 predicted genes of C. elegans. We identified mutant phenotypes for 1,722 genes, about two-thirds of which were not previously associated with a phenotype. We find that genes of similar functions are clustered in distinct, multi-megabase regions of individual chromosomes; genes in these regions tend to share transcriptional profiles. Our resulting data set and reusable RNAi library of 16,757 bacterial clones will facilitate systematic analyses of the connections among gene sequence, chromosomal location and gene function in C. elegans.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Ahringer, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	jaa@mole.bio.cam.ac.uk	Kanapin, Alexander/E-7632-2013; Kanapin, Alexander A/Q-7590-2016; Durbin, Richard/AAE-7178-2019; Moreno, Sergio/K-3671-2014	Kanapin, Alexander A/0000-0001-9802-5297; Durbin, Richard/0000-0002-9130-1006; Moreno, Sergio/0000-0002-8039-1413; Ahringer, Julie/0000-0002-7074-4051; Le Bot, Nathalie/0000-0002-5258-2837; Poulin, Gino/0000-0003-1016-348X; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BARNES TM, 1995, GENETICS, V141, P159; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Kuwabara PE, 1999, CURR TOP DEV BIOL, V41, P99; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SPELLMAN PT, 2002, J BIOL, V1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	40	2552	3033	8	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					231	237		10.1038/nature01278	http://dx.doi.org/10.1038/nature01278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529635				2022-12-01	WOS:000180397600038
J	Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK				Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK			Increased CO2 uncouples growth from isoprene emission in an agriforest ecosystem	NATURE			English	Article							BIOGENIC HYDROCARBONS; ATMOSPHERIC CO2; PLANTS; IMPACT; PATHWAY; LEAVES; OZONE; OAK	The emission of isoprene from the leaves of forest trees is a fundamental component of biosphere-atmosphere interactions, controlling many aspects of photochemistry in the lower atmosphere(1-3). As almost all commercial agriforest species emit high levels of isoprene(4), proliferation of agriforest plantations has significant potential to increase regional ozone pollution(5-7) and enhance the lifetime of methane(8), an important determinant of global climate. Here we show that growth of an intact Populus deltoides plantation under increased CO2 (800 mumol mol(-1) and 1,200 mumol mol(-1)) reduced ecosystem isoprene production by 21% and 41%, while above-ground biomass accumulation was enhanced by 60% and 82%, respectively. Exposure to increased CO2 significantly reduced the cellular content of dimethylallyl diphosphate, the substrate for isoprene synthesis, in both leaves and leaf protoplasts. We identify intracellular metabolic competition for phosphoenolpyruvate as a possible control point in explaining the suppression of isoprene emission under increased CO2. Our results highlight the potential for uncoupling isoprene emission from biomass accumulation in an agriforest species, and show that negative air-quality effects of proliferating agriforests may be offset by increases in CO2.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Columbia University	Rosenstiel, TN (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.		Griffin, Kevin L./B-2629-2013; Griffin, Kevin Lee/GWZ-4828-2022; TATSUTA, HARUKI/F-2997-2010	Griffin, Kevin L./0000-0003-4124-3757; 				BROWN S, 1996, CLIMATE CHANGE 1995, P776; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Crutzen PJ, 1999, TELLUS A, V51, P123, DOI 10.1034/j.1600-0870.1999.t01-1-00010.x; EDWARDS GE, 1978, ARCH BIOCHEM BIOPHYS, V190, P421, DOI 10.1016/0003-9861(78)90295-3; *FAO, 1995, FAO FOR SER, V30; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Fenning TM, 2002, TRENDS BIOTECHNOL, V20, P291, DOI 10.1016/S0167-7799(02)01983-2; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Gielen B, 2001, ENVIRON POLLUT, V115, P335, DOI 10.1016/S0269-7491(01)00226-3; Griffin KL, 2002, GLOBAL CHANGE BIOL, V8, P479, DOI 10.1046/j.1365-2486.2002.00487.x; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harley P, 1997, TREE PHYSIOL, V17, P705; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; JENKINS CLD, 1989, PLANT PHYSIOL, V91, P1356, DOI 10.1104/pp.91.4.1356; Karl T, 2002, PLANTA, V215, P894, DOI 10.1007/s00425-002-0825-2; Lerdau M, 2002, TRENDS ECOL EVOL, V17, P309, DOI 10.1016/S0169-5347(02)02535-1; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; MAGIN NC, 1997, PLANT PHYSIOL, V115, P1681; MARINO BDV, 1999, BIOSPHERE 2 RES PRES; Monson RK, 2001, ANNU REV ECOL SYST, V32, P547, DOI 10.1146/annurev.ecolsys.32.081501.114136; MULLER JF, 1992, J GEOPHYS RES-ATMOS, V97, P3787, DOI 10.1029/91JD02757; Pierce T, 1998, J GEOPHYS RES-ATMOS, V103, P25611, DOI 10.1029/98JD01804; Poisson N, 2000, J ATMOS CHEM, V36, P157, DOI 10.1023/A:1006300616544; Rosenstiel TN, 2002, PLANT PHYSIOL, V129, P1276, DOI 10.1104/pp.002717; SANADZE GA, 1990, SOV PLANT PHYSIOL+, V37, P1; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; SHARKEY TD, 1991, PLANT CELL ENVIRON, V14, P333, DOI 10.1111/j.1365-3040.1991.tb01509.x; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998	30	245	250	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					256	259		10.1038/nature01312	http://dx.doi.org/10.1038/nature01312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529640				2022-12-01	WOS:000180397600044
J	Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T				Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T			Severe acute interstitial pneumonia and gefitinib	LANCET			English	Article								Gefitinib is an oral selective inhibitor of the epidermal growth factor receptor tyrosine kinase that is an effective treatment for patients with advanced non-small cell lung cancer who do not respond to platinum-based chemotherapy. We assessed four patients who had non-small cell lung cancer causing severe acute interstitial pneumonia in association with gefitinib. Although two patients recovered after treatment with steroids, the other two died from progressive respiratory dysfunction. On the basis of autopsies and bilateral distribution of diffuse ground-glass opacities In chest CTs, we diagnosed diffuse alveolar damage, which was consistent with acute interstitial pneumonia. Patients with interstitial pneumonia also had other pulmonary disorders such as previous thoracic irradiation and poor performance status. Physicians should be aware of the alveolar damage induced by gefitinib, especially for patients with these characteristic features.	Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Mol Med & Gene Transfer Res, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University	Inoue, A (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.	akinoue@idac.tohoku.ac.jp	Moriya, Takuya/AAM-6974-2020					FUKUOKA M, 2002, P AN M AM SOC CLIN, V22, pA298; Giaccone G, 2002, ANN ONCOL, V13, P217, DOI 10.1093/annonc/mdf663; Kris MG, 2002, P AN M AM SOC CLIN, V21, p292a; *PMDEC, 2002, REV GEF; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081	5	348	361	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					137	139		10.1016/S0140-6736(03)12190-3	http://dx.doi.org/10.1016/S0140-6736(03)12190-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531582				2022-12-01	WOS:000180428000014
J	Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E				Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E			Incidence of coronary heart disease in a health authority in London: review of a community register	BRITISH MEDICAL JOURNAL			English	Article							ANGINA-PECTORIS; PROGNOSIS		Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England; Bromley Hosp, Bromley Hosp NHS Trust, London BR2 9AQ, England	Imperial College London	Wood, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England.							*DEP HLTH, 1999, SAV LIV OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; GANDHI MM, 1995, BRIT HEART J, V73, P193; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Wood D, 1998, HEART, V80, pS1	5	19	19	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					20	20		10.1136/bmj.326.7379.20	http://dx.doi.org/10.1136/bmj.326.7379.20			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511455	Bronze, Green Published			2022-12-01	WOS:000180302000019
J	Abbott, A				Abbott, A			Genomics - Sorry, dogs - man's got a new best friend	NATURE			English	Editorial Material																		Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					729	729		10.1038/420729a	http://dx.doi.org/10.1038/420729a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490903	Bronze			2022-12-01	WOS:000179897300012
J	Crowcroft, NS; Catchpole, M				Crowcroft, NS; Catchpole, M			Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates	BRITISH MEDICAL JOURNAL			English	Article									Off Natl Stat, London SW1V 2QQ, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Public Health England	Crowcroft, NS (corresponding author), Off Natl Stat, London SW1V 2QQ, England.							*DEP HLTH STAT HEA, HOSP ACQ INF; PRATT SJ, 2001, J HOSP INFECT S, V47, pS3; Reacher MH, 2000, BMJ-BRIT MED J, V320, P213, DOI 10.1136/bmj.320.7229.213; Rooney C, 1999, HLTH STAT Q, P21; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1	5	44	45	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1390	1391		10.1136/bmj.325.7377.1390	http://dx.doi.org/10.1136/bmj.325.7377.1390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480853	Green Published			2022-12-01	WOS:000179975000022
J	Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D				Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D			A green algal apicoplast ancestor	SCIENCE			English	Article							MITOCHONDRIAL GENOME; PARASITES; NUCLEAR; GENES; APICOMPLEXAN; EVOLUTION; PLASTIDS; ORIGIN; DNA		Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Jefferson University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gonzalez-Halphen, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		Gonzalez-Halphen, Diego/C-2664-2013; Funes, Soledad/A-1278-2010	Gonzalez-Halphen, Diego/0000-0003-0654-655X; Funes, Soledad/0000-0003-1815-1977; Magallon, Susana/0000-0002-6838-7497	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059646] Funding Source: NIH RePORTER; FIC NIH HHS [TW01176] Funding Source: Medline; NHLBI NIH HHS [HL59646] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	9	105	116	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2155	2155		10.1126/science.1076003	http://dx.doi.org/10.1126/science.1076003			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481129				2022-12-01	WOS:000179773700038
J	Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S				Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S			Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis	LANCET			English	Article							ACUTE CEREBROVASCULAR-DISEASE; CORONARY HEART-DISEASE; CIGARETTE-SMOKING; PROJECT 1981-86; ISCHEMIC STROKE; COMMUNITY; WOMEN; RISK; RENFREW/PAISLEY; POPULATIONS	Background Since both cerebral infarction and coronary heart disease are caused by atherosclerosis, they would be expected to have similar secular trends in mortality. Because differential diagnosis of stroke subtype on routine death certificates is inaccurate, we aimed to estimate secular trends in cerebral infarct and haemorrhage throughout the 20th century, for England and Wales, with data from autopsy studies. Methods We calculated the ratio of cerebral infarct to cerebral haemorrhage from all available sources of autopsy data from the 20th century. These data were used to estimate the ratio of cerebral infarct to haemorrhage for every year, and hence to estimate rates of cerebral infarct and cerebral haemorrhage from the total stroke mortality rate, obtained from the UK Office for National Statistics. Findings Data about stroke subtypes from autopsies were available from 1932 to 1999. The ratio of cerebral infarct to cerebral haemorrhage increased fourfold from 0.5 in the 1930s to 2.0 by the 1990s; most of the increase took place between the 1930s and the 1970s. Estimated secular trends suggested that there was a steady fall in mortality from cerebral haemorrhage throughout the 20th century, whereas mortality from cerebral infarct increased to a peak in the 1970s and then fell. Trends in estimated cerebral infarct mortality closely matched those for coronary heart disease mortality. Interpretation The closely related trends in cerebral infarct and coronary heart disease suggest common causes, but the very different trend in cerebral haemorrhage shows that its cause probably differs importantly from these conditions.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; London Sch Hyg & Trop Med, London WC1, England	University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	D.A.Lawlor@bristol.ac.uk	Leon, David A/G-2195-2010; Sterne, Jonathan/Z-3106-2019; Davey Smith, George/A-7407-2013	Leon, David A/0000-0001-9747-1762; Sterne, Jonathan/0000-0001-8496-6053; Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				ALLEN CMC, 1983, Q J MED, V52, P515; ANDERSON TW, 1968, LANCET, V1, P1137; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; CROFTON E, 1963, BRIT MED J, P1161, DOI 10.1136/bmj.2.5366.1161; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Falkeborn M, 1996, EPIDEMIOLOGY, V7, P67, DOI 10.1097/00001648-199601000-00012; Gale CR, 1997, J ROY SOC MED, V90, P138, DOI 10.1177/014107689709000307; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; HART CL, IN PRESS J EPIDEMIOL; *HER MAJ STAT OFF, 1956, REG GEN STAT REV ENG; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kodama K, 1993, Ann Epidemiol, V3, P524; KULLER L, 1971, AM J EPIDEMIOL, V93, P1; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; McCarron P, 2001, J EPIDEMIOL COMMUN H, V55, P404, DOI 10.1136/jech.55.6.404; MITCHINSON MJ, 1980, LANCET, V1, P244; Newson R., 2000, STATA TECHNICAL B, V57, P20; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; SAKUGAWA H, 1999, J CLIN PATHOL, V47, P31; SANDERCOCK P, 1985, BRIT MED J, V290, P193, DOI 10.1136/bmj.290.6463.193; Shinton R, 1997, J EPIDEMIOL COMMUN H, V51, P138, DOI 10.1136/jech.51.2.138; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Smith GD, 1997, J EPIDEMIOL COMMUN H, V51, P134, DOI 10.1136/jech.51.2.134; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; TERENT A, 1988, STROKE, V19, P598, DOI 10.1161/01.STR.19.5.598; YATES PO, 1964, LANCET, V1, P65; YATES PO, 1961, MED RES COUNCIL SPEC, V300; [No title captured]	30	97	105	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1818	1823		10.1016/S0140-6736(02)11769-7	http://dx.doi.org/10.1016/S0140-6736(02)11769-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480358				2022-12-01	WOS:000179706100008
J	Fitzsimons, EJ; Sturrock, RD				Fitzsimons, EJ; Sturrock, RD			The chronic anaemia of rheumatoid arthritis: iron banking or blocking?	LANCET			English	Editorial Material							CHRONIC DISEASE		Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Fac Med, Ctr Rheumat Dis, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow; University of Glasgow	Fitzsimons, EJ (corresponding author), Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland.	ejf1s@clinmed.gla.ac.uk						Davis D, 1997, BRIT J RHEUMATOL, V36, P950; DROSOS AA, 1990, CLIN RHEUMATOL, V9, P333, DOI 10.1007/BF02114393; Fitzsimons EJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P166, DOI 10.1002/art.10247; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; Suominen P, 2000, ARTHRITIS RHEUM, V43, P1016, DOI 10.1002/1529-0131(200005)43:5<1016::AID-ANR9>3.0.CO;2-3	9	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2002	360	9347					1713	1714		10.1016/S0140-6736(02)11725-9	http://dx.doi.org/10.1016/S0140-6736(02)11725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480421				2022-12-01	WOS:000179636800005
J	Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A				Reissmann, S; Hochleitner, E; Wang, HF; Paschos, A; Lottspeich, F; Glass, RS; Bock, A			Taming of a poison: Biosynthesis of the NiFe-hydrogenase cyanide ligands	SCIENCE			English	Article							MARINE	NiFe-hydrogenases have an Ni-Fe site in which the iron has one CO and two CN groups as ligands. Synthesis of the CN ligands requires the activity of two hydrogenase maturation proteins: HypF and HypE. HypF is a carbamoyltransferase that transfers the carbamoyl moiety of carbamoyladenylate to the COOH-terminal cysteine of HypE and thus forms an enzyme-thiocarbamate. HypE dehydrates the S-carbamoyl moiety in an adenosine triphosphate-dependent process to yield the enzyme thiocyanate. Chemical model reactions corroborate the feasibility of this unprecedented biosynthetic route and show that thiocyanates can donate CN to iron. This finding underscores a striking parallel between biochemistry and organometallic chemistry in the formation of an iron-cyano complex.	Univ Munich, Dept Biol 1, D-80638 Munich, Germany; Max Planck Inst Biochem, Prot Chem Abt, D-82152 Martinsried, Germany; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Munich; Max Planck Society; University of Arizona	Bock, A (corresponding author), Univ Munich, Dept Biol 1, Maria Ward Str 1A, D-80638 Munich, Germany.							Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; BURKHARDT G, 1965, J AM CHEM SOC, V87, P591, DOI 10.1021/ja01081a035; BUSETTO L, 1968, INORG CHIM ACTA, V2, P391; FREY M, 2001, HDB METALLOPROTEINS, P880; HAUSINGER RP, 1996, MECH METALLOCENTER A, P1; HOCHLEITNER E, UNPUB; JIMENEZ C, 1991, TETRAHEDRON, V47, P2097, DOI 10.1016/S0040-4020(01)96120-4; JUNGBAUER A, 1980, J ORGANOMET CHEM, V186, P361, DOI 10.1016/S0022-328X(00)82417-1; Lai CH, 1998, J AM CHEM SOC, V120, P10103, DOI 10.1021/ja982053a; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; PASCHOS A, UNPUB; PHAM AT, 1991, TETRAHEDRON LETT, V32, P4843, DOI 10.1016/S0040-4039(00)93475-0; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RANGANATHAN D, 1990, J ORG CHEM, V55, P2351, DOI 10.1021/jo00295a022; RIERA V, 1990, J ORGANOMET CHEM, V384, P339, DOI 10.1016/0022-328X(90)87126-X; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Simpson JS, 1998, TETRAHEDRON LETT, V39, P5819, DOI 10.1016/S0040-4039(98)01149-6; VANWAZER JR, 1996, J AM CHEM SOC, V88, P4415; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x	21	169	177	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1067	1070		10.1126/science.1080972	http://dx.doi.org/10.1126/science.1080972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586941				2022-12-01	WOS:000180960000048
J	Bower, P; Roland, M; Campbell, J; Mead, N				Bower, P; Roland, M; Campbell, J; Mead, N			Setting standards based on patients' views on access and continuity: secondary analysis of data from the general practice assessment survey	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; QUALITY; PRIORITIES	Objectives To examine patients' views on access and continuity in general practice to derive quality standards. Design Secondary analysis of data from general practice research studies and routine quality assessment activities undertaken by practices and primary care trusts. Setting General practice. Participants General practice patients. Results Satisfactory standards of access were next day appointments with general practitioners and a 6-10 minute wait for consultations to begin. A satisfactory level of continuity was seeing the same general practitioner "a lot of the time." Standards varied with the analytic method used and by sociodemographic group. Conclusions Standards expected by patients in primary care can be derived from linked report-assessment pairs. Patients may have expectations of access that are in excess of government targets. Patients also have high expectations of continuity of care. It is unclear the degree to which such standards are reliable or valid, how conflicts between access and continuity should be resolved, or how these standards relate to other priorities of patients such as high quality interpersonal care.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Peninsula Med Sch, Dept Gen Practice & Primary Care, Exeter EX2 5DW, Devon, England	University of Manchester; University of Exeter	Bower, P (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.		Bower, Peter/A-1508-2011	Bower, Peter/0000-0001-9558-3349; Campbell, John/0000-0002-6752-3493				Bamford C, 1992, Qual Health Care, V1, P153, DOI 10.1136/qshc.1.3.153; Bower P, 2002, FAM PRACT, V19, P489, DOI 10.1093/fampra/19.5.489; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Campbell SM, 2001, BMJ-BRIT MED J, V323, P784, DOI 10.1136/bmj.323.7316.784; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; GROL R, 2000, PATIENTS EVALUATE GE; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Kearley KE, 2001, BRIT J GEN PRACT, V51, P712; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; MEAD N, 2002, THESIS U MANCHESTER; Neuberger J, 1998, BMJ-BRIT MED J, V317, P260, DOI 10.1136/bmj.317.7153.260; *NHS EX, 1998, 1 CLASS SERV QUAL NE; *NHS EX, 1999, NAT SURV NHS PAT; *PMS NAT EV TEAM, 2000, NAT EV 1 WAV NHS PER; Ramsay J, 2000, FAM PRACT, V17, P372, DOI 10.1093/fampra/17.5.372; Roland M., 2002, GEN PRACTICE ASSESSM; Salisbury C, 2002, BRIT J GEN PRACT, V52, P554; Scott A, 1999, SCOT J POLIT ECON, V46, P111, DOI 10.1111/1467-9485.00124; Scott A., 2001, EVIDENCE BASED PATIE, P66; Secretary of State for Health, 2000, NHS PLAN; SMITH CH, 1989, BRIT MED J, V299, P494, DOI 10.1136/bmj.299.6697.494; Stewart M, 2001, BRIT MED J, V322, P444, DOI 10.1136/bmj.322.7284.444; Vick S, 1998, J HEALTH ECON, V17, P587, DOI 10.1016/S0167-6296(97)00035-0; Wensing M, 1998, SOC SCI MED, V47, P1573, DOI 10.1016/S0277-9536(98)00222-6; Williamson C, 2000, QUAL HEALTH CARE, V9, P190, DOI 10.1136/qhc.9.3.190	26	57	60	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					258	260A		10.1136/bmj.326.7383.258	http://dx.doi.org/10.1136/bmj.326.7383.258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560279	Bronze, Green Published			2022-12-01	WOS:000180908300022
J	Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T				Cheutin, T; McNairn, AJ; Jenuwein, T; Gilbert, DM; Singh, PB; Misteli, T			Maintenance of stable heterochromatin domains by dynamic HP1 binding	SCIENCE			English	Article							MAMMALIAN-CELLS; HISTONE H3; LYSINE 9; CHROMATIN; PROTEINS; DROSOPHILA; YEAST; RNA	One function of heterochromatin is the epigenetic silencing by sequestration of genes into transcriptionally repressed nuclear neighborhoods. Heterochromatin protein 1 (HP1) is a major component of heterochromatin and thus is a candidate for establishing and maintaining the transcriptionally repressive heterochromatin structure. Here we demonstrate that maintenance of stable heterochromatin domains in living cells involves the transient binding and dynamic exchange of HP1 from chromatin. HP1 exchange kinetics correlate with the condensation level of chromatin and are dependent on the histone methyltransferase Suv39h. The chromodomain and the chromoshadow domain of HP1 are both required for binding to native chromatin in vivo, but they contribute differentially to binding in euchromatin and heterochromatin. These data argue against HP1 repression of transcription by formation of static, higher order oligomeric networks but support a dynamic competition model, and they demonstrate that heterochromatin is accessible to regulatory factors.	NCI, NIH, Bethesda, MD 20892 USA; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; Inst Mol Pathol, A-1030 Vienna, Austria; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.		Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; McNairn, Adrian/0000-0003-4727-3770	NATIONAL CANCER INSTITUTE [Z01BC010309, ZIABC010309] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Cheng TH, 2000, GENE DEV, V14, P452; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirschmann DA, 2000, CANCER RES, V60, P3359; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000	24	486	491	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					721	725		10.1126/science.1078572	http://dx.doi.org/10.1126/science.1078572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560555				2022-12-01	WOS:000180687700052
J	Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ				Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ			The public and the smallpox threat	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIOTERRORISM	BACKGROUND: The potential for a bioterrorist attack involving smallpox has led to a debate about what national precautions should be taken. What is unclear is the public's knowledge of smallpox and views about precautions. METHODS: We conducted a national survey of 1006 adults selected by means of random-digit dialing. Respondents were asked about their knowledge of and beliefs about the smallpox virus and the vaccine, their possible reactions to a bioterrorist attack involving smallpox, and a number of proposed state emergency powers. RESULTS: The majority of the respondents have a number of beliefs about smallpox and smallpox vaccination that are false. The majority believe that there is an effective treatment for smallpox, that there have been cases of smallpox in the past five years, and that there is not enough smallpox vaccine to vaccinate everyone in the United States. Thirty percent believe that vaccination earlier in their lives would protect them from the disease. The majority of respondents said they wanted to be vaccinated; however, only 21 percent would want to be vaccinated if physicians declined vaccination. There was strong support among the respondents for several proposed state emergency powers. CONCLUSIONS: Our results suggest the need for public education about smallpox. These data also point to the importance of a discussion in the medical community about the advisability of vaccination of individual physicians at this time.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Int Commun Res, Media, PA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.		DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X; Weldon, Kathleen/0000-0001-5884-6947				ALTMAN LK, 2002, NY TIMES        1012, P20; *AM ASS PUBL OP RE, 2000, STAND DEF FIN DISP C; Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; [Anonymous], 2002, SMALLP FACT SHEET SM; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BLENDON RJ, 2002, MEDSCAPE GEN MED, V4; *CDCP, 2002, SMALLP VACC VACC MET; *CDCP, 2002, MOD STAT EM HLTH POW; Cohen J, 2001, SCIENCE, V294, P985, DOI 10.1126/science.294.5544.985; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; FLAHERTY T, 2002, AMA ANSWERS NEEDED W; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; MILLER J, 2002, NY TIMES        1203, pA18; Miller Judith, 2002, NEW YORK TIMES  1112, pA1; O'Toole T, 2002, CLIN INFECT DIS, V34, P972, DOI 10.1086/339909; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; STOLBERG SG, 2002, NY TIMES        1128, pA22; TANNER L, 2002, 434 CAT I; WLEZIEN C, 1995, AM POLIT SCI REV, V89, P981; 2002, NY TIMES        1214, pA14	26	62	66	1	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					426	432		10.1056/NEJMsa023184	http://dx.doi.org/10.1056/NEJMsa023184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496352				2022-12-01	WOS:000180643800009
J	Alder, NN; Theg, SM				Alder, NN; Theg, SM			Energetics of protein transport across biological membranes: A study of the thylakoid Delta pH-dependent/cpTat pathway	CELL			English	Article							TWIN-ARGININE MOTIF; ESCHERICHIA-COLI TRANSLOCASE; OXYGEN-EVOLVING COMPLEX; SIGNAL PEPTIDE; EXPORT PATHWAY; IN-VITRO; ELECTRON STOICHIOMETRY; ESSENTIAL COMPONENT; PRECURSOR PROTEINS; PH/TAT MACHINERY	Among the pathways for protein translocation across biological membranes, the DeltapH-dependent/Tat system is unusual in its sole reliance upon the transmembrane pH gradient to drive protein transport. The free energy cost of protein translocation via the chloroplast DeltapH-dependent/Tat pathway was measured by conducting in vitro transport assays with isolated thylakoids while concurrently monitoring energetic parameters. These experiments revealed a substrate-specific energetic barrier to cpTat-mediated transport as well as direct utilization of protons from the gradient, consistent with a H+/protein antiporter mechanism. The magnitude of proton flux was assayed by four independent approaches and averaged 7.9 x 10(4) protons released from the gradient per transported protein. This corresponds to a DeltaG(transport) of 6.9 x 10(5) W-mol protein translocated(-1), representing the utilization of an energetic equivalent of 10(4) molecules of ATP. At this cost, we estimate that the DeltapH-dependent/cpTat pathway utilizes approximately 3% of the total energy output of the chloroplast.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Theg, SM (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	smtheg@ucdavis.edu		Alder, Nathan/0000-0003-4474-7803				Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder N ., 2002, THESIS U CALIFORNIA; Asai T, 1999, J BIOL CHEM, V274, P20075, DOI 10.1074/jbc.274.29.20075; Berghofer J, 1999, FEBS LETT, V460, P328, DOI 10.1016/S0014-5793(99)01365-4; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2000, BBA-BIOENERGETICS, V1459, P325, DOI 10.1016/S0005-2728(00)00168-7; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berry S, 1996, BBA-BIOENERGETICS, V1276, P51, DOI 10.1016/0005-2728(96)00031-X; Berry S, 1999, BBA-BIOENERGETICS, V1410, P248, DOI 10.1016/S0005-2728(99)00003-1; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Brink S, 1998, FEBS LETT, V434, P425, DOI 10.1016/S0014-5793(98)01028-X; BROCK IW, 1995, J BIOL CHEM, V270, P1657, DOI 10.1074/jbc.270.4.1657; CAPELLOS C, 1980, KINETIC SYSTEMS; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chance B., 1967, METHODS ENZYMOL, V10, P641; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; GRZESIEK S, 1988, BIOCHIM BIOPHYS ACTA, V938, P411, DOI 10.1016/0005-2736(88)90139-3; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Herrmann JM, 2000, BBA-BIOENERGETICS, V1459, P331, DOI 10.1016/S0005-2728(00)00169-9; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; JUNGE W, 1979, BIOCHIM BIOPHYS ACTA, V546, P121, DOI 10.1016/0005-2728(79)90175-0; JUNGE W, 1989, ANN NY ACAD SCI, V574, P268; KAWASAKI S, 1993, J BIOL CHEM, V268, P8193; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Leheny EA, 1998, PLANT PHYSIOL, V116, P805, DOI 10.1104/pp.116.2.805; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Ma XY, 2000, J BIOL CHEM, V275, P10016, DOI 10.1074/jbc.275.14.10016; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Mori H, 2001, FEBS LETT, V501, P65, DOI 10.1016/S0014-5793(01)02626-6; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Musser SM, 2000, BIOCHEMISTRY-US, V39, P8228, DOI 10.1021/bi000115f; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; NISHIMURA H, 1993, LASER PART BEAMS, V11, P89, DOI 10.1017/S0263034600006947; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nouwen N, 1996, MOL MICROBIOL, V19, P1205, DOI 10.1111/j.1365-2958.1996.tb02466.x; PROKS P, 1992, GEN PHYSL BIOPHYS, V11, P411; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Robinson C, 2001, NAT REV MOL CELL BIO, V2, P350, DOI 10.1038/35073038; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; ROTTENBERG H, 1979, BIOCHIM BIOPHYS ACTA, V549, P225, DOI 10.1016/0304-4173(79)90001-6; ROTTENBERG H, 1973, BIOPHYS J, V13, P503, DOI 10.1016/S0006-3495(73)86004-7; RUMBERG B, 1976, BIOELECTROCH BIOENER, V3, P393, DOI 10.1016/0302-4598(76)80033-5; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHONKNECHT G, 1990, FEBS LETT, V277, P65, DOI 10.1016/0014-5793(90)80810-6; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SIGALAT C, 1993, BIOCHEMISTRY-US, V32, P10193, DOI 10.1021/bi00089a040; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; TANI K, 1990, J BIOL CHEM, V265, P17341; Teter SA, 1998, P NATL ACAD SCI USA, V95, P1590, DOI 10.1073/pnas.95.4.1590; THEG SM, 1989, J BIOL CHEM, V264, P6730; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; van Dalen A, 1999, J BIOL CHEM, V274, P19913, DOI 10.1074/jbc.274.28.19913; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VREDENBERG WJ, 1976, INTACT CHLOROPLAST; Walker MB, 1999, J CELL BIOL, V147, P267, DOI 10.1083/jcb.147.2.267; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WICKNER WT, 1994, SCIENCE, V266, P1197, DOI 10.1126/science.7973701; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	82	83	87	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					231	242		10.1016/S0092-8674(03)00032-1	http://dx.doi.org/10.1016/S0092-8674(03)00032-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553911	Bronze			2022-12-01	WOS:000181191600012
J	Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK				Xu, X; Zhou, ZH; Wang, XL; Kuang, XW; Zhang, FC; Du, XK			Four-winged dinosaurs from China	NATURE			English	Article							EARLY EVOLUTION; ORIGIN; BIRD; ARCHAEOPTERYX; PALEONTOLOGY; FEATHERS; FLIGHT	Although the dinosaurian hypothesis of bird origins is widely accepted, debate remains about how the ancestor of birds first learned to fly. Here we provide new evidence suggesting that basal dromaeosaurid dinosaurs were four-winged animals and probably could glide, representing an intermediate stage towards the active, flapping-flight stage. The new discovery conforms to the predictions of early hypotheses that proavians passed through a tetrapteryx stage.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Tianjin Museum Nat Hist, Tianjin 300074, Peoples R China; Beijing Univ, Peoples Hosp, Dept Radiol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Peking University	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xing_xu@sina.com						Arnold EN, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P195; BEEBE CW, 1915, TETRAPTERYX STAGE AN; BOCK WJ, 1986, MEM CALIF ACAD SCI, V8, P57; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Burns T, 2000, HIST HUM SCI, V13, P1, DOI 10.1177/09526950022120845; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1999, B AM MUS NAT HIST, P3; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; FEDUCCIA A, 1979, SCIENCE, V203, P1021, DOI 10.1126/science.203.4384.1021; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HEILMANN G, 1927, ORIGIN BIRDS; Holtz Jr T. R., 2000, GAIA, V15, P5; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Norberg, 1990, VERTEBRATE FLIGHT; Norberg U.M., 1985, P293; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; OSTROM JH, 1986, MEM CALIF ACAD SCI, V8, P73; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Rayner J.M.V., 1985, P289; Rayner J.M.V., 1985, P279; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1992, SCIENCE, V255, P845, DOI 10.1126/science.255.5046.845; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; SPEAKMAN JR, 1994, NATURE, V370, P514, DOI 10.1038/370514a0; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Yalden D.W., 1997, Archaeopteryx, V15, P107; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237	46	320	363	7	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					335	340		10.1038/nature01342	http://dx.doi.org/10.1038/nature01342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540892	Green Published			2022-12-01	WOS:000180533000032
J	Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L				Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L			Contributions of the visual ventral pathway to long-range apparent motion	SCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; TOPOLOGICAL-STRUCTURE; PERCEPTION; BRAIN; RECOGNITION; ACTIVATION; VARIABLES; VISION; COLOR; NAME	Objects displaced intermittently across the visual field will nonetheless give an illusion of continuous motion [called apparent motion (AM)] under many common conditions. It is believed that form perception is of minor importance in determining AM, and that AM is mediated by motion-sensitive areas in the where pathway of the cortex. However, form and motion typically interact in specific ways when natural objects move through the environment. We used functional magnetic resonance imaging to measure cortical activation to long-range AM, compared to short-range AM and flicker, while we varied stability of structural differences between forms. Long-range AM activated the anterior-temporal lobe in the visual ventral pathway, and the response varied according to the form stability. The results suggest that long-range AM is associated with neural systems for form perception.	Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, Beijing 100101, Peoples R China; Beijing Hosp, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chinese Academy of Sciences, CAS; Beijing Hospital	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, 15 Datun Rd, Beijing 100101, Peoples R China.		Wang, Danny JJ/O-2482-2018; Meng, Ming/A-5829-2008; Rao, Hengyi/A-7064-2009; Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/K-5152-2019	Wang, Danny JJ/0000-0002-0840-7062; Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 				ANSTIS S, 1986, SENSORY PROCESS PERC, V1, P16; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; CHEN L, 1985, PERCEPTION, V14, P197, DOI 10.1068/p140197; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; CHEN L, 1990, PERCEPT PSYCHOPHYS, V47, P47, DOI 10.3758/BF03208163; Chen L, 2001, VIS COGN, V8, P287, DOI 10.1080/13506280143000016; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; KOLERS PA, 1971, J EXP PSYCHOL, V87, P99, DOI 10.1037/h0030156; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Moore CJ, 1999, BRAIN, V122, P943, DOI 10.1093/brain/122.5.943; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; PALMER P, 1999, VISION SCI; PETERSIK JT, 1989, PSYCHOL BULL, V106, P107, DOI 10.1037/0033-2909.106.1.107; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; PRAZDNY K, 1986, PERCEPTION, V15, P37, DOI 10.1068/p150037; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Todd JT, 1998, PERCEPTION, V27, P273, DOI 10.1068/p270273; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P263; Wang JJ, 1999, HUM BRAIN MAPP, V8, P170, DOI 10.1002/(SICI)1097-0193(1999)8:4<170::AID-HBM2>3.0.CO;2-W; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	33	82	90	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					417	420		10.1126/science.1077091	http://dx.doi.org/10.1126/science.1077091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	635YB	12532023				2022-12-01	WOS:000180426800053
J	Madeley, CR				Madeley, CR			Diagnosing smallpox in possible bioterrorist attack	LANCET			English	Editorial Material							VIRUS					dickmadeley@aol.com						ANDERSON T, 1951, LANCET, V260, P1248; Biel SS, 2001, J CLIN VIROL, V22, P1, DOI 10.1016/S1386-6532(01)00151-2; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Calisher CH, 2000, VIRAL IMMUNOL, V13, P411, DOI 10.1089/vim.2000.13.411; *CDCP, 2002, EV PAT SMALLP VERS 1; Elliott RM, 2001, SYMP SOC GEN MICROBI, V60, P53, DOI 10.1017/CBO9780511754883.004; GELDERBLOM HR, 2001, BIOFORUM INT, V5, P64; Nakano JH, 1989, DIAGNOSTIC PROCEDURE, P453; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2002, TIMES           1203, P21	10	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					97	98		10.1016/S0140-6736(03)12241-6	http://dx.doi.org/10.1016/S0140-6736(03)12241-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531572				2022-12-01	WOS:000180428000004
J	Bisley, JW; Goldberg, ME				Bisley, JW; Goldberg, ME			Neuronal activity in the lateral intraparietal area and spatial attention	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SELECTIVE VISUAL-ATTENTION; MOTOR INTENTION ACTIVITY; SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; MONKEY; MACAQUES; ENHANCEMENT; RESPONSES; PLAN	Although the parietal cortex has been implicated in the neural processes underlying visual attention, the nature of its contribution is not well understood. We tracked attention in the monkey and correlated the activity of neurons in the lateral intraparietal area (LIP) with the monkey's attentional performance. The ensemble activity in LIP across the entire visual field describes the spatial and temporal dynamics of a monkey's attention. Activity subtending a single location in the visual. field describes the attentional priority at that area but does not predict that the monkey will actually attend to or make an eye movement to that location.	New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, New York, NY 10032 USA; NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Neurol, Mahoney Ctr Mind & Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Psychiat, Mahoney Ctr Mind & Brain, New York, NY 10032 USA	New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University; Columbia University; Columbia University	Bisley, JW (corresponding author), New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, Room 5-06,1051 Riverside Dr, New York, NY 10032 USA.			Bisley, James/0000-0002-2841-0306				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Basso MA, 1998, J NEUROSCI, V18, P7519; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; PLATT ML, 1997, J NEUROPHYSIOL, V78, P157; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; Witte EA, 1996, BEHAV BRAIN RES, V82, P103, DOI 10.1016/S0166-4328(97)81113-8; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yantis S, 1996, J EXP PSYCHOL HUMAN, V22, P1505, DOI 10.1037/0096-1523.22.6.1505; Yarbus A. L., 1967, EYE MOVEMENTS VISION	43	614	621	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					81	86		10.1126/science.1077395	http://dx.doi.org/10.1126/science.1077395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511644				2022-12-01	WOS:000180165800036
J	Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M				Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M			Synthesis of serotonin by a second tryptophan hydroxylase isoform	SCIENCE			English	Article									Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, Charite, Fac Med, Inst Pharmacol & Toxicol, D-10117 Berlin, Germany; Free Univ Berlin, Sch Vet Med, Inst Pharmacol & Toxicol, D-14195 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Walther, DJ (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.		Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164				Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Humble M, 2001, BIOL PSYCHIAT, V49, P360, DOI 10.1016/S0006-3223(00)00956-2; KUHN DM, 1980, ARCH BIOCHEM BIOPHYS, V199, P355, DOI 10.1016/0003-9861(80)90291-X; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1	5	1127	1204	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					76	76		10.1126/science.1078197	http://dx.doi.org/10.1126/science.1078197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511643				2022-12-01	WOS:000180165800034
J	Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS				Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS			Binge drinking among US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK FACTOR SURVEILLANCE; REPORTED ALCOHOL-USE; HARVARD-SCHOOL; CONSUMPTION; ENFORCEMENT; VALIDITY; TRENDS; PERIOD; SALES; DEATH	Context Binge drinking (consuming greater than or equal to5 alcoholic drinks on 1 occasion) generally results in acute impairment and has numerous adverse health consequences. Reports indicate that binge drinking may be increasing in the United States. Objectives To quantify episodes of binge drinking among US adults in 1993-2001, to characterize adults who engage in binge drinking, and to describe state and regional differences in binge drinking. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey of adults aged 18 years or older that is conducted annually in all states. The sample size ranged from 102263 in 1993 to 212 510 in 2001. Main Outcome Measures Binge-drinking prevalence, episodes, and episodes per person per year. Results Between 1993 and 2001, the total number of binge-drinking episodes among US adults increased from approximately 1.2 billion to 1.5 billion; during this time, binge-drinking episodes per person per year increased by 17% (from 6.3 to 7.4, P for trend = .03). Between 1995 and 2001, binge-drinking episodes per person per year increased by 35% (P for trend = .005). Men accounted for 81% of binge-drinking episodes in the study years. Although rates of binge-drinking episodes were highest among those aged 18 to 25 years, 69% of binge-drinking episodes during the study period occurred among those aged 26 years or older. Overall, 47% of binge-drinking episodes occurred among otherwise moderate (ie, non-heavy) drinkers, and 73% of all binge drinkers were moderate drinkers. Binge drinkers were 14 times more likely to drive while impaired by alcohol compared with non-binge drinkers. There were substantial state and regional differences in per capita binge-drinking episodes. Conclusions Binge drinking is common among most strata of US adults, including among those aged 26 years or older. Per capita binge-drinking episodes have increased, particularly since 1995. Binge drinking is strongly associated with alcohol-impaired driving. Effective interventions to prevent the mortality and morbidity associated with binge drinking should be widely adopted, including screening patients for alcohol abuse in accordance with national guidelines.	Ctr Dis Control & Prevent, Alcohol Team, Analyt Methods Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Behav Surveillance Branch, Div Adult & Community Hlth, Atlanta, GA USA; Ctr Dis Control & Prevent, Chron Dis Nutr Branch, Div Nutr & Phys Act, Atlanta, GA USA; Ctr Dis Control & Prevent, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Alcohol Team, Emerging Invest Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Naimi, TS (corresponding author), CDC, Alcohol Team, MS K-67,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	tbn7@cdc.gov		Naimi, Timothy/0000-0001-9849-4413				*ALC EP PROGR, 2000, ALC POL US HIGHL 50; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P173; Center for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P1064; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P273; CHALOUPKA FJ, 1993, J LEGAL STUD, V22, P161, DOI 10.1086/468161; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Chikritzhs TN, 2001, MED J AUSTRALIA, V174, P281, DOI 10.5694/j.1326-5377.2001.tb143269.x; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; Cook PJ, 2002, HEALTH AFFAIR, V21, P120, DOI 10.1377/hlthaff.21.2.120; *FED TRAD COMM, 2002, SELF REG ALC IND; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Gentry E M, 1985, Am J Prev Med, V1, P9; Gladstone J, 1996, REPROD TOXICOL, V10, P3, DOI 10.1016/0890-6238(95)02024-1; Gmel G, 2001, ADDICTION, V96, P273, DOI 10.1046/j.1360-0443.2001.96227311.x; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Holder HD, 2000, JAMA-J AM MED ASSOC, V284, P2341, DOI 10.1001/jama.284.18.2341; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Jacobs EA, 2001, PEDIATRICS, V108, P185, DOI 10.1542/peds.108.1.185; Jacobson Joseph L, 1994, Alcohol Health Res World, V18, P30; LENDER ME, 1987, DRINKING AM; Liu S, 1997, JAMA-J AM MED ASSOC, V277, P122, DOI 10.1001/jama.277.2.122; Maier SE, 1997, ALCOHOL CLIN EXP RES, V21, P1418; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MCKNIGHT AJ, 1994, ACCIDENT ANAL PREV, V26, P79, DOI 10.1016/0001-4575(94)90070-1; MIDANIK LT, 1988, BRIT J ADDICT, V83, P1019; MORSE J, 2002, TIME, V159, P56; Nelson DE, 2002, JAMA-J AM MED ASSOC, V287, P2659, DOI 10.1001/jama.287.20.2659; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; *PARTN PREV, 2002, ALC HLTH RISK US MEA; RAE S, 1991, DRINK DRINKERS DRINK; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; SAFFER H, 1987, J LEGAL STUD, V16, P351, DOI 10.1086/467834; SHAH BV, 1997, SUDAAN USERS MANUAL; SHULTZ JM, 1991, PUBLIC HEALTH REP, V106, P443; SMITH PF, 1990, AM J PUBLIC HEALTH, V80, P309, DOI 10.2105/AJPH.80.3.309; Stout EM, 2000, J STUD ALCOHOL, V61, P402, DOI 10.15288/jsa.2000.61.402; *SUBST AB MENT HLT, 2002, NAT HOUS DRUG AB SUM; U. S. Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; *US DEP HLTH HUM S, 2000, HOM GARD B, V232; US Department of Health and Human Services, 2000, SAYING IT CLEARL; *US PREV SERV TASK, 1996, SCREEN PROBL DRINK G, P567; WAGENAAR AC, 1995, PUBLIC HEALTH REP, V110, P419; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wechsler H, 1998, J STUD ALCOHOL, V59, P122, DOI 10.15288/jsa.1998.59.122; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; World Health Organization, 2000, INT GUID MON ALC CON	53	722	741	0	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					70	75		10.1001/jama.289.1.70	http://dx.doi.org/10.1001/jama.289.1.70			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503979				2022-12-01	WOS:000180136600028
J	Smith, G				Smith, G			Scared to death?	BRITISH MEDICAL JOURNAL			English	Article									Pomona Coll, Dept Econ, Claremont, CA 91711 USA	Claremont Colleges; Pomona College	Smith, G (corresponding author), Pomona Coll, Dept Econ, Claremont, CA 91711 USA.			Smith, Gary/0000-0002-5173-2741				Glaser JH, 2002, BRIT MED J, V324, P1098, DOI 10.1136/bmj.324.7345.1098; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Phillips DP, 2001, BRIT MED J, V323, P1443, DOI 10.1136/bmj.323.7327.1443; PHILLIPS DP, 1993, LANCET, V342, P1142, DOI 10.1016/0140-6736(93)92124-C	5	9	9	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1442	1443		10.1136/bmj.325.7378.1442	http://dx.doi.org/10.1136/bmj.325.7378.1442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493656	Green Published			2022-12-01	WOS:000180188600008
J	Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C				Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C			Rates of behavior and aging specified by mitochondrial function during development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; RNA INTERFERENCE; EXTENDS LIFE; GENE; LONGEVITY; NEMATODE; MUTANTS	To explore the role of mitochondrial activity in the aging process, we have lowered the activity of the electron transport chain and adenosine 5'-triphosphate (ATP) synthase with RNA interference (RNAi) in Caenorhabditis elegans. These perturbations reduced body size and behavioral rates and extended adult life-span. Restoring messenger RNA to near-normal levels during adulthood did not elevate ATP levels and did not correct any of these phenotypes. Conversely, inhibiting respiratory-chain components during adulthood only did not reset behavioral rates and did not affect life-span. Thus, the developing animal appears to contain a regulatory system that monitors mitochondrial activity early in life and, in response, establishes rates of respiration, behavior, and aging that persist during adulthood.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England	University of California System; University of California San Francisco; University of Cambridge	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	Hsu, Ao-Lin Allen/AAX-1856-2020	Hsin, Honor/0000-0002-0510-7494; Hsu, Ao-Lin/0000-0002-2864-3134; Kenyon, Cynthia/0000-0003-3446-2636; Fraser, Andrew/0000-0001-9939-6014; Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DILLIN A, UNPUB; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; SLATER EC, 1983, TRENDS BIOCHEM SCI, V8, P239, DOI 10.1016/0968-0004(83)90348-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; WONG A, 1995, GENETICS, V139, P1247	22	745	783	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2398	2401		10.1126/science.1077780	http://dx.doi.org/10.1126/science.1077780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12471266				2022-12-01	WOS:000179915900060
J	Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G				Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G			HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway	CELL			English	Article							RIBOSYLATION FACTOR 6; PLASMA-MEMBRANE; CELL-SURFACE; COMPLEX; TRAFFICKING; MOLECULES; PROTEINS; BINDING; PHOSPHORYLATION; ACTIVATION	The HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the trans-Golgi network (TGN) enables HIV-1 to escape immune surveillance. However, the cellular pathway used by Nef to downregulate MHC-I is unknown. Here, we show that Nef and PACS-1 combine to usurp the ARF6 endocytic pathway by a PI3K-dependent process and downregulate cell surface MHC-I to the TGN. This mechanism requires the hierarchical actions of three Nef motifs-the acidic cluster (EEEE65)-E-62, the SH3 domain binding site (PXXP75)-P-72, and M-20-in controlling PACS-1-dependent sorting to the TGN, ARF6 activation, and sequestering internalized MHC-I to the TGN, respectively. These data provide new insights into the cellular basis of HIV-1 immunoevasion.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Thomas, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	thomasg@ohsu.edu	Feliciangeli, Sylvain/Q-1292-2016	Feliciangeli, Sylvain/0000-0003-3358-3719	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49793, R01 AI049793, AI8585] Funding Source: Medline; NIDDK NIH HHS [DK37274] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P27896, DOI 10.1074/jbc.273.43.27896; Capps GG, 2000, MOL IMMUNOL, V37, P59, DOI 10.1016/S0161-5890(00)00019-5; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Chang AH, 2001, EUR J IMMUNOL, V31, P2382, DOI 10.1002/1521-4141(200108)31:8<2382::AID-IMMU2382>3.0.CO;2-K; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hitt M M, 1997, Adv Pharmacol, V40, P137, DOI 10.1016/S1054-3589(08)60140-4; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marsh M, 2000, TRAFFIC, V1, P525, DOI 10.1034/j.1600-0854.2000.010701.x; Matafora V, 2001, J CELL SCI, V114, P4509; Munch J, 2001, J VIROL, V75, P10532, DOI 10.1128/JVI.75.21.10532-10536.2001; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Peters PJ, 2001, TRAFFIC, V2, P885, DOI 10.1034/j.1600-0854.2001.21204.x; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Schibeci SD, 2000, AIDS, V14, P1701, DOI 10.1097/00002030-200008180-00003; Swann SA, 2001, VIROLOGY, V282, P267, DOI 10.1006/viro.2000.0816; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	49	231	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					853	866		10.1016/S0092-8674(02)01162-5	http://dx.doi.org/10.1016/S0092-8674(02)01162-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526811	Bronze			2022-12-01	WOS:000179862600011
J	Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK				Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK			Rainfall variability, carbon cycling, and plant species diversity in a mesic grassland	SCIENCE			English	Article							CLIMATE VARIABILITY; EXTREMES; FIRE	Ecosystem responses to increased variability in rainfall, a prediction of general circulation models, were assessed in native grassland by reducing storm frequency and increasing rainfall quantity per storm during a 4-year experiment. More extreme rainfall patterns, without concurrent changes in total rainfall quantity, increased temporal variability in soil moisture and plant species diversity. However, carbon cycling processes such as soil CO2 flux, CO2 uptake by the dominant grasses, and aboveground net primary productivity (ANPP) were reduced, and ANPP was more responsive to soil moisture variability than to mean soil water content. Our results show that projected increases in rainfall variability can rapidly alter key carbon cycling processes and plant community composition, independent of changes in total precipitation.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Natl Sci Fdn, Ecol Studies Program, Arlington, VA 22230 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	Kansas State University; National Science Foundation (NSF); National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Knapp, AK (corresponding author), Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.	aknapp@ksu.edu	Collins, Scott L/P-7742-2014; Blair, John M/I-4082-2014; Fay, Philip A./I-1853-2012; Smith, Melinda D/J-8987-2014; Knapp, Alan K/A-2931-2008; Noojipady, Praveen/B-2511-2010	Collins, Scott L/0000-0002-0193-2892; Blair, John M/0000-0003-0072-0721; Fay, Philip A./0000-0002-8291-6316; 				Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Gates D.M., 1993, CLIMATE CHANGE ITS B; GORDON HB, 1992, CLIM DYNAM, V8, P83, DOI 10.1007/BF00209165; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SYNT; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Johnson LC, 2001, ECOLOGY, V82, P3377, DOI 10.1890/0012-9658(2001)082[3377:FAGRBP]2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 1998, ECOL APPL, V8, P760, DOI 10.2307/2641264; KNAPP AK, 1993, ECOLOGY, V74, P549, DOI 10.2307/1939315; Koch G, 1996, CARBON DIOXIDE TERRE; Ludwig J. A., 1988, STAT ECOLOGY; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MEARNS LO, 1990, J GEOPHYS RES-ATMOS, V95, P20469, DOI 10.1029/JD095iD12p20469; Mearns LO, 1997, CLIMATIC CHANGE, V35, P367, DOI 10.1023/A:1005358130291; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Plummer N, 1999, CLIMATIC CHANGE, V42, P183, DOI 10.1023/A:1005472418209; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; RIND D, 1989, CLIMATIC CHANGE, V14, P5, DOI 10.1007/BF00140173; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; SCHIMEL DS, 1991, ECOLOGY, V72, P672, DOI 10.2307/2937207; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257	27	816	911	42	679	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2202	2205		10.1126/science.1076347	http://dx.doi.org/10.1126/science.1076347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481139				2022-12-01	WOS:000179773700051
J	Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM				Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM			Rotting smell of dead-horse arum florets - These blooms chemically fool flies into pollinating them.	NATURE			English	Article							DECEPTION; MIMICRY		Swedish Univ Agr Sci, Dept Crop Sci, S-23053 Alnarp, Sweden; Univ Cagliari, Dept Expt Biol, I-4500 Monserrato, Italy	Swedish University of Agricultural Sciences; University of Cagliari	Stensmyr, MC (corresponding author), Swedish Univ Agr Sci, Dept Crop Sci, POB 44, S-23053 Alnarp, Sweden.		Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Celander, Malin/0000-0002-4350-751X; Stensmyr, Marcus/0000-0003-4009-9212				ARN H, 1975, Z NATURFORSCH C, V30, P722; BROWN MH, 1982, MEAT MICROBIOLOGY; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Fridlender Alain, 2000, Webbia, V55, P7; Kite Geoffrey C., 2000, Kew Bulletin, V55, P237, DOI 10.2307/4117785; Linnaeus C., 1745, C LINNAEI OLANDSKA G; Rosello JA, 1997, ACTA BOT BARC, V44, P169; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2000, J COMP PHYSIOL A, V186, P567, DOI 10.1007/s003590000112	10	157	159	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					625	626		10.1038/420625a	http://dx.doi.org/10.1038/420625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478279				2022-12-01	WOS:000179751800031
J	Chen, LC; Thurston, G				Chen, LC; Thurston, G			World Trade Center cough	LANCET			English	Article									NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	New York University	Chen, LC (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.		Cjem, Lung-Chi/H-5030-2012	Chen, Lung Chi/0000-0003-1154-2107	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))			0	35	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S37	S38		10.1016/S0140-6736(02)11814-9	http://dx.doi.org/10.1016/S0140-6736(02)11814-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504497				2022-12-01	WOS:000180064500018
J	Murray, VSG; Bailey, MR; Spratt, BG				Murray, VSG; Bailey, MR; Spratt, BG			Depleted uranium: a new battlefield hazard	LANCET			English	Article									Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England; Natl Radiol Protect Board, Dose Assessments Dept, Chilton, England; St Marys Hosp, Imperial Coll, Dept Infect Dis Epidemiol, London, England	Imperial College London	Murray, VSG (corresponding author), Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England.		Spratt, Brian G/A-1676-2009					*ROYAL SOC, 2001, HLTH HAZ DEPL UR M 1; Royal Society, 2002, HLTH HAZ DEPL UR M 2; World Health Organization, 2001, DEPL UR SOURC EXP HL, P273	3	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S31	S32		10.1016/S0140-6736(02)11811-3	http://dx.doi.org/10.1016/S0140-6736(02)11811-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504494				2022-12-01	WOS:000180064500015
J	Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS				Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS		HOPS Investigators	Protease inhibitors and cardiovascular outcomes in patients with HIV-1	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; CORONARY-ARTERY DISEASE	Protease inhibitors for treatment of HIV-1 have been linked with increased risk of hyperlipidaemia and hyperglycaemia. In a cohort of 5672 outpatients with HIV-1 seen at nine US HIV clinics between January, 1993, and January, 2002, the frequency of myocardial infarctions increased after the introduction of protease inhibitors in 1996 (test for trend, p=0.0125). We noted that 19 of 3247 patients taking, but only two of 2425 who did not take, protease inhibitors had a myocardial infarction (odds ratio 7.1, 95% CI 1.6-44.3; Cox proportional hazards model-adjusted for smoking, sex, age, diabetes, hyperlipidaemia, and hypertension-hazard ratio 6.5, 0.9-47.8). Our findings suggest that, although infrequent, use of protease inhibitors is associated with increased risk of myocardial infarction in patients with HIV-1.	Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; Dupont Circle Phys Grp, Washington, DC USA; Cerner Corp, McLean, VA USA	Centers for Disease Control & Prevention - USA	Holmberg, SD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.			Moorman, Anne/0000-0003-2411-2798				BARBARO G, 2002, 14 INT C AIDS BARC J; BOZZETTE SA, 2002, 9 C RETR OPP INF SEA; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Passalaris JD, 2000, CLIN INFECT DIS, V31, P787	5	362	380	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1747	1748		10.1016/S0140-6736(02)11672-2	http://dx.doi.org/10.1016/S0140-6736(02)11672-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480430				2022-12-01	WOS:000179636800014
J	Lobell, DB; Asner, GP				Lobell, DB; Asner, GP			Climate and management contributions to recent trends in US agricultural yields	SCIENCE			English	Article							WORLD		Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Lobell, DB (corresponding author), Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA.		Zhong, Hong Lin/C-2633-2012; Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Lobell, David/0000-0002-5969-3476				Brown RA, 1997, AGR FOREST METEOROL, V83, P171, DOI 10.1016/S0168-1923(96)02352-0; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Conway G, 1999, NATURE, V402, pC55, DOI 10.1038/990141; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0	5	536	607	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1032	1032		10.1126/science.1077838	http://dx.doi.org/10.1126/science.1077838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586935				2022-12-01	WOS:000180960000036
J	Grodstein, F; Clarkson, TB; Manson, JE				Grodstein, F; Clarkson, TB; Manson, JE			Understanding the divergent data on postmenopausal hormone therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTROGEN REPLACEMENT THERAPY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CORONARY EVENTS; WOMEN; ATHEROSCLEROSIS; MORTALITY; RISK; INFLAMMATION		Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.							Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Cline JM, 1996, AM J OBSTET GYNECOL, V174, P93, DOI 10.1016/S0002-9378(96)70379-4; Collaborative Group on Hormonal Factors in Breast Cancer, 1997, LANCET, V350, P1484; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grodstein F, 1999, AM J MED, V106, P574, DOI 10.1016/S0002-9343(99)00063-7; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, NEW ENGL J MED, V335, P1406; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; GRODSTEIN F, 2002, THROMBOSIS THROMBOEM; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 2001, ARTERIOSCL THROM VAS, V21, P1955, DOI 10.1161/hq1201.100241; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; MCGILL HC, 1979, ATHER REV, V4, P157; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rimm EB, 2000, MED CLIN N AM, V84, P239, DOI 10.1016/S0025-7125(05)70216-9; Rodriguez C, 2001, AM J EPIDEMIOL, V153, P145, DOI 10.1093/aje/153.2.145; ROSENBERG L, 1993, AM J EPIDEMIOL, V137, P54, DOI 10.1093/oxfordjournals.aje.a116602; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; Sourander L, 1999, LANCET, V353, P330; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; TEJADA C, 1968, LAB INVEST, V18, P509; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	40	258	265	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					645	650		10.1056/NEJMsb022365	http://dx.doi.org/10.1056/NEJMsb022365			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584376				2022-12-01	WOS:000180912900012
J	Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A				Buavirat, A; Page-Shafer, K; van Griensven, GJP; Mandel, JS; Evans, J; Chuaratanaphong, J; Chiamwongpat, S; Sacks, R; Moss, A			Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ATTRIBUTABLE RISK; PRISON SYSTEM; TRANSMISSION; PREVENTION; BEHAVIOR; INMATES; COHORT; POLICY	Objectives To identify risks for HIV infection related to incarceration among injecting drug users in Bangkok, Thailand. Design Case-control study of sexual and parenteral exposures occurring before, during, and after the most recent incarceration. Setting Metropolitan Bangkok. Participants Non-prison based injecting drug users formerly incarcerated for at least six months in the previous five years, with documented HIV serostatus since their most recent release; 175 HIV positive cases and 172 HIV negative controls from methadone clinics. Main outcome measure Injection of heroin and methamphetamine, sharing of needles, sexual behaviour, and tattooing before, during, and after incarceration. Results In the month before detention cases were more likely than controls to have injected methamphetamine and to have borrowed needles. More cases than controls reported using drugs (60% v 45%; P=0.005) and sharing needles (50% v 31%; P<0.01) in the holding cell before incarceration. Independent risk factors for prevalent HIV infection included injection of methamphetamine before detention (adjusted odds ratio 3.3, 95% confidence interval 1.01 to 10.7), sharing needles in the holding cell (1.9, 1.2 to 3.0), being tattooed while in prison (2.1, 1.3 to 3.4), and borrowing needles after release (2.5, 1.3 to 4.4). Conclusions Injecting drug users in Bangkok are at significantly increased risk of HIV infection through sharing needles with multiple partners while in holding cells before incarceration. The time spent in holding cells is an important opportunity to provide risk reduction counselling and intervention to reduce the incidence of HIV.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA 94105 USA; Dept Hlth, Hlth Promot Div, Bangkok 10400, Thailand; Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Minist Publ Hlth, HIV AIDS Program, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ministry of Public Health - Thailand; University of California System; University of California San Francisco	Page-Shafer, K (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, 74 New Montgomery, San Francisco, CA 94105 USA.		; van Griensven, Frits/G-4719-2013	Page, Kimberly/0000-0002-7120-1673; van Griensven, Frits/0000-0002-0971-2843	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [5 P50 MH42459, P50 MH042459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allwright S, 2000, BRIT MED J, V321, P78, DOI 10.1136/bmj.321.7253.78; *ASS STAT TERR HLT, 1999, WHY PUBL HLTH SHOULD, P1; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Braithwaite RL, 1999, J PUBLIC HEALTH POL, V20, P459, DOI 10.2307/3343131; BREWER TF, 1988, AIDS, V2, P363, DOI 10.1097/00002030-198810000-00005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BUAVIRAT A, IN PRESS AIDS PUBLIC; Chesney MA, 1998, AM J PUBLIC HEALTH, V88, P113, DOI 10.2105/AJPH.88.1.113; CHOOPANYA K, 1991, AIDS, V5, P1509, DOI 10.1097/00002030-199112000-00014; Diaz RS, 1999, AIDS, V13, P1417, DOI 10.1097/00002030-199907300-00024; DOLAN K, 1995, AIDS, V9, P825, DOI 10.1097/00002030-199508000-00001; Dolan KA, 1999, MED J AUSTRALIA, V171, P14, DOI 10.5694/j.1326-5377.1999.tb123490.x; Edwards A, 1999, INT J STD AIDS, V10, P464, DOI 10.1258/0956462991914474; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; Frischer M, 1997, ADDICTION, V92, P419, DOI 10.1046/j.1360-0443.1997.9244196.x; Gaiter J, 1996, AM J PUBLIC HEALTH, V86, P1201, DOI 10.2105/AJPH.86.9.1201; Grinstead OA, 1999, HEALTH EDUC BEHAV, V26, P225, DOI 10.1177/109019819902600206; KITAYAPORN D, 1994, AIDS, V8, P1443, DOI 10.1097/00002030-199410000-00011; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Mahon N, 1996, AM J PUBLIC HEALTH, V86, P1211, DOI 10.2105/AJPH.86.9.1211; Sattah MV, 2002, ADDICTION, V97, P801, DOI 10.1046/j.1360-0443.2002.00131.x; Surasiengsunk S, 1998, AIDS, V12, P775, DOI 10.1097/00002030-199807000-00014; TAYLOR A, 1995, BRIT MED J, V310, P289, DOI 10.1136/bmj.310.6975.289; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013	24	87	92	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 8	2003	326	7384					308	310A		10.1136/bmj.326.7384.308	http://dx.doi.org/10.1136/bmj.326.7384.308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645UD	12574043	Green Published, Bronze			2022-12-01	WOS:000180997000017
J	Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI				Foth, BJ; Ralph, SA; Tonkin, CJ; Struck, NS; Fraunholz, M; Roos, DS; Cowman, AF; McFadden, GI			Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum	SCIENCE			English	Article							CHLOROPLAST TRANSIT PEPTIDES; TOXOPLASMA-GONDII; SIGNAL PEPTIDES; LEADER SEQUENCE; IN-VIVO; MITOCHONDRIAL; IDENTIFICATION; PRECURSORS; PROTEINS; IMPORT	Transit peptides mediate protein targeting into plastids and are only poorly understood. We extracted amino acid features from transit peptides that target proteins to the relict plastid (apicoplast) of malaria parasites. Based on these amino acid characteristics, we identified 466 putative apicoplast proteins in the Plasmodium falciparum genome. Altering the specific charge characteristics in a model transit peptide by site-directed mutagenesis severely disrupted organellar targeting in vivo. Similarly, putative Hsp70 (DnaK) binding sites present in the transit peptide proved to be important for correct targeting.	Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Melbourne; University of Pennsylvania; Walter & Eliza Hall Institute	McFadden, GI (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3010, Australia.	gim@unimelb.edu.au	Cowman, Alan F/C-7642-2013; McFadden, Geoffrey McFadden I/F-7667-2014; Tonkin, Christopher/K-6534-2019; Ralph, Stuart/C-8590-2014	Cowman, Alan F/0000-0001-5145-9004; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Tonkin, Christopher/0000-0002-7036-6222; Roos, David Siker/0000-0001-6725-4089; Ralph, Stuart/0000-0003-0114-7808				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heard TS, 1998, J BIOL CHEM, V273, P29389, DOI 10.1074/jbc.273.45.29389; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Ivey RA, 2000, CELL STRESS CHAPERON, V5, P62, DOI 10.1379/1466-1268(2000)005<0062:IVAIVI>2.0.CO;2; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Jarvis P, 2002, BBA-MOL CELL RES, V1590, P177, DOI 10.1016/S0167-4889(02)00176-3; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; van Dooren GG, 2001, BBA-MOL CELL RES, V1541, P34, DOI 10.1016/S0167-4889(01)00154-9; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Yung S, 2001, MOL BIOCHEM PARASIT, V118, P11, DOI 10.1016/S0166-6851(01)00359-0; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	27	371	379	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					705	708		10.1126/science.1078599	http://dx.doi.org/10.1126/science.1078599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560551				2022-12-01	WOS:000180687700046
J	Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA				Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA			Ancient tripartite coevolution in the attine ant-microbe symbiosis	SCIENCE			English	Article							FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; HYMENOPTERA; AGRICULTURE; FORMICIDAE; MUTUALISM; PHYLOGENY; BACTERIA	The symbiosis between fungus-growing ants and the fungi they cultivate for food has been shaped by 50 million years of coevolution. Phylogenetic analyses indicate that this long coevolutionary history includes a third symbiont lineage: specialized microfungal parasites of the ants fungus gardens. At ancient levels, the phylogenies of the three symbionts are perfectly congruent, revealing that the ant-microbe symbiosis is the product of tripartite coevolution between the farming ants, their cultivars, and the garden parasites. At recent phylogenetic levels, coevolution has been punctuated by occasional host-switching by the parasite, thus intensifying continuous coadaptation between symbionts in a tripartite arms race.	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Texas, Austin, TX 78712 USA; Smithsonian Inst, Natl Museum Nat Hist, MRC 188, Washington, DC 20013 USA; ARS, Insect Biocontrol Lab, USDA, Beltsville, MD 20705 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	University of Kansas; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Toronto; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Oregon State University	Currie, CR (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.							Ahmadjian V, 1986, SYMBIOSIS INTRO BIOL; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Boucher Douglas H., 1985, BIOL MUTUALISM ECOLO; Castle A, 1998, APPL ENVIRON MICROB, V64, P133; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; CURRIE CR, IN PRESS OIKOS; FUTUYMA DJ, 1983, COEVOLUTION; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; Margulis L, 1991, SYMBIOSIS SOURCE EVO; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; QUINLAN RJ, 1977, ECOL ENTOMOL, V2, P161, DOI 10.1111/j.1365-2311.1977.tb00877.x; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466	23	272	290	1	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					386	388		10.1126/science.1078155	http://dx.doi.org/10.1126/science.1078155			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532015				2022-12-01	WOS:000180426800043
J	Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL				Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL			Production of alpha 1,3-galactosyltransferase-deficient pigs	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE; TOXIN-A; XENOTRANSPLANTATION; GAL-ALPHA-1-3GAL-BETA-1-4GLCNAC-R; EXPRESSION; EPITOPES; CELLS; MOUSE	The enzyme alpha1,3-galactosyltransferase (alpha1,3GT or GGTA1) synthesizes alpha1,3-galactose (alpha1,3Gal) epitopes (Galbeta1,3Galbeta1,4GlcNac-R), which are the major xenoantigens causing hyperacute rejection in pig-to-human xenotransplantation. Complete removal of alpha1,3Gal from pig organs is the critical step toward the success of xenotransplantation. We reported earlier the targeted disruption of one allele of the alpha1,3GT gene in cloned pigs. A selection procedure based on bacterial toxin was used to select for cells in which the second allele of the gene was knocked out. Sequencing analysis demonstrated that knockout of the second allele of the alpha1,3GT gene was caused by T-to-G single point mutation at the second base of exon 9, which resulted in inactivation of the alpha1,3GT protein. Four healthy alpha1,3GT double-knockout female piglets were produced by three consecutive rounds of cloning. The piglets carrying point mutation in the alpha1,3GT gene hold significant value, as they would allow production of alpha1,3Gal-deficient pigs free of antibiotic-resistance genes and thus have the potential to make safer product for human use.	PPL Therapeut Inc, Blacksburg, VA 24060 USA; PPL Therapeut Ltd, Roslin EH25 9PP, Midlothian, Scotland; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; Childrens Hosp, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dai, YF (corresponding author), PPL Therapeut Inc, 1700 Kraft Dr, Blacksburg, VA 24060 USA.		Polejaeva, Irina/G-4881-2012	Dai, Yifan/0000-0003-2872-8442; Bertera, Suzanne/0000-0002-9228-4279; Polejaeva, Irina/0000-0002-0858-5889; Yang, Haiyuan/0000-0001-5253-0079	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER; NIADDK NIH HHS [R01 AM007772] Funding Source: Medline; NIDDK NIH HHS [R01 DK029961-19, DK29961, R01 AM007772] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARK GF, 1987, ARCH BIOCHEM BIOPHYS, V257, P217, DOI 10.1016/0003-9861(87)90561-3; COOPER DKC, 1993, LANCET, V342, P682, DOI 10.1016/0140-6736(93)91791-J; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Drake JW, 1998, GENETICS, V148, P1667; GALILI U, 1988, J BIOL CHEM, V263, P17755; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; GOOD AH, 1992, TRANSPL P, V24, P559; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Koike C, 2002, J BIOL CHEM, V277, P10114, DOI 10.1074/jbc.M110527200; KUSHNARYOV VM, 1990, CYTOBIOS, V64, P181; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Logan JS, 2000, CURR OPIN IMMUNOL, V12, P563, DOI 10.1016/S0952-7915(00)00139-4; MOHAN R, 2001, PROTEIN, V44, P428; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Tanemura M, 2000, TRANSPLANTATION, V69, P187, DOI 10.1097/00007890-200001150-00034; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004	17	818	915	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					411	414		10.1126/science.1078942	http://dx.doi.org/10.1126/science.1078942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12493821	Green Accepted			2022-12-01	WOS:000180426800051
J	Doebeli, M; Dieckmann, U				Doebeli, M; Dieckmann, U			Speciation along environmental gradients	NATURE			English	Article							SYMPATRIC SPECIATION; DIVERGENCE; COMPETITION; RADIATION; ORIGIN; MORPHS	Traditional discussions of speciation are based on geographical patterns of species ranges(1,2). In allopatric speciation, long-term geographical isolation generates reproductively isolated and spatially segregated descendant species(1,3). In the absence of geographical barriers, diversification is hindered by gene flow(1,3,4). Yet a growing body of phylogenetic and experimental data suggests that closely related species often occur in sympatry or have adjacent ranges in regions over which environmental changes are gradual and do not prevent gene flow(5-14). Theory has identified a variety of evolutionary processes that can result in speciation under sympatric conditions(15-25), with some recent advances concentrating on the phenomenon of evolutionary branching(18,23-25). Here we establish a link between geographical patterns and ecological processes of speciation by studying evolutionary branching in spatially structured populations. We show that along an environmental gradient, evolutionary branching can occur much more easily than in non-spatial models. This facilitation is most pronounced for gradients of intermediate slope. Moreover, spatial evolutionary branching readily generates patterns of spatial segregation and abutment between the emerging species. Our results highlight the importance of local processes of adaptive divergence for geographical patterns of speciation, and caution against pitfalls of inferring past speciation processes from present biogeographical patterns.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada; Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria	University of British Columbia; University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca	Doebeli, Michael/D-5391-2012; Dieckmann, Ulf/E-1424-2011	Dieckmann, Ulf/0000-0001-7089-0393				Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Endler J.A., 1977, Monographs in Population Biology, pi; Feder JL, 1998, ENDLESS FORMS, P130; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI [10.2307/2410998, 10.1111/j.1558-5646.1997.tb05099.x]; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; KNOX EB, 1995, P NATL ACAD SCI USA, V92, P10349, DOI 10.1073/pnas.92.22.10349; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mayr E, 1963, ANIMAL SPECIES EVOLU; MIZERA F, IN PRESS EVOL ECOL R; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SLATKIN M, 1978, J THEOR BIOL, V70, P213, DOI 10.1016/0022-5193(78)90348-X; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Doorn GS, 2001, P ROY SOC B-BIOL SCI, V268, P2155, DOI 10.1098/rspb.2001.1780; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	30	516	531	2	229	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					259	264		10.1038/nature01274	http://dx.doi.org/10.1038/nature01274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529641	Green Submitted			2022-12-01	WOS:000180397600045
J	Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG				Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG			Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde	CELL			English	Article							ACTIVE-SITE; P53; PROTEASE; PATHWAY; ISOPEPTIDASE; DEGRADATION; SPECIFICITY; MECHANISMS; DIVERSITY; ALIGNMENT	The ubiquitin-specific processing protease (UBP) family of deubiquitinating enzymes plays an essential role in numerous cellular processes. HAUSP, a representative UBP, specifically deubiquitinates and hence stabilizes the tumor suppressor protein p53. Here, we report the crystal structures of the 40 kDa catalytic core domain of HAUSP in isolation and in complex with ubiquitin aldehyde. These studies reveal that the UBP deubiquitinating enzymes exhibit a conserved three-domain architecture, comprising Fingers, Palm, and Thumb. The leaving ubiquitin moiety is specifically coordinated by the Fingers, with its C terminus placed in the active site between the Palm and the Thumb. Binding by ubiquitin aldehyde induces a drastic conformational change in the active site that realigns the catalytic triad residues for catalysis.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Princeton University; Columbia University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X				Baek KH, 2001, BLOOD, V98, P636, DOI 10.1182/blood.V98.3.636; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Chung JY, 2002, J CELL SCI, V115, P679; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DUNTEN RL, 1989, J BIOL CHEM, V264, P16739; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Gilchrist CA, 2000, BBA-PROTEIN STRUCT M, V1481, P297, DOI 10.1016/S0167-4838(00)00134-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Schwartz AL, 1999, ANNU REV MED, V50, P57; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu JW, 2001, J BIOL CHEM, V276, P20688, DOI 10.1074/jbc.M100174200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200	53	470	497	3	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1041	1054		10.1016/S0092-8674(02)01199-6	http://dx.doi.org/10.1016/S0092-8674(02)01199-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507430	Bronze			2022-12-01	WOS:000180086000013
J	Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA				Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA			Natural history of alkaptonuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOMOGENTISIC ACID; MUTATIONS; IDENTIFICATION; DIOXYGENASE; OCHRONOSIS; INHIBITION; SLOVAKIA; GENE; NTBC	Background: Alkaptonuria, caused by mutations in the HGO gene and a deficiency of homogentisate 1,2-dioxygenase, results in an accumulation of homogentisic acid (HGA), ochronosis, and destruction of connective tissue. There is no effective therapy for this disorder, although nitisinone inhibits the enzyme that produces HGA. We performed a study to delineate the natural history of alkaptonuria. Methods: We evaluated 58 patients with alkaptonuria (age range, 4 to 80 years), using clinical, radiographic, biochemical, and molecular methods. A radiographic scoring system was devised to assess the severity of spinal and joint damage. Two patients were treated with nitisinone for 10 and 9 days, respectively. Results: Life-table analyses showed that joint replacement was performed at a mean age of 55 years and that renal stones developed at 64 years, cardiac-valve involvement at 54 years, and coronary-artery calcification at 59 years. Linear regression analysis indicated that the radiographic score for the severity of disease began increasing after the age of 30 years, with a more rapid increase in men than in women. Twenty-three new HGO mutations were identified. In a 51-year-old woman, urinary HGA excretion fell from 2.9 to 0.13 g per day after a 10-day course of nitisinone (7 days at a dose of 0.7 mg per day and 3 days at 2.8 mg per day). In a 59-year-old woman, urinary HGA fell from 6.4 g to 1.7 g per day after nine days of treatment with nitisinone (0.7 mg per day). Plasma tyrosine levels in these patients rose from approximately 1.1 mg per deciliter (60 micromol per liter) in both to approximately 12.8 mg per deciliter (700 micromol per liter) and 23.6 mg per deciliter (1300 micromol per liter), respectively, with no clinical signs or symptoms. Conclusions: The reported data on the natural history of alkaptonuria provide a basis for the evaluation of long-term therapies. Although nitisinone can reduce HGA production in humans with homogentisate 1,2-dioxygenase deficiency, the long-term safety and efficacy of this treatment require further evaluation.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, Bethesda, MD 20892 USA; Natl Inst Hlth Clin Ctr, Dept Rehabil Med, Bethesda, MD USA; Armed Forces Inst Pathol, Dept Radiol Pathol, Washington, DC 20306 USA; Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); United States Department of Defense; University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Gahl, WA (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1851,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Huizing, Marjan/AAR-8860-2020	Gerber, Lynn/0000-0001-7525-680X				Anikster Y, 1998, AM J HUM GENET, V63, P920, DOI 10.1086/302027; BAHN AK, 1972, BASIC MED STATISTICS, P154; Baumann E, 1891, Z PHYSL CHEM, V15, P228; Boedeker C., 1859, Z RATION MED, V7, P130; de Bernabe DBV, 1999, AM J HUM GENET, V64, P1316, DOI 10.1086/302376; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; Deutsch JC, 1996, J CHROMATOGR B, V677, P147, DOI 10.1016/0378-4347(95)00442-4; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; de Jorge EG, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.7.e40; Hall MG, 2001, BRIT J CLIN PHARMACO, V52, P169, DOI 10.1046/j.0306-5251.2001.01421.x; Introne WJ, 2002, MOL GENET METAB, V77, P136, DOI 10.1016/S1096-7192(02)00121-X; KHAN MA, 1984, SPONDYLARTHROPATHIES, P69; LADU BN, 1958, J BIOL CHEM, V230, P251; LADU BN, 2002, CONNECTIVE TISSUE IT, P809; LADU BN, 2001, METABOLIC MOL BASES, V2, P2109; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; LUSTBERG TJ, 1971, CLIN CHIM ACTA, V35, P325, DOI 10.1016/0009-8981(71)90202-6; MACRAE IF, 1969, ANN RHEUM DIS, V28, P584, DOI 10.1136/ard.28.6.584; Mitchell GA, 2001, METABOLIC MOL BASES, P1777; MOLL JMH, 1971, ANN RHEUM DIS, V30, P381, DOI 10.1136/ard.30.4.381; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P55; NEUBAUER O, 1909, DTSCH ARCH KLIN MED, V95, P211; OBRIEN WM, 1963, AM J MED, V34, P813, DOI 10.1016/0002-9343(63)90089-5; Porfirio B, 2000, J MED GENET, V37, P309, DOI 10.1136/jmg.37.4.309; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Schober P., 1937, MUNCH MED WOCHENSCHR, V84, P336; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; Srsen S, 2002, MOL GENET METAB, V75, P353, DOI 10.1016/S1096-7192(02)00002-1; STENN FF, 1977, SCIENCE, V197, P566, DOI 10.1126/science.327549; Suzuki Y, 1999, J HUM GENET, V44, P79, DOI 10.1007/s100380050114; WARE JE, 1981, AM J PUBLIC HEALTH, V71, P620, DOI 10.2105/AJPH.71.6.620; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WOLFF JA, 1989, PEDIATR RES, V26, P140, DOI 10.1203/00006450-198908000-00015; Zatkova A, 2000, AM J HUM GENET, V67, P1333	38	361	378	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2111	2121		10.1056/NEJMoa021736	http://dx.doi.org/10.1056/NEJMoa021736			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501223				2022-12-01	WOS:000180040900004
J	Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B				Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B			Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation	LANCET			English	Article							COMPLEMENT ACTIVATION; ENDOCRINE PANCREAS; HUMAN BLOOD; COAGULATION; BIOMATERIAL; EXPRESSION; INHIBITION; RECEPTOR; MODEL; RNA	Background Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis remains a possible complication. The thrombotic reaction may explain why graft loss occurs and islets from more than one donor are needed, since contact between human islets and ABO-compatible blood in vitro triggers a thrombotic reaction that damages the islets. We investigated the possible mechanism and treatment of such thrombotic reactions. Methods Coagulation activation and islet damage were monitored in four patients undergoing clinical islet transplantation according to a modified Edmonton protocol. Expression of tissue factor (TF) in the islet preparations was investigated by immunohistochemistry, immunoprecipitation, electron microscopy, and RT-PCR. To assess TF activity in purified islets, human islets were mixed with non-anticoagulated ABO-compatible blood in tubing loops coated with heparin. Findings Coagulation activation and subsequent release of insulin were found consistently after clinical islet transplantation, even in the absence of signs of intraportal thrombosis. The endocrine, but not the exocrine, cells of the pancreas were found to synthesise and secrete active TF. The clotting reaction triggered by pancreatic islets in vitro could be abrogated by blocking the active site of TF with specific antibodies or site-inactivated factor Vlla, a candidate drug for inhibition of TF activity in vivo. Interpretation Blockade of TF represents a new therapeutic approach that might increase the success of islet transplantation in patients with type 1 diabetes, in terms of both the risk of intraportal thrombosis and the need for islets from more than one donor.	Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, Div Pathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Div Med, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Surg Sci, Div Transplantat Surg, S-75185 Uppsala, Sweden; Dept Transplantat Surg, Oslo, Norway; Malmo Univ Hosp, Dept Nephrol & Transplantat, Malmo, Sweden; Skejby Hosp, Dept Urol, Aarhus, Denmark; Univ Helsinki, Surg Hosp, Div Transplantat, Helsinki, Finland; Dept Transplantat Surg, Stockholm, Sweden; Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Lund University; Skane University Hospital; Aarhus University; University of Helsinki; Linnaeus University; University of Kalmar	Nilsson, B (corresponding author), Univ Uppsala Hosp, Rudbeck Lab, Div Clin Immunol, Dept Radiol Oncol & Clin Immunol, S-75185 Uppsala, Sweden.		Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012	Nilsson, Bo/0000-0003-0057-2730; Korsgren, Olle/0000-0002-8524-9547				Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Colman RW, 1996, BLOOD, V87, P2089; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Ekdahl KN, 1997, ARTHRITIS RHEUM, V40, P2178, DOI 10.1002/art.1780401212; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Froberg MK, 1997, HUM PATHOL, V28, P1295, DOI 10.1016/S0046-8177(97)90204-5; Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309; Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7; LUKINIUS A, 1992, DEV BIOL, V153, P376, DOI 10.1016/0012-1606(92)90122-W; Lukinius A, 2001, DIABETES, V50, P962, DOI 10.2337/diabetes.50.5.962; Luther T, 1996, AM J PATHOL, V149, P101; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; PARKER RC, 1957, NY ACAD SCI, V5, P303; Pazzagli M, 1999, CLIN APPL THROMB-HEM, V5, P228, DOI 10.1177/107602969900500404; Peppelenbosch MP, 2001, TRENDS CARDIOVAS MED, V11, P335, DOI 10.1016/S1050-1738(01)00137-2; POTGENS AJG, 1994, THROMB HAEMOSTASIS, V71, P208; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; VANSUYLICHEM PTR, 1995, CELL TRANSPLANT, V4, P609, DOI 10.1016/0963-6897(95)00026-7; WILDGOOSE P, 1990, BIOCHEMISTRY-US, V29, P3413, DOI 10.1021/bi00465a039; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	30	433	443	2	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2039	2045		10.1016/S0140-6736(02)12020-4	http://dx.doi.org/10.1016/S0140-6736(02)12020-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504401				2022-12-01	WOS:000179974200013
J	Abbott, A				Abbott, A			Talkin' about regeneration	NATURE			English	Article																			0	0	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					456	457		10.1038/420456b	http://dx.doi.org/10.1038/420456b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466810	Bronze			2022-12-01	WOS:000179611600013
J	Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG				Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG			Risk factors for suicide in China: a national case-control psychological autopsy study	LANCET			English	Article								Background Suicide is the fifth most important cause of death in China, but the reasons for the high rate and unique pattern of characteristics of those who kill themselves are unknown. Methods We pretested, and then administered a comprehensive interview to family members and close associates of 519 people who committed suicide and of 536 people who died from other injuries (controls) randomly selected from 23 geographically representative sites in China. Findings After adjustment for sex, age, location of residence, and research site, eight significant predictors of suicide remained in the final unconditional logistic regression model. In order of importance they were: high depression symptom score, previous suicide attempt, acute stress at time of death, low quality of life, high chronic stress, severe interpersonal conflict in the 2 days before death, a blood relative with previous suicidal behaviour, and a friend or associate with previous suicidal behaviour. Suicide risk increased substantially with exposure to multiple risk factors: none of the 265 deceased people who were exposed to one or fewer of the eight risk factors died by suicide, but 30% (90/299) with two or three risk factors, 85% (320/377) with four or five risk factors, and 96% (109/114) with six or more risk factors died by suicide. Interpretation Despite substantial differences between characteristics of people who commit suicide in China and the west, risk factors for suicide do not differ greatly. Suicide prevention programmes that concentrate on a single risk factor are unlikely to reduce suicide rates substantially; preventive efforts should focus on individuals exposed to multiple risk factors.	Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.		Phillips, Michael Robert/AAE-7585-2021; Zhang, Xiao/V-9027-2017; Zhou, Maigeng/HCH-7703-2022	Phillips, Michael Robert/0000-0002-5973-2439; Zhang, Xiao/0000-0002-2932-5875; 				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 2008, INT HDB SUICIDE ATTE; Appleby L, 1999, BRIT J PSYCHIAT, V175, P168, DOI 10.1192/bjp.175.2.168; Beautrais AL, 2001, PSYCHOL MED, V31, P837; BRENT DA, 1989, SUICIDE LIFE-THREAT, V19, P43; Cavanagh JTO, 1999, PSYCHOL MED, V29, P1141, DOI 10.1017/S0033291799001038; *CHIN SOC PSYCH, 2000, CHIN CLASS MENT DIS; CLARK D. C., 1992, ASSESSMENT PREDICTIO, P144; Cooper JE, 1996, MENTAL DISORDERS CHI; First MB, 1996, STRUCTURED CLIN INTE; Fleiss J.L., 1981, STAT METHODS RATES P; GURURAJ G, 2001, NAT I MENTAL HLTH NE, V43; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; LI SR, 1998, CHIN J PSYCHIAT, V31, P80; Li X, 2001, CHIN J EPIDEMIOL, V22, P281; Lonnqvist J. K., 2000, INT HDB SUICIDE ATTE, P107, DOI [DOI 10.1002/9780470698976.CH7, 10.1002/9780470698976.ch7]; Ma C, 1999, CHIN MENT HLTH J, V13, P110; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Nagelkerle N, 1991, BIOMETRIKA, V78, P791; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; United Nations, 1996, PREV SUIC GUID FORM; Vijayakumar L, 1999, ACTA PSYCHIAT SCAND, V99, P407, DOI 10.1111/j.1600-0447.1999.tb00985.x; *WHO, 2001, WORKSH SUIC PREV CHI; World Health Organization, 1999, WORLD HLTH REP 1999; Yang GH., 1991, EXPLORING ADULT MORT; Zhang B, 2000, SHANGHAI J PREV MED, V12, P282; Zhang W.X., 1998, CHINESE J PSYCHIAT, V31, P69; Zhao M., 2000, SHANGHAI PSYCHIATRIC, V12, P222, DOI [10.3969/j.issn.1002-0829.2000.04.015, DOI 10.3969/J.ISSN.1002-0829.2000.04.015]	34	558	684	3	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1728	1736		10.1016/S0140-6736(02)11681-3	http://dx.doi.org/10.1016/S0140-6736(02)11681-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622FU	12480425				2022-12-01	WOS:000179636800009
J	Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R				Wedlich-Soldner, R; Altschuler, SJ; Wu, LF; Li, R			Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase	SCIENCE			English	Article							EXCHANGE FACTOR CDC24; SACCHAROMYCES-CEREVISIAE; VESICULAR TRANSPORT; ACTIN CYTOSKELETON; SECRETORY VESICLES; PLASMA-MEMBRANE; YEAST; POLARITY; GROWTH; GENE	Cell polarization can occur in the absence of any spatial cues. To investigate the mechanism of spontaneous cell polarization, we used an assay in yeast where expression of an activated form of Cdc42, a Rho-type guanosine triphosphatase (GTPase) required for cell polarization, could generate cell polarity without any recourse to a preestablished physical cue. The polar distribution of Cdc42 in this assay required targeted secretion directed by the actin cytoskeleton. A mathematical simulation showed that a stable polarity axis could be generated through a positive feedback loop in which a stochastic increase in the local concentration of activated Cdc42 on the plasma membrane enhanced the probability of actin polymerization and increased the probability of further Cdc42 accumulation to that site.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Li, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rong_li@hms.harvard.edu			NIGMS NIH HHS [GM057063] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Arkowitz RA, 1999, TRENDS CELL BIOL, V9, P20, DOI 10.1016/S0962-8924(98)01412-3; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; Lechler T, 2001, J CELL BIOL, V155, P261, DOI 10.1083/jcb.200104094; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; NOVICK P, 1993, CIBA F SYMP, V176, P218; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seeley TD, 2002, BIOL BULL-US, V202, P314, DOI 10.2307/1543484; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WEDLICHSOLDNER R, UNPUB; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	30	309	314	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1231	1235		10.1126/science.1080944	http://dx.doi.org/10.1126/science.1080944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12560471				2022-12-01	WOS:000181065500040
J	Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW				Levene, MJ; Korlach, J; Turner, SW; Foquet, M; Craighead, HG; Webb, WW			Zero-mode waveguides for single-molecule analysis at high concentrations	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; INHIBITED SPONTANEOUS EMISSION; TOTAL INTERNAL-REFLECTION; CROSS-CORRELATION; DNA; DYNAMICS; MICROSCOPY	Optical approaches for observing the dynamics of single molecules have required pico- to nanomolar concentrations of fluorophore in order to isolate individual molecules. However, many biologically relevant processes occur at micromolar ligand concentrations, necessitating a reduction in the conventional observation volume by three orders of magnitude. We show that arrays of zero-mode waveguides consisting of subwavelength holes in a metal film provide a simple and highly parallel means for studying single-molecule dynamics at micromolar concentrations with microsecond temporal resolution. We present observations of DNA polymerase activity as an example of the effectiveness of zero-mode waveguides for performing single-molecule experiments at high concentrations.	Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	Cornell University	Webb, WW (corresponding author), Cornell Univ, Grad Program Biochem Mol & Cell Biol, Clark Hall, Ithaca, NY 14853 USA.		Webb, Watt W./B-5905-2011		NCRR NIH HHS [P41-RR04224] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004224] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Castro A, 1997, ANAL CHEM, V69, P3915, DOI 10.1021/ac970389h; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; de Lange F, 2001, J CELL SCI, V114, P4153; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Jackson JD., 1999, CLASSICAL ELECTRODYN, V3rd edn; Keller RA, 2002, ANAL CHEM, V74, p316a, DOI 10.1021/ac022035i; KLEPPNER D, 1981, PHYS REV LETT, V47, P233, DOI 10.1103/PhysRevLett.47.233; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; KORLACH J, 2000, Patent No. 0070073; Lerch HP, 2002, P NATL ACAD SCI USA, V99, P15410, DOI 10.1073/pnas.232376799; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Mertz J, 1995, OPT LETT, V20, P2532, DOI 10.1364/OL.20.002532; Meyer-Almes FJ, 2000, BIOCHEMISTRY-US, V39, P13261, DOI 10.1021/bi000057y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PURCELL EM, 1946, PHYS REV, V69, P681; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; RICKA J, 1989, PHYS REV A, V39, P2646, DOI 10.1103/PhysRevA.39.2646; Rippe K, 2000, BIOCHEMISTRY-US, V39, P2131, DOI 10.1021/bi9922190; Schomburg D, 2001, SPRINGER HDB ENZYMES; Starr TE, 2001, BIOPHYS J, V80, P1575, DOI 10.1016/S0006-3495(01)76130-9; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Xu, 2002, T FLUOR SP, P471; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	30	1012	1448	9	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					682	686		10.1126/science.1079700	http://dx.doi.org/10.1126/science.1079700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560545				2022-12-01	WOS:000180687700039
J	Friedman, MA; den Besten, H; Attaran, A				Friedman, MA; den Besten, H; Attaran, A			Out-licensing: a practical approach for improvement of access to medicines in poor countries	LANCET			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, Cambridge, MA 02138 USA; Int Dispensary Assoc, Amsterdam, Netherlands; Pharmacia Corp, Peapack, NJ USA	Harvard University; Pfizer	Attaran, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Carr Ctr Human Rights Policy, 79 JFK St, Cambridge, MA 02138 USA.	amir_attaran@harvard.edu						ACHMAT Z, 2002, 14 INT AIDS C BARC; ACHMAT Z, 2001, GUARDIAN        1201; *ACT UP, 2002, ACT UP DEM BREAK PAT; *AIDS HEALTHC FDN, 2002, US LARG AIDS ORG CAL; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; BAKER BK, 2001, TRIPS REFORM VOLUNTA; BOOKER S, 2001, NATION          0709; BOSELEY S, 2002, GUARDIAN        1004; *BRIST MYERS SQUIB, 2001, BRIST SQUIBB ANN ACC; COHEN M, 2001, ASS PRESS WORLD 0516; *CONS PROJ TECHN H, 2001, JOINT STAT WTO WHO D; *HLTH GAP, 2002, WHAT IS HLTH GAP; *MED SANS FRONT, 2002, DURB BARC OV TREATM; *MERCK, 2000, HIV AIDS DEV WORLD M; Murray CJL, 1966, GLOBAL BURDEN DIS CO, P43; PEARL D, 2001, WALL STREET J   0216; *PFIZER, 2002, ALL BUILD 1ST LARG S; *TREATM ACT CAMP, 2002, DEF CAMP QUEST ANSW; *UNAIDS, 2002, 12 M GEN MAY 28; WALDHOLZ M, 2002, WALL STREET J   0627; *WHO COMM MACR HLT, 2002, MACR HLTH INV HLTH E; *WHO WORLD TRADE O, 2002, WORKSH DIFF PRIC FIN; World Health Organization, 2002, SEL US ESS MED REP W; 2002, OXFAM IMPLAUSIBLE DE; 2002, REUTERS MED NEW 1115	25	16	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					341	344		10.1016/S0140-6736(03)12331-8	http://dx.doi.org/10.1016/S0140-6736(03)12331-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559883				2022-12-01	WOS:000180643900029
J	Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M				Poremba, A; Saunders, RC; Crane, AM; Cook, M; Sokoloff, L; Mishkin, M			Functional mapping of the primate auditory system	SCIENCE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; CORTEX; ORGANIZATION; AREAS; LOCALIZATION; AFFERENTS; PATHWAYS; NEURONS; MONKEYS; STREAMS	Cerebral auditory areas were delineated in the awake, passively listening, rhesus monkey by comparing the rates of glucose utilization in an intact hemisphere and in an acoustically isolated contralateral hemisphere of the same animal. The auditory system defined in this way occupied large portions of cerebral tissue, an extent probably second only to that of the visual system. Cortically, the activated areas included the entire superior temporal gyrus and large portions of the parietal, prefrontal, and limbic lobes. Several auditory areas overlapped with previously identified visual areas, suggesting that the auditory system, like the visual system, contains separate pathways for processing stimulus quality, location, and motion.	Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; Univ Texas, Ctr Perceptual Syst, Austin, TX 78712 USA; NIMH, Cerebral Metab Lab, Bethesda, MD 20892 USA	University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Poremba, A (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	amy-poremba@uiowa.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH000882, ZIAMH001101, Z01MH001101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Bell AH, 2001, CAN J EXP PSYCHOL, V55, P123, DOI 10.1037/h0087359; Bonin G, 1947, NEOCORTEX MACACA MUL; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURTON H, 1982, J COMP NEUROL, V210, P109, DOI 10.1002/cne.902100203; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Fuster J, 1989, PREFRONTAL CORTEX; Galuske RAW, 2000, SCIENCE, V289, P1946, DOI 10.1126/science.289.5486.1946; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; IMIG TJ, 1977, BRAIN RES, V138, P241, DOI 10.1016/0006-8993(77)90743-0; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; JULIANO SL, 1981, J NEUROPHYSIOL, V46, P1260, DOI 10.1152/jn.1981.46.6.1260; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; KENNEDY C, 1978, ANN NEUROL, V4, P293, DOI 10.1002/ana.410040402; Kosaki H, 1997, J COMP NEUROL, V386, P304; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; MACKO KA, 1982, SCIENCE, V218, P394, DOI 10.1126/science.7123241; MACKO KA, 1985, BRAIN IMAGING BRAIN; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; PANDYA DN, 1995, REV NEUROL, V151, P486; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; SAVAKI HE, 1993, J NEUROSCI, V13, P2772; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549; WALLACE MT, 1993, PROG BRAIN RES, V112, P301; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Woolsey C. N., 1982, CORTICAL SENSORY ORG, V3, P231	45	169	171	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					568	572		10.1126/science.1078900	http://dx.doi.org/10.1126/science.1078900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543977				2022-12-01	WOS:000180559800051
J	Burkhart, CN				Burkhart, CN			Fomite transmission with head lice: a continuing controversy	LANCET			English	Editorial Material									Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA		Burkhart, CN (corresponding author), Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA.							BACOT AW, 1915, PARASITOLOGY, V9, P228; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; BURGESS IF, 2001, PESTICIDE OUTLOOK, V10, P109; Burkhart CN., 1999, J CLIN DERMATOL, V2, P15; Canyon DV, 2002, J INVEST DERMATOL, V119, P629, DOI 10.1046/j.1523-1747.2002.00540.x; CARTER DG, 1992, THESIS U CAMBRIDGE U; MAUDER JW, 1993, HLTH VISITOR, V66, P317; MEINKING TL, 1999, CURRENT PROBLEMS DER, P77; NOBLE ER, 1982, PARASITOLOGY BIOL AN, P339; Taplin D, 1988, PEDIAT DERMATOLOGY, V2, P1465	10	18	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					99	100		10.1016/S0140-6736(03)12243-X	http://dx.doi.org/10.1016/S0140-6736(03)12243-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531574				2022-12-01	WOS:000180428000006
J	Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP				Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP			Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c	NATURE			English	Article							3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; ACTIN-FILAMENTS; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN-CELLS; IN-VIVO; GLUT4; TRANSLOCATION; MEMBRANE; VESICLES	Insulin stimulates glucose uptake in muscle and adipocytes by signalling the translocation of GLUT4 glucose transporters from intracellular membranes to the cell surface(1,2). The translocation of GLUT4 may involve signalling pathways that are both independent of and dependent on phosphatidylinositol-3-OH kinase (PI(3) K)(3-5). This translocation also requires the actin cytoskeleton(6-8), and the rapid movement of GLUT4 along linear tracks may be mediated by molecular motors(9). Here we report that the unconventional myosin Myo1c is present in GLUT4-containing vesicles purified from 3T3-L1 adipocytes. Myo1c, which contains a motor domain, three IQ motifs and a carboxy-terminal cargo domain, is highly expressed in primary and cultured adipocytes. Insulin enhances the localization of Myo1c with GLUT4 in cortical tubulovesicular structures associated with actin filaments, and this colocalization is insensitive to wortmannin. Insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane is augmented by the expression of wild-type Myo1c and inhibited by a dominant-negative cargo domain of Myo1c. A decrease in the expression of endogenous Myo1c mediated by small interfering RNAs inhibits insulin-stimulated uptake of 2-deoxyglucose. Thus, myosin Myo1c functions in a PI(3) K-independent insulin signalling pathway that controls the movement of intracellular GLUT4-containing vesicles to the plasma membrane.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.			Nicoloro, Sarah/0000-0002-8638-4556				BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Czech MP, 2000, NATURE, V407, P147, DOI 10.1038/35025183; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeOca GM, 1997, ARCH MED RES, V28, P321; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; JIANG ZY, UNPUB P NATL ACAD SC; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; LAURIE SM, 1993, J BIOL CHEM, V268, P19110; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; OKADA T, 1994, J BIOL CHEM, V269, P3568; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; RUPPERT C, 1995, J CELL SCI, V108, P3775; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	202	207	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					821	824		10.1038/nature01246	http://dx.doi.org/10.1038/nature01246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490950				2022-12-01	WOS:000179897300058
J	Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC				Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC			Association of neural tube defects and folic acid food fortification in Canada	LANCET			English	Article							WOMEN	Many women do not receive folic acid supplements before conception. In response, most of Canada's cereal grain products were being fortified with folic acid by January, 1998, thereby providing an additional 0.1-0.2 mg per day of dietary folate to the Canadian population. We assessed the effect of supplementation on prevalence of open neural tube defects in the province of Ontario. Among 336 963 women who underwent maternal serum screening over 77 months, the prevalence of open neural tube defects declined from 1.13 per 1000 pregnancies before fortification to 0.58 per 1000 pregnancies thereafter (prevalence ratio 0.52, 95% Cl 0.40-0.67, p<0.0001). At a population level, folic acid food fortification is associated with a pronounced reduction in open neural tube defects.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Prehosp Care Programme, Toronto, ON, Canada; N York Gen Hosp, Genet Programme, Ontario Maternal Serum Screening Database Dept, Toronto, ON, Canada; MDS Serv, Toronto, ON, Canada; N York Gen Hosp, Dept Genet, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Paediat Genet, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University of Toronto	Ray, JG (corresponding author), 235A Medland St, Toronto, ON M6P 2N6, Canada.	Jray515445@aol.com						Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026	5	195	200	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2047	2048		10.1016/S0140-6736(02)11994-5	http://dx.doi.org/10.1016/S0140-6736(02)11994-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504403				2022-12-01	WOS:000179974200015
J	Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V				Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V			Experimental identification of downhill protein folding	SCIENCE			English	Article							KINETICS; BINDING; DYNAMICS; COMPLEX; DOMAIN	Theory predicts the existence of barrierless protein folding. Without barriers, folding should be noncooperative and the degree of native structure should be coupled to overall protein stability. We investigated the thermal unfolding of the peripheral subunit binding domain from Escherichia coli's 2-oxoglutarate dehydrogenase multienzyme complex (termed BBL) with a combination of spectroscopic techniques and calorimetry. Each technique probed a different feature of protein structure. BBL has a defined three-dimensional structure at low temperatures. However, each technique showed a distinct unfolding transition. Global analysis with a statistical mechanical model identified BBL as a downhill-folding protein. Because of BBL's biological function, we propose that downhill folders may be molecular rheostats, in which effects could be modulated by altering the distribution of an ensemble of structures.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Granada	Garcia-Mira, MM (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	vm48@umail.umd.edu	Fischer, Niels/ABA-5342-2021; Garcia-Mira, Maria del Mar/E-2623-2018; Sadqi, Mourad/J-3180-2018; Sanchez-Ruiz, Jose/H-2849-2015	Fischer, Niels/0000-0002-4609-4052; Garcia-Mira, Maria del Mar/0000-0003-0245-8093; Sadqi, Mourad/0000-0003-3553-3408; Sanchez-Ruiz, Jose/0000-0002-9056-3928				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Eaton WA, 1999, P NATL ACAD SCI USA, V96, P5897, DOI 10.1073/pnas.96.11.5897; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Freire E, 2000, P NATL ACAD SCI USA, V97, P11680, DOI 10.1073/pnas.97.22.11680; GARCIAMIRA MM, UNPUB; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hardin C, 1999, PROTEINS, V34, P281; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Leeson DT, 2000, P NATL ACAD SCI USA, V97, P2527, DOI 10.1073/pnas.040580397; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Munoz V, 2001, CURR OPIN STRUC BIOL, V11, P212, DOI 10.1016/S0959-440X(00)00192-5; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; PACKMAN LC, 1986, FEBS LETT, V206, P193, DOI 10.1016/0014-5793(86)80979-6; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; SADQI M, UNPUB; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Spector S, 1999, J MOL BIOL, V293, P763, DOI 10.1006/jmbi.1999.3189; Spector S, 1998, J MOL BIOL, V276, P479, DOI 10.1006/jmbi.1997.1522; Thirumalai D, 2002, ADV CHEM PHYS, V120, P35; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Young M, 1999, PROTEIN SCI, V8, P1752, DOI 10.1110/ps.8.9.1752	30	274	278	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2191	2195		10.1126/science.1077809	http://dx.doi.org/10.1126/science.1077809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481137				2022-12-01	WOS:000179773700048
J	Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R				Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R			Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PCR	Context Bioterrorist attacks involving letters and mail-handling systems in Washington, DC, resulted in Bacillus anthracis (anthrax) spore contamination in the Hart Senate Office Building and other facilities in the US Capitol's vicinity. Objective To provide information about the nature and extent of indoor secondary aerosolization of B anthracis spores. Design Stationary and personal air samples, surface dust, and swab samples were collected under semiquiescent (minimal activities) and then simulated active office conditions to estimate secondary aerosolization of B anthracis spores. Nominal size characteristics, airborne concentrations, and surface contamination of a anthracis particles (colony-forming units) were evaluated. Results Viable B anthracis spores reaerosolized under semiquiescent conditions, with a marked increase in reaerosolization during simulated active office conditions. Increases were observed for B anthracis collected on open sheep blood agar plates (P<.001) and personal air monitors (P=.01) during active office conditions. More than 80% of the B anthracis particles collected on stationary monitors were within an alveolar respirable size range of 0.95 to 3.5 &mu;m. Conclusions Bacillus anthracis spores used in a recent terrorist incident reaerosolized under common office activities. These findings have important implications for appropriate respiratory protection, remediation, and reoccupancy of contaminated office environments.	US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Denver, CO 80225 USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; US PHS, Denver, CO USA; US EPA, Cleveland Off, Westlake, OH USA; Naval Med Res Ctr, Biol Def Directorate, Silver Spring, MD USA	United States Environmental Protection Agency; United States Public Health Service; United States Environmental Protection Agency; Naval Medical Research Center (NMRC)	Weis, CP (corresponding author), US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Bldg 53,POB 25227, Denver, CO 80225 USA.		Weis, Christopher/GWR-1351-2022					Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; BRACHMAN PS, 1966, BACTERIOL REV, V30, P646, DOI 10.1128/MMBR.30.3.646-659.1966; CHINN KS, 1996, REAEROSOLIZATION HAZ; DAVIDS DE, 1981, 321 DEF RES EST SUFF; DRUETT HA, 1953, J HYG-CAMBRIDGE, V51, P359, DOI 10.1017/S0022172400015795; FELLER W, 1950, INTRO PROBABILITY TH, P324; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Keim M, 1999, ANN EMERG MED, V34, P177, DOI 10.1016/S0196-0644(99)70227-1; Linn William S., 1993, Journal of Occupational Medicine and Toxicology, V2, P1; LINN WS, 1993, J CLEAN TECHNOL ENV, V3, P101; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Marple V.A., 1986, CASCADE IMPACTOR SAM, P79; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; PARKER JS, 2001, TERRORISM MAIL PROTE; PATRICK WC, 1999, RISK ASSESSMENT BIOL; Peters CJ, 2002, LANCET, V359, P710, DOI 10.1016/S0140-6736(02)07792-9; Resnick IG, 1990, EVALUATION NEED DETE; WATSON A, 1994, EPIDEMIOL INFECT, V113, P47	21	91	97	3	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2853	2858		10.1001/jama.288.22.2853	http://dx.doi.org/10.1001/jama.288.22.2853			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472327	Bronze			2022-12-01	WOS:000179732600030
J	Galvao, J				Galvao, J			Access to antiretroviral drugs in Brazil	LANCET			English	Article								Since 1996, the Brazilian Ministry of Health has guaranteed free and universal access to antiretroviral treatment for people living with HIV/AIDS. Implementation of this policy has had political, financial, and logistical challenges. I have investigated the history and context of antiretroviral policy in Brazil, the logistics of the drugs' distribution, and the government's strategies for acquisition of the drugs. Many antiretrovirals used in Brazil are produced domestically; the remainder, including some of the most expensive drugs, are purchased from abroad. Although the Brazilian policy of antiretroviral distribution has had notable success, it remains threatened by the high cost of acquisition of drugs, which has led to disputes with international pharmaceutical companies over prices and patents. Whether or not the Brazilian model of guaranteeing access to antiretroviral treatment for people living with HIV/AIDS can be applied in other countries or regions, much can be learnt from the country's experience.	Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Galvao, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA.			Galvao, Jane/0000-0003-1598-9125	FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; FIC NIH HHS [1-D43-TW00003] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Ashraf H, 2001, LANCET, V357, P2112, DOI 10.1016/S0140-6736(00)05244-2; BIEHL J, 1999, THESIS U CALIFORNIA; *BRAZ MIN HLTH, 2002, AIDS 2 REL IMPL AV D; *BRAZ MIN HLTH, 2001, MIN HLTH ANN COMP LI; *BRAZ MIN HLTH, 2002, NAT AIDS DRUG POL; *BRAZ MIN HLTH, 2001, WTO PAN CALLS BRAZ P; *BRAZ MIN HLTH, 1999, DIR CENTR TEST AC; *BRAZ MIN HLTH, 2002, B EP AIDS; *BRAZ MIN HLTH, 2000, SUS PRINC CONQ; DANIEL H, 1989, VIDA ANTES MORTE LIF; FALCAO D, 1997, FOLHA S PAULO, P1; Galvão Jane, 2002, Cad. Saúde Pública, V18, P213, DOI 10.1590/S0102-311X2002000100022; GALVAO JANE, 2000, AIDS NO BRASIL AGEND, P256; LIMA RM, 2000, ACAO ANTI AIDS, V43, P6; Lima RM, 2000, 13 INT AIDS C DURB S; PASSARELLI C, 2001, B ABIA, V46, P8; RICH JL, 2001, NY TIMES        0901, pB1; ROSENBERG T, 2001, NY TIMES MAGAZI 0126; *UN, 2001, ACC MED CONTEXT PAND; VELOSO V, 2000, 13 INT AIDS C DURB; *WORLD TRAD ORG, 2001, UR ROUND FIN ACT; World Trade Organization, 2001, DECL TRIPS AGR PUBL; 2001, OXFAM DRUG CO VS BRA	23	110	114	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1862	1865		10.1016/S0140-6736(02)11775-2	http://dx.doi.org/10.1016/S0140-6736(02)11775-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480377				2022-12-01	WOS:000179706100027
J	Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y				Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y		FANTOM Consurtium; RIKEN Genome Exploration Res Grp	Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs	NATURE			English	Article							HUMAN GENOME; GENE; SEQUENCE; PROTEIN; RNA; CLASSIFICATION; IDENTIFICATION; CHROMOSOME-21; EVOLUTION; DISCOVERY	Only a small proportion of the mouse genome is transcribed into mature messenger RNA transcripts. There is an international collaborative effort to identify all full-length mRNA transcripts from the mouse, and to ensure that each is represented in a physical collection of clones. Here we report the manual annotation of 60,770 full-length mouse complementary DNA sequences. These are clustered into 33,409 'transcriptional units', contributing 90.1% of a newly established mouse transcriptome database. Of these transcriptional units, 4,258 are new protein-coding and 11,665 are new non-coding messages, indicating that non-coding RNA is a major component of the transcriptome. 41% of all transcriptional units showed evidence of alternative splicing. In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs. The present work, completely supported by physical clones, provides the most comprehensive survey of a mammalian transcriptome so far, and is a valuable resource for functional genomics.	RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, Yokohama, Kanagawa 2300045, Japan; Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; NTT Software Corp, Naka Ku, Kanagawa 2318554, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Div Genom Informat Resources Sci Biol Supramol Sy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Biomed Knowledge Discovery Team, Kanagawa 2300045, Japan; Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Jackson Lab, Mouse Genome Informat Grp, Bar Harbor, ME 04609 USA; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Inst Genom Res TIGR, Rockville, MD 20850 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5608531, Japan; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Labs Informat Technol, Singapore 119613, Singapore; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; LNCIB, Funct Genom, I-34012 Trieste, Italy; Ist Tumori Milano, I-20133 Milan, Italy; The Scripps Res Inst, Res Inst, La Jolla, CA 92037 USA; Univ Oregon, Zebrafish Int Resource Ctr, Eugene, OR 97403 USA; Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Univ Milan, I-20133 Milan, Italy; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75390 USA; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Addenbrookes Hosp, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge CB2 2XY, England; NHGRI, NIH, Bethesda, MD 20892 USA; Canberra Hosp, Autoimmun Res Unit, Woden, ACT 2606, Australia; Appl Genom Inc, Sunnyvale, CA 94085 USA; Hirakata Ryoikuen, Osaka 5650874, Japan; Hyogo Med Univ, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02141 USA	RIKEN; Yokohama City University; Keio University; University of Tsukuba; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Jackson Laboratory; University of Queensland; University of Queensland; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; European Molecular Biology Laboratory (EMBL); Osaka University; Novartis; Boys Town National Research Hospital; MRC Laboratory Molecular Biology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Scripps Research Institute; University of Oregon; Rockefeller University; University of Milan; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; University of Tokyo; University of Edinburgh; Duke University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Australian National University; Canberra Hospital; Hyogo College of Medicine; University of Hyogo; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; University of Bonn; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute	Hayashizaki, Y (corresponding author), RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yosihide@gsc.riken.go.jp	Petrovsky, Nikolai/P-1912-2017; Kanapin, Alexander/E-7632-2013; Ravasi, Timothy/B-8777-2008; King, Benjamin/AAI-1492-2019; Jarvis, Erich D/A-2319-2008; Semple, Colin A M/A-5613-2009; Suzuki, Harukazu/N-9553-2015; Yang, Ivana V/P-3059-2018; Taylor, Martin S/C-3825-2009; Kawai, Jun/A-6451-2016; Forrest, Alistair/A-6597-2008; Dragani, Tommaso A./K-4493-2016; Dalla, Emiliano/AAH-3039-2020; Hume, David A/C-7695-2013; Sandelin, Albin/G-2881-2011; Schriml, Lynn/AFO-9472-2022; Brusic, Vladimir/B-1478-2008; Kasukawa, Takeya/N-5070-2015; Konno, Hideaki/N-4366-2014; Kawaji, Hideya/N-5116-2015; Bono, Hidemasa/AAF-3649-2020; Kurochkin, Igor/Q-5646-2019; Pesole, Graziano/E-9051-2014; Pesole, Graziano/C-1408-2009; Marchionni, Luigi/S-6774-2017; Nikaido, Itoshi/K-2058-2014; Reid, James/G-2496-2010; Grimmond, Sean/K-3246-2019; Konno, Hideaki/A-9191-2012; Kanai, Akio/C-4921-2014; Zimmer, Andreas/B-8357-2009; Teasdale, Rohan/AAD-6698-2019; Carninci, Piero/K-1568-2014; Wells, Christine A/A-5071-2010; Schönbach, Christian/B-1998-2009; Teasdale, Rohan D/B-2538-2009; Wahlestedt, Claes/A-7039-2009; Pesole, Graziano/K-5283-2019; Konagaya, Akihiko/F-9302-2014; Itoh, Masayoshi/N-5363-2015; Kanapin, Alexander A/Q-7590-2016; Godzik, Adam/AAW-1467-2020; Hayashizaki, Yoshihide/N-6590-2015; Yuan, Zheng/A-1344-2008; Zavolan, Mihaela/S-3888-2016; Grimmond, Sean M/J-5304-2016; Godzik, Adam/A-7279-2009; Waki, Kazunori/T-6444-2019; Gariboldi, Manuela/K-4744-2016	Petrovsky, Nikolai/0000-0002-1580-5245; Jarvis, Erich D/0000-0001-8931-5049; Semple, Colin A M/0000-0003-1765-4118; Suzuki, Harukazu/0000-0002-8087-0836; Yang, Ivana V/0000-0002-1018-489X; Taylor, Martin S/0000-0001-7656-330X; Forrest, Alistair/0000-0003-4543-1675; Dragani, Tommaso A./0000-0001-5915-4598; Dalla, Emiliano/0000-0002-4687-6011; Sandelin, Albin/0000-0002-7109-7378; Brusic, Vladimir/0000-0003-0523-5266; Kasukawa, Takeya/0000-0001-5085-0802; Konno, Hideaki/0000-0002-8470-4835; Kawaji, Hideya/0000-0002-0575-0308; Bono, Hidemasa/0000-0003-4413-0651; Pesole, Graziano/0000-0003-3663-0859; Pesole, Graziano/0000-0003-3663-0859; Marchionni, Luigi/0000-0002-7336-8071; Nikaido, Itoshi/0000-0002-7261-2570; Grimmond, Sean/0000-0002-8102-7998; Kanai, Akio/0000-0002-6362-2419; Teasdale, Rohan/0000-0001-7455-5269; Carninci, Piero/0000-0001-7202-7243; Wells, Christine A/0000-0003-3133-3628; Schönbach, Christian/0000-0002-0693-7617; Teasdale, Rohan D/0000-0001-7455-5269; Itoh, Masayoshi/0000-0002-1772-318X; Kanapin, Alexander A/0000-0001-9802-5297; Godzik, Adam/0000-0002-2425-852X; Grimmond, Sean M/0000-0002-8102-7998; Godzik, Adam/0000-0002-2425-852X; Osato, Naoki/0000-0002-7584-5388; Ravasi, Timothy/0000-0002-9950-465X; Jackson, Ian/0000-0001-6526-0688; Waki, Kazunori/0000-0001-7311-7208; Blake, Judith/0000-0001-8522-334X; Gustincich, Stefano/0000-0002-2749-2514; Birney, Ewan/0000-0001-8314-8497; Matsuda, Hideo/0000-0002-4701-3779; Kurochkin, Igor V/0000-0002-6231-9004; Gariboldi, Manuela/0000-0001-8406-165X; Schriml, Lynn/0000-0001-8910-9851; Quackenbush, John/0000-0002-2702-5879; King, Benjamin/0000-0001-6463-1336; Hume, David/0000-0002-2615-1478; Wilming, Laurens/0000-0002-4154-7358; Osato, Naoki/0000-0001-9716-6725; Zavolan, Mihaela/0000-0002-8832-2041; Fukuda, Shiro/0000-0002-0065-662X; Reid, James/0000-0001-6997-2850; Okazaki, Yasushi/0000-0003-3241-5502; Batalov, Sergey/0000-0002-0925-0554; Lenhard, Boris/0000-0002-1114-1509; Gissi, Carmela/0000-0002-2269-079X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000136, ZIAHG000136] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Carninci P, 2002, BIOTECHNIQUES, V32, P984, DOI 10.2144/02325bm01; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Daly MJ, 2002, CELL, V109, P283, DOI 10.1016/S0092-8674(02)00742-0; Dreyer SD, 1999, GENOMICS, V62, P119, DOI 10.1006/geno.1999.5981; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hill DP, 2001, GENOMICS, V74, P121, DOI 10.1006/geno.2001.6513; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kawaji H, 2002, GENOME RES, V12, P367, DOI 10.1101/gr.193702; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Konno H, 2001, GENOME RES, V11, P281, DOI 10.1101/gr.GR-1457R; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Poirier GMC, 1999, J IMMUNOL, V163, P4960; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schweighoffer F, 2000, Pharmacogenomics, V1, P187, DOI 10.1517/14622416.1.2.187; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563	52	1276	1462	3	179	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					563	573		10.1038/nature01266	http://dx.doi.org/10.1038/nature01266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466851	Bronze, Green Published			2022-12-01	WOS:000179611600054
J	Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S				Karlsson, A; Parales, JV; Parales, RE; Gibson, DT; Eklund, H; Ramaswamy, S			Crystal structure of naphthalene dioxygenase: Side-on binding of dioxygen to iron	SCIENCE			English	Article							SP STRAIN NCIB-9816; PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; SOLUBLE METHANE MONOOXYGENASE; 1,2-DIOXYGENASE; ACTIVATION; COMPONENT; OXIDATION; DIHYDROXYLATION; FERREDOXINNAP; PURIFICATION	Binding of oxygen to iron is exploited in several biological and chemical processes. Although computational and spectroscopic results have suggested side-on binding, only end-on binding of oxygen to iron has been observed in crystal structures. We have determined structures of naphthalene dioxygenase that show a molecular oxygen species bound to the mononuclear iron in a side-on fashion. In a complex with substrate and dioxygen, the dioxygen molecule is lined up for an attack on the double bond of the aromatic substrate. The structures reported here provide the basis for a reaction mechanism and for the high stereospecificity of the reaction catalyzed by naphthalene dioxygenase.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biol, S-75124 Uppsala, Sweden; Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Ctr Biocatalysis & Bioproc, Iowa City, IA 52242 USA	University of Iowa; Swedish University of Agricultural Sciences; University of Iowa; University of Iowa	Ramaswamy, S (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.		Subramanian, Ramaswamy/Q-8671-2019; Karlsson, Andreas/AAD-1984-2019; ID, IMCACAT/D-5867-2014	Subramanian, Ramaswamy/0000-0002-6709-190X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062904, R01GM029909] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62904, GM29909] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD S, 1988, INORG CHEM, V27, P2230, DOI 10.1021/ic00286a006; Boyd DR, 1998, NAT PROD REP, V15, P309; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Chen K, 1999, ANGEW CHEM INT EDIT, V38, P2227, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2227::AID-ANIE2227>3.0.CO;2-B; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; Harris DL, 2001, CURR OPIN CHEM BIOL, V5, P724, DOI 10.1016/S1367-5931(01)00272-1; Hudlicky T, 1999, ALDRICHIM ACTA, V32, P35; JEFFREY AM, 1975, BIOCHEMISTRY-US, V14, P575, DOI 10.1021/bi00674a018; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; LI HY, 1995, J AM CHEM SOC, V117, P6297, DOI 10.1021/ja00128a019; LIPSCOMB JD, 1994, ANNU REV MICROBIOL, V48, P371, DOI 10.1146/annurev.mi.48.100194.002103; MATHER F, 2002, J AM CHEM SOC, V124, P4966; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Poulos TL, 1995, CURR OPIN STRUC BIOL, V5, P767, DOI 10.1016/0959-440X(95)80009-3; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2003, J BIOL CHEM, V278, P829, DOI 10.1074/jbc.M209604200; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	30	365	370	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1039	1042		10.1126/science.1078020	http://dx.doi.org/10.1126/science.1078020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586937				2022-12-01	WOS:000180960000039
J	Burke, JP				Burke, JP			Infection control - A problem for patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIBIOTIC-PROPHYLAXIS; EPIDEMIOLOGY		Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA; Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Burke, JP (corresponding author), Latter Day St Hosp, Dept Clin Epidemiol & Infect Dis, Salt Lake City, UT 84143 USA.							[Anonymous], 1996, Am J Infect Control, V24, P380; BURKE JP, 1971, NEW ENGL J MED, V284, P115, DOI 10.1056/NEJM197101212840301; BURKE JP, 1983, AM J INFECT CONTROL, V11, P165, DOI 10.1016/0196-6553(83)90076-7; BURKE JP, 1991, J HOSP INFECT, V18, P424, DOI 10.1016/0195-6701(91)90052-A; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Calfee DP, 2002, INFECT CONT HOSP EP, V23, P407, DOI 10.1086/502077; CLASSEN DC, 1992, NEW ENGL J MED, V326, P281, DOI 10.1056/NEJM199201303260501; CLASSEN DC, 1992, JAMA-J AM MED ASSOC, V267, P1922; Eggimann P, 2001, CHEST, V120, P2059, DOI 10.1378/chest.120.6.2059; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Farr BM, 2000, INFECT CONT HOSP EP, V21, P411, DOI 10.1086/501783; Fleming CA, 2000, LUNG BIOL HEALTH DIS, V150, P53; GARIBALDI RA, 1974, NEW ENGL J MED, V291, P215, DOI 10.1056/NEJM197408012910501; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HUNT TK, 1981, AM J MED, V70, P712, DOI 10.1016/0002-9343(81)90602-1; Jarvis WR, 2001, EMERG INFECT DIS, V7, P170, DOI 10.3201/eid0702.010202; JARVIS WR, 2001, SEMIN INFECT CONTROL, V1, P74; KRITCHEVSKY SB, 1995, INFECT CONT HOSP EP, V16, P33; LANGMUIR AD, 1980, PUBLIC HEALTH REP, V95, P470; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEDERBERG J, 1992, EMERGING INFECT MICR, P121; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; OLSEN MA, 2002, SEMIN INFECT CONTROL, V2, P26; Peterson LR, 2002, J CLIN MICROBIOL, V40, P1, DOI 10.1128/JCM.40.1.1-4.2002; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2000, LANCET, V356, P2196; Platt R, 2002, INFECT CONT HOSP EP, V23, P361, DOI 10.1086/502066; ROTHMAN KJ, 1985, NEW ENGL J MED, V313, P258, DOI 10.1056/NEJM198507253130409; Scheckler WE, 1998, INFECT CONT HOSP EP, V19, P114; SCHECKLER WE, 2002, SEMIN INFECT CONTROL, V2, P81; Silver A, 1996, AM J SURG, V171, P548, DOI 10.1016/S0002-9610(96)00036-0; Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Weinstein RA, 2001, NEW ENGL J MED, V344, P1544, DOI 10.1056/NEJM200105173442009; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; 2001, EVID REP TECHNOL ASS, V43, P1; 2000, MMWR MORB MORTAL WKL, V49, P149; 1992, MMWR MORB MORTAL WKL, V41, P783; 2000, MMWR MORB MORTAL WKL, V49, P189	41	684	722	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 13	2003	348	7					651	656		10.1056/NEJMhpr020557	http://dx.doi.org/10.1056/NEJMhpr020557			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644HY	12584377				2022-12-01	WOS:000180912900013
J	Herz, J; Marschang, P				Herz, J; Marschang, P			Coaxing the LDL receptor family into the fold	CELL			English	Review							TYROSINE PHOSPHORYLATION; LIPOPROTEIN; PROTEIN; DOMAIN; HYPERCHOLESTEROLEMIA; CHAPERONE	Low-density-lipoprotein (LDL) receptor family members control diverse developmental and physiological pathways. In this issue of Cell, both Culi and Mann and Hsieh et al. report on Boca/MESD, a highly conserved chaperone required for transport of LDLR family proteins to the cell surface. Together with recent insights into the atomic structure of the LDL receptor, they shed new light on the synthesis and trafficking of this important class of multifunctional receptors.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Marschang, Peter/0000-0002-8239-3447	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Swertfeger DK, 2002, J BIOL CHEM, V277, P4141, DOI 10.1074/jbc.M109124200; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1	20	60	64	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					289	292		10.1016/S0092-8674(03)00073-4	http://dx.doi.org/10.1016/S0092-8674(03)00073-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581519	Bronze			2022-12-01	WOS:000181252200001
J	Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO				Nisoli, E; Clementi, E; Paolucci, C; Cozzi, V; Tonello, C; Sciorati, C; Bracale, R; Valerio, A; Francolini, M; Moncada, S; Carruba, MO			Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide	SCIENCE			English	Article							RECEPTOR-GAMMA COACTIVATOR-1; NECROSIS-FACTOR-ALPHA; SYNTHASE; GENE; DIFFERENTIATION; THERMOGENESIS; ADIPOCYTES; ACTIVATION; EXPRESSION; NUCLEAR	Nitric oxide was found to trigger mitochondrial biogenesis in cells as diverse as brown adipocytes and 3T3-L1, U937, and HeLa cells. This effect of nitric oxide was dependent on guanosine 3',5'-monophosphate (cGMP) and was mediated by the induction of peroxisome proliferator-activated receptor gamma coactivator 1alpha, a master regulator of mitochondrial biogenesis. Moreover, the mitochondrial biogenesis induced by exposure to cold was markedly reduced in brown adipose tissue of endothelial nitric oxide synthase null-mutant (eNOS(-/-)) mice, which had a reduced metabolic rate and accelerated weight gain as compared to wild-type mice. Thus, a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and body energy balance.	Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy; Ist Auxol Italiano, I-20149 Milan, Italy; Ist Sci San Raffaele, DIBIT H, I-20132 Milan, Italy; Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, I-20129 Milan, Italy; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of Milan; Luigi Sacco Hospital; IRCCS Istituto Auxologico Italiano; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Calabria; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); University of London; University College London	Nisoli, E (corresponding author), Univ Milan, L Sacco Hosp Vialba, Dept Preclin Sci, Ctr Study & Res Obes, I-20157 Milan, Italy.	enzo.nisoli@unimi.it	Valerio, Alessandra/B-3413-2009; Nisoli, Enzo/D-6526-2014; sciorati, clara/K-4823-2016	Valerio, Alessandra/0000-0001-5844-2256; Nisoli, Enzo/0000-0002-6670-1630; BRACALE, Renata/0000-0003-3650-7033; Carruba, Michele/0000-0003-4589-387X; FRANCOLINI, MAURA/0000-0002-3126-1575; sciorati, clara/0000-0003-2030-9366				Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HIMMSHAGEN J, 1995, P SOC EXP BIOL MED, V208, P159, DOI 10.3181/00379727-208-43847A; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751; Nisoli E, 1998, BRIT J PHARMACOL, V125, P888, DOI 10.1038/sj.bjp.0702131; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	20	965	1021	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					896	899		10.1126/science.1079368	http://dx.doi.org/10.1126/science.1079368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574632				2022-12-01	WOS:000180830900054
J	Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM				Torchin, ME; Lafferty, KD; Dobson, AP; McKenzie, VJ; Kuris, AM			Introduced species and their missing parasites	NATURE			English	Article							POPULATION INTERACTIONS; STABILITY	Damage caused by introduced species results from the high population densities and large body sizes that they attain in their new location(1-4). Escape from the effects of natural enemies is a frequent explanation given for the success of introduced species(5,6). Because some parasites can reduce host density(7-13) and decrease body size(14), an invader that leaves parasites behind and encounters few new parasites can experience a demographic release and become a pest(4,15). To test whether introduced species are less parasitized, we have compared the parasites of exotic species in their native and introduced ranges, using 26 host species of molluscs, crustaceans, fishes, birds, mammals, amphibians and reptiles. Here we report that the number of parasite species found in native populations is twice that found in exotic populations. In addition, introduced populations are less heavily parasitized (in terms of percentage infected) than are native populations. Reduced parasitization of introduced species has several causes, including reduced probability of the introduction of parasites with exotic species (or early extinction after host establishment), absence of other required hosts in the new location, and the host-specific limitations of native parasites adapting to new hosts.	Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Western Ecol Res Ctr, US Geol Survey, Santa Barbara, CA 93106 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; Princeton University	Torchin, ME (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.		Lafferty, Kevin D./B-3888-2009					ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Chapman F. M., 1966, HDB BIRDS E N AM; CROFTON HD, 1971, PARASITOLOGY, V63, P343, DOI 10.1017/S0031182000079890; Dobson A.P., 1986, Ecological Studies, P58; GREGORY RD, 1991, PARASITOL TODAY, V7, P316, DOI 10.1016/0169-4758(91)90269-T; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HAIR JD, 1970, AM MIDL NAT, V83, P555, DOI 10.2307/2423962; HARADA M, 1989, Japanese Journal of Parasitology, V38, P388; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KURIS AM, 1992, CAN J FISH AQUAT SCI, V49, P327, DOI 10.1139/f92-037; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; RYBAKOV AV, 1988, TREMATODA ECHINOSTOM, V22, P224; SCOTT ME, 1987, PARASITOLOGY, V95, P111, DOI 10.1017/S0031182000057590; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SHIMURA S, 1980, Japanese Journal of Parasitology, V29, P369; Torchin ME, 2001, BIOL INVASIONS, V3, P333, DOI 10.1023/A:1015855019360; Torchin ME, 2002, PARASITOLOGY, V124, pS137, DOI 10.1017/S0031182002001506; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	22	994	1051	2	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 6	2003	421	6923					628	630		10.1038/nature01346	http://dx.doi.org/10.1038/nature01346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12571595				2022-12-01	WOS:000180803200041
J	Freed, GL; Davis, MM; Clark, SJ				Freed, GL; Davis, MM; Clark, SJ			Variation in public and private supply of pneumococcal conjugate vaccine during a shortage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In late August 2001, a serious shortage of the heptavalent pneumococcal conjugate vaccine (PCV7) developed in 34 state immunization programs. In September 2001, the Centers for Disease Control and Prevention published revised recommendations advising physicians to prioritize PCV7 to specific groups of children. The effect of the shortage at the practice level is unknown. Objective To determine the variation between public and private markets in the supply of PCV7 and the nature and extent of the PCV7 shortage at the practice level. Design, Setting, and Participants Semistructured interviews with office staff responsible for ordering vaccines at private practices in 12 states were conducted between October 19 and November 2, 2001. Main Outcome Measures Variation in supply of PCV7 obtained from public sources and through purchase on,the private market. Supply was characterized into 3 categories: "no problem," "problem obtaining a consistent supply, " and "out of stock. Results Interviews were completed at 405 practices, representing a response rate of 74%. Overall, 51% of practices reported at least 1 episode of being out of stock of public PCV7 and 64% of private PCV7, with significant state-to-state variation. Only 2 of 12 study states had a substantially higher proportion of practices experiencing out-of-stock episodes for public compared with private PCV7, while in 6 states public PCV7 was less frequently out of stock than private PCV7. Only 23% of practices in this study altered their administration policy for private PCV7, while 27% altered their policy for public PCV7. Conclusions The distribution and supply of PCV7 varied between public and private supplies and between states during the shortage. Few practices changed their administration schedules in response to revised recommendations.	Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Freed, GL (corresponding author), Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, 300 N Ingalls 6E08, Ann Arbor, MI 48109 USA.							*CDC, 2001, JAMA-J AM MED ASSOC, V286, P2232; *CDC, 2001, MMWR-MORBID MORTAL W, V50, P783; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Davis MM, 2001, AMBUL PEDIATR, V1, P302, DOI 10.1367/1539-4409(2001)001<0302:PECRTT>2.0.CO;2; Freed GL, 2000, AM J PREV MED, V19, P32, DOI 10.1016/S0749-3797(00)00219-1; *I MED, 2000, CALL SHOTS REP COMM; ORENSTEIN WA, 1999, VACCINES; Wood D, 1998, ARCH PEDIAT ADOL MED, V152, P238	8	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					575	578		10.1001/jama.289.5.575	http://dx.doi.org/10.1001/jama.289.5.575			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578490	Bronze			2022-12-01	WOS:000180787500028
J	He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM				He, L; Lu, XY; Jolly, AF; Eldridge, AG; Watson, SJ; Jackson, PK; Barsh, GS; Gunn, TM			Spongiform degeneration in mahoganoid mutant mice	SCIENCE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; AGOUTI PROTEIN; PIGMENTATION; MUTATIONS; ATTRACTIN; SUBSTRATE; RECEPTOR; OBESITY; SYSTEM	mahoganoid is a mouse coat-color mutation whose pigmentary phenotype and genetic interactions resemble those of Attractin (Atrn). Atrn mutations also cause spongiform neurodegeneration. Here, we show that a null mutation for mahoganoid causes a similar age-dependent neuropathology that includes many features of prion diseases but without accumulation of protease-resistant prion protein. The gene mutated in mahoganoid encodes a RING-containing protein with E3 ubiquitin ligase activity in vitro. Similarities in phenotype, expression, and genetic interactions suggest that mahoganoid and Atrn genes are part of a conserved pathway for regulated protein turnover whose function is essential for neuronal viability.	Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Pediat,Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA	Cornell University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Michigan System; University of Michigan	Barsh, GS (corresponding author), Cornell Univ, Dept Biomed Sci, T4 018 VRT, Ithaca, NY 14853 USA.		Lu, Xin-Yun/M-8657-2016	Gunn, Teresa/0000-0003-2688-6420; Jackson, Peter/0000-0002-1742-2539				Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; GOMI H, 1994, BRAIN RES, V653, P66, DOI 10.1016/0006-8993(94)90373-5; Gunn TM, 2001, GENETICS, V158, P1683; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson IJ, 1999, TRENDS GENET, V15, P429, DOI 10.1016/S0168-9525(99)01824-7; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kuramoto T, 2002, MAMM GENOME, V13, P36, DOI 10.1007/s00335-001-2116-9; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; LANE PW, 1960, MOUSE NEWS LETT, V22, P35; LIBERSKI PP, 1993, LIGHT ELECT MICROSCO, P155; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Milhavet O, 2002, BRAIN RES REV, V38, P328, DOI 10.1016/S0165-0173(01)00150-3; Miller KA, 1997, GENETICS, V146, P1407; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Phillips R.J., 1963, MOUSE NEWS LETT, V29, P38; PHILLIPS RJS, 1979, MOUSE NEWS LETT, V60, P46; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRUSINER SB, 1997, MOL GENETIC BASIS NE, P103; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627	26	114	120	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					710	712		10.1126/science.1079694	http://dx.doi.org/10.1126/science.1079694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560552				2022-12-01	WOS:000180687700048
J	Xiao, YP; Wang, Y; Felleman, DJ				Xiao, YP; Wang, Y; Felleman, DJ			A spatially organized representation of colour in macaque cortical area V2	NATURE			English	Article							FUNCTIONAL-ORGANIZATION; FORM; SEGREGATION; MECHANISMS; DISPARITY; CORTEX; MONKEY; V4	Neurons responding selectively to different colours have been found in various cortical areas in macaque monkeys(1); however, little is known about whether and how the representation of colour is spatially organized in any cortical area. Cortical area V2 contains modules that respond preferentially to chromatic modulation, which are located in thin cytochrome oxidase stripes(2-4). Here we show that within and beyond these modules, gratings of different colours produce activations that peak at different locations. Optical recording of intrinsic signals revealed that the peak regions of the responses to different colours were spatially organized in the same order as colour stimuli are arranged in the DIN (German standard colour chart) colour system. Nearby regions represented colours of a similar hue. We found that the set of colour-specific regions formed 0.07-0.32-mm-wide and approximately 1.3-mm long bands that varied in shape from linear to nearly circular. Our finding suggests that thin stripes in V2 contain functional maps where the colour of a stimulus is represented by the location of its response activation peak.	Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Xiao, YP (corresponding author), Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA.			Xiao, Youping/0000-0003-3954-3443				BURKHALTER A, 1986, J NEUROSCI, V6, P2327; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; Komatsu H, 1998, CURR OPIN NEUROBIOL, V8, P503, DOI 10.1016/S0959-4388(98)80038-X; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Moutoussis K, 2002, J NEUROPHYSIOL, V87, P2104, DOI 10.1152/jn.00248.2001; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; ROE AW, 1995, J NEUROSCI, V15, P3689; TOOTELL RBH, 1989, J NEUROSCI, V9, P2620; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Yoshioka T, 1996, BEHAV BRAIN RES, V76, P51, DOI 10.1016/0166-4328(95)00183-2	15	169	172	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					535	539		10.1038/nature01372	http://dx.doi.org/10.1038/nature01372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556893				2022-12-01	WOS:000180670600046
J	Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L				Tang, Y; Katuri, V; Dillner, A; Mishra, B; Deng, CX; Mishra, L			Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice	SCIENCE			English	Article							TGF-BETA; LIVER DEVELOPMENT; EPITHELIAL-CELLS; SMAD PROTEINS; PATHWAY; CANCER	Disruption of the adaptor protein ELF, a beta-spectrin, leads to disruption of transforming growth factor-beta (TGF-beta) signaling by Smad proteins in mice. Elf(-/-) mice exhibit a phenotype similar to smad2(+/-)/smad3(+/-) mutant mice of midgestational death due to gastrointestinal, liver, neural, and heart defects. We show that TGF-beta triggers phosphorylation and association of ELF with Smad3 and Smad4, followed by nuclear translocation. ELF deficiency results in mislocalization of Smad3 and Smad4 and loss of the TGF-beta-dependent transcriptional response, which could be rescued by overexpression of the COOH-terminal region of ELF. This study reveals an unexpected molecular link between a major dynamic scaffolding protein and a key signaling pathway.	NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA; Georgetown Univ, Dept Med, Dev Biol Lab, Washington, DC 20007 USA; Dept Vet Affairs, Washington, DC 20422 USA; Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mishra, B (corresponding author), NIDDKD, Genet Dev & Dis Branch, NIH, US Dept HHS, Bethesda, MD 20878 USA.	lm229@georgetown.edu	deng, chuxia/N-6713-2016	Mishra, Lopa/0000-0002-6850-0808	NIDDK NIH HHS [R01 DK56111, R03 DK53861, R01 DK58637] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, R03DK053861, R01DK056111, ZIADK056001] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; De Matteis MA, 2000, J CELL SCI, V113, P2331; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; Engel ME, 1998, J CELL BIOCHEM, P111; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Mishra L, 1999, ONCOGENE, V18, P353, DOI 10.1038/sj.onc.1202313; Mishra L, 1998, INT J DEV BIOL, V42, P221; Moustakas A, 2002, GENE DEV, V16, P1867, DOI 10.1101/gad.1016802; Moustakas A, 2001, J CELL SCI, V114, P4359; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	22	215	224	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					574	577		10.1126/science.1075994	http://dx.doi.org/10.1126/science.1075994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543979	Green Published			2022-12-01	WOS:000180559800053
J	Thiele, A; Stoner, G				Thiele, A; Stoner, G			Neuronal synchrony does not correlate with motion coherence in cortical area MT	NATURE			English	Article							VISUAL-CORTEX; CONNECTIVITY; TRANSPARENCY; PERCEPTION; RESPONSES; RULES; CUE	Natural visual scenes are cluttered with multiple objects whose individual features must somehow be selectively linked (or 'bound') if perception is to coincide with reality. Recent neurophysiological evidence(1,2) supports a 'binding-by-synchrony' hypothesis3 : neurons excited by features of the same object fire synchronously, while neurons excited by features of different objects do not. Moving plaid patterns offer a straightforward means to test this idea. By appropriate manipulations of apparent transparency, the component gratings of a plaid pattern can be seen as parts of a single coherently moving surface or as two non-coherently moving surfaces. We examined directional tuning and synchrony of area-MT neurons in awake, fixating primates in response to perceptually coherent and non-coherent plaid patterns. Here we show that directional tuning correlated highly with perceptual coherence, which is consistent with an earlier study(4). Although we found stimulus-dependent synchrony, coherent plaids elicited significantly less synchrony than did non-coherent plaids. Our data therefore do not support the binding-by-synchrony hypothesis as applied to this class of motion stimuli in area MT.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Stoner, G (corresponding author), Univ Newcastle Upon Tyne, Henry Wellcome Bldg Neuroecol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Thiele, Alexander/0000-0003-4894-0213				AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BATSCHELET E, 1972, ANIMAL ORIENTATION N, P61; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; deOliveira SC, 1997, J NEUROSCI, V17, P9248; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lindsey DT, 1996, VISION RES, V36, P207, DOI 10.1016/0042-6989(95)00096-I; Movshon JA, 1985, STUDY GROUP PATTERN, P117, DOI [DOI 10.1007/978-3-662-09224-8_7., DOI 10.1007/978-3-662-09224-8_]; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stoner GR, 1996, VISION RES, V36, P1291, DOI 10.1016/0042-6989(95)00195-6; STONER GR, 1992, VISION RES, V32, P465, DOI 10.1016/0042-6989(92)90238-E; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x	20	116	117	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					366	370		10.1038/nature01285	http://dx.doi.org/10.1038/nature01285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540900				2022-12-01	WOS:000180533000041
J	Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA				Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA			Role of anthocyanidin reductase, encoded by BANYULS in plant flavonoid biosynthesis	SCIENCE			English	Article							CONDENSED TANNINS; GENE ENCODES; FLAVAN-3-OL BIOSYNTHESIS; FORAGE LEGUMES; DOMAIN PROTEIN; PROANTHOCYANIDINS; CONVERSION; LEUCOCYANIDIN; ACCUMULATION; EXPRESSION	Condensed tannins (CTs) are flavonoid oligomers, many of which have beneficial effects on animal and human health. The flavanol (-)-epicatechin is a component of many CTs and contributes to flavor and astringency in tea and wine. We show that the BANYULS ( BAN) genes from Arabidopsis thaliana and Medicago truncatula encode anthocyanidin reductase, which converts anthocyanidins to their corresponding 2,3-cis-avan-3-ols. Ectopic expression of BAN in tobacco flower petals and Arabidopsis leaves results in loss of anthocyanins and accumulation of CTs.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA	Noble Research Institute; University of Mississippi	Dixon, RA (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	radixon@noble.org		XIE, DE-YU/0000-0002-3054-1188				Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; ALBRECHT KA, 1991, CROP SCI, V31, P464, DOI 10.2135/cropsci1991.0011183X003100020048x; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barry TN, 1999, BRIT J NUTR, V81, P263, DOI 10.1017/S0007114599000501; BRODERICK GA, 1995, J ANIM SCI, V73, P2760; Dalzell SA, 1998, J SCI FOOD AGR, V78, P405, DOI 10.1002/(SICI)1097-0010(199811)78:3&lt;405::AID-JSFA133&gt;3.0.CO;2-G; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Douglas GB, 1999, NEW ZEAL J AGR RES, V42, P55, DOI 10.1080/00288233.1999.9513353; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; FOO LY, 1983, J CHEM SOC PERK T 1, P1535, DOI 10.1039/p19830001535; KORVER O, 1971, TETRAHEDRON, V27, P5459, DOI 10.1016/S0040-4020(01)91712-0; KRISTIANSEN KN, 1986, CARLSBERG RES COMMUN, V51, P51, DOI 10.1007/BF02907995; Lin LC, 2002, J NAT PROD, V65, P505, DOI 10.1021/np010414l; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; NEL RJJ, 1999, J CHEM RES S, P606; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pataki T, 2002, AM J CLIN NUTR, V75, P894, DOI 10.1093/ajcn/75.5.894; Porter L.J., 1989, TANNINS METHODS PLAN, V1, P389; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Singh S, 1997, PHYTOCHEMISTRY, V44, P425, DOI 10.1016/S0031-9422(96)00415-3; Skadhauge B, 1997, AM J BOT, V84, P494, DOI 10.2307/2446026; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; STAFFORD HA, 1983, PHYTOCHEMISTRY, V22, P2643, DOI 10.1016/S0031-9422(00)97664-7; STAFFORD HA, 1984, PLANT PHYSIOL, V76, P184, DOI 10.1104/pp.76.1.184; Stafford HA, 1990, FLAVONOID METABOLISM, P63; TANNER GJ, 1993, ANAL BIOCHEM, V209, P274, DOI 10.1006/abio.1993.1119; van Rensburg H, 1999, J CHEM RES-S, P450, DOI 10.1039/a901599j; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485	33	526	619	16	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					396	399		10.1126/science.1078540	http://dx.doi.org/10.1126/science.1078540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532018	Green Submitted			2022-12-01	WOS:000180426800046
J	Katan, MB; de Roos, NM				Katan, MB; de Roos, NM			Public health - Toward evidence-based health claims for foods	SCIENCE			English	Editorial Material							TRENDS		Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands; Univ Med Ctr, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Katan, MB (corresponding author), Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands.	wcfs1@wur.nl						Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; *EUR COMM, SANCO18322002 EUR CO; GUTHRIE JF, 1999, AM EATING HABITS CHA, P269; HELLER IR, 1999, FUNCTIONAL FOODS PUB, P9; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; *I MED, 2002, PROP FRAM EV SAF DIE; Jacobson MF, 1999, BMJ-BRIT MED J, V319, P205, DOI 10.1136/bmj.319.7204.205; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; NESTLE M, 2002, FOOD POLITICS FOOD I, P316; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sloan AE, 2002, FOOD TECHNOL-CHICAGO, V56, P32; Southon S, 2000, ROY SOC CH, P3; Truswell AS, 2001, LANCET, V357, P1061, DOI 10.1016/S0140-6736(00)04308-7; *US GEN ACC OFF, 2000, GAORCED00156; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5	17	26	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					206	207		10.1126/science.1078638	http://dx.doi.org/10.1126/science.1078638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522235				2022-12-01	WOS:000180284000022
J	Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M				Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M			Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis	NATURE			English	Article							SHEAR-STRESS; BLOOD-FLOW; CARDIAC DEVELOPMENT; ENDOTHELIAL-CELLS; ZEBRAFISH; MECHANOTRANSDUCTION; EXPRESSION; SYSTEM; HEART; GENE	The pattern of blood flow in the developing heart has long been proposed to play a significant role in cardiac morphogenesis. In response to flow-induced forces, cultured cardiac endothelial cells rearrange their cytoskeletal structure and change their gene expression profiles(1,2). To link such in vitro data to the intact heart, we performed quantitative in vivo analyses of intracardiac flow forces in zebrafish embryos. Using in vivo imaging, here we show the presence of high-shear, vortical flow at two key stages in the developing heart, and predict flow-induced forces much greater than might have been expected for micro-scale structures at low Reynolds numbers. To test the relevance of these shear forces in vivo, flow was occluded at either the cardiac inflow or outflow tracts, resulting in hearts with an abnormal third chamber, diminished looping and impaired valve formation. The similarity of these defects to those observed in some congenital heart diseases argues for the importance of intracardiac haemodynamics as a key epigenetic factor in embryonic cardiogenesis.	CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Hove, JR (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	jhove@caltech.edu; rkoeste1@gg.caltech.edu	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Koster, Reinhard/0000-0001-6593-8196; Gharib, Mohammed/0000-0001-9611-1693				Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Di Stefano I, 1998, J VASC RES, V35, P1, DOI 10.1159/000025559; HELMLINGER G, 1991, J BIOMECH ENG-T ASME, V113, P123, DOI 10.1115/1.2891226; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; HOU PCL, 1995, AM J PHYSIOL-REG I, V269, pR1126, DOI 10.1152/ajpregu.1995.269.5.R1126; Icardo JM, 1996, J EXP ZOOL, V275, P144, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<144::AID-JEZ7>3.3.CO;2-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langille BL, 1995, FLOW DEPENDENT REGUL, P277; Liao EC, 2002, DEVELOPMENT, V129, P649; Long QM, 1997, DEVELOPMENT, V124, P4105; MANASEK FJ, 1972, DEV BIOL, V27, P584, DOI 10.1016/0012-1606(72)90196-0; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; OBRIEN SPM, 1999, FETAL PROGRAMMING IN; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Taber LA, 1998, PROG BIOPHYS MOL BIO, V69, P237, DOI 10.1016/S0079-6107(98)00010-8; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 1995, ZEBRAFISH BOOK; WILLERT CE, 1991, EXP FLUIDS, V10, P181	29	771	786	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					172	177		10.1038/nature01282	http://dx.doi.org/10.1038/nature01282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520305				2022-12-01	WOS:000180267200043
J	Pearson, H				Pearson, H			Stem cells - Articles of faith adulterated	NATURE			English	Editorial Material							BONE-MARROW; BRAIN											Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	14	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					734	735		10.1038/420734a	http://dx.doi.org/10.1038/420734a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490909				2022-12-01	WOS:000179897300018
J	Chan, D; Rossor, MN				Chan, D; Rossor, MN			"-but who is that on the other side of you?" - Extracampine hallucinations revisited	LANCET			English	Editorial Material							PARKINSONS-DISEASE; LEWY BODIES; DEMENTIA; AREA; BODY		Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London WC1N 3BG, England; Univ London Imperial Coll Sci & Technol, Fac Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Chan, D (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, Queen Sq, London WC1N 3BG, England.		Rossor, Martin/C-1598-2008	Rossor, Martin/0000-0001-8215-3120				Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; CELESIA GG, 1970, ARCH NEUROL-CHICAGO, V23, P193, DOI 10.1001/archneur.1970.00480270003001; Critchley M, 1943, SHIPWRECK SURVIVORS; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Harding AJ, 2002, BRAIN, V125, P391, DOI 10.1093/brain/awf033; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; PERRY EK, 1993, J NEURAL TRANSM-PARK, V6, P167, DOI 10.1007/BF02260919; Shackleton E, 1919, SOUTH; Ungerleider L.G., 1982, ANAL VISUAL BEHAV	13	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2064	2066		10.1016/S0140-6736(02)11998-2	http://dx.doi.org/10.1016/S0140-6736(02)11998-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504418				2022-12-01	WOS:000179974200029
J	Sharp, D				Sharp, D			Cholera and climate - the evidence grows	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999	4	0	0	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1902	1902		10.1016/S0140-6736(02)11937-4	http://dx.doi.org/10.1016/S0140-6736(02)11937-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493254				2022-12-01	WOS:000179870200006
J	Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA				Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA			Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; OCULAR PHOTORECEPTION; CRYPTOCHROMES; ENTRAINMENT; RHYTHMS; BLIND; MOUSE; CELLS; NIGHT; OPSIN	The master circadian oscillator in the hypothalamic suprachiasmatic nucleus is entrained to the day/night cycle by retinal photoreceptors. Melanopsin (Opn4), an opsin-based photopigment, is a primary candidate for photoreceptor-mediated entrainment. To investigate the functional role of melanopsin in light resetting of the oscillator, we generated melanopsin-null mice (Opn4(-/-)). These mice entrain to a light/dark cycle and do not exhibit any overt defect in circadian activity rhythms under constant darkness. However, they display severely attenuated phase resetting in response to brief pulses of monochromatic light, highlighting the critical role of melanopsin in circadian photoentrainment in mammals.	Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Sao Paulo, Dept Physiol, BR-05422 Sao Paulo, Brazil; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Uniformed Services University of the Health Sciences - USA; Novartis; Scripps Research Institute; Universidade de Sao Paulo; Radboud University Nijmegen	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.		de Grip, W.J./L-4335-2015; Kay, Steve A/F-6025-2011; Panda, Satchidananda/J-6891-2012; Jansen, Heiko T./A-5770-2008; Castrucci, Ana Maria L/C-3296-2014	Kay, Steve A/0000-0002-0402-2878; Jansen, Heiko T./0000-0003-0178-396X; Castrucci, Ana Maria/0000-0002-2065-8198	NIMH NIH HHS [MH 62405, MH51573] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062405, R01MH051573] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Nielsen HS, 2001, NEUROSCIENCE, V103, P433, DOI 10.1016/S0306-4522(00)00563-7; PICKARD GE, 1994, NEUROREPORT, V5, P2186, DOI 10.1097/00001756-199410270-00049; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yanovsky MJ, 2000, CURR BIOL, V10, P1013, DOI 10.1016/S0960-9822(00)00651-5	24	604	624	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2213	2216		10.1126/science.1076848	http://dx.doi.org/10.1126/science.1076848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481141				2022-12-01	WOS:000179773700055
J	Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF				Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF			Role of melanopsin in circadian responses to light	SCIENCE			English	Article							RETINAL GANGLION-CELLS; OCULAR PHOTORECEPTION; MICE; CRYPTOCHROMES; PROJECTIONS; EXPRESSION; MELATONIN; SYSTEM; BLIND	Melanopsin has been proposed as an important photoreceptive molecule for the mammalian circadian system. Its importance in this role was tested in melanopsin knockout mice. These mice entrained to a light/dark cycle, phase-shifted after a light pulse, and increased circadian period when light intensity increased. Induction of the immediate-early gene c-fos was observed after a nighttime light pulse in both wild-type and knockout mice. However, the magnitude of these behavioral responses in knockout mice was 40% lower than in wild-type mice. Although melanopsin is not essential for the circadian clock to receive photic input, it contributes significantly to the magnitude of photic responses.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Deltagen Inc, Redwood City, CA 94063 USA	Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	ruby@stanford.edu; bfo@stanford.edu	Franken, Paul/A-9633-2018; Heller, H. Craig/C-9785-2011	Franken, Paul/0000-0002-2500-2921; Xie, Xinmin Simon/0000-0002-4049-6499; Heller, H Craig/0000-0003-4479-5880	NHLBI NIH HHS [HL64148] Funding Source: Medline; NIDA NIH HHS [DA13349] Funding Source: Medline; NIMH NIH HHS [MH60385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013349] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lucas RJ, 1999, J BIOL RHYTHM, V14, P4, DOI 10.1177/074873099129000380; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 1998, J BIOL RHYTHM, V13, P506, DOI 10.1177/074873098129000336; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SUTIN EL, 1992, MOL BRAIN RES, V15, P281, DOI 10.1016/0169-328X(92)90119-V; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; UNDERWOOD H, 1990, EXPERIENTIA, V46, P120, DOI 10.1007/BF01955437; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; YOSHIMURA T, 1994, J BIOL RHYTHM, V9, P51, DOI 10.1177/074873049400900105	26	475	491	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2211	2213		10.1126/science.1076701	http://dx.doi.org/10.1126/science.1076701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481140				2022-12-01	WOS:000179773700054
J	Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA				Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA			Dissolved organic carbon support of respiration in the dark ocean	SCIENCE			English	Article							FLUX		Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Las Palmas Gran Canaria 35017, Spain; UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Oslas Baleares, Spain; CCCMM XUGA, Vilagarcia De Arousa, Spain; CSIC, IIM, Vigo 36208, Spain; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Miami	Aristegui, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Campus Univ Tafira, Las Palmas Gran Canaria 35017, Spain.		Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Alvarez-Salgado, Xose Anton/A-8365-2012; Agusti, Susana/G-2864-2017; Arístegui, Javier/D-5833-2013; Hansell, Dennis A./AAC-1271-2019; Agusti, Susana/H-8421-2012	Duarte, Carlos M/0000-0002-1213-1361; Alvarez-Salgado, Xose Anton/0000-0002-2387-9201; Agusti, Susana/0000-0003-0536-7293; Arístegui, Javier/0000-0002-7526-7741; Hansell, Dennis A./0000-0001-9275-3445; Doval, Marylo/0000-0002-8565-8703				Alvarez-Salgado XA, 2001, SCI MAR, V65, P1; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Doval MD, 2000, MAR CHEM, V68, P249, DOI 10.1016/S0304-4203(99)00081-X; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685, DOI [10.1016/B978-012323841-2/50017-8, DOI 10.1016/B978-012323841-2/50017-8]; Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; PELTZER ET, 1996, DEEP SEA RES 2, V43, P155; SCHOLTEN JC, 2001, DEEP SEA RES 2, V48, P243	10	100	102	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1967	1967		10.1126/science.1076746	http://dx.doi.org/10.1126/science.1076746			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471250	Green Submitted			2022-12-01	WOS:000179629200037
J	Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS				Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS		Canadian Critical Care Trials Grp	One-year outcomes in survivors of the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; ACUTE LUNG INJURY; TERM-FOLLOW-UP; PULMONARY-FUNCTION; RECOVERY; ABNORMALITIES; DYSFUNCTION; SF-36; ARDS	BACKGROUND: As more patients survive the acute respiratory distress syndrome, an understanding of the long-term outcomes of this condition is needed. METHODS: We evaluated 109 survivors of the acute respiratory distress syndrome 3, 6, and 12 months after discharge from the intensive care unit. At each visit, patients were interviewed and underwent a physical examination, pulmonary-function testing, a six-minute-walk test, and a quality-of-life evaluation. RESULTS: Patients who survived the acute respiratory distress syndrome were young (median age, 45 years) and severely ill (median Acute Physiology, Age, and Chronic Health Evaluation score, 23) and had a long stay in the intensive care unit (median, 25 days). Patients had lost 18 percent of their base-line body weight by the time they were discharged from the intensive care unit and stated that muscle weakness and fatigue were the reasons for their functional limitation. Lung volume and spirometric measurements were normal by 6 months, but carbon monoxide diffusion capacity remained low throughout the 12-month follow-up. No patients required supplemental oxygen at 12 months, but 6 percent of patients had arterial oxygen saturation values below 88 percent during exercise. The median score for the physical role domain of the Medical Outcomes Study 36-item Short-Form General Health Survey (a health-related quality-of-life measure) increased from 0 at 3 months to 25 at 12 months (score in the normal population, 84). The distance walked in six minutes increased from a median of 281 m at 3 months to 422 m at 12 months; all values were lower than predicted. The absence of systemic corticosteroid treatment, the absence of illness acquired during the intensive care unit stay, and rapid resolution of lung injury and multiorgan dysfunction were associated with better functional status during the one-year follow-up. CONCLUSIONS: Survivors of the acute respiratory distress syndrome have persistent functional disability one year after discharge from the intensive care unit. Most patients have extrapulmonary conditions, with muscle wasting and weakness being most prominent.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Univ Hlth Network, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Interdept Div Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Publ Hlth Sci, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Anaesthesia, Toronto, ON, Canada; St Michaels Hosp, Dept Anesthesia & Crit Care Med, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Dept Med & Crit Care Med, Toronto, ON M5B 1W8, Canada; Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Anesthesia, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; McMaster University; McMaster University	Herridge, MS (corresponding author), Toronto Gen Hosp, EN 10-212,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	margaret.herridge@uhn.on.ca	Slutsky, Arthur/M-3325-2019; Slutsky, Arthur S/A-6013-2008; Mehta, Sangeeta/C-4623-2015	Slutsky, Arthur S/0000-0002-6063-3876; Herridge, Margaret/0000-0002-2903-1631; Mazer, Cyril David/0000-0003-2566-4308; Cheung, Angela M./0000-0001-8332-0744	Canadian Institutes of Health Research [44917] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; ALBERTS WM, 1983, CHEST, V84, P272, DOI 10.1378/chest.84.3.272; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Anzueto A, 1999, CLIN CHEST MED, V20, P435, DOI 10.1016/S0272-5231(05)70151-9; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; Cooper AB, 1999, CRIT CARE MED, V27, P2616, DOI 10.1097/00003246-199912000-00002; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; DOWNS JB, 1974, CHEST, V65, P92, DOI 10.1378/chest.65.1.92; ELLIOTT CG, 1987, AM REV RESPIR DIS, V135, P634; ELLIOTT CG, 1981, AM REV RESPIR DIS, V123, P492; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; GHIO AJ, 1989, AM REV RESPIR DIS, V140, P862; GHIO AJ, 1989, AM REV RESPIR DIS, V139, P1158, DOI 10.1164/ajrccm/139.5.1158; HALEVY A, 1984, RESPIR CARE, V29, P132; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hupcey J E, 2000, Am J Crit Care, V9, P192; Jacobs JWG, 1999, RHEUMATOLOGY, V38, P1145, DOI 10.1093/rheumatology/38.11.1145; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; KLEIN JJ, 1976, CHEST, V69, P350, DOI 10.1378/chest.69.3.350; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; LAKSHMINARAYAN S, 1978, CHEST, V74, P489, DOI 10.1378/chest.74.5.489; LAKSHMINARAYAN S, 1976, AM REV RESPIR DIS, V113, P7; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548; PETERS JI, 1989, AM REV RESPIR DIS, V139, P1163, DOI 10.1164/ajrccm/139.5.1163; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; RICHARDSON JV, 1976, SOUTH MED J, V69, P735, DOI 10.1097/00007611-197606000-00022; RICHARDSON JV, 1976, SOUTH MED J, V69, P740; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; ROTMAN HH, 1977, CHEST, V72, P190, DOI 10.1378/chest.72.2.190; Schelling G, 2000, INTENS CARE MED, V26, P1304, DOI 10.1007/s001340051342; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; SHAW RA, 1981, ARCH INTERN MED, V141, P741, DOI 10.1001/archinte.141.6.741; SIMPSON DL, 1978, AM REV RESPIR DIS, V117, P449; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Weisman IM, 2001, CLIN CHEST MED, V22, P679, DOI 10.1016/S0272-5231(05)70060-5; YAHAV J, 1978, CHEST, V74, P247, DOI 10.1378/chest.74.3.247; YERNAULT JC, 1975, THORAX, V30, P252, DOI 10.1136/thx.30.3.252	45	1460	1530	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					683	693		10.1056/NEJMoa022450	http://dx.doi.org/10.1056/NEJMoa022450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594312				2022-12-01	WOS:000181014400003
J	LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N				LeCouter, J; Moritz, DR; Li, B; Phillips, GL; Liang, XH; Gerber, HP; Hillan, KJ; Ferrara, N			Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1	SCIENCE			English	Article							GROWTH-FACTOR VEGF; TYROSINE KINASE; FLT-1 VEGFR-1; RECEPTOR; CELLS; BINDING; REGENERATION; MIGRATION; MITOGEN; KDR	The vascular endothelium was once thought to function primarily in nutrient and oxygen delivery, but recent evidence suggests that it may play a broader role in tissue homeostasis. To explore the role of sinusoidal endothelial cells (LSECs) in the adult liver, we studied the effects of vascular endothelial growth factor (VEGF) receptor activation on mouse hepatocyte growth. Delivery of VEGF-A increased liver mass in mice but did not stimulate growth of hepatocytes in vitro, unless LSECs were also present in the culture. Hepatocyte growth factor (HGF) was identified as one of the LSEC-derived paracrine mediators promoting hepatocyte growth. Selective activation of VEGF receptor-1 (VEGFR-1) stimulated hepatocyte but not endothelial proliferation in vivo and reduced liver damage in mice exposed to a hepatotoxin. Thus, VEGFR-1 agonists may have therapeutic potential for preservation of organ function in certain liver disorders.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.							Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BARUCH Y, 1995, J HEPATOL, V23, P328, DOI 10.1016/0168-8278(95)80477-3; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; JAKEMAN LB, 1992, J CLIN INVEST, V89, P244, DOI 10.1172/JCI115568; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kliche S, 2001, IUBMB LIFE, V52, P61, DOI 10.1080/15216540252774784; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LECOUTER J, UNPUB; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; PARK JE, 1994, J BIOL CHEM, V269, P25646; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; SIMIONESCU N, 1992, ENDOTHELIAL CELL FUN; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; YAMANE A, 1994, ONCOGENE, V9, P2683; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200	30	502	527	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					890	893		10.1126/science.1079562	http://dx.doi.org/10.1126/science.1079562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574630				2022-12-01	WOS:000180830900052
J	Evans, WE; McLeod, HL				Evans, WE; McLeod, HL			Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONVERTING ENZYME-INHIBITOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; S-METHYLTRANSFERASE DEFICIENCY; APOLIPOPROTEIN-E POLYMORPHISM; LEFT-VENTRICULAR HYPERTROPHY; SEROTONIN TRANSPORTER GENE; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; BETA(2)-ADRENERGIC RECEPTOR; CORONARY ATHEROSCLEROSIS		St Jude Childrens Res Hosp, Memphis, TN 38101 USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Washington Univ, Sch Med, St Louis, MO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL)	Evans, WE (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38101 USA.	william.evans@stjude.org	Evans, William E./C-2069-2012; McLeod, Howard/ABD-8364-2021	Evans, William E./0000-0002-9333-5322; McLeod, Howard/0000-0002-9004-9232	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA078224, P30CA091842, R37CA036401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM063340, U01GM061394] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA36401, R01 CA78224, CA21765, CA091842] Funding Source: Medline; NIGMS NIH HHS [U01 GM61393, U01 GM63340, U01 GM61394] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Ballantyne CM, 2000, J AM COLL CARDIOL, V36, P1572, DOI 10.1016/S0735-1097(00)00918-9; Basile VS, 1999, NEUROPSYCHOPHARMACOL, V21, P17, DOI 10.1016/S0893-133X(98)00114-6; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brinkmann U, 2001, DRUG DISCOV TODAY, V6, P835, DOI 10.1016/S1359-6446(01)01892-X; Cargill M, 2000, Pharmacogenomics, V1, P27, DOI 10.1517/14622416.1.1.27; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; de Maat MPM, 1999, AM J CARDIOL, V83, P852, DOI 10.1016/S0002-9149(98)01073-X; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Eichhammer P, 2000, AM J MED GENET, V96, P187, DOI 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8; Esteller M, 2000, NEW ENGL J MED, V343, P1740; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; Herrington DM, 2002, NEW ENGL J MED, V346, P967, DOI 10.1056/NEJMoa012952; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Hwu HG, 1998, BIOL PSYCHIAT, V44, P483, DOI 10.1016/S0006-3223(98)00134-6; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Israel E, 2001, INT ARCH ALLERGY IMM, V124, P183, DOI 10.1159/000053705; Issa AM, 2000, CAN J PSYCHIAT, V45, P917, DOI 10.1177/070674370004501007; Jacobsen P, 1998, KIDNEY INT, V53, P1002, DOI 10.1046/j.1523-1755.1998.00847.x; Kaiser R, 2000, MOL PSYCHIATR, V5, P418, DOI 10.1038/sj.mp.4000729; Kalow W, 1998, PHARMACOGENETICS, V8, P283; KALOW W, 1956, LANCET, V2, P576; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kohno M, 1999, AM J MED, V106, P544, DOI 10.1016/S0002-9343(99)00067-4; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Liggett SB, 2000, AM J RESP CRIT CARE, V161, pS197, DOI 10.1164/ajrccm.161.supplement_2.a1q4-10; Lima JJ, 1999, CLIN PHARMACOL THER, V65, P519, DOI 10.1016/S0009-9236(99)70071-8; Liotta LA, 2001, JAMA-J AM MED ASSOC, V286, P2211, DOI 10.1001/jama.286.18.2211; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Marian AJ, 2000, J AM COLL CARDIOL, V35, P89, DOI 10.1016/S0735-1097(99)00535-5; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874; McDonald OG, 2002, PHARMACOGENETICS, V12, P93, DOI 10.1097/00008571-200203000-00003; McLeod HL, 2002, LANCET, V359, P78, DOI 10.1016/S0140-6736(02)07296-3; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; Mukae S, 2000, HYPERTENSION, V36, P127, DOI 10.1161/01.HYP.36.1.127; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; Ohmichi N, 1997, AM J HYPERTENS, V10, P951, DOI 10.1016/S0895-7061(97)00121-0; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Ongphiphadhanakul B, 2000, CLIN ENDOCRINOL, V52, P581, DOI 10.1046/j.1365-2265.2000.00979.x; ORDOVAS JM, 1995, ATHEROSCLEROSIS, V113, P157, DOI 10.1016/0021-9150(94)05439-P; Pedro-Botet J, 2001, ATHEROSCLEROSIS, V158, P183, DOI 10.1016/S0021-9150(01)00410-5; Penno G, 1998, DIABETES, V47, P1507, DOI 10.2337/diabetes.47.9.1507; Perna A, 2000, KIDNEY INT, V57, P274, DOI 10.1046/j.1523-1755.2000.00818.x; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Prasad A, 2000, CIRCULATION, V102, P35, DOI 10.1161/01.CIR.102.1.35; Psaty BM, 2002, JAMA-J AM MED ASSOC, V287, P1680, DOI 10.1001/jama.287.13.1680; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Richard F, 1997, LANCET, V349, P539, DOI 10.1016/S0140-6736(97)80089-X; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakaeda T, 2001, PHARMACEUT RES, V18, P1400, DOI 10.1023/A:1012244520615; Sasaki M, 1996, J HYPERTENS, V14, P1403, DOI 10.1097/00004872-199612000-00003; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Sham P, 2001, PHARMACOGENOMICS, V2, P195, DOI 10.1517/14622416.2.3.195; Siest G, 2000, CLIN CHEM LAB MED, V38, P841, DOI 10.1515/CCLM.2000.122; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stavroulakis GA, 2000, CARDIOVASC DRUG THER, V14, P427, DOI 10.1023/A:1007820401377; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; VESELL ES, 1989, PHARMACOL THERAPEUT, V41, P535, DOI 10.1016/0163-7258(89)90130-7; WATANABE J, 1993, DIABETES RES CLIN PR, V20, P21, DOI 10.1016/0168-8227(93)90018-Z; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Whale R, 2000, PSYCHOPHARMACOLOGY, V150, P120, DOI 10.1007/s002130000432; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	95	1212	1343	2	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2003	348	6					538	549		10.1056/NEJMra020526	http://dx.doi.org/10.1056/NEJMra020526			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642JY	12571262				2022-12-01	WOS:000180801400008
J	Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M				Huopio, H; Otonkoski, T; Vauhkonen, I; Reimann, F; Ashcroft, FM; Laakso, M			A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1	LANCET			English	Article							K-ATP CHANNEL; INSULIN-SECRETION; SEQUENCE VARIANTS; HYPERINSULINEMIC HYPOGLYCEMIA; KNOCKOUT MICE; MELLITUS; PANCREAS; GLUCOSE; NESIDIOBLASTOSIS; DEFINITION	Background ATP-sensitive potassium (K-ATP) channels are major regulators of glucose-induced insulin secretion in pancreatic P cells. We have described a dominant heterozygous mutation-E1506K-in the sulfonylurea receptor 1 (SUR1) gene (ABCC8) in a Finnish family, which leads to congenital hyperinsulinaemia due to reduction of K-ATP-channel activity. We aimed to characterise glucose metabolism in adults heterozygous for the E1506K mutation. Methods Glucose tolerance was assessed by an oral glucose tolerance test, insulin secretion by the intravenous glucose tolerance test and hyperglycaemic clamp, and insulin sensitivity by hyperinsulinaemic euglycaemic clamp in 11 people heterozygous for the E1506K mutation and 19 controls. Findings Four people who were heterozygous for the SUR1 E1506K mutation had diabetes, five had impaired glucose tolerance, one had impaired fasting glucose, and one had normal glucose tolerance. Although glucose-induced, first-phase insulin secretion was normal in children younger than 10 years of age who were heterozygous for the SUR1 E1506K mutation (n=2; 66 and 334 pmol/L), it fell rapidly after puberty (n=3; 12-32 pmol/L), and was almost completely lost in adulthood (n=11; 12-32 pmol/L). Furthermore, these heterozygous people had a substantial reduction in maximum glucose-stimulated insulin secretion during hyperglycemic clamp (carriers without diabetes 422 pmol/L; carriers with diabetes 97 pmol/L). By contrast, insulin sensitivity (M/I value) was normal in carriers of the E1506K mutation who did not have diabetes and was reduced by 15% in those who were heterozygous with diabetes (0.07 in those without diabetes and 0.05 in those with the disorder; not significantly different from controls). Interpretation Heterozygous E1506K substitution in the SUR1 gene causes congenital hyperinsulinism in infancy, loss of insulin secretory capacity in early adulthood, and diabetes in middle-age. This variant represents a new subtype of autosomal dominant diabetes.	Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; Univ Kuopio, Dept Paediat, FIN-70211 Kuopio, Finland; Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; Addenbrookes Hosp, Dept Clin Biochem, Cambridge, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Eastern Finland; University of Eastern Finland; University of Helsinki; University of Helsinki; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford	Laakso, M (corresponding author), Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland.	Markku.Laakso@kuh.fi	Otonkoski, Timo/F-1189-2011	Reimann, Frank/0000-0001-9399-6377				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DORIA A, 2000, CURR OPIN ENDOCRINOL, V7, P203; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; Glaser B, 1999, DIABETES, V48, P1652, DOI 10.2337/diabetes.48.8.1652; Goksel DL, 1998, HUM GENET, V103, P280, DOI 10.1007/s004390050817; Hansen T, 1998, DIABETES, V47, P598, DOI 10.2337/diabetes.47.4.598; Huopio H, 2000, J CLIN INVEST, V106, P897, DOI 10.1172/JCI9804; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Ishiyama-Shigemoto S, 1998, DIABETIC MED, V15, P826, DOI 10.1002/(SICI)1096-9136(199810)15:10<826::AID-DIA685>3.0.CO;2-H; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281; LEIBOWITZ G, 1995, J CLIN ENDOCR METAB, V80, P386, DOI 10.1210/jc.80.2.386; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; Miki T, 2001, DIABETES, V50, pS48, DOI 10.2337/diabetes.50.2007.S48; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; RANKE M, 1996, TESTS BETA CELL FUNC, P448; Saltiel AR, 2000, J CLIN INVEST, V106, P163, DOI 10.1172/JCI10533; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2000, DIABETES, V49, P311, DOI 10.2337/diabetes.49.3.311; 't Hart LM, 1999, DIABETOLOGIA, V42, P617, DOI 10.1007/s001250051203; Vauhkonen I, 1998, J CLIN INVEST, V101, P86, DOI 10.1172/JCI716; Weisnagel SJ, 2001, DIABETES, V50, P697, DOI 10.2337/diabetes.50.3.697; *WHO, 1985, DIAB MELL, P10	28	120	129	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					301	307		10.1016/S0140-6736(03)12325-2	http://dx.doi.org/10.1016/S0140-6736(03)12325-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559865				2022-12-01	WOS:000180643900012
J	Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY				Zeineh, MM; Engel, SA; Thompson, PM; Bookheimer, SY			Dynamics of the hippocampus during encoding and retrieval of face-name pairs	SCIENCE			English	Article							EVENT-RELATED FMRI; SPATIAL MEMORY DEFICITS; RECOGNITION MEMORY; FUNCTIONAL MRI; PARAHIPPOCAMPAL CORTEX; PREFRONTAL CORTEX; BRAIN ACTIVITY; HUMANS; ACTIVATIONS; LESIONS	The medial temporal lobe (MTL) is critical in forming new memories, but how subregions within the MTL carry out encoding and retrieval processes in humans is unknown. Using new high-resolution functional magnetic resonance imaging (fMRI) acquisition and analysis methods, we identified mnemonic properties of different subregions within the hippocampal circuitry as human subjects learned to associate names with faces. The cornu ammonis (CA) fields 2 and 3 and the dentate gyrus were active relative to baseline only during encoding, and this activity decreased as associations were learned. Activity in the subiculum showed the same temporal decline, but primarily during retrieval. Our results demonstrate that subdivisions within the hippocampus make distinct contributions to new memory formation.	Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Med Scientist Training Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Lab Neuroimaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bookheimer, SY (corresponding author), Univ Calif Los Angeles, Sch Med, Ahmanson Lovelace Brain Mapping Ctr, 660 Charles Young Dr S, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867; Bookheimer, Susan/0000-0002-3417-5891; Zeineh, Michael/0000-0002-6940-9096	NATIONAL INSTITUTE ON AGING [R01AG013308] Funding Source: NIH RePORTER; NIA NIH HHS [AG 13308] Funding Source: Medline; NIMH NIH HHS [MH12167] Funding Source: Medline; OHS HRSA HHS [MSTP GM08042] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OHS HRSA HHS		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Crane J, 2002, NEUROPSYCHOLOGIA, V40, P530, DOI 10.1016/S0028-3932(01)00131-2; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; THOMPSON PM, 1998, BRAIN WARPING, P311; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Zeineh MM, 2000, NEUROIMAGE, V11, P668, DOI 10.1006/nimg.2000.0561; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061	28	383	393	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					577	580		10.1126/science.1077775	http://dx.doi.org/10.1126/science.1077775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543980				2022-12-01	WOS:000180559800054
J	Chakravarti, A; Little, P				Chakravarti, A; Little, P			Nature, nurture and human disease	NATURE			English	Article								What has been learnt about individual human biology and common diseases 50 years on from the discovery of the structure of DNA? Unfortunately the double helix has not, so far, revealed as much as one would have hoped. The primary reason is an inability to determine how nurture fits into the DNA paradigm. We argue here that the environment exerts its influence at the DNA level and so will need to be understood before the underlying causal factors of common human diseases can be fully recognized.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	Johns Hopkins University; University of New South Wales Sydney	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Jefferson St Bldg 2-109, Baltimore, MD 21287 USA.							Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Jaroff Leon, 1989, Time, V133, P62; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; MacGregor AJ, 2000, TRENDS GENET, V16, P131, DOI 10.1016/S0168-9525(99)01946-0; Munger K, 2002, CANCER INVEST, V20, P71, DOI 10.1081/CNV-120000369; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Stucker I, 2002, CARCINOGENESIS, V23, P1475, DOI 10.1093/carcin/23.9.1475; Sullivan PF, 2001, AM J MED GENET, V105, P266, DOI 10.1002/ajmg.1324; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wertz DC, 2002, NAT REV GENET, V3, P496, DOI 10.1038/nrg854; Wright A. F., 2002, Pharmacogenomics Journal, V2, P75, DOI 10.1038/sj.tpj.6500085	17	100	106	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					412	414		10.1038/nature01401	http://dx.doi.org/10.1038/nature01401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540911	Bronze			2022-12-01	WOS:000180533000052
J	Gatenby, RA; Maini, PK				Gatenby, RA; Maini, PK			Mathematical oncology: Cancer summed up	NATURE			English	Editorial Material							MODEL		Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA; Univ Arizona, Dept Appl Math, Tucson, AZ 85724 USA; Math Inst, Ctr Math Biol, Oxford OX1 3LB, England	University of Arizona; University of Arizona; University of Oxford	Gatenby, RA (corresponding author), Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.							ADAM JA, 1996, SURVEY MODELS TUMOUR; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gatenby RA, 1996, CANCER RES, V56, P5745; Keener J.P., 1998, MATH PHYSL, V8	4	151	156	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					321	321		10.1038/421321a	http://dx.doi.org/10.1038/421321a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540881	Bronze			2022-12-01	WOS:000180533000023
J	Moore, T; Armstrong, KM				Moore, T; Armstrong, KM			Selective gating of visual signals by microstimulation of frontal cortex	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; SPATIAL ATTENTION; CORTICAL AREAS; MACAQUE; FIELDS; V4; REPRESENTATIONS; STIMULATION; TOPOGRAPHY; PRIMATES	Several decades of psychophysical and neurophysiological studies have established that visual signals are enhanced at the locus of attention(1-5). What remains a mystery is the mechanism that initiates biases in the strength of visual representations(6). Recent evidence argues that, during spatial attention, these biases reflect nascent saccadic eye movement commands(7,8). We examined the functional interaction of saccade preparation and visual coding by electrically stimulating sites within the frontal eye fields (FEF) and measuring its effect on the activity of neurons in extrastriate visual cortex. Here we show that visual responses in area V4 could be enhanced after brief stimulation of retinotopically corresponding sites within the FEF using currents below that needed to evoke saccades. The magnitude of the enhancement depended on the effectiveness of receptive field stimuli as well as on the presence of competing stimuli outside the receptive field. Stimulation of non-corresponding FEF representations could suppress V4 responses. The results suggest that the gain of visual signals is modified according to the strength of spatially corresponding eye movement commands.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Moore, T (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.							Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GODOY J, 1990, NEUROLOGY, V40, P296, DOI 10.1212/WNL.40.2.296; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nakamura K, 1999, J NEUROPHYSIOL, V81, P2374, DOI 10.1152/jn.1999.81.5.2374; Penfield W., 1950, CEREBRAL CORTEX MAN; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; VANHOOFF JAR, 1972, NONVERBAL COMMUNICAT, pCH7; Yarbus A. L., 1967, EYE MOVEMENTS VISION; Zipser K, 1996, J NEUROSCI, V16, P7376	26	822	828	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					370	373		10.1038/nature01341	http://dx.doi.org/10.1038/nature01341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540901				2022-12-01	WOS:000180533000042
J	Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP				Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP			Effect of fetal sex on labour and delivery: retrospective review	BRITISH MEDICAL JOURNAL			English	Article							GENDER		Natl Matern Hosp, Dublin 2, Ireland	National Maternity Hospital, Dublin	Eogan, MA (corresponding author), Natl Matern Hosp, Holles St, Dublin 2, Ireland.							Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; Makhseed M, 1998, INT J GYNECOL OBSTET, V63, P55, DOI 10.1016/S0020-7292(98)00078-2; ODRISCOLL K, 1993, ACTIVE MANAGEMENT LA; SPINILLO A, 1994, AM J OBSTET GYNECOL, V171, P1273, DOI 10.1016/0002-9378(94)90146-5	5	40	42	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					137	137		10.1136/bmj.326.7381.137	http://dx.doi.org/10.1136/bmj.326.7381.137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531846	Green Published, Bronze			2022-12-01	WOS:000180575900025
J	Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R				Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R			SAP is required for generating long-term humoral immunity	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-CELLS; VIRAL-INFECTION; ENCODING GENE; PLASMA-CELLS; BONE-MARROW; B-CELLS; MUTATIONS; MEMORY	Long-lived plasma cells and memory B cells are the primary cellular components of long-term humoral immunity and as such are vitally important for the protection afforded by most vaccines. The SAP gene has been identified as the genetic locus responsible for X-linked lymphoproliferative disease, a fatal immunodeficiency(1-4). Mutations in SAP have also been identified in some cases of severe common variable immunodeficiency disease(5,6). The underlying cellular basis of this genetic disorder remains unclear. We have used a SAP knockout mouse model system to explore the role of SAP in immune responses. Here we report that mice lacking expression of SAP generate strong acute IgG antibody responses after viral infection, but show a near complete absence of virus-specific long-lived plasma cells and memory B cells, despite the presence of virus-specific memory CD4(+) T cells. Adoptive transfer experiments show that SAP-deficient B cells are normal and the defect is in CD4(+) T cells. Thus, SAP has a crucial role in CD4(+) T-cell function: it is essential for late B-cell help and the development of long-term humoral immunity but is not required for early B-cell help and class switching.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123, ZIAHG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Morra M, 2001, BLOOD, V98, P1321, DOI 10.1182/blood.V98.5.1321; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nistala K, 2001, CLIN EXP IMMUNOL, V126, P126, DOI 10.1046/j.1365-2249.2001.01599.x; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Sumegi J, 2000, BLOOD, V96, P3118; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	30	335	348	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					282	287		10.1038/nature01318	http://dx.doi.org/10.1038/nature01318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529646				2022-12-01	WOS:000180397600051
J	Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD				Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD			Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway	SCIENCE			English	Article							ACIDIC NUCLEAR-PROTEIN; CYTOCHROME-C; ACTIVATION; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; BINDING; FAMILY; GENE; RICH	A small molecule, alpha-(trichloromethyl)-4-pyridineethanol (PETCM), was identified by high-throughput screening as an activator of caspase-3 in extracts of a panel of cancer cells. PETCM was used in combination with biochemical fractionation to identify a pathway that regulates mitochondria-initiated caspase activation. This pathway consists of tumor suppressor putative HLA-DR associated proteins (PHAP) and oncoprotein prothymosin-alpha (ProT). PHAP proteins promoted caspase-9 activation after apoptosome formation, whereas ProT negatively regulated caspase-9 activation by inhibiting apoptosome formation. PETCM relieved ProT inhibition and allowed apoptosome formation at a physiological concentration of deoxyadenosine triphosphate. Elimination of ProT expression by RNA interference sensitized cells to ultraviolet irradiation induced apoptosis and negated the requirement of PETCM for caspase activation. Thus, this chemical-biological combinatory approach has revealed the regulatory roles of oncoprotein ProT and tumor suppressor PHAP in apoptosis.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Abbott Labs, Abbott Pk, IL 60064 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Abbott Laboratories	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu	Kim, Hyun-Eui/GOV-5988-2022	Kim, Hyun-Eui/0000-0003-1495-1993; Wang, Xiaodong/0000-0001-9885-356X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; DOSIL M, 1993, EXP CELL RES, V204, P94, DOI 10.1006/excr.1993.1013; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Magdalena C, 2000, BRIT J CANCER, V82, P584, DOI 10.1054/bjoc.1999.0968; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Mutai H, 2000, BIOCHEM BIOPH RES CO, V274, P427, DOI 10.1006/bbrc.2000.3133; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; SBURLATI AR, 1991, P NATL ACAD SCI USA, V88, P253, DOI 10.1073/pnas.88.1.253; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SMITH MR, 1993, BLOOD, V82, P1127; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang XD, 2001, GENE DEV, V15, P2922; Wu CG, 1997, BRIT J CANCER, V76, P1199, DOI 10.1038/bjc.1997.533; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhu LJ, 1997, BIOCHEM MOL BIOL INT, V42, P927; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	329	350	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					223	226		10.1126/science.1076807	http://dx.doi.org/10.1126/science.1076807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522243				2022-12-01	WOS:000180284000030
J	Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K				Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K			Nephron number in patients with primary hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; BLOOD-PRESSURE; ADULT HYPERTENSION; SIZE; KIDNEY; TRANSPLANTATION; GLOMERULI	BACKGROUND: A diminished number of nephrons has been proposed as one of the factors contributing to the development of primary hypertension. METHODS: To test this hypothesis, we used a three-dimensional stereologic method to compare the number and volume of glomeruli in 10 middle-aged white patients (age range, 35 to 59 years) with a history of primary hypertension or left ventricular hypertrophy (or both) and renal arteriolar lesions with the number and volume in 10 normotensive subjects matched for sex, age, height, and weight. All 20 subjects had died in accidents. RESULTS: Patients with hypertension had significantly fewer glomeruli per kidney than matched normotensive controls (median, 702,379 vs. 1,429,200). Patients with hypertension also had a significantly greater glomerular volume than did the controls (median, 6.50x10(sup -3) mm(sup 3) vs. 2.79x10(sup -3) mm(sup 3); P<0.001) but very few obsolescent glomeruli. CONCLUSIONS: The data support the hypothesis that the number of nephrons is reduced in white patients with primary hypertension.	Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Forens Med, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Internal Med, D-6900 Heidelberg, Germany; City Hosp Darmstadt, Dept Pathol, Darmstadt, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Klinikum Darmstadt	Amann, K (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany.	kerstin.amann@patho.imed.uni-erlangen.de						BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bertram J. F., 2001, Journal of the American Society of Nephrology, V12, p724A; BIANCHI G, 1974, CLIN SCI MOL MED, V47, P435, DOI 10.1042/cs0470435; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; DAHL LK, 1974, CIRC RES, V34, P94, DOI 10.1161/01.RES.34.1.94; Fassi A, 1998, J AM SOC NEPHROL, V9, P1399; GENNSER G, 1988, BMJ-BRIT MED J, V296, P1498, DOI 10.1136/bmj.296.6635.1498; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Gurnani Anuradha, 2000, Journal of the American Society of Nephrology, V11, p390A; HAKIM RM, 1984, KIDNEY INT, V25, P930, DOI 10.1038/ki.1984.112; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; Merlet-Benichou C, 1999, LAB INVEST, V79, P515; MERLETBENICHOU C, 1993, M S-MED SCI, V9, P777, DOI 10.4267/10608/2991; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Pesce CM, 1994, J NEPHROL, P355; RETTIG R, 1990, AM J PHYSIOL, V258, pF606, DOI 10.1152/ajprenal.1990.258.3.F606; SCHMIDT K, 1992, J AM SOC NEPHROL, V3, P229; SKOV K, 1994, J HYPERTENS, V12, P1373; Spencer J, 2001, AM J KIDNEY DIS, V37, P915, DOI 10.1016/S0272-6386(05)80006-X; STRANDGAARD S, 1986, BRIT MED J, V292, P1041, DOI 10.1136/bmj.292.6527.1041; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Yiu V, 1999, AM J KIDNEY DIS, V33, P253, DOI 10.1016/S0272-6386(99)70297-0	26	760	787	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					101	108		10.1056/NEJMoa020549	http://dx.doi.org/10.1056/NEJMoa020549			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519920				2022-12-01	WOS:000180263900002
J	Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T				Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T			Mobilization of a transposon in the rice genome	NATURE			English	Article							INVERTED-REPEAT ELEMENTS; ORYZA-SATIVA L.; RETROTRANSPOSONS; IDENTIFICATION; PROTEIN; GENES	Rice (Oryza sativa L.) is an important crop worldwide and, with the availability of the draft sequence(1,2), a useful model for analysing the genome structure of grasses(3),(4). To practice efficient rice breeding through genetic engineering techniques, it is important to identify the economically important genes in this crop. The use of mobile transposons as gene tags in intact plants is a powerful tool for functional analysis because transposon insertions often inactivate genes(5). Here we identify an active rice transposon named miniature Ping (mPing) through analysis of the mutability of a slender mutation of the glume(6)-the seed structure that encloses and determines the shape of the grain. The mPing transposon is inserted in the slender glume (slg) mutant allele but not in the wild-type allele. Search of the O. sativa variety Nipponbare genome identified 34 sequences with high nucleotide similarity to mPing, indicating that mPing constitutes a family of transposon elements. Excision of mPing from slg plants results in reversion to a wild-type phenotype. The mobility of the transposon mPing in intact rice plants represents a useful alternative tool for the functional analysis of rice genes.	Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan; Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496433, Japan	Kyoto University; Kindai University (Kinki University)	Tanisaka, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan.		Teraishi, Masayoshi/AAC-1055-2021; Teraishi, Masayoshi/D-8602-2018	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052				BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Cartinhour SW, 1997, PLANT MOL BIOL, V35, P241, DOI 10.1023/A:1005797203035; Delseny M, 2001, PLANT PHYSIOL BIOCH, V39, P323, DOI 10.1016/S0981-9428(01)01245-1; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Hirochika H, 1999, MOLECULAR BIOLOGY OF RICE, P43; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jurka J, 2001, P NATL ACAD SCI USA, V98, P12315, DOI 10.1073/pnas.231490598; Kumar A, 2001, TRENDS PLANT SCI, V6, P127, DOI 10.1016/S1360-1385(00)01860-4; KUNZE R, 1997, ADV BOT RES, V27, P321; Maes T, 1999, TRENDS PLANT SCI, V4, P90, DOI 10.1016/S1360-1385(99)01375-8; Nakazaki T, 1998, BREEDING SCI, V48, P371; STEPHEN A, 2002, SCIENCE, V296, P92; Teraishi M, 1999, MOL GEN GENET, V261, P487, DOI 10.1007/s004380050992; Teraishi M, 2001, GENOME, V44, P1, DOI 10.1139/gen-44-1-1; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	21	182	210	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					170	172		10.1038/nature01219	http://dx.doi.org/10.1038/nature01219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520304				2022-12-01	WOS:000180267200042
J	Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J				Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J			Chloroplast to nucleus communication triggered by accumulation of Mg-protoporphyrinIX	NATURE			English	Article							TETRAPYRROLE BIOSYNTHESIS; CHLOROPHYLL PRECURSORS; SIGNAL-TRANSDUCTION; LIGHT INDUCTION; EXPRESSION; SEEDLINGS; BINDING; GENES; INVOLVEMENT; MUTANTS	Plant cells coordinately regulate the expression of nuclear and plastid genes that encode components of the photosynthetic apparatus. Nuclear genes that regulate chloroplast development and chloroplast gene expression provide part of this coordinate control. There is evidence that information also flows in the opposite direction, from chloroplasts to the nucleus(1),(2). Until now, at least three different signalling pathways have been identified that originate in the plastid and control nuclear gene expression(3,4) but the molecular nature of these signals has remained unknown. Here we show that the tetrapyrrole intermediate Mg-protoporphyrin (Mg-ProtoIX) acts as a signalling molecule in one of the signalling pathways between the chloroplast and nucleus. Accumulation of Mg-ProtoIX is both necessary and sufficient to regulate the expression of many nuclear genes encoding chloroplastic proteins associated with photosynthesis.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; RIKEN, Plant Funct Lab, Wako, Saitama 3510198, Japan	Salk Institute; Howard Hughes Medical Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	Chory@salk.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Strand, Åsa/C-5093-2012	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; 				ANDERSON SL, 1994, PLANT J, V6, P457, DOI 10.1046/j.1365-313X.1994.6040457.x; BURGESS DG, 1987, PLANTA, V170, P520, DOI 10.1007/BF00402986; CRAWFORD MS, 1983, PLANT PHYSIOL, V71, P303, DOI 10.1104/pp.71.2.303; DAMM B, 1991, PLANT TISSUE CULTURE; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Ghassemian M, 2001, TRENDS PLANT SCI, V6, P448, DOI 10.1016/S1360-1385(01)02092-1; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Jarvis P, 2001, CURR BIOL, V11, pR307, DOI 10.1016/S0960-9822(01)00171-3; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; KITTSTEINER U, 1991, PHYSIOL PLANTARUM, V81, P190, DOI 10.1111/j.1399-3054.1991.tb02128.x; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; Kropat J, 2000, PLANT J, V24, P523, DOI 10.1046/j.1365-313x.2000.00898.x; La Rocca N, 2001, PLANTA, V213, P101, DOI 10.1007/s004250000477; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; MAYFIELD SP, 1984, EUR J BIOCHEM, V144, P79, DOI 10.1111/j.1432-1033.1984.tb08433.x; MAYFIELD SP, 1986, PLANTA, V169, P23, DOI 10.1007/BF01369771; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; SATO R, 1991, PLANT PHYSIOL, V96, P432, DOI 10.1104/pp.96.2.432; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; TERZAGI WB, 1995, ANNU REV PLANT PHYS, V40, P211	26	429	462	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					79	83		10.1038/nature01204	http://dx.doi.org/10.1038/nature01204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511958				2022-12-01	WOS:000180165500041
J	Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ				Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ			SAR11 clade dominates ocean surface bacterioplankton communities	NATURE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; LABELED OLIGONUCLEOTIDE PROBES; PLANKTONIC BACTERIA; SARGASSO SEA; IDENTIFICATION; ACCESSIBILITY; SENSITIVITY; DIVERSITY; INCREASE	The most abundant class of bacterial ribosomal RNA genes detected in seawater DNA by gene cloning belongs to SAR11-an alpha-proteobacterial clade(1). Other than indications of their prevalence in seawater, little is known about these organisms. Here we report quantitative measurements of the cellular abundance of the SAR11 clade in northwestern Sargasso Sea waters to 3,000 m and in Oregon coastal surface waters. On average, the SAR11 clade accounts for a third of the cells present in surface waters and nearly a fifth of the cells present in the mesopelagic zone. In some regions, members of the SAR11 clade represent as much as 50% of the total surface microbial community and 25% of the subeuphotic microbial community. By extrapolation, we estimate that globally there are 2.4 x 10(28) SAR11 cells in the oceans, half of which are located in the euphotic zone. Although the biogeochemical role of the SAR11 clade remains uncertain, these data support the conclusion that this microbial group is among the most successful organisms on Earth.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Oregon State University; University of California System; University of California Santa Barbara	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.		Morris, Robert/C-5188-2012; Connon, Stephanie A/K-1959-2012	VERGIN, KEVIN/0000-0002-8972-2813				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; BUCK KR, 1996, AQUAT MICROB ECOL, V10, P238; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Frischer ME, 1996, CAN J MICROBIOL, V42, P1061, DOI 10.1139/m96-136; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Fuhrman Jed. A., 1998, Aquatic Ecology, V32, P3, DOI 10.1023/A:1009974817127; Giovannoni S., 2000, P47; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; LEE SH, 1993, MAR ECOL PROG SER, V101, P193, DOI 10.3354/meps101193; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Schonhuber W, 1997, APPL ENVIRON MICROB, V63, P3268; SIERACKI ME, 1985, APPL ENVIRON MICROB, V49, P799, DOI 10.1128/AEM.49.4.799-810.1985; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintzingerode Friedrich V., 1997, FEMS Microbiology Reviews, V21, P213	27	787	808	3	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					806	810		10.1038/nature01240	http://dx.doi.org/10.1038/nature01240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490947				2022-12-01	WOS:000179897300054
J	Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE				Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE			Calibration of sulfate levels in the Archean Ocean	SCIENCE			English	Article							SULFUR CYCLE; ISOTOPE; ATMOSPHERE; REDUCTION; WATER; MODEL	The size of the marine sulfate reservoir has grown through Earth's history, reflecting the accumulation of oxygen into the atmosphere. Sulfur isotope fractionation experiments on marine and freshwater sulfate reducers, together with the isotope record, imply that oceanic Archean sulfate concentrations were <200 mu M, which is less than one-hundredth of present marine sulfate levels and one-fifth of what was previously thought. Such low sulfate concentrations were maintained by volcanic outgassing of SO2 gas, and severely suppressed sulfate reduction rates allowed for a carbon cycle dominated by methanogenesis.	Univ So Denmark, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Southern Denmark; University of Southern Denmark; University of Virginia	Canfield, DE (corresponding author), Univ So Denmark, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Thamdrup, Bo/F-3889-2016; Canfield, Don/C-1735-2012	Thamdrup, Bo/0000-0002-1221-7077; Canfield, Don/0000-0001-7602-8366				Berner E.K, 2012, GLOBAL ENV WATER AIR; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Cypionka H., 1995, BIOTECH HAN, V8, P151; de Hoog JCM, 2001, EARTH PLANET SC LETT, V189, P237, DOI 10.1016/S0012-821X(01)00355-7; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGVORSEN K, 1984, ARCH MICROBIOL, V139, P61, DOI 10.1007/BF00692713; INGVORSEN K, 1984, APPL ENVIRON MICROB, V27, P1029; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; Kakegawa T, 1999, PRECAMBRIAN RES, V96, P209, DOI 10.1016/S0301-9268(99)00006-6; Kakegawa T, 2000, GEOCHEM J, V34, P121, DOI 10.2343/geochemj.34.121; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; MARTENS CS, 1980, GEOCHIM COSMOCHIM AC, V44, P471, DOI 10.1016/0016-7037(80)90045-9; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Roychoudhury AN, 1998, APPL GEOCHEM, V13, P269, DOI 10.1016/S0883-2927(97)00064-4; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; STOIBER RE, 1987, J VOLCANOL GEOTH RES, V33, P1, DOI 10.1016/0377-0273(87)90051-5; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	26	566	592	6	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2372	2374		10.1126/science.1078265	http://dx.doi.org/10.1126/science.1078265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493910				2022-12-01	WOS:000179915900051
J	Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN				Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN			Control of facial muscle development by MyoR and capsulin	SCIENCE			English	Article							HELIX TRANSCRIPTION FACTOR; CRANIAL PARAXIAL MESODERM; SKELETAL-MUSCLE; GENE; MYF-5; MESENCHYME; EXPRESSION; UPSTREAM; KIDNEY; CELLS	Members of the MyoD family of basic helix-loop-helix (bHLH) transcription factors control the formation of all skeletal muscles in vertebrates, but little is known of the molecules or mechanisms that confer unique identities to different types of skeletal muscles. MyoR and capsulin are related bHLH transcription factors expressed in specific facial muscle precursors. We show that specific facial muscles are missing in mice lacking both MyoR and capsulin, reflecting the absence of MyoD family gene expression and ablation of the corresponding myogenic lineages. These findings identify MyoR and capsulin as unique transcription factors for the development of specific head muscles.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Rochester, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rochester	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eolson@hamon.swmed.edu	Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040				Brohmann H, 2000, DEVELOPMENT, V127, P437; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Hacker A, 1998, DEVELOPMENT, V125, P3461; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hidai H, 1998, MECH DEVELOP, V73, P33, DOI 10.1016/S0925-4773(98)00031-8; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Lu J., UNPUB; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; OTT MO, 1991, DEVELOPMENT, V111, P1097; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rawls A, 1997, CELL, V89, P5, DOI 10.1016/S0092-8674(00)80175-0; Rawls A, 1998, DEVELOPMENT, V125, P2349; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397	24	153	162	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2378	2381		10.1126/science.1078273	http://dx.doi.org/10.1126/science.1078273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493912				2022-12-01	WOS:000179915900053
J	Smaglik, P				Smaglik, P			Turning oil into science - Norway	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A13	+		10.1038/420a13a	http://dx.doi.org/10.1038/420a13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501121	Bronze			2022-12-01	WOS:000179817500003
J	Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L				Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L			Functional neuroimaging of speech perception in infants	SCIENCE			English	Article							CORTICAL REPRESENTATION; BRAIN; LANGUAGE; ACTIVATION; DISCRIMINATION; ACQUISITION; RETRIEVAL; MEMORY; CORTEX; HUMANS	Human infants begin to acquire their native language in the first months of life. To determine which brain regions support language processing at this young age, we measured with functional magnetic resonance imaging the brain activity evoked by normal and reversed speech in awake and sleeping 3-month-old infants. Left-lateralized brain regions similar to those of adults, including the superior temporal and angular gyri, were already active in infants. Additional activation in right prefrontal cortex was seen only in awake infants processing normal speech. Thus, precursors of adult cortical language areas are already active in infants, well before the onset of speech production.	CNRS, Lab Sci Cognit & Psycholinguist, F-75270 Paris 06, France; Ecole Hautes Etud Sci Sociales, F-75270 Paris, France; CEA, Unite Neuroanat Fonct, Serv Hosp Frederic Joliot, F-91401 Orsay, France; Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Radiol Pediat, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Dehaene-Lambertz, G (corresponding author), CNRS, Lab Sci Cognit & Psycholinguist, 54 Blvd Raspail, F-75270 Paris 06, France.		Dehaene, Ghislaine/O-3633-2017	Dehaene, Ghislaine/0000-0003-2221-9081; Hertz-Pannier, Lucie/0000-0003-4952-7009				Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; Bates E., 1996, RETHINKING INNATENES; BERTONCINI J, 1989, BRAIN LANG, V37, P591, DOI 10.1016/0093-934X(89)90113-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Born AP, 2000, NEUROPEDIATRICS, V31, P24, DOI 10.1055/s-2000-15402; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dehaene-Lambertz G, 1998, LANG SPEECH, V41, P21, DOI 10.1177/002383099804100102; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jusczyk P.W., 1997, DISCOVERY SPOKEN LAN; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Moore RJ, 2001, HUM BRAIN MAPP, V12, P94, DOI 10.1002/1097-0193(200102)12:2<94::AID-HBM1006>3.0.CO;2-E; Morita T, 2000, NEUROSCI RES, V38, P63, DOI 10.1016/S0168-0102(00)00146-2; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; PINKER S, 1994, LANGUAGE INSTINCT MI; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Vaissiere J., 1983, PROSODY MODELS MEASU, P53, DOI DOI 10.1007/978-3-642-69103-4_5; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007	27	664	680	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2013	2015		10.1126/science.1077066	http://dx.doi.org/10.1126/science.1077066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471265				2022-12-01	WOS:000179629200052
J	Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA				Pepys, MB; Bybee, A; Booth, DR; Bishop, MT; Will, RG; Little, AM; Prokupek, B; Madrigal, JA			MHC typing in variant Creutzfeldt-Jakob disease	LANCET			English	Article								Identification of factors that cause susceptibility to, and clinical expression of, variant Creutzfeldt-Jakob disease (vCJD) is essential for future management of the disease. We established MHC genotypes of 76 individuals with vCJD and 131 controls, and analysed MHC phenotypes in relation to age of onset of vCJD and its duration from presentation to death. There were no significant differences between vCJD and control populations in frequencies of any MHC types, nor were there associations between MHC type and age of onset or duration of vCJD disease. Our results do not support the idea of an association between MHC types and either susceptibility to, or expression of, vCJD.	UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland; UCL Royal Free Hosp, Anthony Nolan Res Inst & Histocompatibil Labs, London NW3 2QG, England	University of London; University College London; UCL Medical School; University of Edinburgh; University of London; University College London	Pepys, MB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	m.pepys@rfc.ucl.ac.uk		Madrigal, Alejandro/0000-0001-8359-9917				Arguello JR, 1998, BONE MARROW TRANSPL, V22, P527, DOI 10.1038/sj.bmt.1701383; Arguello JR, 1998, NAT GENET, V18, P192, DOI 10.1038/ng0298-192; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x	5	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2003	361	9356					487	489		10.1016/S0140-6736(03)12455-5	http://dx.doi.org/10.1016/S0140-6736(03)12455-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644CP	12583949				2022-12-01	WOS:000180900600014
J	Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL				Mackey, D; Belkhadir, Y; Alonso, JM; Ecker, JR; Dangl, JL			Arabidopsis RIN4 is a target of the type III virulence effector AvrRpt2 and modulates RPS2-mediated resistance	CELL			English	Article							NUCLEOTIDE-BINDING SITE; SYRINGAE PV. TOMATO; DISEASE-RESISTANCE; GENE-PRODUCT; SECRETION SYSTEM; AVIRULENCE GENE; PLANT-PATHOGENS; BACTERIAL; PROTEIN; THALIANA	Type III pili deliver effector proteins (virulence factors) from bacterial pathogens to host cells. Plants express disease resistance (R) proteins that respond specifically to a particular type III effector by activating immune responses. We demonstrated previously that two unrelated type III effectors from Pseudomonas syringae target and modify the Arabidopsis RIN4 protein. Here, we show that AvrRpt2, a third, unrelated type III effector, also targets RIN4 and induces its post-transcriptional disappearance. This effect is independent of the presence of RPS2, the Arabidopsis R protein that senses AvrRpt2. RIN4 overexpression inhibits multiple phenotypes associated with AvrRpt2 function. Conversely, disruption of RIN4 results in RPS2-dependent lethality. RPS2 and RIN4 physically associate in the plant. We suggest that RIN4 is the target of the AvrRpt2 virulence function, and that perturbation of RIN4 activates RPS2. Thus, RIN4 is a point of convergence for the activity of at least three unrelated P. syringae type III effectors.	Univ N Carolina, Curriculum Genet, Dept Biol, Chapel Hill, NC 27599 USA; Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; Univ N Carolina, Curriculum Genet, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Dangl, JL (corresponding author), Univ N Carolina, Curriculum Genet, Dept Biol, Coker Hall CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Belkhadir, Youssef/GXM-6743-2022	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; Belkhadir, Youssef/0000-0001-7149-7139				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Chang JH, 2000, MOL PLANT MICROBE IN, V13, P568, DOI 10.1094/MPMI.2000.13.5.568; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collins N, 1999, PLANT CELL, V11, P1365, DOI 10.1105/tpc.11.7.1365; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lawrence G, 1995, TRENDS MICROBIOL, V3, P475, DOI 10.1016/S0966-842X(00)89014-9; LAWRENCE GJ, 1981, PHYTOPATHOLOGY, V71, P12, DOI 10.1094/Phyto-71-12; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2001, CURR OPIN PLANT BIOL, V4, P288, DOI 10.1016/S1369-5266(00)00175-8; Oldroyd GED, 1998, P NATL ACAD SCI USA, V95, P10300, DOI 10.1073/pnas.95.17.10300; ORLANDI EW, 1992, PHYSIOL MOL PLANT P, V40, P173, DOI 10.1016/0885-5765(92)90058-4; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	45	705	736	2	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					379	389		10.1016/S0092-8674(03)00040-0	http://dx.doi.org/10.1016/S0092-8674(03)00040-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581527	Green Published, Bronze			2022-12-01	WOS:000181252200009
J	Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM				Wetzel, MS; Kaptchuk, TJ; Haramati, A; Eisenberg, DM			Complementary and alternative medical therapies: Implications for medical education	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; JOHNS WORT; SCHOOLS; TRENDS; CARE	Increased use of complementary and alternative medicine (CAM) has made it imperative that these topics be included in medical education from the preclinical years through residency and beyond. There has been progress in this direction in recent years, with a steady increase in the number of medical schools that include CAM therapies in their curricula. There remains, however, a lack of clear goals and concrete suggestions for implementing these changes. This article examines the questions that arise when medical educators consider how to incorporate CAM therapies as an integral part of the medical curriculum. It offers practical suggestions for finding time in an already packed curriculum, getting started, including faculty and students in the process, and sustaining the initiative with the necessary administrative and institutional support.	Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Georgetown Univ, Sch Med, Washington, DC 20057 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Georgetown University	Wetzel, MS (corresponding author), Harvard Univ, Sch Med, 10 Shattuck St,Suite 612, Boston, MA 02115 USA.		Haramati, Aviad/ABB-1587-2020		NIAMS NIH HHS [U24 AR 43441] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM ASS MED COLL, 1998, LEARN OBJ MED STUD E, V6, P8; *AM MED ASS COUNC, 1997, ENC MED STUD ED COMP; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Barzansky B, 2000, JAMA-J AM MED ASSOC, V284, P1114, DOI 10.1001/jama.284.9.1114; Berman BM, 2001, BRIT MED J, V322, P121, DOI 10.1136/bmj.322.7279.121; Carlston M, 1997, Fam Med, V29, P559; Caspi O, 2000, ARCH INTERN MED, V160, P3193, DOI 10.1001/archinte.160.21.3193; Coulter I, 1998, ALTERN THER HEALTH M, V4, P64; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Fontanarosa PB, 1998, JAMA-J AM MED ASSOC, V280, P1618, DOI 10.1001/jama.280.18.1618; Frenkel M, 2001, ACAD MED, V76, P251, DOI 10.1097/00001888-200103000-00012; *HARV MED SCH CTR, 2000, WOM HLTH 10 CURR THE, V2, P1; *HARV MED SCH OFF, 2000, NEW HMS DIV PROB COM; JENSEN CB, 1997, ALTERN COMPLEMENT TH, V3, P276; Kligler B, 2000, FAM MED, V32, P30; Laken M P, 1995, J Altern Complement Med, V1, P93, DOI 10.1089/acm.1995.1.93; Marshall E, 2000, SCIENCE, V288, P1571, DOI 10.1126/science.288.5471.1571; MUEHSAM PA, 2000, GEA CORRESPONDENT, V13, P8; MUEHSAM PA, 1999, GEA CORRESPONDENT, V12, P13; *NAT CTR COMPL ALT, 1999, REQ PROP CAM ED GRAN; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; OH VMS, 1994, BRIT MED J, V309, P69, DOI 10.1136/bmj.309.6947.69; Pelletier KR, 1999, AM J HEALTH PROMOT, V14, P125, DOI 10.4278/0890-1171-14.2.125; Piscitelli SC, 2000, LANCET, V355, P547, DOI 10.1016/S0140-6736(99)05712-8; Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7; SLOAN DA, 1995, ANN SURG, V222, P735, DOI 10.1097/00000658-199512000-00007; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784	30	106	109	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					191	196		10.7326/0003-4819-138-3-200302040-00011	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558358				2022-12-01	WOS:000181018600005
J	Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA				Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA			PDGFRA activating mutations in gastrointestinal stromal tumors	SCIENCE			English	Article							C-KIT; CELLS; GENE; IDENTIFICATION; FLT3	Most gastrointestinal stromal tumors (GISTS) have activating mutations in the KIT receptor tyrosine kinase, and most patients with GISTS respond well to Gleevec, which inhibits KIT kinase activity. Here we show that similar to35% (14 of 40) of GISTS lacking KIT mutations have intragenic activation mutations in the related receptor tyrosine kinase, plate let-derived growth factor receptor alpha (PDGFRA). Tumors expressing KIT or PDGFRA oncoproteins were indistinguishable with respect to activation of downstream signaling intermediates and cytogenetic changes associated with tumor progression. Thus, KIT and PDGFRA mutations appear to be alternative and mutually exclusive oncogenic mechanisms in GISTs.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Pathol, Portland, OR 97201 USA; Portland VA Med Ctr, Portland, OR 97201 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Heinrich, MC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	heinrich@ohsu.edu; jfletcher@partners.org	ravegnini, gloria/K-1330-2016; Heinrich, Michael/AAC-6745-2019	ravegnini, gloria/0000-0002-7774-402X; Heinrich, Michael/0000-0003-3790-0478; Duensing, Anette/0000-0002-0168-4067; Singer, Samuel/0000-0001-9713-8230				Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Lokker NA, 2002, CANCER RES, V62, P3729; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Rubin BP, 2001, CANCER RES, V61, P8118; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Sun L, 2000, J MED CHEM, V43, P2655, DOI 10.1021/jm9906116; Taniguchi M, 1999, CANCER RES, V59, P4297; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	17	1751	1944	6	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					708	710		10.1126/science.1079666	http://dx.doi.org/10.1126/science.1079666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522257				2022-12-01	WOS:000180687700047
J	Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R				Wang, JW; Wong, AM; Flores, J; Vosshall, LB; Axel, R			Two-photon calcium imaging reveals an odor-evoked map of activity in the fly brain	CELL			English	Article							RAT OLFACTORY-BULB; ANTENNAL LOBE; DROSOPHILA-MELANOGASTER; PYRAMIDAL NEURONS; DENDRITIC SPINES; REPRESENTATIONS; RECEPTORS; ORGANIZATION; INFORMATION; EXPRESSION	An understanding of the logic of odor perception requires a functional analysis of odor-evoked patterns of activity in neural assemblies in the brain. We have developed a sensitive imaging system in the Drosophila brain that couples two-photon microscopy with the specific expression of the calcium-sensitive fluorescent protein, G-CaMP. At natural odor concentration, each odor elicits a distinct and sparse spatial pattern of activity in the antennal lobe that is conserved in different flies. Patterns of glomerular activity are similar upon imaging of sensory and projection neurons, suggesting the faithful transmission of sensory input to higher brain centers. Finally, we demonstrate that the response pattern of a given glomerulus is a function of the specificity of a single odorant receptor. The development of this imaging system affords an opportunity to monitor activity in defined neurons throughout the fly brain with high sensitivity and excellent spatial resolution.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA	Columbia University; Rockefeller University	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Axel, Richard/0000-0002-3141-4076; Vosshall, Leslie/0000-0002-6060-8099	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 50733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DETHIER VG, 1952, J GEN PHYSIOL, V35, P823, DOI 10.1085/jgp.35.6.823; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1994, J NEUROSCI, V14, P2993; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Meister M, 2001, J NEUROSCI, V21, P1351; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SINGLETON K, 1994, DEV BIOL, V161, P154, DOI 10.1006/dbio.1994.1017; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang JW, 2001, J NEUROPHYSIOL, V85, P977, DOI 10.1152/jn.2001.85.2.977; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	56	598	612	4	86	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					271	282		10.1016/S0092-8674(03)00004-7	http://dx.doi.org/10.1016/S0092-8674(03)00004-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553914	Bronze			2022-12-01	WOS:000181191600015
J	Sanchez, I; Mahlke, C; Yuan, JY				Sanchez, I; Mahlke, C; Yuan, JY			Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders	NATURE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; PROTEIN AGGREGATION; TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; HEAT-SHOCK; CAG REPEAT; CONGO RED; TOXICITY; INHIBITION	The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease(1). It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice(2-7). The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to beta-sheets containing amyloid fibrils(8,9) and can specifically inhibit oligomerization(10) and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sanchez, I (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 715 Albany St, Boston, MA 02118 USA.		Sanchez, Ivelisse/E-3856-2010; Sánchez, Ivelisse/H-8765-2013	Sanchez, Ivelisse/0000-0002-7605-5337; Sánchez, Ivelisse/0000-0002-7605-5337				BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Carter RJ, 1999, J NEUROSCI, V19, P3248; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chai YH, 1999, J NEUROSCI, V19, P10338; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; FARRER LA, 1985, CLIN GENET, V27, P62; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Howlett DR, 1999, BIOCHEM J, V343, P419, DOI 10.1042/0264-6021:3430419; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; KLUNK WE, 1995, NEUROBIOL AGING, V16, P541, DOI 10.1016/0197-4580(95)00058-M; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moulder KL, 1999, J NEUROSCI, V19, P705; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Sanchez I, 1999, NEURON, V22, P623, DOI 10.1016/S0896-6273(00)80716-3; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898	30	392	404	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					373	379		10.1038/nature01301	http://dx.doi.org/10.1038/nature01301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540902				2022-12-01	WOS:000180533000043
J	Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S				Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S			Acknowledgement of "no fault" medical injury: review of patients' hospital records in New Zealand	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Div Community Hlth, Auckland 1, New Zealand; Univ Auckland, Dept Stat, Auckland 1, New Zealand; Univ Western Australia, Dept Anaesthesia, Perth, WA 6009, Australia	University of Otago; University of Auckland; University of Auckland; University of Western Australia	Davis, P (corresponding author), Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, POB 4345, Christchurch, New Zealand.		Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315				Blendon RJ, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.3.233; Davis P, 2001, 3 MIN HLTH; Gostin L, 2000, JAMA-J AM MED ASSOC, V283, P1742, DOI 10.1001/jama.283.13.1742; Miller R, 1993, MARYLAND LAW REV, V52, P1070; National Audit Office, 2001, HANDL CLIN NEGL CLAI	5	17	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					79	80		10.1136/bmj.326.7380.79	http://dx.doi.org/10.1136/bmj.326.7380.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521970	Green Published, Bronze			2022-12-01	WOS:000180426900014
J	Hemmi, JM; Zeil, J				Hemmi, JM; Zeil, J			Robust judgement of inter-object distance by an arthropod	NATURE			English	Article							UCA LACTEA ANNULIPES; FIDDLER-CRABS; RESOLUTION; OCYPODIDAE; HORIZON; MODELS; WORLD; EYES	Animals use several strategies for depth vision, reflecting the constraints imposed by body size, the structure of the visual system and the visual geometry of the environment(1). Arthropods in particular have restricted depth perception, because they are small and possess closely set, low-resolution compound eyes. Yet, here we show that fiddler crabs defending their burrows from conspecifics can judge how close other crabs are to their burrow. When confronted with small dummy crabs, the burrow owners assess the dummy's position and motion relative to their burrow and not relative to themselves-in other words, by using an allocentric rather than an egocentric frame of reference. Irrespective of their own distance from the dummy, the likelihood that the crabs rush back to defend their burrow increases strongly as the dummy approaches the burrow. In addition, the mean dummy-burrow distance at which the crabs respond is constant and independent of the dummy's direction of approach. We propose that to solve this sophisticated task of relative distance judgement, the crabs combine visual information on dummy position and direction with information on burrow location acquired during path integration(2). In doing so, the crabs, like humans(3), make clever use of the visual geometry of their environment.	Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia	Australian National University	Hemmi, JM (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, POB 475, Canberra, ACT 2601, Australia.		Hemmi, Jan M/B-6458-2008; Zeil, Jochen/C-9223-2009	Hemmi, Jan M/0000-0003-4629-9362; 				Collett T.S., 1982, P111; Crane J., 1975, FIDDLER CRABS WORLD, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; HYATT GW, 1978, BEHAVIOUR, V65, P182, DOI 10.1163/156853978X00602; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; MONTAGUE CL, 1980, CONTRIB MAR SCI, V23, P25; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; SCHALL R, 1991, BIOMETRIKA, V78, P719; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; Zeil J, 2002, CRUSTACEAN EXPERIMENTAL SYSTEMS IN NEUROBIOLOGY, P227; Zeil J, 1998, J COMP PHYSIOL A, V183, P367, DOI 10.1007/s003590050263; ZEIL J, 1986, J COMP PHYSIOL A, V159, P801, DOI 10.1007/BF00603733; Zeil J, 1996, J EXP BIOL, V199, P1569	14	43	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					160	163		10.1038/nature01247	http://dx.doi.org/10.1038/nature01247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520301				2022-12-01	WOS:000180267200039
J	Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ				Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ			Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; DOPPLER-ECHOCARDIOGRAPHY; EJECTION FRACTION; NATRIURETIC PEPTIDE; FILLING PRESSURE; POPULATION; AGE; PREVALENCE; UTILITY	Context Approximately half of patients with overt congestive heart failure (CHF) have diastolic dysfunction without reduced ejection fraction (EF). Yet, the prevalence of diastolic dysfunction and its relation to systolic dysfunction and CHF in the community remain undefined. Objectives To determine the prevalence of CHF and preclinical diastolic dysfunction and systolic dysfunction in the community and determine if diastolic dysfunction is predictive of all-cause mortality. Design, Setting, Participants Cross-sectional survey of 2042 randomly selected residents of Olmsted County, Minnesota, aged 45 years or older from June 1997 through September 2000. Main Outcome Measures Doppler echocardiographic assessment of systolic and diastolic function. Presence of CHF diagnosis by review of medical records with designation as validated CHF if Framingham criteria are satisfied. Subjects without a CHF diagnosis but with diastolic or systolic dysfunction were considered as having either preclinical diastolic or preclinical systolic dysfunction. Results The prevalence of validated, CHF was 2.2% (95% confidence interval [CI], 1.6%-2.8%) with 44% having an EF higher than 50%. Overall, 20.8% (95% CI, 19.0%-22.7%) of the population had mild diastolic dysfunction, 6.6% (95% CI, 5.5%7.8%) had moderate diastolic dysfunction, and 0.7% (95% CI, 0.3%-1.1%) had severe diastolic dysfunction with 5.6% (95% CI, 4.5%-6.7%) of the population having moderate or severe diastolic dysfunction with normal EF. The prevalence of any systolic dysfunction (EF less than or equal to50%) was 6.0% (95% CI, 5.0%-7.1%) with moderate or severe systolic dysfunction (EF less than or equal to40.%) being present in 2.0% (95% CI, 1.4%-2.5%). CHF was much more common among those with systolic or diastolic dysfunction than in those with normal ventricular function. However, even among those with moderate or severe diastolic or systolic dysfunction, less than half had recognized CHF. In multivariate analysis, controlling for age, sex, and EF, mild diastolic dysfunction (hazard ratio, 8.31 [95% CI, 3.00-23.1], P<.001) and moderate or severe diastolic dysfunction (hazard ratio, 10.17 [95% CI, 3.28-31.0], P<.001) were predictive of all-cause mortality. Conclusions In the community, systolic dysfunction is frequently present in individuals without recognized CHF. Furthermore, diastolic dysfunction as rigorously defined by comprehensive Doppler techniques is common, often not accompanied by recognized CHF, and associated with marked increases in all-cause mortality.	Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Clin Epidemiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Guggenheim 9,200 1st St SW, Rochester, MN 55905 USA.		omidvari, elham/Q-6686-2016	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [HL 55502] Funding Source: Medline; NIAMS NIH HHS [AR 30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Gandhi SK, 2000, PHYSIOL REV, V344, P17; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hart CYT, 2001, CIRCULATION, V104, P215, DOI 10.1161/01.CIR.104.2.215; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hurrell DG, 1997, J AM COLL CARDIOL, V30, P459, DOI 10.1016/S0735-1097(97)00184-8; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Lloyd-Jones D M, 2001, Curr Cardiol Rep, V3, P184, DOI 10.1007/s11886-001-0021-1; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; MURRAY JA, 1968, CIRCULATION, V37, P800, DOI 10.1161/01.CIR.37.5.800; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Ommen SR, 2000, CIRCULATION, V102, P1788; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SHUB C, 1994, MAYO CLIN PROC, V69, P205, DOI 10.1016/S0025-6196(12)61058-1; SOBUE T, 1995, J AM COLL CARDIOL, V25, P91, DOI 10.1016/0735-1097(94)00347-S; STARLING MR, 1981, CIRCULATION, V63, P1075, DOI 10.1161/01.CIR.63.5.1075; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; Yamamoto K, 1997, J AM COLL CARDIOL, V30, P1819, DOI 10.1016/S0735-1097(97)00390-2; Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	41	2233	2327	1	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					194	202		10.1001/jama.289.2.194	http://dx.doi.org/10.1001/jama.289.2.194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517230	Bronze			2022-12-01	WOS:000180226400030
J	Lundin, J; Lundin, M; Isola, J; Joensuu, H				Lundin, J; Lundin, M; Isola, J; Joensuu, H			A web-based system for individualised survival estimation in breast cancer	BRITISH MEDICAL JOURNAL			English	Article									Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; Tampere Univ Hosp, FIN-33014 Tampere, Finland; Univ Helsinki, Mol Canc Biol Res Programme, FIN-00290 Helsinki, Finland	University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Lundin, J (corresponding author), Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland.		Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Joensuu, Heikki/0000-0003-0281-2507				Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; *IH, 2000, J NATL CANC I MONOGR, V30, P5; Kattan M, 2002, J CLIN ONCOL, V20, P885, DOI 10.1200/JCO.2002.20.4.885; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28	4	26	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					29	29		10.1136/bmj.326.7379.29	http://dx.doi.org/10.1136/bmj.326.7379.29			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511459	Green Published, Bronze			2022-12-01	WOS:000180302000023
J	Buck, SW; Sandmeier, JJ; Smith, JS				Buck, SW; Sandmeier, JJ; Smith, JS			RNA polymerase I propagates unidirectional spreading of rDNA silent chromatin	CELL			English	Article							TRANSCRIPTION FACTOR UAF; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL DNA; PROTEIN SIR2; YEAST RDNA; LIFE-SPAN; SWITCH; GENE; HETEROCHROMATIN; DEACETYLASE	The ribosomal DNA (rDNA) tandem array in Saccharomyces cerevisiae induces transcriptional silencing of RNA polymerase II-transcribed genes. This SIR2-dependent form of repression (rDNA silencing) also functions to limit rDNA recombination and is involved in life span control. In this report, we demonstrate that rDNA silencing spreads into the centromere-proximal unique sequence located downstream of RNA polymerase I (Pol I) transcription, but fails to enter the upstream telomere-proximal sequences. The spreading of silencing correlates with SIR2-dependent histone H3 and H4 deacetylation and can be extended by SIR2 overexpression. Surprisingly, rDNA silencing required transcription by RNA polymerase I and the direction of spreading was controlled by the direction of Pol I transcription.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Smith, JS (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Box 80073,Jordan Hall, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061692] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Brachmann CB, 1998, YEAST, V14, P115; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Cioci F, 2002, J MOL BIOL, V322, P41, DOI 10.1016/S0022-2836(02)00749-0; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MUSTERS W, 1989, NUCLEIC ACIDS RES, V17, P9661, DOI 10.1093/nar/17.23.9661; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Reeder RH, 1999, MOL CELL BIOL, V19, P7369; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Thon G, 2000, GENETICS, V155, P551; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; Vu L, 1999, P NATL ACAD SCI USA, V96, P4390, DOI 10.1073/pnas.96.8.4390; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	41	70	71	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1003	1014		10.1016/S0092-8674(02)01193-5	http://dx.doi.org/10.1016/S0092-8674(02)01193-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507427	Bronze			2022-12-01	WOS:000180086000010
J	Jansens, A; van Duijn, E; Braakman, I				Jansens, A; van Duijn, E; Braakman, I			Coordinated nonvectorial folding in a newly synthesized multidomain protein	SCIENCE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; DISULFIDE BOND FORMATION; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; NMR STRUCTURE; BIOSYNTHESIS; CONCATEMER; ISOMERASE; PATHWAY; DOMAINS	The low-density lipoprotein receptor (LDL-R) is a typical example of a multidomain protein, for which in vivo folding is assumed to occur vectorially from the amino terminus to the carboxyl terminus. Using a pulse-chase approach in intact cells, we found instead that newly synthesized LDL-R molecules folded by way of "collapsed" intermediates that contained non-native disulfide bonds between distant cysteines. The most amino-terminal domain acquired its native conformation late in folding instead of during synthesis. Thus, productive LDL-R folding in a cell is not vectorial but is mostly posttranslational, and involves transient long-range non-native disulfide bonds that are isomerized into native short-range cysteine pairs.	Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@chem.uu.nl	Jansens, A./L-4409-2015	Braakman, Ineke/0000-0003-1592-4364				BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BIERI S, 1995, FEBS LETT, V371, P341, DOI 10.1016/0014-5793(95)00939-7; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3677, DOI 10.1021/bi00065a022; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679	26	136	138	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2401	2403		10.1126/science.1078376	http://dx.doi.org/10.1126/science.1078376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493918	Green Submitted			2022-12-01	WOS:000179915900061
J	Kaech, SM; Hemby, S; Kersh, E; Ahmed, R				Kaech, SM; Hemby, S; Kersh, E; Ahmed, R			Molecular and functional profiling of memory CD8 T cell differentiation	CELL			English	Article							VIRAL-INFECTION; CYTOKINE PRODUCTION; EFFECTOR FUNCTION; GENE-EXPRESSION; IN-VIVO; ACTIVATION; NAIVE; LYMPHOCYTES; GENERATION; IMMUNITY	How and when memory T cells form during an immune response are long-standing questions. To better understand memory CD8 T cell development, a time course of gene expression and functional changes in antigen-specific T cells during viral infection was evaluated. The expression of many genes continued to change after viral clearance in accordance with changes in CD8 T cell functional properties. Even though memory cell precursors were present at the peak of the immune response, these cells did not display hallmark functional traits of memory T cells. However, these cells gradually acquired the memory cell qualities of self-renewal and rapid recall to antigen suggesting the model that antigen-specific CD8 T cells progressively differentiate into memory cells following viral infection.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Hemby, Scott/0000-0002-6987-1133	NIAID NIH HHS [AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1987, J VIROL, V61, P3920, DOI 10.1128/JVI.61.12.3920-3929.1987; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Chao CC, 1997, J IMMUNOL, V159, P1686; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Deeths MJ, 1999, J IMMUNOL, V163, P102; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; HATHCOCK K, 2003, IN PRESS J IMMUNOL; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JOHNSON ED, 1975, J EXP MED, V141, P866; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.0.CO;2-L; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; VOLKERT M, 1974, J EXP MED, V139, P1329, DOI 10.1084/jem.139.5.1329; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	42	738	752	2	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					837	851		10.1016/S0092-8674(02)01139-X	http://dx.doi.org/10.1016/S0092-8674(02)01139-X			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526810	Bronze			2022-12-01	WOS:000179862600010
J	Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S				Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S			The Molecule Pages database	NATURE			English	Article								The Alliance for Cellular Signaling (AfCS)-Nature Molecule Pages will be a comprehensive database of key facts about more than 3,000 proteins involved in cell signalling. Each entry will be created by invited experts and be peer-reviewed. Alongside the large-scale experiments being conducted by the AfCS scientists, the wealth of information contained in this database offers the potential of accelerating the pace of discovery in signal transduction research.	Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; Nat Publishing Grp, London N1 9XW, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Califano, Andrea/F-7239-2012	Hannay, Timo/0000-0002-5941-3390					0	50	52	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					716	717		10.1038/nature01307	http://dx.doi.org/10.1038/nature01307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478304	Bronze			2022-12-01	WOS:000179751800057
J	Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H				Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H			Unravelling the signal-transduction network in B lymphocytes	NATURE			English	Article							LYMPHOMA-CELLS; WEHI-231; ACTIVATION; CHEMOKINES; EXPRESSION	The Alliance for Cellular Signaling has chosen the mouse B lymphocyte as a model system to understand basic principles that govern cellular signalling. Progress to that end has focused initially on establishing a reproducible experimental cell system and characterizing essential signalling responses. Although unravelling this complex network will take years, findings revealed in the interim will prove immensely useful to the scientific community at large.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; San Francisco Vet Adm Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; Stanford University; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu						BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Hasler P, 2001, FASEB J, V15, P2085, DOI 10.1096/fj.00-0860rev; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; IANNONE MA, 1989, J BIOL CHEM, V264, P20177; JAKWAY JP, 1986, J IMMUNOL, V137, P2225; Klaus G G, 1997, Int Rev Immunol, V15, P5, DOI 10.3109/08830189709068169; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nisimoto Y, 2002, EUR J BIOCHEM, V269, P2622, DOI 10.1046/j.1432-1033.2002.02939.x; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tarakhovsky A, 1997, RES IMMUNOL, V148, P457, DOI 10.1016/S0923-2494(97)82670-3	22	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					708	710		10.1038/nature01305	http://dx.doi.org/10.1038/nature01305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478302				2022-12-01	WOS:000179751800055
J	Movassaghi, M; Jacobsen, EN				Movassaghi, M; Jacobsen, EN			The simplest "enzyme"	SCIENCE			English	Editorial Material									Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Movassaghi, M (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D; Danishefsky SJ, 1996, J AM CHEM SOC, V118, P2843, DOI 10.1021/ja952692a; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; EDER U, 1971, Patent No. 2014857; Hajos Z.G., 1971, [No title captured], Patent No. [2102623, DE 2102623]; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378	11	233	234	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1904	1905		10.1126/science.1076547	http://dx.doi.org/10.1126/science.1076547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471240				2022-12-01	WOS:000179629200027
J	Bhatia, R; Thorne-Lyman, AL				Bhatia, R; Thorne-Lyman, AL			Food shortages and nutrition in North Korea	LANCET			English	Article							FAMINE		World Food Programme, I-00148 Rome, Italy		Bhatia, R (corresponding author), World Food Programme, Via CG Viola 68,Parco Medici, I-00148 Rome, Italy.							Natsios A., 2001, GREAT N KOREAN FAMIN; Noland M, 2001, ECON DEV CULT CHANGE, V49, P741, DOI 10.1086/452523; YOUNG H, 1995, DISASTERS, V19, P94, DOI 10.1111/j.1467-7717.1995.tb00361.x	3	13	13	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S27	S28		10.1016/S0140-6736(02)11809-5	http://dx.doi.org/10.1016/S0140-6736(02)11809-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504492				2022-12-01	WOS:000180064500013
J	Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M				Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M			Measurement of volume of cerebral blood flow in healthy preterm and term neonates with ultrasound	LANCET			English	Article							COLOR DUPLEX MEASUREMENT; REPRODUCIBILITY; ADULTS	Changes in cerebral blood flow are important in the pathogenesis of ischaemic brain damage, but standard methods cannot measure volume of cerebral blood flow quantitatively in neonates. We used colour duplex sonography of the extracranial cerebral arteries to measure volume of global cerebral blood flow in 67 healthy preterm and term neonates. Volume of cerebral blood flow increased between the postmenstrual ages of 34 weeks (median 33 mL/min [range 23-43]) and 42 weeks (85 mL/min [57-104]). However, intersession and interobserver variability was quite large. This non-invasive method will allow quantitative bedside monitoring of global brain perfusion in preterm and term neonates with pathological disorders, and could also be used to monitor effects of neuroprotective measures.	Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Childrens Hosp, Dept Neonatol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Schoning, M (corresponding author), Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany.		Schoening, Martin/H-7559-2012					ALTMAN DI, 1988, ANN NEUROL, V24, P218, DOI 10.1002/ana.410240208; MATTHEW E, 1993, J CEREBR BLOOD F MET, V13, P748, DOI 10.1038/jcbfm.1993.95; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P523, DOI 10.1097/00004647-199605000-00020	5	34	40	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1749	1750		10.1016/S0140-6736(02)11720-X	http://dx.doi.org/10.1016/S0140-6736(02)11720-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480431				2022-12-01	WOS:000179636800015
J	Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM				Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM			Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton	SCIENCE			English	Article							T-CELL LEUKEMIA; HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION MOLECULE-1; SYNCYTIUM FORMATION; TYPE-1 INFECTION; TRANSMISSION; ANTIBODIES; ACTIVATION; EXPRESSION; ADENOVIRUS	Cell contact is required for efficient transmission of human T cell leukemia virus-type 1 (HTLV-1) between cells and between individuals, because naturally infected lymphocytes produce virtually no cell-free infectious HTLV-I particles. However, the mechanism of cell-to-cell spread of HTLV-I is not understood. We show here that cell contact rapidly induces polarization of the cytoskeleton of the infected cell to the cell-cell junction. HTLV-I core (Gag protein) complexes and the HTLV-I genome accumulate at the cell-cell junction and are then transferred to the uninfected cell. Other lymphotropic viruses, such as HIV-1, may similarly subvert normal T cell physiology to allow efficient propagation between cells.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England; Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Ryukyus, Fac Med, Okinawa Asia Res Ctr Med Sci, Dept Immunol & Infect Dis, Okinawa 9030215, Japan	Imperial College London; Imperial College London; Kagoshima University; University of Oxford; University of Ryukyus	Bangham, CRM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Goon, Peter/AAF-2508-2021	Bangham, Charles/0000-0003-2624-3599; Griffiths, Gillian/0000-0003-0434-5842; stinchcombe, jane/0000-0003-1459-9299				Cullen BR, 2001, CELL, V105, P697, DOI 10.1016/S0092-8674(01)00392-0; Daenke S, 1999, J GEN VIROL, V80, P1429, DOI 10.1099/0022-1317-80-6-1429; Delamarre L, 1997, J VIROL, V71, P259, DOI 10.1128/JVI.71.1.259-266.1997; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; GESSAIN A, 1985, LANCET, V2, P407; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hildreth JEK, 1997, J VIROL, V71, P1173, DOI 10.1128/JVI.71.2.1173-1180.1997; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Jassal SR, 2001, VIRUS RES, V78, P17, DOI 10.1016/S0168-1702(01)00279-9; Le Blanc I, 2002, J VIROL, V76, P905, DOI 10.1128/JVI.76.2.905-911.2002; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; MERIC C, 1986, J VIROL, V60, P450; MEULLER NE, 1997, VIRAL INFECT HUMANS, P785; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; NAGY K, 1984, HUMAN T CELL LEUKEMI, P121; OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x; OSAME M, 1986, LANCET, V1, P1031; PEARCEPRATT R, 1994, J VIROL, V68, P2898, DOI 10.1128/JVI.68.5.2898-2905.1994; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; SOMMERFELT MA, 1988, SCIENCE, V242, P1557, DOI 10.1126/science.3201246; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Valentin H, 1997, J VIROL, V71, P8522, DOI 10.1128/JVI.71.11.8522-8530.1997; Yamamoto A, 1997, J NEUROL SCI, V151, P121, DOI 10.1016/S0022-510X(97)00121-4; YAMAMOTO N, 1982, SCIENCE, V217, P737, DOI 10.1126/science.6980467	29	526	539	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1713	1716		10.1126/science.1080115	http://dx.doi.org/10.1126/science.1080115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12589003				2022-12-01	WOS:000181519500039
J	Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC				Hsieh, JC; Lee, L; Zhang, LQ; Wefer, S; Brown, K; DeRossi, C; Wines, ME; Rosenquist, T; Holdener, BC			Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity	CELL			English	Article							RECEPTOR-RELATED PROTEIN; SUBCELLULAR-LOCALIZATION; MESODERM INDUCTION; PRIMITIVE ENDODERM; NODAL EXPRESSION; BODY PLAN; AXIS; GASTRULATION; DISABLED-2; RETENTION	Specification of embryonic polarity and pattern formation in multicellular organisms requires inductive signals from neighboring cells. One approach toward understanding these interactions is to study mutations that disrupt development. Here, we demonstrate that mesd, a gene identified in the mesoderm development (mesd) deletion interval on mouse chromosome 7, is essential for specification of embryonic polarity and mesoderm induction. MESD functions in the endoplasmic reticulum as a specific chaperone for LRP5 and LRP6, which in conjunction with Frizzled, are coreceptors for canonical WNT signal transduction. Disruption of embryonic polarity and mesoderm differentiation in mesd-deficient embryos likely results from a primary defect in WNT signaling. However, phenotypic differences between mesd-deficient and wnt3(-/-) embryos suggest that MESD may function on related members of the low-density lipoprotein receptor (LDLR) family, whose members mediate diverse cellular processes ranging from cargo transport to signaling.	SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Holdener, BC (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA.	bernadette.holdener@stonybrook.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053964] Funding Source: NIH RePORTER; NICHD NIH HHS [HD53964] Funding Source: Medline; NIGMS NIH HHS [R01 GM053964] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANG SL, 1994, DEVELOPMENT, V120, P2979; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; HO SN, 1989, BIOTECHNIQUES, V16, P51; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOGAN B, 1994, MANIPULATING MOUSE E, V1; HOLDENER BC, 1994, DEVELOPMENT, V120, P1335; HOLDENERKENNY B, 1992, BIOESSAYS, V14, P831, DOI 10.1002/bies.950141208; Jorgensen MM, 2000, J BIOL CHEM, V275, P33861, DOI 10.1074/jbc.M004663200; LAWSON KA, 1991, CIBA FOUND S, V165, P891; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Morris SM, 2002, EMBO J, V21, P1555, DOI 10.1093/emboj/21.7.1555; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; SCHEDL A, 1992, GENOMICS, V14, P288, DOI 10.1016/S0888-7543(05)80218-6; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Tam PPL, 2001, BIOESSAYS, V23, P508, DOI 10.1002/bies.1070; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Varlet I, 1997, DEVELOPMENT, V124, P1033; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Wines ME, 2001, GENOMICS, V72, P88, DOI 10.1006/geno.2000.6466; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810	39	198	220	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					355	367		10.1016/S0092-8674(03)00045-X	http://dx.doi.org/10.1016/S0092-8674(03)00045-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581525	Bronze			2022-12-01	WOS:000181252200007
J	Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH				Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH			Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene	NATURE			English	Article							TRANSCRIPTION FACTOR SCL; HEMATOPOIETIC LINEAGES; MICE; PROGENITOR; ERYTHROPOIESIS; MESODERM; PROTEINS; BINDING	The production of blood cells is sustained throughout the lifetime of an individual by haematopoietic stem cells (HSCs)(1). Specification of HSCs from mesoderm during embryonic development requires the stem cell leukaemia SCL/tal-1 gene product(2-6). Forced expression of SCL/tal-1 strongly induces blood formation in embryos, indicating that this gene has a dominant role in commitment to haematopoiesis(7,8). In the adult haematopoietic system, expression of SCL/tal-1 is enriched in HSCs and multipotent progenitors, and in erythroid and megakaryocytic lineages(9-11), consistent with roles for this factor in adult haematopoiesis. Here we assess by conditional gene targeting whether SCL/tal-1 is required continuously for the identity and function of HSCs. We find that SCL/tal-1 is dispensable for HSC engraftment, self-renewal and differentiation into myeloid and lymphoid lineages; however, the proper differentiation of erythroid and megakaryocytic precursors is dependent on SCL/tal-1. Thus, SCL/tal-1 is essential for the genesis of HSCs, but its continued expression is not essential for HSC functions. These findings contrast with lineage choice mechanisms, in which the identity of haematopoietic lineages requires continuous transcription factor expression(12,13).	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA.			Schlaeger, Thorsten/0000-0002-1599-9908; Klintman, Jenny/0000-0002-9544-5058				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Choi K, 1998, DEVELOPMENT, V125, P725; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Faloon P, 2000, DEVELOPMENT, V127, P1931; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mead PE, 2001, DEVELOPMENT, V128, P2301; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Porcher C, 1999, DEVELOPMENT, V126, P4603; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robertson SM, 2000, DEVELOPMENT, V127, P2447; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yamamoto Hiroyuki, 1995, Journal of Marine Biotechnology, V2, P95; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	24	295	299	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					547	551		10.1038/nature01345	http://dx.doi.org/10.1038/nature01345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540851				2022-12-01	WOS:000180670600049
J	Bluher, M; Kahn, BB; Kahn, CR				Bluher, M; Kahn, BB; Kahn, CR			Extended longevity in mice lacking the insulin receptor in adipose tissue	SCIENCE			English	Article							LIFE-SPAN; FOOD RESTRICTION; CALORIC RESTRICTION; GENE; MUTATIONS; EXTENSION; ELEGANS; GROWTH; MUTANT; MUSCLE	Caloric restriction has been shown to increase longevity in organisms ranging from yeast to mammals. In some organisms, this has been associated with a decreased fat mass and alterations in insulin/insulin-like growth factor 1 (IGF-1) pathways. To further explore these associations with enhanced longevity, we studied mice with a fat-specific insulin receptor knockout (FIRKO). These animals have reduced fat mass and are protected against age-related obesity and its subsequent metabolic abnormalities, although their food intake is normal. Both male and female FIRKO mice were found to have an increase in mean life-span of similar to134 days (18%), with parallel increases in median and maximum life-spans. Thus, a reduction of fat mass without caloric restriction can be associated with increased longevity in mice, possibly through effects on insulin signaling.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK043051, R01DK043051, P01DK056116] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 56116, DK 43051, DK 30136, R01 DK043051] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIM H, 1992, DIABETOLOGIA, V35, P261, DOI 10.1007/BF00400927; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee SS, 2002, NATURE, V418, P287, DOI 10.1038/418287a; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Piantanelli L, 2001, MECH AGEING DEV, V122, P463, DOI 10.1016/S0047-6374(00)00256-6; Pletcher SD, 2000, J GERONTOL A-BIOL, V55, pB381, DOI 10.1093/gerona/55.8.B381; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; TAYLOR SI, 1990, DIABETES CARE, V13, P257, DOI 10.2337/diacare.13.3.257; WEINDRUCH W, 1998, RETARDATION AGING DI; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	33	984	1010	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					572	574		10.1126/science.1078223	http://dx.doi.org/10.1126/science.1078223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543978				2022-12-01	WOS:000180559800052
J	Hyman, SE; Fenton, WS				Hyman, SE; Fenton, WS			Medicine: What are the right targets for psychopharmacology?	SCIENCE			English	Editorial Material							SCHIZOPHRENIA; DYSFUNCTION; DEFICITS		NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA; Harvard Univ, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University	Fenton, WS (corresponding author), NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA.	SEH@harvard.edu; wfenton@mail.nih.gov						American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Center for Mental Health Services and National Institute of Mental Health, 1999, MENT HLTH REP SURG G; Cowan WM, 2002, ANNU REV NEUROSCI, V25, P1, DOI 10.1146/annurev.neuro.25.112701.142853; Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y; Friedman JI, 1999, BIOL PSYCHIAT, V45, P1, DOI 10.1016/S0006-3223(98)00287-X; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hyman SE, 2002, PSYCHOPATHOLOGY, V35, P139, DOI 10.1159/000065134; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; Merikangas K, 2002, ACTA PSYCHIAT SCAND, V105, P3, DOI 10.1034/j.1600-0447.2002.01001.x; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; Murray CJL., 1996, GLOBAL BURDEN DIS CO; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838; World Health Organization, 1992, ICD 10 CLASS MENT BE	22	214	223	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					350	351		10.1126/science.1077141	http://dx.doi.org/10.1126/science.1077141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532001				2022-12-01	WOS:000180426800028
J	Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH				Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH			Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes	LANCET			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INTENSIVE-CARE UNIT; BACTERIAL BIOFILMS; INFECTIONS; ADHERENCE; MORTALITY; ADHESION; RP62A; IRON	Background Bacterial colonisation of indwelling medical devices by coagulase-negative staphylococci is a prevalent risk in intensive-care units. Factors determining biofilm formation and progression to catheter related infection are incompletely understood. We postulated that administration of inotropic agents via indwelling intravenous catheters may stimulate growth and formation of biofilms by Staphylococcus epidermidis. Methods Inocula representing physiologically relevant infecting doses of S epidermidis were incubated in a minimum medium supplemented with fresh human plasma in the presence or absence of pharmacological concentrations of norepinephrine or dobutamine. Biofilm formation on polystyrene and medical-grade silicone was examined. After incubation, cultures were assessed for growth and formation of biofilms by colony counting and scanning electronmicroscopy. The production of exopolysaccharide, a major constituent of S epidermidis biofilms, was also assessed by use of immunofluorescence microscopy. Findings Incubation of S epidermidis with catecholamine inotropes in the presence of human plasma resulted in a significant increase in growth compared with control on both polystyrene and silicone surfaces, with pronounced increases in biofilm formation as visualised by scanning electronmicroscopy. Experiments with transferrin labelled with radioactive iron showed the ability of catecholamine inotropes to facilitate acquisition of iron by S epidermidis. Immunofluorescence microscopy revealed extensive exopolysaccharide production associated with S epidermidis biofilms. Interpretation The ability of catecholamine inotropic drugs to stimulate bacterial proliferation and biofilm formation may be an aetiological factor in the development of intravascular catheter colonisation and catheter-related infection. The removal of iron from transferrin for subsequent use by S epidermidis is a possible mechanism by which catecholamine inotropes stimulate bacterial growth as biofilms.	Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, Minneapolis, MN 55404 USA; Minnesota State Univ Mankato, Dept Biol Sci, Mankato, MN USA; Univ Leicester, Dept Microbiol & Immunol, Leicester, Leics, England; Univ Nottingham, Div Orthopaed & Accid Surg, Biomat Related Infect Grp, Nottingham NG7 2RD, England	Hennepin County Medical Center; Minneapolis Medical Research Foundation; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Leicester; University of Nottingham	Lyte, M (corresponding author), Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, 914 S 8th St,D3, Minneapolis, MN 55404 USA.	lytex001@umn.edu	Bayston, Roger/E-7699-2019; Lyte, Mark/C-3865-2008; Lyte, Mark/AAI-7602-2020; Bayston, Roger/AAD-5427-2019	Lyte, Mark/0000-0001-8512-2581; Bayston, Roger/0000-0002-8312-3844; Haigh, Richard/0000-0001-8597-9980	NIMH NIH HHS [MH50431] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050431] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLAWSON CC, 1971, AM J PATHOL, V65, P381; COOPER EV, 1946, LANCET, V250, P459; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442, DOI 10.1128/JCM.28.11.2442-2447.1990; EVANS DG, 1948, BRIT J EXP PATHOL, V29, P20; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Galloway MT, 1998, AM HEART J, V135, P888, DOI 10.1016/S0002-8703(98)70051-1; GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877; INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0; Linton CJ, 1999, J APPL MICROBIOL, V86, P194, DOI 10.1046/j.1365-2672.1999.00650.x; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; LYTE M, 1992, LIFE SCI, V50, P203, DOI 10.1016/0024-3205(92)90273-R; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9; Neal CP, 2001, FEMS MICROBIOL LETT, V194, P163, DOI 10.1016/S0378-1097(00)00523-1; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; RELLO J, 1994, INTENS CARE MED, V20, P94, DOI 10.1007/BF01707661; Renaud M, 1930, CR SOC BIOL, V103, P1052; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; SMYTHE MA, 1993, CRIT CARE MED, V21, P1319, DOI 10.1097/00003246-199309000-00014; Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	30	145	158	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					130	135		10.1016/S0140-6736(03)12231-3	http://dx.doi.org/10.1016/S0140-6736(03)12231-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531580				2022-12-01	WOS:000180428000012
J	Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY				Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY			The plant MITE mPing is mobilized in anther culture	NATURE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; REPETITIVE-DNA ELEMENTS; ARABIDOPSIS-THALIANA; FAMILY; RICE; GENOME; MAIZE; TOURIST; GENE; AMPLIFICATION	Transposable elements constitute a large portion of eukaryotic genomes and contribute to their evolution and diversification. Miniature inverted-repeat transposable elements (MITEs) constitute one of the main groups of transposable elements and are distributed ubiquitously in the genomes of plants and animals 1 such as maize(2-5), rice(3), Arabidopsis(6,7), human(8), insect(9,10) and nematode(11). Because active MITEs have not been identified, the transposition mechanism of MITEs and their accumulation in eukaryotic genomes remain poorly understood. Here we describe a new class of MITE, called miniature Ping (mPing), in the genome of Oryza sativa (rice). mPing elements are activated in cells derived from anther culture, where they are excised efficiently from original sites and reinserted into new loci. An mPing-associated Ping element, which has a putative PIF family(5) transposase, is implicated in the recent proliferation of this MITE family in a subspecies of rice.	Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Tokyo 1920397, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Metropolitan University	Hirano, HY (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.		Hirano, Hiro-Yuki/G-4928-2014	Hirano, Hiro-Yuki/0000-0001-7364-8893				Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; Casacuberta E, 1998, PLANT J, V16, P79, DOI 10.1046/j.1365-313x.1998.00267.x; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2000, GENE, V250, P109, DOI 10.1016/S0378-1119(00)00187-6; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano HY, 1998, MOL BIOL EVOL, V15, P978, DOI 10.1093/oxfordjournals.molbev.a026013; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Morishima H., 1992, OXFORD SURV EVOL BIO, V8, P135; NEGISHI T, 1994, Patent No. 06036698; Raina SK, 1997, PL BRED RE, V15, P141; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Surzycki SA, 1999, J MOL EVOL, V48, P684, DOI 10.1007/PL00006512; Tu ZJ, 2000, MOL BIOL EVOL, V17, P1313, DOI 10.1093/oxfordjournals.molbev.a026415; WESSLER S, 1990, P NATL ACAD SCI USA, V87, P8731, DOI 10.1073/pnas.87.22.8731; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	23	212	240	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					167	170		10.1038/nature01218	http://dx.doi.org/10.1038/nature01218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520303				2022-12-01	WOS:000180267200041
J	Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I				Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I			Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12	NATURE			English	Article							POLYMERASE-II HOLOENZYME; SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; CELL-TYPE; KINASE; ACTIVATION	The budding yeast Saccharomyces cerevisiae differentiates into filamentous invasively growing forms under conditions of nutrient limitation(1,2). This response is dependent on the transcription factor Ste12 and on the mating pheromone-response mitogen-activated protein (MAP) kinase cascade 1, but a mechanism for regulation of Ste12 by nutrient limitation has not been defined. Here we show that Ste12 function in filamentous growth is regulated by the cyclin-dependent kinase Srb10 (also known as Cdk8), which is associated with the RNA polymerase II holoenzyme. Srb10 inhibits filamentous growth in cells growing in rich medium by phosphorylating Ste12 and decreasing its stability. Under conditions of limiting nitrogen, loss of Srb10 protein and kinase activity occurs, with a corresponding loss of Ste12 phosphorylation. Mutation of the Srb10-dependent phosphorylation sites increases pseudohyphal development but has no effect on the pheromone response of haploid yeast. Srb10 kinase activity is also regulated independently of the mating pheromone-response pathway. This indicates that Srb10 controls Ste12 activity for filamentous growth in response to nitrogen limitation and is consistent with the hypothesis that Srb10 regulates gene-specific activators in response to physiological signals to coordinate gene expression with growth potential.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Sadowski, I (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	sadowski@interchange.ubc.ca						BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chang YW, 2001, GENETICS, V157, P17; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; FIELDS S, 1987, MOL CELL BIOL, V7, P3818, DOI 10.1128/MCB.7.10.3818; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Morillon S, 2000, MOL CELL BIOL, V20, P5766, DOI 10.1128/MCB.20.15.5766-5776.2000; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000	15	120	125	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					187	190		10.1038/nature01243	http://dx.doi.org/10.1038/nature01243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520306				2022-12-01	WOS:000180267200046
J	Boles, LC; Lohmann, KJ				Boles, LC; Lohmann, KJ			True navigation and magnetic maps in spiny lobsters	NATURE			English	Article							SEA-TURTLES; COIL SYSTEMS; ORIENTATION; INFORMATION; FIELDS; SENSE	Animals are capable of true navigation if, after displacement to a location where they have never been, they can determine their position relative to a goal without relying on familiar surroundings, cues that emanate from the destination, or information collected during the outward journey(1,2). So far, only a few animals, all vertebrates, have been shown to possess true navigation(3). Those few invertebrates that have been carefully studied return to target areas using path integration, landmark recognition, compass orientation and other mechanisms that cannot compensate for displacements into unfamiliar territory(4,5). Here we report, however, that the spiny lobster Panulirus argus oriented reliably towards a capture site when displaced 12-37 km to unfamiliar locations, even when deprived of all known orientation cues en route. Little is known about how lobsters and other animals determine position during true navigation. To test the hypothesis that lobsters derive positional information from the Earth's magnetic field, lobsters were exposed to fields replicating those that exist at specific locations in their environment. Lobsters tested in a field north of the capture site oriented themselves southwards, whereas those tested in a field south of the capture site oriented themselves northwards. These results imply that true navigation in spiny lobsters, and perhaps in other animals, is based on a magnetic map sense.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boles, LC (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Able KP, 2001, J AVIAN BIOL, V32, P174, DOI 10.1034/j.1600-048X.2001.320211.x; ABLE KP, 1991, AM ZOOL, V31, P157; CREASER EP, 1950, SCIENCE, V112, P169, DOI 10.1126/science.112.2902.169; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; GREGORY DR, 1986, CAN J FISH AQUAT SCI, V43, P2228, DOI 10.1139/f86-273; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Groeneveld JC, 2002, MAR ECOL PROG SER, V232, P225, DOI 10.3354/meps232225; Herrnkind W.F., 1980, P349; Herrnkind W.F., 1975, Science Bull nat Hist Mus Los Ang Cty, VNo. 20, P31; Kirschvink J. L., 1985, MAGNETITE BIOMINERAL, V1st; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Papi F, 2001, ITAL J ZOOL, V68, P171, DOI 10.1080/11250000109356405; Phillips JB, 1996, J THEOR BIOL, V180, P309, DOI 10.1006/jtbi.1996.0105; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Walcott C, 1996, J EXP BIOL, V199, P21; Walcott C., 1991, ORIENTATION BIRDS, P38; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1997, ORIENTATION COMMUNIC, P187; Wehner R, 1996, J EXP BIOL, V199, P129; Wiltschko R., 1995, TIEROSYCHOL; Zar J., 1996, BIOSTAT ANAL	30	250	260	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					60	63		10.1038/nature01226	http://dx.doi.org/10.1038/nature01226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511953				2022-12-01	WOS:000180165500036
J	McDowell, N				McDowell, N			Joint European plan will tackle Africa's killer diseases	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					5	5		10.1038/421005b	http://dx.doi.org/10.1038/421005b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511923	Bronze			2022-12-01	WOS:000180165500008
J	Kazmierczak, J; Altermann, W				Kazmierczak, J; Altermann, W			Neoarchean biomineralization by benthic cyanobacteria	SCIENCE			English	Article							TRANSVAAL SUPERGROUP; MICROFOSSILS		Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	University of Pretoria; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Altermann, W (corresponding author), Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa.	wlady.altermann@iaag.geo.uni-muenchen.de	Altermann, Wladyslaw/AAV-7520-2021; Altermann, Wladyslaw/B-4336-2008	Altermann, Wladyslaw/0000-0002-9499-424X; Altermann, Wladyslaw/0000-0002-9499-424X				Altermann W, 1998, SEDIMENT GEOL, V120, P225, DOI 10.1016/S0037-0738(98)00034-7; ALTERMANN W, 1995, PRECAMBRIAN RES, V75, P65, DOI 10.1016/0301-9268(95)00018-Z; Barker WW, 1998, GEOMICROBIOL J, V15, P223, DOI 10.1080/01490459809378078; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KEMPE S, 1991, NATURE, V349, P605, DOI 10.1038/349605a0; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KLEIN C, 1987, PRECAMBRIAN RES, V36, P81, DOI 10.1016/0301-9268(87)90018-0; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a	10	60	65	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2351	2351		10.1126/science.1075933	http://dx.doi.org/10.1126/science.1075933			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493906				2022-12-01	WOS:000179915900045
J	Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA				Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA			Crystal structures of the Bacillus stearothermophilus CCA-adding enzyme and its complexes with ATP or CTP	CELL			English	Article							TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; MAMMALIAN POLY(A) POLYMERASE; DNA-POLYMERASE; BINDING; PRIMER; REGION; BETA; END	CCA-adding enzymes polymerize CCA onto the 3' terminus of immature tRNAs without using a nucleic acid template. The 3.0 Angstrom resolution crystal structures of the CCA-adding enzyme from Bacillus stearothermophilus and its complexes with ATP or CTP reveal a sea-horse-shaped subunit consisting of four domains: head, neck, body, and tail. The head is structurally homologous to the palm domain of DNA polymerase beta but has additional structural features and functions. The neck, body, and tail represent new protein folding motifs. The neck provides a specific template for the incoming ATP or CTP, whereas the body and tail may bind tRNA. Each subunit has one active site capable of switching its base specificity between ATP and CTP, an important component of the CCA-adding mechanism.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Washington; University of Washington Seattle	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Tomita, Kozo/E-9390-2017; Tomita, Kozo/J-5746-2013; Steitz, Thomas A./C-6559-2009	Tomita, Kozo/0000-0002-7374-3898; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059804, R01GM057510] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM59804, GM57510] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI M, 1990, J BIOL CHEM, V265, P16216; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EVANS JA, 1978, J BIOL CHEM, V253, P7276; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; MILLER JP, 1971, J BIOL CHEM, V246, P1280; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAKON J, 1993, BIOCHEMISTRY-US, V32, P11977, DOI 10.1021/bi00096a006; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; SPRINZL M, 1977, EUR J BIOCHEM, V81, P579, DOI 10.1111/j.1432-1033.1977.tb11985.x; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	38	97	98	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					815	824		10.1016/S0092-8674(02)01115-7	http://dx.doi.org/10.1016/S0092-8674(02)01115-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526808	Bronze			2022-12-01	WOS:000179862600008
J	Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI				Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI			Large clusters of co-expressed genes in the Drosophila genome	NATURE			English	Article							DOSAGE COMPENSATION; HISTONE ACETYLATION; TRANSCRIPTION; LOCUS; POTENTIATION; ACTIVATION	Clustering of co-expressed, non-homologous genes on chromosomes implies their co-regulation. In lower eukaryotes, coexpressed genes are often found in pairs(1,2). Clustering of genes that share aspects of transcriptional regulation has also been reported in higher eukaryotes(3,4). To advance our understanding of the mode of coordinated gene regulation in multicellular organisms, we performed a genome-wide analysis of the chromosomal distribution of co-expressed genes in Drosophila. We identified a total of 1,661 testes-specific genes, one-third of which are clustered on chromosomes. The number of clusters of three or more genes is much higher than expected by chance. We observed a similar trend for genes upregulated in the embryo and in the adult head, although the expression pattern of individual genes cannot be predicted on the basis of chromosomal position alone. Our data suggest that the prevalent mechanism of transcriptional co-regulation in higher eukaryotes operates with extensive chromatin domains that comprise multiple genes.	Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Anim, Moscow 123182, Russia	Tufts University; Russian Academy of Sciences	Nurminsky, DI (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA.	dmitry.nurminsky@tufts.edu	Boutanaev, Alexander/AAO-7132-2021; Kalmykova, Alla/AAG-2381-2021	Shevelyov, Yuri/0000-0002-0568-9236	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061549] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061549-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bhadra U, 1999, GENETICS, V152, P249; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kramer JA, 1998, DEVELOPMENT, V125, P4749; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; MEIKLEJOHN CD, 2002, 43 ANN DROS RES C GE; Meller VH, 2000, TRENDS CELL BIOL, V10, P54, DOI 10.1016/S0962-8924(99)01693-1; PARISI MJ, 2002, 43 ANN DROS RES C GE; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schubeler D, 2000, GENE DEV, V14, P940; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Soury E, 2001, IMMUNOGENETICS, V53, P634, DOI 10.1007/s00251-001-0374-z; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wynn SL, 2000, GENOMICS, V68, P57, DOI 10.1006/geno.2000.6254	22	256	263	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					666	669		10.1038/nature01216	http://dx.doi.org/10.1038/nature01216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478293				2022-12-01	WOS:000179751800045
J	Check, E				Check, E			Safety panel backs principle of gene-therapy trials	NATURE			English	News Item																			0	13	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					595	595		10.1038/420595b	http://dx.doi.org/10.1038/420595b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478252	Bronze			2022-12-01	WOS:000179751800008
J	Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S				Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S			Structural basis of BMP signalling inhibition by the cystine knot protein Noggin	NATURE			English	Article							BONE-MORPHOGENETIC PROTEIN; PROGRAMMED CELL-DEATH; TGF-BETA-S; SEQUENCE ALIGNMENT; SPEMANN ORGANIZER; DIRECT BINDING; LIMB; MUTATIONS; EXPRESSION; RECEPTOR	The interplay between bone morphogenetic proteins (BMPs) and their antagonists governs developmental and cellular processes as diverse as establishment of the embryonic dorsal-ventral axis, induction of neural tissue, formation of joints in the skeletal system and neurogenesis in the adult brain. So far, the three-dimensional structures of BMP antagonists and the structural basis for inactivation have remained unknown. Here we report the crystal structure of the antagonist Noggin bound to BMP-7, which shows that Noggin inhibits BMP signalling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors. The BMP-7-binding affinity of site-specific variants of Noggin is correlated with alterations in bone formation and apoptosis in chick limb development, showing that Noggin functions by sequestering its ligand in an inactive complex. The scaffold of Noggin contains a cystine (the oxidized form of cysteine) knot topology similar to that of BMPs; thus, ligand and antagonist seem to have evolved from a common ancestral gene.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Inst Gulbenkian Ciencias, P-2780901 Oeiras, Portugal; Biozentrum, CH-4056 Basel, Switzerland; Regeneron Pharmaceut Inc, New York, NY 10591 USA	Salk Institute; Salk Institute; Salk Institute; Instituto Gulbenkian de Ciencia; Regeneron	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	choe@salk.edu	Leon, Joaquin Maria Rodriguez/C-6957-2013; Leon, Joaquin Maria Rodriguez/S-9814-2019	Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Affolter, Markus/0000-0002-5171-0016; Economides, Aris/0000-0002-6508-8942				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; ECONOMIDES AN, 2000, Patent No. 6075007; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Hatta T, 2000, BIOPOLYMERS, V55, P399, DOI 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.0.CO;2-N; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Macias D, 1997, DEVELOPMENT, V124, P1109; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	49	410	475	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					636	642		10.1038/nature01245	http://dx.doi.org/10.1038/nature01245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478285				2022-12-01	WOS:000179751800037
J	Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R				Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R			Arsenic in cooked rice in Bangladesh	LANCET			English	Article								In Bangladesh, rice Is boiled with an excessive amount of water, and the water remaining after cooking will be discarded. We did an on-site experiment to assess the effect of this cooking method on the amount of arsenic retained in cooked rice. The concentration of arsenic in cooked rice was higher than that in raw rice and absorbed water combined, suggesting a chelating effect by rice grains, or concentration of arsenic because of water evaporation during cooking, or both. The method of cooking and water used can affect the amount of arsenic in cooked rice, which will have implications for the assessment of the health risks of arsenic.	Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Tokyo 1130033, Japan; Saga Univ, Fac Agr, Dept Environm Sociol, Saga 840, Japan; Natl Inst Publ Hlth, Dept Hlth Promot & Res, Wako, Saitama, Japan; Directorate Gen Hlth Serv, Dhaka, Bangladesh	University of Tokyo; Saga University; National Institute of Public Health - Japan	Watanabe, C (corresponding author), Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.			Sekiyama, Makiko/0000-0002-2104-9140				JAHAN K, 1998, NATURE EXTENT MALNUT, P10; Schoof RA, 1998, HUM ECOL RISK ASSESS, V4, P117, DOI 10.1080/10807039891284235; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; YAMAZAKI K, 1983, COOKERY ITS THEORY	4	143	148	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1839	1840		10.1016/S0140-6736(02)11738-7	http://dx.doi.org/10.1016/S0140-6736(02)11738-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480363				2022-12-01	WOS:000179706100013
J	Donovan, P				Donovan, P			Rape and HIV/AIDS in Rwanda	LANCET			English	Article											Donovan, P (corresponding author), POB 39773, Nairobi, Kenya.								0	41	42	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S17	S18		10.1016/S0140-6736(02)11804-6	http://dx.doi.org/10.1016/S0140-6736(02)11804-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504487				2022-12-01	WOS:000180064500008
J	Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J				Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J			The DNA sequence and analysis of human chromosome 14	NATURE			English	Article							GENE; MAP; IDENTIFICATION; RECOMBINATION; LOCALIZATION; POLYMORPHISM; TRANSCRIPTS; MUTATIONS; FORM	Chromosome 14 is one of five acrocentric chromosomes in the human genome. These chromosomes are characterized by a heterochromatic short arm that contains essentially ribosomal RNA genes, and a euchromatic long arm in which most, if not all, of the protein-coding genes are located. The finished sequence of human chromosome 14 comprises 87,410,661 base pairs, representing 100% of its euchromatic portion, in a single continuous segment covering the entire long arm with no gaps. Two loci of crucial importance for the immune system, as well as more than 60 disease genes, have been localized so far on chromosome 14. We identified 1,050 genes and gene fragments, and 393 pseudogenes. On the basis of comparisons with other vertebrate genomes, we estimate that more than 96% of the chromosome 14 genes have been annotated. From an analysis of the CpG island occurrences, we estimate that 70% of these annotated genes are complete at their 5' end.	Genoscope Ctr Natl Sequencage, F-91000 Evry, France; CNRS, UMR 8030, F-91000 Evry, France; Univ Evry, F-91000 Evry, France; Ctr Natl Genotypage, F-91000 Evry, France; Inst Syst Biol, Seattle, WA 98103 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institute for Systems Biology (ISB); Washington University (WUSTL)	Heilig, R (corresponding author), Genoscope Ctr Natl Sequencage, F-91000 Evry, France.	heilig@genoscope.cns.fr	McPherson, John D/D-2633-2017; Wilson, Richard K./AAF-4139-2019; Jaillon, Olivier/GRY-6287-2022; Belser, Caroline/X-5482-2019; Matsuda, Fumihiko/B-9893-2009	McPherson, John D/0000-0001-8049-9347; Wilson, Richard K./0000-0002-1992-1358; Belser, Caroline/0000-0002-8108-9910; Petit, Jean-Louis/0000-0002-8566-0571; DA SILVA, Corinne/0000-0002-7618-7831; Pelletier, Eric/0000-0003-4228-1712; de Berardinis, Veronique/0000-0002-3273-4135; Vacherie, Benoit/0000-0002-1564-0575; Cruaud, Corinne/0000-0002-4752-7278				Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Araki O, 1999, CYTOGENET CELL GENET, V84, P73, DOI 10.1159/000015218; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chen CQ, 1997, J IMMUNOL, V159, P1310; Chu FF, 1996, GENOMICS, V32, P272, DOI 10.1006/geno.1996.0115; Clay O, 2001, GENE, V276, P25, DOI 10.1016/S0378-1119(01)00668-0; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Erdmann VA, 1999, NUCLEIC ACIDS RES, V27, P192, DOI 10.1093/nar/27.1.192; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hernandez A, 1998, GENOMICS, V53, P119, DOI 10.1006/geno.1998.5505; Kamnasaran D, 2002, J MED GENET, V39, P81, DOI 10.1136/jmg.39.2.81; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wintle RF, 1997, GENOMICS, V40, P409, DOI 10.1006/geno.1996.4572; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhen YY, 2002, J CELL SCI, V115, P3207	39	83	589	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					601	U1		10.1038/nature01348	http://dx.doi.org/10.1038/nature01348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12508121	Bronze			2022-12-01	WOS:000180803200034
J	Quill, TE; Cassel, CK				Quill, TE; Cassel, CK			Professional organizations' position statements on physician-assisted suicide: A case for studied neutrality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VOLUNTARY ACTIVE EUTHANASIA; OF-LIFE CARE; TERMINALLY-ILL; WASHINGTON-STATE; UNITED-STATES; OREGON DEATH; DIGNITY ACT; ATTITUDES; EXPERIENCES; DEPRESSION	Position statements opposing legalization of physician-assisted suicide by organizations such as the American College of Physicians-American Society of Internal Medicine rightly emphasize that palliative care should be the standard of care for the dying, and that the inadequacies that exist in its delivery should be remedied. But such position statements generally understate the limitations of palliative care to alleviate some end-of-life suffering, and they do not provide adequate guidance about how physicians should approach patients with intractable suffering who are prepared to die. In this manuscript, we briefly present. data about severe suffering before death for terminally ill patients, including those enrolled in hospice programs. We also review some of what is known about requests and responses for physician-assisted suicide in Oregon and in the rest of the United States. Preliminary data from Oregon suggest that legally sanctioned access to physician-assisted suicide is used by a very small number of patients and seems to be associated with improved delivery of hospice and palliative care. Physicians of good will, deep religious convictions, and considerable palliative care experience exist on both sides of the debate about legalization of physician-assisted suicide. In an effort to respect this diversity, and to encourage out profession to continue to struggle with the genuine dilemmas faced by some patients toward the end of their lives and by their families, we argue in favor of medical organizations' taking a position of studied neutrality on this contentious issue.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA	University of Rochester; Oregon Health & Science University	Quill, TE (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.							[Anonymous], 1995, J Am Geriatr Soc, V43, P577; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BATTIN MP, 1995, ACAD MED, V70, P583; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BROCK DW, 1992, HASTINGS CENT REP, V22, P10, DOI 10.2307/3562560; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHOCHINOV HM, 1994, AM J PSYCHIAT, V151, P537; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; COHEN LM, 1995, ARCH INTERN MED, V155, P42, DOI 10.1001/archinte.155.1.42; Coyle N, 1990, J Pain Symptom Manage, V5, P83; DONNELLY S, 1995, SEMIN ONCOL, V22, P67; DUBERSEIN PR, 1995, J AM GERIATR SOC, V43, P395, DOI 10.1111/j.1532-5415.1995.tb05814.x; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FOLEY KM, 1995, PAIN FORUM, V4, P163; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Ingham JM, 1996, HEMATOL ONCOL CLIN N, V10, P21, DOI 10.1016/S0889-8588(05)70325-7; JACOBSON JA, 1995, J CLIN ETHIC, V6, P149; KANE RL, 1985, JAMA-J AM MED ASSOC, V253, P2683, DOI 10.1001/jama.253.18.2683; KASTING GA, 1993, PHYSICIAN ASSISTED D, P25; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *NAT AC, 1997, APPR DEATH IMPR CAR; NEU S, 1986, NEW ENGL J MED, V314, P14, DOI 10.1056/NEJM198601023140103; Orentlicher D, 1997, NEW ENGL J MED, V337, P1236, DOI 10.1056/NEJM199710233371713; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Sachs GA, 2000, JAMA-J AM MED ASSOC, V284, P2423, DOI 10.1001/jama.284.19.2423; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Slome LR, 1997, NEW ENGL J MED, V336, P417, DOI 10.1056/NEJM199702063360606; Snyder L, 2001, ANN INTERN MED, V135, P209, DOI 10.7326/0003-4819-135-3-200108070-00015; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; *TASK FORC IMPR CA, 2002, OR DEATH DIG ACT GUI; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015; Ventafridda V, 1990, J Palliat Care, V6, P7; Whitney SN, 2001, J GEN INTERN MED, V16, P290, DOI 10.1046/j.1525-1497.2001.04159.x; 1996, BRIEF AMICUS CURIAE	46	28	28	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2003	138	3					208	211		10.7326/0003-4819-138-3-200302040-00013	http://dx.doi.org/10.7326/0003-4819-138-3-200302040-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646DB	12558360				2022-12-01	WOS:000181018600007
J	Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y				Li, Z; Gindler, J; Wang, H; Berry, RJ; Li, S; Correa, A; Zheng, JC; Erickson, JD; Wang, Y			Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study	LANCET			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL MULTIVITAMIN USE; CONOTRUNCAL HEART-DEFECTS; TWIN PREGNANCIES; RISK; CHINA; PREVENTION; GESTATIONS; SINGLETON	Background Folic acid supplements are recommended for women of childbearing age to prevent neural tube defects in their offspring. Results of some studies, however, suggest an increase in multiple births associated with use of vitamin supplements that contain folic acid during pregnancy. Our aim was to assess this association. Methods We used data from a population-based cohort study from which we assessed the occurrence of multiple births in women (n=242 015) who had participated in a campaign to prevent neural tube defects with folic acid supplements (400 mug per day) in China. Folic acid use was ascertained before pregnancy outcome was known. We studied the relation between multiple births and any use of folic acid pills before or during early pregnancy; additionally, we investigated mechanisms by which folic acid could potentially affect the occurrence of multiple births by examining pill-taking at three time periods: before ovulation, around the time of fertilisation, and after conception. Findings 1496 (0.62%) multiple births occurred in a cohort of 242 015 women who had registered with the study between October, 1993, and September, 1995, and who had a pregnancy not affected by a birth defect; the rate of multiple births in women who did and did not take folic acid before or during early pregnancy was 0.59% and 0.65%, respectively (rate ratio 0.91; 95% CI 0.82-1.00). Interpretation Our findings suggest that consumption of folic acid supplements during pregnancy is not associated with an increased occurrence of multiple births.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Peking Univ, Hlth Sci Ctr, Natl Ctr Maternal & Infant Hlth, Beijing, Peoples R China; Peking Univ, Hlth Sci Ctr, Dept Hlth Care Epidemiol, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.			Berry, Robert/0000-0002-7162-5046				Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2002, EPIDEMIOLOGY, V13, P114, DOI 10.1097/00001648-200201000-00021; Botto LD, 1996, PEDIATRICS, V98, P911; CHEN CJ, 1987, ACTA GENET MED GEMEL, V36, P335, DOI 10.1017/S0001566000006085; Cornel MC, 1997, TERATOLOGY, V55, P134; Czeizel A. E., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P175; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; Gindler J, 2001, LANCET, V358, P796, DOI 10.1016/S0140-6736(01)05969-4; Hasbargen U, 2000, HUM REPROD, V15, P2659, DOI 10.1093/humrep/15.12.2659; Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8; KIRKE PN, 1992, ARCH DIS CHILD, V67, P1442, DOI 10.1136/adc.67.12.1442; LI DK, 1995, EPIDEMIOLOGY, V6, P212, DOI 10.1097/00001648-199505000-00004; Little J., 1988, TWINNING TWINS, P37; LUKE B, 1990, Fetal Diagnosis and Therapy, V5, P61; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Mastroiacovo P., 1994, Acta Geneticae Medicae et Gemellologiae, V43, P57; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Mathews F, 1999, LANCET, V353, P291, DOI 10.1016/S0140-6736(05)74937-0; Myers MF, 2001, AM J EPIDEMIOL, V154, P1051, DOI 10.1093/aje/154.11.1051; NYLANDER PPS, 1979, ACTA GENET MED GEMEL, V28, P261, DOI 10.1017/S0001566000008746; POLLARD R, 1995, HUM BIOL, V67, P921; Schwartz DB, 1999, AM J OBSTET GYNECOL, V181, P912, DOI 10.1016/S0002-9378(99)70324-8; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; TOLAROVA M, 1995, TERATOLOGY, V51, P71, DOI 10.1002/tera.1420510205; VOGEL F, 1997, HUMAN GENETICS PROBL, P230; WALD N, 1991, LANCET, V338, P131; Werler MM, 1997, AM J MED GENET, V71, P93; WHIPLEY PW, 1966, AM J EPIDEMIOL, V85, P147; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; 2001, FOLIC ACID PREVENTIO	32	54	61	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					380	384		10.1016/S0140-6736(03)12390-2	http://dx.doi.org/10.1016/S0140-6736(03)12390-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573374				2022-12-01	WOS:000180787000010
J	Bakkenist, CJ; Kastan, MB				Bakkenist, CJ; Kastan, MB			DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation	NATURE			English	Article							S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA GENE; NIJMEGEN BREAKAGE SYNDROME; FIELD GEL-ELECTROPHORESIS; TOPOISOMERASE-II; MAMMALIAN-CELLS; IN-VIVO; METAPHASE CHROMOSOMES; IONIZING IRRADIATION; CHROMATIN STRUCTURE	The ATM protein kinase, mutations of which are associated with the human disease ataxia-telangiectasia, mediates responses to ionizing radiation in mammalian cells. Here we show that ATM is held inactive in unirradiated cells as a dimer or higher-order multimer, with the kinase domain bound to a region surrounding serine 1981 that is contained within the previously described 'FAT' domain. Cellular irradiation induces rapid intermolecular autophosphorylation of serine 1981 that causes dimer dissociation and initiates cellular ATM kinase activity. Most ATM molecules in the cell are rapidly phosphorylated on this site after doses of radiation as low as 0.5 Gy, and binding of a phosphospecific antibody is detectable after the introduction of only a few DNA double-strand breaks in the cell. Activation of the ATM kinase seems to be an initiating event in cellular responses to irradiation, and our data indicate that ATM activation is not dependent on direct binding to DNA strand breaks, but may result from changes in the structure of chromatin.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.kastan@stjude.org						Alligood KJ, 2000, HYBRIDOMA, V19, P317, DOI 10.1089/027245700429864; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CEDERVALL B, 1995, RADIAT RES, V143, P8, DOI 10.2307/3578920; Chehab NH, 2000, GENE DEV, V14, P278; DEALMODOVAR JMR, 1994, INT J RADIAT BIOL, V65, P641, DOI 10.1080/09553009414550751; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JABERABOANSARI A, 1988, RADIAT RES, V114, P94, DOI 10.2307/3577147; JENSEN PB, 1994, CANCER RES, V54, P2959; JEPPESEN P, 1992, CHROMOSOMA, V101, P322, DOI 10.1007/BF00346011; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; KRAJEWSKI WA, 1995, FEBS LETT, V361, P149, DOI 10.1016/0014-5793(95)00144-X; Krajewski WA, 1999, J BIOMOL STRUCT DYN, V16, P1097, DOI 10.1080/07391102.1999.10508318; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Malyapa RS, 1996, INT J RADIAT ONCOL, V35, P963, DOI 10.1016/0360-3016(96)00211-8; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; MEISENHELDER J, 1999, CURRENT PROTOCOLS S, V48; Richardson C, 1999, METH MOL B, V113, P453; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROTI JLR, 1987, CYTOMETRY, V8, P461, DOI 10.1002/cyto.990080505; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Snyder RD, 2000, ENVIRON MOL MUTAGEN, V35, P13, DOI 10.1002/(SICI)1098-2280(2000)35:1<13::AID-EM3>3.0.CO;2-1; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; WARD WS, 1989, CHROMOSOMA, V98, P153, DOI 10.1007/BF00329678; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	51	2546	2652	3	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					499	506		10.1038/nature01368	http://dx.doi.org/10.1038/nature01368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556884				2022-12-01	WOS:000180670600036
J	Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR				Natesh, R; Schwager, SLU; Sturrock, ED; Acharya, KR			Crystal structure of the human angiotensin-converting enzyme-lisinopril complex	NATURE			English	Article							ACTIVE-SITE; COMPETITIVE INHIBITORS; MOLECULAR-CLONING; IDENTIFICATION; HYDROLYSIS; ACTIVATION; DEPENDENCE; SUBSTRATE; RESIDUES; BINDING	Angiotensin-converting enzyme (ACE) has a critical role in cardiovascular function by cleaving the carboxy terminal His-Leu dipeptide from angiotensin I to produce a potent vasopressor octapeptide, angiotensin II. Inhibitors of ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy. Notably, these inhibitors were developed without knowledge of the structure of human ACE, but were instead designed on the basis of an assumed mechanistic homology with carboxypeptidase A(1). Here we present the X-ray structure of human testicular ACE and its complex with one of the most widely used inhibitors, lisinopril (N-2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline; also known as Prinivil or Zestril), at 2.0 Angstrom resolution. Analysis of the three-dimensional structure of ACE shows that it bears little similarity to that of carboxypeptidase A, but instead resembles neurolysin(2) and Pyrococcus furiosus carboxypeptidase(3)-zinc metallopeptidases with no detectable sequence similarity to ACE. The structure provides an opportunity to design domain-selective ACE inhibitors that may exhibit new pharmacological profiles.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Cape Town, Sch Med, Div Med Biochem, ZA-7925 Observatory, South Africa; Univ Cape Town, Sch Med, MRC, UCT Liver Res Ctr, ZA-7925 Observatory, South Africa	University of Bath; University of Cape Town; University of Cape Town	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	sturrock@curie.uct.ac.za; bsskra@bath.ac.uk	NATESH, Ramanathan/C-4488-2008	NATESH, Ramanathan/0000-0002-1145-5962; Acharya, K. Ravi/0000-0002-3009-4058				ABRAHAMS JP, 1996, ACTA CRYSTALLOGR D, V52, P110; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arndt JW, 2002, STRUCTURE, V10, P215, DOI 10.1016/S0969-2126(02)00698-6; BERNSTEIN KE, 1990, BIOCHEM BIOPH RES CO, V167, P310, DOI 10.1016/0006-291X(90)91766-L; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUNNING P, 1978, BIOCHEM BIOPH RES CO, V83, P1442, DOI 10.1016/0006-291X(78)91382-7; BUNNING P, 1983, BIOCHEMISTRY-US, V22, P110, DOI 10.1021/bi00270a016; Chubb AJ, 2002, BIOCHEM BIOPH RES CO, V297, P1225, DOI 10.1016/S0006-291X(02)02324-0; CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066; CUSHMAN DW, 1977, BIOCHEMISTRY-US, V16, P5484, DOI 10.1021/bi00644a014; DELAFORTELLE E, 1997, METHOD ENZYMOL, V276, P272; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P7118, DOI 10.1021/bi00243a012; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; Esther CR, 1997, J CLIN INVEST, V99, P2375, DOI 10.1172/JCI119419; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Junot C, 2001, J PHARMACOL EXP THER, V297, P606; Liu XF, 2001, J BIOL CHEM, V276, P33518, DOI 10.1074/jbc.M101495200; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patchett A A, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P1; PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0; SHAPIRO R, 1983, BIOCHEMISTRY-US, V22, P3850, DOI 10.1021/bi00285a021; SKIDGEL RA, 1984, PEPTIDES, V5, P769, DOI 10.1016/0196-9781(84)90020-2; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; WEI L, 1992, J BIOL CHEM, V267, P13398; WILLIAMS TA, 1994, J BIOL CHEM, V269, P29430; Yu XC, 1997, J BIOL CHEM, V272, P3511, DOI 10.1074/jbc.272.6.3511	30	609	651	9	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					551	554		10.1038/nature01370	http://dx.doi.org/10.1038/nature01370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540854	Green Published			2022-12-01	WOS:000180670600050
J	Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC				Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC			External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ILLNESS CARE; MANAGEMENT PROGRAMS; SELF-MANAGEMENT; DEPRESSION; INTERVENTIONS; ASTHMA; MODEL; PERFORMANCE; OUTCOMES; IMPACT	Context Organized care management processes (CMPs) can Improve healthcare quality for patients with chronic diseases. The Institute of Medicine of the National Academy of Sciences has called for public and private purchasers of health care to create incentives for physician organizations (POs) to use CMPs and for the government to assist POs in implementing information technology (IT) to facilitate CMP use. Research is lacking about the extent to which POs use CMPs or about the degree to which incentives, IT, or other factors are associated with their use. Objectives To determine the extent to which POs with 20 or more physicians use CMPs and to identify key factors associated with CMP use for 4 chronic diseases (asthma, congestive heart failure, depression, and diabetes). Design, Setting, and Participants One thousand five hundred eighty-seven US POs (medical groups and independent practice associations) with 20 or more physicians were identified using 5 large databases. one thousand one hundred four of these POs (70%) agreed to participate in a telephone survey conducted between September 2000 and September 2001. Sixty-four responding POs were excluded because they did not treat any of the 4 diseases, leaving 1040 POs. Main Outcome Measures Extent of use of CMPs as calculated on the basis of a summary measure, a PO care management index (POCMI; range, 0-6) and factors associated with CMP use. Results Physician organizations' mean use of CMPs was 5.1 of a possible 16; 50% used 4 or fewer. External incentives and clinical IT were most strongly associated with CMP use, Controlling for other factors, use of the 2 most strongly associated incentives-public recognition and better contracts for health care quality-was associated with use of 1.3 and 0.7 additional CMPs, respectively (P<.001 and P=.007). Each additional IT capability was associated with 0.37 additional CMPs (P<.001). However, 33% of POs reported no external incentives and 50% reported no clinical IT capability. Conclusions The use of CMPs varies greatly among POs, but it is low on average. Government and private purchasers of health care may increase CMP use by providing external incentives for improvement of health care quality to POs and by assisting them in improving their clinical IT capability.	Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Healthcare Consulting, Berkeley, CA USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Casalino, L (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	casalino@health.bsd.uchicago.edu	Casalino, Lawrence/ABE-1245-2020; Greiver, Michelle/N-8764-2015; Tao, Youyou/D-2367-2014; Young, Alexander/A-1523-2009	Casalino, Lawrence/0000-0002-7927-7859; Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213				*AG HEALTHC RES QU, PARTN QUAL; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Becher EC, 2001, HEALTH AFFAIR, V20, P68, DOI 10.1377/hlthaff.20.3.68; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bonomi AE, 2002, HEALTH SERV RES, V37, P791, DOI 10.1111/1475-6773.00049; BURNES B, 1995, LOGISTICS FOCUS, V3, P10; Burns LR, 2000, AD HEA CA M, V1, P273; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Christianson JB, 2002, HEALTH AFFAIR, V21, P76, DOI 10.1377/hlthaff.21.1.76; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Dudley RA, 2000, MED CARE RES REV, V57, P116, DOI 10.1177/107755800773743754; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Enthoven AC, 2002, J HEALTH POLIT POLIC, V27, P37, DOI 10.1215/03616878-27-1-37; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; GRIFFIN S, 2000, COCHRANE REV; Griffin SJ, 2001, BRIT MED J, V323, P946, DOI 10.1136/bmj.323.7319.946; Grimshaw JM., 2001, MED CARE S2, V39, P2, DOI [10.1097/00005650-200108002-00002, DOI 10.1097/00005650-200108002-00002]; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Hersh WR, 2002, JAMA-J AM MED ASSOC, V288, P1955, DOI 10.1001/jama.288.16.1955; Holloway F, 2001, INT J SOC PSYCHIATR, V47, P21, DOI 10.1177/002076400104700303; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Institute of Medicine, 2001, CROSSING QUALITY CHA; IOM (Institute of Medicine), 2002, LEAD EX COORD GOV RO; Jessup M, 2001, NEW ENGL J MED, V345, P1490, DOI 10.1056/NEJMed010109; Jowers JR, 2000, AM J MANAG CARE, V6, P585; Kerr EA, 1996, JAMA-J AM MED ASSOC, V276, P1236, DOI 10.1001/jama.276.15.1236; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kohn L, 2000, ERR IS HUMAN BUILDIN; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Leatherman ST, 2002, QUALITY HLTH CARE US; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Maxwell J, 2002, J HEALTH POLIT POLIC, V27, P5, DOI 10.1215/03616878-27-1-5; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2001, HEALTH AFFAIR, V20, P82, DOI 10.1377/hlthaff.20.3.82; Miller RH, 2002, J HEALTH POLIT POLIC, V27, P401, DOI 10.1215/03616878-27-3-401; *NAT COMM QUAL ASS, HLTH PLAN EMPL DAT I; *NAT HEART LUNG BL, 1996, CONGESTIVE HEART FAI; Newhouse JP, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.4.13; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; OBRIEN MAT, 2002, COCHRANE REV; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Philbin EF, 1999, J GEN INTERN MED, V14, P130, DOI 10.1046/j.1525-1497.1999.00291.x; *R WOOD JOHNS FDN, REW RES AL INC HIGH; Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rich MW, 2001, AM J MED, V110, P410, DOI 10.1016/S0002-9343(01)00632-5; ROBINSON JC, 1999, CALIF MILBANK S, P1; Rossiter LF, 2000, INQUIRY-J HEALTH CAR, V37, P188; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Schoenbaum M, 2001, JAMA-J AM MED ASSOC, V286, P1325, DOI 10.1001/jama.286.11.1325; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shortell SM, 2001, MED CARE, V39, pI62; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P171; Songer TJ, 1998, STUDIES COST DIABETE; Thomson O'Brien MA, 2000, COCHRANE DB SYST REV, V2; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; WAGNER EH, 2001, IT COMM J QUAL IMPRO, V27, P63; WEINGARTEN S, 2002, BMJ-BRIT MED J, V325; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wholey DR, 1997, HEALTH AFFAIR, V16, P75, DOI 10.1377/hlthaff.16.6.75	74	357	358	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					434	441		10.1001/jama.289.4.434	http://dx.doi.org/10.1001/jama.289.4.434			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533122	Bronze, Green Published			2022-12-01	WOS:000180472300024
J	Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA				Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA			Insulin staining of ES cell progeny from insulin uptake	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; PANCREATIC-ISLETS; IN-VITRO		Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Kume, Shoen/M-4356-2016; Young, Richard A/F-6495-2012	Kume, Shoen/0000-0002-4292-205X; Young, Richard A/0000-0001-8855-8647; Anderson, William/0000-0001-7823-8340				Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; BENVENISTY N, COMMUNICATION; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Ramiya VK, 2000, NAT MED, V6, P278; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	9	371	445	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					363	363						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532008				2022-12-01	WOS:000180426800035
J	Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W				Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W			KCNQ1 gain-of-function mutation in familial atrial fibrillation	SCIENCE			English	Article							LONG QT SYNDROME; CARDIAC-ARRHYTHMIAS; POTASSIUM CHANNEL; KVLQT1; INTERVAL	Atrial fibrillation (AF) is a common cardiac arrhythmia whose molecular etiology is poorly understood. We studied a family with hereditary persistent AF and identified the causative mutation (S140G) in the KCNQ1 (KvLQT1) gene on chromosome 11p15.5. The KCNQ1 gene encodes the pore-forming alpha subunit of the cardiac I-Ks channel (KCNQ1/KCNE1), the KCNQ1/KCNE2 and the KCNQ1/KCNE3 potassium channels. Functional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome. Thus, the S140G mutation is likely to initiate and maintain AF by reducing action potential duration and effective refractory period in atrial myocytes.	Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China; Tongji Univ, Inst Med Genet, Shanghai 200065, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Hlth Sci Ctr, Inst Biol Sci, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Shanghai 200025, Peoples R China; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Sophia Antipolis, France; Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom, Shanghai 200025, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Chen, YH (corresponding author), Tongji Hosp, Dept Cardiol, 399 Xin Cun Rd, Shanghai 200065, Peoples R China.	drchen@public7.sta.net.cn; xusj@chgc.sh.cn						Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Cannom DS, 2000, AM J CARDIOL, V85, p25D; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Mazhari R, 2002, J CLIN INVEST, V109, P1083, DOI 10.1172/JCI200215062; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; PAI GR, 1989, BRIT HEART J, V61, P510; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SEED WA, 1987, BRIT HEART J, V57, P32; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x	21	716	770	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					251	254		10.1126/science.1077771	http://dx.doi.org/10.1126/science.1077771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522251				2022-12-01	WOS:000180284000039
J	Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T				Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T			A distinct signaling pathway used by the IgG-containing B cell antigen receptor	SCIENCE			English	Article							CO-RECEPTORS; CD22; ACTIVATION; LYMPHOCYTES; CD72; ASSOCIATION; RESPONSES; COMPLEX; ROLES; MICE	The immunoglobulin G (IgG)-containing B lymphocyte antigen receptor (IgG-BCR) transmits a signal distinct from that of IgM-BCR or IgD-BCR, although all three use the same signal-transducing component, Igalpha/Igbeta. Here we demonstrate that the inhibitory coreceptor CD22 down-modulates signaling through IgM-BCR and IgD-BCR, but not that through IgG-BCR, because of the IgG cytoplasmic tail, which prevents CD22 phosphorylation. These results suggest that the cytoplasmic tail of IgG specifically enhances IgG-BCR signaling by preventing CD22-mediated signal inhibition. Enhanced signaling through IgG-BCR may be involved in efficient IgG production, which is crucial for immunity to pathogens.	Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; Univ Freiburg, Dept Mol Immunol Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Tokyo Medical & Dental University (TMDU); University of Freiburg; Max Planck Society	Tsubata, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258				Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; Adachi T, 1998, J IMMUNOL, V160, P4662; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; ORourke L, 1997, CURR OPIN IMMUNOL, V9, P324, DOI 10.1016/S0952-7915(97)80077-5; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.immunol.10.1.97; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Tsubata T, 1999, CURR OPIN IMMUNOL, V11, P249, DOI 10.1016/S0952-7915(99)80041-7; WAKABAYASHI C, UNPUB; WEISER P, 1994, EUR J IMMUNOL, V24, P665, DOI 10.1002/eji.1830240327; WIENANDS J, 1990, EMBO J, V9, P449, DOI 10.1002/j.1460-2075.1990.tb08130.x	23	139	145	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2392	2395		10.1126/science.1076963	http://dx.doi.org/10.1126/science.1076963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493916				2022-12-01	WOS:000179915900058
J	Willner, I				Willner, I			Biomaterials for sensors, fuel cells, and circuitry	SCIENCE			English	Article							GLUCOSE-OXIDASE; DNA; IMMUNOSENSOR; ELECTRODES		Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Willner, I (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	willnea@vms.huji.ac.il						Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Caruana DJ, 1999, J AM CHEM SOC, V121, P769, DOI 10.1021/ja983328p; Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164; DIGLERIA K, 1986, ANAL CHEM, V58, P1203, DOI 10.1021/ac00297a050; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8; Katz E, 2001, J AM CHEM SOC, V123, P10752, DOI 10.1021/ja0167102; KONIG B, 1993, ANAL CHIM ACTA, V280, P37, DOI 10.1016/0003-2670(93)80238-G; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H; Patolsky F, 2002, J AM CHEM SOC, V124, P770, DOI 10.1021/ja0119752; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P3398, DOI 10.1002/1521-3773(20020916)41:18<3398::AID-ANIE3398>3.0.CO;2-W; Patolsky F, 2001, ANGEW CHEM INT EDIT, V40, P2261, DOI 10.1002/1521-3773(20010618)40:12<2261::AID-ANIE2261>3.0.CO;2-P; Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704; RISHPON J, 1989, BIOSENSORS, V4, P61, DOI 10.1016/0265-928X(89)80023-9; SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048; Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j; Wang LM, 2000, J AM CHEM SOC, V122, P7435, DOI 10.1021/ja0010195; Weizmann Y, 2001, ANALYST, V126, P1502, DOI 10.1039/b106613g; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1; Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698	26	277	287	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2407	2408		10.1126/science.298.5602.2407	http://dx.doi.org/10.1126/science.298.5602.2407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493919				2022-12-01	WOS:000179915900062
J	Axtell, MJ; Staskawicz, BJ				Axtell, MJ; Staskawicz, BJ			Initiation of RPS2-specified disease resistance in Arabidopsis is coupled to the AvrRpt2-directed elimination of RIN4	CELL			English	Article							NUCLEOTIDE-BINDING SITE; AVIRULENCE GENE AVRRPT2; LEUCINE-RICH REPEATS; PSEUDOMONAS-SYRINGAE; PLASMA-MEMBRANE; PTO KINASE; BACTERIAL PATHOGENESIS; MUTATIONAL ANALYSIS; PLANT IMMUNITY; PROTEIN	Plants have evolved a sophisticated innate immune system to recognize invading pathogens and to induce a set of host defense mechanisms resulting in disease resistance. Pathogen recognition is often mediated by plant disease resistance (R) proteins that respond specifically to one or a few pathogen-derived molecules. This specificity has led to suggestions of a receptor-ligand mode of R protein function. Delivery of the bacterial effector protein AvrRpt2 by Pseudomonas syringae specifically induces disease resistance in Arabidopsis plants expressing the RPS2 R protein. We demonstrate that RPS2 physically interacts with Arabidopsis RIN4 and that AvrRpt2 causes the elimination of RIN4 during activation of the RPS2 pathway. AvrRpt2-mediated RIN4 elimination also occurs in the rps2, ndr1, and Atrar1 mutant backgrounds, demonstrating that this activity can be achieved independent of an RPS2-mediated signaling pathway. Therefore, we suggest that RPS2 initiates signaling based upon perception of RIN4 disappearance rather than direct recognition of AvrRpt2.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Staskawicz, BJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.							Ausubel F. M., 1994, CURRENT PROTOCOLS MO; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guttman DS, 2001, MOL PLANT MICROBE IN, V14, P145, DOI 10.1094/MPMI.2001.14.2.145; Harlow, 1999, USING ANTIBODIES LAB; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; Leister RT, 1996, P NATL ACAD SCI USA, V93, P15497, DOI 10.1073/pnas.93.26.15497; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Nebenfuhr A, 1999, PLANT PHYSIOL, V121, P1127, DOI 10.1104/pp.121.4.1127; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Ritter C, 1996, PLANT CELL, V8, P251, DOI 10.1105/tpc.8.2.251; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; Sedbrook JC, 2002, PLANT CELL, V14, P1635, DOI 10.1105/tpc.002360; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tao Y, 2000, PLANT CELL, V12, P2541, DOI 10.1105/tpc.12.12.2541; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439	51	609	639	4	111	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 7	2003	112	3					369	377		10.1016/S0092-8674(03)00036-9	http://dx.doi.org/10.1016/S0092-8674(03)00036-9			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581526	Bronze			2022-12-01	WOS:000181252200008
J	Bernhard, JM				Bernhard, JM			Potential symbionts in bathyal foraminifera	SCIENCE			English	Article									Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bernhard, JM (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Norman J Arnold Sch Publ Hlth, Columbia, SC 29208 USA.		Bernhard, Joan/M-3260-2013	Bernhard, Joan/0000-0003-2121-625X				AHARON P, 2001, GEOL SOC AM ABSTR, V33, pA162; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; Giere O, 1996, BIOSYST ECOL SER, P353; Grzymski J, 2002, LIMNOL OCEANOGR, V47, P1569, DOI 10.4319/lo.2002.47.6.1569; Van Dover C., 2000, ECOLOGY DEEP SEA HYD; VETTER RD, 1985, MAR BIOL, V88, P33, DOI 10.1007/BF00393041	7	77	85	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					861	861		10.1126/science.1077314	http://dx.doi.org/10.1126/science.1077314			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574621				2022-12-01	WOS:000180830900042
J	Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C				Zalfa, F; Giorgi, M; Primerano, B; Moro, A; Di Penta, A; Reis, S; Oostra, B; Bagni, C			The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at Synapses	CELL			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; BC200 RNA; RIBONUCLEOPROTEIN PARTICLE; CLINICAL PHENOTYPE; DENDRITIC LOCATION; KNOCKOUT MICE; CGG REPEAT; GENE; IDENTIFICATION	The Fragile X syndrome, which results from the absence of functional FMRP protein, is the most common heritable form of mental retardation. Here, we show that FMRP acts as a translational repressor of specific mRNAs at synapses. Interestingly, FMRP associates not only with these target mRNAs, but also with the dendritic, non-translatable RNA BC1. Blocking of BC1 inhibits the interaction of FMRP with its target mRNAs. Furthermore, BC1 binds directly to FMRP and can also associate, in the absence of any protein, with the mRNAs regulated by FMRP. This suggests a mechanism where BC1 could determine the specificity of FMRP function by linking the regulated mRNAs and FMRP. Thus, when FMRP is not present, loss of translational repression of specific mRNAs at synapses could result in synaptic dysfunction phenotype of Fragile X patients.	Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; IRCCS, Fdn Santa Lucia, Ist Neurosci Sperimentali, Rome, Italy; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of Rome Tor Vergata; IRCCS Santa Lucia; Erasmus University Rotterdam; Erasmus MC	Bagni, C (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, Via Ric Sci, I-00133 Rome, Italy.	bagni@uniroma2.it	Zalfa, Francesca/J-7759-2018	Zalfa, Francesca/0000-0002-1922-9468; Bagni, Claudia/0000-0002-4419-210X	NICHD NIH HHS [5 R01 HD38038] Funding Source: Medline; Telethon [GGP02357] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adinolfi S, 1999, RNA, V5, P1248, DOI 10.1017/S1355838299990647; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Ceman S, 2000, BIOCHEM BIOPH RES CO, V279, P904, DOI 10.1006/bbrc.2000.4035; Cheng JG, 1997, NEUROSCI LETT, V224, P206, DOI 10.1016/S0304-3940(97)13471-1; Cheng JG, 1996, DNA CELL BIOL, V15, P549, DOI 10.1089/dna.1996.15.549; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, J NEUROSCI, V17, P1539; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HIRST M, 1995, AM J HUM GENET, V56, P67; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; MEIJER H, 1994, HUM MOL GENET, V3, P615; Mila M, 2000, MOL CELL PROBE, V14, P115, DOI 10.1006/mcpr.2000.0293; Muller Dominique, 2002, Current Molecular Medicine (Hilversum), V2, P605, DOI 10.2174/1566524023362041; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Oostra BA, 2002, TRENDS MOL MED, V8, P102, DOI 10.1016/S1471-4914(02)02271-2; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Sung YJ, 2000, BIOCHEM BIOPH RES CO, V275, P973, DOI 10.1006/bbrc.2000.3405; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tamanini F, 1996, HUM MOL GENET, V5, P809, DOI 10.1093/hmg/5.6.809; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang HD, 2002, J NEUROSCI, V22, P10232; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; WOHRLE D, 1992, AM J HUM GENET, V51, P299; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	62	518	541	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 7	2003	112	3					317	327		10.1016/S0092-8674(03)00079-5	http://dx.doi.org/10.1016/S0092-8674(03)00079-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FK	12581522	Bronze, Green Published			2022-12-01	WOS:000181252200004
J	Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK				Westneat, MW; Betz, O; Blob, RW; Fezzaa, K; Cooper, WJ; Lee, WK			Tracheal respiration in insects visualized with synchrotron X-ray imaging	SCIENCE			English	Article							VENTILATION	Insects are known to exchange respiratory gases in their system of tracheal tubes by using either diffusion or changes in internal pressure that are produced through body motion or hemolymph circulation. However, the inability to see inside living insects has limited our understanding of their respiration mechanisms. We used a synchrotron beam to obtain x-ray videos of living, breathing insects. Beetles, crickets, and ants exhibited rapid cycles of tracheal compression and expansion in the head and thorax. Body movements and hemolymph circulation cannot account for these cycles; therefore, our observations demonstrate a previously unknown mechanism of respiration in insects analogous to the inflation and deflation of vertebrate lungs.	Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Univ Kiel, Dept Zool, Kiel, Germany; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; Argonne Natl Lab, Adv Photon Source, Expt Facilities Div, Argonne, IL 60439 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); University of Kiel; Clemson University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Westneat, MW (corresponding author), Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA.	mwestneat@fieldmuseum.org	Lee, Wah-Keat/GRR-9734-2022	Blob, Richard/0000-0001-5026-343X; Cooper, W. James/0000-0003-4204-4266				BRAINERD EL, 1989, SCIENCE, V246, P1593, DOI 10.1126/science.246.4937.1593; Carrier DR, 1996, J EXP BIOL, V199, P1455; Chapman RF., 1998, INSECTS STRUCTURE FU, DOI 10.1017/CBO9780511818202; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; HILL AV, 1948, J PHYSIOL-LONDON, V107, P518, DOI 10.1113/jphysiol.1948.sp004296; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Komai Y, 1998, J EXP BIOL, V201, P2359; Krogh A, 1920, PFLUG ARCH GES PHYS, V179, P95, DOI 10.1007/BF01722125; Mill P.J., 1985, P517; Miller P.L., 1981, P367; Schmidt-Nielsen K, 1979, ANIMAL PHYSL; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; Tartes U, 2000, PHYSIOL ENTOMOL, V25, P151, DOI 10.1046/j.1365-3032.2000.00180.x; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Wasserthal LT, 1996, ADV INSECT PHYSIOL, V26, P297, DOI 10.1016/S0065-2806(08)60033-8; WEISFOGH T, 1964, J EXP BIOL, V41, P207; Westneat MW, 1998, J EXP BIOL, V201, P3041	18	179	188	3	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					558	560		10.1126/science.1078008	http://dx.doi.org/10.1126/science.1078008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543973				2022-12-01	WOS:000180559800047
J	Michaelsson, K; Lithell, H; Vessby, B; Melhus, H				Michaelsson, K; Lithell, H; Vessby, B; Melhus, H			Serum retinol levels and the risk of fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; VITAMIN-A INTAKE; BONE-MINERAL DENSITY; HIP FRACTURE; ALPHA-TOCOPHEROL; BETA-CAROTENE; HYPERVITAMINOSIS-A; GENE-EXPRESSION; PLASMA RETINOL	BACKGROUND Although studies in animals and epidemiologic studies have indicated that a high vitamin A intake is associated with increased bone fragility, no biologic marker of vitamin A status has thus far been used to assess the risk of fractures in humans. METHODS We enrolled 2322 men, 49 to 51 years of age, in a population-based, longitudinal cohort study. Serum retinol and beta carotene were analyzed in samples obtained at enrollment. Fractures were documented in 266 men during 30 years of follow-up. Cox regression analysis was used to determine the risk of fracture according to the serum retinol level. RESULTS The risk of fracture was highest among men with the highest levels of serum retinol. Multivariate analysis of the risk of fracture in the highest quintile for serum retinol (>75.62 microg per deciliter [2.64 micromol per liter]) as compared with the middle quintile (62.16 to 67.60 microg per deciliter [2.17 to 2.36 micromol per liter]) showed that the rate ratio was 1.64 (95 percent confidence interval, 1.12 to 2.41) for any fracture and 2.47 (95 percent confidence interval, 1.15 to 5.28) for hip fracture. The risk of fracture was further increased within the highest quintile for serum retinol. Men with retinol levels in the 99th percentile (>103.12 microg per deciliter [3.60 micromol per liter]) had an overall risk of fracture that exceeded the risk among men with lower levels by a factor of seven (P<0.001). The level of serum beta carotene was not associated with the risk of fracture. CONCLUSIONS Our findings, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.	Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Geriatr, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Clin Nutr Res, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Clin Pharmacol Sect, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Michaelsson, K (corresponding author), Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217				Ballew C, 2001, J BONE MINER RES, V16, P2306, DOI 10.1359/jbmr.2001.16.12.2306; Ballew C, 2001, AM J CLIN NUTR, V73, P586; Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; BERSHAD S, 1985, NEW ENGL J MED, V313, P981, DOI 10.1056/NEJM198510173131604; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; BITZEN U, 1994, SCAND J CLIN LAB INV, V54, P611, DOI 10.3109/00365519409087540; COMSTOCK GW, 1993, CLIN CHEM, V39, P1075; CRUZ JAA, 1991, EUR J CLIN NUTR, V45, P121; Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Denke MA, 2002, JAMA-J AM MED ASSOC, V287, P102, DOI 10.1001/jama.287.1.102; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; FRAME B, 1974, ANN INTERN MED, V80, P44, DOI 10.7326/0003-4819-80-1-44; GARRY PJ, 1987, AM J CLIN NUTR, V46, P989, DOI 10.1093/ajcn/46.6.989; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HALLFRISCH J, 1994, AM J CLIN NUTR, V60, P176, DOI 10.1093/ajcn/60.2.176; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; JOHANSSON S, IN PRESS BONE; JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186; JOHNSON EJ, 1992, J AM COLL NUTR, V11, P682; KATZ CM, 1972, METABOLISM, V21, P1171, DOI 10.1016/0026-0495(72)90112-6; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; KINDMARK A, 1993, BIOCHEM BIOPH RES CO, V192, P1367, DOI 10.1006/bbrc.1993.1567; KRASINSKI SD, 1990, METABOLISM, V39, P357, DOI 10.1016/0026-0495(90)90249-C; Leo MA, 1999, AM J CLIN NUTR, V69, P1071; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; MILNE DB, 1986, CLIN CHEM, V32, P874; MURRAY JC, 1983, ARCH DERMATOL, V119, P675, DOI 10.1001/archderm.119.8.675; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; Neuhouser ML, 2001, J NUTR, V131, P2184, DOI 10.1093/jn/131.8.2184; Nierenberg DW, 1997, AM J CLIN NUTR, V66, P315, DOI 10.1093/ajcn/66.2.315; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; ROIDT L, 1988, AM J EPIDEMIOL, V128, P645, DOI 10.1093/oxfordjournals.aje.a115012; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; STAUBER PM, 1991, AM J CLIN NUTR, V54, P878, DOI 10.1093/ajcn/54.5.878; Stephensen CB, 2000, AM J CLIN NUTR, V72, P1170; Sundstrom J, 2001, CIRCULATION, V103, P836, DOI 10.1161/01.CIR.103.6.836; Underwood BA, 1984, RETINOIDS, P281; vonReinersdorff D, 1996, J LIPID RES, V37, P1875; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631	51	234	246	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					287	294		10.1056/NEJMoa021171	http://dx.doi.org/10.1056/NEJMoa021171			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540641				2022-12-01	WOS:000180507200003
J	Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O				Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O			Periodic Notch inhibition by lunatic fringe underlies the chick segmentation clock	NATURE			English	Article							SOMITE BOUNDARY FORMATION; INTRACELLULAR DOMAIN; DELTA-HOMOLOG; EXPRESSION; GENE; GLYCOSYLTRANSFERASE; REQUIRES; SOMITOGENESIS; OSCILLATOR; RELEASE	The segmented aspect of the vertebrate body plan first arises through the sequential formation of somites. The periodicity of somitogenesis is thought to be regulated by a molecular oscillator, the segmentation clock, which functions in presomitic mesoderm cells. This oscillator controls the periodic expression of 'cyclic genes', which are all related to the Notch pathway(1-7). The mechanism underlying this oscillator is not understood. Here we show that the protein product of the cyclic gene lunatic fringe (Lfng), which encodes a glycosyltransferase that can modify Notch activity, oscillates in the chick presomitic mesoderm. Overexpressing Lfng in the paraxial mesoderm abolishes the expression of cyclic genes including endogenous Lfng and leads to defects in segmentation. This effect on cyclic genes phenocopies inhibition of Notch signalling in the presomitic mesoderm. We therefore propose that Lfng establishes a negative feedback loop that implements periodic inhibition of Notch, which in turn controls the rhythmic expression of cyclic genes in the chick presomitic mesoderm. This feedback loop provides a molecular basis for the oscillator underlying the avian segmentation clock.	Univ Mediterranee AP Marseille, Lab Genet & Phys Dev, Inst Biol Dev Marseille, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Pourquié, Olivier/CAJ-5443-2022; Dale, Kim/A-4480-2016	Pourquié, Olivier/0000-0001-5189-1227; Dale, Kim/0000-0002-9294-947X				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; CONLON RA, 1995, DEVELOPMENT, V121, P1533; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Maroto M, 2001, CURR TOP DEV BIOL, V51, P221, DOI 10.1016/S0070-2153(01)51007-8; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Sato Y, 2002, DEVELOPMENT, V129, P3633; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	29	250	257	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					275	278		10.1038/nature01244	http://dx.doi.org/10.1038/nature01244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529645				2022-12-01	WOS:000180397600049
J	Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM				Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM			An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; CONTAMINATION; ENDOSCOPY	Background: Endoscopes, including bronchoscopes, are the medical devices most frequently associated with outbreaks of nosocomial infections. We investigated an outbreak of Pseudomonas aeruginosa infections after bronchoscopic procedures. Methods: Microbiologic results were reviewed to determine the rates of recovery of P. aeruginosa from bronchoalveolar-lavage specimens. Environmental samples from endoscopes and the endoscopy suite were cultured. Medical records were reviewed to identify infections in the 14 days after a bronchoscopy. Results: The rate of recovery of P. aeruginosa from bronchoalveolar-lavage specimens obtained with use of endoscopy-suite bronchoscopes increased from 10.4 percent at base line to 31.0 percent during the outbreak (relative risk, 2.97; 95 percent confidence interval, 2.28 to 3.90). Cultures of samples from three bronchoscopes grew P. aeruginosa, whereas cultures of samples from the environment, instrument-cleaning machines, and gastrointestinal endoscopes did not. The three bronchoscopes had been part of a nationwide recall. A total of 414 patients underwent bronchoscopy during the outbreak, and there were 48 respiratory tract and bloodstream infections among 39 of these patients (9.4 percent). In 32 infections (66.7 percent), P. aeruginosa was confirmed as a potentially causative organism. Exposure to a potentially contaminated bronchoscope may have had a role in the death of three patients. The rate of recovery of P. aeruginosa returned to base line after the instruments were removed from service. Conclusions: This large outbreak of P. aeruginosa infections related to bronchoscopy was apparently caused by a loose biopsy-port cap in the bronchoscopes. Instrument safety and surveillance methods for bronchoscopy must be improved, and better recall procedures are needed for medical devices.	Johns Hopkins Med Inst, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Nephrol, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Srinivasan, A (corresponding author), Johns Hopkins Univ Hosp, Off Antibiot Management, 600 N Wolfe St,Carnegie Bldg,Rm 284, Baltimore, MD 21287 USA.				ODCDC CDC HHS [UR8/CCU315092] Funding Source: Medline	ODCDC CDC HHS		Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; [Anonymous], 1994, NNIS MAN NAT NOS INF; Colt HG, 2000, CHEST, V118, P183, DOI 10.1378/chest.118.1.183; Diette GB, 1999, CHEST, V115, P397, DOI 10.1378/chest.115.2.397; *FDA, 2002, FDA REC POL; GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595; Institute of Medicine Committee on Quality of Health Care in America, 2000, ERR IS HUMAN BUILDIN; Kirkpatrick BD, 1999, CLIN INFECT DIS, V29, P1268, DOI 10.1086/313456; Kirschke DL, 2003, NEW ENGL J MED, V348, P214, DOI 10.1056/NEJMoa021791; MARKOVITZ A, 1979, WESTERN J MED, V131, P550; MARTIN MA, 1994, AM J INFECT CONTROL, V22, P19, DOI 10.1016/0196-6553(94)90087-6; Mehta AC, 1999, CLIN CHEST MED, V20, P19, DOI 10.1016/S0272-5231(05)70123-4; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; NELSON KE, 1983, AM REV RESPIR DIS, V127, P97, DOI 10.1164/arrd.1983.127.1.97; PAPPAS SA, 1983, AM REV RESPIR DIS, V127, P391; PEREIRA W, 1975, AM REV RESPIR DIS, V112, P59; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Walter V A, 2000, Gastrointest Endosc Clin N Am, V10, P265; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	20	126	137	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					221	227		10.1056/NEJMoa021808	http://dx.doi.org/10.1056/NEJMoa021808			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529462				2022-12-01	WOS:000180390600006
J	Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA				Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA			Trends in care by nonphysician clinicians in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSE PRACTITIONERS; PATIENT-CARE; PHYSICIAN ASSISTANTS; OUTCOMES	BACKGROUND: The 1990s saw rising numbers of graduates of training programs for nonphysician clinicians, passage of legislation expanding their scope of practice, and a proliferation of managed-care models that emphasized the use of these providers as a strategy for containing health care costs. METHODS: We used two nationally representative surveys to examine trends in outpatient care provided by physicians and nonphysician clinicians between 1987 and 1997, adjusting for the case mix. Analyses examined care provided by 10 categories of nonphysician clinicians: chiropractors, midwives, nurses or nurse practitioners, optometrists, podiatrists, physician assistants, physical or occupational therapists, psychologists, social workers, and others. RESULTS: Between 1987 and 1997, the proportion of patients who saw a nonphysician clinician rose from 30.6 percent to 36.1 percent (adjusted relative risk for 1997 as compared with 1987, 1.42 [95 percent confidence interval, 1.35 to 1.50]). The trend was driven by an increase in the proportion of persons who visited both a physician and a nonphysician clinician (from 23.5 percent to 30.9 percent; adjusted relative risk, 1.49 [95 percent confidence interval, 1.40 to 1.58]), rather than an increase in the proportion who saw only a nonphysician clinician (from 7.2 percent to 5.3 percent; adjusted relative risk, 0.81 [95 percent confidence interval, 0.70 to 0.93]). This pattern was consistent in analyses of specific medical conditions and specific types of nonphysician clinicians. There was an increase in the proportion of patients obtaining preventive services from nonphysician clinicians and a decline in the proportion receiving acute care services from such clinicians. CONCLUSIONS: From 1987 to 1997, there was a degree of differentiation between physicians and nonphysician clinicians with respect to the services they provided but not with respect to the patients they treated. The implications of these findings hinge on the degree to which the increase in conjoint service delivery represents growing coordination or fragmentation of care.	Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; RAND, Washington, DC USA; RAND, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Emory University; Rollins School Public Health; University of Pennsylvania; Columbia University; RAND Corporation; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Druss, BG (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.		Olfson, Mark/AAA-8547-2021		NIMH NIH HHS [K08-MH01556-01A] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001556] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HEALTHC RES QU, 2002, CLIN CLASS SOFTW ICD; COHEN SB, 2000, AHRQ PUBLICATION; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; DIAL TH, 1995, HEALTH AFFAIR, V14, P168, DOI 10.1377/hlthaff.14.2.168; EDWARDS WS, 1989, DHHS PUBLICATION PHS; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; GOODE E, 2002, NY TIMES        0611, pF1; Grumbach K, 1998, JAMA-J AM MED ASSOC, V280, P825, DOI 10.1001/jama.280.9.825; *HLTH POL TRACK SE, 2002, NAT C STAT LEG JUN; HOFFMAN C, 1994, HEALTH AFFAIR, V13, P140, DOI 10.1377/hlthaff.13.4.140; Hooker RS, 2001, HEALTH AFFAIR, V20, P231, DOI 10.1377/hlthaff.20.4.231; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; KIRBY JB, 2001, AHRQ PUBLICATION; MELFI C, 1995, J CLIN EPIDEMIOL, V48, P917, DOI 10.1016/0895-4356(94)00202-2; Mundinger, 2000, JAMA, V283, P2521; SEKSCENSKI ES, 1994, NEW ENGL J MED, V331, P1266, DOI 10.1056/NEJM199411103311905; SHAH BV, 1997, SUDAAN USERS MANUAL; SOX HC, 1979, ANN INTERN MED, V91, P459, DOI 10.7326/0003-4819-91-3-459; STARFIELD B, 1998, PRIMARY CARE BALANCI, P94; STARFIELD BH, 1976, MED CARE, V14, P625, DOI 10.1097/00005650-197607000-00008; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; *WHO, 1977, 9 REV C 1975 GEN WHO; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zuvekas SH, 2002, INQUIRY-J HEALTH CAR, V39, P76, DOI 10.5034/inquiryjrnl_39.1.76	25	117	118	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					130	137		10.1056/NEJMsa020993	http://dx.doi.org/10.1056/NEJMsa020993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519924				2022-12-01	WOS:000180263900006
J	Dalton, R				Dalton, R			Palaeoanthropology - Face to face with our past	NATURE			English	Editorial Material																		Brunet M, 2002, NATURE, V419, P582, DOI 10.1038/419582a; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a	5	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	736		10.1038/420735a	http://dx.doi.org/10.1038/420735a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490911				2022-12-01	WOS:000179897300019
J	Dennis, C				Dennis, C			Small RNAs - The genome's guiding hand?	NATURE			English	Editorial Material							ELEGANS											Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	14	19	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					732	732		10.1038/420732a	http://dx.doi.org/10.1038/420732a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490907				2022-12-01	WOS:000179897300016
J	Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M				Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M			Chloroplast avoidance movement reduces photodamage in plants	NATURE			English	Article							BLUE-LIGHT; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; PHOTOSYSTEM-II; STRESS; NPL1; PHOTOPROTECTION; PHOTOSYNTHESIS; RELOCATION; MEDIATE	When plants are exposed to light levels higher than those required for photosynthesis, reactive oxygen species are generated in the chloroplasts and cause photodamage. This can occur even under natural growth conditions. To mitigate photodamage, plants have developed several protective mechanisms(1-3). One is chloroplast avoidance movement(4-6), in which chloroplasts move from the cell surface to the side walls of cells under high light conditions, although experimental support is still awaited(7,8). Here, using different classes of mutant defective in chloroplast avoidance movement, we show that these mutants are more susceptible to damage in high light than wild-type plants. Damage of the photosynthetic apparatus and subsequent bleaching of leaf colour and necrosis occur faster under high light conditions in the mutants than in wild-type plants. We conclude that chloroplast avoidance movement actually decreases the amount of light absorption by chloroplasts, and might therefore be important to the survival of plants under natural growth conditions.	Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & combined Circuit, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Tokyo Metropolitan University; National Institute of Agrobiological Sciences - Japan	Wada, M (corresponding author), Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan.		Suetsugu, Noriyuki/AAB-5274-2019	Suetsugu, Noriyuki/0000-0002-3328-3313; Oikawa, Kazusato/0000-0002-1033-9089				Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; BRUGNOLI E, 1992, PHOTOSYNTH RES, V32, P23, DOI 10.1007/BF00028795; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1992, BOT MAG TOKYO, V105, P265, DOI 10.1007/BF02489420; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Miyagawa Y, 2000, PLANT CELL PHYSIOL, V41, P311, DOI 10.1093/pcp/41.3.311; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; SUKENIK A, 1987, NATURE, V327, P704, DOI 10.1038/327704a0; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; WADA M, 2001, PHOTOMOVEMENT, P897; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50	22	411	444	6	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					829	832		10.1038/nature01213	http://dx.doi.org/10.1038/nature01213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490952				2022-12-01	WOS:000179897300060
J	Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS				Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS			The draft genome of Ciona intestinalis: Insights into chordate and vertebrate origins	SCIENCE			English	Article							GENE-EXPRESSION PROFILES; ASCIDIAN EMBRYOS; HOMEOBOX GENES; EVOLUTION; CLUSTER; SYSTEM; DROSOPHILA; SEQUENCE; BIOLOGY; PLANT	The first chordates appear in the fossil record at the time of the Cambrian explosion, nearly 550 million years ago. The modern ascidian tadpole represents a plausible approximation to these ancestral chordates. To illuminate the origins of chordate and vertebrates, we generated a draft of the protein-coding portion of the genome of the most studied ascidian, Ciona intestinalis. The Ciona genome contains similar to16,000 protein-coding genes, similar to the number in other invertebrates, but only half that found in vertebrates. Vertebrate gene families are typically found in simplified form in Ciona, suggesting that ascidians contain the basic ancestral complement of genes involved in cell signaling and development. The ascidian genome has also acquired a number of lineage-specific innovations, including a group of genes engaged in cellulose metabolism that are related to those in bacteria and fungi.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan; Marine Biol Labs, Woods Hole, MA 02543 USA; Serono Reprod Biol Inst, Rockland, MA 02370 USA; Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 93950 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Genet, Berkeley, CA 94720 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 6110011, Japan; IBDM, LGPD, F-13288 Marseille 09, France; Dalhousie Univ, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan; Stn Zool Anton Dohrn, I-80121 Naples, Italy; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Tohoku Univ, Grad Sch Sci, Asamushi Marine Biol Stn, Asamushi, Aomori 0393501, Japan; Univ Maryland, College Pk, MD 20742 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Programs Dev Biol Genet & Human Genet, San Francisco, CA 94143 USA; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kyoto University; Marine Biological Laboratory - Woods Hole; University of Queensland; Stanford University; University of California System; University of California Berkeley; McGill University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; UDICE-French Research Universities; Aix-Marseille Universite; Dalhousie University; University of Tokyo; Tokyo Metropolitan University; Tohoku University; H Lee Moffitt Cancer Center & Research Institute; Hokkaido University; Stazione Zoologica Anton Dohrn di Napoli; International Business Machines (IBM); Tohoku University; University System of Maryland; University of Maryland College Park; University of California System; University of California San Francisco; University of Edinburgh; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley	Kohara, Y (corresponding author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	ykohara@lab.nig.ac.jp; mlevine@uclink4.berkeley.edu; satoh@ascidian.zool.kyoto-u.ac.jp; dsrokhsar@lbl.gov	Di Gregorio, Anna/C-4766-2008; Francino, M.Pilar/H-9090-2015; Necula, Sabina/P-7113-2019; Putnam, Nicholas/B-9968-2008; Satou, Yutaka/K-7131-2012; Kawashima, Takeshi/M-4510-2015; Matassi, Giorgio/G-6301-2014; Wang, Hong-Gang/A-3018-2015; Rigoutsos, Isidore/C-5381-2012; Satou, Yutaka/AAJ-2194-2021; Hotta, Kohji/D-1162-2014; Satoh, Nori/C-4123-2009; Campbell, Robert/G-4112-2012; Terry, Astrid Y/A-2538-2011; Lemaire, Patrick/B-5560-2012; Lemaire, Patrick/P-8228-2019; Lemaire, Patrick/D-4237-2009; NONAKA, MASARU/G-4929-2014	Francino, M.Pilar/0000-0002-4510-5653; Necula, Sabina/0000-0001-6912-2450; Putnam, Nicholas/0000-0002-1315-782X; Satou, Yutaka/0000-0001-5193-0708; Matassi, Giorgio/0000-0003-4923-226X; Wang, Hong-Gang/0000-0003-0551-0571; Satou, Yutaka/0000-0001-5193-0708; Hotta, Kohji/0000-0003-4614-7473; Satoh, Nori/0000-0002-4480-3572; Terry, Astrid Y/0000-0002-5234-1224; Lemaire, Patrick/0000-0003-4925-2009; Lemaire, Patrick/0000-0003-4925-2009; Davidson, Brad/0000-0001-5082-7872; Rokhsar, Daniel/0000-0002-8704-2224; Levine, Michael/0000-0001-7629-0081; Mount, Steve/0000-0003-2748-8205; Meinertzhagen, Ian/0000-0002-6578-4526; Stainier, Didier/0000-0002-0382-0026; Spagnuolo, Antonietta/0000-0001-6660-071X; Imai, Kaoru/0000-0001-9113-6074; Kobayashi, Kenji/0000-0002-9312-7857; Degnan, Bernard/0000-0001-7573-8518; Goodstein, David/0000-0001-6287-2697; Rigoutsos, Isidore/0000-0003-1529-8631	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-37105] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burglin T.R, 1994, EVOLUTION HOMEOBOX G, P27; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Capponi AM, 2002, TRENDS ENDOCRIN MET, V13, P118, DOI 10.1016/S1043-2760(01)00538-0; CHOURROUT D, COMMUNICATION; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Darwin C., 1871, ORIGIN SPECIES DESCE; Di Gregorio A, 2002, DIFFERENTIATION, V70, P132; DIGREGORIO A, 1995, GENE, V156, P253, DOI 10.1016/0378-1119(95)00035-5; DOLLE P, 1994, DEVELOPMENT, P143; Dunn JT, 2001, THYROID, V11, P407, DOI 10.1089/105072501300176363; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gee H., 1996, BACKBONE VIEWS ORIGI; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; HAFAFUJI N, 2002, P NATL ACAD SCI USA, V99, P6802; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hill CS, 1999, INT J BIOCHEM CELL B, V31, P1249, DOI 10.1016/S1357-2725(99)00093-X; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOLLAND PWH, 1994, DEVELOPMENT, P125; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2001, INT REV CYTOL, V203, P3; JOOST P, IN PRESS GENOME BIOL; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; KEYS DN, UNPUB; Kirsten D, 2000, Neonatal Netw, V19, P11; KOVILUR S, 1993, J MOL EVOL, V36, P361; Kowalevsky A., 1866, Mem. Acad. Imp. des Sciences de St. Petersbourg, tome, Vx, P1; KRISHNAN G, 1975, INDIAN J EXP BIOL, V13, P172; Kusakabe T, 2002, DEV BIOL, V242, P188, DOI 10.1006/dbio.2002.0538; Lacroix L, 2001, THYROID, V11, P1017, DOI 10.1089/105072501753271699; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; MEEDEL TH, 1984, DEV BIOL, V105, P479, DOI 10.1016/0012-1606(84)90305-1; Meinertzhagen LA, 2001, TRENDS NEUROSCI, V24, P401, DOI 10.1016/S0166-2236(00)01851-8; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1997, INT REV CYTOL, V176, P24; Nishino A, 2001, GENESIS, V29, P36, DOI 10.1002/1526-968X(200101)29:1<36::AID-GENE1003>3.0.CO;2-J; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Ornitz DM, 2001, GENOME BIOL, V2; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Pennisi E, 2000, SCIENCE, V287, P2182, DOI 10.1126/science.287.5461.2182; PUTNAM N, UNPUB; Read SM, 2002, SCIENCE, V295, P59, DOI 10.1126/science.1068155; Romer A. S., 1970, VERTEBRATE BODY; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Satoh N, 2001, DIFFERENTIATION, V68, P1, DOI 10.1046/j.1432-0436.2001.068001001.x; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, DEVELOPMENT, V128, P2893; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Tomarev SI, 1997, INT J DEV BIOL, V41, P835; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; VANDEKERCKHOVE J, 1984, J MOL BIOL, V179, P391, DOI 10.1016/0022-2836(84)90072-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weichert C.K., 1953, ELEMENTS CHORDATE AN; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	90	1303	1348	4	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2157	2167		10.1126/science.1080049	http://dx.doi.org/10.1126/science.1080049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481130				2022-12-01	WOS:000179773700039
J	Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA				Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA			Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL-CELL CULTURES; HIV PROTEASE INHIBITORS; INSULIN-RESISTANCE; PERIPHERAL LIPODYSTROPHY; HYPERLIPIDEMIA; CLEARANCE; APOPTOSIS; MORTALITY	BACKGROUND: Metabolic abnormalities associated with human immunodeficiency virus (HIV) infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease. METHODS: We conducted a retrospective study of the risk of cardiovascular and cerebrovascular disease among the 36,766 patients who received care for HIV infection at Veterans Affairs facilities between January 1993 and June 2001. RESULTS: For antiretroviral therapy, 70.2 percent of the patients received nucleoside analogues, 41.6 percent received protease inhibitors, and 25.6 percent received nonnucleoside reverse-transcriptase inhibitors for a median of 17 months, 16 months, and 9 months, respectively. Approximately 1000 patients received combination therapy with a protease inhibitor for at least 48 months, and approximately 1000 patients received combination therapy with a nonnucleoside reverse-transcriptase inhibitor for at least 24 months. Between 1995 and 2001, the rate of admissions for cardiovascular or cerebrovascular disease decreased from 1.7 to 0.9 per 100 patient-years, and the rate of death from any cause decreased from 21.3 to 5.0 deaths per 100 patient-years. Patient-level regression analyses indicated that there was no relation between the use of nucleoside analogues, protease inhibitors, or nonnucleoside reverse-transcriptase inhibitors and the hazard of cardiovascular or cerebrovascular events, but the use of antiretroviral drugs was associated with a decreased hazard of death from any cause. CONCLUSIONS: Use of newer therapies for HIV was associated with a large benefit in terms of mortality that was not diminished by any increase in the rate of cardiovascular or cerebrovascular events or related mortality. Fear of accelerated vascular disease need not compromise antiretroviral therapy over the short term. However, prolonged survival among HIVinfected patients means that longer-term observation and analysis are required.	Vet Affairs San Diego Hlth Care Syst, Vet Affairs Qual Enhancement Res Initiat HIV, San Diego, CA USA; Vet Affairs San Diego Hlth Care Syst, Ctr Res Patient Oriented Care, San Diego, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA; RAND Hlth, Santa Monica, CA USA; Vet Affairs Ctr Qual Management Publ Hlth, Palo Alto, CA USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; RAND Corporation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bozzette, SA (corresponding author), San Diego Vet Affairs Med Ctr, Dept Med, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.							Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CURRIER J, 2001, ANTIVIR THER, V6, P36; Dube M, 2002, POSTCOLONIALISM FEMI, P100; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; FISHER A, 1998, 12 WORLD AIDS C GEN, P575; Gallet B, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(05)78643-8; GEFFNER ME, 1993, PEDIATR RES, V34, P66, DOI 10.1203/00006450-199307000-00016; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; HOMMES MJT, 1991, METABOLISM, V40, P651, DOI 10.1016/0026-0495(91)90059-6; Huang MB, 1999, AIDS RES HUM RETROV, V15, P1265, DOI 10.1089/088922299310160; Huang MB, 2001, J ACQ IMMUN DEF SYND, V27, P213; Jia HY, 2001, BIOCHEM BIOPH RES CO, V283, P469, DOI 10.1006/bbrc.2001.4790; Jia HY, 2001, BIOCHEM BIOPH RES CO, V284, P245, DOI 10.1006/bbrc.2001.4930; Lenert LA, 2002, AM J MED, V113, P229, DOI 10.1016/S0002-9343(02)01156-7; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *NAT CTR HLTH STAT, 2002, CLASS DIS FUNCT DIS; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Vittecoq D, 1998, LANCET, V351, P1959, DOI 10.1016/S0140-6736(05)78644-X; [No title captured]	26	451	475	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					702	710		10.1056/NEJMoa022048	http://dx.doi.org/10.1056/NEJMoa022048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594314	Bronze			2022-12-01	WOS:000181014400005
J	Hope, MD				Hope, MD			Pain and forgetting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Hope, MD (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.								0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2003	289	5					617	617		10.1001/jama.289.5.617	http://dx.doi.org/10.1001/jama.289.5.617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CV	12578502	Bronze			2022-12-01	WOS:000180787500036
J	Herting, E; Stichtenoth, G; Robertson, B				Herting, E; Stichtenoth, G; Robertson, B			Syringes with rubber-coated plungers and inactivation of surfactant	LANCET			English	Article								Injectable drugs are generally administered to newborns with 1 mL syringes. During in-vitro measurements of surface tension with a pulsating bubble surfactometer, we noticed that surfactant was inactivated after repeated aspiration into a 1 mL syringe with a rubber-coated plunger. Inactivation did not take place, however, when we used rubber-free two-part syringes with polyethylene pistons. Results of further studies showed that the silicone fluid used to lubricate the rubber surface of the syringe was inactivating the surfactant. Our findings suggest that contact with rubber surfaces should be avoided in the handling of surfactant material for biophysical assessment or clinical use.	Univ Gottingen, Dept Paediat, D-37075 Gottingen, Germany; Karolinska Hosp, Dept Surg Sci, Lab Survactant Res, S-10401 Stockholm, Sweden	University of Gottingen; Karolinska Institutet; Karolinska University Hospital	Herting, E (corresponding author), Univ Gottingen, Dept Paediat, Robert Koch Str 40, D-37075 Gottingen, Germany.							Herting E, 2001, PEDIATR RES, V50, P44, DOI 10.1203/00006450-200107000-00010; JOBE AH, 1993, NEW ENGL J MED, V328, P861; Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278; Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249; Mooibroek H, 2000, APPL MICROBIOL BIOT, V53, P355, DOI 10.1007/s002530051627	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 25	2003	361	9354					311	313		10.1016/S0140-6736(03)12334-3	http://dx.doi.org/10.1016/S0140-6736(03)12334-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559869				2022-12-01	WOS:000180643900016
J	Schneider, RA; Helms, JA				Schneider, RA; Helms, JA			The cellular and molecular origins of beak morphology	SCIENCE			English	Article							NEURAL CREST; SONIC HEDGEHOG; CRANIOFACIAL MORPHOGENESIS; EXPRESSION; MESODERM; REGION; EMBRYO; FGF8	Cellular and molecular mechanisms underlying differences in beak morphology likely involve interactions among multiple embryonic populations. We exchanged neural crest cells destined to participate in beak morphogenesis between two anatomically distinct species. Quail neural crest cells produced quail beaks in duck hosts and duck neural crest produced duck bills in quail hosts. These transformations involved morphological changes to non neural crest host beak tissues. To achieve these changes, donor neural crest cells executed autonomous molecular programs and regulated gene expression in adjacent host tissues. Thus, neural crest cells are a source of molecular information that generates interspecific variation in beak morphology.	Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Helms, JA (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, 533 Parnassus Ave,Suite U-453, San Francisco, CA 94143 USA.			Helms, Jill/0000-0002-0463-396X; Schneider, Richard/0000-0002-2626-3111	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007236, R29DE012462, R03DE014795, K02DE000421] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-7-3263] Funding Source: Medline; NIDCR NIH HHS [K02 DE 00421, R03 DE014795-01, R03 DE014795, T32 DE07236, R29 DE12462-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; ANDRES G., 1949, GENETICA, V24, P387, DOI 10.1007/BF01487210; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Coppinger Raymond, 1995, P21; Couly G, 2002, DEVELOPMENT, V129, P1061; COULY GF, 1993, DEVELOPMENT, V117, P409; Darwin C, 1962, ORIGIN SPECIES; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison RG, 1933, AM NAT, V67, P306, DOI 10.1086/280493; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hu D, 1999, DEVELOPMENT, V126, P4873; Kontges G, 1996, DEVELOPMENT, V122, P3229; LUCAS AM, 1972, AGR HDB USDA, V362; MINA M, 1995, DEV DYNAM, V202, P195, DOI 10.1002/aja.1002020211; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Schneider RA, 1999, DEV BIOL, V208, P441, DOI 10.1006/dbio.1999.9213; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; SOHAL GS, 1976, BRAIN RES, V113, P35, DOI 10.1016/0006-8993(76)90004-4; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Wagner G., 1959, Roux Archiv fuer Entwicklungsmechanik Organismen, V151, P136	22	224	227	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					565	568		10.1126/science.1077827	http://dx.doi.org/10.1126/science.1077827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543976				2022-12-01	WOS:000180559800050
J	Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G				Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G			Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ENDOTHELIAL GROWTH-FACTOR; CHEMOKINE RECEPTOR EXPRESSION; RECOMBINANT INTERLEUKIN-2; PROGNOSTIC-SIGNIFICANCE; PATIENT SURVIVAL; INTERFERON-GAMMA; CARCINOMA CELLS; DENDRITIC CELLS; INHIBITION	Background: Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical outcome has not been established. Methods: We performed immunohistochemical analysis of 186 frozen specimens from advanced-stage ovarian carcinomas to assess the distribution of tumor-infiltrating T cells and conducted outcome analyses. Molecular analyses were performed in some tumors by real-time polymerase chain reaction. Results: CD3+ tumor-infiltrating T cells were detected within tumor-cell islets (intratumoral T cells) in 102 of the 186 tumors (54.8 percent); they were undetectable in 72 tumors (38.7 percent); the remaining 12 tumors (6.5 percent) could not be evaluated. There were significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons). The five-year overall survival rate was 38.0 percent among patients whose tumors contained T cells and 4.5 percent among patients whose tumors contained no T cells in islets. Significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons) were also seen among 74 patients with a complete clinical response after debulking and platinum-based chemotherapy: the five-year overall survival rate was 73.9 percent among patients whose tumors contained T cells and 11.9 percent among patients whose tumors contained no T cells in islets. The presence of intratumoral T cells independently correlated with delayed recurrence or delayed death in multivariate analysis and was associated with increased expression of interferon-(gamma), interleukin-2, and lymphocyte-attracting chemokines within the tumor. The absence of intratumoral T cells was associated with increased levels of vascular endothelial growth factor. Conclusions: The presence of intratumoral T cells correlates with improved clinical outcome in advanced ovarian carcinoma.	Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Turin, Dept Obstet & Gynecol, Turin, Italy; Univ Heraklion, Dept Obstet & Gynecol, Iraklion, Greece	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Turin	Coukos, G (corresponding author), Univ Penn, Ctr Res Reprod & Womens Hlth, 1355 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Gimotty, Phyllis/GWZ-4136-2022; Liebman, Michael/A-8556-2009; Conejo-Garcia, Jose R/V-1897-2019; Zhang, Lin/K-8478-2012; Rubin, Stephen/U-8535-2019; Coukos, George/ABG-7389-2020	Gimotty, Phyllis/0000-0002-3850-9799; Liebman, Michael/0000-0002-8626-8432; Conejo-Garcia, Jose R/0000-0001-6431-4074; Rubin, Stephen/0000-0003-3688-5333; Makrigiannakis, Antonis/0000-0002-8475-1500; Coukos, George/0000-0001-8813-7367	NCI NIH HHS [CA-83638] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berek JS, 1999, GYNECOL ONCOL, V75, P10, DOI 10.1006/gyno.1999.5532; Chen CA, 1999, GYNECOL ONCOL, V74, P235, DOI 10.1006/gyno.1999.5418; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dadmarz R D, 1996, Cancer J Sci Am, V2, P263; Favero J, 1998, BIOCHEM PHARMACOL, V56, P1539, DOI 10.1016/S0006-2952(98)00213-5; Freedman R S, 1996, Cancer Treat Res, V82, P115; Freedman RS, 2000, CLIN CANCER RES, V6, P2268; Fujita K, 1995, CLIN CANCER RES, V1, P501; HALAPI E, 1993, CANCER IMMUNOL IMMUN, V36, P191, DOI 10.1007/BF01741091; Halpern AC, 1997, SEMIN ONCOL, V24, pS2; Hartenbach EM, 1997, CANCER LETT, V121, P169, DOI 10.1016/S0304-3835(97)00350-9; Hayashi K, 1999, GYNECOL ONCOL, V74, P86, DOI 10.1006/gyno.1999.5430; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Jemal A, 2002, CA-CANCER J CLIN, V52, P119; Jemal A, 2002, CA-CANCER J CLIN, V52, P181; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Katsaros D, 2001, EUR J CANCER, V37, P478, DOI 10.1016/S0959-8049(00)00423-8; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; KOOI S, 1993, LYMPHOKINE CYTOK RES, V12, P429; Loercher AE, 1999, J IMMUNOL, V163, P6251; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Naito Y, 1998, CANCER RES, V58, P3491; Nakano O, 2001, CANCER RES, V61, P5132; Nakashima M, 1999, NAT MED, V5, P938, DOI 10.1038/11383; Negus RPM, 1997, AM J PATHOL, V150, P1723; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ozols RF, 2000, SEMIN ONCOL, V27, P47; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Pertl U, 2001, J IMMUNOL, V166, P6944, DOI 10.4049/jimmunol.166.11.6944; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.3.CO;2-M; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Santin AD, 2000, OBSTET GYNECOL, V96, P422, DOI 10.1016/S0029-7844(00)00916-9; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; *SAS I, 2000, SAS STAT US GUID VER; SCHLIENGER K, IN PRESS CLIN CANC R; Schumacher K, 2001, CANCER RES, V61, P3932; Shen GH, 2000, BRIT J CANCER, V83, P196; *SPSS, 1997, SPSS ADV STAT VERS 7; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; Sun H, 2001, J IMMUNOTHER, V24, P138, DOI 10.1097/00002371-200103000-00008; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; VESALAINEN S, 1994, EUR J CANCER, V30A, P1797, DOI 10.1016/0959-8049(94)E0159-2; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; Woo EY, 2001, CANCER RES, V61, P4766	50	2421	2509	4	111	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					203	213		10.1056/NEJMoa020177	http://dx.doi.org/10.1056/NEJMoa020177			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529460	Bronze			2022-12-01	WOS:000180390600004
J	Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW				Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW			Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice	SCIENCE			English	Article							GANGLION-CELLS; OLIVARY	In the mammalian retina, a small subset of retinal ganglion cells (RGCs) are intrinsically photosensitive, express the opsin-like protein melanopsin, and project to brain nuclei involved in non image-forming visual functions such as pupillary light re ex and circadian photoentrainment. We report that in mice with the melanopsin gene ablated, RGCs retrograde-labeled from the suprachiasmatic nuclei were no longer intrinsically photosensitive, although their number, morphology, and projections were unchanged. These animals showed a pupillary light re ex indistinguishable from that of the wild type at low irradiances, but at high irradiances the re ex was incomplete, a pattern that suggests that the melanopsin-associated system and the classical rod/cone system are complementary in function.	Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, London W6 8RF, England; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Imperial College London; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Brown University	Lucas, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, Charing Cross Campus,St Dunstans Rd, London W6 8RF, England.	r.j.lucas@ic.ac.uk; kwyau@mail.jhmi.edu	Hattar, Samer/W-6927-2019	Lucas, Robert/0000-0002-1088-8029; FOSTER, RUSSELL/0000-0001-6055-2067	NATIONAL EYE INSTITUTE [R37EY006837, R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY006837, R37 EY006837-15, R01 EY006837-16A1, R37 EY006837-14, R37 EY006837-13, R37 EY006837, R01 EY014596-01, R37 EY006837-15S1, R01 EY014596] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	12	611	630	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					245	247		10.1126/science.1077293	http://dx.doi.org/10.1126/science.1077293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522249				2022-12-01	WOS:000180284000037
J	Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE				Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE			Single-gene greenbeard effects in the social amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELL-ADHESION	Selection can favor reproductive altruism if an altruism allele aids copies of itself by helping relatives. The alternative "greenbeard" mechanism, in which an allele directly recognizes and aids copies of itself in others, is generally thought to be too complex for a single gene to carry out. The csA gene in Dictyostelium discoideum acts as a single-gene greenbeard. When wild-type cells are mixed with csA-knockout cells, the wild type is more altruistic, but is also able preferentially to direct the benefits to other wild-type cells. Both properties derive directly from homophilic cell adhesion of the protein encoded by csA.	Rice Univ, Dept Ecol & Evolut, Houston, TX 77251 USA; Univ Turin, Osped S Luigi, Dept Clin & Biol Sci, I-10043 Orbassano, Italy	Rice University; University of Turin	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolut, POB 1892, Houston, TX 77251 USA.			bozzaro, salvatore/0000-0001-6323-6190; Strassmann, Joan/0000-0003-0638-8440				Alexander RD., 1979, DARWINISM HUMAN AFFA; Bozzaro S, 1995, EXPERIENTIA, V51, P1175, DOI 10.1007/BF01944735; Dawkins R., 1976, SELFISH GENE; FORTUNATO A, IN PRESS MOL ECOL; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAIG D, 1996, BEHAV ECOLOGY EVOLUT, P284; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Maree AFM, 1999, J THEOR BIOL, V199, P297, DOI 10.1006/jtbi.1999.0958; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	18	202	207	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					105	106		10.1126/science.1077742	http://dx.doi.org/10.1126/science.1077742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511650				2022-12-01	WOS:000180165800043
J	Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW				Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW			Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour	NATURE			English	Article							AMPHETAMINE ADMINISTRATION ALTERS; RAT NUCLEUS-ACCUMBENS; IN-VIVO; GLUTAMATE TRANSMISSION; PREFRONTAL CORTEX; EXPRESSION; NEURONS; SENSITIZATION; SENSITIVITY; RESPONSES	Cocaine addiction is thought to involve persistent neurobiological changes that facilitate relapse to drug use despite efforts to abstain. But the propensity for relapse may be reduced by extinction training-a form of inhibitory learning that progressively reduces cocaine-seeking behaviour in the absence of cocaine reward(1). Here we show that extinction training during withdrawal from chronic cocaine self-administration induces experience-dependent increases in the GluR1 and GluR2/3 subunits of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) glutamate receptors in the nucleus accumbens shell, a brain region that is critically involved in cocaine reward(2-5). Increases in the GluR1 subunit are positively associated with the level of extinction achieved during training, suggesting that GluR1 may promote extinction of cocaine seeking. Indeed, viral-mediated overexpression of both GluR1 and GluR2 in nucleus accumbens shell neurons facilitates extinction of cocaine- but not sucrose-seeking responses. A single extinction training session, when conducted during GluR subunit overexpression, attenuates stress-induced relapse to cocaine seeking even after GluR overexpression declines. Our findings indicate that extinction-induced plasticity in AMPA receptors may facilitate control over cocaine seeking by restoring glutamatergic tone in the nucleus accumbens, and may reduce the propensity for relapse under stressful situations in prolonged abstinence.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Div Mol Psychiat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; Harvard University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.		Jansen, Heiko T./A-5770-2008; Schmidt, Eric F./AAE-8723-2019; Sutton, Michael/C-6264-2011	Jansen, Heiko T./0000-0003-0178-396X; Schmidt, Eric F./0000-0002-7869-0270; Sutton, Michael/0000-0002-0692-6459				Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Fabbricatore A. T., 1998, Society for Neuroscience Abstracts, V24, P1736; Guitart X, 2000, NEUROPSYCHOPHARMACOL, V23, P539, DOI 10.1016/S0893-133X(00)00142-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Keys AS, 1998, SYNAPSE, V30, P393, DOI 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H; London ED, 1999, CRIT REV NEUROBIOL, V13, P227, DOI 10.1615/CritRevNeurobiol.v13.i3.10; Lu WX, 1997, SYNAPSE, V26, P269, DOI 10.1002/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5; Lu WX, 1999, SYNAPSE, V32, P119, DOI 10.1002/(SICI)1098-2396(199905)32:2<119::AID-SYN5>3.0.CO;2-F; MCLENNAN H, 1980, NEUROSCI LETT, V18, P313, DOI 10.1016/0304-3940(80)90303-1; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Robbins SJ, 1997, ADDICT BEHAV, V22, P157, DOI 10.1016/S0306-4603(96)00007-X; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1992, SYNAPSE, V11, P184, DOI 10.1002/syn.890110303; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	30	266	272	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					70	75		10.1038/nature01249	http://dx.doi.org/10.1038/nature01249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511956				2022-12-01	WOS:000180165500039
J	Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M				Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M			Dignity in the terminally ill: a cross-sectional, cohort study	LANCET			English	Article							PHYSICIAN-ASSISTED SUICIDE; CANCER-PATIENTS; EUTHANASIA; EXPERIENCES; DEPRESSION; ATTITUDES; ILLNESS; OREGON; DEATH; LIFE	Background Considerations of dignity are often raised in reference to the care of dying patients. However, little research that addresses this issue has been done. Our aim was to identify the extent to which dying patients perceive they are able to maintain a sense of dignity, and to ascertain how demographic and disease-specific variables relate to the issue of dignity in these individuals. Methods We did a cross-sectional study of a cohort of terminally ill patients with cancer, who had a life expectancy of less than 6 months. We enrolled 213 patients from two palliative care units in Winnipeg, Canada, and asked them to rate their sense of dignity. Our main outcome measures included: a 7-point sense of dignity item; the symptom distress scale; the McGill pain questionnaire; the index of independence in activities of daily living (IADL); a quality of life scale; a brief battery of self-report measures, including screening for desire for death, anxiety, hopelessness, and will to live; burden to others; and requirement for social support. Findings 16 of 213 patients (7.5%; 95% Cl 4-11) indicated that loss of dignity was a great concern. These patients were far more than likely than the rest of the cohort to report psychological distress and symptom distress, heightened dependency needs, and loss of will to live. Interpretation Loss of dignity is closely associated with certain types of distress often seen among the terminally ill. Preservation of dignity should be an overall aim of treatment and care in patients who are nearing death.	Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada; Univ Manitoba, Fac Nursing, Winnipeg, MB R3E 3N4, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; Edith Cowan Univ, Perth, WA, Australia	University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba; Children's Hospital Research Institute of Manitoba; Edith Cowan University	Chochinov, HM (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada.	chochin@cc.UManitoba.CA	McClement, Susan E/H-7031-2016; Hack, Thomas/C-5174-2012	McClement, Susan E/0000-0002-9537-9900; Hack, Thomas/0000-0002-6913-8732; Chochinov, Harvey/0000-0003-2656-4704				Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BRORSSON B, 1984, SCAND J REHABIL MED, V16, P125; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CRAIG TJ, 1974, AM J PSYCHIAT, V131, P1323; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; GRAHAM KY, 1987, CANCER NURS, V10, P338; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; LEVINE PM, 1978, CANCER, V42, P1385, DOI 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0; MADAN TN, 1992, SOC SCI MED, V35, P425, DOI 10.1016/0277-9536(92)90335-N; McCorkle R, 1978, Cancer Nurs, V1, P373; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; NOYES R, 1990, PSYCHOSOMATICS, V31, P321, DOI 10.1016/S0033-3182(90)72170-6; Pannuti F, 1993, World Health Forum, V14, P172; Pullman D, 1996, Health Law J, V4, P197; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	29	246	257	4	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2026	2030		10.1016/S0140-6736(02)12022-8	http://dx.doi.org/10.1016/S0140-6736(02)12022-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504398				2022-12-01	WOS:000179974200010
J	Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R				Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R			Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia	LANCET			English	Article							CD38 EXPRESSION; ATP RECEPTOR; LEUKEMIA; P2X(7); CELLS	Background The P2X7 receptor is a ligand-gated cation channel that mediates ATP-induced apoptotic death in haemopoietic and chronic lymphocytic leukaemia (CLL) cells. We aimed to investigate the clinical effect of a single nucleotide polymorphism in the P2X7 receptor gene (1513A-->C) and correlate findings with the immunoglobulin heavy chain variable (V-H) gene mutation status, a prognostic marker in CLL. Methods We investigated tumour DNA in 170 patients with CLL using PCR-RFLP analysis with Hhal restriction enzyme cleavage to screen for the polymorphism in the P2X7 receptor gene. The V gene mutation status was assessed in 165 patients by PCR amplification and nucleotide sequencing. We correlated the findings of the P2X7 receptor genotype with the V-H gene mutation data and overall survival and screened for the P2X7 receptor polymorphism in 200 healthy controls. Findings Of the 170 patients, 35 (21%) were heterozygous and one (1%) homozygous for the 1513C allele; whereas 134 (79%) had the 1513A/A genotype of the P2X7 receptor gene. Overall survival was significantly longer for patients with CLL heterozygous for the 1513C allele than those with the 1513A/A genotype. Median survival for heterozygous patients was 104 months (range 33-467) and 72 months (1-190) for homozygous patients (p=0.009). Of the 165 patients with CLL in whom we assessed the V-H gene mutation status, the V-H genes were mutated in 71 (43%) patients and unmutated in 94; 18 (25%) of the 71 patients with mutated genes had 1513C allele compared with 17 (18%) of 94 who had unmutated genes. In patients with mutated V-H genes, those with CLL who were 1513C positive had 53 months' longer median survival than did those with the 1513A/A genotype (151 vs 98 months, p=0.011). Interpretation The P2X7 polymorphism could affect clinical outcome in CLL, especially in patients with mutated V-H genes. Studies are necessary to elucidate the biological role of the P2X7 polymorphism in CLL in vivo.	Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Oncol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Radiol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Clin Immunol, S-75185 Uppsala, Sweden; Karolinska Inst, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Umea University	Rosenquist, R (corresponding author), Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.		Padyukov, Leonid/A-4890-2009; Söderberg, Ola/O-5130-2017	Padyukov, Leonid/0000-0003-2950-5670; Söderberg, Ola/0000-0003-2883-1925; Klareskog, Lars/0000-0001-9601-6186; Rosenquist, Richard/0000-0002-0211-8788				Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Bange J, 2002, CANCER RES, V62, P840; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Jaffe ES, 2001, WHO CLASSIFICATION T; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li AH, 1999, EUR J HAEMATOL, V63, P211; MATUTES E, 1994, LEUKEMIA, V8, P1640; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Thunberg U, 2001, BLOOD, V97, P1892, DOI 10.1182/blood.V97.6.1892; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224	24	78	80	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1935	1939		10.1016/S0140-6736(02)11917-9	http://dx.doi.org/10.1016/S0140-6736(02)11917-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493261				2022-12-01	WOS:000179870200013
J	Colegrave, N				Colegrave, N			Sex releases the speed limit on evolution	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; RECOMBINATION; SELECTION; ADAPTATION	Explaining the evolutionary maintenance of sex remains a key problem in evolutionary biology(1-3). One potential benefit of sex is that it may allow a more rapid adaptive response when environmental conditions change, by increasing the efficiency with which selection can fix beneficial mutations(4-7). Here I show that sex can increase the rate of adaptation in the facultatively sexual single-celled chlorophyte Chlamydomonas reinhardtii, but that the benefits of sex depend crucially on the size of the population that is adapting: sex has a marked effect in large populations but little effect in small populations. Several mechanisms have been proposed to explain the benefits of sex in a novel environment, including stochastic effects in small populations, clonal interference and epistasis between beneficial alleles. These results indicate that clonal interference is important in this system.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Colegrave, N (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Colegrave, Nick/F-3916-2010					Bell G., 1982, MASTERPIECE NATURE; Burt A, 2000, EVOLUTION, V54, P337; Colegrave N, 2002, EVOLUTION, V56, P14; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Fisher R., 2005, TEACHING CHILDREN TH; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Maynard-Smith J., 1978, MODELS ECOLOGY; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; West SA, 1999, J EVOLUTION BIOL, V12, P1003	15	185	189	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					664	666		10.1038/nature01191	http://dx.doi.org/10.1038/nature01191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478292	Green Published			2022-12-01	WOS:000179751800044
J	Sagata, N				Sagata, N			Untangling checkpoints	SCIENCE			English	Editorial Material							DNA-DAMAGE; REPLICATION CHECKPOINT; CDC25; CHK1; PATHWAY; ATR		Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	Kyushu University	Sagata, N (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan.							Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Walworth NC, 2001, CURR OPIN GENET DEV, V11, P78, DOI 10.1016/S0959-437X(00)00160-X; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	15	15	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1905	+		10.1126/science.1079225	http://dx.doi.org/10.1126/science.1079225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471241				2022-12-01	WOS:000179629200028
J	Hopkins, DR; Withers, PC				Hopkins, DR; Withers, PC			Sudan's war and eradication of dracunculiasis	LANCET			English	Article									Carter Ctr, Programme Support Hlth Programmes, Atlanta, GA 30307 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Hopkins, DR (corresponding author), Carter Ctr, Programme Support Hlth Programmes, 1 Copenhill,453 Freedom Pkwy, Atlanta, GA 30307 USA.							FISCHER I, 2000, NY TIMES        0211; HOPKINS DR, IN PRESS AM J TROP M; *US CDC, 2001, MMWR-MORBID MORTAL W, V50, P269	3	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S21	S22		10.1016/S0140-6736(02)11806-X	http://dx.doi.org/10.1016/S0140-6736(02)11806-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504489				2022-12-01	WOS:000180064500010
J	Birgens, H				Birgens, H			Clinical errors	LANCET			English	Editorial Material									Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Birgens, H (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1775	1775		10.1016/S0140-6736(02)11670-9	http://dx.doi.org/10.1016/S0140-6736(02)11670-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480444				2022-12-01	WOS:000179636800028
J	Fromm, RE; Weltge, A; Varon, J				Fromm, RE; Weltge, A; Varon, J			Public use of automatic defibrillators: a bolt from the blue	LANCET			English	Editorial Material									Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Fromm, RE (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA.		Varon, Joseph/R-5198-2019; Varon, Joseph/T-9481-2019	Varon, Joseph/0000-0002-7622-9974				[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P123; Becker LB, 1991, AM J EMERG MED, V20, P335; Bigger JT, 2002, NEW ENGL J MED, V346, P931, DOI 10.1056/NEJMe020011; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; CUMMINS RO, 1984, ANN EMERG MED, V13, P798, DOI 10.1016/S0196-0644(84)80441-2; DIACK AW, 1979, MED INSTRUM, V13, P78; Fromm RE, 1997, RESUSCITATION, V33, P219, DOI 10.1016/S0300-9572(96)01036-2; WALTERS G, 1994, RESUSCITATION, V27, P39, DOI 10.1016/0300-9572(94)90020-5; 2000, CIRCULATION S1, V102, P60	9	0	0	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1712	1712		10.1016/S0140-6736(02)11724-7	http://dx.doi.org/10.1016/S0140-6736(02)11724-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480420				2022-12-01	WOS:000179636800004
J	Colburn, KA; Johnson, PRS				Colburn, KA; Johnson, PRS			Air pollution concerns not changed by S-PLUS flaw	SCIENCE			English	Editorial Material									NESCAUM, Boston, MA 02114 USA		Johnson, PRS (corresponding author), NESCAUM, Boston, MA 02114 USA.	pjohnson@nescaum.org						[Anonymous], 2000, 94 HLTH EFF I; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; DEVLIN RB, IN PRESS EUR RESP J; DOCKERY DW, 1993, NEW ENGL J MED, V329, P24; DOMINICI F, 2002, REPORT HLTH EFFECTS; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Health Effects Institute, 2001, AIRB PART HLTH HEI E; *HLTH EFF I, 2002, IMP NEW FIND NMMAPS; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; KATSOUYANNI K, 1997, BMJ-BRIT MED J, V314, P7095; Krewski D., 2000, REANALYSIS HARVARD 6; Peters A, 2000, EPIDEMIOLOGY, V11, P11, DOI 10.1097/00001648-200001000-00005; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, CIRCULATION, V103, P2810; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P3; SAMOLI E, 2001, ENV HLTH PERSPECT, V109, P4; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; SCHWARTZ J, 2000, ENV HLTH PERSPECT, V108, P6; SCHWARTZ J, 1996, J AIR WASTE MANAGE, V46, P10; SCHWARTZ J, 2002, ENV HLTH PERSPECT, V110, P10; SCHWARTZ J, 2002, CLEAN AIR SCI ADV CO; SCHWARTZ J, 2002, REANALYSIS NMMAPS MO; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; *US EPA, 2002, CLEAN AIR SCI ADV CO, P175; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015; [No title captured]	30	15	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					665	666		10.1126/science.1082105	http://dx.doi.org/10.1126/science.1082105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560535				2022-12-01	WOS:000180687700029
J	Zilberman, D; Cao, XF; Jacobsen, SE				Zilberman, D; Cao, XF; Jacobsen, SE			ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation	SCIENCE			English	Article							EPIGENETIC ALLELES; GENE; ARABIDOPSIS; PROTEINS; RNA	Proteins of the ARGONAUTE family are important in diverse posttranscriptional RNA-mediated gene-silencing systems as well as in transcriptional gene silencing in Drosophila and fission yeast and in programmed DNA elimination in Tetrahymena. We cloned ARGONAUTE4 (AGO4) from a screen for mutants that suppress silencing of the Arabidopsis SUPERMAN (SUP) gene. The ago4-1 mutant reactivated silent SUP alleles and decreased CpNpG and asymmetric DNA methylation as well as histone H3 lysine-9 methylation. In addition, ago4-1 blocked histone and DNA methylation and the accumulation of 25-nucleotide small interfering RNAs (siRNAs) that correspond to the retroelement AtSN1. These results suggest that AGO4 and long siRNAs direct chromatin modifications, including histone methylation and non-CpG DNA methylation.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.			Zilberman, Daniel/0000-0002-0123-8649	NIGMS NIH HHS [GM07185, GM60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE D, COMMUNICATION; CAO X, 2002, P NATL ACAD SCI US; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	22	798	875	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					716	719		10.1126/science.1079695	http://dx.doi.org/10.1126/science.1079695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522258				2022-12-01	WOS:000180687700050
J	Breman, JG; Arita, I; Fenner, F				Breman, JG; Arita, I; Fenner, F			Preventing the return of smallpox	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Fogarty Int Ctr, Bethesda, MD 20892 USA; Agcy Cooperat Int Hlth, Kumamoto, Japan; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Australian National University; John Curtin School of Medical Research	Breman, JG (corresponding author), Fogarty Int Ctr, Bldg 16,Rm 214,16 Ctr Dr, Bethesda, MD 20892 USA.							Alibek K, 1999, BIOHAZARD CHILLING T; Basu RN, 1979, ERADICATION SMALLPOX; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; *CBW ARM ARMS LIM, 2003, CONV PROH DEV PROD S; Centers for Disease Control and Prevention, 2002, SMALLP RESP PLAN GUI; CONNOLLY C, 2002, WASHINGTON POST 1224, pA5; Connolly C, 2002, WASH POST, pA1; Fenner F., 1988, SMALLPOX ITS ERADICA; FOEGE WH, 1971, AM J EPIDEMIOL, V94, P311, DOI 10.1093/oxfordjournals.aje.a121325; Gellman B., 2002, WASHINGTON POST 0120, pA1; GELLMAN B, 2002, WASHINGTON POST 1104, pA4; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Preston R., 2002, DEMON FREEZER TRUE S; *UN, 2002, BIOL WEAP CONV; WHO, 2002, WHOCDSCSRGAR20024, P6; *WHO, 2002, WHA5516 WHO; World Health Organisation, 2002, WHOCDSCSREPH200216; 2002, MONTEREY I INT STUDI	18	15	19	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					463	466		10.1056/NEJMp025175	http://dx.doi.org/10.1056/NEJMp025175			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12556549	Bronze			2022-12-01	WOS:000180643800015
J	Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK				Pantelis, C; Velakoulis, D; McGorry, PD; Wood, SJ; Suckling, J; Phillips, LJ; Yung, AR; Bullmore, ET; Brewer, W; Soulsby, B; Desmond, P; McGuire, PK			Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison	LANCET			English	Article							HIPPOCAMPAL VOLUME; FUNCTIONAL-PSYCHOSIS; MATTER CHANGES; SCHIZOPHRENIA; BRAIN; DISORDER; RISK; ENLARGEMENT; ILLNESS; ATLAS	Background Psychotic disorders, such as schizophrenia, are associated with neuroanatomical abnormalities, but whether these predate the onset of symptoms or develop progressively over the course of illness is unclear. We investigated this issue with MRI to study people with prodromal symptoms who are at ultra high-risk for the development of psychosis. Methods We did two comparisons, cross-sectional and longitudinal. For the cross-sectional comparison, 75 people with prodromal signs of psychosis were scanned with MRI. After at least 12 months of follow-up, 23 (31%) had developed psychosis and 52 (69%) had not. Baseline MRI data from these two subgroups were compared. For the longitudinal comparison, 21 of the ultra high-risk individuals were scanned again with MRI after at least 12 months. Ten of these had developed psychosis and 11 had not. MRI data from baseline and follow-up were compared within each group of people. Findings In the cross-sectional comparison, compared with people who did not develop psychosis, those who did develop the disorder had less grey matter in the right medial temporal, lateral temporal, and inferior frontal cortex, and in the cingulate cortex bilaterally. In the longitudinal comparison, when re-scanned, individuals who had developed psychosis showed a reduction in grey matter in the left parahippocampal, fusiform, orbitofrontal and cerebellar cortices, and the cingulate gyri. In those who had not become psychotic, longitudinal changes were restricted to the cerebellum. Interpretation Some of the grey-matter abnormalities associated with psychotic disorders predate the onset of frank symptoms, whereas others appear in association with their first expression.	Univ Melbourne, Dept Psychiat, Mental Hlth Programme, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; Univ Melbourne, Cognit Neuropsychiat Res & Acad Unit, Melbourne, Vic, Australia; Sunshine Hosp, Melbourne, Vic, Australia; Mental Hlth Res Inst Victoria, Appl Schizophrenia Div, Melbourne, Vic, Australia; Univ Melbourne, Personal Assessment & Crisis Evaluat Clin, Early Psychosis Prevent & Intervent Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia; Guys Kings & St Thomas Med Sch, Clin Age Res Unit, London, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 1TN, England; Inst Psychiat, Sect Neuroimaging, London, England; S London & Maudsley NHS Trust, Outreach & Support S London, London, England	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of London; King's College London; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust	Pantelis, C (corresponding author), Sunshine Hosp, Cognit Neuropsychiat Res & Acad Unit, POB 294, St Albans, Vic 3021, Australia.	cpant@unimelb.edu.au	Suckling, John/ABD-7246-2021; Yung, Alison/N-6729-2019; McGorry, Patrick/O-4115-2019; Wood, Stephen/ABF-4086-2020; Velakoulis, Dennis/A-4778-2008; Pantelis, Christos/H-7722-2014; Wood, Stephen J/M-8652-2014; Bullmore, Ed/C-1706-2012; Desmond, Patricia/D-1966-2014	Suckling, John/0000-0002-5098-1527; Yung, Alison/0000-0002-0401-9791; Wood, Stephen/0000-0003-4186-5919; Velakoulis, Dennis/0000-0002-8842-8479; Pantelis, Christos/0000-0002-9565-0238; Wood, Stephen J/0000-0003-4186-5919; Bullmore, Ed/0000-0002-8955-8283; McGorry, Patrick/0000-0002-3789-6168; Desmond, Patricia/0000-0002-4803-6323; McGuire, Philip/0000-0003-4381-0532; Phillips, Lisa/0000-0003-1060-6068				AASLY J, 1993, ACTA NEUROL SCAND, V87, P210; Altshuler LL, 2000, BIOL PSYCHIAT, V48, P147, DOI 10.1016/S0006-3223(00)00836-2; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cannon TD, 2001, NEUROIMAGE, V13, pS1034; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Crespo-Facorro B, 1999, AM J PSYCHIAT, V156, P386; CROW TJ, 1990, ACTA PSYCHIAT SCAND, V81, P401, DOI 10.1111/j.1600-0447.1990.tb05471.x; Dickey CC, 1999, BIOL PSYCHIAT, V45, P1393, DOI 10.1016/S0006-3223(99)00030-X; ELKIS H, 1995, ARCH GEN PSYCHIAT, V52, P735; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; JOHNSTONE EC, 1992, PSYCHOL MED, V22, P331, DOI 10.1017/S0033291700030270; KESHAVAN MS, 1994, LANCET, V344, P1434, DOI 10.1016/S0140-6736(94)90599-1; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; McGorry PD, 2002, ARCH GEN PSYCHIAT, V59, P921, DOI 10.1001/archpsyc.59.10.921; MCGORRY PD, 1990, SCHIZOPHR RES, V3, P221, DOI 10.1016/0920-9964(90)90002-O; PANTELIS C, 2001, COGNITIVE DEFICITS B, P217; Phillips LJ, 2002, SCHIZOPHR RES, V58, P145, DOI 10.1016/S0920-9964(01)00392-9; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Roy PD, 1998, BIOL PSYCHIAT, V44, P418, DOI 10.1016/S0006-3223(98)00105-X; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; Suckling J, 1999, MAGN RESON IMAGING, V17, P1065, DOI 10.1016/S0730-725X(99)00055-7; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; van Os J, 1999, SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, VOL IV, P59; Velakoulis D, 1999, ARCH GEN PSYCHIAT, V56, P133, DOI 10.1001/archpsyc.56.2.133; Videbech P, 1997, ACTA PSYCHIAT SCAND, V96, P157, DOI 10.1111/j.1600-0447.1997.tb10146.x; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Wood SJ, 2001, SCHIZOPHR RES, V52, P37, DOI 10.1016/S0920-9964(01)00175-X; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; WYATT RJ, 1995, BIOL PSYCHIAT, V38, P1, DOI 10.1016/0006-3223(95)00191-I; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602	32	977	993	1	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2003	361	9354					281	288		10.1016/S0140-6736(03)12323-9	http://dx.doi.org/10.1016/S0140-6736(03)12323-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RV	12559861	Green Submitted			2022-12-01	WOS:000180643900008
J	Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B				Sundareshwar, PV; Morris, JT; Koepfler, EK; Fornwalt, B			Phosphorus limitation of coastal ecosystem processes	SCIENCE			English	Article							NITROGEN-FIXATION; SPARTINA-ALTERNIFLORA; BACTERIA; GROWTH; BACTERIOPLANKTON	Primary production in coastal wetlands is conventionally thought to be limited by nitrogen. Although the plant community in a pristine salt marsh was found to be limited primarily by nitrogen availability, the bacterial community in the soil was limited by phosphorus. Hence, in coastal wetlands, and possibly in many ecosystems, individual trophic groups may respond differently to nitrogen and phosphorus loading. Phosphorus limitation of the growth of nitrogen-transforming bacteria will affect carbon fixation, storage, and release mediated by plants, a result that has important implications for ecosystem management.	Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; Coastal Carolina Univ, Dept Marine Sci, Conway, SC 29526 USA	Duke University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Coastal Carolina University	Sundareshwar, PV (corresponding author), Duke Univ, Wetland Ctr, Nicholas Sch Environm & Earth Sci, Box 90333, Durham, NC 27708 USA.	pvs@duke.edu	morris, james/ABC-8111-2020; morris, james t/A-7003-2009					Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bonin P, 2002, WATER RES, V36, P722, DOI 10.1016/S0043-1354(01)00269-X; BOYLE CD, 1981, NEW PHYTOL, V89, P275, DOI 10.1111/j.1469-8137.1981.tb07488.x; BROOME SW, 1975, SOIL SCI SOC AM J, V39, P301, DOI 10.2136/sssaj1975.03615995003900020022x; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; CREWS TE, 1993, BIOGEOCHEMISTRY, V21, P141, DOI 10.1007/BF00001115; deSouza MP, 1997, ESTUAR COAST SHELF S, V45, P547, DOI 10.1006/ecss.1996.0221; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; FINDLAY SEG, 1984, J MICROBIOL METH, V2, P57, DOI 10.1016/0167-7012(84)90031-9; GALLARDO A, 1994, SOIL BIOL BIOCHEM, V26, P1409, DOI 10.1016/0038-0717(94)90225-9; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; JANSSON M, 1988, HYDROBIOLOGIA, V170, P157, DOI 10.1007/BF00024903; KROER N, 1993, LIMNOL OCEANOGR, V38, P1282, DOI 10.4319/lo.1993.38.6.1282; Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260; Mallin MA, 2000, AM SCI, V88, P26, DOI 10.1511/2000.1.26; MORRIS JT, 1990, ECOLOGY, V71, P2209, DOI 10.2307/1938633; Morris JT, 1999, LIMNOL OCEANOGR, V44, P699, DOI 10.4319/lo.1999.44.3.0699; NOWICKI BL, 1994, ESTUAR COAST SHELF S, V38, P137, DOI 10.1006/ecss.1994.1009; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; POMEROY LR, 1995, MAR ECOL PROG SER, V117, P259, DOI 10.3354/meps117259; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SEITZINGER SP, 1983, SCIENCE, V222, P1244, DOI 10.1126/science.222.4629.1244; SMITH VH, 1992, BIOGEOCHEMISTRY, V18, P19, DOI 10.1007/BF00000424; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; VALIELA I, 1974, ECOLOGY HALOPHYTES, P547, DOI DOI 10.1016/B978-0-12-586450-3.50025-1; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Welsh DT, 2000, ECOL LETT, V3, P58, DOI 10.1046/j.1461-0248.2000.00111.x; WHEELER PA, 1986, LIMNOL OCEANOGR, V31, P998, DOI 10.4319/lo.1986.31.5.0998	30	271	299	14	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					563	565		10.1126/science.1079100	http://dx.doi.org/10.1126/science.1079100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543975				2022-12-01	WOS:000180559800049
J	Martin, SG; St Johnston, D				Martin, SG; St Johnston, D			A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; TUMOR-SUPPRESSOR; RNA LOCALIZATION; PAR-1; LKB1/STK11; HOMOLOG; ENCODES; MOSAICS; PKA	The PAR-4 and PAR-1 kinases are necessary for the formation of the anterior-posterior (A-P) axis in Caenorhabditis elegans(1-3). PAR-1 is also required for A-P axis determination in Drosophila(4,5). Here we show that the Drosophila par-4 homologue, lkb1, is required for the early A-P polarity of the oocyte, and for the repolarization of the oocyte cytoskeleton that defines the embryonic A-P axis. LKB1 is phosphorylated by PAR-1 in vitro, and overexpression of LKB1 partially rescues the par-1 phenotype. These two kinases therefore function in a conserved pathway for axis formation in flies and worms. lkb1 mutant clones also disrupt apical-basal epithelial polarity, suggesting a general role in cell polarization. The human homologue, LKB1, is mutated in Peutz-Jeghers syndrome(6,7) and is regulated by prenylation and by phosphorylation by protein kinase A(8,9). We show that protein kinase A phosphorylates Drosophila LKB1 on a conserved site that is important for its activity. Thus, Drosophila and human LKB1 may be functional homologues, suggesting that loss of cell polarity may contribute to tumour formation in individuals with Peutz-Jeghers syndrome.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	ds139@mole.bio.cam.ac.uk	St Johnston, Daniel/C-9568-2009; Martin, Sophie/AAE-3198-2019	Martin, Sophie/0000-0002-5317-2557; St Johnston, Daniel/0000-0001-5582-3301				Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Chou TB, 1996, GENETICS, V144, P1673; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hemminki A, 1999, CELL MOL LIFE SCI, V55, P735, DOI 10.1007/s000180050329; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; Martin J, 2001, J TURBUL, V2, P1; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Spradling Allan C., 1993, P1; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Watts JL, 2000, DEVELOPMENT, V127, P1467; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843	30	239	248	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2003	421	6921					379	384		10.1038/nature01296	http://dx.doi.org/10.1038/nature01296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540903				2022-12-01	WOS:000180533000044
J	Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ				Timms, JM; Bell, A; Flavell, JR; Murray, PG; Rickinson, AB; Traverse-Glehen, A; Berger, F; Delecluse, HJ			Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma	LANCET			English	Article							REED-STERNBERG CELLS; INFECTED B-CELLS; V-H GENES; SOMATIC HYPERMUTATION; IN-VIVO; EXPRESSION; DISORDERS; HETEROGENEITY; STRATEGIES; MUTATIONS	Background Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) encompasses a histologically broad range of lesions, arising from the expanded pool of EBV-infected B cells in the immunocompromised host. Identification of the precise cellular origin of these tumours could clarify their pathogenesis. Methods Of 13 cases of EBV-positive cases of PTLD characterised by histological analysis, pattern of EBV gene expression, and clinical course, 11 had monoclonal or biclonal lesions in which we determined the progenitor B cell by immunoglobulin heavy chain (IgH) genotyping. Results Two tumours had a naive B cell genotype and two showed patterns of IgH somatic mutation typical of antigen-selected (post-germinal-centre) memory cells. All four arose early post-transplant and expressed the markers of EBV transformation-Epstein-Barr nuclear antigen (EBNA) 2 and latent membrane protein (LMP) 1. However, seven tumours, either of early or late onset and including some with downregulated EBNA 2 and LMP 1, arose from post-germinal cells with randomly mutated or sterile IgH genotypes usually incompatible with B-cell survival in vivo. Interpretation PTLD can arise from a broad range of target B cells and not only from the pool of antigen-selected memory cells that EBV generally colonises in immunocompetent individuals. Tumour development seems frequently associated with the EBV-induced rescue and expansion of B cells that have failed the physiological process of germinal centre selection into memory. This finding shows an unexpected connection between pathogenesis of PTLD and that of EBV-positive Hodgkin's lymphoma, another B-cell malignancy of atypical post-germinal-centre cell origin.	Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Ctr Hosp Lyon Sud, Serv Anat Pathol, F-69310 Pierre Benite, France	University of Birmingham; Cancer Research UK; University of Birmingham; CHU Lyon	Delecluse, HJ (corresponding author), Univ Birmingham, Dept Pathol, Birmingham B15 2TT, W Midlands, England.	H.Delecluse@bham.ac.uk		Delecluse, Henri-Jacques/0000-0002-1744-6274; Bell, Andrew/0000-0001-9520-4417				AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; AUBIN J, 1995, LEUKEMIA, V9, P471; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bierman PJ, 1996, ANN ONCOL, V7, P265; Brauninger A, 2001, J EXP MED, V194, P927, DOI 10.1084/jem.194.7.927; Cesarman E, 1998, BLOOD, V92, P2294, DOI 10.1182/blood.V92.7.2294.2294_2294_2302; CHAPMAN CJ, 1995, BLOOD, V85, P2176, DOI 10.1182/blood.V85.8.2176.bloodjournal8582176; DELECLUSE HJ, 1995, AM J PATHOL, V146, P1113; Garnier JL, 1996, TRANSPLANTATION, V61, P71, DOI 10.1097/00007890-199601150-00015; HANTO DW, 1989, TRANSPLANTATION, V47, P458, DOI 10.1097/00007890-198903000-00012; HERBST H, 1991, P NATL ACAD SCI USA, V88, P4766, DOI 10.1073/pnas.88.11.4766; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Klein U, 1998, IMMUNOL REV, V162, P261; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kurth J, 2000, IMMUNITY, V13, P485, DOI 10.1016/S1074-7613(00)00048-0; LEVY S, 1988, J EXP MED, V168, P475, DOI 10.1084/jem.168.2.475; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; NALESNIK MA, 1993, CANCER-AM CANCER SOC, V72, P2568, DOI 10.1002/1097-0142(19931101)72:9<2568::AID-CNCR2820720910>3.0.CO;2-D; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rowlings PA, 1999, J CLIN ONCOL, V17, P3122, DOI 10.1200/JCO.1999.17.10.3122; STARZL TE, 1984, LANCET, V1, P583; TAMARU J, 1995, AM J PATHOL, V147, P1398; THOMAS JA, 1990, TRANSPLANTATION, V49, P944, DOI 10.1097/00007890-199005000-00022; World Health Organization, 2001, PATH GEN TUM HAEM LY; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	29	119	120	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2003	361	9353					217	223		10.1016/S0140-6736(03)12271-4	http://dx.doi.org/10.1016/S0140-6736(03)12271-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637VX	12547545				2022-12-01	WOS:000180535400011
J	Whiting, MF; Bradler, S; Maxwell, T				Whiting, MF; Bradler, S; Maxwell, T			Loss and recovery of wings in stick insects	NATURE			English	Article							CHARACTER STATES; DNA-SEQUENCES; PHYLOGENY; FLIGHTLESSNESS	The evolution of wings was the central adaptation allowing insects to escape predators, exploit scattered resources, and disperse into new niches, resulting in radiations into vast numbers of species(1). Despite the presumed evolutionary advantages associated with full-sized wings (macroptery), nearly all pterygote (winged) orders have many partially winged (brachypterous) or wingless (apterous) lineages, and some entire orders are secondarily wingless (for example, fleas, lice, grylloblattids and mantophasmatids), with about 5% of extant pterygote species being flightless(2,3). Thousands of independent transitions from a winged form to winglessness have occurred during the course of insect evolution; however, an evolutionary reversal from a flightless to a volant form has never been demonstrated clearly for any pterygote lineage. Such a reversal is considered highly unlikely because complex interactions between nerves, muscles, sclerites and wing foils are required to accommodate flight(4). Here we show that stick insects (order Phasmatodea) diversified as wingless insects and that wings were derived secondarily, perhaps on many occasions. These results suggest that wing developmental pathways are conserved in wingless phasmids, and that 're-evolution' of wings has had an unrecognized role in insect diversification.	Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA; Univ Gottingen, Inst Zool & Anthropol, D-3400 Gottingen, Germany; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Brigham Young University; University of Gottingen; Washington University (WUSTL)	Whiting, MF (corresponding author), Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA.	Michael_Whiting@byu.edu	Bradler, Sven/D-8655-2015	Bradler, Sven/0000-0001-9307-1032				Andersen Nils Moller, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P91; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Bradler S., 2001, ZOOLOGY S3, V104, P69, DOI DOI 10.1016/J.CRVI.2011.01.006; COHEN B, 1993, DEVELOPMENT, V117, P597; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dudley R., 2000, BIOMECHANICS INSECT; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Gunther K., 1953, Beitraege zur Entomologie Berlin, V3, P541; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; KAMP JW, 1973, CAN ENTOMOL, V105, P1235, DOI 10.4039/Ent1051235-9; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kristensen N.P., 1991, P125; KUTSCH W, 1991, J COMP PHYSIOL A, V168, P483, DOI 10.1007/BF00199608; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Maddison D.R., 2000, MACCLADE 4 ANAL PHYL; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1999, DISCRETE; ROFF DA, 1994, EVOL ECOL, V8, P639, DOI 10.1007/BF01237847; Sorenson MD, 1999, TREEROT VERSION 2; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Wheeler W, 1999, CLADISTICS, V15, P379, DOI 10.1111/j.1096-0031.1999.tb00274.x; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1006/clad.2000.0147, 10.1111/j.1096-0031.2001.tb00115.x]; Whiting MF, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P69; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	29	322	336	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					264	267		10.1038/nature01313	http://dx.doi.org/10.1038/nature01313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529642				2022-12-01	WOS:000180397600046
J	Bedinghaus, JM				Bedinghaus, JM			Family history	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		POSKANZER DC, 1977, HARRISONS PRINCIPLES, P1903	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					142	142		10.1001/jama.289.2.142	http://dx.doi.org/10.1001/jama.289.2.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517205				2022-12-01	WOS:000180226400001
J	Villanueva, P; Peiro, S; Librero, J; Pereiro, I				Villanueva, P; Peiro, S; Librero, J; Pereiro, I			Accuracy of pharmaceutical advertisements in medical journals	LANCET			English	Article							SELF-REGULATION; PROMOTION; INDUSTRY; EDITORS; CODES	Background Because of the effect of the ever-growing evidence-based medicine movement on prescribing behaviour of doctors, the pharmaceutical industry incorporates bibliographical references to clinical trials that endorse their products in their advertisements. We aimed to assess whether the references about efficacy, safety, convenience, or cost of anti hypertensive and lipid-lowering drugs included in advertisements supported the promotional claims. Methods We assessed all advertisements for anti hypertensive and lipid-lowering drugs published in six Spanish medical journals in 1997 that had at least one bibliographical reference. Two pairs of investigators independently reviewed the advertisements to see whether the studies quoted to endorse the advertising messages supported the corresponding claims. Findings We identified 264 different advertisements for anti hypertensive drugs and 23 different advertisements for lipid-lowering drugs. We recorded at least one reference in 31 advertisements in the anti hypertensive group and at least one reference in every seven advertisements in the lipid-lowering group, providing a total of 125 promotional claims with references. We could not retrieve 23 (18%) references from monographic works and non-published data on file. 79 (63%) of the 125 references were from journals with a high impact factor; 84 (82%) of the 102 references retrieved were from randomised clinical trials. In 45 claims (44.1%; 95% CI 34.3-54.3) the promotional statement was not supported by the reference, most frequently because the slogan recommended the drug in a patient group other than that assessed in the study. Interpretation Doctors should be cautious in assessment of advertisements that claim a drug has greater efficacy, safety, or convenience, even though these claims are accompanied by bibliographical references to randomised clinical trials published in reputable medical journals and seem to be evidence-based.	Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Valencia 46017, Spain; Inst Social Marina, Valencia, Spain		Peiro, S (corresponding author), Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Juan de Garay 21, Valencia 46017, Spain.		Peiro, Salvador/H-5778-2017; Librero, Julian/F-4947-2017	Peiro, Salvador/0000-0002-3902-569X; Librero, Julian/0000-0002-4859-9054				Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; CARANDANG ED, 1994, MED J AUSTRALIA, V161, P671, DOI 10.5694/j.1326-5377.1994.tb126915.x; CAUDILL TS, 1992, J DRUG ISSUES, V22, P331, DOI 10.1177/002204269202200212; Greenhalgh T, 1997, BRIT MED J, V315, P1623, DOI 10.1136/bmj.315.7122.1623; HEALING E, 1994, BRIT MED J, V308, P474, DOI 10.1136/bmj.308.6926.474a; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; KESSLER DA, 1990, JAMA-J AM MED ASSOC, V264, P2409, DOI 10.1001/jama.264.18.2409; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; LEXCHIN J, 1994, INT J HEALTH SERV, V24, P91, DOI 10.2190/EKEP-D9JE-31A4-KTE5; Lexchin J, 1997, CAN FAM PHYSICIAN, V43, P1997; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Mansfield PR, 1997, MED J AUSTRALIA, V167, P590, DOI 10.5694/j.1326-5377.1997.tb138906.x; Mindell J, 1997, BRIT MED J, V315, P1622; PERMAN E, 1990, NEW ENGL J MED, V323, P616, DOI 10.1056/NEJM199008303230921; RENNIE D, 1991, JAMA-J AM MED ASSOC, V265, P2394, DOI 10.1001/jama.265.18.2394; Roughead EE, 1998, INT J HEALTH SERV, V28, P269, DOI 10.2190/B81X-4A53-TY5M-C2HR; Sackett D.L., 1997, EVIDENCE BASED MED P; Smart S, 1997, BRIT MED J, V315, P1622; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916; 1894, JAMA, V22, P958; 1982, LANCET, V2, P1257; 1994, B OFICIAL ESTADO	27	105	111	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					27	32		10.1016/S0140-6736(03)12118-6	http://dx.doi.org/10.1016/S0140-6736(03)12118-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517463				2022-12-01	WOS:000180191600017
J	Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ				Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ			Synaptic depression in the localization of sound	NATURE			English	Article							INTERAURAL TIME DIFFERENCES; STEM AUDITORY NUCLEI; COINCIDENCE DETECTION; BRAIN-STEM; PHASE-LOCKING; LAMINARIS; NEURONS; MAGNOCELLULARIS; LATERALIZATION; ORGANIZATION	Short-term synaptic plasticity, which is common in the central nervous system, may contribute to the signal processing functions of both temporal integration and coincidence detection(1-3). For temporal integrators, whose output firng rate depends on a running average of recent synaptic inputs, plasticity modulates input synaptic strength and thus may directly control signalling gain(2) and the function of neural networks(1-4). But the firing probability of an ideal coincidence detector would depend on the temporal coincidence of events rather than on the average frequency of synaptic events. Here we have examined a specific case of how synaptic plasticity can affect temporal coincidence detection, by experimentally characterizing synaptic depression at the synapse between neurons in the nucleus magnocellularis and coincidence detection neurons in the nucleus laminaris in the chick auditory brainstem(5). We combine an empirical description of this depression with a biophysical model of signalling in the nucleus laminaris. The resulting model predicts that synaptic depression provides an adaptive mechanism for preserving interaural time-delay information (a proxy for the location of sound in space) despite the confounding effects of sound-intensity-related information. This mechanism may help nucleus laminaris neurons to pass specific sound localization information to higher processing centres.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA; Univ Washington, Dept Neurol, Seattle, WA 98105 USA; Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98105 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Spain, WJ (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA.	spain@u.washington.edu			BLRD VA [I01 BX000386] Funding Source: Medline; Veterans Affairs [I01BX000386] Funding Source: NIH RePORTER	BLRD VA; Veterans Affairs(US Department of Veterans Affairs)		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; Bruckner S, 1998, EUR J NEUROSCI, V10, P3438, DOI 10.1046/j.1460-9568.1998.00353.x; CARR CE, 1990, J NEUROSCI, V10, P3227; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; JEFFRESS LA, 1968, J ACOUST SOC AM, V44, P187, DOI 10.1121/1.1911053; Koppl C, 1997, J NEUROSCI, V17, P3312; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; Pena JL, 1996, J NEUROSCI, V16, P7046; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; TOBIAS JV, 1959, J ACOUST SOC AM, V31, P1591, DOI 10.1121/1.1907664; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Yang LC, 1999, J NEUROSCI, V19, P2313; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; ZHOU N, 1991, HEARING RES, V52, P195, DOI 10.1016/0378-5955(91)90199-J	30	139	139	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					66	70		10.1038/nature01248	http://dx.doi.org/10.1038/nature01248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511955				2022-12-01	WOS:000180165500038
J	Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG				Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG			Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity	NATURE			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; DROSOPHILA; PHOSPHORYLATION; LOCALIZATION; ASSOCIATION; FIBROBLASTS; EXPRESSION	Two prominent characteristics of epithelial cells, apical-basal polarity and a highly ordered cytoskeleton, depend on the existence of precisely localized protein complexes associated with the apical plasma membrane(1,2), and on a separate machinery that regulates the spatial order of actin assembly(3). ERM (ezrin, radixin, moesin) proteins have been proposed to link transmembrane proteins to the actin cytoskeleton(4) in the apical domain, suggesting a structural role in epithelial cells, and they have been implicated in signalling pathways(5). Here, we show that the sole Drosophila ERM protein Moesin functions to promote cortical actin assembly and apical-basal polarity. As a result, cells lacking Moesin lose epithelial characteristics and adopt invasive migratory behaviour. Our data demonstrate that Moesin facilitates epithelial morphology not by providing an essential structural function, but rather by antagonizing activity of the small GTPase Rho. Thus, Moesin functions in maintaining epithelial integrity by regulating cell-signalling events that affect actin organization and polarity. Furthermore, our results show that there is negative feedback between ERM activation and activity of the Rho pathway.	Duke Univ, Dept Biol, DCMB Grp, Durham, NC 27708 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fehon, RG (corresponding author), Duke Univ, Dept Biol, DCMB Grp, Box 91000, Durham, NC 27708 USA.		Hughes, Sarah/D-3677-2009; Noren Hooten, Nicole/J-5498-2019	Noren Hooten, Nicole/0000-0002-1683-3838	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; FEHON RG, 1994, DEVELOPMENT, V120, P545; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Halsell SR, 2000, GENETICS, V156, P469; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7	30	200	210	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					83	87		10.1038/nature01295	http://dx.doi.org/10.1038/nature01295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511959				2022-12-01	WOS:000180165500042
J	Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT				Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT			The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila	NATURE			English	Article							HEAT-SHOCK LOCI; TRANSCRIPTION ELONGATION; PROMOTER; SPT5; IDENTIFICATION; INFORMATION; RECRUITMENT; COMPLEX; HSF	The RNA polymerase II elongation complex contains several factors that facilitate transcription elongation and catalyse the processing of precursor messenger RNAs (pre-mRNAs)(1-3). The conserved elongation factor Spt6 is recruited rapidly and robustly to sites of active transcription(4,5). Here we show that Drosophila Spt6 (dSpt6) co-purifies with the exosome, a complex of 3' to 5' exoribonucleases that is implicated in the processing of structural RNA and in the degradation of improperly processed pre-mRNA(6-10). Immunoprecipitation assays of Drosophila nuclear extracts show that the exosome also associates with the elongation factor dSpt5 and RNA polymerase II. In vivo, exosome subunits colocalize with dSpt6 at transcriptionally active loci on polytene chromosomes during normal development and are strongly recruited to heat-shock loci on gene induction. At higher resolution, chromatin immunoprecipitation analysis shows that the exosome is recruited to transcriptionally active units of heat-shock genes. These data provide a physical basis for the hypothesis that exosome-mediated pre-mRNA surveillance accompanies transcription elongation.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hirose Y, 2000, GENE DEV, V14, P1415; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Lis JT, 2000, GENE DEV, V14, P792; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	23	206	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					837	841		10.1038/nature01181	http://dx.doi.org/10.1038/nature01181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490954				2022-12-01	WOS:000179897300062
J	Shinkai, K; Mohrs, M; Locksley, RM				Shinkai, K; Mohrs, M; Locksley, RM			Helper T cells regulate type-2 innate immunity in vivo	NATURE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; AIRWAY HYPERRESPONSIVENESS; EOSINOPHILS; DEGRANULATION; IL-5; INTERLEUKIN-5; EXPRESSION; RESPONSES; INDUCTION; PROTEINS	Type-2 immunity requires orchestration of innate and adaptive immune responses to protect mucosal sites from pathogens. Dysregulated type-2 responses result in allergy or asthma(1). T helper 2 (T(H)2) cells elaborate cytokines, such as interleukin (IL)-4, IL-5, IL-9 and IL-13, which work with toxic mediators of innate immune cells to establish environments that are inhospitable to helminth or arthropod invaders(2). The importance of T(H)2 cells in coordinating innate immune cells at sites of inflammation is not known. Here we show that polarized type-2 immune responses are initiated independently of adaptive immunity. In the absence of B and T cells, IL-4-expressing eosinophils were recruited to tissues of mice infected with the helminth Nippostrongylus brasiliensis, but eosinophils failed to degranulate. Reconstitution with CD4 T cells promoted accumulation of degranulated IL-4-expressing cells, but only if T cells were stimulated with cognate antigen. Degranulation correlated with tissue destruction, which was attenuated if eosinophils were depleted. Helper T cells confer antigen specificity on eosinophil cytotoxicity, but not cytokine responses, so defining a novel mechanism that focuses tissue injury at sites of immune challenge.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.							Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Dvorak AM, 1998, INT REV CYTOL, V180, P87; Dvorak AM, 2000, CHEM IMMUNOL, V76, P1; Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Foster PS, 2002, TRENDS MOL MED, V8, P162, DOI 10.1016/S1471-4914(02)02302-X; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Karawajczyk M, 2000, AM J RESP CELL MOL, V23, P521, DOI 10.1165/ajrcmb.23.4.4025; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee NA, 1997, J IMMUNOL, V158, P1332; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mould AW, 2000, J IMMUNOL, V164, P2142, DOI 10.4049/jimmunol.164.4.2142; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rumbley CA, 1999, J IMMUNOL, V162, P1003; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SCHNARE M, 2001, NAT IMMUNOL, V29, P47; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Walsh GM, 2001, CURR OPIN HEMATOL, V8, P28, DOI 10.1097/00062752-200101000-00006; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	30	158	165	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					825	829		10.1038/nature01202	http://dx.doi.org/10.1038/nature01202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490951				2022-12-01	WOS:000179897300059
J	Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C				Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C			Nanotechnology - Carbon nanotubes with DNA recognition	NATURE			English	Article							ROOM-TEMPERATURE; TRANSISTORS		Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands; CSIC, Inst Biol Mol Barcelona, Barcelona 08034, Spain	Delft University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Williams, KA (corresponding author), Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands.		de la Torre, Beatriz G/AAF-1419-2020; de la Torre, Beatriz G./N-6995-2019; Eritja, Ramon/B-5613-2008	de la Torre, Beatriz G./0000-0001-8521-9172; Eritja, Ramon/0000-0001-5383-9334; Dekker, Cees/0000-0001-6273-071X				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Huang WJ, 2002, NANO LETT, V2, P311, DOI [10.1021/nl010095i, 10.1021/n1010095i]; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wang J, 1998, BIOSENS BIOELECTRON, V13, P757, DOI 10.1016/S0956-5663(98)00039-6; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873	12	459	482	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					761	761		10.1038/420761a	http://dx.doi.org/10.1038/420761a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490938	Green Submitted			2022-12-01	WOS:000179897300045
J	Blat, Y; Protacio, RU; Hunter, N; Kleckner, N				Blat, Y; Protacio, RU; Hunter, N; Kleckner, N			Physical and functional interactions among basic chromosome organizational features govern early steps of meiotic chiasma formation	CELL			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; DOUBLE-STRAND BREAKS; RECOMBINATION INITIATION; CROSSOVER INTERFERENCE; SYNAPTONEMAL COMPLEXES; AXIAL ELEMENT; MEIOSIS; PROTEIN; SITES	Analysis of meiotic recombination by functional genomic approaches reveals prominent spatial and functional interactions among diverse organizational determinants. Recombination occurs between chromatin loop sequences; however, these sequences are spatially tethered to underlying chromosome axes via their recombinosomes. Meiotic chromosomal protein, Red1, localizes to chromosome axes; however, Red1 loading is modulated by R/G-bands isochores and thus by bulk chromatin state. Recombination is also modulated by isochore determinants: R-bands differentially favor double-strand break (DSB) formation but disfavor subsequent loading of meiotic RecA homolog, Dmc1. Red1 promotes DSB formation in both R- and G-bands and then promotes Dmc1 loading, specifically counteracting disfavoring R-band effects. These complexities are discussed in the context of chiasma formation as a series of coordinated local changes at the DNA and chromosome-axis levels.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NIGMS NIH HHS [R01-GM44794] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blumental-Perry A, 2000, EMBO REP, V1, P232, DOI 10.1093/embo-reports/kvd047; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Debrauwere H, 1999, NAT GENET, V23, P367, DOI 10.1038/15557; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; John B., 1990, MEIOSIS; Kaback DB, 1999, GENETICS, V152, P1475; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KING JS, 1990, GENETICS, V126, P1127; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; MaoDraayer Y, 1996, GENETICS, V144, P71; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; ROCKMILL B, 1990, GENETICS, V126, P563; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; TEASE C, 1978, NATURE, V272, P823, DOI 10.1038/272823a0; Thompson DA, 1999, GENETICS, V153, P621; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; VONWETTS.D, 1971, P NATL ACAD SCI USA, V68, P851, DOI 10.1073/pnas.68.4.851; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	53	247	252	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					791	802		10.1016/S0092-8674(02)01167-4	http://dx.doi.org/10.1016/S0092-8674(02)01167-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526806	Bronze			2022-12-01	WOS:000179862600006
J	Casper, AM; Nghiem, P; Arlt, MF; Glover, TW				Casper, AM; Nghiem, P; Arlt, MF; Glover, TW			ATR regulates fragile site stability	CELL			English	Article							DNA-REPLICATION; ATAXIA-TELANGIECTASIA; FHIT GENE; MOLECULAR CHARACTERIZATION; FREQUENT DELETIONS; INTEGRATION SITE; CANCER-CELLS; CHECKPOINT; FRA3B; EXPRESSION	Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Cutaneous Oncol Unit, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.		Nghiem, Paul T/A-9210-2011	Nghiem, Paul T/0000-0003-2784-963X; Casper, Anne/0000-0003-4975-5749	NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627, R37GM038627] Funding Source: NIH RePORTER; NCI NIH HHS [CA43222] Funding Source: Medline; NIAMS NIH HHS [K08-AR02087] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Bednarek AK, 2001, CANCER RES, V61, P8068; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Corbin S, 2002, CANCER RES, V62, P3477; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Druck T, 1997, CANCER RES, V57, P504; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glover TW, 1998, RECENT RES CANCER, V154, P185; GLOVER TW, 1987, AM J HUM GENET, V41, P882; Glover TW, 1998, CANCER RES, V58, P3409; GLOVER TW, 1986, CANCER GENET CYTOGEN, V19, P141, DOI 10.1016/0165-4608(86)90381-X; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Harborth J, 2001, J CELL SCI, V114, P4557; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.3.CO;2-M; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michael D, 1997, ONCOGENE, V15, P1653; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Paige AJW, 2000, CANCER RES, V60, P1690; Pincheira J, 2001, MUTAGENESIS, V16, P419, DOI 10.1093/mutage/16.5.419; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiraishi T, 2001, P NATL ACAD SCI USA, V98, P5722, DOI 10.1073/pnas.091095898; SMEETS DFCM, 1990, CYTOGENET CELL GENET, V53, P8, DOI 10.1159/000132885; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; Telatar M, 1996, AM J HUM GENET, V59, P40; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Thorland EC, 2000, CANCER RES, V60, P5916; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; Wang L, 1999, HUM MOL GENET, V8, P431, DOI 10.1093/hmg/8.3.431; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Wright J, 1996, AM J HUM GENET, V59, P839; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	62	450	459	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					779	789		10.1016/S0092-8674(02)01113-3	http://dx.doi.org/10.1016/S0092-8674(02)01113-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526805	Bronze			2022-12-01	WOS:000179862600005
J	Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY				Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY			Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear	CELL			English	Article							LONG-TERM POTENTIATION; BOMBESIN-LIKE PEPTIDES; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; CA3-CA1 SYNAPSES; KINASE PATHWAYS; DEFICIENT MICE; MESSENGER-RNA; RECEPTOR; PROTEIN	We identified the Grp gene, encoding gastrin-releasing peptide, as being highly expressed both in the lateral nucleus of the amygdala, the nucleus where associations for Pavlovian learned fear are formed, and in the regions that convey fearful auditory information to the lateral nucleus. Moreover, we found that GRP receptor (GRPR) is expressed in GABAergic interneurons of the lateral nucleus. GRP excites these interneurons and increases their inhibition of principal neurons. GRPR-deficient mice showed decreased inhibition of principal neurons by the interneurons, enhanced long-term potentiation (LTP), and greater and more persistent long-term fear memory. By contrast, these mice performed normally in hippocampus-dependent Morris maze. These experiments provide genetic evidence that GRP and its neural circuitry operate as a negative feedback regulating fear and establish a causal relationship between Grpr gene expression, LTP, and amygdala-dependent memory for fear.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; NINDS, NIH, Bethesda, MD 20892 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA	Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Howard Hughes Medical Institute; Harvard University; McLean Hospital	Kandel, ER (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15098] Funding Source: Medline; NINDS NIH HHS [NS44185] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Bast T, 2001, EXP BRAIN RES, V139, P39, DOI 10.1007/s002210100746; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HARRELL AV, 2001, 31 ANN M SAN DIEG CA; Hellmich MR, 1999, J BIOL CHEM, V274, P23901, DOI 10.1074/jbc.274.34.23901; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; IshikawaBrush Y, 1997, HUM MOL GENET, V6, P1241, DOI 10.1093/hmg/6.8.1241; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KAPP B S, 1992, P229; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee K, 1999, J PHYSIOL-LONDON, V518, P791, DOI 10.1111/j.1469-7793.1999.0791p.x; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Merali Z, 1998, J NEUROSCI, V18, P4758; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Parent MB, 2002, BIOCHEM PHARMACOL, V63, P57, DOI 10.1016/S0006-2952(01)00856-5; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharif TR, 1997, MOL CELL ENDOCRINOL, V130, P119, DOI 10.1016/S0303-7207(97)00080-4; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; Wang C, 2001, J NEUROPHYSIOL, V86, P1422, DOI 10.1152/jn.2001.86.3.1422; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Woodson W, 2000, SYNAPSE, V38, P124, DOI 10.1002/1098-2396(200011)38:2<124::AID-SYN3>3.0.CO;2-N; Yu BJ, 1997, J NEUROPHYSIOL, V77, P690, DOI 10.1152/jn.1997.77.2.690	49	243	257	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					905	918		10.1016/S0092-8674(02)01116-9	http://dx.doi.org/10.1016/S0092-8674(02)01116-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526815	Bronze			2022-12-01	WOS:000179862600015
J	Byrne, S; Ingersoll, AP				Byrne, S; Ingersoll, AP			A sublimation model for martian south polar ice features	SCIENCE			English	Article							SUMMER TEMPERATURES; CARBON-DIOXIDE; WATER-VAPOR; MARS; TOPOGRAPHY; STABILITY; MISSION; MERCURY; MOON; CO2	In their pioneering work, Leighton and Murray argued that the Mars atmosphere, which at present is 95% carbon dioxide, is controlled by vapor equilibrium with a much larger polar reservoir of solid carbon dioxide. Here we argue that the polar reservoir is small and cannot function as a long-term buffer to the more massive atmosphere. Our work is based on modeling of the circular depressions commonly found on the south polar cap. We argue that a carbon dioxide ice layer about 8 meters thick is being etched away to reveal water ice underneath. This is consistent with thermal infrared data from the Mars Odyssey mission.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Byrne, S (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Byrne, Shane/B-8104-2012					BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; CHRISTENSEN PR, 1992, J GEOPHYS RES-PLANET, V97, P7719, DOI 10.1029/92JE00453; CHRISTENSEN PR, UNPUB; Durham WB, 1999, GEOPHYS RES LETT, V26, P3493, DOI 10.1029/1999GL008373; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; INGERSOL.AP, 1974, J GEOPHYS RES, V79, P3403, DOI 10.1029/JC079i024p03403; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; James P.B., 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MURRAY BC, 1973, SCIENCE, V182, P437, DOI 10.1126/science.182.4111.437; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas P., 1992, MARS, P767; Thomas PC, 2000, NATURE, V404, P161, DOI 10.1038/35004528; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WOOD SE, 1992, ICARUS, V99, P1, DOI 10.1016/0019-1035(92)90166-5	22	129	129	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1051	1053		10.1126/science.1080148	http://dx.doi.org/10.1126/science.1080148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586939				2022-12-01	WOS:000180960000043
J	Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC				Fabiani, A; Hoelzel, AR; Galimberti, F; Muelbert, MMC			Long-range paternal gene flow in the southern elephant seal	SCIENCE			English	Article							MIROUNGA-LEONINA; POPULATIONS		Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; Elephant Seal Res Grp, I-20145 Milan, Italy; Univ Fed Rio Grande, BR-96200970 Rio Grande, Brazil	Durham University; Universidade Federal do Rio Grande	Hoelzel, AR (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.		Fabiani, Anna/B-8623-2011; Muelbert, Monica/T-3935-2019					Cornuet JM, 1999, GENETICS, V153, P1989; Gemmell NJ, 1997, MOL ECOL, V6, P661, DOI 10.1046/j.1365-294X.1997.00235.x; Hindell MA, 2000, MAR MAMMAL SCI, V16, P504, DOI 10.1111/j.1748-7692.2000.tb00944.x; HOELZEL AR, 1993, J HERED, V84, P443, DOI 10.1093/oxfordjournals.jhered.a111370; HOELZEL AR, 2001, P R SOC LONDON B, V268, P1; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Slade RW, 1998, GENETICS, V149, P1945	8	49	51	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					676	676		10.1126/science.299.5607.676	http://dx.doi.org/10.1126/science.299.5607.676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12560542				2022-12-01	WOS:000180687700036
J	Fuat, A; Pali, A; Hungin, S; Murphy, JJ				Fuat, A; Pali, A; Hungin, S; Murphy, JJ			Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							OPEN-ACCESS ECHOCARDIOGRAPHY; GENERAL-PRACTITIONERS; INHIBITORS	Objective To ascertain the beliefs, current practices, and decision making of general practitioners in the diagnosis and management of suspected heart failure in primary care, with a view to identifying barriers to good care. Design A qualitative approach using focus groups with 30 general practitioners from four primary care groups. The sampling strategy was stratified and purposive. The contents of interviews were transcribed and analysed according to the principles of "pragmatic variant" grounded theory. Setting North east England. Results Three categories of difficulties contribute to variations in medical practice and to the reasons why general practitioners experience difficulties in diagnosing and managing heart failure. The first is uncertainty about clinical practice, including lack of confidence in establishing an accurate diagnosis and worries about using angiotensin converting enzyme inhibitors, beta blockers, and spironolactone in patients who are often elderly and frail, with comorbidity and polypharmacy. The second is a lack of awareness of relevant research evidence in what was perceived to be a complex and rapidly changing therapeutic field. Doubts about the applicability of research findings in primary care, and fear of information overload also ernerged. The third category consists of influences of individual preference and local organisational factors. Medical training, negative clinical experiences, and outside agencies influenced the behaviour of general practitioners and professional culture. Local factors included the availability of diagnostic services, resources (such as accessible cardiologists), and interactions between professionals in primary or secondary care, and they seemed to shape the practice and decision making processes in primary care. Conclusions The national service framework for coronary heart disease stresses that the substandard care of patients with heart failure is unacceptable. This study identified barriers to be overcome across primary and secondary care in implementation strategies that are specific to the locality and multifaceted. Single strategies-for example, the provision of guidelines-are unlikely to have an impact on clinical outcomes, and new, conjoint models of care need to be explored.	Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England; Darlington Mem Hosp, Darlington DL3 6HX, Durham, England	Durham University	Fuat, A (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England.			hungin, amritpal Pali/0000-0001-7275-8927				Bloor M, 1997, CONTEXT METHOD QUALI, P37; CLARKE KW, 1994, BRIT HEART J, V71, P584; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; CLELAND JGF, 1988, BRIT MED J, P824; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Glasser B.G., 1967, DISCOVERY GROUNDED T; GLASSER BG, 1967, DISCOVERY GROUNED TH; Guba E., 1994, COMPETING PARADIGMS; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Hobbs FDR, 2000, BRIT J GEN PRACT, V50, P735; Horne R, 1999, BRIT J GEN PRACT, V49, P353; Houghton AR, 1997, INT J CARDIOL, V59, P7, DOI 10.1016/S0167-5273(96)02904-X; Khunti K, 2000, BRIT J GEN PRACT, V50, P50; MCMURRAY J, 1993, MED ECON, V6, P90; MCMURRAY J, 1993, BR J MED EC, V6, P99; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Murphy JJ, 1996, BRIT J GEN PRACT, V46, P475; ORAM JJ, 1997, CARING 4 AGE PRACTIC; Patton M.Q., 1990, QUALITATIVE RES EVAL, V2nd ed.; Patton MQ., 1999, QUALITATIVE EVALUATI; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; REMES J, 1996, EUR HEART J, V46, P475; Remme WJ, 1997, EUR HEART J, V18, P736; Rimington H, 1996, LANCET, V348, P555, DOI 10.1016/S0140-6736(05)64722-8; Toal M, 2000, EUR J HEART FAIL, V2, P201, DOI 10.1016/S1388-9842(00)00071-4; WHEELDON NM, 1993, Q J MED, V86, P17	28	187	193	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2003	326	7382					196	200		10.1136/bmj.326.7382.196	http://dx.doi.org/10.1136/bmj.326.7382.196			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640LD	12543836	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000180689600018
J	Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF				Eferl, R; Ricci, R; Kenner, L; Zenz, R; David, JP; Rath, M; Wagner, EF			Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53	CELL			English	Article							NF-KAPPA-B; HUMAN HEPATOCELLULAR CARCINOMAS; STRESS-INDUCED APOPTOSIS; TERMINAL PHOSPHORYLATION; MOUSE DEVELOPMENT; TRANSGENIC MICE; JNK ACTIVATION; GENE; EXPRESSION; INDUCTION	The transcription factor c-Jun mediates several cellular processes, including proliferation and survival, and is upregulated in many carcinomas. Liver-specific inactivation of c-Jun at different stages of tumor development was used to study its role in chemically induced hepatocellular carcinomas (HCCs) in mice. The requirement for c-jun was restricted to early stages of tumor development, and the number and size of hepatic tumors was dramatically reduced when c-jun was inactivated after the tumor had initiated. The impaired tumor development correlated with increased levels of p53 and its target gene noxa, resulting in the induction of apoptosis without affecting cell proliferation. Primary hepatocytes lacking c-Jun showed increased sensitivity to TNF-alpha-induced apoptosis, which was abrogated in the absence of p53. These data indicate that c-Jun prevents apoptosis by antagonizing p53 activity, illustrating a mechanism that might contribute to the early stages of human HCC development.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Ricci, Romeo/K-3009-2013	Ricci, Romeo/0000-0002-9766-4369; Kenner, Lukas/0000-0003-2184-1338; Wagner, Erwin F/0000-0001-7872-0196; Eferl, Robert/0000-0002-6074-7144				Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BELLET DH, 1984, P NATL ACAD SCI-BIOL, V81, P3869, DOI 10.1073/pnas.81.12.3869; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Gillet R, 2000, ONCOGENE, V19, P3498, DOI 10.1038/sj.onc.1203671; HACKER HJ, 1991, CANCER RES, V51, P1952; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KATO M, 1993, FUND APPL TOXICOL, V20, P155, DOI 10.1006/faat.1993.1021; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LEIST M, 1994, J IMMUNOL, V153, P1778; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Masui T, 1997, CANCER LETT, V112, P33, DOI 10.1016/S0304-3835(96)04543-0; MURAKAMI Y, 1991, CANCER RES, V51, P5520; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; PINKUS R, 1993, BIOCHEM J, V290, P637, DOI 10.1042/bj2900637; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; Preston GA, 1996, MOL CELL BIOL, V16, P211; ROGLER CE, 1994, J BIOL CHEM, V269, P13779; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHULTEHERMANN R, 1992, TOXICOL LETT, V64-5, P569, DOI 10.1016/0378-4274(92)90233-A; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; VESSELINOVITCH SD, 1984, J CANCER RES CLIN, V108, P60, DOI 10.1007/BF00390974; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; ZHANG XK, 1990, ONCOGENE, V5, P909	47	388	410	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 24	2003	112	2					181	192		10.1016/S0092-8674(03)00042-4	http://dx.doi.org/10.1016/S0092-8674(03)00042-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553907	Bronze			2022-12-01	WOS:000181191600008
J	Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G				Geldner, N; Anders, N; Wolters, H; Keicher, J; Kornberger, W; Muller, P; Delbarre, A; Ueda, T; Nakano, A; Jurgens, G			The Arabidopsis GNOM ARF-GEF mediates endosomal recycling, auxin transport, and auxin-dependent plant growth	CELL			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; ENDOPLASMIC-RETICULUM; PATTERN-FORMATION; PLASMA-MEMBRANE; GOLGI NETWORK; RAB GTPASE; PROTEIN; EFFLUX	Exchange factors for ARF GTPases (ARF-GEFs) regulate vesicle trafficking in a variety of organisms. The Arabidopsis protein GNOM is a brefeldin A (BFA) sensitive ARF-GEF that is required for the proper polar localization of PIN1, a candidate transporter of the plant hormone auxin. Mutations in GNOM lead to developmental defects that resemble those caused by interfering with auxin transport. Both PIN1 localization and auxin transport are also sensitive to BFA. In this paper, we show that GNOM localizes to endosomes and is required for their structural integrity. We engineered a BFA-resistant version of GNOM. In plants harboring this fully functional GNOM variant, PIN1 localization and auxin transport are no longer sensitive to BFA, while trafficking of other proteins is still affected by the drug. Our results demonstrate that GNOM is required for the recycling of auxin transport components and suggest that ARF-GEFs regulate specific endosomal trafficking pathways.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; CNRS, Inst Sci Vegetales, F-91198 Gif Sur Yvette, France; RIKEN, Mol Membrane Biol lab, Wako, Saitama 3510198, Japan	Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; RIKEN	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Nakano, Akihiko/A-6420-2016; Nakano, Akihiko/G-4942-2014; Ueda, Takashi/G-6984-2011; Geldner, Niko/Y-2481-2019; Nakano, Akihiko/C-6185-2009; UEDA, TAKASHI/G-4939-2014	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; Ueda, Takashi/0000-0002-5190-892X; Geldner, Niko/0000-0002-2300-9644; Anders, Nadine/0000-0001-9854-576X				AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; BarPeled M, 1997, PLANT PHYSIOL, V114, P315, DOI 10.1104/pp.114.1.315; Bassham DC, 2000, MOL BIOL CELL, V11, P2251, DOI 10.1091/mbc.11.7.2251; Bednarek SY, 2002, TRAFFIC, V3, P621, DOI 10.1034/j.1600-0854.2002.30904.x; Boman AL, 2001, J CELL SCI, V114, P3413; Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/s004380050121; D'Souza-Schorey C, 1998, J CELL BIOL, V140, P603, DOI 10.1083/jcb.140.3.603; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Grebe M, 2002, CURR BIOL, V12, P329, DOI 10.1016/S0960-9822(02)00654-1; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hadfi K, 1998, DEVELOPMENT, V125, P879; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; Jurgens G, 2002, TRAFFIC, V3, P605, DOI 10.1034/j.1600-0854.2002.30902.x; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee MH, 2002, PLANT PHYSIOL, V129, P1507, DOI 10.1104/pp.003624; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAYER U, 1993, DEVELOPMENT, V117, P149; Morris DA, 1998, PLANTA, V205, P606, DOI 10.1007/s004250050363; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; ORCI L, 1991, CELL, V64, P1183; Parry G, 2001, PLANT J, V25, P399, DOI 10.1046/j.1365-313x.2001.00970.x; Parton RM, 2001, J CELL SCI, V114, P2685; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Sanderfoot AA, 2001, PLANT CELL, V13, P659, DOI 10.1105/tpc.13.3.659; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; SATIATJEUNEMAITRE B, 1992, J CELL SCI, V103, P1153; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shevell DE, 2000, PLANT CELL, V12, P2047, DOI 10.1105/tpc.12.11.2047; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Takeuchi M, 2002, PLANT J, V31, P499, DOI 10.1046/j.1365-313X.2002.01372.x; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221; Yasuhara H, 2000, PLANT CELL PHYSIOL, V41, P300, DOI 10.1093/pcp/41.3.300; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	64	837	890	5	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					219	230		10.1016/S0092-8674(03)00003-5	http://dx.doi.org/10.1016/S0092-8674(03)00003-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553910	Bronze			2022-12-01	WOS:000181191600011
J	Nair, SK; Burley, SK				Nair, SK; Burley, SK			X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors	CELL			English	Article							C-MYC; CRYSTAL-STRUCTURE; LEUCINE ZIPPER; INDUCED-DIFFERENTIATION; TRANSFORMING ACTIVITY; NUCLEOTIDE-SEQUENCE; BURKITT-LYMPHOMA; GENE-REGULATION; REPRESSOR SIN3; TARGET GENES	X-ray structures of the basic/helix-loop-helix/leucine zipper (bHLHZ) domains of Myc-Max and Mad-Max heterodimers bound to their common DNA target (Enhancer or E box hexanucleotide, 5'-CACGTG-3') have been determined at 1.9 Angstrom and 2.0 Angstrom resolution, respectively. E box recognition by these two structurally similar transcription factor pairs determines whether a cell will divide and proliferate (Myc-Max) or differentiate and become quiescent (Mad-Max). Deregulation of Myc has been implicated in the development of many human cancers, including Burkitt's lymphoma, neuroblastomas, and small cell lung cancers. Both quasi-symmetric heterodimers resemble the symmetric Max homodimer, albeit with marked structural differences in the coiled-coil leucine zipper regions that explain preferential homo- and heteromeric dimerization of these three evolutionarily related DNA-binding proteins. The Myc-Max heterodimer, but not its Mad-Max counterpart, dimerizes to form a bivalent heterotetramer, which explains how Myc can upregulate expression of genes with promoters bearing widely separated E boxes.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Struct Genomix Inc, 10505 Roselle St, San Diego, CA 92121 USA.	stephen_burley@stromix.com	Nair, Satish/AAY-2510-2021	Burley, Stephen/0000-0002-2487-9713				AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BACA M, 1995, J AM CHEM SOC, V117, P1881, DOI 10.1021/ja00112a003; Bao JX, 1996, ONCOGENE, V12, P2171; BENVENISTY N, 1992, ONCOGENE, V7, P2399; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 1999, MOL CELLS, V9, P1; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kretzner L, 1992, Curr Top Microbiol Immunol, V182, P435; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Larsson LG, 1997, ONCOGENE, V15, P737, DOI 10.1038/sj.onc.1201390; LARSSON LG, 1994, ONCOGENE, V9, P1247; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOORE JP, 1987, ONCOGENE RES, V2, P65; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Rudolph C, 1999, ANAL BIOCHEM, V269, P66, DOI 10.1006/abio.1999.3095; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SHEINESS D, 1978, J VIROL, V28, P600, DOI 10.1128/JVI.28.2.600-610.1978; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P3642, DOI 10.1073/pnas.80.12.3642; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; Winston RL, 2000, CHEM BIOL, V7, P245, DOI 10.1016/S1074-5521(00)00099-5; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	69	366	398	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 24	2003	112	2					193	205		10.1016/S0092-8674(02)01284-9	http://dx.doi.org/10.1016/S0092-8674(02)01284-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DL	12553908	Bronze			2022-12-01	WOS:000181191600009
J	Tulin, A; Spradling, A				Tulin, A; Spradling, A			Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci	SCIENCE			English	Article							EXPRESSION	Steroid response and stress-activated genes such as hsp70 undergo puffing in Drosophila larval salivary glands, a local loosening of polytene chromatin structure associated with gene induction. We find that puffs acquire elevated levels of adenosine diphosphate ( ADP)-ribose modified proteins and that poly( ADP) ribose polymerase ( PARP) is required to produce normal-sized puffs and normal amounts of Hsp70 after heat exposure. We propose that chromosomal PARP molecules become activated by developmental or environmental cues and strip nearby chromatin proteins off DNA to generate a puff. Such local loosening may facilitate transcription and may transiently make protein complexes more accessible to modi cation, promoting chromatin remodeling during development.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, Baltimore, MD 21210 USA	Carnegie Institution for Science	Tulin, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Res Labs, 115 W Univ Pkwy, Baltimore, MD 21210 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027875, R01GM027875] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM27875] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTWRIGHT IL, 1986, MOL CELL BIOL, V6, P779, DOI 10.1128/MCB.6.3.779; Hagstrom K, 1997, CURR OPIN GENET DEV, V7, P814, DOI 10.1016/S0959-437X(97)80045-7; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MEYEROWITZ EM, 1985, COLD SPRING HARB SYM, V50, P347, DOI 10.1101/SQB.1985.050.01.044; SIMON JA, 1985, CHROMOSOMA, V93, P26, DOI 10.1007/BF01259442; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	10	370	381	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2003	299	5606					560	562		10.1126/science.1078764	http://dx.doi.org/10.1126/science.1078764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12543974				2022-12-01	WOS:000180559800048
J	Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R				Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R			A reversibly switching surface	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; IN-SITU STRUCTURE; GOLD ELECTRODES; ACTIVE CONTROL; NUCLEIC-ACIDS; FORCE-FIELD; CONTACT; SPECTROSCOPY; INTERFACE		MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Chem, Div Mat Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Langer, R (corresponding author), MIT, Dept Chem Engn, 45 Carleton St, Cambridge, MA 02139 USA.	rlanger@mit.edu	Lahann, Joerg/J-7663-2013; CHOI, INSUNG S./C-1592-2011					ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Abbott S, 1999, LANGMUIR, V15, P8923, DOI 10.1021/la990558o; ABRAHAM MH, 1984, J CHEM SOC FARAD T 1, V80, P153, DOI 10.1039/f19848000153; ANDERSON MR, 1994, LANGMUIR, V10, P1638, DOI 10.1021/la00018a002; Aydogan N, 1999, LANGMUIR, V15, P722, DOI 10.1021/la9807208; Baldelli S, 1999, J PHYS CHEM B, V103, P8920, DOI 10.1021/jp991649x; Byloos M, 2001, J PHYS CHEM B, V105, P5900, DOI 10.1021/jp003066p; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; CHEN YL, 1991, J PHYS CHEM-US, V95, P10736, DOI 10.1021/j100179a041; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crevoisier GB, 1999, SCIENCE, V285, P1246, DOI 10.1126/science.285.5431.1246; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; EVERETT WR, 1995, ANAL CHIM ACTA, V307, P253, DOI 10.1016/0003-2670(95)00004-J; FINKLEA HO, 1987, LANGMUIR, V3, P409, DOI 10.1021/la00075a024; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; HAUTMAN J, 1989, J CHEM PHYS, V91, P4994, DOI 10.1063/1.457621; HINES MA, 1995, LANGMUIR, V11, P493, DOI 10.1021/la00002a022; IANNELLI A, 1994, J ELECTROANAL CHEM, V376, P49, DOI 10.1016/0022-0728(94)03463-X; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054; Li TW, 1998, J PHYS CHEM B, V102, P2935, DOI 10.1021/jp980049f; NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2; ONG TH, 1993, LANGMUIR, V9, P1836, DOI 10.1021/la00031a035; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Schoenfisch MH, 1999, LANGMUIR, V15, P509, DOI 10.1021/la9811618; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Shimazu K, 2002, J AM CHEM SOC, V124, P652, DOI 10.1021/ja004091b; STOLE SM, 1990, LANGMUIR, V6, P1199, DOI 10.1021/la00096a029; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; WILSON MD, 1988, J AM CHEM SOC, V110, P8718, DOI 10.1021/ja00234a035; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Zamborini FP, 1998, LANGMUIR, V14, P3279, DOI 10.1021/la971121o	34	968	1010	13	573	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					371	374		10.1126/science.1078933	http://dx.doi.org/10.1126/science.1078933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532011				2022-12-01	WOS:000180426800038
J	Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ				Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ			Selective trafficking of non-cell-autonomous proteins mediated by NtNCAPP1	SCIENCE			English	Article							TOBACCO MOSAIC-VIRUS; TO-CELL; MOVEMENT PROTEIN; MESSENGER-RNA; PLASMODESMATA; TRANSPORT; IDENTIFICATION; NUCLEAR; PHLOEM; LEAFY	In plants, cell-to-cell communication is mediated by plasmodesmata and involves the trafficking of non cell-autonomous proteins (NCAPs). A component in this pathway, Nicotiana tabacum NON-CELL-AUTONOMOUS PATHWAY PROTEIN1 (NtNCAPP1), was affinity purified and cloned. Protein overlay assays and in vivo studies showed that NtNCAPP1 is located on the endoplasmic reticulum at the cell periphery and displays specificity in its interaction with NCAPs. Deletion of the NtNCAPP1 amino-terminal transmembrane domain produced a dominant-negative mutant that blocked the trafficking of specific NCAPs. Transgenic tobacco plants expressing this mutant form of NtNCAPP1 and plants in which the NtNCAPP1 gene was silenced were compromised in their ability to regulate leaf and oral development. These results support a model in which NCAP delivery to plasmodesmata is both selective and regulated.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA; Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder	Lucas, WJ (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.			Gomez-Ospina, Natalia/0000-0002-6740-1154; Lee, Jung-Youn/0000-0003-4604-7974; Staehelin, Andrew/0000-0002-0611-4346; Lee, Jinkee/0000-0001-5590-0549	NIGMS NIH HHS [GM18639] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahearn KP, 2001, PLANT CELL PHYSIOL, V42, P1130, DOI 10.1093/pcp/pce143; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; Citovsky V, 1999, PHILOS T ROY SOC B, V354, P637, DOI 10.1098/rstb.1999.0415; DING BA, 1995, VIROLOGY, V207, P345, DOI 10.1006/viro.1995.1093; FUJIWARA T, 1993, PLANT CELL, V5, P1783, DOI 10.1105/tpc.5.12.1783; Haywood V, 2002, PLANT CELL, V14, pS303, DOI 10.1105/tpc.000778; Kragler F, 2000, EMBO J, V19, P2856, DOI 10.1093/emboj/19.12.2856; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; ROBARDS AW, 1990, ANNU REV PLANT PHYS, V41, P369, DOI 10.1146/annurev.pp.41.060190.002101; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; TURNER A, 1994, J CELL SCI, V107, P3351; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; WU X, 2002, GENE DEV, V6, P151; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	21	127	136	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					392	396		10.1126/science.1077813	http://dx.doi.org/10.1126/science.1077813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532017				2022-12-01	WOS:000180426800045
J	Visser, K; Thunell, R; Stott, L				Visser, K; Thunell, R; Stott, L			Magnitude and timing of temperature change in the Indo-Pacific warm pool during deglaciation	NATURE			English	Article							CLIMATE-CHANGE; TROPICAL PACIFIC; NORTH-ATLANTIC; OCEAN; ANTARCTICA; WATERS; CO2	Ocean-atmosphere interactions in the tropical Pacific region have a strong influence on global heat and water vapour transport and thus constitute an important component of the climate system(1,2). Changes in sea surface temperatures and convection in the tropical Indo-Pacific region are thought to be responsible for the interannual to decadal climate variability observed in extratropical regions(1,3), but the role of the tropics in climate changes on millennial and orbital timescales is less clear. Here we analyse oxygen isotopes and Mg/Ca ratios of foraminiferal shells from the Makassar strait in the heart of the Indo-Pacific warm pool, to obtain synchronous estimates of sea surface temperatures and ice volume. We find that sea surface temperatures increased by 3.5-4.0 degreesC during the last two glacial-interglacial transitions, synchronous with the global increase in atmospheric CO2 and Antarctic warming, but the temperature increase occurred 2,000-3,000 years before the Northern Hemisphere ice sheets melted. Our observations suggest that the tropical Pacific region plays an important role in driving glacial-interglacial cycles, possibly through a system similar to how El Nino/Southern Oscillation regulates the poleward flux of heat and water vapour.	Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Southern California	Thunell, R (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA.			Ackerman, Kate/0000-0003-3925-721X				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P319, DOI 10.1029/96GB00039; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BOYLE EA, 1995, PALEOCEANOGRAPHY, V10, P881, DOI 10.1029/95PA01625; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Broecker WS, 1997, GLOBAL BIOGEOCHEM CY, V11, P589, DOI 10.1029/97GB02267; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CLIMAP Climate: Long-Range Investigation Mapping and Prediction Project Members, 1981, GEOL SOC AM MAP CHAR, V36, P1; DEKENS PS, 2002, GEOCHEM GEOPHYS GEOS, V3; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; GUILDERSON T, 2000, GEOCHEM GEOPHYS GEOS, V1; Guilderson TP, 2001, MAR GEOL, V172, P75, DOI 10.1016/S0025-3227(00)00115-8; HASTENRATH S, 1982, J PHYS OCEANOGR, V12, P922, DOI 10.1175/1520-0485(1982)012<0922:OMHTIT>2.0.CO;2; HASTINGS D, 2001, EOS, V82; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; MARTENS R, 1987, SPORT PSYCHOL, V1, P29, DOI DOI 10.1123/TSP.1.1.29; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0	31	280	332	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					152	155		10.1038/nature01297	http://dx.doi.org/10.1038/nature01297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520298				2022-12-01	WOS:000180267200036
J	Hypponen, E; Smith, GD; Power, C				Hypponen, E; Smith, GD; Power, C			Parental diabetes and birth weight of offspring: intergenerational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSOCIATION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	University of London; University College London; University of Bristol	Hypponen, E (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Davey Smith, George/A-7407-2013; Hypponen, Elina/B-2596-2014	Davey Smith, George/0000-0002-1407-8314; Hypponen, Elina/0000-0003-3670-9399	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Butler N.R., 1963, PERINATAL MORTALITY; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Pennison EH, 2001, AM J OBSTET GYNECOL, V184, P1118, DOI 10.1067/mob.2001.114918; Tynelius P, 2001, AM J EPIDEMIOL, V153, pS47	5	67	68	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					19	20		10.1136/bmj.326.7379.19	http://dx.doi.org/10.1136/bmj.326.7379.19			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511454	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000180302000018
J	Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K				Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K			Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex	NATURE			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINES; VISUAL-CORTEX; FUNCTIONAL REORGANIZATION; PYRAMIDAL CELLS; IN-VIVO; SYNAPSES; MEMORY; CA1	Do new synapses form in the adult cortex to support experience-dependent plasticity? To address this question, we repeatedly imaged individual pyramidal neurons in the mouse barrel cortex over periods of weeks. We found that, although dendritic structure is stable, some spines appear and disappear. Spine lifetimes vary greatly: stable spines, about 50% of the population, persist for at least a month, whereas the remainder are present for a few days or less. Serial-section electron microscopy of imaged dendritic segments revealed retrospectively that spine sprouting and retraction are associated with synapse formation and elimination. Experience-dependent plasticity of cortical receptive fields was accompanied by increased synapse turnover. Our measurements suggest that sensory experience drives the formation and elimination of synapses and that these changes might underlie adaptive remodelling of neural circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Washington University (WUSTL)	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.		Feng, Guoping/Y-2827-2019	Knott, Graham W/0000-0002-2956-9052				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; SANDISON DR, 1994, 3 DIMENSIONAL CONFOC, P29; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	1396	1420	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					788	794		10.1038/nature01273	http://dx.doi.org/10.1038/nature01273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490942				2022-12-01	WOS:000179897300049
J	Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S				Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S			Soil warming and carbon-cycle feedbacks to the climate system	SCIENCE			English	Article							TRACE GAS FLUXES; ORGANIC-CARBON; AVAILABILITY; TEMPERATURE; RESPIRATION; NITROGEN; FORESTS; PRAIRIE	In a decade-long soil warming experiment in a mid-latitude hardwood forest, we documented changes in soil carbon and nitrogen cycling in order to investigate the consequences of these changes for the climate system. Here we show that whereas soil warming accelerates soil organic matter decay and carbon dioxide fluxes to the atmosphere, this response is small and short-lived for a mid-latitude forest, because of the limited size of the labile soil carbon pool. We also show that warming increases the availability of mineral nitrogen to plants. Because plant growth in many mid-latitude forests is nitrogen-limited, warming has the potential to indirectly stimulate enough carbon storage in plants to at least compensate for the carbon losses from soils. Our results challenge assumptions made in some climate models that lead to projections of large long-term releases of soil carbon in response to warming of forest ecosystems.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Res Designs, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole; University System Of New Hampshire; University of New Hampshire	Melillo, JM (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.							Bergh J, 1999, FOREST ECOL MANAG, V119, P51, DOI 10.1016/S0378-1127(98)00509-X; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; FRIEDLINGSTEIN P, IN PRESS TELLUS; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Merriam J, 1996, SOIL SCI SOC AM J, V60, P1050, DOI 10.2136/sssaj1996.03615995006000040013x; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Rustad L, 2001, NATURE, V413, P578, DOI 10.1038/35098162; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Woodwell GM, 1995, BIOTIC FEEDBACKS GLO, P3	17	927	1153	27	730	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2173	2176		10.1126/science.1074153	http://dx.doi.org/10.1126/science.1074153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481133				2022-12-01	WOS:000179773700042
J	Lambert, JD; Nagy, LM				Lambert, JD; Nagy, LM			Asymmetric inheritance of centrosomally localized mRNAs during embryonic cleavages	NATURE			English	Article							C-ELEGANS EMBRYOS; ILYANASSA-OBSOLETA; ASCIDIAN EMBRYO; MESSENGER-RNA; PIE-1 PROTEIN; DROSOPHILA; SPECIFICATION; CELLS; GENE; CENTRIOLES	During development, different cell fates are generated by cell-cell interactions or by the asymmetric distribution of patterning molecules. Asymmetric inheritance is known to occur either through directed transport along actin microfilaments into one daughter cell(1,2) or through capture of determinants by a region of the cortex inherited by one daughter(3-5). Here we report a third mechanism of asymmetric inheritance in a mollusc embryo. Different messenger RNAs associate with centrosomes in different cells and are subsequently distributed asymmetrically during division. The segregated mRNAs are diffusely distributed in the cytoplasm and then localize, in a microtubule-dependent manner, to the pericentriolar matrix. During division, they dissociate from the core mitotic centrosome and move by means of actin filaments to the presumptive animal daughter cell cortex. In experimental cells with two interphase centrosomes, mRNAs accumulate on the correct centrosome, indicating that differences between centrosomes control mRNA targeting. Blocking the accumulation of mRNAs on the centrosome shows that this event is required for subsequent cortical localization. These events produce a complex pattern of mRNA localization, in which different messages distinguish groups of cells with the same birth order rank and similar developmental potentials.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Nagy, LM (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.			Lambert, J. David/0000-0002-7005-0244				Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Boyd L, 1996, DEVELOPMENT, V122, P3075; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1976, AM ZOOL, V16, P447; CLEMENT AC, 1952, J EXP ZOOL, V132, P427; Conklin Edwin G., 1902, Journal of the Academy of Natural Sciences of Philadelphia Ser 2, V12; Crampton HE, 1896, ROUXS ARCH ENTW MECH, V3, P1; Goto S, 1997, DEV GENES EVOL, V207, P194, DOI 10.1007/s004270050107; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Lambert JD, 2001, DEVELOPMENT, V128, P45; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Sweet HC, 1998, DEVELOPMENT, V125, P4033; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wilson EB, 1904, J EXP ZOOL, V1, P197, DOI 10.1002/jez.1400010202; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397; Yoshida S, 1996, DEVELOPMENT, V122, P2005	28	169	177	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					682	686		10.1038/nature01241	http://dx.doi.org/10.1038/nature01241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478296				2022-12-01	WOS:000179751800049
J	Warren, LA; Kauffman, ME				Warren, LA; Kauffman, ME			Microbial geoengineers	SCIENCE			English	Editorial Material							ACID-MINE DRAINAGE; MICROORGANISMS		McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada; Idaho Natl Engn & Environm Lab, Idaho Falls, ID 83415 USA	McMaster University; United States Department of Energy (DOE); Idaho National Laboratory	Warren, LA (corresponding author), McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada.							Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; HAACK EA, 2002, FALL AGU M SAN FRANC; HANSEL CM, 2002, FALL AGU M SAN FRANC; MORIN G, 2002, FALL AGU M SAN FRANC; Nealson KH, 1997, REV MINERAL, V35, P5; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; O'Day PA, 1999, REV GEOPHYS, V37, P249, DOI 10.1029/1998RG900003; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; 2002, FALL AGU M SAN FRANC	15	11	23	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1027	+		10.1126/science.1072076	http://dx.doi.org/10.1126/science.1072076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12586932				2022-12-01	WOS:000180960000033
J	Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT				Langenau, DM; Traver, D; Ferrando, AA; Kutok, JL; Aster, JC; Kanki, JP; Lin, S; Prochownik, E; Trede, NS; Zon, LI; Look, AT			Myc-induced T cell leukemia in transgenic zebrafish	SCIENCE			English	Article							NEOPLASTIC PHENOTYPE; C-MYC; MODELS; HEART	The zebrafish is an attractive model organism for studying cancer development because of its genetic accessibility. Here we describe the induction of clonally derived T cell acute lymphoblastic leukemia in transgenic zebrafish expressing mouse c-myc under control of the zebrafish Rag2 promoter. Visualization of leukemic cells expressing a chimeric transgene encoding Myc fused to green fluorescent protein (GFP) revealed that leukemias arose in the thymus, spread locally into gill arches and retro-orbital soft tissue, and then disseminated into skeletal muscle and abdominal organs. Leukemic cells homed back to the thymus in irradiated fish transplanted with GFP-labeled leukemic lymphoblasts. This transgenic model provides a platform for drug screens and for genetic screens aimed at identifying mutations that suppress or enhance c-myc-induced carcinogenesis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15213 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Aster, Jon C/B-6857-2009; Langenau, David/GXI-0197-2022	Langenau, David/0000-0001-6664-8318	NCI NIH HHS [CA-68484, CA-06516] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006516, P01CA068484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Beckwith LG, 2000, LAB INVEST, V80, P379, DOI 10.1038/labinvest.3780042; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Driever W, 1996, DEVELOPMENT, V123, P37; Haffter P, 1996, DEVELOPMENT, V123, P1; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Hsu K, 2001, CURR OPIN HEMATOL, V8, P245, DOI 10.1097/00062752-200107000-00011; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jessen JR, 1999, NAT GENET, V23, P15, DOI 10.1038/12609; Jessen JR, 2001, GENESIS, V29, P156, DOI 10.1002/gene.1019; LOOK AT, 1998, GENETIC BASIS HUMAN, pCH5; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; STUART GW, 1988, DEVELOPMENT, V103, P403; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; TRAVER D, UNPUB; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wu XM, 2001, TRENDS CELL BIOL, V11, pS2, DOI 10.1016/S0962-8924(01)82000-6; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606	24	407	441	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 7	2003	299	5608					887	890		10.1126/science.1080280	http://dx.doi.org/10.1126/science.1080280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12574629				2022-12-01	WOS:000180830900051
J	Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R				Keavney, B; Parish, S; Palmer, A; Clark, S; Youngman, L; Danesh, J; McKenzie, C; Delepine, M; Lathrop, M; Peto, R; Collins, R		ISIS Collaborators	Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon 2/epsilon 3/epsilon 4 genotype	LANCET			English	Article							CORONARY HEART-DISEASE; MYOCARDIAL-INFARCTION; MEN	Results from two small studies, involving a total of only 174 cases, have suggested that the increased. risk of coronary heart disease conferred by cigarette smoking Is substantially affected by genotype at the apolipoprotein E (APOE) epsilon2/epsilon3/epsilon4 polymorphism. We have established APOE genotypes in 4484 patients With acute myocardial infarction diagnosed before the age of 55 years for male and 65 years for female patients, and in 5757 controls with no history of cardiovascular disease. On average, the hazard ratio for myocardial infarction was 1.17 (95% CI 1.09-1.25; p<0.00001) per stepwise change from &epsilon;3/2 to &epsilon;3/3 to &epsilon;3/4 genotype. Among individuals in this study with known cigarette smoking status, the hazard ratio for myocardial infarction in smokers versus non-smokers was 4.6 (4.2-5.1). There was, however, no significant difference between the smoker/non-smoker hazard ratios for those with different APOE genotypes (&chi;(2)(2)=0.69; p=0.7). When differences in risk between different genotypes are not extreme (as with this APOE polymorphism), reliable assessment of hypothesised gene-environment interactions will often require the study of many thousands of disease cases.	Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England; Univ W Indies, Trop Metab Res Unit, Kingston 7, Jamaica; Ctr Natl Genotypage, Paris, France	Newcastle University - UK; University of Oxford; University of Oxford; University West Indies Mona Jamaica; CEA	Keavney, B (corresponding author), Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.			Keavney, Bernard/0000-0001-9573-0812				Humphries SE, 2001, LANCET, V358, P115, DOI 10.1016/S0140-6736(01)05330-2; Keavney B, 2000, LANCET, V355, P434; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Stengard JH, 1999, CLIN GENET, V56, P367; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	5	40	42	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 1	2003	361	9355					396	398		10.1016/S0140-6736(03)12386-0	http://dx.doi.org/10.1016/S0140-6736(03)12386-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642CP	12573381				2022-12-01	WOS:000180787000017
J	van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH				van Leeuwen, R; Vingerling, JR; Hofman, A; de Jong, PTVM; Stricker, BH			Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement	BRITISH MEDICAL JOURNAL			English	Article							MACULAR DEGENERATION		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Jong, PTVM (corresponding author), Netherlands Ophthalm Res Inst, KNAW, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.							Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x	5	60	61	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2003	326	7383					255	256		10.1136/bmj.326.7383.255	http://dx.doi.org/10.1136/bmj.326.7383.255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644FY	12560276	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000180908300019
J	Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ				Shu, DG; Morris, SC; Han, J; Zhang, ZF; Yasui, K; Janvier, P; Chen, L; Zhang, XL; Liu, JN; Li, Y; Liu, HQ			Head and backbone of the Early Cambrian vertebrate Haikouichthys	NATURE			English	Article							EVOLUTION; CHINA; PERSPECTIVES; AMPHIOXUS; HAGFISHES; INSIGHTS; LAMPREYS; ORIGIN	Agnathan fish hold a key position in vertebrate evolution, especially regarding the origin of the head and neural-crest-derived tissue(1). In contrast to amphioxus(2), lampreys and other vertebrates possess a complex brain and placodes that contribute to well-developed eyes, as well as auditory and olfactory systems(3). These sensory sytems were arguably a trigger to subsequent vertebrate diversifications. However, although they are known from skeletal impressions in younger Palaeozoic agnathans(4), information about the earliest records of these systems has been largely wanting. Here we report numerous specimens of the Lower Cambrian vertebrate Haikouichthys ercaicunensis, until now only known from the holotype(5). Haikouichthys shows significant differences from other fossil agnathans: key features include a small lobate extension to the head, with eyes and possible nasal sacs, as well as what may be otic capsules. A notochord with separate vertebral elements is also identifiable. Phylogenetic analysis indicates that this fish lies within the stem-group craniates. Although Haikouichthys somewhat resembles the ammocoete larva of modern lampreys, this is because of shared general craniate characters; adult lampreys and hagfishes (the cyclostomes if monophyletic(6,7)) are probably derived in many respects.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Div Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; CNRS, UMR 8569, Lab Paleontol, Museum Natl Hist Nat, F-75005 Paris, France; Museum Nat Hist, Dept Palaeontol, London SW7 5BD, England	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Natural History Museum London	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.			zhang, zhifei/0000-0003-0325-5116				Bardack D., 1971, BIOL LAMPREYS, V1, P67; Cohn MJ, 2002, NATURE, V416, P386, DOI 10.1038/416386a; COLE WC, 1982, AM J ANAT, V165, P131, DOI 10.1002/aja.1001650205; Farris JS, 1988, HENNIG86 VERSION 1 5; Fritzsch B, 1998, OTOLARYNG HEAD NECK, V119, P182, DOI 10.1016/S0194-5998(98)70053-1; GABBOTT SE, 1995, NATURE, V374, P800, DOI 10.1038/374800a0; Gagnier P. Y., 1993, Annales de Paleontologie, V79, P119; Gagnier Pierre-Yves, 1993, Annales de Paleontologie, V79, P19; Holland LZ, 2001, J ANAT, V199, P85, DOI 10.1046/j.1469-7580.199.parts1-2.8.x; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 1999, NATURE, V402, P21, DOI 10.1038/46909; JANVIER P., 1996, EARLY VERTEBRATES; KLEEREKOPER H, 1972, BIOL LAMPREYS, V2, P373; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Lacalli TC, 2001, PHILOS T ROY SOC B, V356, P1565, DOI 10.1098/rstb.2001.0974; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Northcutt R. Glenn, 1996, Israel Journal of Zoology, V42, P273; RAMOS TC, 1996, TREE GARDNERER VERSI; Ritchie A., 1968, Palaeontology, V11, P21; Shigetani Y, 2002, SCIENCE, V296, P1316, DOI 10.1126/science.1068310; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V411, P472, DOI 10.1038/35078069; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	29	207	228	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					526	529		10.1038/nature01264	http://dx.doi.org/10.1038/nature01264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12556891				2022-12-01	WOS:000180670600043
J	Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U				Bunge, M; Adrian, L; Kraus, A; Opel, M; Lorenz, WG; Andreesen, JR; Gorisch, H; Lechner, U			Reductive dehalogenation of chlorinated dioxins by an anaerobic bacterium	NATURE			English	Article							DIBENZO-P-DIOXINS; MICROBIAL CONSORTIUM; ESTUARINE SEDIMENTS; DECHLORINATION; TETRACHLOROETHENE; DIVERSITY; CULTURES; PCDD/F; RIVER	Polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) are among the most notorious environmental pollutants. Some congeners, particularly those with lateral chlorine substitutions at positions 2, 3, 7 and 8, are extremely toxic and carcinogenic to humans(1). One particularly promising mechanism for the detoxification of PCDDs and PCDFs is microbial reductive dechlorination. So far only a limited number of phylogenetically diverse anaerobic bacteria have been found that couple the reductive dehalogenation of chlorinated compounds-the substitution of a chlorine for a hydrogen atom-to energy conservation and growth in a process called dehalorespiration(2). Microbial dechlorination of PCDDs occurs in sediments and anaerobic mixed cultures from sediments, but the responsible organisms have not yet been identified or isolated. Here we show the presence of a Dehalococcoides species in four dioxin-dechlorinating enrichment cultures from a freshwater sediment highly contaminated with PCDDs and PCDFs. We also show that the previously described chlorobenzene-dehalorespiring bacterium Dehalococcoides sp. strain CBDB1 (ref. 3) is able to reductively dechlorinate selected dioxin congeners. Reductive dechlorination of 1, 2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD) demonstrates that environmentally significant dioxins are attacked by this bacterium.	Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany; Univ Halle Wittenberg, Inst Analyt & Umweltchem, D-06099 Halle Saale, Germany; Tech Univ Berlin, Inst Biotechnol, Fachgebiet Tech Biochem, D-13353 Berlin, Germany; GfA Gesell Arbeitsplatz & Umweltanalyt mbH, D-06896 Straach, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Technical University of Berlin	Bunge, M (corresponding author), Univ Halle Wittenberg, Inst Mikrobiol, D-06099 Halle Saale, Germany.		Adrian, Lorenz/A-4443-2012; Bunge, Michael/J-6261-2012	Adrian, Lorenz/0000-0001-8205-0842; Bunge, Michael/0000-0001-7124-2750				ADRIAENS P, 1994, CHEMOSPHERE, V29, P2253, DOI 10.1016/0045-6535(94)90392-1; ADRIAENS P, 1995, ENVIRON SCI TECHNOL, V29, P2252, DOI 10.1021/es00009a015; Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Albrecht ID, 1999, ENVIRON SCI TECHNOL, V33, P737, DOI 10.1021/es980791t; Ballerstedt H, 1997, ENVIRON SCI TECHNOL, V31, P1749, DOI 10.1021/es960737h; Barkovskii AL, 1996, APPL ENVIRON MICROB, V62, P4556, DOI 10.1128/AEM.62.12.4556-4562.1996; BEURSKENS JEM, 1995, ENVIRON TOXICOL CHEM, V14, P939, DOI 10.1002/etc.5620140603; BEURSKENS JEM, 1993, ENVIRON TOXICOL CHEM, V12, P1549, DOI 10.1002/etc.5620120905; Breitenstein A, 2001, ARCH MICROBIOL, V175, P133, DOI 10.1007/s002030000248; Brzuzy LP, 1996, ENVIRON SCI TECHNOL, V30, P1797, DOI 10.1021/es950714n; Bunge M, 2001, CHEMOSPHERE, V43, P675, DOI 10.1016/S0045-6535(00)00420-3; Cutter LA, 2001, ENVIRON MICROBIOL, V3, P699, DOI 10.1046/j.1462-2920.2001.00246.x; *DIN EN, 1997, 19483 DIN EN; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; GRIBBLE GW, 1998, ENCY ENV ANAL REMEDI, P972; Hendrickson ER, 2002, APPL ENVIRON MICROB, V68, P485, DOI 10.1128/AEM.68.2.485-495.2002; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Kaiser J, 2000, SCIENCE, V288, P1941; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; MEHARG AA, 1995, NATURE, V375, P353, DOI 10.1038/375353a0; Muller JF, 1999, CHEMOSPHERE, V39, P1707, DOI 10.1016/S0045-6535(99)00065-X; RAPPE C, 1999, ORGANOHALOGEN COMPD, V43, P111; von Wintzingerode F, 1999, APPL ENVIRON MICROB, V65, P283; Wu QZ, 2002, APPL ENVIRON MICROB, V68, P807, DOI 10.1128/AEM.68.2.807-812.2002; ZOLLER W, 1985, FRESEN Z ANAL CHEM, V321, P247, DOI 10.1007/BF00470365	28	264	280	10	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					357	360		10.1038/nature01237	http://dx.doi.org/10.1038/nature01237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12540897				2022-12-01	WOS:000180533000038
J	Levy, JA				Levy, JA			Is HIV superinfection worrisome?	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; AIDS PATIENT; INFECTION; INDIVIDUALS; COINFECTION; TYPE-1; WOMEN		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barker E, 1996, J GEN VIROL, V77, P2953, DOI 10.1099/0022-1317-77-12-2953; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; EVANS LA, 1988, LANCET, V2, P1389; FULTZ PN, 1987, J VIROL, V61, P4026, DOI 10.1128/JVI.61.12.4026-4029.1987; Goulder PJR, 2002, NEW ENGL J MED, V347, P756, DOI 10.1056/NEJMe020091; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kampinga GA, 1997, VIROLOGY, V227, P63, DOI 10.1006/viro.1996.8318; Levy JA, 2001, LANCET, V357, P223, DOI 10.1016/S0140-6736(00)03601-1; Levy JA, 1998, HIV PATHOGENESIS AID; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; RAYFIELD M, 1988, J INFECT DIS, V158, P1170, DOI 10.1093/infdis/158.6.1170; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Stranford SA, 2001, P NATL ACAD SCI USA, V98, P597, DOI 10.1073/pnas.021550598; Takehisa J, 1997, J ACQ IMMUN DEF SYND, V14, P81, DOI 10.1097/00042560-199701010-00015; 2002, REUTERS         0904	18	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					98	99		10.1016/S0140-6736(03)12242-8	http://dx.doi.org/10.1016/S0140-6736(03)12242-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531573				2022-12-01	WOS:000180428000005
J	Tuomisto, H; Ruokolainen, K; Yli-Halla, M				Tuomisto, H; Ruokolainen, K; Yli-Halla, M			Dispersal, environment, and floristic variation of western Amazonian forests	SCIENCE			English	Article							RAIN-FOREST; PATTERNS; BASIN; DIVERSITY; ECOLOGY; HISTORY	The distribution of plant species, the species compositions of different sites, and the factors that affect them in tropical rain forests are not well understood. The main hypotheses are that species composition is either (i) uniform over large areas, (ii) random but spatially autocorrelated because of dispersal limitation, or (iii) patchy and environmentally determined. Here we test these hypotheses, using a large data set from western Amazonia. The uniformity hypothesis gains no support, but the other hypotheses do. Environmental determinism explains a larger proportion of the variation in floristic differences between sites than does dispersal limitation; together, these processes explain 70 to 75% of the variation. Consequently, it is important that management planning for conservation and resource use take into account both habitat heterogeneity and biogeographic differences.	Univ Turku, Dept Biol, FIN-20014 Turku, Finland; MTT Agrifood Res Finland, FIN-31600 Jokioinen, Finland	University of Turku; Natural Resources Institute Finland (Luke)	Tuomisto, H (corresponding author), Univ Turku, Dept Biol, FIN-20014 Turku, Finland.	hantuo@utu.fi	Tuomisto, Hanna/G-6483-2012; Yli-Halla, Markku/B-5567-2015; Ruokolainen, Kalle/G-3141-2013	Tuomisto, Hanna/0000-0003-1640-490X; Ruokolainen, Kalle/0000-0002-7494-9417				BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Condit R, 1996, TRENDS ECOL EVOL, V11, P4, DOI 10.1016/0169-5347(96)81054-8; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; RASANEN M, 1992, GEOL MAG, V129, P293, DOI 10.1017/S0016756800019233; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2002, SCIENCE, V297; SANCHEZ PA, 1974, SOIL SCI SOC AM J, V38, P117, DOI 10.2136/sssaj1974.03615995003800010036x; Terborgh J, 1998, J TROP ECOL, V14, P645, DOI 10.1017/S0266467498000455; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tuomisto H, 1996, J BIOGEOGR, V23, P283, DOI 10.1046/j.1365-2699.1996.00044.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; TUOMISTO H, IN PRESS ECOL APPL; Vormisto J, 2000, ECOGRAPHY, V23, P349, DOI 10.1034/j.1600-0587.2000.d01-1644.x; Whitfield J, 2002, NATURE, V417, P480, DOI 10.1038/417480a; WHITTAKER RH, 1977, THEOR POPUL BIOL, V12, P117, DOI 10.1016/0040-5809(77)90039-9	29	722	781	9	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					241	244		10.1126/science.1078037	http://dx.doi.org/10.1126/science.1078037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522248				2022-12-01	WOS:000180284000036
J	Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y				Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y			IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice	NATURE			English	Article							INSULIN-RECEPTOR; GROWTH-HORMONE; DWARF MICE; LONGEVITY; GENE; MUTATIONS; EXTENSION; CANCER; TISSUE	Studies in invertebrates have led to the identification of a number of genes that regulate lifespan, some of which encode components of the insulin or insulin-like signalling pathways(1-3). Examples include the related tyrosine kinase receptors InR (Drosophila melanogaster) and DAF-2 (Caenorhabditis elegans) that are homologues of the mammalian insulin-like growth factor type 1 receptor (IGF-1R). To investigate whether IGF-1R also controls longevity in mammals, we inactivated the IGF-1R gene in mice (Igf1r). Here, using heterozygous knockout mice because null mutants are not viable, we report that Igf1r (+/-) mice live on average 26% longer than their wild-type littermates (P < 0.02). Female Igf1r (+/-) mice live 33% longer than wild-type females (P < 0.001), whereas the equivalent male mice show an increase in lifespan of 16%, which is not statistically significant. Long-lived Igf1r (+/-) mice do not develop dwarfism, their energy metabolism is normal, and their nutrient uptake, physical activity, fertility and reproduction are unaffected. The Igf1r (+/-) mice display greater resistance to oxidative stress, a known determinant of ageing. These results indicate that the IGF-1 receptor may be a central regulator of mammalian lifespan.	INSERM, U515, F-75571 Paris 12, France; Hop St Antoine, Serv Anat & Cytol Pathol, F-75571 Paris 12, France; INRA, F-37380 Nouzilly, France; Inst Natl Sci Appl, INSERM, U352, F-69621 Villeurbanne, France; INA PG, INRA, F-75231 Paris 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE	Holzenberger, M (corresponding author), INSERM, U515, F-75571 Paris 12, France.	holzenberger@st-antoine.inserm.fr	GELOEN, Alain/D-6725-2011; Holzenberger, Martin/N-9732-2018	Even, Patrick/0000-0001-5733-3023; Holzenberger, Martin/0000-0003-4869-725X; Ducos, Bertrand/0000-0002-5322-1339; GELOEN, Alain/0000-0001-7921-1254				Bartke A, 2001, TRENDS ENDOCRIN MET, V12, P233, DOI 10.1016/S1043-2760(01)00426-X; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hunter WS, 1999, PHYSIOL BEHAV, V67, P433, DOI 10.1016/S0031-9384(99)00098-0; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tissenbaum HA, 1998, GENETICS, V148, P703; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	30	1505	1566	3	187	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					182	187		10.1038/nature01298	http://dx.doi.org/10.1038/nature01298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483226	Green Submitted			2022-12-01	WOS:000180267200045
J	Taylor, MS; Hellberg, ME				Taylor, MS; Hellberg, ME			Genetic evidence for local retention of pelagic larvae in a Caribbean reef fish	SCIENCE			English	Article							SEXUAL SELECTION; POPULATION; CONNECTIVITY; RECRUITMENT; VARIANCE	The pelagic larvae of many marine organisms can potentially disperse across hundreds of kilometers, but whether oceanographic or behavioral mechanisms can constrain dispersal over periods sufficient for the evolution of genetic differentiation remains unclear. Here, we concurrently examine larval duration and genetic population differentiation in a cleaner goby, Elacatinus evelynae, a member of the most species-rich genus of Caribbean reef fishes. Despite evidence for extended pelagic duration (21 days), populations of E. evelynae show strong genetic differentiation: among color forms (1.36 to 3.04% divergent at mitochondrial cytochrome b) and among island populations within color forms (Phi(ST) up to 70%). These results suggest that marine populations can remain demographically closed for thousands of generations despite extended larval duration, and that recognition cues such as color may promote speciation when geographic barriers are transient or weak.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Taylor, MS (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.		Gilbert, Marcus TP/A-8936-2013; 平山, 幸恵 Ｓ/G-9307-2012	Gilbert, Marcus TP/0000-0002-5805-7195; 				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BOHLKE JE, 1968, P ACAD NAT SCI PHILA, V120, P45; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Burton R.S., 1982, ESTUARINE COMP, P537, DOI [10.1016/b978-0-12-404070-0.50038-7., DOI 10.1016/B978-0-12-404070-0.50038-7]; Colin P., 1975, COLIN; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; EXCOFFIER L, 1992, GENETICS, V131, P479; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Leis J.M., 1991, P183; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Palumbi SR, 1998, ENDLESS FORMS, P271; Riginos C, 2001, P ROY SOC B-BIOL SCI, V268, P1931, DOI 10.1098/rspb.2001.1748; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Warner RR, 1997, CORAL REEFS, V16, pS115, DOI 10.1007/s003380050247	23	433	441	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					107	109		10.1126/science.1079365	http://dx.doi.org/10.1126/science.1079365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511651				2022-12-01	WOS:000180165800044
J	Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M				Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M			Pringle's manoeuvre in living donors	LANCET			English	Article							TRANSPLANTATION	The safety of the donor is paramount in living donor liver transplantation. The most important risk to the donor during hepatectomy is bleeding, and the inflow occlusion technique (Pringle's manoeuvre) has been reported to decrease bleeding without inducing liver injury in liver surgery. However, most transplant centres are doing donor hepatectomies without this technique for fear that it would result in ischaemic injury to the graft. We have done 46 living donor hepatectomies with Pringle's manoeuvre without any negative outcome on the quality of the graft. Surgeons should not hesitate to apply this technique in living donor hepatectomy.	Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	University of Tokyo; Kyoto University	Makuuchi, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makuuchi-tky@umin.ac.jp	幕内, 雅敏 m/A-2140-2012; Sano, Keiji/ABI-6150-2020					Arai M, 2000, HEPATOLOGY, V32, P297, DOI 10.1053/jhep.2000.8896; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Strong RW, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80024-6; Surman OS, 2002, NEW ENGL J MED, V346, P1038, DOI 10.1056/NEJM200204043461402; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629	5	82	83	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2049	2050		10.1016/S0140-6736(02)11995-7	http://dx.doi.org/10.1016/S0140-6736(02)11995-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504404				2022-12-01	WOS:000179974200016
J	Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J				Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J			Risk factors for recurrence of primary sclerosing cholangitis of liver allograft	LANCET			English	Article								Primary sclerosing cholangitis (PSC) is a disease of unknown cause that effects the biliary tree and is closely associated with inflammatory bowel disease. We did a retrospective analysis of the risk factors associated with recurrence of PSC in an allograft after liver transplantation. Recurrence of disease, assessed by liver histology or imaging the biliary tree, occurred in 56 of 152 patients (37%) at a median of 36 months (range 1.4-120 months). Multivariate analysis showed that being male (relative risk 1.2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease.	Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Neuberger, J (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.	J.M.Neuberger@bham.ac.uk	Neuberger, James/ABG-3010-2020	Gunson, Bridget/0000-0001-6149-9915				Cullen S, 2001, BEST PRACT RES CL GA, V15, P577, DOI 10.1053/bega.2001.0206; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; HARRISON RF, 1994, HEPATOLOGY, V20, P356, DOI 10.1002/hep.1840200214; Sheng R, 1996, AM J ROENTGENOL, V166, P1109, DOI 10.2214/ajr.166.5.8615253; Zein C O, 2001, Semin Gastrointest Dis, V12, P103	5	138	139	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1943	1944		10.1016/S0140-6736(02)11861-7	http://dx.doi.org/10.1016/S0140-6736(02)11861-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493264				2022-12-01	WOS:000179870200016
J	Check, E				Check, E			All mutants great and small	NATURE			English	Article																			0	1	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					457	457		10.1038/420457a	http://dx.doi.org/10.1038/420457a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466811				2022-12-01	WOS:000179611600014
J	Adam, D				Adam, D			Royal Institution's director blasts scientific sexism	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-01	WOS:000179611600011
J	Adam, D				Adam, D			Field trials excluded from UK crop appraisal	NATURE			English	News Item																		Gura T, 2001, NATURE, V412, P760, DOI 10.1038/35090645; 2002, NATURE, V419, P327	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-01	WOS:000179611600010
J	Wilson, AM; Watson, JC; Lichtwark, GA				Wilson, AM; Watson, JC; Lichtwark, GA			Biomechanics: A catapult action for rapid limb protraction	NATURE			English	Article							HORSE; MUSCLE		Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; UCL, Inst Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	Lichtwark, Glen A/B-6002-2008	Lichtwark, Glen A/0000-0001-7366-3348; Wilson, Alan/0000-0001-9914-3455				Alexander RM., 1988, ELASTIC MECH ANIMAL; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; DYCE KM, 1987, TXB VET ANATOMY, P542; HERMANSON JW, 1990, ACTA ANAT, V137, P146, DOI 10.1159/000146875; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; PRATT GW, 1978, AM J VET RES, V39, P249; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; WOLEDGE R, 1985, MONOGR PHYSL SOC, V41	13	107	111	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					35	36		10.1038/421035a	http://dx.doi.org/10.1038/421035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12569935				2022-12-01	WOS:000180165500027
